Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7673353050418643,-2.7863262722595667,0.0,0.0,0.0,71/91,14.99%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;SRPRA;RPL19;RPS3;RPS21;RPL4;RPL32;RPS16;RPL5;RPL21;SSR1;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;ARL6IP1;RPS9;RPL23A;RPL17;RPL23;SEC62;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;RPL36A;RPL31;SRP14;RPS26;RPL36
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7672038782151077,-2.747766743145156,0.0,0.0,0.0,68/87,14.99%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPS3;RPS21;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;RPL23A;RPL17;RPL23;SEC61B;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;RPL36A;RPL31;SRP14;RPS26;RPL36
prerank,protein targeting to ER (GO:0045047),-0.7456439143881584,-2.720365065859681,0.0,0.0,0.0,80/99,19.95%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;SRPRA;RPL19;RPS3;RPS21;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;RPL23A;RPL17;RPL23;SEC62;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;SGTB;RPL36A;RPL31;SRP14;SPCS1;RPS26;RPL36;SRPRB;RPSA;RPL13A;ZFAND2B;RPL35;CHMP4B;CHMP4A;RPL24;RPS13
prerank,cytoplasmic translation (GO:0002181),-0.7315821330998302,-2.663875779648229,0.0,0.0,0.0,67/91,14.99%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPS3;RPS21;EIF3M;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;EIF2B3;RPL6;RPL36A;RPL31;RPS26;RPL36
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6621958404036212,-2.4811822334596605,0.0,0.0,0.0,80/110,20.91%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPS3;RPS21;RPL4;RPL32;RPS16;RPL5;PPP2R1A;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;RPL36A;SMG5;RPL31;RPS26;RPL36;RPSA;RNPS1;PABPC1;RPL13A;PNRC2;RPL35;RPL24;RPS13;EIF4A3;DHX34;HELZ2;RPL11
prerank,peptide biosynthetic process (GO:0043043),-0.5854212427282522,-2.296135788724196,0.0,0.0,0.0,70/153,14.99%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPS3;RPS21;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;ABCF1;RPL39;PCSK5;RPS17;RPL34;RPL28;RPL14;EEF1A1;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;RPL36A;RPL31;HBS1L;RPS26;RPL36
prerank,translation (GO:0006412),-0.5288727102664037,-2.159448383975624,0.0,0.0007422683890667241,0.005,100/208,23.21%,RPS24;RPS12;LARS2;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;WARS2;RPS15;RPL30;RPL19;RPS3;RPS21;EEF2K;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;ABCF1;RPL39;RPS17;RPL34;RPL28;RPL14;EEF1A1;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;GARS1;RPS10;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPS4X;DARS2;RPS5;RPL6;RPL36A;RPL31;HBS1L;RPS26;RPL36;APEH;ABCE1;RPSA;RPL13A;EEFSEC;RPL35;MRPL16;EEF2;COPS5;RPL24;RPS13;MRPL34;EEF1D;RPL11;IARS1;RSL24D1;MRPS16;CARS1;RPL22L1;MRPS2;MRPS21;MRPL13;MRPL10;RPS27A;TUFM;EEF1G
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6866196482797255,-2.105500765962911,0.0,0.0015587636170401205,0.012,22/37,15.74%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIN2B;GRIA2;GRM8;PTK2B;GRIA3;GRIK4;GRIN3A;APP;GRIN2A;GRM1;KCNB1;HOMER1;CDK5R1;GRIK3;GRIN1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.639972194800673,-2.1053981184148083,0.0,0.0013855676595912183,0.012,16/56,5.14%,NRP1;NLGN1;CNTNAP2;NRXN1;GRID2;PTPRD;IL1RAPL1;PTPRJ;TEK;CAV1;CLSTN2;CLDN5;EPHB1;IL1RAP;SYNDIG1;KDR
prerank,action potential (GO:0001508),-0.6605495905939024,-2.1043974061403126,0.0,0.0012470108936320965,0.012,18/44,15.47%,KCND2;ANK3;AKAP6;KCNJ2;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;KCNQ1;SCN3A;SCN9A;KCNB1;GPER1;GNA14;SCN8A;KCNE4;CACNA1H
prerank,regulation of synapse assembly (GO:0051963),-0.6337108911656398,-2.0576850645902733,0.0,0.002645174622855962,0.027,18/46,11.07%,NLGN1;NRXN1;GRID2;MEF2C;PTPRD;ROBO2;IL1RAPL1;CLSTN2;EPHB1;GPC6;LRFN5;IL1RAP;IL1RAPL2;SYNDIG1;APP;EPHB2;SLITRK1;GPC4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.503293755335829,-1.9928832017250682,0.0,0.009352581702240721,0.098,92/168,22.39%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPS3;RPS21;RPL4;RPL32;RPS16;RPL5;PPP2R1A;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;RPL9;RPL12;RPL7A;CNOT2;RPS25;RPS2;RPS11;RPS10;DCP1B;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;RPL36A;SMG5;TNKS1BP1;RPL31;NBAS;RPS26;RPL36;RPSA;RNPS1;PABPC1;RPL13A;PNRC2;RPL35;XRN2;ERI1;RPL24;RPS13;LSM1;EIF4A3;DHX34;HELZ2;CNOT6L;RPL11;CNOT7;EXOSC10;DCP2;CNOT11
prerank,regulation of fatty acid oxidation (GO:0046320),0.8537399487952031,1.9912933385934775,0.0,0.10025014362580838,0.086,4/16,1.81%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.698240870937259,-1.973859522028828,0.0,0.012550045532066609,0.135,9/25,6.89%,PDE4D;SPTBN1;PDE4B;RUNX1;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,neuron development (GO:0048666),-0.49729097704762226,-1.9670091220942238,0.0,0.013731965197734395,0.153,41/141,9.85%,FRY;NLGN1;CNTNAP2;TENM2;MEF2C;PTPRM;CNTN4;EPHA5;TENM3;TGFB2;PLP1;PBX3;TENM4;ATP8A2;SH3GL2;RUNX1;NTRK2;MYT1L;TMEM108;UGCG;LYN;GSK3B;GPM6B;STX3;APP;STMN2;APOE;VSX1;DCX;SRRM4;B4GALT5;LGI1;ULK1;GPRIN3;MYOC;RASGRF1;ETV1;RP1;PPT1;UHMK1;PBX1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5380976348798215,-1.9546801618242982,0.0,0.015587636170401204,0.182,31/88,14.48%,NRP1;PTPRM;TEK;CDH13;CAV1;BMPR2;THBS1;VEGFC;NRP2;SEMA5A;TIE1;PPP1R16B;CAV2;F3;ACVRL1;AKT3;KDR;APOE;ECM1;BMP2;PROX1;ATOH8;XDH;FLT4;FGF2;ITGB3;BMP4;PRKD1;HIF1A;VEGFA;SCG2
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.46988530121053673,-1.9437549120770887,0.0,0.017211348271484662,0.21,83/224,16.92%,NLGN1;DLG2;NRXN1;GRIK2;KCND2;SYT1;CACNB2;GRIA4;GRM7;GRM5;SLC12A7;CACNA1E;GRM3;SNAP25;CHRM3;GABRG3;GRIK1;HTR2C;GRIN2B;GRIA1;GABRB3;GRIA2;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;SLC1A2;GRIA3;GLRB;DLGAP1;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;GABRB2;MBP;GLRA3;PDE7B;CALM1;MINK1;PTCHD1;HTR2A;CACNA1B;GRIN2A;AMPH;SYPL1;GRM1;CHRM2;CAMK4;GLRA1;HTR1F;GABRG2;GABBR2;HTR7;CAMKK2;RPS6KA2;GABRA4;RPS6KA3;GABRG1;NRXN2;SLC12A4;HCRTR2;PRKAR2B;PRKAR1B;HOMER1;HTR4;SLC12A6;GLRA2;SNCA;RPS6KA1;HTR1B;SLC1A6;GRIN1;SLC12A5;HRH1;GABRA5;CHRFAM7A;CHRNA7;GABRE;SCN2B
prerank,regulation of interleukin-2 production (GO:0032663),-0.5965455843858936,-1.9243141455525679,0.0,0.02420668205285834,0.299,12/43,6.89%,PDE4D;SPTBN1;PDE4B;NAV3;CD34;RUNX1;HDAC7;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,positive regulation of synapse assembly (GO:0051965),-0.6686971534519958,-1.9212841983907973,0.00234192037470726,0.024882485886825626,0.318,12/27,10.13%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SEMA4D;EPHB2;AGRN
prerank,chemical synaptic transmission (GO:0007268),-0.4500586539507562,-1.9209270968362038,0.0,0.023572881366466385,0.318,83/284,12.45%,NLGN1;DLG2;NRXN1;GRID2;GRIK2;KCND2;SYT1;CACNB2;GRIA4;GRM7;GRM5;SLC12A7;CDH8;CACNA1E;GRM3;SNAP25;CHRM3;RIMS1;GABRG3;GRIK1;HTR2C;GRIN2B;GRIA1;GABRB3;GRIA2;GABRB1;LIN7A;RIT2;GABRA3;PLP1;KCNQ3;SLC1A2;GRIA3;GLRB;DLGAP1;GABRA2;PTPRN2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;SHISA6;GABRB2;MBP;GLRA3;PDE7B;DLGAP2;CALM1;MINK1;APOE;PTCHD1;HSPA8;HTR2A;CACNA1B;GRIN2A;AMPH;SYPL1;SLC1A4;GRM1;CHRM2;CAMK4;GLRA1;HTR1F;GABRG2;GRID1;GABBR2;HTR7;CAMKK2;RPS6KA2;GABRA4;ERC1;RPS6KA3;SLC17A6;GABRG1;NRXN2;SLC12A4;HCRTR2;PRKAR2B;PRKAR1B;HOMER1;HTR4;SLC12A6
prerank,dendrite self-avoidance (GO:0070593),-0.7559842111767803,-1.9178292190070232,0.002178649237472767,0.02353733061730582,0.33,7/16,8.00%,BSG;CNTN4;NPTN;DSCAML1;CNTN6;ROBO4;EMB
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8176804435843783,-1.9146519663285027,0.0,0.02380207300940628,0.348,7/12,10.88%,PDE4D;CAV1;CAMK2D;GJD3;CALM1;CALM2;CALM3
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6791045191093575,-1.904924193286891,0.0,0.026357275706314767,0.389,10/25,13.17%,NRP1;ITGA6;THBS1;AR;APP;PSEN1;BTBD10;PTH1R;ILK;SNCA
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.8077708110529275,-1.9046158615344142,0.0,0.025301670305578765,0.389,8/13,10.88%,PDE4D;SLC8A1;CAV1;ANK3;CAMK2D;CALM1;CALM2;CALM3
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8326065534491313,-1.8758713931316717,0.0,0.038622698511105204,0.538,8/11,13.85%,ADIPOR2;CD34;NDNF;KDR;GATA2;MCAM;ITGB3;VEGFA
prerank,smooth muscle cell differentiation (GO:0051145),-0.7942352374052114,-1.8749140815204168,0.0022123893805309734,0.03761816195790157,0.543,10/12,15.72%,MEF2C;MRTFB;TBX18;MRTFA;TMEM204;HEY2;BMP4;MYOCD;EDNRB;APLNR
prerank,positive regulation of nervous system development (GO:0051962),-0.5998114691099128,-1.8743734763520659,0.0,0.03645108766001512,0.547,14/42,11.09%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SERPINF1;MME;EPHB2;NAP1L1;GPER1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.6601872210166724,-1.8681485260193882,0.0,0.0382955505914795,0.582,12/24,15.07%,NRP1;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;VEGFA;SEMA4C
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4704779244360212,-1.8634147587081626,0.0,0.04000826617069643,0.613,53/159,11.23%,NLGN1;ADGRL3;CDH11;GRID2;TENM2;LRRC4C;CADM1;PTPRM;PTPRD;ROBO2;HMCN1;IL1RAPL1;CDH2;CDH8;CDH13;PECAM1;KIRREL3;BSG;CLDN5;CNTN4;GPC6;LRFN5;UNC5D;NPTN;PTPRT;TENM3;TGFB2;VCAM1;ATP2C1;CDH10;TENM4;CDH12;CLDN11;NTNG1;DSCAML1;IGSF11;CNTN6;ICAM1;CDH6;PTPRF;ITGB1;CDH7;CDH20;CDH19;ROBO4;EMB;CEACAM1;SLITRK1;PKD1;PVR;CDH1;GPC4;CLDN14
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5950085458777544,-1.8629716955822186,0.0,0.038987007249187376,0.615,17/39,8.33%,ACTN4;GCNT2;THBS1;EFNA5;CASK;ACER2;NEXMIF;NOTCH1;JAG1;SEMA3E;AJAP1;FZD4;CORO2B;ADAM15;CORO1C;MYOC;SPOCK1
prerank,negative regulation of vascular permeability (GO:0043116),-0.8052048211823924,-1.8597184683984975,0.0021231422505307855,0.03966187425579862,0.634,8/12,9.32%,SLIT2;PTPRJ;PDE3A;CLDN5;SH3GL2;RAMP2;CEACAM1;PDE2A
prerank,neuronal action potential (GO:0019228),-0.6790701082942022,-1.858405016605367,0.0,0.03898585132511097,0.637,11/22,15.47%,ANK3;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;SCN3A;SCN9A;GPER1;SCN8A;CACNA1H
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.6146236708207297,-1.8543584582996582,0.0025974025974025974,0.04062527676910814,0.659,19/34,21.03%,GRID2;MEF2C;GABRG3;GRIN2B;GABRA3;GABRA2;GSK3B;GRIN2A;GLRA1;GABRG2;GABRA4;GABRG1;GRIN1;GABRA5;INSYN2A;GABRE;ARRB2;GABRA1;DRD2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8348704726757589,1.850560468464381,0.0,1.0,0.791,4/14,1.95%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.7348978662773082,-1.84739289706117,0.002257336343115124,0.043897302669776324,0.699,11/17,10.02%,SERPINE2;TENM4;NOTCH1;HES1;TNFRSF1B;BMP2;PTPRZ1;BIN1;TGFB1;PTN;ID2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6509112691880935,1.8458443231329233,0.0,0.7536604648632779,0.814,16/50,9.25%,RORA;TULP3;FGFR2;DCDC2;FBXL17;GLI3;SUFU;TTC23;GAS1;SMO;RAB34;MGRN1;ZIC1;BTRC;IFT122;GLI1
prerank,rRNA metabolic process (GO:0016072),-0.4631312919844075,-1.8436645821727682,0.0,0.044837376984271704,0.719,66/160,18.42%,RPS24;RPL8;RPL13;RPL41;RPS6;RPLP2;RPL18A;RPL37;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;WDR3;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPL6;EMG1;RPL36A;MAPT;MDN1;RPL31;NOP53;TRIR;DDX10;RPL36;NOL11;RPL13A;TEX10;RPL35;FBL;XRN2;UTP15
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.593648195271211,-1.8413746893499017,0.0,0.04483301069963013,0.727,18/35,17.83%,NRP1;SEMA3C;SEMA6A;SEMA6D;NRP2;SEMA5A;SEMA7A;SEMA3E;FLNA;MET;SEMA4D;PLXNA4;SEMA3D;SEMA3G;SEMA4C;PLXND1;ARHGDIA;SEMA4A
prerank,limb development (GO:0060173),0.7249139275564416,1.8393514777610407,0.003430531732418525,0.6341064909923705,0.845,7/28,8.49%,SMOC1;RSPO2;LRP4;GLI3;CHD7;COMP;IFT122
prerank,positive regulation of developmental growth (GO:0048639),-0.5611756653519548,-1.8375211698495169,0.0,0.04615672266013246,0.749,16/49,15.64%,GHR;SYT1;RIMS2;RIMS1;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;PPIB;AGRN;MAPT;SMURF1;BDNF
prerank,neural crest cell migration (GO:0001755),-0.5950045246001476,-1.83695888551237,0.0,0.045162016147757,0.749,12/36,7.65%,NRP1;SEMA3C;SEMA6A;ERBB4;SEMA6D;FN1;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6077351469985435,-1.8345755318904255,0.002564102564102564,0.045340878544781055,0.755,17/33,16.27%,NLGN1;NRG3;GRID2;GRIK2;LRRC4C;GRIK1;ABR;NGF;GRIK4;CACNA1B;RELN;GRID1;LRP8;FABP5;GRIK3;BDNF;CX3CR1
prerank,axon development (GO:0061564),-0.5164737150986983,-1.822575869015315,0.0,0.05297131744744888,0.805,28/78,14.05%,CTNNA2;GRM7;MAP1B;KLF7;ANK3;ACTB;CNTN4;RTN4;DCC;SEMA5A;PAK3;PLP1;NTNG1;DSCAML1;S100A6;SHTN1;APP;NRCAM;EPHB2;GAP43;S100B;SLITRK1;PLPPR4;MARK2;MAPT;ADGRB1;CDK5R1;RTN4RL1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.7437455489106479,-1.8191714422363041,0.004291845493562232,0.05414105629852685,0.821,7/14,9.34%,GHR;PIK3R1;STAT3;LYN;SOCS2;PTK2;STAT5B
prerank,aspartate family amino acid catabolic process (GO:0009068),0.7611795881266677,1.817787625758432,0.003787878787878788,0.7344539648547088,0.92,9/19,13.59%,DDO;ALDH7A1;ASPA;PIPOX;GOT2;OGDH;DLD;AASS;GCDH
prerank,axonogenesis (GO:0007409),-0.4335676639483973,-1.8128809663882435,0.0,0.05766158095554917,0.843,72/237,10.33%,NRP1;NRXN1;NRXN3;SLIT2;CTNNA2;SPTBN1;ROBO2;RPS6KA5;SEMA3C;UNC5C;SEMA6A;LAMA1;SEMA6D;PIK3R1;MAP1B;BSG;SHANK3;KLF7;ANK3;ACTB;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;DCC;NOTCH3;EPHA5;NPTN;DAB1;EFNA5;EPHA6;NRP2;SEMA5A;SEMA7A;PAK3;CXCL12;EVL;GAB1;LAMA2;NTNG1;DSCAML1;S100A6;NOTCH1;HSP90AB1;SHTN1;SEMA3E;NTN4;CNTN6;APP;NRCAM;SEMA4D;B4GALT5;LAMA3;KIF5C;LGI1;ULK1;FEZ1;ROBO4;RELN;EMB;EPHB2;ULK2;SLC9A6;EPHA7;TNR;PTK2;S100B;SLITRK1;PLPPR4;HSP90AA1;DOK6
prerank,chloride transmembrane transport (GO:1902476),-0.559087799987212,-1.8115839214963427,0.0,0.05715466595813775,0.845,29/48,16.86%,SLC12A7;ANO4;GABRG3;ANO1;GABRB3;GABRB1;GABRA3;SLC12A2;GLRB;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;GABRG1;SLC12A4;SLC12A6;GLRA2;CLCN1;ANO5;CLCN3;ANO2;SLC12A5;GABRA5;GABRE
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.6265633635712158,-1.805681598419298,0.0024330900243309003,0.06090053201459075,0.869,11/29,12.31%,SLC4A10;GRIK2;MCTP1;SHISA6;SHISA9;APP;APOE;EPHB2;NETO1;ZDHHC2;NCDN
prerank,carnitine shuttle (GO:0006853),0.8496980640919191,1.8008260979061212,0.0,0.8007034125194016,0.96,5/11,8.33%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2
prerank,regulation of dendrite development (GO:0050773),-0.5803935333449782,-1.7967547103200006,0.0,0.06716854131609247,0.896,20/37,15.53%,CSMD3;ADGRB3;HECW2;BMP5;MARK1;HECW1;DCC;CDKL5;NEDD4L;GSK3B;DAB2IP;SEMA4D;LZTS1;PTN;RAP2A;MFSD2A;VLDLR;LRP8;COBL;PACSIN1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7814882735696032,-1.7967079908024288,0.0,0.06567590706462374,0.896,6/11,13.69%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;QDPR
prerank,regulation of T cell migration (GO:2000404),-0.7004098921458923,-1.7860132494082945,0.004246284501061571,0.07416552108322776,0.926,6/18,9.55%,LRCH1;CD200;CXCL12;APP;DOCK8;APOD
prerank,mesonephros development (GO:0001823),0.8079856289528115,1.7854921943715725,0.007677543186180422,0.8590088589739865,0.976,3/11,1.08%,FGF1;BMP7;OSR1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4797326924858587,-1.7835680363072548,0.0,0.0747322131290157,0.931,32/107,8.08%,NLGN1;NRG3;GRID2;GRIK2;MEF2C;LRRC4C;SYT1;GRM7;GRM5;RIMS2;CDH2;CLSTN2;GRM3;MCTP1;DGKI;RIMS1;GRIK1;ABR;GRM8;SLC12A2;DLGAP1;NGF;GRIK4;TMEM108;DLGAP2;APP;CACNA1B;ITGB1;CNTNAP4;LGI1;RELN;GRM1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5758110296781175,-1.7826462000524703,0.0,0.0741928182721735,0.934,10/37,3.64%,NLGN1;GRID2;TENM2;CADM1;PTPRD;HMCN1;IL1RAPL1;TENM3;VCAM1;TENM4
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.6202382833604361,-1.7814167047772813,0.002506265664160401,0.07371785486845522,0.938,9/27,7.35%,CTNNA2;IL1RAPL1;MARK1;NTNG1;CCDC88A;MBOAT1;GSK3B;DISC1;PSEN1
prerank,platelet aggregation (GO:0070527),-0.5852897527547195,-1.778756405535445,0.004878048780487805,0.07475830307324417,0.944,17/33,17.70%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;HSPB1;STXBP3
prerank,histone H3-K4 methylation (GO:0051568),0.693724775882511,1.7782328800623022,0.0035714285714285713,0.8327818363090514,0.981,14/26,21.36%,KMT2A;CXXC1;CTR9;TET2;ASH2L;KMT2C;WDR82;KMT2D;OGT;BEND3;SETD1B;TET3;SETD1A;KDM6A
prerank,mesenchymal cell differentiation (GO:0048762),0.6271469982802033,1.7761683164802196,0.0015455950540958269,0.7611224496639044,0.985,12/51,4.22%,RANBP3L;TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR2;FBXL17;FGFR1;TGFBR1;FOXC1;LOXL3
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7539206869194444,-1.77578808514381,0.004484304932735426,0.07596170933758914,0.949,7/13,13.69%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;MTHFD1L;QDPR
prerank,positive regulation of chemotaxis (GO:0050921),-0.5583595823800099,-1.774812911513163,0.0,0.07550011468176378,0.95,19/43,15.36%,NRP1;NTRK3;CDH13;TMSB4X;THBS1;SEMA5A;F3;KDR;STX3;MET;TGFB1;PTN;FGF2;P2RY12;PRKD1;EDN3;VEGFA;PPM1F;RARRES2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6691152354105261,1.7722903924935365,0.0034482758620689655,0.7245262807286579,0.989,6/32,2.18%,PRKAG2;SORBS1;PRKAA2;PPARA;AVIL;ZBTB20
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.7030677008678833,1.7717880658925245,0.0016835016835016834,0.6635267670343663,0.99,8/26,8.74%,EYA1;EYA2;FGFR1;EYA4;MAP2K5;TERT;PPP2R1B;GDNF
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6065318556527328,-1.7690681971623832,0.002183406113537118,0.07911460622335706,0.957,11/24,15.72%,PDE4D;PDE3A;PDE3B;PDE11A;PEX5L;GNAI1;PDE2A;PRKAR2B;PRKAR1B;UBE2B;APLNR
prerank,synaptic membrane adhesion (GO:0099560),-0.7289705503584347,-1.7679735257497706,0.0,0.07868869666761795,0.961,8/14,11.07%,LRRC4C;PTPRD;GPC6;LRFN5;NTNG1;PTPRF;SLITRK1;GPC4
prerank,basement membrane organization (GO:0071711),-0.7362890195821622,-1.7674934004262215,0.006109979633401222,0.07776813391196528,0.961,5/14,5.29%,FLRT2;COL4A1;NTNG1;RAMP2;NTN4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7353646361014408,1.7671531231854167,0.003527336860670194,0.5980568687699458,0.99,6/21,8.74%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7353646361014408,1.7671531231854167,0.003527336860670194,0.5980568687699458,0.99,6/21,8.74%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,regulation of osteoblast differentiation (GO:0045667),0.5823264723731306,1.7631292539744472,0.0,0.58773558544562,0.994,12/82,3.29%,RANBP3L;SMOC1;TMEM64;BMP6;BMP7;WNT4;DDX5;IGF1;FGFR2;NPNT;BMPR1A;SUFU
prerank,epithelial tube morphogenesis (GO:0060562),-0.600456990266293,-1.7621384092933732,0.0,0.08233612105722637,0.966,17/32,14.09%,SLIT2;MEF2C;COL4A1;PODXL;RYR2;ACVRL1;RASIP1;PAK1;SOX17;HES1;MET;RHOB;PKD1;BMP4;CTNNB1;MTSS1;ACVR1
prerank,adherens junction organization (GO:0034332),-0.5389185805274854,-1.7570609731770088,0.002617801047120419,0.086269817962969,0.971,18/48,12.06%,CDH11;CADM2;CADM1;CDH2;CDH8;CDH13;ACTB;CDH10;CDH12;RAMP2;CDH6;CDH7;CDH20;CDH19;SMAD7;PVR;CDH1;CTNNB1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.7913005272407733,-1.753750162275437,0.0020964360587002098,0.08832993829894016,0.976,10/10,20.93%,GABRG3;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,endoderm formation (GO:0001706),-0.5693106883749551,-1.7529170457435097,0.0024330900243309003,0.08792483588999188,0.976,19/35,22.56%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;SOX17;LAMA3;ITGA4;DUSP1;SOX7;SETD2;MMP15;ITGB2;ITGA5;INHBA;ITGA7;COL11A1;VTN;LHX1
prerank,glycerolipid catabolic process (GO:0046503),-0.6714513888336304,-1.7525164896768222,0.006802721088435374,0.08689241185211426,0.976,6/19,7.76%,ABHD2;PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1
prerank,chloride transport (GO:0006821),-0.5005877375705953,-1.7498045067092425,0.0,0.08838104530277754,0.979,34/74,16.86%,SLC4A10;SLC12A7;SLC26A7;CLIC4;ANO4;GABRG3;ANO1;GABRB3;GABRB1;GABRA3;SLC12A2;GLRB;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;CLIC5;GABRG1;SLC12A4;SLC12A6;GLRA2;CLCN1;ANO5;TTYH1;CLCN3;ANO2;SLC12A5;GABRA5;GABRE
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7257146425837174,1.7467489417465174,0.0054249547920434,0.6807925611145511,0.998,4/20,7.09%,C1QTNF3;WNT4;SIK1;GCK
prerank,cellular response to zinc ion (GO:0071294),-0.7143118878584997,-1.746415258080844,0.002188183807439825,0.09054237698119065,0.98,11/15,14.22%,GLRA1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;GLRA2;MT3
prerank,vasoconstriction (GO:0042310),-0.7667312589424411,-1.7396197167352485,0.0021141649048625794,0.09623097292922818,0.983,7/11,16.22%,SLC8A1;EDNRA;ACTA2;EDN1;EDN3;EDNRB;PIK3C2A
prerank,cellular glucan metabolic process (GO:0006073),0.8181350323077834,1.739175795034397,0.0038240917782026767,0.7053400578526992,0.999,3/11,3.04%,PRKAG2;PYGM;PHKB
prerank,maturation of 5.8S rRNA (GO:0000460),0.7527705495322492,1.7357189742861006,0.0,0.694537117261383,0.999,2/17,0.30%,NSA2;MPHOSPH6
prerank,cation transmembrane transport (GO:0098655),0.6290488195421237,1.733861003707156,0.004746835443037975,0.6716867767636417,0.999,10/44,7.24%,TRPM3;ATP1A2;TRPM6;SLC7A2;SFXN2;SLC25A20;SLC6A9;P2RX3;SLC22A5;TRPM5
prerank,regulation of membrane repolarization (GO:0060306),-0.7288481055413321,-1.733833254608388,0.0,0.10127092374457532,0.989,7/13,7.88%,CAV1;AKAP6;KCNJ2;CACNA2D1;NEDD4L;YWHAE;KCNQ1
prerank,cellular response to copper ion (GO:0071280),-0.6953427507578221,-1.7314599368317087,0.0,0.10239877915017406,0.989,10/16,14.22%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SNCA;MT3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6381434389884367,-1.7276472973291777,0.009433962264150943,0.1054920831734223,0.992,11/20,17.83%,SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C;SEMA4A
prerank,neuron cell-cell adhesion (GO:0007158),-0.7054313695456937,-1.7260100839748835,0.008869179600886918,0.10615102681614512,0.992,7/14,3.17%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6329990108797435,-1.7199639839092753,0.0,0.11267415831800792,0.997,9/23,15.36%,SLIT2;BMP5;THBS1;LYN;STK10;PTK2;MSN;CMKLR1;RARRES2
prerank,alpha-amino acid catabolic process (GO:1901606),0.6681615863736001,1.71803277157507,0.00505902192242833,0.7728533044877727,1.0,7/29,12.37%,DDO;PRODH;ACADSB;ALDH4A1;GOT2;MTRR;FAH
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.701120329490849,-1.7179072842504044,0.0,0.11360148756844085,0.998,6/15,5.14%,NTRK3;CDH13;VEGFC;CXCL12;F3;KDR
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6121760799620636,-1.7169364034588033,0.007009345794392523,0.11332953764270742,0.998,12/24,15.91%,NRP1;PTPRJ;TEK;PIK3R1;KDR;IQSEC1;MYOC;DUSP3;VEGFA;PPM1F;LIMS1;ARF6
prerank,ganglion development (GO:0061548),-0.7480943296028579,-1.7153170433830958,0.006036217303822937,0.1137092445144103,0.998,3/11,2.95%,NRP1;UNC5C;NRP2
prerank,regulation of cation channel activity (GO:2001257),-0.4783874958705031,-1.714434972019766,0.0,0.11324129017867393,0.998,39/89,14.97%,PDE4D;NLGN1;DLG2;FGF14;MEF2C;CACNB2;GRIA4;AHNAK;FGF12;ANK3;LRRC7;CAMK2D;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;KCNAB1;SHISA6;SHISA9;CALM1;MINK1;APP;CALM2;GRIN2A;ITGB1;RELN;NETO1;FGF13;FKBP1A;JPH2;CTSS;HOMER1;DAPK1;NOS1;SHANK1;CACNG8;SELENON;STAC
prerank,endothelial cell migration (GO:0043542),-0.5594463304793945,-1.7108465002283701,0.005494505494505495,0.11624533056392351,0.998,18/37,16.65%,NRP1;CDH13;NOS3;FAP;ID1;CCN3;CYP1B1;MYH9;PLEKHG5;STARD13;SOX18;EMP2;LPXN;VEGFA;SCG2;PTP4A3;NR4A1;PLXND1
prerank,regulation of dendritic spine development (GO:0060998),-0.652502725716561,-1.707140382637661,0.011933174224343675,0.12005288434302694,0.998,11/19,15.91%,NLGN1;MEF2C;PPFIA2;SHANK3;TANC2;GRIN3A;APOE;PSEN1;LLPH;SHANK1;ARF6
prerank,long-chain fatty acid transport (GO:0015909),0.6634369617151304,1.7067558972097543,0.00333889816360601,0.8410792389732265,1.0,8/30,9.90%,PRKAG2;ACSL1;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2;SPX
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7063261411232451,-1.70638240791231,0.00425531914893617,0.11783706010220842,0.998,3/14,4.07%,ABCG2;HMOX2;SLCO2B1
prerank,heme catabolic process (GO:0042167),-0.7063261411232451,-1.70638240791231,0.00425531914893617,0.11783706010220842,0.998,3/14,4.07%,ABCG2;HMOX2;SLCO2B1
prerank,positive regulation of protein secretion (GO:0050714),0.5708663914462883,1.7047718921697848,0.0030534351145038168,0.8195669393135319,1.0,17/69,9.40%,NNAT;BMP6;C1QTNF3;FRMD4A;WLS;IGF1;NLGN2;MCU;MYO18A;EZR;TLR4;PTPN23;GCK;RBP4;TCF7L2;DNM1L;GOLPH3L
prerank,positive regulation of vasoconstriction (GO:0045907),-0.7181532280390158,-1.7035506006805228,0.008791208791208791,0.11966716010644804,0.999,2/13,2.27%,CAV1;ADRA1B
prerank,cellular response to sterol (GO:0036315),0.7697885254097601,1.7034980448475439,0.01981981981981982,0.7945244172003058,1.0,5/13,7.21%,RORA;GRAMD1B;INSIG2;SMO;RORC
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.6190454209583857,-1.695625686117144,0.014742014742014743,0.12895105170368656,0.999,9/23,15.94%,SLC12A7;SLC12A2;ATP6V0A4;SLC9A7;SLC12A8;SLC12A4;SLC12A6;CLCN3;SLC12A5
prerank,regulation of glucose import (GO:0046324),0.6593356915147057,1.6917851941096236,0.0017006802721088435,0.8738562540620276,1.0,8/30,6.64%,PRKAG2;APPL2;OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6642873159391824,-1.6907750579711436,0.013856812933025405,0.13480345609643168,0.999,6/16,6.50%,KCNC2;NOS3;NDNF;GUCY1B1;GUCY1A1;APOE
prerank,negative regulation of axon extension (GO:0030517),-0.5683320082521732,-1.6901268459755352,0.007633587786259542,0.133988722581407,0.999,13/30,15.07%,SEMA3C;SEMA6A;SEMA6D;RTN4;SEMA5A;SEMA7A;SEMA3E;SEMA4D;DIP2B;SEMA3D;SEMA3G;MT3;SEMA4C
prerank,cellular response to glucose starvation (GO:0042149),0.6176630084639562,1.6898566958983656,0.0032948929159802307,0.8560599845457885,1.0,14/41,11.60%,PRKAG2;PRKAA2;MTMR3;CPEB4;PRKAG3;SESN1;SESN2;NUAK2;SIK1;TP53;PICK1;BRSK1;BECN1;IMPACT
prerank,regulation of gluconeogenesis (GO:0006111),0.6737973107743047,1.6889093604703753,0.006633499170812604,0.8313559483438883,1.0,15/27,25.01%,C1QTNF3;PPARGC1A;SIK1;GCK;SIRT1;USP7;OGT;CLK2;CRY1;GNMT;SELENOS;EP300;PDK2;ARPP19;DGKQ
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.7213851851587297,-1.6797503093455395,0.010141987829614604,0.14735768646356234,0.999,6/11,15.68%,CACNB2;CAMK2D;CACNA2D1;BIN1;NOS1;SESTD1
prerank,thyroid hormone generation (GO:0006590),0.796084630737904,1.6790333492258045,0.0038910505836575876,0.8903470560105401,1.0,2/10,1.24%,CPQ;SLC5A5
prerank,positive regulation of tissue remodeling (GO:0034105),0.8278800228017489,1.6785215763360875,0.009765625,0.8626342815410265,1.0,4/10,8.66%,ROCK2;IL18;IL12B;HRG
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.497960540815155,-1.6776030177368113,0.002967359050445104,0.14903300923895785,0.999,19/54,9.39%,KCNIP4;DPP10;CAV1;AKAP6;KCNJ3;DPP6;KCNMA1;KCNJ2;KCNN2;KCNIP1;KCNAB1;KCNMB2;NEDD4L;GNG2;YWHAE;FLNA;KCNQ1;BIN1;GABBR2
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4833556013285889,-1.6775384056306044,0.0,0.14736263271134312,0.999,21/64,8.80%,UTRN;LIMCH1;CDH13;THBS1;EFNA5;PEAK1;CASK;ACER2;NEXMIF;PTK2B;ACTG1;JAG1;SEMA3E;GSK3B;GPM6B;AJAP1;MINK1;ADAM15;CORO1C;MYOC;PTK2
prerank,axon guidance (GO:0007411),-0.4133154916832707,-1.6773730514640917,0.0,0.1458928518710646,0.999,60/201,9.60%,NRP1;NRXN1;NRXN3;SLIT2;SPTBN1;PTPRM;ROBO2;RPS6KA5;SEMA3C;UNC5C;SEMA6A;LAMA1;SEMA6D;PIK3R1;BSG;SHANK3;KLF7;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;DCC;NOTCH3;EPHA5;NPTN;DAB1;EFNA5;EPHA6;NRP2;SEMA5A;SEMA7A;CXCL12;TMEFF1;EVL;GAB1;CHN1;LAMA2;DSCAML1;NOTCH1;NTN1;SEMA3E;NTN4;CNTN6;SEMA4D;LAMA3;KIF5C;LGI1;FEZ1;ROBO4;RELN;EMB;EPHB2;PLXNA4;PLXNC1;EPHA7;TNR;PTK2;GAP43;RHOH
prerank,lipid phosphorylation (GO:0046834),-0.7537327259742275,-1.6749142470413123,0.010460251046025104,0.1479419492533529,0.999,6/10,12.72%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,positive regulation of behavior (GO:0048520),-0.7586662578391642,-1.6723025269040035,0.004123711340206186,0.150342146691575,0.999,4/10,7.83%,NLGN1;MEF2C;SGIP1;STRA6
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7437923966736557,1.6720474739151747,0.015625,0.8889031459081734,1.0,3/15,5.07%,OSBPL8;PPARA;OSBPL11
prerank,lipid modification (GO:0030258),-0.5338464022170446,-1.6690917303608865,0.002680965147453083,0.15379801021462522,0.999,11/37,12.72%,DGKH;DGKB;DGKI;PLPP1;MBOAT1;PLPPR1;PLPPR5;PLPPR4;DGKK;DGKG;DGKZ
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6229008399032736,-1.6671587544672175,0.011682242990654205,0.15519145041773685,1.0,11/22,16.71%,NTRK3;SH3GL2;NGF;NTRK2;TMEM108;RAP1A;STMN2;MAPT;BDNF;WASF1;ACAP2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7011390745255699,-1.6668417612885678,0.006382978723404255,0.15398482832603075,1.0,4/13,5.68%,SLC4A10;GRIK2;SHISA6;SHISA9
prerank,ribosome biogenesis (GO:0042254),-0.41899157846484897,-1.6654987044144933,0.0,0.15420213411533934,1.0,70/187,18.78%,RPS24;RPL8;RPL13;RPL41;RPS6;RPLP2;RPL18A;RPL37;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;XPO1;RPS17;RPL34;RPL28;RPL14;WDR3;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPL6;EMG1;RPL36A;MALSU1;MDN1;RPL31;NOP53;LTV1;DDX10;RPL36;ABCE1;NOL11;RPL13A;TEX10;RPL35;FBL;XRN2;RBIS;UTP15;RAN
prerank,regulation of presynapse assembly (GO:1905606),-0.6463329415241471,-1.6640512150313949,0.011185682326621925,0.15302992379463445,1.0,9/18,13.17%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,regulation of presynapse organization (GO:0099174),-0.6463329415241471,-1.6640512150313949,0.011185682326621925,0.15302992379463445,1.0,9/18,13.17%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,bicarbonate transport (GO:0015701),-0.5879523383387605,-1.6640318784320496,0.009195402298850575,0.1514067886085565,1.0,4/25,6.82%,SLC4A10;SLC26A7;CA4;CA2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6365712881875729,-1.6618742462633385,0.015384615384615385,0.15317892679225467,1.0,6/18,12.92%,SLIT2;MTUS1;PTK2B;LYN;PTN;EDN3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.4699209672597193,-1.6617760665109225,0.0,0.15165402657294197,1.0,28/75,15.72%,NRP1;TEK;CDH13;BMPR2;VEGFC;NRP2;SEMA5A;PPP1R16B;F3;AKT3;KDR;ECM1;ITGA4;GATA2;BMP2;PROX1;AGTR1;FLT4;JCAD;FGF2;ITGB3;BMP4;PRKD1;HIF1A;VEGFA;SCG2;NR4A1;APLNR
prerank,substantia nigra development (GO:0021762),-0.5432063002068432,-1.661450144969114,0.005025125628140704,0.15043151379171216,1.0,18/37,21.21%,ACTB;PLP1;GNB4;YWHAE;MBP;CALM1;CALM2;BASP1;DYNLL1;HSPA5;GLUD1;CALM3;SUDS3;FGF9;NDRG2;YWHAQ;SIRT2;PADI2
prerank,fatty acid transmembrane transport (GO:1902001),0.7017461074369329,1.6552385947161652,0.012433392539964476,1.0,1.0,6/19,8.33%,PRKAG2;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.7576284048276756,1.6523008806057509,0.009416195856873822,1.0,1.0,9/13,18.82%,ADHFE1;GPT2;GOT2;OGDH;IDH1;D2HGDH;GOT1;IDH2;PHYH
prerank,negative regulation of cell adhesion (GO:0007162),-0.47161733365502234,-1.646052138723428,0.012738853503184714,0.1745600988044792,1.0,30/72,13.15%,SEMA6A;CDH13;GCNT2;PODXL;PDE3B;SEMA5A;ACER2;NEXMIF;ACVRL1;NOTCH1;JAG1;CYP1B1;FZD4;PTPRC;CORO2B;SEMA4D;TGFBI;EPHB2;ARHGDIB;PLXNA4;SPOCK1;PLXNC1;TGFB1;PTK2;ADAM22;DUSP1;CDH1;RASA1;LPXN;DMTN
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.6282377176782227,1.6460157074408843,0.015384615384615385,1.0,1.0,4/31,4.75%,RANBP3L;TMEM64;SUFU;SMAD6
prerank,negative regulation of viral life cycle (GO:1903901),-0.6677893248038254,-1.6456833455882003,0.017660044150110375,0.17336208418359814,1.0,5/15,11.76%,GSN;LY6E;MID2;PPIA;IFITM3
prerank,histone H3-K4 trimethylation (GO:0080182),0.7610193700591023,1.6378378652766903,0.020876826722338204,1.0,1.0,10/11,19.83%,KMT2A;CTR9;TET2;WDR82;KMT2D;OGT;BEND3;SETD1B;TET3;SETD1A
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5544006047275711,-1.6376463831031989,0.010256410256410256,0.18569755655930487,1.0,14/32,8.13%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;APP;GRIN2A;RELN;EPHB2
prerank,metal ion homeostasis (GO:0055065),-0.5307691904728279,-1.6366045820480224,0.0110803324099723,0.18588775721075784,1.0,15/40,15.94%,SLC8A1;TMTC2;SLC12A7;CAV1;ANK3;SLC12A2;SLC12A8;JPH2;SLC12A4;SLC12A6;SNCA;MT3;SELENON;GRIN1;SLC12A5
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5286512513626119,-1.636382555557057,0.0024330900243309003,0.1844279725111826,1.0,11/35,7.41%,NLGN1;CDH11;CDH8;CDH13;ATP2C1;CDH10;CDH12;CDH6;CDH7;CDH20;CDH19
prerank,endothelial cell differentiation (GO:0045446),-0.6959767099845844,-1.6363268214052296,0.01284796573875803,0.18273192310608888,1.0,7/12,11.98%,BMPR2;TIE1;ACVRL1;JAG1;KDR;PROX1;SOX18
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6533122009518382,1.6361091954014944,0.02512562814070352,1.0,1.0,7/26,5.31%,CACNA1D;ACTN2;ATP1B3;ANK2;DLG1;NEDD4;KCNS1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6880949173134532,-1.6359216596495008,0.0064516129032258064,0.18164388453844874,1.0,7/13,13.85%,NRP1;COL4A1;ENG;SEMA3E;KDR;CTNNB1;VEGFA
prerank,nuclear migration (GO:0007097),0.7338778345397265,1.6350114350615086,0.038817005545286505,1.0,1.0,5/13,9.70%,SYNE2;SYNE3;CLMN;FBXW11;DOCK7
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7412991017986662,1.6347526563245667,0.030476190476190476,1.0,1.0,4/13,3.48%,DAB2;BMP6;BMPR1A;TGFBR1
prerank,cellular response to purine-containing compound (GO:0071415),-0.7347517698819748,-1.6334624574567116,0.01443298969072165,0.18449366298095374,1.0,7/10,21.47%,SLC8A1;RYR2;RYR3;P2RY1;TRPM2;CASQ2;GSTM2
prerank,extracellular matrix assembly (GO:0085029),-0.5864975574165661,-1.6333261144875035,0.009070294784580499,0.18301369400829148,1.0,9/23,11.60%,GAS6;NTNG1;RAMP2;NTN4;GPM6B;TGFB1;MYH11;TNXB;MFAP4
prerank,energy reserve metabolic process (GO:0006112),0.6836559961393156,1.6326504544026672,0.026737967914438502,1.0,1.0,4/19,3.04%,PRKAG2;LEPR;PYGM;PHKB
prerank,detection of calcium ion (GO:0005513),-0.6769013474658502,-1.6323031191514692,0.014925373134328358,0.18302237714793715,1.0,6/13,10.88%,SYT1;RYR2;KCNMB2;CALM1;CALM2;CALM3
prerank,regulation of small molecule metabolic process (GO:0062012),0.6336621420470039,1.6308378463831998,0.020942408376963352,1.0,1.0,9/28,12.14%,RORA;PPARA;PRKN;NCOR2;RORC;SIRT1;MLYCD;ARV1;TTC39B
prerank,dendritic spine morphogenesis (GO:0060997),-0.6694587921165496,-1.6302055078798645,0.01293103448275862,0.18516752101237965,1.0,8/15,13.66%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;DIP2A;SHANK1
prerank,regulation of dendrite extension (GO:1903859),-0.6276635659871412,-1.6298805143698725,0.02188183807439825,0.18395335080600633,1.0,4/18,4.77%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.6330038747901825,-1.6296647100261472,0.023404255319148935,0.18269472289504482,1.0,9/18,12.08%,DAAM2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;OPALIN
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.7287907840273591,1.6294643934643656,0.03505535055350553,1.0,1.0,5/15,11.22%,MOXD1;SMOX;SAT1;PAOX;ASMT
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5600298938570615,-1.6277419371917337,0.007936507936507936,0.1844631417353054,1.0,16/32,13.15%,THBS1;CLASP2;CASK;ACER2;NEXMIF;ACVRL1;JAG1;SEMA3E;AJAP1;ADAM15;CORO1C;MYOC;APOD;FAM107A;RASA1;DMTN
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6766185751548791,1.625156395196364,0.020761245674740483,1.0,1.0,4/21,1.93%,CACNA1D;ANK2;KCNA5;SNTA1
prerank,sodium ion export across plasma membrane (GO:0036376),0.7465874964225306,1.6251556151828668,0.02702702702702703,0.9955666569053278,1.0,3/13,6.27%,ATP1A2;ATP1B3;ATP4A
prerank,intracellular lipid transport (GO:0032365),0.6664314195995431,1.623636144146678,0.020942408376963352,0.9854092971601481,1.0,7/21,11.42%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2;PLEKHA8;ARV1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7219657163797855,1.6228159189587072,0.03682170542635659,0.9685748966676576,1.0,3/14,3.27%,AUTS2;KMT2A;CTR9
prerank,endocardial cushion development (GO:0003197),-0.6073864867258311,-1.622352583327423,0.013157894736842105,0.19201346417713439,1.0,10/21,14.09%,BMPR2;ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6949551975806384,1.6219524529970657,0.026168224299065422,0.9535646987283937,1.0,3/17,1.14%,ATP1A2;BMP7;TFPI
prerank,myelination (GO:0042552),-0.5084798915722438,-1.6213593432721287,0.008264462809917356,0.1922382344134182,1.0,26/46,24.11%,ADGRG6;ACER3;MAL;PLP1;EPB41L3;NFASC;SCN2A;MBP;B4GALT5;MYOC;PLLP;MARVELD1;TNFRSF21;ABCD2;SCN8A;GAL3ST1;MAL2;CMTM8;MALL;TPPP;SIRT2;LGI4;MPZ;SOX10;CXCR4;B4GALT6
prerank,acylglycerol metabolic process (GO:0006639),-0.5305400530331356,-1.6203573953286603,0.00997506234413965,0.19237626020567716,1.0,11/37,13.87%,DGKH;DGKB;ABHD2;CAV1;DGKI;MGLL;APOE;DGKK;DGKG;DGKZ;PNPLA3
prerank,positive regulation of axon extension (GO:0045773),-0.5711246591880114,-1.6177258896895783,0.02102803738317757,0.19546531134614795,1.0,6/22,5.07%,NRP1;SEMA5A;SEMA7A;CDKL5;NTN1;SHTN1
prerank,response to copper ion (GO:0046688),-0.5988146769184299,-1.617699115647039,0.02040816326530612,0.19381079454073338,1.0,10/20,14.22%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SNCA;MT3
prerank,synaptic vesicle cycle (GO:0099504),-0.5462291055688804,-1.6169666003989636,0.007317073170731708,0.19351064880277954,1.0,8/30,14.20%,NLGN1;SNAP25;RIMS1;PCLO;SYNDIG1;SLC17A6;SNCA;SYT7
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6744168570035687,-1.6158691763886077,0.021834061135371178,0.19386400837113793,1.0,8/13,20.88%,CDH13;CD9;LDLR;SREBF2;ITGB1;SYK;ITGB2;CD81
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5447774176846917,-1.6153663337402202,0.0024154589371980675,0.19294323212277967,1.0,14/30,7.25%,PECAM1;ACTB;CLDN5;ESAM;SLC12A2;F11R;ACTG1;LAMA2;SLC1A1;LSR;MBP;OCLN;JAM2;ITGB1
prerank,positive regulation of dendrite extension (GO:1903861),-0.6343350340080561,-1.6141436578333024,0.021321961620469083,0.19349627017577026,1.0,4/17,4.77%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7022066963729252,-1.613529488004277,0.006109979633401222,0.192801739832118,1.0,3/11,4.23%,MECOM;CD34;RUNX1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6893933418146714,1.6123061563648624,0.04380952380952381,1.0,1.0,5/16,10.51%,RORA;PRKN;RORC;SIRT1;MLYCD
prerank,regulation of macrophage migration (GO:1905521),-0.7375445248910215,-1.6122633538465658,0.01948051948051948,0.19344986486957969,1.0,6/10,20.88%,MTUS1;CD200;PTK2B;P2RY12;CX3CR1;CD81
prerank,membrane repolarization (GO:0086009),0.7130788161842327,1.611269202126167,0.0456140350877193,1.0,1.0,3/15,1.35%,ATP1A2;ATP1B3;KCND3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.76282176379794,1.6110610110220527,0.022058823529411766,0.9817023878865833,1.0,2/11,0.35%,DAB2;WNT5B
prerank,negative regulation of gluconeogenesis (GO:0045721),0.7679687115281625,1.6106641582785135,0.0150093808630394,0.9642113070359974,1.0,3/11,7.09%,C1QTNF3;SIK1;GCK
prerank,neurotransmitter secretion (GO:0007269),-0.5109907589885794,-1.610052633193112,0.015873015873015872,0.19605498455416642,1.0,10/44,6.74%,NRXN1;SYT1;RIMS2;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,carboxylic acid transport (GO:0046942),0.5657541198355505,1.6095595485863559,0.010903426791277258,0.9532280040148164,1.0,7/55,1.83%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.7363631435025106,1.6079582004028061,0.02524271844660194,0.9462683955200882,1.0,6/13,12.34%,SORBS1;PRKCZ;ECHDC3;GKAP1;SIRT1;PTPN11
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5262694639200808,-1.607291735305381,0.007211538461538462,0.19921759398268857,1.0,12/36,10.14%,SLIT2;MEF2C;PTPRM;THBS1;DCN;ACVRL1;NOTCH1;DAB2IP;APOE;TGFB1;FGF2;ATP2B4
prerank,positive regulation of locomotion (GO:0040017),-0.5563136407549082,-1.6057849304388438,0.01405152224824356,0.20034302703742538,1.0,10/27,15.36%,SPOCK2;THBS1;CAVIN1;NTN1;STX3;TGFB1;P2RY12;TWIST1;PPM1F;RARRES2
prerank,modified amino acid transport (GO:0072337),0.7116345965013904,1.60572377478242,0.020793950850661626,0.946731210726445,1.0,5/15,8.79%,SLC6A13;SLC16A12;PDPN;SLC19A1;CTNS
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6465293518479154,1.6046332425701884,0.024096385542168676,0.9368321531405498,1.0,9/26,14.91%,LGR4;APPL2;TLR3;GPS2;FLOT2;IRF1;LRRC14;TLR5;BIRC3
prerank,negative regulation of TOR signaling (GO:0032007),0.6014463269947613,1.6041721910310183,0.01765650080256822,0.9229339678948815,1.0,18/36,17.22%,RNF152;PRKAA2;FNIP1;NPRL3;SESN1;DEPTOR;SESN2;ATM;NPRL2;UBR2;SIRT1;FLCN;KPTN;DEPDC5;TSC1;TMEM127;UBR1;TBC1D7
prerank,positive regulation of cell projection organization (GO:0031346),-0.4174190137559815,-1.6016274965419608,0.010752688172043012,0.20644681014377234,1.0,37/115,9.84%,SLIT2;PTPRD;ROBO2;IL1RAPL1;NTRK3;ITGA6;ROR1;LRRC7;NPTN;GRIP1;TENM3;RIT2;PTK2B;TOX;FUT9;NDNF;CARMIL1;SERPINI1;CDKL5;NGF;NTRK2;LYN;DAB2IP;TIAM1;FZD4;RAP1A;STMN2;APOE;ROR2;RELN;PLXNA4;PLXNC1;SCARF1;MAP6;PTN;SLITRK1;PLPPR5
prerank,cellular response to drug (GO:0035690),-0.5726231083406312,-1.6010406931632617,0.015189873417721518,0.2059794779660159,1.0,10/25,14.41%,MEF2C;PDE4B;ACER2;GAS6;TFRC;KCNQ1;RAP2A;AIM2;HTR1B;PPM1F
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6560109675614054,-1.6008202015593402,0.023206751054852322,0.20480762905256805,1.0,7/14,19.27%,DAB2IP;HSPA5;DDRGK1;BFAR;BCL2L11;COPS5;PTPN1
prerank,detection of visible light (GO:0009584),0.6955856530837136,1.599035434397251,0.03333333333333333,0.9454255164212984,1.0,4/16,5.90%,ABCA4;CEP250;GNAT2;RHO
prerank,cyclooxygenase pathway (GO:0019371),0.7756879672939493,1.5990157224275467,0.040515653775322284,0.9279717088411983,1.0,2/10,1.02%,PTGDS;PTGS1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.703872361691196,-1.5979143040269366,0.018442622950819672,0.20821672128243734,1.0,7/10,15.72%,PDE4D;PDE3A;PDE3B;PDE11A;PDE2A;UBE2B;APLNR
prerank,vascular transport (GO:0010232),0.5256422362304084,1.5978273958656555,0.01694915254237288,0.920620162726466,1.0,19/81,8.24%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC22A5;SLC19A1;SLC1A3;SLC27A1;SLC38A1;LRP1
prerank,glycogen metabolic process (GO:0005977),0.6164541653706732,1.597056562492317,0.018092105263157895,0.9102636567466128,1.0,4/27,5.38%,PRKAG2;PYGM;PHKB;GYS1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.7043088714967568,1.5959736920089733,0.020676691729323307,0.9028147834753434,1.0,4/16,7.86%,AUTS2;KMT2A;CTR9;BCOR
prerank,regulation of exocytosis (GO:0017157),-0.49964520785017713,-1.5945893462639444,0.008241758241758242,0.21322436268441836,1.0,10/46,6.44%,STXBP6;SYT1;IL1RAPL1;RIMS2;CADPS;STXBP5L;CLASP2;RAB3C;ANXA1;RAB27A
prerank,triglyceride homeostasis (GO:0070328),0.6337593268472632,1.59431783927623,0.0288135593220339,0.8996502259663899,1.0,7/26,12.74%,RORA;C1QTNF3;IL18;ANGPTL8;SIRT1;PLA2G12B;MLXIPL
prerank,cGMP-mediated signaling (GO:0019934),-0.6617254090672973,-1.593451675416645,0.01910828025477707,0.21371048872598777,1.0,6/13,9.32%,PDE3A;KCNC2;HTR2C;GUCY1B1;APOE;PDE2A
prerank,neural crest cell development (GO:0014032),-0.49941671658197145,-1.5928177957524323,0.0056657223796034,0.21316588252978172,1.0,17/44,18.20%,SEMA3C;SEMA6A;ERBB4;SEMA6D;CDH2;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C;SEMA3D;SEMA3G;SEMA4C;KLHL12;SEMA4A;SOX8
prerank,protein ADP-ribosylation (GO:0006471),0.6303436183618711,1.5920132867849424,0.03146853146853147,0.9014264601193102,1.0,16/28,13.51%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;PARP12;SIRT3;PARP9;ZC3HAV1;SIRT1;PARP11;PARP6;SIRT4;ART4
prerank,transport across blood-brain barrier (GO:0150104),0.5209196613660765,1.588779816528844,0.016736401673640166,0.9111732309808506,1.0,19/83,8.24%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC22A5;SLC19A1;SLC1A3;SLC27A1;SLC38A1;LRP1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5751050279876042,-1.5885448266501423,0.018518518518518517,0.21969119948041213,1.0,14/24,21.60%,PDE4D;AKAP6;CAMK2D;CALM1;CALM2;FKBP1A;CALM3;JPH2;NOS1;SELENON;CASQ2;DMD;GSTM2;JPH3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4714360009598404,-1.5882221132847216,0.0,0.21877384098808708,1.0,32/63,16.86%,SLC12A7;ANO4;GABRG3;ANO1;GABRB3;SLC26A2;GABRB1;GABRA3;SLC12A2;GLRB;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;SLC5A6;XPR1;GLRA1;GABRG2;SLC12A8;GABRA4;GABRG1;SLC12A4;SLC12A6;GLRA2;CLCN1;ANO5;CLCN3;ANO2;SLC12A5;GABRA5;GABRE
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6886933764699174,1.5875468996607518,0.05555555555555555,0.9062402367523539,1.0,12/15,25.07%,SPHK1;SIRT3;SAMD8;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A;ORMDL3;ORMDL1;PRKCD
prerank,regulation of MAP kinase activity (GO:0043405),0.5041688126752039,1.5875070138224816,0.002898550724637681,0.8917333477169463,1.0,14/92,6.83%,FGF1;ROBO1;BMP7;TPD52L1;KSR1;KIT;CD300A;PPEF2;FGFR1;LRRK2;ADRA2A;PDGFRB;TRIB2;FLT1
prerank,diacylglycerol metabolic process (GO:0046339),-0.5619676346435422,-1.5867634567390407,0.018223234624145785,0.22001832128878238,1.0,8/23,13.20%,DGKH;DGKB;PLCE1;DGKI;DGKK;DGKG;DGKZ;LIPE
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6156777901727088,1.5863401330758506,0.034420289855072464,0.8863231221779361,1.0,13/26,19.83%,KMT2A;CTR9;KMT5C;TET2;KMT5B;WDR82;KMT2D;OGT;BEND3;SETD1B;TET3;SETD3;SETD1A
prerank,response to ethanol (GO:0045471),-0.6458584413510562,-1.5861531539760882,0.03455723542116631,0.2195508932603374,1.0,8/14,15.74%,GRIN2B;ADCY7;GRIN3A;GRIN2A;GLRA1;GLRA2;SDF4;GRIN1
prerank,linoleic acid metabolic process (GO:0043651),0.6749583348808481,1.5845563976848518,0.02197802197802198,0.8852032933900833,1.0,2/17,2.37%,ACSL1;ALOX12
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6217000869978133,-1.5839360745629012,0.02586206896551724,0.2218793034882893,1.0,10/18,10.73%,GRID2;GRIK2;CDH8;GRIK1;GRIA2;UNC13B;GRIK4;SLC1A4;GRID1;SLC17A6
prerank,dendritic spine organization (GO:0097061),-0.5586038717757817,-1.5835261543806989,0.022113022113022112,0.22092724627693697,1.0,9/26,13.66%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;MTMR2;DIP2A;SHANK1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6099288122138424,1.5820697333570592,0.03163444639718805,0.8897331268262746,1.0,7/28,9.64%,PRKAG2;PRKAA2;AVIL;MITF;SIRT5;CTNS;SIRT1
prerank,response to sterol (GO:0036314),0.7346417356919773,1.5818910432085664,0.04693877551020408,0.8776975284167752,1.0,4/11,7.47%,RORA;TGFBR1;RORC;TGFBR2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.645220140503425,-1.5813639572811082,0.028985507246376812,0.22357339028947426,1.0,5/15,9.24%,TGFB2;TGFB3;TGFB1;SMAD7;IRAK3
prerank,bone development (GO:0060348),0.5873206271233631,1.5804887761926898,0.016611295681063124,0.8750424071068241,1.0,8/39,6.65%,RANBP3L;DYM;FGFR2;AKAP13;SULF2;CYP26B1;SH3PXD2B;TP53
prerank,regulation of neuron projection development (GO:0010975),-0.4046796565264079,-1.5791920588129833,0.0,0.22611417552699495,1.0,56/163,14.50%,CSMD3;CTNNA2;LRRC4C;IL1RAPL1;PPFIA2;NTRK3;MARK1;CDH2;ITGA6;SHANK3;ROR1;DCC;LRRC7;NPTN;TANC2;TENM3;RIT2;PAK3;CHN1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NTNG1;CCDC88A;MBOAT1;NTRK2;LYN;GSK3B;DAB2IP;RAP1A;PAK1;STMN2;APOE;DISC1;PRAG1;ROR2;PSEN1;RELN;SPOCK1;SCARF1;TRPV4;PTN;PLPPR5;MFSD2A;MARK2;ABI3;PRKD1;CFL1;RET;CDK5R1;RTN4RL1;MT3;FES
prerank,regulation of cardiac conduction (GO:1903779),0.5539828325697149,1.5781973906755027,0.02365930599369085,0.8794359401280581,1.0,11/54,6.25%,ATP1A2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;NPR2;AHCYL1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7012948043957331,-1.576564073900483,0.02880658436213992,0.22955392200277508,1.0,3/10,4.22%,CAV1;ANK3;KCNAB1
prerank,positive chemotaxis (GO:0050918),-0.6232685260341422,-1.5762252231810268,0.024608501118568233,0.228648143995521,1.0,8/17,17.19%,NRP1;PTPRJ;SEMA5A;MET;VEGFA;FGF7;SCG2;SCRIB
prerank,sphingolipid metabolic process (GO:0006665),-0.423511794513865,-1.5733015225993336,0.0,0.2328192756456075,1.0,30/108,12.83%,ST6GALNAC3;ELOVL7;CERT1;SGMS1;ESYT2;SGMS2;ELOVL5;ACER3;ACER2;PRKD3;PPM1L;PLPP1;UGCG;SPTLC2;DEGS2;SPNS2;PSAP;PPP2R1A;GLTP;HEXB;B3GALNT1;PPT1;CERS4;ESYT3;ENPP2;SERINC1;ELOVL6;ASAH2;GAL3ST1;PRKD1
prerank,histone H3-K36 demethylation (GO:0070544),0.7392526049982842,1.5705180944247958,0.053231939163498096,0.9227188539663191,1.0,4/10,12.26%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,epithelial cell development (GO:0002064),0.6566259631519842,1.5704380314890165,0.047957371225577264,0.9101628504302068,1.0,5/20,8.78%,WNT5B;PKHD1;RILPL1;DACT2;LRTOMT
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.4813773269796652,-1.5704332487620454,0.00804289544235925,0.2372736170628297,1.0,15/46,12.77%,NRP1;TMEFF2;TEK;PIK3R1;PARVB;FN1;PEAK1;LAMC3;NTNG1;NTN4;ITGA4;ITGB3;ITGA8;ILK;LPXN
prerank,cellular response to arsenic-containing substance (GO:0071243),0.6962482614561605,1.5701198995392462,0.036231884057971016,0.8998385994450551,1.0,2/15,5.48%,CPEB2;DDX3X
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3692938295176442,-1.5698891727962412,0.0,0.2366361933627898,1.0,124/306,23.21%,ST3GAL4;POLA1;RPS24;RPS12;RPL8;FUT9;RPS23;RPL13;RPL41;RPS8;EXT1;RPS6;RPLP2;RPL18A;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;PTMA;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;APOE;RPS3;RPS21;EEF2K;RPL4;RPL32;B4GALT5;RPS16;RPL5;RPL21;RPL18;RPS7;ABCF1;RPL39;RPS17;RPL34;RPL28;RPL14;EEF1A1;POLD3;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;NAP1L1;EXT2;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;RPS4X;RPS5;RPL6;RPL36A;TAF1B;DUT;POLR2J;RPL31;HBS1L;TIPIN;RNASEH2A;RPS26;RPL36;RPA1;ORC5;GCNT1;RPSA;RNPS1;ORC2;RPL13A;BRIP1;BARD1;CDC45;EEFSEC;BCL3;RPL35;EEF2;COPS5;DNA2;RFC4;INHBA;PAX8;RPL24;RPS13;MRPL34;EEF1D;RPL11;POLD1;RSL24D1;MRPS16;RFC2;POLR2C;MRPS21;BLM;MRPL13;MLF1;MRPL10;POLR2L;RPS27A;TUFM;RECQL5;EEF1G
prerank,regulation of actomyosin structure organization (GO:0110020),0.7126973805674639,1.5696869604540107,0.034358047016274866,0.890395929099396,1.0,7/13,14.58%,ROCK2;FHOD1;AKAP13;ASAP3;CDC42;ALMS1;TSC1
prerank,regulation of glycolytic process (GO:0006110),0.5271084117130254,1.568744432401785,0.020527859237536656,0.885345163876121,1.0,14/68,13.70%,PRKAG2;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1;GCK;HDAC4;NUP42;NUP98;MLXIPL;OGT;NUP43;NCOR1
prerank,B cell receptor signaling pathway (GO:0050853),-0.5221100613133351,-1.568140834259375,0.010309278350515464,0.23837258237412157,1.0,13/32,18.11%,MEF2C;RFTN1;CD38;PTPRC;BMX;PLCG2;PLEKHA1;BCAR1;TEC;SH2B2;BLNK;SYK;BTK
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5862699795723317,-1.5679831615267286,0.02237136465324385,0.23707442263183715,1.0,8/19,15.58%,NRP1;PTPRJ;TEK;KDR;MYOC;VEGFA;PPM1F;LIMS1
prerank,anion transport (GO:0006820),0.6006212469643137,1.5675836194221846,0.024179620034542316,0.8814436663903403,1.0,6/33,6.19%,SLC22A6;SLC13A4;SLC13A3;VDAC2;SLC26A3;SLC19A1
prerank,photoreceptor cell development (GO:0042461),-0.6396474224277677,-1.5674231073583607,0.017167381974248927,0.23661395476621258,1.0,6/14,13.85%,RORB;DCX;RP1;MFSD2A;AHI1;VEGFA
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5371381659503102,-1.5645245190137456,0.02696078431372549,0.24118707317715377,1.0,17/32,16.22%,RHOJ;THBS1;HDAC9;HDAC7;MEOX2;NOTCH1;AKT3;KDR;ANXA1;GATA2;PTGS2;JCAD;FGF2;STARD13;VEGFA;SRPX2;PIK3C2A
prerank,sprouting angiogenesis (GO:0002040),-0.4715547599498707,-1.5638939346593064,0.008426966292134831,0.2406563640697378,1.0,16/51,5.16%,NRP1;SLIT2;TEK;BMPER;CDH13;RSPO3;ENG;CCBE1;THBS1;VEGFC;SEMA5A;PTK2B;ACVRL1;SEMA3E;KDR;RAMP2
prerank,endothelial tube morphogenesis (GO:0061154),-0.6985555037987223,-1.5637687542123437,0.032520325203252036,0.23934988535608498,1.0,5/10,12.06%,ACVRL1;RHOB;STARD13;BMP4;CTNNB1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.613578440482948,1.5626648565172596,0.04882154882154882,0.9041589652682618,1.0,3/26,1.67%,PRKAG2;LPGAT1;PRKAA2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5561064510213909,-1.5621508879251846,0.014388489208633094,0.24086855009449987,1.0,8/24,8.14%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6108655429853078,1.5615988141971142,0.044444444444444446,0.9003046879016774,1.0,4/25,0.78%,WNK4;ACTN2;ATP1B3;ANK2
prerank,retinoic acid metabolic process (GO:0042573),0.6894707388332985,1.5610601605830896,0.037366548042704624,0.8922275422987406,1.0,3/14,7.48%,ALDH1A2;CYP26B1;SCPEP1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5714449751387284,-1.5609785020315639,0.029411764705882353,0.2415468304984408,1.0,17/21,30.15%,PDE4D;CAV1;RASSF2;NCK2;SMAD7;DDIT4;CNKSR3;DMTN;PPM1F;NCK1;DMD;PAQR3;GPD1L;NLRP2B;INPP5J;INPP5K;RACK1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.5469379964009754,-1.5606431564076528,0.0106951871657754,0.24051824490904028,1.0,10/29,20.88%,MEF2C;TFRC;CD38;PTPRC;EPHB2;TIRAP;CD74;IRS2;CD320;CD81
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6601863026514038,-1.5603330513520322,0.034,0.2395907402018464,1.0,6/12,18.33%,PTPRJ;F3;APOD;SNCA;CBL;NDRG4
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5488548652808946,-1.559582208307606,0.023923444976076555,0.2395065438930807,1.0,12/26,14.50%,NAV3;PAK1;OCLN;STMN2;MET;RPS3;TRPV4;CDK5RAP2;CLIP1;MAPT;CDK5R1;FES
prerank,regulation of receptor binding (GO:1900120),-0.7190275498136413,-1.559569912033909,0.02188183807439825,0.23799789106670696,1.0,6/10,15.64%,GREM2;B2M;PTPRF;ADAM15;ATP2A3;BDNF
prerank,negative regulation of ion transport (GO:0043271),0.6234367482856157,1.5590031505581503,0.03547297297297297,0.8948392207734591,1.0,5/24,3.85%,WNK4;ACTN2;SYT11;ADRA2A;NEDD4
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5959135249204566,-1.5586574435911964,0.03225806451612903,0.23831543113176024,1.0,7/18,7.51%,NLGN1;RIMS2;RIMS1;GSK3B;RAP1B;RAP1A;PREPL
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.4627117873991287,-1.5566590599807955,0.01744186046511628,0.24090461504196425,1.0,19/57,8.49%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;DLGAP1;SHISA6;SHISA9;DLGAP2;MINK1;APP;GRIN2A;RELN;NETO1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4726970454019065,-1.5560116845669338,0.014245014245014245,0.24062473831683906,1.0,19/57,14.26%,RPS24;RPS6;RPL26;RPL38;RPS19;RPL7;RPS28;RPL35A;RPS15;RPS16;RPL5;RPS7;XPO1;RPS17;RPL14;RPS25;EMG1;MALSU1;LTV1
prerank,carboxylic acid catabolic process (GO:0046395),0.6908044450706633,1.5553670176321657,0.05642023346303502,0.9091999323035248,1.0,5/12,12.68%,RENBP;NPL;PON3;GNPDA1;ACOT8
prerank,mesenchyme morphogenesis (GO:0072132),-0.6160752472524134,-1.5538984668135851,0.03076923076923077,0.24309568092581113,1.0,7/17,8.19%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2
prerank,sodium ion transport (GO:0006814),0.504983172840192,1.5538788933630858,0.011834319526627219,0.9084560952110573,1.0,8/85,2.03%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC5A5;SLC8A3
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5700840452614176,1.5537206879991932,0.03559870550161812,0.8983340510139112,1.0,12/38,14.01%,BMP6;SASH1;IFNK;ANKRD17;PLSCR1;DDX60;LY96;DHX58;PRKCA;NMI;IFI35;ACOD1
prerank,eye development (GO:0001654),0.5433962365758579,1.5531454171676051,0.016793893129770993,0.8912244890058989,1.0,10/54,7.88%,SMOC1;COL5A1;SHROOM2;FOXC1;CACNA1C;MEIS1;SH3PXD2B;FBN1;NIPBL;RBP4
prerank,leukocyte tethering or rolling (GO:0050901),-0.6095939290888998,-1.5520687743760615,0.028824833702882482,0.24531647533268677,1.0,9/17,25.77%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.43757432289361686,-1.5505997410356314,0.009900990099009901,0.24679782469959502,1.0,32/86,15.98%,NAV3;SEMA5A;NCK2;EVL;PTK2B;CARMIL1;CDC42EP3;PAK1;APP;OCLN;STMN2;MET;APOE;RPS3;PSEN1;PROX1;BIN1;TRPV4;CDK5RAP2;WDR1;EDN1;SYNPO2;CLIP1;MAPT;PFN2;CDK5R1;CDC42EP2;FES;CLU;NCK1;ARF6;GPX1
prerank,endothelial cell proliferation (GO:0001935),-0.6036417439177525,-1.5505390688841554,0.035955056179775284,0.24539210790793978,1.0,6/17,4.33%,TEK;BMPER;BMPR2;SEMA5A;CD34;ACVRL1
prerank,ameboidal-type cell migration (GO:0001667),-0.4691417065094273,-1.5500299917095917,0.014084507042253521,0.24491598099932818,1.0,22/51,18.39%,SEMA3C;SEMA6A;ERBB4;SEMA6D;SEMA5A;SEMA7A;CCN3;SEMA3E;TBX1;SEMA4D;ITGA4;CORO1C;PDLIM1;AMOT;SEMA3D;SEMA3G;PKN3;FAT2;SEMA4C;SEMA4A;SOX8;AMOTL1
prerank,excitatory postsynaptic potential (GO:0060079),-0.5805354460793318,-1.5486896419168534,0.03325942350332594,0.24602643206486977,1.0,5/19,7.25%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A
prerank,ganglioside biosynthetic process (GO:0001574),-0.6178128755638187,-1.5485361783224842,0.024553571428571428,0.24490117053103033,1.0,6/15,8.47%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;B4GALT5;ST8SIA6
prerank,inhibitory synapse assembly (GO:1904862),-0.6747534664605067,-1.547687490070578,0.04421052631578947,0.2450899105164041,1.0,6/11,11.97%,GABRB3;GABRA2;GABRB2;GABRG2;FGF13;LGI2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6023989203141564,-1.5475848851584988,0.029345372460496615,0.2437918668190566,1.0,9/18,25.77%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5269175633833273,1.5459383739862511,0.019877675840978593,0.9311572002282068,1.0,13/65,9.64%,EPAS1;CPEB2;RORA;BMP7;SLC8A3;CPEB4;FAM162A;TP53;TERT;PICK1;NPEPPS;AK4;SIRT1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4990445298736738,-1.5458855127075555,0.012165450121654502,0.24566975460198792,1.0,17/39,18.90%,RPS24;RPS6;RPS19;RPS28;RPS15;RPS16;RPS7;RPS17;WDR3;RPS25;RPS27;RPS5;EMG1;LTV1;NOL11;RPSA;RPS27L
prerank,cardiac ventricle development (GO:0003231),-0.5802398526477736,-1.5453241711937535,0.040268456375838924,0.24531882932962396,1.0,7/20,9.32%,ENG;NOTCH1;HES1;STRA6;HEYL;HEY2;PDE2A
prerank,positive regulation of glucose import (GO:0046326),0.6408001959668755,1.544729683829347,0.05419580419580419,0.929075042342602,1.0,6/21,6.64%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5810979106446382,-1.543205761964124,0.03111111111111111,0.24807738157821363,1.0,11/22,20.92%,SLIT2;GSN;TMSB4X;KANK3;KANK4;PFN2;KANK1;HIP1R;MYADM;TWF2;SSH2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.48252071537240954,-1.5424271791079702,0.017391304347826087,0.24834487782338815,1.0,13/43,15.72%,MEF2C;ENG;RYR2;MICAL2;TBX3;NOTCH1;SOX17;HES1;VANGL2;SOX18;AHI1;ACVR1;APLNR
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6524024378113384,1.5414064795306288,0.054307116104868915,0.9414696526457985,1.0,3/17,1.81%,PRKAG2;PRKAA2;PPARA
prerank,positive regulation of histone methylation (GO:0031062),0.6327712933444449,1.5411002287082407,0.04325259515570934,0.9324915707727316,1.0,9/24,17.01%,AUTS2;KMT2A;JARID2;CTR9;SIRT1;PHF1;OGT;TET1;SMAD4
prerank,odontogenesis (GO:0042476),0.5847090328894008,1.5395500458061249,0.03484320557491289,0.9321999182863642,1.0,11/35,11.52%,OSR1;FGFR2;WNT6;GLI2;TUFT1;FOXC1;EDA;COL1A2;BCOR;HDAC1;AXIN2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6130533028221287,1.5394731988440913,0.044444444444444446,0.9221708103584538,1.0,7/26,6.64%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;BRAF;CREBL2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5894918670939084,-1.5376822852766543,0.0514018691588785,0.2571149050627565,1.0,8/18,17.36%,HEG1;RASIP1;MET;KCTD10;MYOC;CUL3;STMN1;KANK1
prerank,cellular response to starvation (GO:0009267),0.4682066979818347,1.5371394056727927,0.005277044854881266,0.9283992247157604,1.0,32/147,11.60%,PRKAG2;RNF152;PRKAA2;PPARA;FNIP1;MTMR3;CPEB4;PRKAG3;NPRL3;SESN1;ATP6V0E1;LRRK2;LAMP2;SESN2;NPRL2;ATG5;NUAK2;EIF2AK2;ATP6V0B;WIPI1;SIK1;TP53;NUPR2;PICK1;SIRT1;BRSK1;ATG7;BECN1;ATP6V1D;ATF2;ATP6V1E1;IMPACT
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6414681916829309,1.5368212300019102,0.03383458646616541,0.9203655310975645,1.0,5/21,7.30%,DAB2;BMP6;BMPR1A;TGFBR1;WWTR1
prerank,substrate-dependent cell migration (GO:0006929),-0.6250445964073634,-1.5368093559823295,0.03696098562628337,0.25743488778741147,1.0,7/14,10.17%,NRP1;VEGFC;NTN1;SHTN1;PTPRC;CD2AP;P2RY12
prerank,membrane lipid biosynthetic process (GO:0046467),-0.45249019634915716,-1.5354940067926994,0.01524390243902439,0.25880226560556024,1.0,17/58,10.72%,ST3GAL4;ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;ACER2;PRKD3;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA6;CERS4;ELOVL6
prerank,negative regulation of calcium ion transport (GO:0051926),0.6837377249667334,1.534922545281111,0.04780114722753346,0.9227655117162721,1.0,2/15,3.76%,ATP1A2;ADRA2A
prerank,cAMP-mediated signaling (GO:0019933),-0.546099684628042,-1.5338445304930015,0.02528735632183908,0.26082130310276624,1.0,9/24,5.53%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;CAP2;PDE7B
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5759566524400193,-1.5334410654556807,0.04523809523809524,0.2601755543846815,1.0,6/21,15.36%,MTUS1;THBS1;PTK2B;PTK2;CMKLR1;RARRES2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6348648510742602,1.5327089025335443,0.05166051660516605,0.927959170324415,1.0,3/23,0.50%,UACA;BMP7;C1QTNF3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.5123738658595254,1.532030661895552,0.017991004497751123,0.9223034144808033,1.0,10/66,6.83%,FGF1;ROBO1;TPD52L1;KIT;SASH1;FGFR1;LRRK2;ADRA2A;PDGFRB;FLT1
prerank,regulation of ruffle assembly (GO:1900027),-0.5512406020644327,-1.5317756519264143,0.04212860310421286,0.26194818252049873,1.0,8/23,13.00%,NLGN1;CAV1;EVL;RDX;P2RY12;EPS8;ABI3;PFN2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6193012174872808,-1.531085253746643,0.050314465408805034,0.2618374549562142,1.0,7/15,15.31%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1;GRIK3
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6296955555926202,1.5307284603466962,0.04631217838765009,0.9210028945850062,1.0,4/22,10.66%,ALDH1A2;RBP1;CYP2R1;GC
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4181896857180816,-1.5304630922647464,0.0033333333333333335,0.261595174130822,1.0,34/93,15.88%,PDE4D;NTRK3;CAV1;RASSF2;NCK2;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;SMAD7;FNIP2;DDIT4;CD44;CNKSR3;ATP2B4;HSP90AA1;NOS1;PRKD1;PFN2;AXIN1;DMTN;SNCA;TNKS1BP1;TXN;PINK1;VEGFA;TERF2IP;PPM1F;BDNF;NCK1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7226420270104403,1.527710615626958,0.05925925925925926,0.9314298730151374,1.0,2/11,1.50%,NECAB1;BACE2
prerank,regulation of DNA repair (GO:0006282),0.5564473270415817,1.5273893463891686,0.035830618892508145,0.9240796258873691,1.0,14/44,14.63%,EYA1;EYA2;EYA4;BABAM2;RNF8;TRIP12;UBR5;SIRT1;AXIN2;UIMC1;KAT7;PML;BABAM1;SMCHD1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5394512037150114,1.5271766204516557,0.024390243902439025,0.9156969129364075,1.0,10/53,9.64%,EYA1;EYA2;DDX5;EYA4;BABAM2;NACC2;ATM;RNF8;FBH1;SIRT1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.5447916340702676,-1.526870878717222,0.019230769230769232,0.2674643162557313,1.0,11/27,14.86%,PPP1R16B;PPP2R5A;PPIA;CALM1;CAMTA1;CALM2;BMP2;TGFB1;CALM3;MTMR9;SPPL3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5932615833884971,-1.5265766715797489,0.035794183445190156,0.2665771272980555,1.0,13/18,16.22%,RHOJ;HDAC9;HDAC7;AKT3;KDR;ANXA1;GATA2;PTGS2;JCAD;FGF2;VEGFA;SRPX2;PIK3C2A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6700412515762484,-1.526518288837671,0.046370967741935484,0.26523967136002546,1.0,6/11,22.79%,NRP1;PAK1;BCAR1;STMN1;SIRT2;HGF
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5398970212478028,-1.5263096848914792,0.028985507246376812,0.2642160807825651,1.0,14/24,25.34%,PECAM1;VCAM1;F11R;ICAM1;SEMA4D;ITGB1;ITGA4;MSN;NT5E;SYK;ITGB2;CERCAM;FERMT3;SELP
prerank,endodermal cell differentiation (GO:0035987),-0.5213958679660791,-1.5259039793914013,0.03926096997690531,0.2636978666736881,1.0,16/31,21.63%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;LAMA3;ITGA4;SETD2;MMP15;ITGB2;CDC73;ITGA5;INHBA;ITGA7;COL11A1;VTN
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.7330441381797094,1.5252693461286793,0.060218978102189784,0.9188669544398816,1.0,3/11,1.42%,ACTN2;LEPROT;PICALM
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7012177764535916,1.525126063235863,0.05040322580645161,0.9105587724168992,1.0,5/13,9.55%,RHOQ;LRRK2;OPA1;AK4;AK3
prerank,gliogenesis (GO:0042063),-0.6195656719381231,-1.5246681182824249,0.03023758099352052,0.26477751017478635,1.0,7/15,15.32%,CDH2;CD9;TGFB2;ANXA1;RELN;PAX2;METTL3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.7088281310118996,1.5241984491436789,0.06759443339960239,0.9072832658608718,1.0,5/12,12.34%,SORBS1;PRKCZ;GKAP1;SIRT1;PTPN11
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5288531850569393,1.5237720077232406,0.028189910979228485,0.9010659838111688,1.0,7/61,3.00%,NOTCH2;ROBO1;AUTS2;LPAR1;IGF1;ALS2;AKAP13
prerank,dicarboxylic acid transport (GO:0006835),0.592872159150645,1.5236372829880374,0.037800687285223365,0.8931194263225574,1.0,7/28,10.07%,SLC22A6;SLC13A3;PDPN;SLC19A1;SLC1A3;SLC26A1;SLC25A12
prerank,kidney development (GO:0001822),0.5148967569092728,1.522739880438287,0.015151515151515152,0.8901842332100719,1.0,12/65,4.86%,BMP7;ACE;LRP4;WNT4;OSR1;GREB1L;GLI2;KANK2;TGFBR1;FOXC1;SULF2;CTSH
prerank,positive regulation of interferon-beta production (GO:0032728),0.583962721780386,1.5226857539978633,0.030612244897959183,0.8820178338459612,1.0,14/33,13.58%,OAS2;TLR3;RNF135;TLR4;TRIM56;DDX3X;RIPK2;MAVS;TOMM70;DHX58;IRF1;PTPN11;POLR3A;OAS3
prerank,fat cell differentiation (GO:0045444),0.5255428419057407,1.5216314757506706,0.029548989113530325,0.8803566241862136,1.0,19/57,17.65%,WNT5B;C1QTNF3;OSBPL8;PPARGC1A;ADIG;METRNL;SMAD6;OSBPL11;TCF7L2;SIRT1;CBY1;MKKS;FAM120B;ERAP1;PER2;BBS2;CLIP3;MED1;CTBP2
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.4323245624870649,-1.5213222156771977,0.014792899408284023,0.2703635204856896,1.0,21/70,12.77%,NRP1;TMEFF2;MEF2C;TEK;PIK3R1;PARVB;ACTN1;FN1;PEAK1;LAMC3;NTNG1;NTN4;ITGA4;RELN;PROX1;ARL13B;ITGB3;ITGA8;ATF4;ILK;LPXN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.601548489909,-1.5209630419806304,0.04375,0.2697324361146234,1.0,6/15,13.81%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6253636481110783,1.520927538159338,0.04529616724738676,0.8762108633116313,1.0,3/23,2.40%,PRKAG2;BMP7;SPHK1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.49633406812728686,-1.5207248560659161,0.017326732673267328,0.2687616379701521,1.0,18/39,15.18%,NRP1;SLIT2;COL4A1;ENG;TIE1;RASIP1;SEMA3E;KDR;PAK1;MET;SIX1;BMP2;FGF2;PKD1;BMP4;CTNNB1;VEGFA;PAX2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.47977320905722093,-1.52014852302694,0.024861878453038673,0.26859958327312394,1.0,15/42,15.96%,UTRN;NRP1;PTPRJ;TEK;CDH13;PTK2B;KDR;GSK3B;MYOC;EMP2;VEGFA;PPM1F;RRAS;LIMS1;SKAP1
prerank,regulation of cytoplasmic translation (GO:2000765),0.6924040280463823,1.519941960700697,0.06751824817518248,0.8740801017413282,1.0,4/14,8.71%,CPEB2;CPEB4;ZCCHC13;CPEB3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.43749508416393135,-1.5195241923288703,0.015625,0.268520836144496,1.0,29/70,22.37%,PIK3R1;ACTB;MYO10;ACTG1;HSP90AB1;DOCK1;LYN;PAK1;ACTR2;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;WASF2;VAV1;SYK;NCKAP1;YES1;WIPF1;FYN;ARPC3
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.6153864500808873,-1.5185046512344063,0.05399568034557235,0.2692439406016591,1.0,5/15,9.85%,CDH13;PTPN12;CEACAM1;ERBB2;MVB12B
prerank,negative regulation of chemotaxis (GO:0050922),-0.4997925206162277,-1.5184167672176139,0.028277634961439587,0.2680104241857998,1.0,14/31,12.23%,SLIT2;ROBO2;SEMA3C;SEMA6A;SEMA6D;THBS1;SEMA5A;SEMA7A;NOTCH1;SEMA3E;SEMA4D;DUSP3;SEMA3D;SEMA3G
prerank,cell-cell junction assembly (GO:0007043),-0.4437160166450608,-1.5177938083412865,0.014285714285714285,0.2678555830587327,1.0,22/63,10.47%,CDH11;CTNND2;CDH2;CDH8;ACTB;CLDN5;CD9;CDH10;EPB41L3;CDH12;ACTG1;CLDN11;GJC1;GJD3;RAMP2;CDH6;CDH7;CDH20;CDH19;SMAD7;TRPV4;WDR1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6691174461905488,-1.5174797104869098,0.04743083003952569,0.26712145745003774,1.0,4/10,9.34%,GHR;STAT3;LYN;STAT5B
prerank,mononuclear cell differentiation (GO:1903131),-0.5331962076812723,-1.5162603944783595,0.03553299492385787,0.2683406264817502,1.0,12/24,19.36%,GAS6;MYH9;LYN;IKZF1;MT1G;BMP4;THOC5;VEGFA;TRPM2;IL31RA;RELB;IRF8
prerank,cardiac cell development (GO:0055006),-0.6600439654156975,-1.5160621040224425,0.04294478527607362,0.26741631663569854,1.0,5/11,13.85%,SLC8A1;NOTCH1;JAG1;MYH11;VEGFA
prerank,blood vessel morphogenesis (GO:0048514),-0.45146216821262247,-1.515829469856385,0.015105740181268883,0.2664751014410035,1.0,26/54,12.50%,NRP1;LAMA1;CDH2;CAV1;COL4A1;ENG;CCBE1;ID1;RASIP1;SLC1A1;CYP1B1;KDR;RAMP2;TBX1;SOX17;HES1;ITGB8;STRA6;PROX1;TGFB1;HEY2;SMAD7;FLT4;RASA1;SOX18;LOX
prerank,rRNA processing (GO:0006364),-0.37950068553999655,-1.5151894474087526,0.0,0.2663266439955216,1.0,65/172,18.42%,RPS24;RPL8;RPL13;RPL41;RPS6;RPLP2;RPL18A;RPL37;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;WDR3;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;SART1;RPL6;EMG1;RPL36A;MDN1;RPL31;NOP53;DDX10;RPL36;NOL11;RPL13A;TEX10;RPL35;FBL;XRN2;UTP15
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6724604541796317,1.5151620405638684,0.08534322820037106,0.8952128746017327,1.0,8/14,19.81%,AMACR;ACOXL;ACOT8;CRAT;ACOX3;EHHADH;ECI2;CROT
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5666702753661728,-1.5143884302325308,0.03773584905660377,0.26671484663301154,1.0,11/21,22.31%,GRIN2B;NGF;EPHA7;AIM2;MT3;USP50;PSMB9;GRIN1;SOX2;PYCARD;FYN
prerank,ncRNA processing (GO:0034470),-0.36944740290677247,-1.5143529672766287,0.0,0.26543960738332956,1.0,69/200,18.62%,RPS24;RPL8;RPL13;RPL41;RPS6;RPLP2;RPL18A;RPL37;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS19;RPL7;RPL22;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPL4;RPL32;RPS16;RPL5;RPL21;RPL18;RPS7;RPL39;RPS17;RPL34;RPL28;RPL14;SMAD1;WDR3;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;DROSHA;RPL6;EMG1;RPL36A;MDN1;RPL31;NOP53;DDX10;RPL36;METTL3;LIN28B;NOL11;RPL13A;TEX10;RPL35;FBL;XRN2;UTP15;ADAT1
prerank,regulation of dopamine secretion (GO:0014059),0.6005612206107067,1.5143447335378901,0.05545927209705372,0.8922414582148414,1.0,5/25,3.97%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,histone lysine demethylation (GO:0070076),0.6002800957685571,1.5142523857700578,0.06104129263913824,0.8846433680236826,1.0,11/25,21.45%,KDM7A;KDM2B;KDM2A;HR;KDM3B;RIOX2;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,stem cell differentiation (GO:0048863),0.55708138864211,1.514200768597977,0.05945121951219512,0.8769980420731633,1.0,7/39,2.48%,ACE;OSR1;KIT;FGFR2;JARID2;HOXB4;FBXL17
prerank,regulation of catecholamine secretion (GO:0050433),0.5736013678803278,1.5141403480587272,0.05695142378559464,0.8696022123963044,1.0,5/29,3.97%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,histone lysine methylation (GO:0034968),0.569072780171646,1.5139801622650026,0.043402777777777776,0.8630435725717308,1.0,14/33,21.36%,KMT2A;CXXC1;SMYD3;ASH2L;PRDM5;WDR82;KMT2D;DOT1L;SETD1B;SETDB2;EHMT2;SETD3;N6AMT1;KDM6A
prerank,carbohydrate derivative transport (GO:1901264),-0.5734100169848259,-1.5134667841014924,0.03139013452914798,0.2659261019539205,1.0,9/18,17.10%,SCARB1;PLTP;SLC10A7;ABCG1;NPC2;MFSD2A;VLDLR;SLC29A1;LBP
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4348145371889731,-1.5131440728250474,0.015527950310559006,0.2652252931443865,1.0,21/72,11.11%,NLGN1;NRXN1;GRIK2;SYT1;RIMS2;CLSTN2;SLC24A2;SHANK3;RIMS1;NPTN;GRIN2B;PTK2B;PLK2;APP;GRIN2A;LGI1;RELN;EPHB2;GPER1;ZDHHC2;SHANK2
prerank,regulation of histone methylation (GO:0031060),0.6924029920005169,1.5131353045633176,0.05783582089552239,0.8609798572475745,1.0,6/13,15.39%,JARID2;CTR9;NSD1;MTHFR;AASS;TET1
prerank,lamellipodium organization (GO:0097581),-0.513165273884584,-1.51199491315393,0.04336734693877551,0.2662225625939568,1.0,14/29,13.15%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ABLIM3;ARHGEF7;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.434674926192753,-1.511849430347432,0.018808777429467086,0.2652534106954744,1.0,29/71,22.37%,PIK3R1;ACTB;MYO10;ACTG1;HSP90AB1;DOCK1;LYN;PAK1;ACTR2;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;WASF2;VAV1;SYK;NCKAP1;YES1;WIPF1;FYN;ARPC3
prerank,regulation of stem cell proliferation (GO:0072091),0.6633942688586213,1.5118413016776509,0.05514705882352941,0.8613387392943981,1.0,7/17,17.66%,ACE;FBLN1;EIF2AK2;TERT;ZFP36L1;YAP1;KDM1A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.478708972933932,-1.5102535487176187,0.024725274725274724,0.26757262063120413,1.0,16/39,19.54%,TEK;THBS1;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;ITGA4;GATA2;GPER1;ECSCR;SCG2;PDCD4;RGCC;PAK4
prerank,positive regulation of neuron migration (GO:2001224),-0.6540189214776527,-1.5096299440245216,0.06517311608961303,0.26761536520829227,1.0,4/11,5.74%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.6192748449360986,-1.5085075194323043,0.03648068669527897,0.26855698548196993,1.0,8/13,31.65%,TBX3;NOTCH1;TGFB1;BMP4;SOX8;EID2B;SOSTDC1;ANKRD2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.6502660400066642,-1.5084980856088885,0.0518018018018018,0.26729191235994515,1.0,7/11,24.09%,GSN;ST18;FAS;HTRA2;LGALS9;PRR7;PLAUR
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.6969052857314515,1.508315702253679,0.06513409961685823,0.875779146403666,1.0,3/13,7.09%,SORBS1;IGF1;GCK
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6636613423556396,-1.507618767391033,0.03837953091684435,0.2677807440397114,1.0,6/12,10.29%,EPHB1;HSP90AB1;B4GALT5;MYCBP2;EPHB2;HSP90AA1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7118124198191503,1.507268504994962,0.0625,0.8746078416930537,1.0,3/12,7.09%,SORBS1;IGF1;GCK
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5337138264804407,-1.5056765367508274,0.03807106598984772,0.27046641882146066,1.0,6/25,8.78%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A;GLRA1
prerank,phosphate ion homeostasis (GO:0055062),-0.6846682092094443,-1.5045515927641058,0.039603960396039604,0.2714307438049674,1.0,3/10,8.36%,SFRP4;XPR1;ENPP1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6721474037101122,-1.5039268238548857,0.028747433264887063,0.27136635338655896,1.0,6/10,21.03%,SHANK3;NPTN;APP;NETO1;CAMK2B;DRD2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6878224719787027,1.5038880686154175,0.06262626262626263,0.8881054150349198,1.0,7/13,16.47%,DDO;ASPA;GOT2;GLUL;ACOT8;QPRT;GOT1
prerank,polyol biosynthetic process (GO:0046173),0.6606841101495093,1.5022240435264167,0.08235294117647059,0.8913568493501038,1.0,5/16,9.91%,ISYNA1;CYP27A1;CYP2R1;ITPKB;PPIP5K2
prerank,sodium ion transmembrane transport (GO:0035725),0.4864861595546395,1.5009275060912173,0.022857142857142857,0.891634185997471,1.0,7/84,2.03%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC8A3
prerank,organic acid transport (GO:0015849),0.47384742266094504,1.499737001375966,0.015514809590973202,0.8915610542563869,1.0,18/94,8.83%,SLC22A6;SLC13A3;SLC6A13;ACSL1;SLC6A12;SLC38A4;SLC38A3;SLC7A2;SLC7A11;PDPN;SLC25A48;SLC10A4;SLC19A1;SLC27A1;GOT2;SLC26A1;SLC38A1;SLC51A
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5695487015384562,-1.4990689118106053,0.04838709677419355,0.2802715254975222,1.0,10/19,18.21%,PTPRJ;GRM5;RYR2;VCAM1;KDR;PTPRC;DMTN;TRPM2;STIMATE;BCAP31
prerank,signal release from synapse (GO:0099643),-0.47833613331547914,-1.4990381806280644,0.02356020942408377,0.2790307708890733,1.0,9/43,6.74%,NRXN1;SYT1;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,lysine metabolic process (GO:0006553),0.6968859779430224,1.498784253941167,0.06952965235173825,0.8825715935875691,1.0,6/12,13.59%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,lysine catabolic process (GO:0006554),0.6968859779430224,1.498784253941167,0.06952965235173825,0.8825715935875691,1.0,6/12,13.59%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,regulation of epithelial cell proliferation (GO:0050678),0.483584357942445,1.4987050012861811,0.024566473988439308,0.8759642795565761,1.0,11/85,4.48%,FGF1;TGFBR3;BMP6;OSR1;IGF1;FGFR2;MCC;LAMC1;PKHD1;NUPR1;FUT1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.505170151767801,-1.4964251724828013,0.03535353535353535,0.28346405035803673,1.0,11/34,12.55%,PDE4D;SLC8A1;PDE4B;RYR2;ATP1B1;CALM1;CALM2;KCNQ1;SMAD7;CALM3;NOS1
prerank,sensory perception of sound (GO:0007605),0.4865251443841867,1.4962024119769326,0.036414565826330535,0.8837118291780579,1.0,17/88,10.54%,EYA1;CACNA1D;KIT;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;NIPBL;CDC14A;LRTOMT;EPS8L2;COL11A2;MKKS
prerank,glycerolipid metabolic process (GO:0046486),-0.6518869615200505,-1.4953793654284582,0.07377049180327869,0.28431752598245463,1.0,6/11,19.07%,DGKB;DGKG;GAL3ST1;DGKZ;PNPLA3;PLA2G15
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4878755239238263,-1.495255063047119,0.030732860520094562,0.28325166020838227,1.0,10/33,10.25%,MEF2C;THBS1;ACVRL1;MEOX2;NOTCH1;APOE;TGFB1;FGF2;ATP2B4;STARD13
prerank,neuron projection development (GO:0031175),-0.3800963866494254,-1.4945871728813882,0.0,0.28343874318617207,1.0,54/168,15.99%,FRY;NLGN1;CNTNAP2;CTNND2;PTPRM;DCLK1;GRM7;DOCK10;SHANK3;EPHB1;CNTN4;NYAP2;PAK3;PLP1;EPB41L3;SH3GL2;NGF;TRIO;NRK;TMEM108;SHTN1;LYN;GSK3B;GPM6B;DAB2IP;STX3;MINK1;PAK1;APP;STMN2;APOE;LGI1;ULK1;EPHB2;GPRIN3;MYOC;RASGRF1;SLC9A6;UHMK1;MARK2;DIP2A;NCDN;MAPT;ERCC6;MAP4;GPM6A;SHANK1;CDK5R1;UBB;STMN1;MYO16;PACSIN1;BDNF;BICDL1
prerank,phospholipid transport (GO:0015914),-0.4590864780752902,-1.4943474636821947,0.030054644808743168,0.28263218492604725,1.0,21/52,14.38%,ATP10A;ATP8A1;ATP8B1;PITPNC1;ATP11A;ATP8A2;SCARB1;PLTP;APOE;LDLR;ABCG1;ATP11C;NPC2;PITPNB;TNFAIP8L3;MTTP;MFSD2A;PITPNA;TMEM30A;ABCB4;ATP8B2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5139505046774877,1.4939211047997407,0.02967359050445104,0.8905098672731117,1.0,16/61,14.63%,EYA1;EYA2;SMOC2;EYA4;BABAM2;USP9X;PDGFRB;ATRX;RNF8;SIRT1;UIMC1;RAD50;USP7;PML;BABAM1;SMCHD1
prerank,carnitine metabolic process (GO:0009437),0.6753852095287479,1.4937025808497986,0.07364341085271318,0.8847318500568915,1.0,6/12,12.81%,CPT1A;BBOX1;TMLHE;CPT2;ACADM;CRAT
prerank,regulation of focal adhesion assembly (GO:0051893),-0.44749554114210965,-1.4935419234076726,0.027548209366391185,0.28298965539766385,1.0,21/54,14.41%,NRP1;LIMCH1;PTPRJ;TEK;THBS1;CLASP2;EFNA5;PEAK1;ACTG1;ACVRL1;KDR;GPM6B;CORO1C;MYOC;PTK2;APOD;DUSP3;FAM107A;DMTN;VEGFA;PPM1F
prerank,myofibril assembly (GO:0030239),0.5362087641750409,1.493146738643378,0.05374592833876222,0.8812264407568688,1.0,9/42,6.00%,ACTN2;OBSL1;CSRP3;CFLAR;TMOD2;TPM1;TMOD3;KLHL41;PDGFRB
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6204263787180926,1.4927654239992514,0.0570902394106814,0.8767266267267957,1.0,10/21,20.87%,DCDC2;TTC23;SMO;RAB34;GLI1;STK36;EVC;IHH;GAS8;DLG5
prerank,histone modification (GO:0016570),0.4702538535707317,1.4913884883653772,0.027816411682892908,0.8783230283284603,1.0,27/109,16.03%,EYA1;EYA2;BRD8;CCNA2;EYA4;USP3;PADI6;CPA4;NSD1;TBL1X;BAZ1B;HUWE1;KAT6B;TBL1XR1;HDAC1;NSD3;HDAC4;SIRT1;PRDM5;AURKB;HLCS;SIN3A;MTA2;MIER3;CREBBP;EHMT2;EHMT1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.645834051852044,-1.4910837267610253,0.04772234273318872,0.286995063436477,1.0,4/12,11.76%,GSN;LY6E;MID2;IFITM3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5826900626209441,-1.490113371279983,0.058577405857740586,0.2878936211083367,1.0,6/17,9.85%,MAML2;NOTCH3;NOTCH1;HEYL;WWC1;PBX1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4259901092192713,-1.4901104791144777,0.018691588785046728,0.28661302090582047,1.0,29/73,22.37%,PIK3R1;ACTB;MYO10;ACTG1;HSP90AB1;DOCK1;LYN;PAK1;ACTR2;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;WASF2;VAV1;SYK;NCKAP1;YES1;WIPF1;FYN;ARPC3
prerank,negative regulation of cellular protein localization (GO:1903828),0.5675866728889908,1.4898005851254286,0.0491283676703645,0.881098683212378,1.0,4/34,1.42%,ROCK2;ACTN2;LEPROT;PICALM
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6542961590690273,-1.4895520079426612,0.06722689075630252,0.2865400105623292,1.0,5/10,21.84%,PTPRC;CEACAM1;CX3CR1;ARRB2;LGALS9
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7152501014542857,1.4893726140625878,0.0890909090909091,0.8769454311344985,1.0,3/10,7.35%,APPL2;CD300A;ANO6
prerank,ERBB signaling pathway (GO:0038127),-0.4327970411295007,-1.4890211349222169,0.012048192771084338,0.28624233831263,1.0,17/64,10.38%,RPS6KA5;ERBB4;PIK3R1;PLCE1;REPS2;PTPN12;IQGAP1;NCK2;GAB1;PTK2B;NRG2;TGFB1;PTK2;ERBB2;ERBIN;HSP90AA1;BCAR1
prerank,peripheral nervous system development (GO:0007422),-0.5378397834578882,-1.488981376427847,0.05463182897862233,0.2850591825828818,1.0,14/23,30.73%,ADGRG6;SERPINI1;NFASC;NGF;SCN8A;ADGRB1;BDNF;SOX8;SOX10;ERBB3;ADGRB2;NF1;GPC1;NTF3
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.7249248916341642,1.4881326073683543,0.07809523809523809,0.8709458210319831,1.0,3/10,12.10%,CEP250;GNAT2;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.7249248916341642,1.4881326073683543,0.07809523809523809,0.8709458210319831,1.0,3/10,12.10%,CEP250;GNAT2;CACNA2D4
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5693890911493497,1.4875698399996238,0.05641025641025641,0.8678324371364387,1.0,7/30,9.64%,DAB2;DDX5;KLK2;NCOR2;SMARCA4;HDAC1;SIRT1
prerank,positive regulation of heart rate (GO:0010460),-0.5949217305177252,-1.4873858484800606,0.05286343612334802,0.2869993748578928,1.0,6/17,12.92%,PDE4D;RYR2;ADRA1B;KCNQ1;EDN1;EDN3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.617912761266956,1.487363073308942,0.06822262118491922,0.8626321610565706,1.0,10/23,19.25%,C1QTNF3;PPARA;NUPR1;SIK1;GCK;HDAC4;NCOR1;CLK2;CRY1;PLEK
prerank,positive regulation of fat cell differentiation (GO:0045600),0.53437946125257,1.4873179041027007,0.04595879556259905,0.8566197518124492,1.0,9/47,6.64%,TMEM64;BMP7;MEDAG;NAPEPLD;ADIG;METRNL;RREB1;FNDC5;CREBL2
prerank,central nervous system development (GO:0007417),-0.35476337145302317,-1.4871407782350716,0.0,0.28624526986688137,1.0,61/250,10.77%,CNTNAP2;ADGRL3;ADGRL2;ROBO2;DCLK1;ZFHX3;CDH2;SLC2A1;GSN;WWP1;COL4A1;CNTN4;GRIK1;GRIN2B;ADAM23;MAL;TBX3;VIT;IL1RAPL2;SHROOM4;STAT3;PBX3;DNER;SERPINI1;SH3GL2;ZBTB16;DSCAML1;LSR;MBP;SNTG2;CNTN6;PDGFC;MARCKS;NRCAM;DCX;PTCH1;GRIN2A;MOG;RELN;VCAN;PCDH18;MEIS2;PTPRZ1;SPOCK1;PROX1;HSPG2;EPHA7;TUBGCP2;ADAM22;S100B;APOD;PPT1;RAB18;ECRG4;DDIT4;PBX1;UFM1;CDK5RAP2;PKD1;RPS6KA3;MFSD2A
prerank,negative regulation of nuclear division (GO:0051784),0.6855542523998931,1.4867140149896387,0.09523809523809523,0.8537766030909655,1.0,2/11,2.90%,BMP7;TOM1L2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7102344145392621,1.4866781423544067,0.08627450980392157,0.8477813710519749,1.0,5/10,17.33%,OXSR1;ADAM17;WNK1;WNT5A;CCR2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6418383587088888,-1.4851953738996442,0.04318181818181818,0.2889586293559447,1.0,5/11,13.17%,SEMA6A;THBS1;EPN2;KLF2;CREB3L1
prerank,secretion (GO:0046903),0.673359003530139,1.4849340631318717,0.0695970695970696,0.8511737749333286,1.0,2/14,1.94%,SLC22A6;NPR1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.6427284034165158,1.4848208327742676,0.0797872340425532,0.8458066582985817,1.0,6/18,8.48%,NGLY1;NEU2;ADAMTS9;DERA;SAMHD1;MANBA
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7205563034205733,1.4836382928124219,0.08183632734530938,0.8465057423718694,1.0,8/11,10.88%,PARP10;PARP14;TIPARP;PARP4;PARP12;PARP9;PARP11;PARP6
prerank,anion transmembrane transport (GO:0098656),0.5098949013866698,1.4835353880077475,0.03812316715542522,0.8410489508926279,1.0,10/67,7.06%,SLC13A4;SLC13A3;SLC6A13;SLC16A12;SLC7A2;SFXN2;SLC6A9;SLC19A1;SLC1A3;SLC27A1
prerank,response to zinc ion (GO:0010043),-0.5379857049940977,-1.4822342464230363,0.03333333333333333,0.2937268480444461,1.0,13/25,14.22%,PAM;GLRA1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;CRIP1;GLRA2;MT3
prerank,cellular protein metabolic process (GO:0044267),-0.3409546344378671,-1.4818030072696635,0.008547008547008548,0.29328495791073556,1.0,119/396,15.89%,LTBP1;CDH2;MSRB3;ST8SIA4;CHRM3;CST3;FN1;RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;GAS6;RPS6;RPLP2;RPL18A;RPS20;MGAT4A;ST3GAL1;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;DAB2IP;RPL7;RPL22;RPS28;IGFBP4;RPLP0;RPL35A;MSLN;APP;RPS15;RPL30;RPL19;APOE;RPS3;RPS21;SFTPA2;SFTPA1;RPL4;IGFBP6;RPL32;PSEN1;UBE2G1;RPS16;RPL5;RPL21;ST3GAL6;RPL18;RPS7;ABCF1;RPL39;PCSK5;CCN1;VCAN;RPS17;RPL34;RPL28;RPL14;EEF1A1;CKAP4;SIAH2;SHISA5;FBXL2;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;PAPPA;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;SPARCL1;RPL29;BMP4;ZDHHC2;RPS4X;RPS5;LMCD1;LOX;LCMT1;RPL6;RPL36A;UBE2D3;TMEM208;CSNK1G3;MMP15;RPL31;HBS1L;MFGE8;QPCT;SCG2;SPCS1;DUSP12;SPPL3;RPS26;RPL36;GOLM1;RPN1;MSRB2;CPE;PHEX
prerank,ceramide transport (GO:0035627),-0.6324470838401055,-1.4811952953582739,0.05627705627705628,0.2933775986520719,1.0,6/12,14.21%,CERT1;PLTP;PSAP;GLTP;PLEKHA3;ABCB4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4408522207039341,1.481138947302922,0.013801756587202008,0.848293842756006,1.0,32/186,9.96%,DAB2;WWOX;TMEM64;RNF43;LRP4;BICC1;NXN;MCC;PRKN;DKK3;RNF213;TRABD2B;GLI3;APCDD1;CXXC4;VGLL4;LZTS2;APC2;WWTR1;UBAC2;PTPRU;LRP1;TCF7L2;CSNK1A1;TLE1;HDAC1;TMEM170B;GLI1;INVS;GRB10;CBY1;SOX13
prerank,prostaglandin biosynthetic process (GO:0001516),0.6414711334699239,1.4803636978533017,0.05975395430579965,0.8466119594876939,1.0,2/18,1.02%,PTGDS;PTGS1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3786670934012878,-1.479561513941202,0.0,0.295547799081587,1.0,33/138,10.38%,PTPRD;TEK;ERBB4;NTRK3;PTPRG;BMPR2;EPHB1;ROR1;MPZL1;EPHA5;LIFR;MERTK;PTPRT;EPHA6;TIE1;PTK2B;NGF;NTRK2;TRIO;IL6ST;KDR;LYN;MET;PTPRF;ROR2;EPHB2;EPHA7;PTK2;ABI1;FLT4;PTN;ERBB2;BCAR1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.570111467341947,-1.4792723843583901,0.06304347826086956,0.2949578745640003,1.0,9/18,14.09%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,arachidonic acid metabolic process (GO:0019369),0.559412169138055,1.479120151049477,0.05602716468590832,0.8473597058112283,1.0,5/35,6.57%,PTGDS;PTGS1;ALOX12;EPHX1;DAGLA
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6913294709896988,1.479079768676998,0.09349593495934959,0.8417741238932136,1.0,5/10,18.32%,ADRA2A;HBEGF;ADAM17;TGFA;BTC
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6277377653791301,-1.4781852515329477,0.051587301587301584,0.2960241820519018,1.0,4/12,9.22%,CXCL12;APP;JAM2;DOCK8
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.38841343157221636,-1.4777022450685309,0.0037313432835820895,0.2958756965239108,1.0,37/118,13.30%,ADGRB3;MEF2C;LRRC4C;HECW2;PID1;FMNL2;BMPER;PPFIA2;CDH2;SHANK3;HECW1;CLASP2;TANC2;EFNA5;PAK3;PHLDB1;CHN1;NEDD4L;GSK3B;TBX1;PAK1;SEMA4D;TSPAN12;LZTS1;TGFB1;CEACAM1;FLT4;FGF2;ERBB2;LFNG;RAP2A;MARK2;ABI3;CTNNB1;EMP2;MAPT;CFL1
prerank,response to metal ion (GO:0010038),-0.42457149632632407,-1.4774246904780621,0.02786377708978328,0.29525690003217653,1.0,21/67,14.22%,CAV1;KCNMA1;THBS1;GPHN;NEDD4L;TRPC3;SLC25A13;CALM1;CALM2;TRPC1;PPP3CA;PAM;MT1A;MT1X;CALM3;CRIP1;HOMER1;MAPT;HIF1A;SNCA;MT3
prerank,cellular amino acid catabolic process (GO:0009063),0.47688596294207897,1.4770124672580716,0.033973412112259974,0.8472728617275419,1.0,22/87,13.59%,DDO;ALDH7A1;IVD;ASPA;PRODH;ACADSB;ALDH4A1;HNMT;PIPOX;BCAT2;GOT2;OGDH;DLD;GLUL;MCCC1;AASS;UROC1;MTRR;FAH;ABAT;ALDH6A1;GCDH
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7208858482799891,1.4767826448173234,0.07224334600760456,0.8427688004281567,1.0,4/10,12.65%,ACE;HOXB4;TP53;LMBR1L
prerank,cardiac myofibril assembly (GO:0055003),0.6616868650880653,1.476376091196368,0.0708955223880597,0.8394668013880476,1.0,7/15,13.96%,NEBL;OBSL1;CSRP3;PDGFRB;MEF2A;MYLK3;PDGFRA
prerank,prostaglandin metabolic process (GO:0006693),0.5896938578683608,1.4762655775150857,0.04568527918781726,0.8344166297686474,1.0,2/26,1.02%,PTGDS;PTGS1
prerank,lung development (GO:0030324),0.5697597278660983,1.4761644546798343,0.058919803600654665,0.8295161507412715,1.0,6/33,4.22%,FGF1;ERRFI1;FGFR2;GLI2;PDPN;LOXL3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.42562647936651277,-1.4756851139921967,0.02586206896551724,0.29755645225143834,1.0,23/59,11.02%,CADM1;PTPRM;ROBO2;HMCN1;CDH2;CDH13;PECAM1;KIRREL3;BSG;CNTN4;NPTN;PTPRT;TENM3;DSCAML1;IGSF11;CNTN6;ITGB1;ROBO4;EMB;CEACAM1;PKD1;PVR;CDH1
prerank,regulation of striated muscle contraction (GO:0006942),0.5792833070805609,1.4745316770465755,0.059336823734729496,0.8329687040017355,1.0,3/27,2.03%,ATP1A2;ANK2;SLC8A3
prerank,cardiac conduction system development (GO:0003161),0.5897145936771143,1.4742985353431188,0.06371681415929203,0.8287353633260466,1.0,3/24,3.17%,NOTCH2;GJB6;BMPR1A
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6673355540987728,1.4741705284609001,0.06998158379373849,0.8241547667146946,1.0,7/16,9.96%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SIRT1;SOX13
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5423429291056003,1.4726628933165218,0.04265402843601896,0.8267080552025213,1.0,7/41,13.57%,PRKAG2;LACC1;GCK;NUP42;NUP98;OGT;NUP43
prerank,cell junction assembly (GO:0034329),-0.3976571058839475,-1.4725663633588488,0.02247191011235955,0.3029673584664285,1.0,28/100,7.48%,NLGN1;ADGRL3;CDH11;CTNND2;NRXN1;DNM3;CDH2;CDH8;ITGA6;KIRREL3;SHANK3;SPOCK2;ACTB;CLDN5;FN1;CDH10;DNER;CDH12;ACTG1;GJC1;VMP1;CDH6;FLNA;NRCAM;CDH7;CDH20;CDH19;LIMS2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5881661316782293,-1.4723632321869828,0.05217391304347826,0.3021414257527477,1.0,3/16,11.23%,CLDN5;CLDN11;CLDN14
prerank,regulation of glucose metabolic process (GO:0010906),0.5559131406281702,1.4723222286344853,0.06260869565217392,0.8231720252962533,1.0,8/34,13.15%,RORA;PRKN;RORC;SIRT1;SLC45A3;MLYCD;USP7;OGT
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4894678932282546,1.4721230077695924,0.027190332326283987,0.8190770613900691,1.0,15/76,7.39%,UACA;BMP7;C1QTNF3;SASH1;DLG1;SPHK1;NFAT5;TLR3;EZR;TLR4;DDX3X;CD27;EIF2AK2;IL12B;PTPN22
prerank,peptidyl-lysine modification (GO:0018205),0.46505425245781823,1.4721165238576088,0.02920723226703755,0.81393787612806,1.0,21/99,16.14%,NNAT;EYA1;SENP3;LOXL1;LOXL3;PIAS1;SIRT5;NDUFAB1;SIRT3;HDAC4;SIRT1;CTH;NUP42;NUP98;NSMCE2;SIRT4;NUP43;VIPAS39;KAT2B;PIAS3;NUP155
prerank,response to interleukin-6 (GO:0070741),-0.6662903074238731,-1.4721021427688545,0.056485355648535567,0.30141678945150735,1.0,5/10,13.28%,PID1;PTPRT;PTGIS;ST3GAL6;SBNO2
prerank,metal ion export (GO:0070839),0.5839554582352662,1.471342121123156,0.04040404040404041,0.8129325511967328,1.0,4/31,1.75%,ATP1A2;ATP1B3;KCND3;KCNA5
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5949918580827463,-1.470759854166085,0.04904051172707889,0.3031185841959418,1.0,7/15,17.04%,APP;APOE;LDLR;PSEN1;CLU;CHRNA7;IAPP
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.49004727699309475,-1.4704492818715569,0.03970223325062035,0.3025406859663362,1.0,10/32,7.70%,ADGRB3;HECW2;PTPRD;IL1RAPL1;HECW1;CDKL5;NEDD4L;GSK3B;SEMA4D;LZTS1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7017777400996076,1.4702175817237015,0.08935361216730038,0.8139709544927543,1.0,2/12,0.43%,NOTCH2;DOCK11
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6699795415686873,1.4689119128629162,0.08349146110056926,0.8157956072208298,1.0,4/13,5.24%,RNF152;SESN1;SESN2;ATM
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.487262175421186,1.468591418385064,0.03225806451612903,0.812385031296376,1.0,15/72,12.34%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;FLRT1;HNRNPH1;TIA1;POLR2D;FIBP;GTF2F1;KLB;PTPN11
prerank,peptide hormone secretion (GO:0030072),-0.517945585226753,-1.4671828023790472,0.04207920792079208,0.30823649201067366,1.0,5/26,12.92%,RIMS2;LTBP4;ANXA1;EDN1;EDN3
prerank,positive regulation of interleukin-13 production (GO:0032736),0.710568389476788,1.4668450385475935,0.08704061895551257,0.8161674462379852,1.0,2/10,2.05%,PRKCZ;IL18
prerank,cellular response to cadmium ion (GO:0071276),-0.5317592544594384,-1.4661768047896857,0.04225352112676056,0.3091885783794513,1.0,15/24,28.63%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;MT3;MT2A;HSF1;MAPK8;JUN;MAPK3;FOS
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6685558829280333,1.4661464385931218,0.08778625954198473,0.8148015498107039,1.0,5/14,14.25%,TLR3;ANKRD17;DDX60;DHX58;TLR5
prerank,negative regulation of platelet activation (GO:0010544),-0.5809972813398271,-1.4661341579627394,0.05668016194331984,0.3080377753004764,1.0,7/16,10.20%,PRKG1;CD9;SERPINE2;NOS3;APOE;CEACAM1;PDGFA
prerank,ribosomal large subunit assembly (GO:0000027),-0.51996703376746,-1.4660986727505128,0.06205250596658711,0.30687949199238523,1.0,16/24,27.61%,RPL3;RPLP0;RPL5;RPL23A;RPL6;MDN1;NOP53;BRIX1;MRPL20;RPL24;RPL11;RSL24D1;FASTKD2;RRS1;DDX28;RPL10
prerank,skeletal system morphogenesis (GO:0048705),0.5401293856016463,1.4658241833006316,0.049679487179487176,0.8115641379088938,1.0,11/42,10.09%,WWOX;FGFR2;HOXB4;FGFR1;TGFBR1;HOXB3;CYP26B1;HOXB9;HOXA3;HOXC4;DYNC2I1
prerank,positive regulation of protein processing (GO:0010954),-0.559697599278949,-1.4648058667426276,0.06531531531531531,0.30841400615599707,1.0,7/19,21.33%,GSN;CCBE1;MYH9;NKD2;RHBDD1;CLEC3B;BAG2
prerank,regulation of insulin secretion (GO:0050796),0.46358676125690795,1.4646185939080554,0.028735632183908046,0.8131212742339563,1.0,20/101,9.42%,NNAT;ADCY5;CACNA1D;ITPR2;ITPR1;STXBP4;KCNA5;PRKN;NLGN2;MCU;ADRA2A;CACNA1C;RAPGEF3;DPP4;GCK;RBP4;EIPR1;TCF7L2;MIDN;PICK1
prerank,regulation of cell junction assembly (GO:1901888),-0.5158289917848564,-1.4644395015913447,0.046948356807511735,0.30799506391521275,1.0,8/27,6.21%,MEF2C;PRKCH;CLDN5;F11R;RUNX1;RAP1B;RAP1A;OCLN
prerank,base conversion or substitution editing (GO:0016553),-0.6514468170337709,-1.4639431257426272,0.06092436974789916,0.3079313719643905,1.0,4/11,15.32%,ADARB2;ADARB1;APOBEC1;METTL3
prerank,negative regulation of receptor binding (GO:1900121),-0.6634045421732033,-1.4632483020668192,0.05714285714285714,0.30821870113341193,1.0,4/10,9.06%,B2M;PTPRF;ADAM15;ATP2A3
prerank,protein export from nucleus (GO:0006611),0.5820825065731554,1.4629544700161285,0.05054151624548736,0.8166296518182542,1.0,1/27,0.01%,RANBP3L
prerank,apoptotic cell clearance (GO:0043277),-0.4884729728075164,-1.4616952261342648,0.0468384074941452,0.31038495454247905,1.0,9/30,10.36%,RHOBTB1;XKR4;THBS1;SCARB1;GAS6;XKR6;ANXA1;RHOH;ITGB3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6512363999894757,1.4611963161302144,0.08867924528301886,0.8205514858030851,1.0,6/15,15.78%,DAB2;AAK1;NEU3;WASL;BMP2K;SMAP1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6142975545539454,1.4610932927853368,0.04945054945054945,0.8161712863836159,1.0,7/22,12.82%,SORBS1;PPARA;ZBTB20;F2;CREBL2;MLXIPL;SIRT4
prerank,epithelial cell morphogenesis (GO:0003382),0.6314131831743519,1.4607621619546929,0.08582089552238806,0.8131514375071744,1.0,5/17,4.80%,COL22A1;COL18A1;PKHD1;RILPL1;DACT2
prerank,transepithelial transport (GO:0070633),-0.5950036786356108,-1.4606261550565247,0.0613107822410148,0.31164635108770117,1.0,4/15,4.65%,ABCG2;SLC12A2;SLC1A2;SLC1A1
prerank,regulation of viral entry into host cell (GO:0046596),-0.48997283598212793,-1.4605330265759997,0.03278688524590164,0.310587216494368,1.0,12/30,24.51%,GSN;LY6E;HS3ST5;MID2;TRIM14;TRIM27;IFITM3;CD74;TRIM68;LGALS9;IFITM1;IFITM2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6653647529943053,1.4600231493464586,0.08761904761904762,0.8121359428218782,1.0,7/12,16.41%,DAB2;NCOR2;SMARCA4;HDAC1;SIRT1;NCOR1;NODAL
prerank,positive regulation of cell communication (GO:0010647),-0.5139532736188873,-1.4598344772698972,0.054373522458628844,0.3108353260709119,1.0,11/28,12.92%,GRIK2;SYT1;RIMS2;CLSTN2;ANK3;RIMS1;LGI1;EDN1;HOMER1;ILK;EDN3
prerank,regulation of ossification (GO:0030278),-0.47586693654491097,-1.4593684108658094,0.05303030303030303,0.3105639387039779,1.0,15/36,14.09%,MEF2C;BMPR2;SGMS2;TGFB2;ZBTB16;NOTCH1;ECM1;BMP2;ENPP1;S1PR1;PTN;BMP4;TWIST1;TXLNG;ACVR1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5473953327655476,1.4588391536592107,0.05958132045088567,0.8135176226583011,1.0,4/37,2.99%,PRKAG2;BMP7;SPHK1;PPEF2
prerank,mitochondrion distribution (GO:0048311),0.672775082173718,1.4587552471429854,0.07604562737642585,0.8093232915132287,1.0,5/12,9.00%,TRAK1;LRRK2;CLUH;MEF2A;DNM1L
prerank,response to cadmium ion (GO:0046686),-0.5188451350977068,-1.4584488475001607,0.04245283018867924,0.31132577523384775,1.0,15/26,28.63%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;MT3;MT2A;HSF1;MAPK8;JUN;MAPK3;FOS
prerank,regulation of glucose transmembrane transport (GO:0010827),0.626471767019417,1.458380279179793,0.0812274368231047,0.8067230559101181,1.0,3/18,6.05%,PRKAG2;PRKCB;BRAF
prerank,xenobiotic transport (GO:0042908),-0.5549862687305734,-1.4583137991360924,0.07126436781609195,0.3104206525692665,1.0,3/17,3.05%,SLC47A1;ABCG2;SLC7A5
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6591366802451538,-1.457632148028085,0.07608695652173914,0.3107055540037561,1.0,5/10,21.02%,FN1;HSP90AB1;LAPTM4B;TYROBP;GATA6
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.6510852690749223,-1.4575717420909275,0.08235294117647059,0.3095987231096366,1.0,5/10,20.06%,GALNT13;GALNT16;GALNT2;MGAT5B;POGLUT1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4820696554519705,-1.4573690540214586,0.02756892230576441,0.3088573100735729,1.0,12/35,6.50%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;HTR2C;GUCY1B1;CAP2;PDE7B;APOE
prerank,neuron migration (GO:0001764),-0.4540753295749618,-1.4573046954210733,0.03133903133903134,0.30786865589078594,1.0,23/48,14.04%,NRP1;ADGRL3;MEF2C;MARK1;ASTN2;MAP1B;ASTN1;NDNF;DNER;CDKL5;NTRK2;NRCAM;DISC1;DCX;RELN;SPOCK1;TUBGCP2;FGF13;DDIT4;MARK2;GPM6A;VEGFA;CDK5R1
prerank,negative chemotaxis (GO:0050919),-0.47857423085107365,-1.457180331171171,0.050970873786407765,0.30706856001338334,1.0,14/33,12.23%,SLIT2;SEMA3C;UNC5C;SEMA6A;SEMA6D;SEMA7A;NTN1;SEMA3E;SEMA4D;EPHA7;PDGFA;ITGB3;SEMA3D;SEMA3G
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.689813025811926,1.4563342625092341,0.09719626168224299,0.8119774982507829,1.0,6/13,9.96%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SOX13
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4243876029728786,-1.4534715654915844,0.01818181818181818,0.3139369531808325,1.0,17/67,8.79%,UTRN;NRP1;CDH13;FN1;VIT;PTK2B;NDNF;CARMIL1;ARHGEF7;DOCK1;GSK3B;FBLN2;FLNA;CRK;LIMS2;MYOC;CALR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.461144954339691,-1.4528678021527945,0.030470914127423823,0.31397562189949235,1.0,13/46,3.58%,NLGN1;NRXN1;MEF2C;SYT1;GRM7;GRM5;CDH2;SHANK3;GRM3;DGKI;GRIK1;GRM8;PTK2B
prerank,response to muscle stretch (GO:0035994),-0.5865072105803315,-1.4527748679388681,0.05921052631578947,0.31293590478025934,1.0,6/15,12.06%,SLC8A1;CDH2;GSN;RYR2;PTK2;CTNNB1
prerank,tRNA wobble uridine modification (GO:0002098),0.6347091305358611,1.4521822842937318,0.08190476190476191,0.8289511766467548,1.0,1/14,0.82%,TRMT9B
prerank,epithelial to mesenchymal transition (GO:0001837),0.5202363900577145,1.4513839578443237,0.05564142194744977,0.8283295247868896,1.0,8/47,4.22%,TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR1;TGFBR1;LOXL3
prerank,response to progesterone (GO:0032570),-0.5484326083584377,-1.4511267289463827,0.059322033898305086,0.3153045330428717,1.0,6/18,8.59%,ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,prostanoid biosynthetic process (GO:0046457),0.6560390195585442,1.4502618040758473,0.07233273056057866,0.8295091750737755,1.0,2/15,1.02%,PTGDS;PTGS1
prerank,BMP signaling pathway (GO:0030509),0.49094147025622087,1.4501093089248582,0.046012269938650305,0.8257929846026676,1.0,9/62,5.55%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,monocarboxylic acid metabolic process (GO:0032787),0.44894545734722013,1.4500910403834528,0.02452316076294278,0.8213220075618246,1.0,29/117,15.00%,ALDH1A2;ME2;IGF1;PCCA;PPARA;ECHDC3;ALOX12;LDHB;ACADSB;CPT1A;GPAT2;ACSBG2;ALDH4A1;CYP26B1;AMACR;NAAA;SCPEP1;GOT2;DLD;ACOT11;MCCC1;MECR;AASDH;ABAT;HLCS;THEM4;PER2;DLAT;GPAM
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.5582051943055567,-1.4488065949874562,0.06542056074766354,0.3193669070243465,1.0,7/18,14.08%,NAV3;CD34;HDAC7;PTPRC;TRIM27;HAVCR2;LAPTM5
prerank,protein localization to synapse (GO:0035418),-0.6163468216703102,-1.4480447840829682,0.07158351409978309,0.3197774694364899,1.0,5/12,13.66%,NLGN1;NRXN1;PCLO;NRXN2;SHANK1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.6383229100658898,1.4479417641390167,0.0900562851782364,0.8273337495802137,1.0,1/16,0.01%,RANBP3L
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6437110468138897,1.4478672395096353,0.10246679316888045,0.8231531900272024,1.0,4/13,5.87%,RENBP;LARGE1;MGAT3;PGM3
prerank,positive regulation of cell division (GO:0051781),0.534391126092975,1.447435679546659,0.05714285714285714,0.8208483029606014,1.0,7/38,10.98%,FGF1;PKP4;FGFR2;CDC14A;AURKB;CDC14B;CDC42
prerank,negative regulation of leukocyte migration (GO:0002686),-0.6480607276516177,-1.447315271891277,0.07112970711297072,0.3201619942866685,1.0,3/10,1.97%,SLIT2;BMP5;CD200
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6898404866028769,1.4472159699288787,0.10966542750929369,0.8175529424757869,1.0,5/11,8.54%,DAB2;PRKN;EZR;PTPN23;EIPR1
prerank,regulation of TORC1 signaling (GO:1903432),0.552395689718991,1.4461713835275878,0.0711864406779661,0.81821762228637,1.0,16/33,25.37%,RNF152;SESN1;GPR137;SESN2;ATM;FLCN;KPTN;DEPDC5;TELO2;RRAGD;ITFG2;DYRK3;RRAGB;DGKQ;SIK3;RRAGC
prerank,lipid translocation (GO:0034204),-0.5406678626292071,-1.4460608359322866,0.06382978723404255,0.3216860209675935,1.0,9/21,14.38%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;TMEM30A;ABCB4;ATP8B2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.462697535665693,-1.445804817167745,0.04466501240694789,0.3210367880281971,1.0,12/39,9.69%,UTRN;FGF14;HECW2;FGF12;ANK3;HECW1;CAMK2D;FXYD5;NEDD4L;WNK2;NETO1;FGF13
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7024853044523128,1.4453587123172855,0.10095238095238095,0.8178654570782943,1.0,5/10,17.01%,KMT2A;RAPGEF3;CAMK1;SPHK2;SMAD4
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3770519164081044,-1.4443817462752582,0.011673151750972763,0.32319882704847924,1.0,34/124,16.11%,FRY;NLGN1;CNTNAP2;PTPRM;CNTN4;PLP1;CARMIL1;SH3GL2;TMEM108;LYN;GSK3B;GPM6B;STX3;APP;LIMA1;STMN2;APOE;PLEKHA1;LGI1;ULK1;GPRIN3;MYOC;RASGRF1;UHMK1;ARMC2;NCDN;MAPT;ERCC6;MAP4;GPM6A;CDK5R1;STMN1;BICDL1;CEP78
prerank,regulation of mitotic nuclear division (GO:0007088),0.5071072157828845,1.4443626032009687,0.04258675078864353,0.8183557350276366,1.0,8/55,6.28%,BMP7;IGF1;ANAPC15;OBSL1;TOM1L2;PHIP;PDGFRB;CD28
prerank,protein localization to cilium (GO:0061512),0.5491133432029871,1.4437667361045534,0.05759162303664921,0.8169611668434719,1.0,10/32,15.98%,TULP3;ZNF423;IFT122;WDR19;INVS;ATP6V1D;ROPN1;WDR35;RAB29;ARL6
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.4549322545889186,-1.4430415586615635,0.04534005037783375,0.3249559235969651,1.0,21/48,17.18%,RHOJ;TMSB4X;NOS3;THBS1;HDAC9;HDAC7;AKT3;KDR;ANXA1;GATA2;TGFB1;PTGS2;JCAD;FGF2;PRKD1;HIF1A;VEGFA;SRPX2;NUS1;PIK3C2A;HSPB1
prerank,activation of protein kinase B activity (GO:0032148),0.572957450534769,1.442964629079154,0.08135593220338982,0.816590439197898,1.0,8/29,8.69%,FGF1;OSBPL8;IGF1;IL18;ADRA2A;RICTOR;NRG1;PDPK1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5625264551963888,1.441471798060839,0.07413509060955518,0.8198365326637808,1.0,10/31,10.09%,OSR1;FGFR2;HOXB4;TGFBR1;HOXB3;HOXB9;HOXA3;TGFBR2;HOXC4;DYNC2I1
prerank,positive regulation of signaling (GO:0023056),-0.4762046330165159,-1.4405809187550178,0.044854881266490766,0.3290873796709533,1.0,16/37,18.48%,GRIK2;SYT1;RIMS2;CLSTN2;RIMS1;ECE1;LGI1;NSF;EDN1;HOMER1;ILK;EDN3;SNCA;NMU;SCRIB;CDKN2AIP
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6426657978897403,-1.4403565932399192,0.08108108108108109,0.3283495230272431,1.0,5/10,10.88%,PDE4B;CACNB2;CACNA2D1;CALM1;CALM3
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6451326125172493,-1.4401150788065251,0.07883817427385892,0.32771790184538224,1.0,5/10,14.73%,HSP90AB1;SORL1;EGR1;HSP90AA1;CLU
prerank,myoblast differentiation (GO:0045445),0.6553127052264409,1.4396029416888707,0.08349514563106795,0.8252286044116781,1.0,5/14,8.90%,EPAS1;DDX5;IGF1;NRG1;TCF7L2
prerank,monosaccharide transmembrane transport (GO:0015749),0.6318074286232246,1.439398479632955,0.09225092250922509,0.8220975734920472,1.0,3/16,9.86%,SLC2A12;SLC5A3;SLC45A3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6547373400867538,-1.4390202548337632,0.07878787878787878,0.3290387973546984,1.0,5/10,8.76%,PRKG1;CD9;SERPINE2;RDX;CEACAM1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4684807544760462,1.4384212976809705,0.041428571428571426,0.8225558901952839,1.0,7/90,2.05%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,protein K63-linked ubiquitination (GO:0070534),0.5176724177128378,1.4359045549228422,0.05687203791469194,0.8307160644298813,1.0,7/41,7.25%,RNF152;UBE2E2;PRKN;NEDD4;RNF135;TRIM56;RNF8
prerank,transcription by RNA polymerase II (GO:0006366),0.4037878257633835,1.4354594624022214,0.005753739930955121,0.8286477841707274,1.0,77/305,17.43%,NOTCH2;RORA;MAF;THRB;GLIS3;DDX5;PPARGC1A;CCN2;PPARA;POLR2A;SOX5;NCOR2;CTR9;ELOF1;NR6A1;DTX1;PABPN1;ATOH1;RREB1;TTF2;TEAD3;PHAX;AFF4;ESRRA;TBL1X;RORC;WWTR1;CCNT2;TSC22D1;RPRD2;NR1D2;POLR2D;TBL1XR1;HDAC1;TFDP1;NR2C2;TEAD2;ELL;GTF2A1L;MED17;GTF2F1;INTS10;SCAF8;RTF1;TEAD1;RARG;MNT;NELFCD;ZBTB1;NOCT;TAF11;DEAF1;INTS2;INTS5;TAF4;TBP;NCOR1;PMF1;NR3C2;NFKB1;TAF7;KAT2B;CTDP1;INTS3;CREBBP;MED23;CPSF3;MED26;RXRA;INTS1;TAF13;GTF2I;YAP1;INTS7;INTS8;CSTF1;MED1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6236240364555532,-1.4354437511021212,0.07302231237322515,0.3353642808642366,1.0,7/11,32.45%,CAT;GPX1;PRDX1;GPX3;PRDX2;PRDX4;PRDX3
prerank,ubiquinone metabolic process (GO:0006743),0.6404186792153543,1.4353350735376897,0.10144927536231885,0.8250837309896012,1.0,7/15,15.19%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,ERBB2 signaling pathway (GO:0038128),-0.4765003334925966,-1.4346796769303838,0.05822784810126582,0.3360124845652796,1.0,9/31,10.29%,ERBB4;PIK3R1;PTPN12;GAB1;NRG2;MYOC;ERBB2;ERBIN;HSP90AA1
prerank,microvillus organization (GO:0032528),-0.6146806720956239,-1.434344163623807,0.07142857142857142,0.33564271047485883,1.0,6/13,10.17%,FXYD5;MINK1;RAP1B;RAP1A;RAPGEF6;RAP2A
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4587121954485507,-1.4342597556867083,0.05641025641025641,0.3346292777876706,1.0,14/41,10.14%,SLC8A1;SLC24A2;RYR2;HTR2C;GRIN2B;CACNA2D1;RYR3;PTPRC;PLCG2;HTR2A;GRIN2A;TRPV4;FGF2;ATP2B4
prerank,positive regulation of hormone secretion (GO:0046887),0.6168984068596843,1.4328136689026354,0.11827956989247312,0.8332893790828754,1.0,2/17,2.01%,C1QTNF3;SPP1
prerank,regulation of protein neddylation (GO:2000434),0.7005577201800883,1.4324094761232045,0.09980806142034548,0.830989908399069,1.0,1/10,0.14%,EPAS1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.5127384155975406,1.4321191246111635,0.07981220657276995,0.8281732496093602,1.0,11/44,14.38%,PRKAG2;CYP27A1;ALOX12;INSIG2;AMACR;OSBPL9;TM7SF2;ACOT8;SRD5A2;LBR;PER2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.6314994715950049,-1.4316246156012946,0.06540084388185655,0.3395323792309551,1.0,6/11,21.54%,MERTK;CXCL12;GAS6;NOD2;CCL19;HCLS1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5528731792601518,-1.4311244768963889,0.06581740976645435,0.3394312605237002,1.0,10/17,31.45%,NLGN1;CACNA1G;RAB27A;KCNB1;CACNA1H;SYT10;DOC2B;STX1A;RAB3A;SCAMP5
prerank,GTP metabolic process (GO:0046039),0.6385597656706115,1.4309391044712778,0.10784313725490197,0.8300574370887709,1.0,5/15,9.55%,RHOQ;LRRK2;OPA1;AK4;AK3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6101104001263482,1.430349530602236,0.11073253833049404,0.8288777856086376,1.0,7/18,14.57%,DAB2;EZR;PTPN23;SNX12;MAP2K1;MAP2K2;RAB21
prerank,regulation of secretion by cell (GO:1903530),-0.43244560892810924,-1.4301010816033881,0.022792022792022793,0.34058076661920433,1.0,11/54,9.32%,MEF2C;SYT1;RIMS2;MCTP1;RIMS1;STXBP5L;RAB3C;ANXA1;DNAJC1;DISP1;NSF
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3850878813472197,-1.429469289066978,0.020761245674740483,0.34093654397328166,1.0,28/99,15.03%,SLIT2;MEF2C;PDE3A;ACTB;AKAP6;HCN1;GABRB3;GABRB1;RYR3;GABRB2;RAP1B;RAP1A;KCNQ1;SH3BP4;GLRA1;GABRG2;EGR1;PDE2A;P2RY12;CAPN2;CDH1;CTNNB1;SPAAR;GLRA2;DMTN;P2RY1;HTR1B;TRPM2
prerank,phospholipid catabolic process (GO:0009395),-0.5206671355616543,-1.4291569617261504,0.05755395683453238,0.3404022213693633,1.0,6/24,11.65%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;SMPDL3A
prerank,atrial septum development (GO:0003283),0.6606388731126732,1.4289097223072422,0.10841121495327102,0.8319961223922367,1.0,2/13,0.78%,NOTCH2;ANK2
prerank,early endosome to late endosome transport (GO:0045022),0.6030863234026992,1.4278406433736022,0.08862876254180602,0.8327555953139085,1.0,14/20,24.73%,HOOK2;PTPN23;BECN1;ANKRD27;SNF8;EEA1;HOOK3;WDR91;WDR81;RAB7A;PIK3C3;RILP;HOOK1;KIF16B
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5793552927196963,1.4269774868342544,0.0989010989010989,0.8327669993827512,1.0,6/23,12.06%,TGFBR3;FGFR2;TPM1;ADAMTS9;TNNI3;TNNC1
prerank,organic hydroxy compound transport (GO:0015850),-0.4690162443257275,-1.4269699047523392,0.04714640198511166,0.34403189524232436,1.0,9/36,9.05%,ABCC4;ATP8B1;SLCO1C1;SLC16A1;SLCO2B1;STRA6;NPC2;CEACAM1;STARD5
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.5976811277759826,-1.4261684770141974,0.06048387096774194,0.3448056788185484,1.0,4/13,10.04%,PTPRT;PTPRC;HES1;MGAT5
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5372388339877782,-1.4260564638919637,0.052980132450331126,0.3438850373281318,1.0,8/20,15.60%,KCNB2;CAV1;PLCE1;CHRM3;CHRM2;ATP2B1;MYOCD;NMU
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5555612314790863,-1.4251829108384897,0.07724425887265135,0.34467181806012714,1.0,5/17,8.94%,SLIT2;CASK;SFRP4;TMEM204;PCSK6
prerank,protein autoubiquitination (GO:0051865),0.48987940640713673,1.4251396685191848,0.05591054313099041,0.8376873274778466,1.0,16/61,16.01%,RNF220;SH3RF2;PRKN;RNF213;RNF181;RNF8;RNF141;SH3RF1;RNF41;RNF13;WWP2;DDB2;RNF115;AMFR;RNF19B;RNF146
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.42730439586161956,-1.4241895653303733,0.04285714285714286,0.3456802154685606,1.0,16/55,11.07%,GPC5;GPC6;DCN;CEMIP;BGN;LUM;CSPG4;SDC3;VCAN;HSPG2;HEXB;TGFB1;FGF2;CD44;AGRN;GPC4
prerank,bile acid and bile salt transport (GO:0015721),-0.5218998246562371,-1.4240579245033043,0.06466512702078522,0.3447730628873638,1.0,6/24,9.05%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1;STARD5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.46883475115314877,-1.423555274088242,0.04580152671755725,0.34470692371855594,1.0,14/35,20.77%,HEG1;TGFB2;RASIP1;DAB2IP;MET;KCTD10;EPHB2;MYOC;CUL3;SPRY1;STMN1;KANK1;SPRY4;ARHGAP44
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6683116240233307,1.4233082117300782,0.1087378640776699,0.8426212414403753,1.0,4/10,9.84%,ST6GAL1;RENBP;NPL;GNPDA1
prerank,activin receptor signaling pathway (GO:0032924),0.6340842886314494,1.4226072769988531,0.09073724007561437,0.8421311542218765,1.0,4/15,14.49%,SMAD3;TGFBR1;ACVR2B;ACVR1B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5994379979256933,1.4220856386225802,0.09074733096085409,0.8408168198905248,1.0,5/20,6.77%,DAB2;PICALM;RHOQ;PPFIA1;CLTC
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.40034854421660504,-1.4220351730957201,0.023529411764705882,0.3470917201853346,1.0,22/75,10.77%,CTNNA2;MEF2C;MAP1B;KLF7;ANK3;ACTB;CNTN4;DCC;PAK3;NTNG1;DSCAML1;S100A6;SHTN1;MINK1;APP;NRCAM;BTBD3;MAP6;S100B;SLITRK1;PLPPR4;MFSD2A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6856567915861983,1.4216489844360745,0.10575139146567718,0.8388475956927907,1.0,4/10,8.78%,ALDH7A1;HNMT;SMOX;LRTOMT
prerank,positive regulation of neuron projection development (GO:0010976),-0.3948571008901903,-1.4216417837363156,0.019933554817275746,0.3467872915279404,1.0,33/85,15.64%,BMP5;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;RIT2;PTK2B;TOX;FUT9;NDNF;SERPINI1;NTRK2;LYN;DAB2IP;RAP1A;STMN2;APOE;ROR2;RELN;SCARF1;PTN;PLPPR5;MARK2;PRKD1;VLDLR;LRP8;RET;FES;COBL;PACSIN1;BDNF
prerank,positive regulation of integrin activation (GO:0033625),-0.6224046734301667,-1.4211718159271194,0.09207708779443255,0.3466139311922525,1.0,5/11,15.96%,RASIP1;RAP1B;PIEZO1;P2RY12;SKAP1
prerank,mesoderm formation (GO:0001707),-0.5555841112783865,-1.421057651789718,0.09360730593607305,0.3457431541207384,1.0,6/17,14.73%,BMPR2;ITGB4;ITGB1;ITGB3;ITGA8;ITGA2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.6315733236030924,-1.4205851074641087,0.06736842105263158,0.3456333166041784,1.0,5/10,8.59%,CST3;FAP;NOTCH1;TNFRSF1B;TGFB1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6279645023241193,1.4197788868636256,0.1087378640776699,0.8438485379069105,1.0,3/16,2.65%,FGF1;NPNT;FOXD1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6572616079866349,1.4195273990223805,0.1147227533460803,0.8411122945252554,1.0,3/11,9.65%,COLEC12;TLR3;RIPK1
prerank,fibrinolysis (GO:0042730),0.6516403236807258,1.418771666150956,0.11090573012939002,0.8407550333261936,1.0,5/13,14.78%,KRT1;F2;SERPINE1;HRG;PLAT
prerank,cellular response to BMP stimulus (GO:0071773),0.4770656590643071,1.4180985492117728,0.06656580937972768,0.8401054817937379,1.0,9/66,5.55%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5700242497776167,-1.417566113748515,0.09282700421940929,0.35108259079522464,1.0,3/14,0.36%,PRKG1;SLIT2;MEF2C
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49988552344612286,-1.4174793530917176,0.08200455580865604,0.35009555560378136,1.0,12/26,14.22%,SLC39A10;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC30A1;SLC39A12;MT3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.38352628911198283,1.416824449132522,0.0010695187165775401,0.8421826922362108,1.0,104/572,12.55%,PRDM6;AEBP1;DAB2;WWOX;BMP6;THRB;SMAD3;GLIS3;OSR1;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;FOXP4;PRKN;GLI2;DNMT3A;FNIP1;KANK2;ZHX2;ZNF568;MOSPD1;NR2F2;NCOR2;HDAC8;KCNIP3;GLI3;MITF;CTR9;SUFU;NR6A1;CXXC5;PHF21A;FOXC1;NEDD4;PCGF2;NFIB;IFI27;NACC2;EZR;FOXP2;RREB1;CUX2;NSD1;USP9X;WWC2;OTP;GPS2;MAP2K5;ATRX;LCOR;TBL1X;TP53;SMURF2;NIPBL;BHLHE41;RORC;LDB2;LDB1;NR1D2;BCOR;SMARCA4;CBX7;KDM2B;SPEN;MEF2A;TBL1XR1;CPEB3;TCF7L2;IRX1;NUPR2;HDAC1;NR2C2;PARP9;HDAC4;SIRT1;ZFP90;SOX13;LARP7;FOXC2;PRDM5;ZNF219;ATN1;AASS;AURKB;RTF1;RARG;NFATC3;MNT;DICER1;CBX5;IMPACT;SNAI1;SKOR1;ZBTB1;WWP2;ZNF148;DEAF1;FRK;ZMYM5;KMT5A
prerank,Rac protein signal transduction (GO:0016601),-0.5486793453119284,-1.4167477546022458,0.07900677200902935,0.35064464731833206,1.0,8/18,18.64%,CDH13;TIAM1;RHOH;EPS8;ELMO1;HACE1;WASF1;NCKAP1
prerank,regulation of protein localization to membrane (GO:1905475),-0.4864347306404673,-1.416278301240569,0.05060240963855422,0.3505235500406316,1.0,8/28,11.10%,SPTBN1;GPC5;GSN;ACTB;GPC6;AR;GPC4;ZDHHC2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.6210706950774707,-1.4158998293816563,0.08695652173913043,0.3501885974273237,1.0,3/11,5.65%,MEF2C;LYN;ANXA1
prerank,response to histamine (GO:0034776),-0.6321439815964955,-1.415850337301688,0.07368421052631578,0.3491596542178213,1.0,6/10,21.03%,GABRB3;GABRB1;GABRB2;GABRG2;HRH1;DRD2
prerank,metanephric mesenchyme development (GO:0072075),0.6722491049676993,1.4155351253244821,0.10220440881763528,0.8445605973409582,1.0,2/10,1.08%,WNT4;OSR1
prerank,ubiquinone biosynthetic process (GO:0006744),0.6295777748202961,1.4127954587871636,0.11818181818181818,0.8535816891029637,1.0,10/15,24.26%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7;COQ6;NDUFA9;COQ9
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6798779203415575,1.4127415023012975,0.1298449612403101,0.8460353035059355,1.0,7/10,17.70%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6798779203415575,1.4127415023012975,0.1298449612403101,0.8460353035059355,1.0,7/10,17.70%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,T cell differentiation (GO:0030217),0.5171080417082227,1.4119147689170475,0.0744336569579288,0.8459590231047033,1.0,11/40,12.65%,LEPR;KIT;GLI3;NHEJ1;CD28;CHD7;PTPN22;TCF7;SOX13;ADAM17;LMBR1L
prerank,quinone biosynthetic process (GO:1901663),0.6424285429325806,1.4117644356962107,0.12432432432432433,0.8428842524321306,1.0,7/14,15.19%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5994118423063213,-1.4114284281251979,0.08387096774193549,0.35787249383619263,1.0,4/12,10.68%,SLIT2;BMP5;CCN3;DUSP1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.598742893297934,1.4106480102215615,0.08888888888888889,0.8445809353658588,1.0,3/20,3.48%,EPAS1;PRKN;TGFBR1
prerank,retinoid metabolic process (GO:0001523),0.4663851254126894,1.410567205870605,0.06086956521739131,0.84120821244809,1.0,14/71,8.24%,ALDH1A2;ABCA4;NAPEPLD;RBP1;ALDH1A1;AKR1B10;CYP26B1;APOM;RHO;DHRS3;PNLIP;SCPEP1;RBP4;LRP1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.467642351110653,-1.409741561521421,0.05822784810126582,0.36052987841137696,1.0,10/36,10.45%,RHOBTB1;XKR4;GSN;THBS1;XKR6;MYH9;DOCK1;ARHGAP25;RHOH;ELMO1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5900917402881627,-1.40924279759706,0.09896907216494845,0.3605065446728151,1.0,5/12,10.14%,SEMA6A;DCN;DAB2IP;XDH;ATP2B4
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6192369083494121,1.4090319425250286,0.10707456978967496,0.8448785942777689,1.0,6/15,15.90%,PRODH;ALDH4A1;GGACT;GOT2;ABHD12;SARDH
prerank,regulation of heart contraction (GO:0008016),0.45274516776385404,1.4071139832874386,0.05747126436781609,0.8501644758297572,1.0,14/90,7.33%,ATP1A2;CELF2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;TPM1;NPR2;AHCYL1;APLN
prerank,peptidyl-lysine acetylation (GO:0018394),0.6725859009084886,1.406970992908799,0.11650485436893204,0.8470099234300998,1.0,7/10,23.28%,SIRT1;KAT7;KAT2B;CREBBP;BAG6;EP300;ESCO1
prerank,regulation of lipid metabolic process (GO:0019216),0.4589227207482157,1.4069413880661534,0.048104956268221574,0.8434415338549952,1.0,15/88,8.47%,PRKAG2;RORA;NFYC;CHD9;PPARA;NCOR2;NFYB;GPS2;TBL1X;C1QTNF2;SMARCD3;RORC;ANGPTL8;NR1D2;TBL1XR1
prerank,triglyceride biosynthetic process (GO:0019432),0.6146910470578719,1.405719187519896,0.09090909090909091,0.8454369014929515,1.0,4/18,7.09%,LPGAT1;MOGAT3;GPAT2;GK
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5136114419683244,-1.4041849296896065,0.072992700729927,0.37105613663180204,1.0,3/22,0.98%,PDE4B;CACNB2;AHNAK
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5917876847113838,1.4037592050467107,0.09187279151943463,0.851087039909696,1.0,5/20,6.77%,DAB2;PICALM;RHOQ;PPFIA1;CLTC
prerank,amyloid-beta metabolic process (GO:0050435),0.6086181812012035,1.4037222767571274,0.09363295880149813,0.8475390044542225,1.0,5/16,10.71%,ACE;BACE2;MGAT3;APH1B;DYRK1A
prerank,neurotransmitter uptake (GO:0001504),0.6514007525682157,1.4024197781904522,0.10922787193973635,0.8497140320568877,1.0,4/12,9.78%,ATP1A2;SLC1A3;SLC38A1;GLUL
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3879438463037554,-1.402064960187762,0.03257328990228013,0.37447416361265456,1.0,26/79,16.16%,SLIT2;BMPER;BMPR2;THBS1;HTRA3;CASK;VWC2;NOTCH1;VWC2L;EPN2;DAB2IP;SMAD5;SORL1;BMP2;SMAD1;SMAD7;FGF2;ATP2B4;LEMD3;UBE2D3;CREB3L1;SPRY1;BMPR1B;SMURF1;HIPK2;HHEX
prerank,hepaticobiliary system development (GO:0061008),0.5903762798123934,1.4014498235346227,0.11247803163444639,0.8506033382391835,1.0,6/20,13.06%,TGFBR3;WNT4;NIPBL;CDK5RAP3;PHF2;PRKCSH
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4001535825945918,-1.401150177987902,0.04451038575667656,0.3753889150045381,1.0,33/70,36.60%,B2M;PSMB2;MFSD6;CALR;NCF2;PSMD14;PDIA3;PSMC6;CYBA;IKBKB;PSMB9;PSMA4;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;SEC22B;FCGR1A;PSMD7;CD36;PSMF1;NCF1;PSMA5;PSME4;PSMA7;PSMD3;PSMD4;VAMP3
prerank,regulation of T cell chemotaxis (GO:0010819),0.6633801290357618,1.400940663965271,0.11928429423459244,0.8493754928899744,1.0,5/11,17.33%,OXSR1;ADAM17;WNK1;WNT5A;CCR2
prerank,regulation of phospholipase activity (GO:0010517),0.6631519105130845,1.4007212161571911,0.156,0.8468229707520364,1.0,4/10,8.69%,FGFR2;FGFR1;LRP1;PDPK1
prerank,steroid biosynthetic process (GO:0006694),0.48863620963658355,1.400488571306755,0.058823529411764705,0.8442797470701834,1.0,8/56,6.82%,PRKAG2;CYP27A1;INSIG2;CYP21A2;AMACR;FDXR;OSBPL9;DHRS11
prerank,mitotic sister chromatid cohesion (GO:0007064),0.6153262678662821,1.3993809673578441,0.1266294227188082,0.8458946111839181,1.0,7/16,18.58%,DSCC1;NIPBL;PDS5A;MAU2;REC8;RB1;PDS5B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6282873003519123,-1.3989725916394393,0.09218436873747494,0.37919290520341487,1.0,5/10,18.33%,PTPRJ;PTPN12;APOD;SNCA;NDRG4
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4029215994705729,-1.398106035683787,0.03426791277258567,0.3800537075449116,1.0,26/67,17.18%,NRP1;PIK3R1;VEGFC;NRP2;NCK2;PTK2B;KDR;DOCK1;CLEC14A;DAB2IP;CRK;PTK2;NCF2;ABI1;FLT4;HSP90AA1;ITGB3;BCAR1;ELMO1;CYBA;PRKD1;VEGFA;NCK1;WASF2;VAV1;HSPB1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5825473731399586,1.3979813636296956,0.11713286713286714,0.849105698078116,1.0,3/22,1.85%,NOTCH2;STXBP4;FGFR2
prerank,fatty acid beta-oxidation (GO:0006635),0.49433034450023877,1.3972371284670606,0.06677018633540373,0.8490018384366463,1.0,24/51,21.73%,IVD;ACAD11;AMACR;ACAD10;BDH2;CPT2;ACADM;MECR;ACOXL;ACOT8;CRAT;ACOX3;GCDH;ECHDC1;DECR1;EHHADH;SLC25A17;ECI2;ETFDH;CROT;ACADS;HADHA;HADH;ECHS1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6282105398311938,1.3970971547460904,0.11688311688311688,0.8462232845076514,1.0,5/15,9.06%,WNT6;GLI2;FOXC1;EDA;HDAC1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6061227389873096,1.3969266605410107,0.1079646017699115,0.8434394972090766,1.0,5/17,11.31%,BMP6;SASH1;LY96;TRIB1;PRKCA
prerank,lamellipodium assembly (GO:0030032),-0.48463096292236574,-1.3967814672787273,0.09135802469135802,0.38188224080704825,1.0,14/26,13.15%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ABLIM3;ARHGEF7;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5866022001640929,-1.3965798686706317,0.09887640449438202,0.38115387820552343,1.0,5/13,18.38%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5393588391453454,1.3961450542458367,0.09932659932659933,0.8434290978165845,1.0,8/29,16.29%,SMAD3;ZC3H7B;HNRNPA2B1;SNIP1;TUT4;DICER1;PUS10;TUT7
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.605862686685145,-1.3956955540835927,0.12557077625570776,0.3820888583548439,1.0,6/11,7.88%,KCNJ3;KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5822665964277572,1.3956778006886308,0.11304347826086956,0.842047312854745,1.0,4/18,6.62%,GPR137;TLR3;TLR4;FBN1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6116865749304249,1.3954264179145837,0.10968921389396709,0.8397356411195656,1.0,6/15,12.74%,LPGAT1;PPARGC1A;PPARA;SLC45A3;MLYCD;MLXIPL
prerank,histone H3-K9 demethylation (GO:0033169),0.6522371298909219,1.3952016618174217,0.14653465346534653,0.8372753818603197,1.0,3/11,11.59%,KDM7A;HR;KDM3B
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.6061784330975237,-1.3947003876456228,0.09832635983263599,0.38319442193156944,1.0,6/12,20.64%,NOTCH1;JAG1;HES1;N4BP2L2;NELFB;YTHDF2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5488261419448678,1.3946081656181848,0.09515570934256055,0.8366189319093914,1.0,9/29,12.82%,LPGAT1;SORBS1;PPARA;ZBTB20;CREBL2;SLC27A1;SLC45A3;MLXIPL;SIRT4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4350602410519081,-1.3943508530313848,0.05063291139240506,0.3828238745740937,1.0,12/45,10.38%,RPS6KA5;PIK3R1;PLCE1;REPS2;IQGAP1;NCK2;GAB1;PTK2B;TGFB1;PTK2;ERBIN;BCAR1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6039320583695125,-1.394306030366733,0.10337552742616034,0.38175419950993417,1.0,5/12,6.64%,PODXL;PROM1;IQGAP1;JAG1;BASP1
prerank,acylglycerol homeostasis (GO:0055090),0.5880987526049574,1.3935002260264315,0.09838998211091235,0.8384010748631817,1.0,5/20,12.74%,RORA;IL18;ANGPTL8;PLA2G12B;MLXIPL
prerank,chromatin assembly or disassembly (GO:0006333),0.6584881442565178,1.3933340443934028,0.115234375,0.835783016122699,1.0,5/11,14.68%,HDAC8;CHAF1B;TP53;CDAN1;MTA2
prerank,gene silencing by miRNA (GO:0035195),0.5200237569779445,1.3931301037086352,0.1,0.8333979994999867,1.0,16/32,26.22%,TNRC6A;ZC3H7B;SNIP1;TNRC6B;MOV10;AJUBA;DICER1;TNRC6C;WTIP;RBM4;AGO1;XPO5;SPOUT1;AGO2;PUM2;AGO4
prerank,homocysteine metabolic process (GO:0050667),0.6449232686064238,1.393011765617914,0.12208258527827648,0.8304809925147776,1.0,5/11,12.23%,CPS1;MTHFR;CTH;NOX4;MTRR
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.42240015026678723,1.3918193970888837,0.040973111395646605,0.8327068920269233,1.0,21/152,9.18%,RNF220;WNT5B;LRRK1;LGR4;RSPO2;WLS;PTK7;FGFR2;LRRK2;SULF2;DDX3X;CAPRIN2;TBL1X;SMURF2;SMARCA4;TNKS2;TERT;ADGRA2;TBL1XR1;GPRC5B;UBR5
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5582514912152917,1.3911466128311287,0.09595959595959595,0.8326078245813909,1.0,5/27,7.39%,C1QTNF3;SYT11;TLR4;ARRB1;PTPN22
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4758849790062637,-1.3908257763853444,0.0625,0.38876827158950794,1.0,6/27,2.43%,PDE4D;PDE4B;CAV1;CTNNA3;RYR2;CAMK2D
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6094197106435928,-1.3907823171984015,0.10964912280701754,0.3864639901054558,1.0,5/11,19.88%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),-0.6094197106435928,-1.3907823171984015,0.10964912280701754,0.3864639901054558,1.0,5/11,19.88%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,regulation of neuron differentiation (GO:0045664),-0.3913768491568417,-1.3906765681788602,0.04416403785488959,0.38554703061143786,1.0,22/76,10.02%,NLGN1;MEF2C;ZFHX3;BRINP3;CNTN4;BRINP1;NGF;VWC2;ARHGEF2;TIAM1;BEND6;HES1;NRCAM;YWHAG;HEYL;SIX1;BMP2;BIN1;CALR;BRINP2;CDK5RAP2;ID2
prerank,regulation of urine volume (GO:0035809),0.6701303397823462,1.3906212044081097,0.13717693836978131,0.8316636972822495,1.0,4/10,13.78%,NPR1;NPR3;ADM;ADCY6
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6555552852997721,1.3901779258755953,0.14885496183206107,0.8305462223286781,1.0,3/12,6.56%,IL18;IL17D;IL12B
prerank,positive regulation of metabolic process (GO:0009893),0.44602135881000693,1.3896173732790165,0.0425531914893617,0.8298284000962393,1.0,7/103,2.05%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,regulation of tube diameter (GO:0035296),0.64407897123889,1.389322931584736,0.11776061776061776,0.8246152211502136,1.0,4/13,7.48%,ROCK2;ACE;NPR1;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.64407897123889,1.389322931584736,0.11776061776061776,0.8246152211502136,1.0,4/13,7.48%,ROCK2;ACE;NPR1;SCPEP1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.42081703738395676,-1.3889766714809555,0.0443213296398892,0.38842790604724886,1.0,19/54,18.24%,MEF2C;TMSB4X;NOS3;THBS1;ACVRL1;AKT3;KDR;APOE;GATA2;TGFB1;FGF2;ATP2B4;PRKD1;HIF1A;VEGFA;NUS1;ANGPT2;HSPB1;RGCC
prerank,cortical actin cytoskeleton organization (GO:0030866),0.57934145947692,1.3881703056313963,0.1353637901861252,0.8267389351937581,1.0,4/20,2.11%,ROCK2;RHOQ;DLG1;FHOD1
prerank,regulation of neuroinflammatory response (GO:0150077),0.5806305008163586,1.3879013751863671,0.11683848797250859,0.8247266274892648,1.0,5/19,6.57%,IGF1;IL18;SPHK1;NUPR1;DAGLA
prerank,diol metabolic process (GO:0034311),-0.5167235301491512,-1.3874334831647455,0.10648148148148148,0.3908097713961878,1.0,8/19,11.54%,NOS3;PLPP1;DEGS2;CALM1;GCH1;HSP90AA1;PRKG2;ASAH2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5731872828421577,-1.3872472188502964,0.10425531914893617,0.3900722531571653,1.0,4/15,6.71%,SCARB1;PLTP;APOE;ABCG1
prerank,neuron projection morphogenesis (GO:0048812),-0.3565569601736507,-1.3870267513930838,0.0,0.38942794210512294,1.0,37/137,10.07%,NLGN1;CNTNAP2;CTNND2;CTNNA2;DCLK1;DOCK10;MAP1B;SHANK3;KLF7;ANK3;ACTB;EPHB1;CNTN4;DCC;NYAP2;IQGAP1;PAK3;EPB41L3;NTNG1;NGF;DSCAML1;S100A6;TRIO;NRK;SHTN1;DAB2IP;MINK1;PAK1;APP;NRCAM;EPHB2;SLC9A6;BTBD3;MAP6;S100B;SLITRK1;PLPPR4
prerank,monocarboxylic acid transport (GO:0015718),0.4866444320599069,1.3862554622511178,0.08240887480190175,0.8292047622203677,1.0,8/51,7.06%,SLC16A6;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC10A4;SLC16A13;SLC27A1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.6014604888515843,1.3861850251662848,0.11596958174904944,0.8263673993746666,1.0,10/18,16.90%,MSRA;ASPA;ASPG;MTHFR;GOT2;ADI1;SLC25A12;FOLH1;GOT1;MTHFD1
prerank,regulation of plasminogen activation (GO:0010755),-0.5853913012121288,-1.3858621995739846,0.10677618069815195,0.39098592570478485,1.0,3/12,4.23%,SERPINE2;THBS1;RUNX1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.4000438839208219,-1.3855800696091394,0.043478260869565216,0.3903931351420502,1.0,32/67,36.60%,B2M;PSMB2;CALR;NCF2;PSMD14;PDIA3;PSMC6;CYBA;IKBKB;PSMB9;PSMA4;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;SEC22B;FCGR1A;PSMD7;CD36;PSMF1;NCF1;PSMA5;PSME4;PSMA7;PSMD3;PSMD4;VAMP3
prerank,cilium-dependent cell motility (GO:0060285),0.5620358598398164,1.3854630117333209,0.12084063047285463,0.826382186800818,1.0,1/22,0.21%,CFAP44
prerank,positive regulation of transmembrane transport (GO:0034764),0.6310873539960126,1.3852579078821148,0.14620938628158844,0.8241233458971396,1.0,7/13,17.88%,ACSL1;BRAF;ANO6;AZIN1;CLIP3;C2CD5;AZIN2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4518449937917766,-1.3851661165507174,0.08163265306122448,0.39015241131280937,1.0,16/34,17.18%,NRP1;SEMA6A;VEGFC;GAB1;NOTCH1;KDR;RAMP2;ANXA1;DAB2IP;FLT4;MT1G;PRKD1;VEGFA;NUS1;NR4A1;HSPB1
prerank,regulation of TOR signaling (GO:0032006),0.47479472970225356,1.3851021852812186,0.06358381502890173,0.821663337093289,1.0,34/67,26.26%,PRKAA2;FNIP1;PKHD1;NPRL3;DEPTOR;NPRL2;UBR2;RICTOR;PIK3CA;SIRT1;ARAF;FLCN;ROS1;DEPDC5;TSC1;RPTOR;WDR24;TMEM127;UBR1;TELO2;TBC1D7;RRAGD;TSC2;ITFG2;LAMTOR1;GSK3A;DYRK3;TBCK;RRAGB;SLC38A9;DGKQ;RRAGC;HTR6;SEC13
prerank,regulation of endothelial cell migration (GO:0010594),-0.3922060324290363,-1.3848617631403313,0.030821917808219176,0.38965960378579234,1.0,31/85,10.83%,NRP1;SLIT2;PTPRM;TEK;BMPER;RHOJ;BMPR2;THBS1;DCN;NRP2;PTK2B;SCARB1;ACVRL1;KDR;GPI;DAB2IP;FOXP1;APOE;RHOB;PROX1;ATOH8;CEACAM1;CALR;PTK2;FLT4;PTN;FGF2;ITGB3;BCAR1;EDN1;BMP4
prerank,T cell migration (GO:0072678),-0.5853651337590102,-1.3841900760272952,0.1040339702760085,0.3899311941469412,1.0,7/13,29.53%,SLC12A2;S1PR1;CXCL16;MSN;PIK3CD;CXCL10;MYO1G
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5512047047752996,-1.3831950044016745,0.08370044052863436,0.391290114837193,1.0,8/17,21.80%,PODXL;TGFB2;PIEZO1;P2RY12;RET;SKAP1;SYK;RAC3
prerank,striated muscle contraction (GO:0006941),0.48101088043538204,1.383131053848298,0.07740916271721959,0.8272738297417906,1.0,13/53,12.06%,ATP1A2;CSRP3;RCSD1;PGAM2;DTNA;TPM1;KLHL41;CCDC78;ARHGEF11;PIK3CA;MYL4;TNNI3;TNNC1
prerank,regulation of biomineral tissue development (GO:0070167),-0.4893365992988772,-1.383052527682658,0.08274231678486997,0.39041677627274135,1.0,11/26,13.52%,NOS3;SGMS2;GAS6;NOTCH1;ECM1;ENPP1;TGFB1;S1PR1;HEY2;TWIST1;TXLNG
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4538549503948175,-1.3829256270275356,0.07012987012987013,0.38948059488312786,1.0,12/36,14.52%,CAV1;NOS3;NOSTRIN;SCARB1;CALM1;GCH1;APOE;ATP2B4;HSP90AA1;HIF1A;CYGB;NUS1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6143035151515878,-1.38262181503283,0.10816326530612246,0.38910501882533655,1.0,7/10,27.39%,APOE;TMEM30A;ABCB4;TRIAP1;ABCA3;PRELID1;DBI
prerank,calcium ion transport into cytosol (GO:0060402),-0.5108060550266583,-1.3820419171401723,0.08584686774941995,0.3893619344236923,1.0,11/21,17.08%,SLC8A1;RYR2;GRIN2B;CACNA2D1;GRIN2A;TRPV4;ATP2B4;JPH2;TRPM2;GRIN1;ITPR3
prerank,cellular response to type I interferon (GO:0071357),0.5135793178514892,1.381432866887685,0.07653061224489796,0.828584012479768,1.0,14/41,16.32%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;IFI35;OAS3;IFNAR2;SP100
prerank,type I interferon signaling pathway (GO:0060337),0.5135793178514892,1.381432866887685,0.07653061224489796,0.828584012479768,1.0,14/41,16.32%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;IFI35;OAS3;IFNAR2;SP100
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6585722542968477,1.3809555892831584,0.13836477987421383,0.8276423806076428,1.0,2/10,3.76%,ATP1A2;ADRA2A
prerank,synaptic vesicle localization (GO:0097479),-0.5869344969307015,-1.3807080353877133,0.10217391304347827,0.39114697646867136,1.0,5/13,13.42%,NLGN1;SYNDIG1;RAB27A;KIF5C;TMEM230
prerank,inorganic cation transmembrane transport (GO:0098662),0.39412117118646023,1.3801057335425397,0.023121387283236993,0.828018828652,1.0,31/268,8.80%,TRPM3;ATP1A2;SLC6A13;KCNK2;SLC6A1;CACNA1D;SLC41A1;SLC24A3;SLC6A12;ATP1B3;TRPM6;KCND3;KCNA5;LRRC38;SLC8A3;SLC30A10;ATP6V0E1;CACNA1C;SLC30A2;SLC6A9;KCNS1;P2RX3;ATP4A;SLC1A3;CCDC51;TRPM5;ANO6;KCNH4;SLC39A13;SLC6A4;KCNJ14
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5815534026001449,-1.3798720475523176,0.10647181628392484,0.3919862600961029,1.0,9/13,20.57%,TGFB2;SEMA7A;PLCG2;TGFB3;TGFB1;IRAK3;LAPTM5;CD74;CUEDC2
prerank,peptide metabolic process (GO:0006518),0.4607899579083121,1.3797395151140122,0.06616541353383458,0.8265290922568859,1.0,11/75,10.40%,AEBP1;ACE;CPQ;BACE2;GSTT1;MGAT3;NAALADL1;TPP1;CTNS;NPEPPS;GSTA3
prerank,establishment of endothelial barrier (GO:0061028),-0.4837657298378929,-1.379694933332914,0.08478802992518704,0.3913121403191999,1.0,13/29,11.98%,PDE4D;PECAM1;PPP1R16B;F11R;RAP1B;RAP1A;ICAM1;ROBO4;RDX;RAPGEF6;PDE2A;MSN;SOX18
prerank,cellular metal ion homeostasis (GO:0006875),0.4441913311657361,1.3795811668204256,0.06336088154269973,0.8241455802288095,1.0,11/102,3.58%,ATP1A2;ATP13A5;SLC41A1;SLC24A3;ATP1B3;ANK2;ATP13A3;SLC8A3;PKHD1;CSRP3;DMPK
prerank,regulation of catabolic process (GO:0009894),-0.5241215530357444,-1.3795129689154542,0.09691629955947137,0.390593346354106,1.0,7/18,18.35%,FAP;NEDD4L;ITGB1;ZDHHC2;RARRES2;HPGD;CHEK2
prerank,chromatin disassembly (GO:0031498),0.6154870442326477,1.3793475314431185,0.15458015267175573,0.8189981572240067,1.0,6/14,9.31%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),0.6154870442326477,1.3793475314431185,0.15458015267175573,0.8189981572240067,1.0,6/14,9.31%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.44947371095758964,-1.3787285975577588,0.06516290726817042,0.3913178353821887,1.0,11/37,10.88%,PPP1R16B;PPP2R5A;PPIA;YWHAB;CALM1;CAMTA1;CALM2;TGFB1;PPP1R16A;MFHAS1;CALM3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.6054660201879631,-1.3780707431397339,0.10474308300395258,0.3917752974688628,1.0,7/11,24.09%,ANK3;LYN;RDX;JAK1;SYK;PRKCQ;PLAUR
prerank,mesenchyme development (GO:0060485),0.6022016013098279,1.3775505560152235,0.12927756653992395,0.8238380610484344,1.0,3/15,3.48%,BMP7;FGFR2;TGFBR1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5579520520529477,-1.3770355729056853,0.10970464135021098,0.39302530295387245,1.0,5/14,10.14%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,response to nitric oxide (GO:0071731),-0.596016006739653,-1.376875349440205,0.078125,0.39224679604827895,1.0,6/13,20.34%,KCNC2;GUCY1B1;FOXO1;TXN;MT3;CCL19
prerank,microvillus assembly (GO:0030033),-0.5765258092836251,-1.3760062426384263,0.09643605870020965,0.39312886897158067,1.0,6/14,10.17%,FXYD5;MINK1;RAP1B;RAP1A;RAPGEF6;RAP2A
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5860553220431157,-1.3753772130183852,0.12863070539419086,0.3934444787171555,1.0,3/12,7.03%,MBNL1;TGFB2;PTCH1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.598392544017326,-1.375102480937371,0.11984282907662082,0.3928650055317871,1.0,4/10,9.02%,SEMA6A;DCN;DAB2IP;XDH
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4282450681809663,-1.3744603738839634,0.0681198910081744,0.3932597306746629,1.0,18/41,15.05%,ANK3;AKAP6;KCNJ3;KCNMA1;KCNJ2;KCNN2;KCNMB2;GNG2;FLNA;KCNQ1;GABBR2;CTSS;ACE2;NOS1;KCNJ6;STAC;GNB1;KCNJ12
prerank,endothelial cell development (GO:0001885),-0.4946508962484228,-1.374200391710036,0.09027777777777778,0.39275810104493714,1.0,13/25,11.98%,PDE4D;PECAM1;COL15A1;PPP1R16B;RAP1B;RAP1A;ICAM1;MET;ROBO4;RDX;PDE2A;MSN;SOX18
prerank,cellular response to nitrogen compound (GO:1901699),0.5787711775873106,1.374114922149944,0.1282952548330404,0.8360844927840033,1.0,3/20,6.08%,ROCK2;CPS1;ATRX
prerank,aminoglycan catabolic process (GO:0006026),-0.4791854312374282,-1.3729244683279584,0.09429280397022333,0.39463289345496416,1.0,7/28,15.17%,GPC5;GPC6;SDC3;HSPG2;AGRN;GPC4;HPSE2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5485481233456065,1.3724131248134999,0.11604095563139932,0.8404342049511327,1.0,6/26,9.64%,DAB2;KANK2;NCOR2;SMARCA4;HDAC1;SIRT1
prerank,heart morphogenesis (GO:0003007),-0.4225088135445686,-1.3723417195132788,0.06077348066298342,0.3950074804495947,1.0,16/50,10.62%,FLRT2;ENG;NOS3;RYR2;TGFB2;TBX3;ACVRL1;NOTCH1;TBX1;SOX17;HES1;HEYL;BMP2;PTK2;HEY2;FKBP1A
prerank,ceramide biosynthetic process (GO:0046513),-0.4349415866014636,-1.371788841693228,0.042105263157894736,0.39516565783023694,1.0,10/40,11.54%,ST6GALNAC3;ST8SIA4;SGMS1;SGMS2;SPTLC2;DEGS2;ST6GALNAC5;ST8SIA6;CERS4;ASAH2
prerank,digestive tract development (GO:0048565),0.5249694937420594,1.371719092973257,0.11794019933554817,0.840446592435782,1.0,8/32,9.25%,KIT;CLMP;FGFR2;GLI2;GLI3;SMO;NIPBL;GLI1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5154741201686629,-1.3708758426971526,0.10681818181818181,0.3962977201917851,1.0,10/20,27.98%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;LYPD1;CHRNA7;LY6H;RGS10;RGS8
prerank,detection of mechanical stimulus (GO:0050982),-0.514750551761689,-1.370397855106853,0.09297052154195011,0.39628791881903885,1.0,6/19,12.06%,PIEZO2;CDH2;PIEZO1;PTK2;PKD1;CTNNB1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5331567732366168,1.3700349495811381,0.11480865224625623,0.8449318648881441,1.0,6/32,2.86%,PPARGC1A;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4698328895032985,1.3699770523511348,0.08031496062992126,0.8421936351706174,1.0,9/56,6.84%,DAB2;BMP6;BMP7;PMEPA1;BMPR1A;TGFBR1;SMAD6;LDLRAD4;TWSG1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.44798191238038476,1.3695314784197616,0.07296137339055794,0.8410623195593493,1.0,15/85,9.50%,EYA1;CACNA1D;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;NIPBL;CDC14A;LRTOMT;EPS8L2;COL11A2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5560908144036155,1.3694311783702278,0.11672473867595819,0.8385208441844402,1.0,5/24,6.77%,DAB2;PICALM;RHOQ;PPFIA1;CLTC
prerank,signal peptide processing (GO:0006465),-0.5968770270021453,-1.3692144807207476,0.12291666666666666,0.39777726341621583,1.0,5/11,23.68%,PCSK5;SPCS1;SPPL3;CLN5;PARL
prerank,organonitrogen compound catabolic process (GO:1901565),0.47637061842845807,1.3691325810066686,0.08087091757387248,0.8368079656217366,1.0,13/57,10.04%,ACE;CPQ;RENBP;NPL;NAALADL1;GGACT;TPP1;CLPX;CLN6;PLA2G6;NPEPPS;GNPDA1;CTH
prerank,tRNA wobble base modification (GO:0002097),0.6081413480070655,1.368992858898236,0.14990138067061143,0.834465269744068,1.0,1/14,0.82%,TRMT9B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6713050078652932,1.3682829773019498,0.1274131274131274,0.8346807217099023,1.0,8/10,26.40%,IVD;ACAD11;ACADM;GCDH;ETFDH;ACADS;ETFB;ETFA
prerank,melanosome organization (GO:0032438),0.5545929029382451,1.3682162385863241,0.11904761904761904,0.8320124476435244,1.0,12/26,24.75%,SHROOM2;DTNBP1;PIKFYVE;BLOC1S6;HPS1;BLOC1S2;RAB29;AP1M1;KIF13A;SNAPIN;LYST;HPS4
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5068194453835215,-1.3681759457324307,0.08695652173913043,0.3991479840818489,1.0,8/20,18.24%,GSN;THBS1;SFRP4;ITGA4;GPER1;ECSCR;PDCD4;RGCC
prerank,neuron projection fasciculation (GO:0106030),-0.6169015754944664,-1.368129787704447,0.12423625254582485,0.39810851725604246,1.0,6/10,14.04%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2;CDK5R1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.6197182601996962,-1.367379139676289,0.1192468619246862,0.3987894652246791,1.0,3/10,5.31%,CXCL12;GAS6;LYN
prerank,mesonephric tubule development (GO:0072164),0.5996827930517743,1.3672188981285653,0.13733075435203096,0.83336197574521,1.0,5/15,3.66%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5621728549094757,1.367198153802206,0.125,0.8305366047163728,1.0,4/23,6.71%,TGFBR3;SMAD3;DKK3;SMURF2
prerank,protein modification by small protein conjugation (GO:0032446),0.3796558108353474,1.3671222465654986,0.011454753722794959,0.8279954438845776,1.0,90/361,19.32%,RNF220;EPAS1;EYA1;RNF152;PDZRN3;RNF43;ASB2;PRKN;FBXL17;SPSB1;RNF213;TRIM63;CTR9;DTX1;NEDD4;CAND2;RNF151;ATG10;PIAS1;RNF135;ARRB1;USP9X;KLHL41;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;FBH1;HUWE1;BTRC;CDK5RAP3;EIPR1;KLHL7;RNF34;SIRT1;PEX10;ZSWIM8;NUP42;ATG7;RTF1;UBE2M;FBXW8;RNF41;NUP98;FBXO4;PRKDC;DCUN1D5;CUL9;CUL4A;WWP2;UBA6;ASB5;FBXO10;NSMCE2;USP7;TRIM62;NUB1;NUP43;DTX3;ASB12;FBXO11;SDE2;UBE2H;PEX14;AMFR;PIAS3;ANAPC16;BIRC6;NUP155;UBE2E1;UBR1;SYVN1;PEX5;RNF7;KCTD13;CDC34;RNF25;ARIH1;NUP188;MIB1;RNF20;UBA5;CCDC22;SUMO1;KLHL18;ASB1;MIB2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5486798975447245,-1.3666788495692752,0.10329670329670329,0.39928241002545517,1.0,6/15,21.03%,GNAS;UBR3;GNAL;ADCY3;SYT10;DRD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6035832965802169,-1.3648135443089304,0.11062906724511931,0.4012392099186891,1.0,6/11,21.47%,CALM1;CALM2;FKBP1A;CALM3;CASQ2;GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6035832965802169,-1.3648135443089304,0.11062906724511931,0.4012392099186891,1.0,6/11,21.47%,CALM1;CALM2;FKBP1A;CALM3;CASQ2;GSTM2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.49386102500201057,-1.3642702625061935,0.09230769230769231,0.4013359533331192,1.0,6/22,11.09%,PDE3B;PPP2R5A;CEACAM1;APOD;CCDC3;GPER1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.48559260955013017,1.3638272160175824,0.1111111111111111,0.839229964479158,1.0,5/45,3.48%,DAB2;BMP6;BMP7;BMPR1A;TGFBR1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.43407939508376725,-1.3636619189566834,0.07837837837837838,0.4015545900905437,1.0,12/40,9.93%,MEF2C;BRINP3;BRINP1;NGF;VWC2;ARHGEF2;BEND6;NRCAM;HEYL;BMP2;PROX1;BRINP2
prerank,fatty acid metabolic process (GO:0006631),0.4223577191717401,1.3629796953705282,0.07024793388429752,0.8400272978182051,1.0,27/115,16.11%,ACSL1;PPARGC1A;PPARA;ECHDC3;ALOX12;CEL;ACADSB;CPT1A;GPAT2;ACSBG2;NAAA;PON3;NDUFAB1;CPT2;ACADM;ACOT11;MLYCD;MECR;AASDH;ACOT8;CRAT;THEM4;PER2;GPAM;ACBD5;NUDT19;SGPL1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6208624540951506,1.3628897068967474,0.14587332053742802,0.8375468226302011,1.0,5/11,13.76%,DDX5;TP53;RIPK1;MAP2K1;MAP2K2
prerank,extracellular matrix organization (GO:0030198),-0.32062712775239305,-1.362174566736835,0.006711409395973154,0.4040008653344968,1.0,76/276,11.02%,COL8A1;FLRT2;VWF;ELN;COL25A1;COL12A1;LAMA1;ADAMTSL3;TLL1;PECAM1;ITGA6;BSG;SH3PXD2A;GSN;SPOCK2;COL6A3;COL4A1;ADAMTSL1;MFAP5;THBS1;DCN;FN1;ADAMTS5;COL15A1;TGFB2;VIT;COL6A1;LAMC3;VCAM1;DST;COL4A2;COL6A2;NDNF;F11R;LAMA2;GAS6;ADAMTS17;CYP1B1;BGN;ITGB4;COLGALT2;KDR;COL14A1;FBN2;GPM6B;LUM;COL23A1;APP;ICAM1;ADAMTS3;JAM2;ITGB8;ADAM15;TIMP2;ITGB1;COL8A2;LAMA3;ITGA4;TGFBI;PPIB;VCAN;HSPG2;MMP16;ADAMTS6;TGFB1;TNR;DPT;CD47;FGF2;CD44;AGRN;PDGFA;ITGB3;ITGA8;CAPN2;CDH1
prerank,positive regulation of protein polymerization (GO:0032273),-0.39762830813580036,-1.3616337830141012,0.03812316715542522,0.4041176083995749,1.0,24/65,18.64%,NAV3;NCK2;EVL;PTK2B;CARMIL1;CDC42EP3;PAK1;OCLN;MET;RPS3;BIN1;CDK5RAP2;HSP90AA1;CLIP1;MAPT;PFN2;PINK1;CDK5R1;CDC42EP2;FES;NCK1;ARF6;TPPP;NCKAP1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.35992684003897013,1.3609247340890427,0.0,0.8430504271140822,1.0,287/1668,12.61%,PRDM6;AEBP1;EPAS1;HLF;ZKSCAN2;DAB2;FGF1;WWOX;RORA;MAF;BMP6;KDM7A;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;ZIC2;TRAK1;FHL2;KIT;DDX5;MXI1;PPARGC1A;IGF1;KMT2A;RHOQ;NFYC;BRD8;CUX1;DLG1;PKNOX2;PPARA;SSBP2;FGFR2;CREBRF;FOXP4;ZFHX2;PRKN;IL18;IKZF2;GLI2;FHOD1;DNMT3A;HOXB4;CREB5;ZBTB20;FNIP1;ZNF160;HOXB6;KANK2;CSRP3;NPAS3;ZHX2;GABPB1;GABPB2;FOXD1;HOXC6;HOXA1;SOX5;TNRC6A;ZNF568;MOSPD1;ARID4A;NFAT5;NR2F2;NCOR2;HDAC8;KCNIP3;PHIP;PCGF5;BMPR1A;GLI3;TSHZ3;MITF;CTR9;SUFU;ELF1;ZNF697;NR6A1;CXXC5;ARNT2;VGLL3;PHF21A;FOXC1;MLLT10;HOXB3;PCGF2;NFIB;ZBTB38;RFX8;IFI27;MAFG;VEZF1;NACC2;ASCL3;ATOH1;CREB3L2;ZNF462;NFYB;TLR3;SMAD6;NHLH2;PRKCB;SALL4;EZR;FOXP2;MEIS1;PIAS1;RREB1;CHD4;PPP1R13L;CUX2;NSD1;TET2;FBXL19;ATM;TLR4;TEF;DDX3X;FZD5;ARRB1;USP9X;TEAD3;WWC2;OTP;ARID3A;NCOA3;CAPRIN2;GPS2;MAP2K5;SOD2;CAMK1;ATRX;ABHD14B;ESRRA;LCOR;STAT2;HOXB5;TBL1X;HMGA1;HOXB9;BAZ1B;TSHZ1;HOXA3;TP53;BCAS3;CAMTA2;SMURF2;LAGE3;BCLAF3;SMARCD3;SERPINE1;NIPBL;MED12;BHLHE41;RORC;MGA;WWTR1;ZSCAN29;CCNT2;SOX12;PLSCR1;TNRC6B;ZIC5;LDB2;LDB1;ATAD2B;ELF2;NR1D2;BCOR;SMARCA4;PTEN;CBX7;SRCAP;KDM2B;ZSCAN25;SPEN;MEF2A;ZIC1;HOXC4;KDM2A;SLTM;KAT6B;SSBP3;TBL1XR1;TMF1;CALCOCO1;SMARCC2;CPEB3;GDNF;ZIC4;JMJD6;TCF4;TCF7L2;IRX1;NUPR2;NEUROD4;TCF7;HDAC1;TFDP1;KLF3;MYBL1;GLI1;SMARCE1;NR2C2;ZBTB26;TEAD2;PARP9;HDAC4;SIRT1;RIPK1;WASL;ZFP90;RIPK2;MOV10;HIVEP2;HBP1;SOX13;LARP7;FOXC2;MED17;GTF2F1;MAVS;PRDM5;ZBTB8B;ZNF219;ATN1;THRAP3;AASS;ABL1;SAP18;RBL1;ZFP28;KMT2C;FOXL1;BAZ1A;ZMIZ1;AURKB;ZFP3;RTF1;ZNF367;ZBTB6;ZKSCAN5;ATF2;RBBP8;ZNF569;TEAD1;ZFX;PRKDC;RARG;NFATC3;MNT;DICER1;NOP2;ZSCAN22;CBX5;ZBTB48;HR;ZNF467;KDM3B;IMPACT;SNAI1;TFAP2D;SKOR1;IRF1;MLLT6;ZMIZ2;ZBTB1;WWP2;MYBL2;ZNF148;HOXB2;BRWD3;CCDC62;PHF2;HES6;ZNF235;DEAF1;BRD7;FRK;ZMYM5;KMT5A;FOXA2;KMT2D
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4703128463467522,-1.360426358060352,0.08235294117647059,0.4058235429269689,1.0,13/33,13.71%,SLIT2;PTPRM;PTPRG;THBS1;DCN;EVL;ACVRL1;DAB2IP;APOE;CORO1C;ADIPOR1;PFN2;ADGRB1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.566207033648824,1.3603335633055775,0.11003861003861004,0.842843182848967,1.0,9/18,19.83%,KMT2A;SETD7;KMT2D;SETD1B;EHMT2;EHMT1;ASH1L;SETD3;SETD1A
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5914235881999665,1.3596659404291247,0.14857142857142858,0.8429894694345412,1.0,4/17,4.60%,ATP1A2;CACNA1D;ANK2;CACNA1C
prerank,neuromuscular junction development (GO:0007528),0.5478937025277385,1.3594851396950092,0.13903743315508021,0.840953106932009,1.0,7/24,8.12%,PDZRN3;LRP4;UNC13C;LRRK2;NEDD4;CACNB3;PPFIBP2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5360366106630383,1.3590275508466882,0.13157894736842105,0.8400589211546882,1.0,4/30,5.54%,ROBO1;LPAR1;AKAP13;ARRB1
prerank,arachidonic acid secretion (GO:0050482),0.6484274859261123,1.3586367292930148,0.15,0.8361158884770521,1.0,2/10,4.76%,ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),0.6484274859261123,1.3586367292930148,0.15,0.8361158884770521,1.0,2/10,4.76%,ACE;BDKRB2
prerank,sympathetic nervous system development (GO:0048485),-0.5489662451280052,-1.3585301822585407,0.09381663113006397,0.40908603529987714,1.0,2/15,2.95%,NRP1;NRP2
prerank,regulation of microtubule depolymerization (GO:0031114),-0.483000361445953,-1.358446364024341,0.08064516129032258,0.4081601466846352,1.0,8/25,12.34%,MAP1B;NAV3;CLASP2;ARHGEF2;STMN2;TRPV4;FGF13;SPEF1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.49474301739562243,-1.3580140177239985,0.09955752212389381,0.4081495785390856,1.0,7/23,10.59%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;EDN1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5262890345654713,1.3578265979592918,0.12166666666666667,0.8366350358575805,1.0,14/27,24.93%,BRD8;CPA4;KAT6B;KAT7;KAT2B;CREBBP;SGF29;RUVBL1;TAF6L;BAG6;EP300;PHF20;MSL3;NAA50
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4597165594445075,1.3577597033670108,0.08444444444444445,0.8341526789799096,1.0,15/66,12.42%,APPL2;UBE2E2;DLG1;KANK2;DDX3X;ANKRD17;PLK5;PTEN;CCND3;RBL2;TFDP1;HYAL1;RBL1;ADAM17;BRD7
prerank,neuron maturation (GO:0042551),-0.5261425649144539,-1.3576899672012652,0.09813084112149532,0.40784854496031825,1.0,11/18,24.11%,ADGRB3;APP;SRRM4;B4GALT5;SCARF1;C1QA;CLN5;ANKS1A;LGI4;RND1;B4GALT6
prerank,ephrin receptor signaling pathway (GO:0048013),-0.38420266318423346,-1.3573890647628462,0.04827586206896552,0.40742654176865817,1.0,31/82,14.04%,ARHGEF28;ACTB;EPHB1;EPHA5;GRIN2B;EFNA5;EPHA6;PAK3;NCK2;CHN1;ACTG1;ARHGEF7;LYN;TIAM1;PAK1;ACTR2;CRK;PSEN1;DNM1;EPHB2;EPHA7;AP2B1;PTK2;ANKS1B;ACTR3;AP2M1;ARPC1B;RASA1;ARPC5;ARPC4;CDK5R1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5929201244482981,-1.357234233711072,0.12095032397408208,0.40668170554024463,1.0,3/12,10.77%,ACSL3;MTTP;MFSD2A
prerank,negative regulation of cell differentiation (GO:0045596),0.3997348701694671,1.3571445062574348,0.03896103896103896,0.8340487515545492,1.0,17/181,6.34%,RANBP3L;COL5A1;TMEM64;RORA;BMP7;SMAD3;OSR1;PPARA;CTR9;SUFU;TGFBR1;DTX1;SMAD6;MEIS1;GPS2;LDLRAD4;TRIB2
prerank,striated muscle tissue development (GO:0014706),-0.45692760436072444,-1.3570595235394305,0.09112709832134293,0.40603783150788725,1.0,8/29,4.00%,SGCZ;MEF2C;SGCD;PGM5;BMP5;CAV1;BMPR2;MYL6
prerank,neuromuscular process controlling balance (GO:0050885),-0.5806552066498836,-1.356702886117185,0.13016528925619836,0.4058202384250056,1.0,2/12,1.77%,NRXN1;PCDH15
prerank,peptide catabolic process (GO:0043171),0.5529385793556955,1.3561162167352028,0.12367491166077739,0.8359470899729456,1.0,8/23,14.50%,ACE;CPQ;CTSH;NAALADL1;TPP1;NPEPPS;ERAP1;ANPEP
prerank,regulation of stress fiber assembly (GO:0051492),0.44936433629837996,1.3552665280687008,0.06774668630338733,0.8367725371495535,1.0,16/74,5.04%,ARHGAP28;ROCK2;LPAR1;CGNL1;CCN2;ARHGEF10L;ARHGEF18;FHOD1;PPM1E;ASAP3;TGFBR1;CLASP1;ARHGAP6;PPFIA1;RAPGEF3;TPM1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4832066584597211,1.3550037877390981,0.10099337748344371,0.8350452461412259,1.0,16/46,15.22%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5950912915018277,1.3548664586558297,0.14065510597302505,0.8328650792745047,1.0,5/15,13.67%,RENBP;LARGE1;MGAT3;GNPDA1;CHST3
prerank,wound healing (GO:0042060),0.4589625219324407,1.3541999604878507,0.07680722891566265,0.8330064138630118,1.0,11/62,8.66%,FGF1;SMAD3;SYT11;IGF1;MYOF;CFLAR;TGFBR1;TPM1;FER1L5;FUT10;NRG1
prerank,negative regulation of histone methylation (GO:0031061),0.6750282041026083,1.354179528195971,0.15613382899628253,0.8303668695742367,1.0,5/10,17.66%,JARID2;BCOR;AASS;PHF1;KDM1A
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3857754910988698,-1.3533546057946555,0.04776119402985075,0.4126078993300064,1.0,19/71,12.83%,ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;ACER2;PRKD3;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA1;ST6GALNAC5;CERS4;ELOVL6;ASAH2;PRKD1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.47754494615679405,-1.3532519329117554,0.09976798143851508,0.41175826855276565,1.0,10/25,21.34%,CTNNA3;CD200;VCAM1;ITGB1;ITGA4;ITGB3;ITGB2;ITGA5;ITGA7;PKP2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6506222020979695,1.3531333095117792,0.17540322580645162,0.8323352109972877,1.0,2/10,3.09%,DNMT3A;PCGF5
prerank,respiratory tube development (GO:0030323),0.5434778752566024,1.3527520905508168,0.12020033388981637,0.8312444609820449,1.0,5/28,4.22%,FGF1;FGFR2;GLI2;PDPN;LOXL3
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4746842220677141,-1.3522237440653386,0.10512820512820513,0.4130517943518187,1.0,10/28,14.50%,NAV3;PAK1;OCLN;MET;RPS3;CDK5RAP2;CLIP1;MAPT;CDK5R1;FES
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6226671902916896,1.3509427176913806,0.1660377358490566,0.8360635819460936,1.0,2/12,1.42%,ROCK2;PICALM
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5739904745906521,-1.3508732578891778,0.12475247524752475,0.41502218037343824,1.0,7/13,26.70%,SYT1;CACNA1G;KCNB1;CACNA1H;SYT10;DOC2B;STX1A
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.49828524347636166,1.3505789517884756,0.11647254575707154,0.8349019086386263,1.0,6/41,6.76%,ACSL1;PTGS1;ALOX12;EPHX1;DAGLA;SCD5
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.49613122922869407,1.3503866228295327,0.10828025477707007,0.8330372890600726,1.0,6/41,13.57%,PRKAG2;GCK;NUP42;NUP98;OGT;NUP43
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5146569941812614,1.3499067082475038,0.12914485165794065,0.8323575763036646,1.0,10/32,13.86%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;FZR1;UIMC1;BABAM1
prerank,ribosome assembly (GO:0042255),-0.41779645255113756,-1.3497768158662968,0.08108108108108109,0.4164749090182698,1.0,21/47,22.35%,RPL3;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;RPS27;RPS5;RPL6;MDN1;NOP53;RPSA;BRIX1;MRPL20;RPS27L;RPL24;RPL11;RSL24D1;NPM1;MRPS2
prerank,mRNA destabilization (GO:0061157),0.5021811123716423,1.3497012114394284,0.13170731707317074,0.8304819041622964,1.0,9/38,16.33%,ROCK2;TUT4;POLR2D;CPEB3;MOV10;YTHDF3;ZFP36L1;TUT7;PLEKHN1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.44726846135234627,-1.3495525392703163,0.0678391959798995,0.4158988077269839,1.0,17/32,25.56%,AKAP6;CEMIP;CALM1;CALM2;TRPC1;CALM3;JPH2;GPER1;SNCA;APLNR;GSTM2;NPSR1;HAP1;F2R;CXCL10;THY1;PLCG1
prerank,vesicle transport along actin filament (GO:0030050),-0.5137392662436506,-1.348762592120685,0.09663865546218488,0.41666334832790797,1.0,6/19,8.93%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A;MYO6
prerank,artery morphogenesis (GO:0048844),-0.45693808419489546,-1.34864046752183,0.08478802992518704,0.415894911384682,1.0,12/30,10.83%,NRP1;BMPR2;ENG;TGFB2;NOTCH1;JAG1;TBX1;HES1;STRA6;HEY2;SMAD7;BMP4
prerank,melanocyte differentiation (GO:0030318),0.639114216214219,1.3483642825998288,0.15689981096408318,0.8334598932912463,1.0,3/11,3.27%,LRMDA;KIT;MITF
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3897543927465636,1.3482122980777678,0.027946537059538274,0.8314597672628535,1.0,37/248,9.39%,RNF220;DAB2;TMEM64;LRRK1;LGR4;WLS;LRP4;BICC1;PTK7;FGFR2;MCC;PRKN;DKK3;GLI3;LRRK2;LZTS2;DDX3X;CAPRIN2;APC2;TBL1X;SMURF2;WWTR1;UBAC2;PTPRU;TNKS2;BTRC;ADGRA2;TBL1XR1;GPRC5B;TCF7L2;CSNK1A1;TLE1;HDAC1;UBR5;TMEM170B;GLI1;INVS
prerank,platelet degranulation (GO:0002576),-0.3533184269312705,-1.3480626916176146,0.017123287671232876,0.41616964206637397,1.0,43/118,18.86%,PCDH7;ABCC4;VWF;ACTN4;PECAM1;TMSB4X;CD9;THBS1;VEGFC;ACTN1;FN1;TGFB2;GAS6;LYN;OLA1;CALM1;LHFPL2;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;CDC37L1;VEGFA;CLU;ALDOA;RARRES2;NHLRC2;MAGED2;CLEC3B;MANF;BRPF3;QSOX1;TUBA4A
prerank,nervous system development (GO:0007399),-0.3049524875204086,-1.3476958539126234,0.0,0.4160256636760689,1.0,95/429,11.11%,LSAMP;NLGN1;ADGRL3;NRXN1;DNM3;MEF2C;ROBO2;DCLK1;MBNL1;SEMA6A;ERBB4;CDH2;ADGRG6;KIRREL3;SLC2A1;FGF12;GSN;SHANK3;SPOCK2;ST8SIA4;WWP1;RBFOX1;EPHB1;CNTN4;NAV3;CHRM3;GRIK1;MERTK;ADAM23;FN1;EFNA5;SEMA5A;MAL;TBX3;IL1RAPL2;MOBP;EVL;NELL1;STAT3;DNER;SERPINI1;APAF1;GLRB;SH3GL2;NFASC;NGF;SCN2A;ZBTB16;DSCAML1;MYT1L;JAG1;APBA2;MBP;SNTG2;CNTN6;PDGFC;GPM6B;MARCKS;RBFOX3;FKTN;HES1;MET;NRCAM;PCDH1;DCX;SRRM4;SREBF2;MOG;LGI1;FEZ1;RELN;DACT1;VCAN;EPHB2;PTPRZ1;CHRM2;SPOCK1;PROX1;TGFB1;BTBD3;ADAM22;S100B;PTN;PPT1;ECRG4;FGF2;FGF13;SLITRK1;CDK5RAP2;PKD1;RPS6KA3;PRX;NRXN2;CDH1;SHANK2
prerank,protein localization to mitochondrion (GO:0070585),0.6365581184381055,1.347282988778957,0.17261904761904762,0.8327371752827956,1.0,2/11,3.69%,HK2;LRRK2
prerank,neuropeptide signaling pathway (GO:0007218),-0.39661833146953107,-1.346858268908765,0.05730659025787966,0.41673632570848507,1.0,14/58,15.81%,SORCS1;SORCS3;GLRB;GLRA3;SORT1;SORL1;GLRA1;CYSLTR1;HCRTR2;CYSLTR2;GLRA2;NXPH2;NMU;CPE
prerank,heart looping (GO:0001947),-0.43117362943540716,-1.3466211494359859,0.07536231884057971,0.41626219952576043,1.0,9/39,12.92%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5728667488330332,-1.3464101795777084,0.14596949891067537,0.4157504399656451,1.0,6/12,26.50%,PIK3R1;DAB2IP;BCL2L11;PTPN1;ERN1;ATF6
prerank,neuron projection organization (GO:0106027),-0.5409984884256986,-1.3460372040353399,0.11392405063291139,0.4154917728135335,1.0,5/15,9.42%,GSK3B;PLS1;APP;PSEN1;ABCD2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5556594736864647,-1.3451760503361876,0.13225058004640372,0.4164941968053833,1.0,6/13,21.55%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,regulation of neuron migration (GO:2001222),-0.4677641453019883,-1.3449486311284666,0.1095890410958904,0.4159725071500569,1.0,7/26,5.74%,CTNNA2;SEMA6A;NEXMIF;NTNG1;SHTN1;ARHGEF2;DAB2IP
prerank,response to purine-containing compound (GO:0014074),-0.5349574962481233,-1.3447906728717187,0.12631578947368421,0.4152472237828338,1.0,5/17,15.03%,RYR2;ABCC9;TRPC3;P2RY1;TRPM2
prerank,positive regulation of ion transport (GO:0043270),0.4699276801314077,1.3443808343462993,0.10383386581469649,0.8426772049543617,1.0,8/48,8.74%,CACNA1D;ACTN2;ANK2;DLG1;ADRA2A;AHCYL1;ANO6;GDNF
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3430708109605998,-1.3441182396625497,0.028,0.41583909799833085,1.0,33/151,10.20%,NRP1;TEK;BMPER;ERBB4;NTRK3;PDE8A;GCNT2;ROR1;HTR2C;SEMA7A;PTK2B;GAS6;NOTCH1;NTRK2;KDR;TNFRSF11A;PDGFC;RAP1A;PTPRC;APP;ICAM1;APOE;ACKR3;HTR2A;ROR2;BMP2;TGFB1;TNFAIP8L3;MFHAS1;FLT4;FGF2;CD44;PDGFA
prerank,response to prostaglandin E (GO:0034695),0.6468015104420728,1.3440539609675852,0.1644100580270793,0.8414566231922245,1.0,1/10,0.33%,TGFBR3
prerank,ureteric bud development (GO:0001657),0.5797430367632636,1.3436857804811317,0.15355805243445692,0.8404999867661667,1.0,5/17,3.66%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5793080023173598,-1.3426147286519123,0.12445414847161572,0.418316907495496,1.0,4/11,12.49%,LYN;MFHAS1;CYBA;TIRAP
prerank,ketone body metabolic process (GO:1902224),0.6411144651393503,1.3424074736835436,0.14473684210526316,0.8432357120263423,1.0,5/10,9.01%,OXCT1;ACSS3;BDH1;BDH2;HMGCS2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.565219108614865,-1.342200101657877,0.1316348195329087,0.4182813581449663,1.0,7/13,25.58%,RPS15;XPO1;LTV1;ABCE1;RAN;NPM1;RRS1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4641397383878557,1.341886382273664,0.125,0.8428950088220095,1.0,10/55,10.39%,WWOX;TPD52L1;GSDME;NUPR1;TGFBR1;BID;TP53;DNM1L;RIPK1;BECN1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.4183197831543287,-1.3417398850034323,0.07692307692307693,0.41824598788436373,1.0,9/42,12.92%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,endocrine system development (GO:0035270),0.5607424800271538,1.3414507303465186,0.1417910447761194,0.842184632373816,1.0,4/21,3.48%,WNT4;GLI2;DKK3;TGFBR1
prerank,regulation of epithelial cell migration (GO:0010632),-0.40987376200367,-1.3413999363980127,0.07466666666666667,0.41799408283409195,1.0,20/51,13.03%,BMPER;RHOJ;PTPRG;BMPR2;RTN4;CLASP2;TGFB2;EVL;DOCK1;DAB2IP;PLCG2;CORO1C;CEACAM1;PTK2;PTN;ENPP2;ADIPOR1;EMP2;PFN2;HIF1A
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.4855758179417681,1.3409418226278136,0.10588235294117647,0.8417769732230251,1.0,13/43,16.89%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;FZR1;UIMC1;HUS1;BABAM1;INTS3;CLSPN
prerank,calcium ion import into cytosol (GO:1902656),-0.5345663530375735,-1.3407986109944376,0.12364425162689804,0.41830600177117433,1.0,5/15,10.14%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,ether lipid biosynthetic process (GO:0008611),-0.6021183843130747,-1.3404412807106663,0.12379110251450677,0.4181331443922888,1.0,3/10,9.17%,PLA2G4A;LPCAT2;AGPS
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4056749858148319,1.339997413391857,0.06324110671936758,0.8430931337438946,1.0,37/138,16.87%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;TEAD3;ESRRA;TBL1X;RORC;WWTR1;NR1D2;POLR2D;TBL1XR1;HDAC1;NR2C2;TEAD2;MED17;GTF2F1;TEAD1;RARG;TAF11;TAF4;TBP;NCOR1;NR3C2;TAF7;KAT2B;CREBBP;MED23;MED26;RXRA;TAF13;YAP1
prerank,regulation of filopodium assembly (GO:0051489),-0.42603698602311235,-1.339203904233533,0.09230769230769231,0.41985809838465865,1.0,16/38,15.91%,NRP1;NLGN1;TENM2;PIK3R1;MYO10;FNBP1L;PPP1R16B;TGFB3;GAP43;PLPPR5;AGRN;FXR1;DMTN;GPM6A;TRPM2;ARF6
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5933993647408765,-1.3390712916937837,0.125,0.41918591731214916,1.0,4/10,9.23%,DGKH;PRKD3;PLPP1;GAP43
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5742447680445191,-1.3389066987862572,0.13215859030837004,0.4185686441231108,1.0,6/12,19.84%,HSPA5;SEC62;SEC61B;SGTB;CHMP4B;CHMP4A
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.513338622007734,-1.3388542355983724,0.10681818181818181,0.4176534773307284,1.0,10/18,28.12%,CCT2;CCT8;CCT6A;CCT7;NHP2;EXOSC10;DCP2;RUVBL2;DKC1;NAF1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3578606169453603,-1.338241773643179,0.03125,0.41808477781750497,1.0,29/100,12.66%,TEK;PIP5K1B;NTRK3;PIK3R1;ROR1;DCN;FN1;TGFB2;PIP4K2A;PPP1R16B;GAB1;NTRK2;KDR;LYN;PDGFC;DAB2IP;SEMA4D;ROR2;MYOC;CEACAM1;PTK2;FBXL2;FGF2;PIK3AP1;PDGFA;PIK3IP1;GPER1;UNC5B;TWIST1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.48103952916171583,-1.337719483697607,0.14215686274509803,0.4182119272233767,1.0,14/23,42.56%,CADM1;PIK3R6;PVR;ARRB2;RAET1E;LGALS9;RASGRP1;LAMP1;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5517098524238817,-1.3368409566267192,0.14465408805031446,0.41920911257551063,1.0,5/13,8.46%,DCN;BGN;CSPG4;VCAN;HEXB
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.36807615770273655,-1.3368118187709082,0.04777070063694268,0.418268237239099,1.0,35/94,29.96%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;NFKBIA;PSMB2;MAP3K7;EGR1;PSMD14;IRAK3;PSMC6;IKBKB;UBB;PSMB9;PSMA4;PELI1;NOD2;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;RELA;PSMB3;TAB1;PSMB5;MAP3K8;MAPK3;TOLLIP;PSMD7;IRAK4;PSMF1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4411233766165795,1.336504027396331,0.0872093023255814,0.8553051760832635,1.0,17/74,10.29%,EYA1;EYA2;IGF1;CFLAR;PHIP;EYA4;TGFBR1;DDX3X;MAP2K5;SERPINE1;TERT;HTT;GDNF;TCF7L2;RNF34;RIPK1;SH3RF1
prerank,regulation of innate immune response (GO:0045088),0.4684447615847787,1.3364279257725633,0.1062215477996965,0.8529830851716439,1.0,18/57,14.91%,APPL2;RNF135;IFNK;TKFC;PTPN22;PLSCR1;SAMHD1;PARP9;DHX58;IRF1;PTPN11;NMI;IFI35;ACOD1;ERAP1;USP18;IFNAR2;BIRC3
prerank,mesoderm development (GO:0007498),-0.5100131846887367,-1.336372031897253,0.11363636363636363,0.41826442608111114,1.0,7/18,18.11%,TBX3;TIE1;TBX1;BMX;IKZF1;VEGFA;BTK
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5326465625690416,1.3363557625118223,0.1384083044982699,0.850681149570586,1.0,5/25,6.90%,ERRFI1;PPARA;SNX6;SLC6A9;CNRIP1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5935716118870084,1.3352640685849997,0.13878326996197718,0.8527642086502838,1.0,3/14,8.57%,MOXD1;DAGLA;SLC6A4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5356461180199925,1.3348032711713498,0.1325503355704698,0.8521129081730375,1.0,10/26,17.86%,UBE2E2;DDX3X;ANKRD17;CCND3;TFDP1;HYAL1;ADAM17;RPTOR;KMT2E;EIF4G1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5199745710911223,-1.332896468960921,0.13303769401330376,0.425590624376707,1.0,7/18,11.03%,MDFIC;GSK3B;OTUD7B;MFHAS1;APOD;UFM1;CABP1
prerank,protein localization to membrane (GO:0072657),-0.32288802579683623,-1.3325715620162066,0.015151515151515152,0.42545018055491807,1.0,47/187,11.10%,NLGN1;KCNIP4;DLG2;NRXN1;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;SHANK3;ANK3;DPP6;EFR3B;LRRC7;CLASP2;MAP7;LIN7A;RFTN1;ATP1B1;EPB41L3;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;FLNA;SH3GLB1;NKD2;TSPAN14;PTCH1;EHD2;ITGA4;FRMPD1;RDX;RAPGEF6;PTN;FGF13;AGRN;RAP2A;KCNB1;ARL5A;NRXN2;CDH1;ZDHHC2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.40260240297413774,-1.3318652015887846,0.08746355685131195,0.4261427680034991,1.0,17/51,15.87%,BMPER;GREM2;BMPR2;HTRA3;VWC2;NOTCH1;VWC2L;SMAD5;SORL1;BMP2;SMAD1;SMAD7;LEMD3;UBE2D3;BMPR1B;SMURF1;HIPK2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.561736490241425,1.3311019346442037,0.16580310880829016,0.8648322407881851,1.0,2/19,0.51%,BMP6;AFDN
prerank,regulation of macroautophagy (GO:0016241),0.4248239758489514,1.3302229380579134,0.08493150684931507,0.8660773781370803,1.0,18/105,11.43%,PRKAG2;PRKAA2;SNX6;PRKAG3;SESN1;ATP6V0E1;CASP3;LRRK2;NEDD4;SESN2;SNX32;SMG1;ATP6V0B;PIK3CA;LARP1;SIRT1;ATP6V1D;ATP6V1E1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5738098281786885,-1.3298712383845972,0.13577586206896552,0.4297884942538176,1.0,4/12,10.59%,TMEFF2;AR;TGFB1;EDN1
prerank,negative regulation of cell activation (GO:0050866),-0.5480038602665409,-1.3298638653036403,0.14845360824742268,0.4287704384849861,1.0,6/14,11.09%,CD200;NOS3;APOE;LDLR;PDGFA;GPER1
prerank,ceramide metabolic process (GO:0006672),-0.4111047493987931,-1.3292566052046508,0.05994550408719346,0.42922465524128217,1.0,11/49,11.54%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;PLPP1;SPTLC2;DEGS2;PPP2R1A;CERS4;ASAH2
prerank,epiboly involved in wound healing (GO:0090505),-0.532254320033322,-1.3292431027194684,0.1346578366445916,0.4282228414280491,1.0,6/16,9.82%,TMEFF2;FLNA;MRTFA;CCN1;CEACAM1;CD44
prerank,response to interleukin-4 (GO:0070670),-0.5878037244930813,-1.3289308505294697,0.12398373983739837,0.42794602861683734,1.0,1/10,0.47%,LEF1
prerank,sodium-independent organic anion transport (GO:0043252),-0.6048580215278792,-1.328013896097786,0.14516129032258066,0.42906273743876117,1.0,6/10,23.80%,SLCO1C1;SLCO2B1;SLCO4A1;SLC16A2;SLCO5A1;SLCO2A1
prerank,negative regulation of metabolic process (GO:0009892),0.45647629275690144,1.3272415105646047,0.10776545166402536,0.8762066594596328,1.0,16/54,15.22%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC
prerank,membrane depolarization (GO:0051899),-0.44530534965329827,-1.3267213962191133,0.09879518072289156,0.4308511922288413,1.0,10/32,11.63%,CAV1;CACNA1E;SCN1A;SCN2A;CACNA1G;SCN7A;CACNA1B;SCN3A;SCN9A;SCN8A
prerank,modulation by symbiont of host process (GO:0044003),-0.5963374730966228,-1.3266458858538717,0.13267326732673268,0.43001339738209815,1.0,6/10,23.08%,B2M;UBB;MRC1;PGK1;UBC;RPS27A
prerank,metal ion transport (GO:0030001),-0.368073914011429,-1.3264391793291195,0.065625,0.42947578467088154,1.0,29/86,15.03%,SLC8A1;CALCRL;CAV1;CACNA1E;RYR2;CACNA2D1;TPT1;ATP2C1;RYR3;GRIN3A;TRPC3;ATP2B2;RAMP2;TRPC4;NIPAL2;TRPC1;CACNA1B;PSEN1;NDFIP2;ATP2A3;TRPV4;SELENOK;SLC30A1;RAMP1;TRPC5;MT3;NIPA1;CACNG8;TRPM2
prerank,Wnt signaling pathway (GO:0016055),0.42735317711883025,1.3261233478693861,0.08454810495626822,0.8783776177981519,1.0,18/92,11.91%,WNT5B;WLS;NXN;WNT4;WNT6;LRRK2;FZD8;DDX3X;FZD5;PTEN;BTRC;RYK;TCF7L2;CSNK1A1;TCF7;USP34;RARG;PORCN
prerank,regulation of metal ion transport (GO:0010959),0.5918836076957152,1.325742692939267,0.1552346570397112,0.8774145978435198,1.0,3/16,2.07%,ANK2;DLG1;SLC30A10
prerank,microglial cell activation (GO:0001774),-0.48891972381055926,-1.3253838636949355,0.14004914004914004,0.4309254963095353,1.0,11/21,29.70%,APP;MAPT;SNCA;CLU;CX3CR1;ITGB2;C1QA;TYROBP;GRN;JAK2;IFNGR1
prerank,cardiac muscle cell action potential (GO:0086001),0.5073008082629605,1.3251349015343619,0.14967105263157895,0.8774364403874405,1.0,4/30,1.35%,ATP1A2;CACNA1D;ANK2;KCND3
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4176582110401053,1.3249724642719145,0.07744565217391304,0.875392782123188,1.0,24/108,10.98%,WWOX;RSPO2;RNF43;WLS;NXN;PTK7;FGFR2;PRKN;DCDC2;TRABD2B;APCDD1;LRRK2;CXXC4;SULF2;VGLL4;SMARCA4;TERT;LRP1;BTRC;TLE1;GRB10;CBY1;FOXL1;SULF1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6255597127457355,1.3243334446297974,0.16574585635359115,0.8755995590210582,1.0,2/12,2.86%,IL18;NUPR1
prerank,generation of neurons (GO:0048699),-0.32286603789177487,-1.3240584577199086,0.028169014084507043,0.43306850739017577,1.0,41/190,9.79%,NRP1;ADGRL3;MEF2C;PTPRD;IL1RAPL1;MARK1;ASTN2;MAP1B;TAFA1;TGFB2;ASTN1;FUT9;NDNF;DNER;CIT;CDKL5;ACSL3;RUNX1;NTRK2;MYT1L;ATP2B2;MYEF2;FZD4;HES1;MET;NRCAM;DISC1;ACSL4;DCX;LHX6;RELN;HEYL;SIX1;SPOCK1;ATOH8;WNT9A;TUBGCP2;HEY2;FGF13;DDIT4;ERBB2
prerank,sulfur amino acid metabolic process (GO:0000096),0.5295733602840216,1.3240202464125639,0.15008431703204048,0.874287566983105,1.0,7/24,12.23%,MSRA;CPS1;MTHFR;ADI1;CTH;NOX4;MTRR
prerank,axonal fasciculation (GO:0007413),-0.5684343070225604,-1.3237087085582118,0.14314928425357873,0.4329196348848,1.0,5/12,8.13%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3541236214604243,1.323066799792926,0.0010298661174047373,0.8756764056316602,1.0,159/807,14.80%,PRDM6;AEBP1;DAB2;WWOX;BMP6;BMP7;THRB;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;FOXP4;PRKN;GLI2;ZNF423;DNMT3A;JARID2;FNIP1;KANK2;ZHX2;SNX6;FOXD1;DKK3;ZNF568;MOSPD1;ARID4A;NR2F2;NCOR2;HDAC8;KCNIP3;GLI3;TSHZ3;MITF;CTR9;SUFU;NR6A1;CXXC5;PHF21A;FOXC1;PCGF2;ZBTB38;IFI27;LOXL3;NACC2;VGLL4;EZR;FOXP2;RREB1;CUX2;NSD1;SFMBT1;USP9X;WWC2;OTP;GPS2;MAP2K5;LCOR;CBFA2T2;ZNF318;TBL1X;HMGA1;LBH;TP53;SMURF2;NIPBL;BHLHE41;RORC;FBXW11;LDB2;LDB1;NR1D2;BCOR;SMARCA4;CBX7;KDM2B;RBM15;SPEN;MEF2A;BTRC;KDM2A;KAT6B;TBL1XR1;NRG1;SMARCC2;CPEB3;TCF7L2;IRX1;TLE1;NUPR2;HDAC1;NIBAN2;SMARCE1;NR2C2;PARP9;HDAC4;SPINDOC;SIRT1;SCML4;ZFP90;CBY1;SOX13;CHMP1A;LARP7;FOXC2;PRDM5;ZNF219;ATN1;AASS;SAP18;AURKB;RTF1;BAHD1;RARG;MNT;DICER1;CBX5;IMPACT;SNAI1;SKOR1;IRF1;ZBTB1;UIMC1;WWP2;ZNF148;DEAF1;BRD7;FRK;ZMYM5;KMT5A;MLXIPL;KAT7;CBX6;BCL7A;NCOR1;PML;FLCN;BEND3;SIN3A;ZBTB32;GADD45A;TLE2;CRYAB;PER2;NFKB1;ACVR2B;TAF7;MTA2;ZKSCAN3;MIER3
prerank,cardiac muscle cell contraction (GO:0086003),-0.5045967345856847,-1.3220174964371518,0.13129102844638948,0.4360112461599643,1.0,8/19,5.56%,FGF12;GSN;CAMK2D;KCNJ2;CACNA2D1;SCN1A;CACNA1G;ATP1A1
prerank,response to fatty acid (GO:0070542),-0.5120679012019214,-1.3219311298293457,0.13485477178423236,0.4351877747160791,1.0,3/17,9.58%,PID1;FOXO1;SCD
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.3347918668265454,-1.3218890274980166,0.035555555555555556,0.4342659462736239,1.0,42/163,19.55%,PDE4D;MEF2C;PDE4B;PTPRJ;PIK3R1;PAK3;INPP5D;RFTN1;PSMB2;CD38;PAK1;PTPRC;BMX;PLCG2;PLEKHA1;MAP3K7;MOG;PSMD14;TNFRSF21;PSMC6;BCAR1;TEC;IKBKB;EIF2B3;SH2B2;RBCK1;SPPL3;BTN3A3;PSMB9;NCK1;BLNK;SKAP1;PSMA4;NFKBIZ;SYK;SKP1;BTK;PRKCQ;PSMD11;PSMB10;TXK;PSMD2
prerank,cellular response to interleukin-6 (GO:0071354),-0.46671051522372486,-1.3212768552761667,0.1362530413625304,0.43472266252364866,1.0,9/26,13.28%,PID1;PTPRT;ST18;STAT3;PTGIS;IL6ST;ST3GAL6;JAK1;SBNO2
prerank,nucleoside catabolic process (GO:0009164),0.6208945001741697,1.3212473607437667,0.18114602587800369,0.8811821590775653,1.0,3/11,6.69%,UPB1;DPYD;DERA
prerank,regulation of platelet aggregation (GO:0090330),-0.5182242588438689,-1.3212395275760642,0.1350210970464135,0.43377230333212974,1.0,6/17,8.76%,PRKG1;CD9;SERPINE2;F11R;LYN;CEACAM1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.37948881643505994,-1.321183583238507,0.06230529595015576,0.432872281483709,1.0,24/73,14.30%,NTRK3;CAV1;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;FNIP2;CD44;ATP2B4;HSP90AA1;NOS1;PRKD1;PFN2;AXIN1;SNCA;TNKS1BP1;TXN;PINK1;VEGFA;TERF2IP
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.49919624873357626,-1.3209573896700082,0.13090128755364808,0.4324224859843952,1.0,4/18,11.10%,SPTBN1;ACTB;AR;ZDHHC2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6306780131942685,1.3207129089294514,0.19109461966604824,0.8806673850475486,1.0,3/10,9.64%,JARID2;ATRX;SIRT1
prerank,regulation of superoxide anion generation (GO:0032928),-0.5353092559844934,-1.3206882159035496,0.1415525114155251,0.4321215083356022,1.0,6/14,21.55%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,lipid oxidation (GO:0034440),0.618286226157599,1.3203155879411252,0.1954459203036053,0.8797628853498382,1.0,2/12,2.37%,PPARGC1A;ALOX12
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.39572211635279275,-1.320070561630565,0.07901907356948229,0.4324939051990764,1.0,26/48,25.56%,PDE4D;AKAP6;CAMK2D;UBASH3B;PTK2B;CEMIP;CALM1;CALM2;TRPC1;FKBP1A;CALM3;JPH2;GPER1;NOS1;SNCA;SELENON;APLNR;CASQ2;DMD;GSTM2;JPH3;NPSR1;F2R;CXCL10;THY1;PLCG1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5553301425183454,1.3199950083535128,0.18149466192170818,0.8785344962207011,1.0,2/23,0.78%,ATP1A2;ANK2
prerank,gene expression (GO:0010467),-0.30948965290512787,-1.319619551294782,0.0,0.43238570311631636,1.0,141/348,26.01%,RPS24;RPS12;RPL8;RPS23;RPL13;RPL41;RPS8;ADARB2;RPS6;RPLP2;ADARB1;RPL18A;AGFG1;ELAVL4;RPS20;RPS29;RPL37;RPS15A;RPL3;RPL37A;RPL26;RPL38;RPLP1;RPL27A;RPS18;RPS19;RPL7;RPL22;PTMA;RPS28;RPLP0;RPL35A;RPS15;RPL30;RPL19;RPS3;RPS21;RPL4;TSPAN14;RPL32;RPS16;RPL5;TASP1;RPL21;RPL18;SORL1;RPS7;ABCF1;RPL39;RPS17;RPL34;RPL28;RPL14;EEF1A1;SYNCRIP;RPL9;RPL12;RPL7A;RPS25;RPS2;RPS11;RPS10;RPS9;RPL23A;RPL17;RPL23;RPL27;RPS27;RPL10A;RPL29;DROSHA;RPS4X;NUP210;HNRNPK;RPS5;CHTOP;RPL6;RPL36A;SMG5;TAF1B;THOC5;POLR2J;RPL31;HBS1L;GLE1;APOBEC1;RPS26;RPL36;GALNT2;RBM15B;HHEX;ANGPT2;EIF4E;RPSA;RNPS1;TSPAN17;RPL13A;BCL3;NXT1;RPL35;XRN2;WDR33;COPS5;PAX8;RPL24;RPS13;NUP107;EIF4A3;MRPL34;RBM3;RPL11;POM121;TSPAN33;RSL24D1;MRPS16;POLR2C;TSPAN15;MRPS21;MRPL13;MLF1;ZC3H11A;MRPL10;POLR2L;RPS27A;RBM8A;NUP93;NUP50;NUP85;NCBP2;EIF4EBP2;HOXD3;MRPS33;MRPL35;SRSF6;STUB1;EEF1A2;FASTKD2;THOC6;DDX39A;DEDD2;CPSF4
prerank,positive regulation of glycolytic process (GO:0045821),0.5506020119260414,1.3189171723151472,0.17102966841186737,0.8779243758323501,1.0,3/20,2.18%,IGF1;PRKAA2;ZBTB20
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5506020119260414,1.3189171723151472,0.17102966841186737,0.8779243758323501,1.0,3/20,2.18%,IGF1;PRKAA2;ZBTB20
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6173832614258717,1.318741266436265,0.18725868725868725,0.8761071533747902,1.0,6/12,10.88%,PARP10;TIPARP;TNKS2;PARP12;PARP11;PARP6
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5012647206609179,-1.318226535358488,0.1101123595505618,0.43464063026497557,1.0,10/19,30.72%,THBS1;PTK2;MPP1;CMKLR1;RARRES2;MDK;MAPK3;BST1;JAM3;CSF1R
prerank,negative regulation of angiogenesis (GO:0016525),-0.3683240398415393,-1.317913133237523,0.052083333333333336,0.43437307785123985,1.0,24/84,13.71%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;THBS1;DCN;TGFB2;COL4A2;SLC12A2;EPN2;SEMA3E;DAB2IP;SERPINF1;KLF2;STAB1;HSPG2;AMOT;ATP2B4;CTNNB1;ISM1;CREB3L1;ECSCR;ADGRB1
prerank,glycerol metabolic process (GO:0006071),0.6256256595372676,1.3173865807576963,0.20411985018726592,0.8793464306292998,1.0,4/10,16.47%,GK5;TKFC;GK;GOT1
prerank,brain development (GO:0007420),-0.33727069135841026,-1.3171911623020256,0.01652892561983471,0.43506983042933084,1.0,30/136,9.97%,CNTNAP2;ADGRL3;CTNNA2;ADGRL2;ROBO2;ZFHX3;CDH2;SHANK3;COL4A1;CNTN4;GRIN2B;SHROOM4;PBX3;DSCAML1;PTCH1;GRIN2A;RELN;PCDH18;MEIS2;PROX1;HSPG2;EPHA7;TUBGCP2;APOD;PPT1;RAB18;DDIT4;PBX1;UFM1;CDK5RAP2
prerank,contractile actin filament bundle assembly (GO:0030038),0.5883103164140981,1.3165546438397056,0.17636363636363636,0.8778852675158906,1.0,4/15,5.54%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,stress fiber assembly (GO:0043149),0.5883103164140981,1.3165546438397056,0.17636363636363636,0.8778852675158906,1.0,4/15,5.54%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,amide transport (GO:0042886),-0.4641322006826271,-1.31594942267541,0.11219512195121951,0.43683342034920397,1.0,8/26,8.27%,ABCG2;CERT1;PLTP;SLC5A6;AQP11;SLC38A5;GLTP;DISP1
prerank,positive regulation of DNA repair (GO:0045739),0.4788605167996826,1.3154451118240802,0.13050314465408805,0.8800127240171411,1.0,10/46,14.63%,EYA1;EYA2;EYA4;BABAM2;RNF8;SIRT1;UIMC1;BABAM1;MGMT;SMCHD1
prerank,regulation of potassium ion transport (GO:0043266),0.5091287719472634,1.3152317416742665,0.14845024469820556,0.87845113821244,1.0,7/31,3.76%,CACNA1D;ACTN2;ANK2;DLG1;KCNA5;KCNIP3;ADRA2A
prerank,protein homotetramerization (GO:0051289),0.4731898604392555,1.3150099569300895,0.12280701754385964,0.8769730817698764,1.0,8/49,10.04%,ALDH1A2;APPL2;UPB1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,regulation of axon extension (GO:0030516),-0.42290347344276724,-1.314898455832986,0.08439897698209718,0.43826941139578923,1.0,12/37,14.22%,RTN4;SEMA7A;CDKL5;NTN1;SHTN1;GSK3B;APOE;NRCAM;DIP2B;SEMA3G;MAPT;MT3
prerank,regulation of ATP metabolic process (GO:1903578),0.46158649560217807,1.3144868156591252,0.13230769230769232,0.8767110665422878,1.0,9/54,14.38%,PRKAG2;GCK;AK4;NUP42;NUP98;OGT;NUP43;BEND3;SPHK2
prerank,negative regulation of ATPase activity (GO:0032780),0.5758925632576457,1.3143497088956135,0.15229357798165138,0.8747843699505293,1.0,5/16,14.58%,IFIT1;TP53;SIRT1;TNNI3;TSC1
prerank,positive regulation of biosynthetic process (GO:0009891),0.4792358380009777,1.3140652168965914,0.1318864774624374,0.8735484687947646,1.0,8/40,6.64%,WNT4;SORBS1;PPARA;ZBTB20;SLC5A3;TLR4;F2;CREBL2
prerank,peptide cross-linking (GO:0018149),-0.4688980408918567,-1.3140509175730284,0.1026252983293556,0.43932807841053345,1.0,4/25,5.65%,THBS1;FN1;NDNF;ANXA1
prerank,synapse assembly (GO:0007416),-0.3813309330218661,-1.3130149040056756,0.07232704402515723,0.44082494884018225,1.0,22/67,11.97%,NLGN1;ADGRL3;NRXN1;GRID2;DNM3;CDH2;KIRREL3;SHANK3;SPOCK2;GABRB3;LRRTM3;DNER;GABRA2;GABRB2;NRCAM;GABRG2;FGF13;SLITRK1;NRXN2;CDH1;SHANK2;LGI2
prerank,respiratory system development (GO:0060541),0.5132623591069436,1.312733101722435,0.152317880794702,0.8765490018003177,1.0,7/32,7.88%,FGF1;FGFR2;GLI2;PDPN;LOXL3;CHD7;RBP4
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.575143367426623,1.312399502597894,0.1989247311827957,0.8754459456977634,1.0,3/16,5.23%,UPB1;DPYD;TET2
prerank,regulation of wound healing (GO:0061041),-0.4240280077245925,-1.3123174970743305,0.11627906976744186,0.4413487537224819,1.0,12/42,9.68%,CAV1;CASK;ACTG1;AJAP1;ANXA1;OCLN;CRK;CD109;ITGB1;EPHB2;PTK2;FGF2
prerank,circulatory system development (GO:0072359),-0.34424068694267224,-1.3122969201274173,0.014285714285714285,0.44039939652422316,1.0,33/118,12.87%,MEF2C;TEK;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;PLCE1;FN1;MICAL2;TGFB2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;STRA6;PCSK5;BMP2;HSPG2;TGFB1;PDLIM1;HEY2;FLT4;ID2;PKD1;RBM20;SOX18;CRIP1;CDKN1A;PDLIM3
prerank,cellular potassium ion homeostasis (GO:0030007),0.6046338970610957,1.3117777909968564,0.20545454545454545,0.8755779141240365,1.0,2/13,0.74%,ATP1A2;ATP1B3
prerank,membrane assembly (GO:0071709),-0.4422242052638958,-1.3117556701337203,0.11139896373056994,0.44060817526409596,1.0,8/34,4.95%,NLGN1;NRXN1;SPTBN1;PTPRD;IL1RAPL1;ANK3;RFTN1;UGCG
prerank,embryonic heart tube development (GO:0035050),-0.5323574782756935,-1.311744039400005,0.1388888888888889,0.43965073770266133,1.0,7/14,23.49%,RYR2;SOX17;HES1;SOX18;ACVR1;NDRG4;TBX2
prerank,oligosaccharide metabolic process (GO:0009311),-0.40848442882897945,-1.3111071249597288,0.0921409214092141,0.44006762797307114,1.0,15/46,16.05%,ST6GALNAC3;ST3GAL4;ST8SIA4;FUT9;ST6GAL2;ST8SIA1;ST6GALNAC5;ST3GAL6;B3GALT1;ST8SIA6;B3GALT5;MAN1B1;AMY1A;AMY1B;AMY1C
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4850619111997726,1.3109847606064924,0.15548281505728315,0.8764953804586221,1.0,7/40,3.17%,BMP6;BMP7;WNT4;OSR1;KL;WNT6;BMPR1A
prerank,proton transmembrane transport (GO:1902600),0.49798681249268434,1.3106801619340631,0.13679245283018868,0.8752989279665343,1.0,3/36,6.27%,ATP1A2;ATP6V0E1;ATP4A
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3750996134024341,-1.310312726254907,0.05379746835443038,0.4409127368838108,1.0,19/76,15.91%,NRP1;TEK;NTRK3;SEMA5A;NCK2;EVL;PTK2B;CARMIL1;CDC42EP3;PROX1;BIN1;WDR1;EDN1;SYNPO2;PFN2;CDC42EP2;FES;NCK1;ARF6
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5496440875115517,1.310251963421006,0.15892857142857142,0.8747561748446845,1.0,4/21,6.77%,PPARA;PRKN;SLC30A10;SIRT5
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5374372338690692,1.3099994216842998,0.15508021390374332,0.8733883067441927,1.0,6/22,10.83%,AEBP1;AKAP13;MAP2;PIK3CA;ABL1;PRUNE1
prerank,lipid biosynthetic process (GO:0008610),0.439240637412283,1.309862298330191,0.11078717201166181,0.8716257840470236,1.0,10/77,7.55%,ACSL1;PRKAA2;AGPAT4;GPAT2;CYP21A2;FDXR;SCD5;DHRS11;PDSS2;NDUFAB1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5098357494144754,-1.309798453144984,0.1348314606741573,0.4410721139044583,1.0,3/17,1.14%,NRP1;TEK;NTRK3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5084443301068916,-1.3092675540258054,0.14935064935064934,0.4413603886704543,1.0,6/18,3.58%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6285549613299184,1.3086226285824296,0.1866913123844732,0.8742073497551957,1.0,2/11,2.07%,PPARA;SLC30A10
prerank,sodium ion homeostasis (GO:0055078),0.5498053969412955,1.3077908201133805,0.15302491103202848,0.8753321491317425,1.0,2/21,0.74%,ATP1A2;ATP1B3
prerank,regulation of AMPA receptor activity (GO:2000311),-0.46108600727384375,-1.3073698674584577,0.13981042654028436,0.4449611982011238,1.0,7/25,7.72%,NLGN1;MEF2C;SHANK3;SHISA6;SHISA9;MINK1;RELN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5831558570613382,1.3071175853728758,0.15555555555555556,0.875740770010235,1.0,3/15,7.15%,IGF1;PRKN;OPA1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5138749312447306,-1.3069873755378398,0.14957264957264957,0.44486860172826337,1.0,9/18,19.33%,RPS6KA5;CD200;EPHA5;RELN;PRKD1;LRP8;VEGFA;CRTC2;ADCY8
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5051435239355536,-1.3061225560933194,0.14376321353065538,0.44588916068322876,1.0,5/17,12.63%,PRKG1;MEF2C;TGFB3;GPER1;CDKN1A
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4161713711425791,-1.3060022436586707,0.09487179487179487,0.44518013624322866,1.0,7/40,5.76%,SYT1;RIMS2;SNAP25;RIMS1;PCLO;UNC13B;STX3
prerank,regulated exocytosis (GO:0045055),-0.32569604243201994,-1.3054858136162721,0.021929824561403508,0.4454790770032297,1.0,49/173,15.36%,PCDH7;ABCC4;SYT1;VWF;ACTN4;RIMS2;PECAM1;TMSB4X;CD9;SNAP25;RIMS1;THBS1;VEGFC;ACTN1;FN1;TGFB2;PCLO;GAS6;RAB31;MYH9;LYN;OLA1;CALM1;LHFPL2;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;RAB11FIP1;RAB11FIP5;PROS1;CDC37L1;SNCA;VEGFA;SDF4;SYT7;CLU;SYNGR2;ALDOA;RARRES2
prerank,regulation of cellular localization (GO:0060341),0.4769253480878371,1.304625257175976,0.14696485623003194,0.8833978688859229,1.0,7/46,5.39%,PARD6G;ADCY5;STXBP4;PRKN;LRRK2;STXBP2;MAP2
prerank,dendrite morphogenesis (GO:0048813),-0.4302511967687469,-1.3044376144578276,0.10103626943005181,0.4469232229111779,1.0,12/35,9.51%,CTNND2;CTNNA2;DOCK10;SHANK3;KLF7;EPHB1;PAK3;MINK1;EPHB2;BTBD3;MAP6;PTN
prerank,muscle organ development (GO:0007517),-0.39208323040986404,-1.3043225216705228,0.0821529745042493,0.44625077883798153,1.0,11/54,6.40%,UTRN;MEF2C;SGCD;COL6A3;MKX;LAMA2;TEAD4;SGCE;TBX1;SMTN;FKTN
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4488997784766574,1.303733407250377,0.13333333333333333,0.8846763083458282,1.0,16/58,13.86%,PAXX;POLM;BABAM2;DNTT;ATM;UVRAG;NHEJ1;RNF8;KDM2A;IFFO1;XRCC4;PRKDC;UIMC1;RAD50;NSMCE2;BABAM1
prerank,Golgi localization (GO:0051645),0.5960462303721074,1.3035604684306665,0.2052313883299799,0.8829698826313636,1.0,6/11,19.88%,TBCCD1;UVRAG;CDC42;ARHGAP21;HOOK3;RIPOR1
prerank,regulation of blood circulation (GO:1903522),0.48781076951630575,1.3033624422907097,0.15017064846416384,0.8813910554516756,1.0,5/34,5.04%,CELF2;ACE;DMPK;BDKRB2;TPM1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.36142551392648037,-1.3019124612541682,0.060126582278481014,0.45085219529945847,1.0,40/86,23.31%,NRP1;GHR;PTPRJ;PECAM1;EFNA5;PTK2B;ARHGEF2;PTPRC;APP;PLCG2;CSPG4;SEMA4D;RELN;EPHA7;TGFB1;CD44;PDGFA;ITGB3;TEC;ENPP2;SAMSN1;LRP8;DMTN;VEGFA;FGF7;ACVR1;PDCL3;CD74;ITGB2;ITGA5;AGT;CD81;THBS4;CNOT7;HCLS1;VTN;IL6R;FYN;HGF;SFRP1
prerank,heart development (GO:0007507),-0.3273893855095185,-1.3009581231783007,0.03278688524590164,0.45209590356581103,1.0,41/150,14.09%,SGCZ;MEF2C;SGCD;FLRT2;TEK;BMP5;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;BMPR2;PLCE1;FN1;MICAL2;TGFB2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;STRA6;PCSK5;BMP2;TGFB1;PTK2;PDLIM1;ID2;PKD1;FKBP1A;BMP4;RBM20;SOX18;CRIP1;CDKN1A;PDLIM3;MYOCD;VEGFA;ACVR1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.49015210254340214,1.300480951622453,0.16506410256410256,0.8909074666819968,1.0,9/33,11.77%,UBE2E2;STXBP4;DDX3X;ANKRD17;CCND3;TFDP1;GLI1;HYAL1;ADAM17
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6114557604168576,1.3002125546465368,0.17670682730923695,0.8895878962665558,1.0,1/12,0.36%,ACSL1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.41043716474507586,1.2999686095665013,0.07260273972602739,0.888225822891035,1.0,13/101,7.98%,FGF1;ROBO1;TPD52L1;KIT;FGFR1;LRRK2;ADRA2A;DDX3X;CAMK1;PDGFRB;FLT1;SLC27A1;CCND3
prerank,cholesterol transport (GO:0030301),-0.4080908004767098,-1.2998564311802698,0.09819121447028424,0.45366700054226644,1.0,15/45,21.14%,CAV1;SCARB1;LIMA1;APOE;LDLR;ABCG1;NPC2;STARD5;STX12;STARD4;CLU;LDLRAP1;RELCH;OSBP;STARD3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.48475212905608933,-1.2996393155924952,0.13819095477386933,0.45321165119326795,1.0,5/21,6.52%,PRKCH;SLC39A10;PTPRC;FOXP1;RPS3
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5539727341502261,1.299386375273957,0.18840579710144928,0.8883518061802366,1.0,4/18,3.63%,ROCK2;PICALM;EPHA4;CASP3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5607321322175209,-1.2993578639423893,0.16041666666666668,0.45293861151514464,1.0,2/12,0.36%,PRKG1;MEF2C
prerank,ear morphogenesis (GO:0042471),0.5376447049447525,1.2988701945914083,0.17989417989417988,0.8881578743827444,1.0,6/20,8.20%,OSR1;FGFR2;HOXA1;CHD7;NIPBL;ZIC1
prerank,T cell proliferation (GO:0042098),-0.5309379519052295,-1.2987979818490418,0.15825688073394495,0.4532403248548851,1.0,3/13,11.13%,CADM1;DOCK8;MSN
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5842655294364987,-1.2987615736016798,0.1801980198019802,0.4523556705491017,1.0,3/10,9.55%,LRCH1;CD200;APOD
prerank,regulation of fat cell differentiation (GO:0045598),0.42986852196616504,1.2983668788881197,0.1171993911719939,0.888011568399535,1.0,12/74,9.92%,TMEM64;RORA;SMAD3;MEDAG;ADIG;GPS2;TRIB2;CREBL2;RORC;WWTR1;SIRT1;LRP3
prerank,renal system development (GO:0072001),0.45851417486159124,1.2980686146421032,0.11612903225806452,0.886928880064503,1.0,8/52,3.99%,ACE;LRP4;WNT4;GREB1L;GLI2;TGFBR1;FOXC1;SULF2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.36845573001401993,-1.2978624825648433,0.0668693009118541,0.45357557692679656,1.0,20/72,11.09%,TEK;NTRK3;PIK3R1;ROR1;DCN;FN1;TGFB2;GAB1;NTRK2;KDR;LYN;PDGFC;SEMA4D;ROR2;MYOC;PTK2;FGF2;PIK3AP1;PDGFA;GPER1
prerank,sterol metabolic process (GO:0016125),0.4467976957248247,1.2977979668281971,0.12792511700468018,0.8857540750278536,1.0,7/60,5.02%,PRKAG2;CYP27A1;INSIG2;LIPA;CYP21A2;CYP26B1;FDXR
prerank,intracellular cholesterol transport (GO:0032367),-0.5284846445478227,-1.2973915084682388,0.13114754098360656,0.45371753885243077,1.0,8/15,22.91%,LDLR;ABCG1;NPC2;STARD4;LDLRAP1;RELCH;OSBP;LRP6
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5710899957406822,-1.296897717146306,0.16129032258064516,0.4539503211250203,1.0,5/11,10.83%,ZFPM2;TGFB2;JAG1;HEY2;BMP4
prerank,cellular response to ketone (GO:1901655),0.48704347545481796,1.2966060066042384,0.15867768595041323,0.8882038943784861,1.0,4/35,2.01%,ADCY5;ROCK2;SPP1;ADCY1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5372352473051611,1.2966012375474616,0.19294990723562153,0.885871638353097,1.0,3/22,3.76%,TIMP3;SH3D19;ADRA2A
prerank,negative regulation of chemokine production (GO:0032682),0.5901211377680732,1.29654683958045,0.186219739292365,0.8837738752878963,1.0,2/14,5.80%,C1QTNF3;MAP2K5
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4872115449018093,-1.2965269007516793,0.1514476614699332,0.45385499975946175,1.0,9/20,14.22%,NOTCH1;SMAD5;BMP2;SMAD1;ATF4;RUNX2;HIF1A;VEGFA;MT3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.38337483616527135,-1.2964709368705247,0.06134969325153374,0.4529940267076039,1.0,18/63,21.66%,MEF2C;VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;CD38;PTPRC;EPHB2;TIRAP;NCK1;CD74;IRS2;CCL19;CD320;CD81;CD86
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5709920627903424,1.296312679482796,0.1963963963963964,0.8823801273260772,1.0,3/16,6.22%,AUTS2;ALS2;ARHGAP17
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6054088993040893,1.2962003022820114,0.18568665377176016,0.880592138430071,1.0,5/11,15.76%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3920058312530342,1.2953486002181356,0.06842105263157895,0.8816649337495688,1.0,18/141,6.16%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;SLC5A5;SPP1;ADCY1;IL18;CASP3;LRRK2;RAPGEF3;EZR;SLC26A3;NCOA3;P2RX3;TIPARP;LCOR
prerank,aortic valve development (GO:0003176),-0.4278865378454641,-1.2951234650335064,0.09974424552429667,0.4551767019879914,1.0,15/34,10.83%,SLIT2;ROBO2;ELN;BMPR2;NOS3;TIE1;NOTCH1;JAG1;TNFRSF1B;NFATC1;HEYL;BMP2;TGFB1;HEY2;BMP4
prerank,positive regulation of heart contraction (GO:0045823),0.5421926924133227,1.2951042441774518,0.17196261682242991,0.8803305009192661,1.0,3/19,8.13%,ATP1A2;APLN;ADM
prerank,positive regulation of cell differentiation (GO:0045597),0.37306577629386506,1.294810077218031,0.050970873786407765,0.8793080848036315,1.0,44/237,12.16%,RANBP3L;DAB2;TMEM64;BMP6;BMP7;SMAD3;WNT4;IGF1;RIN2;CCN2;MEDAG;IL18;HOXB4;NPNT;ADIG;SOX5;FGFR1;BMPR1A;TGFBR1;FOXC1;PDPN;ATOH1;PPP1R13L;CAMK1;CREBL2;WWTR1;TGFBR2;IGFBP3;MEF2A;GPRC5B;GDNF;TCF4;NEUROD4;NBL1;LRP3;BLOC1S6;ABL1;SUCO;CDC42;AXIN2;IMPACT;SNAI1;NOCT;ATRAID
prerank,positive regulation of cellular component movement (GO:0051272),-0.47484146054526044,-1.2947164698415676,0.1309255079006772,0.45520540743239296,1.0,9/24,15.12%,ACTN4;SPOCK2;CAVIN1;NTN1;LYN;RPS19;TWIST1;VEGFA;TUBB2B
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5054960572767766,-1.2946062770744877,0.1342281879194631,0.4545169376582931,1.0,7/18,27.83%,PIK3R1;USP13;NCK1;BCL2L11;ERN1;TMEM259;PMAIP1
prerank,regulation of cell growth (GO:0001558),-0.32076286042187196,-1.2945745198752763,0.030456852791878174,0.4536288339245247,1.0,52/204,16.10%,NRG3;APBB2;SLIT2;PTPRJ;LTBP4;BMPR2;AKAP6;PLCE1;RTN4;CAMK2D;TGFB2;PAK5;CCN3;ACVRL1;TFRC;NET1;SOX17;SOCS2;ADAM15;LGI1;PPP2R1A;SH3BP4;SPOCK1;ENPP1;AGTR1;RERG;TGFB1;CEACAM1;SERTAD2;CXCL16;BTG1;H3-3A;PPT1;ERBB2;KIF26A;BCAR1;SLC25A33;FRZB;RPS6KA3;MFSD2A;FAM107A;CDKN1A;JADE1;EI24;RPS6KA1;TAF9B;MT3;PTCH2;DCBLD2;RASGRP2;CCDC85B;EGLN2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4927134258431132,-1.2944950549009688,0.13902439024390245,0.4528609257973868,1.0,12/21,25.82%,TOX;DISC1;PROX1;NAP1L1;CTNNB1;VEGFA;CX3CR1;DLL4;DISP3;DRD2;MDK;LRP2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.47347981593932886,-1.2943562879437784,0.12134831460674157,0.4522628766847025,1.0,6/23,6.44%,GHR;ERBB4;PTK2B;NOTCH1;CYP1B1;HES1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.37733547778162463,-1.2942881241318709,0.1069182389937107,0.4514420086173276,1.0,16/65,13.67%,HIP1;PTPRJ;CDH13;SH3KBP1;PTPN12;BCAR3;SH3GL2;CCDC88A;ARHGEF7;DAB2IP;CEACAM1;MVB12B;DUSP3;GPER1;PTPN3;SPRY1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.4884152651968169,-1.2934364291554865,0.1595744680851064,0.4526330805105675,1.0,9/18,25.44%,FLNA;ERBB2;ATF4;EIF2AK3;UTP15;MAF1;PHF8;POLR2L;LYAR
prerank,triglyceride metabolic process (GO:0006641),0.46689653887725124,1.2932641560300653,0.13700787401574804,0.8831700392846672,1.0,8/48,9.64%,LPGAT1;MOGAT3;GPAT2;CPS1;GK5;GK;APOBR;SIRT1
prerank,engulfment of apoptotic cell (GO:0043652),-0.5271702455222547,-1.2930411434142448,0.15932914046121593,0.45260787597228547,1.0,6/15,13.71%,RHOBTB1;XKR4;THBS1;XKR6;RHOH;ADGRB1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4942600149186506,-1.2926411849610993,0.1729957805907173,0.45262190903333616,1.0,8/18,27.98%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;OPRM1;RGS10;RGS8
prerank,sulfur compound transport (GO:0072348),0.49603785427917324,1.292543977991266,0.19023569023569023,0.8839692626366571,1.0,5/27,8.06%,SLC13A4;SLC6A13;SLC35F3;SLC27A1;SLC26A1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4814766215092097,1.2919355203593128,0.16835016835016836,0.8841363591495878,1.0,6/39,8.90%,NNAT;NLGN2;MCU;GCK;RBP4;TCF7L2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5459953317006606,1.2917780832787353,0.19107142857142856,0.882485767675432,1.0,11/20,22.02%,AMPD3;LHPP;AK4;AK3;NT5C2;AMPD2;GART;ADSS1;ADSL;GMPR2;GMPS
prerank,regulation of integrin activation (GO:0033623),-0.5133286570631811,-1.2905693914297705,0.16701461377870563,0.4562740833422546,1.0,10/15,36.23%,RASIP1;RAP1B;PIEZO1;FBLIM1;SKAP1;KIF14;SELP;JAM3;PTGER4;FERMT2
prerank,sterol biosynthetic process (GO:0016126),0.49695662550221975,1.2901972199058953,0.15851602023608768,0.8866784547874897,1.0,2/33,2.49%,PRKAG2;INSIG2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4160244806915506,1.2900618353315556,0.11463046757164404,0.8849404148494555,1.0,16/87,12.34%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;FLRT1;HNRNPH1;TIA1;POLR2D;HYAL1;FIBP;GTF2F1;KLB;PTPN11
prerank,photoperiodism (GO:0009648),0.5068950290925318,1.2895702955911668,0.17747440273037543,0.8847021309006993,1.0,14/28,20.79%,FBXL17;PPP1CB;SIK1;TP53;FBXL12;PML;PER2;RBM4;PER3;CRTC1;CRY1;FBXL22;MTA1;PDE6B
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5017813141907476,1.2888106137579702,0.17123287671232876,0.8854309479487179,1.0,5/30,6.84%,TGFBR3;SMAD3;DKK3;SMURF2;TWSG1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5185543196877006,1.2884496443398439,0.15505226480836237,0.8845445817536948,1.0,4/24,7.09%,SORBS1;IGF1;PPP1R3B;GCK
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5567340411427837,1.2884018925181864,0.1871559633027523,0.8825173413924103,1.0,2/16,1.30%,PPARGC1B;DDX5
prerank,Rho protein signal transduction (GO:0007266),0.45879474284440497,1.2880461498812958,0.1301775147928994,0.8817947814583315,1.0,16/53,12.43%,CELSR1;ARHGAP29;ROCK2;RHOD;PDPN;ARHGAP6;ADRA2A;COL1A2;ARHGEF11;ARHGEF1;CTNNAL1;EPS8L2;PHACTR4;CDC42;CDC42EP1;EPS8L1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5827464223356225,1.2873956944670026,0.19744058500914077,0.8821078464439117,1.0,3/14,6.56%,IL18;IL17D;IL12B
prerank,nucleic acid-templated transcription (GO:0097659),0.4725520576097217,1.2869168460662268,0.1393841166936791,0.881907077778655,1.0,7/42,8.12%,THRB;POLR2A;DTX1;CREBL2;POLR2D;TERT;MEF2A
prerank,negative regulation of translation (GO:0017148),0.4154962671361059,1.2868352194808867,0.1225071225071225,0.8800672984711955,1.0,13/87,10.21%,CPEB2;ROCK2;CPEB4;IGF2BP1;DDX3X;EIF2AK2;IGF2BP2;SAMD4A;LARP1;CNOT10;CPEB3;YTHDF3;LSM14A
prerank,carbohydrate homeostasis (GO:0033500),0.4362192362571653,1.2868073394762176,0.14136904761904762,0.8779915491380994,1.0,9/67,8.90%,APPL2;LEPR;BACE2;PRKAA2;MCU;ADRA2A;GCK;RBP4;TCF7L2
prerank,neuromuscular synaptic transmission (GO:0007274),0.5485497278578979,1.2867156243772755,0.1906474820143885,0.8761779265330066,1.0,7/18,20.90%,FCHSD2;DTNA;KIF1B;TSPOAP1;ERC2;CHRNB1;TBC1D24
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.41276842010722514,1.286464979764462,0.12134502923976608,0.8750253929697026,1.0,14/95,9.64%,DAB2;TGFBR3;SMAD3;PPARA;SNX6;DKK3;PMEPA1;TGFBR1;SMAD6;LDLRAD4;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,manganese ion transport (GO:0006828),-0.5304421722627339,-1.2862793977368356,0.1726457399103139,0.4654208366545626,1.0,7/14,15.04%,ATP2C1;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4604588962505987,-1.2849312119181917,0.15417558886509636,0.4676442082517717,1.0,9/21,9.00%,NOS3;PTK2B;GAS6;NOTCH1;ASPN;ECM1;ENPP1;TGFB1;HEY2
prerank,RNA metabolic process (GO:0016070),0.3940405328099118,1.2838120958367858,0.10054347826086957,0.8836043611782778,1.0,31/127,16.18%,CELF2;POLR2A;RBMS2;TP53RK;PCBP2;PABPN1;HNRNPR;HNRNPH1;DDX3X;SIDT2;LAGE3;HNRNPA2B1;ATXN2;POLR2D;RBM39;RBMS1;EXOSC7;SND1;NOVA1;TENT2;TBRG4;GTF2F1;DICER1;HNRNPL;HNRNPC;WTAP;SNRNP40;RBM4;HNRNPM;PAPOLG;TFIP11
prerank,glucose homeostasis (GO:0042593),0.42459356620840766,1.2833501782735754,0.12719298245614036,0.8832899206268187,1.0,12/83,9.64%,APPL2;LEPR;PPARGC1A;BACE2;PRKAA2;HK2;MCU;ADRA2A;GCK;RBP4;TCF7L2;SIRT1
prerank,glycolipid metabolic process (GO:0006664),-0.39456881370835617,-1.282822306463162,0.10846560846560846,0.4718030358210122,1.0,11/47,10.19%,ST6GALNAC3;ST3GAL4;ESYT2;UGCG;PSAP;ST3GAL6;GLTP;HEXB;ST8SIA6;B3GALNT1;ESYT3
prerank,actomyosin structure organization (GO:0031032),0.4284005924058361,1.281741377231405,0.13313609467455623,0.8874407950637585,1.0,15/75,6.66%,ROCK2;ACTN2;SORBS1;FRMD6;CSRP3;PHACTR1;TMOD2;EPB41L5;MYO18A;TPM1;FAM171A1;TMOD3;ARRB1;KLHL41;CDC42BPG
prerank,ribosomal small subunit assembly (GO:0000028),-0.5114324420255765,-1.2814787695296095,0.15800865800865802,0.4741029563662442,1.0,8/16,18.90%,RPS19;RPS28;RPS15;RPS27;XRCC5;RPS5;RPSA;RPS27L
prerank,regulation of protein targeting to membrane (GO:0090313),-0.4412997043385256,-1.2814003530549856,0.1477832512315271,0.4733123458479937,1.0,8/28,18.29%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1;DMTN;GDI1;ITGB2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5401572570137156,1.2810752996716064,0.20297951582867785,0.8878789407515686,1.0,8/18,13.76%,DDX5;NCOR2;TP53;TERT;RIPK1;MAP2K1;NCOR1;MAP2K2
prerank,cellular response to lipid (GO:0071396),0.37448448578101534,1.2806949356526616,0.06415094339622641,0.88722951568549,1.0,18/191,7.21%,ATP1A2;WNT5B;RORA;ADCY5;ROCK2;TFPI;PTK7;WNT6;SPP1;ADCY1;CTR9;PABPN1;ATM;TLR4;NCOA3;LCOR;SERPINE1;RORC
prerank,response to iron ion (GO:0010039),0.5869130503360958,1.2803196289683725,0.21572212065813529,0.8866213416902594,1.0,1/12,0.40%,BMP6
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5082256838846757,1.2798409176642909,0.18461538461538463,0.8864196987928126,1.0,14/27,20.79%,FBXL17;PPP1CB;SIK1;TP53;FBXL12;PML;PER2;RBM4;PER3;CRTC1;CRY1;FBXL22;MTA1;PDE6B
prerank,protein-DNA complex disassembly (GO:0032986),0.5605951840278148,1.279734122350472,0.20342205323193915,0.8846679104854485,1.0,6/16,9.31%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5979689302385458,1.279679120306025,0.21153846153846154,0.8827261857167483,1.0,3/12,4.03%,PTPN14;NEDD4;IFI27
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.37857025860735116,1.2792406572063706,0.09608091024020228,0.8823822557271016,1.0,40/166,16.87%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;TAF1D;TEAD3;ESRRA;TBL1X;RORC;WWTR1;NR1D2;POLR2D;TBL1XR1;HDAC1;NR2C2;TEAD2;MED17;GTF2F1;TEAD1;RARG;TAF11;POLR1G;TAF4;TBP;NCOR1;NR3C2;TAF7;KAT2B;BRF1;CREBBP;MED23;MED26;RXRA;TAF13;YAP1
prerank,regulation of response to biotic stimulus (GO:0002831),0.5059452034182631,1.2786837743010029,0.1834710743801653,0.88237617621624,1.0,10/28,15.47%,APPL2;RNF135;TKFC;PTPN22;SAMHD1;DHX58;IRF1;ERAP1;BIRC3;ZMPSTE24
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5223477018038855,1.278508993723504,0.18620689655172415,0.8810215745342332,1.0,3/23,2.18%,IGF1;PRKAA2;ZBTB20
prerank,granulocyte chemotaxis (GO:0071621),-0.38961983292871927,-1.2781768026603764,0.1027190332326284,0.48004777091872286,1.0,13/55,20.34%,PDE4B;BSG;TGFB2;ANXA1;PPIA;PPIB;EDN1;EDN3;SCG2;CCL13;SYK;ITGB2;CCL19
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.588286591983813,1.2781514273747605,0.1965648854961832,0.8803543290821928,1.0,4/14,7.47%,IL18;IL12B;PTPN22;TGFBR2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2956408347897961,-1.2781349417040697,0.00847457627118644,0.47913699428475204,1.0,115/390,17.38%,NRP1;ARHGEF28;FLRT2;GHR;PTPRJ;TEK;GRB14;ERBB4;NTRK3;PIK3R1;ACTB;PTPRG;EPHB1;ROR1;MPZL1;EPHA5;VEGFC;ATP6V0A1;MERTK;UBASH3B;GRIN2B;EFNA5;PTPRT;EPHA6;NRP2;TIE1;PAK3;NCK2;GAB1;CHN1;PTK2B;STAT3;COL4A2;BCAR3;ACTG1;CAV2;NGF;NTRK2;ARHGEF7;KDR;DOCK1;LYN;GSK3B;PDGFC;TIAM1;PAK1;ACTR2;NAMPT;AP3S1;MET;SOCS2;CRK;ROR2;FOXO1;ATP6V0A4;PSEN1;SORT1;DNM1;EPHB2;EPHA7;AP2B1;PTK2;ANKS1B;NCF2;ABI1;FLT4;FGF2;DDIT4;ERBB2;PDGFA;HSP90AA1;ACTR3;ITGB3;BCAR1;ELMO1;CYBA;AP2M1;TIAL1;ARPC1B;RASA1;SH2B2;PRKD1;MTSS1;AHI1;ARPC5;POLR2J;RET;ARPC4;VEGFA;FGF7;FGF9;CDK5R1;FES;NUS1;FGFR3;SPRED1;IL31RA;STMN1;RARRES2;BDNF;GRIN1;NCK1;BLNK;ANGPT2;PIK3C2A;APC;EIF2AK3;WASF2;VAV1;COL1A1;GFRA2;CBL;TYRO3;SHOC2;SYK
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3437229155056717,1.2778804624994775,0.00933609958506224,0.8793285047915019,1.0,128/834,11.35%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;PPARGC1A;IGF1;KMT2A;RHOQ;BRD8;PPARA;SSBP2;FGFR2;CREBRF;PRKN;IL18;GLI2;FHOD1;HOXB4;CSRP3;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;NR2F2;HDAC8;PHIP;PCGF5;BMPR1A;GLI3;MITF;ELF1;ARNT2;FOXC1;MLLT10;HOXB3;NFIB;ZBTB38;VEZF1;ASCL3;ZNF462;NFYB;TLR3;NHLH2;MEIS1;RREB1;TET2;ATM;TLR4;DDX3X;FZD5;ARRB1;NCOA3;CAPRIN2;GPS2;MAP2K5;CAMK1;ATRX;ABHD14B;ESRRA;TBL1X;HMGA1;TP53;BCAS3;CAMTA2;LAGE3;BCLAF3;SMARCD3;SERPINE1;MED12;WWTR1;CCNT2;APLN;SOX12;PLSCR1;LDB2;LDB1;ATAD2B;NR1D2;SMARCA4;TERT;MEF2A;HOXC4;KAT6B;SSBP3;TBL1XR1;TMF1;CALCOCO1;GDNF;JMJD6;TCF4;TCF7L2;HDAC1;TFDP1;MYBL1;GLI1;NR2C2;HDAC4;SIRT1;RIPK1;WASL;ELL;RIPK2;LARP7;FOXC2;MED17;GTF2F1;MAVS;THRAP3;ABL1;RBL1;KMT2C;ZMIZ1;ATF2;TEAD1;PRKDC;RARG;NFATC3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5818710242745364,-1.2775927785139218,0.18895966029723993,0.4794227695903123,1.0,4/10,4.92%,PDE3B;ACER2;NEXMIF;CYP1B1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.6038644935605784,1.2775429838237808,0.20359281437125748,0.8785520785796095,1.0,3/12,4.86%,THRB;BRD8;CTSH
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6157831717292461,1.277370808922864,0.2215909090909091,0.8771963062071771,1.0,6/10,25.01%,USP7;OGT;GNMT;SELENOS;PDK2;DGKQ
prerank,acidic amino acid transport (GO:0015800),0.546454558344124,1.276809510879266,0.20441988950276244,0.87731853037453,1.0,2/17,0.37%,SLC6A13;SLC6A1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6160028055538385,1.2766040530362028,0.21485943775100402,0.8760391733501821,1.0,3/10,3.85%,ATP1A2;OSR1;NEDD4
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2859065448841318,-1.2751313898712904,0.010309278350515464,0.48431552186494103,1.0,104/428,19.55%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;PTPRN2;RAB31;HSP90AB1;PRG2;GPI;PPIA;RAP1B;RAP1A;ACTR2;CD93;PTPRC;STK10;RAB27A;PSAP;CTSD;HSPA8;CTSC;TSPAN14;TIMP2;TNFRSF1B;DYNLL1;PSEN1;PGLYRP1;NPC2;SLC44A2;OSTF1;FTL;MME;EEF1A1;HEXB;CKAP4;STOM;CEACAM1;CTSB;PSMD14;CRACR2A;CD47;RAB18;CD44;DOCK2;HSP90AA1;CYBA;IMPDH1;GOLGA7;XRCC5;ENPP4;CTSS;HRNR;ARPC5;TNFAIP6;SLC2A3;LRG1;TMEM30A;SRP14;PGAM1;FABP5;QPCT;DOK3;SCAMP1;TRPM2;ALDOA;RAB6A;APEH;CAT;PKM;PDXK;CCT2;CCT8;SVIP;GCA;SYK;STXBP3;RAB37;C3AR1;ITGB2;CYB5R3;ATP11B;EEF2;QSOX1;SPTAN1;CTSZ;CAND1;PSMD11;TMEM63A;TYROBP;SLC27A2;PSMD2
prerank,synapse organization (GO:0050808),-0.3322564876129483,-1.2751087390838909,0.06324110671936758,0.4833867295842277,1.0,27/125,6.66%,NLGN1;ADGRL3;CTNND2;NRXN1;DNM3;APBB2;LRRC4C;PTPRD;CACNB2;GRM5;PPFIA2;CDH2;KIRREL3;SHANK3;ANK3;SPOCK2;GPC6;LRFN5;PAK3;GPHN;DNER;NTNG1;UNC13B;SEMA3E;APP;NRCAM;PTPRF
prerank,positive regulation of embryonic development (GO:0040019),0.5337891449869729,1.2750680709264224,0.18617021276595744,0.8800913657939015,1.0,5/19,12.58%,WNT4;OSR1;NIBAN2;NR2C2;FOXA2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5442142964194239,1.2741164069096713,0.21228070175438596,0.8818073410585577,1.0,2/17,1.93%,ANK2;SNTA1
prerank,positive regulation of cell migration (GO:0030335),-0.3032863777511361,-1.2738007061315366,0.011049723756906077,0.48565560313222794,1.0,66/253,11.47%,NRP1;LEF1;SEMA3C;ACTN4;SEMA6A;SEMA6D;NTRK3;CDH13;CAV1;PECAM1;ITGA6;BMPR2;GCNT2;PODXL;RTN4;THBS1;CLASP2;FN1;TGFB2;SEMA5A;SEMA7A;CXCL12;GAB1;PTK2B;STAT3;CARMIL1;ACTG1;F3;NOTCH1;ARHGEF7;CEMIP;SHTN1;SEMA3E;KDR;DOCK1;ARHGEF2;PDGFC;DAB2IP;TIAM1;PAK1;PTPRC;PLCG2;SEMA4D;ROR2;ITGB1;VSIR;CCN1;PPP3CA;EPHB2;BMP2;RDX;MYOC;HSPA5;TGFB1;DDRGK1;PTK2;CXCL16;MGAT5;PDGFA;BCAR1;EDN1;ENPP2;TWIST2;GPER1;SEMA3D;FAM107A
prerank,negative regulation of heart contraction (GO:0045822),0.5975371288800018,1.273653786546765,0.21875,0.8815158203074008,1.0,1/11,0.08%,ATP1A2
prerank,regulation of mitochondrial fission (GO:0090140),0.5113139388257727,1.2734070162872706,0.1846435100548446,0.8803989369389011,1.0,8/24,12.41%,PRKN;MCU;LRRK2;STAT2;MYO19;DNM1L;CYRIB;RALBP1
prerank,response to thyroid hormone (GO:0097066),0.5910435470691122,1.2733988167808135,0.20634920634920634,0.878361974483056,1.0,3/13,4.86%,THRB;BRD8;CTSH
prerank,regulation of interferon-beta production (GO:0032648),0.45907976414976776,1.2728461299635225,0.1640378548895899,0.8785296117993296,1.0,15/46,14.36%,OAS2;TLR3;RNF135;TLR4;TRIM56;DDX3X;RIPK2;MAVS;TOMM70;DHX58;IRF1;PTPN11;POLR3A;OAS3;PPM1B
prerank,positive regulation of type 2 immune response (GO:0002830),0.581901135039575,1.2725844912917355,0.18882466281310212,0.8775935413543823,1.0,3/14,9.63%,PRKCZ;IL18;RSAD2
prerank,cellular sodium ion homeostasis (GO:0006883),0.5751755230999585,1.2725583650611183,0.2118491921005386,0.8756476946474331,1.0,2/15,0.74%,ATP1A2;ATP1B3
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3186637091191546,-1.2720028937848564,0.04564315352697095,0.4890602329547357,1.0,28/151,10.77%,ST3GAL4;ELOVL7;CERT1;SGMS1;PLA2G4A;SGMS2;ELOVL5;ACER3;ACER2;GPHN;PRKD3;PPM1L;PLPP1;CEPT1;SPTLC2;DEGS2;SPNS2;GCH1;APOE;SLC44A5;B4GALT5;SLC44A2;PCSK5;LPCAT2;PAM;CERS4;ELOVL6;MFSD2A
prerank,neutrophil degranulation (GO:0043312),-0.2847748513079341,-1.2719049270868334,0.009708737864077669,0.4882964319856643,1.0,103/425,19.55%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;PTPRN2;RAB31;HSP90AB1;PRG2;GPI;PPIA;RAP1B;RAP1A;ACTR2;CD93;PTPRC;STK10;RAB27A;PSAP;CTSD;HSPA8;CTSC;TSPAN14;TIMP2;TNFRSF1B;DYNLL1;PSEN1;PGLYRP1;NPC2;SLC44A2;OSTF1;FTL;MME;EEF1A1;HEXB;CKAP4;STOM;CEACAM1;CTSB;PSMD14;CRACR2A;CD47;RAB18;CD44;DOCK2;HSP90AA1;CYBA;IMPDH1;GOLGA7;XRCC5;ENPP4;CTSS;HRNR;ARPC5;TNFAIP6;SLC2A3;LRG1;TMEM30A;SRP14;PGAM1;FABP5;QPCT;DOK3;SCAMP1;TRPM2;ALDOA;RAB6A;APEH;CAT;PKM;PDXK;CCT2;CCT8;SVIP;GCA;STXBP3;RAB37;C3AR1;ITGB2;CYB5R3;ATP11B;EEF2;QSOX1;SPTAN1;CTSZ;CAND1;PSMD11;TMEM63A;TYROBP;SLC27A2;PSMD2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5380945093629669,-1.2718012070866378,0.18723404255319148,0.48759474972407674,1.0,8/13,30.10%,SORL1;GCC2;TMEM30A;CD81;SAR1B;SEC16B;TMEM30B;SAR1A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5260399970694982,-1.271060136127975,0.19787234042553192,0.4883137310585348,1.0,7/14,14.52%,NRP1;VEGFC;GAB1;KDR;FLT4;VEGFA;NUS1
prerank,mRNA splice site selection (GO:0006376),0.49455907390205656,1.2709909333704763,0.18600682593856654,0.8797431095612653,1.0,11/30,20.41%,CELF2;SRSF5;PRPF39;KHDC4;LUC7L3;SFSWAP;PSIP1;SRSF1;SRSF10;SNRPC;SF1
prerank,central nervous system neuron differentiation (GO:0021953),-0.4205027385167281,-1.2709429026457026,0.13285024154589373,0.4876169482741089,1.0,8/33,12.71%,GRID2;MDGA2;TOX;NTRK2;SPOCK1;PROX1;CTNNB1;MAPT
prerank,regulation of cellular pH (GO:0030641),-0.4405614525324122,-1.2707960552991198,0.15384615384615385,0.4869837333569509,1.0,6/29,12.78%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1
prerank,DNA methylation (GO:0006306),0.5187505496456672,1.270621088459001,0.17064846416382254,0.8791697996491613,1.0,12/23,23.81%,DNMT3A;ATRX;PICK1;MTRR;BEND3;EHMT2;EHMT1;KMT2E;METTL4;N6AMT1;DMAP1;PPM1D
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.48654318489927234,1.2705545479666445,0.1675485008818342,0.8773825159929894,1.0,4/31,3.76%,SYT9;SYT11;SYT12;ADRA2A
prerank,positive regulation of insulin secretion (GO:0032024),0.47708563376492463,1.2697485871332899,0.17259786476868327,0.8784761907436642,1.0,7/36,9.48%,NNAT;NLGN2;MCU;GCK;RBP4;TCF7L2;PLA2G6
prerank,neutral amino acid transport (GO:0015804),-0.44115309017243065,-1.2692180481322186,0.14903846153846154,0.48982604629043713,1.0,10/28,12.48%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5393519629282585,1.2691676582091171,0.1793478260869565,0.8787328089804511,1.0,7/20,15.07%,TNRC6A;MOV10L1;TNRC6B;MOV10;AJUBA;TNRC6C;WTIP
prerank,muscle cell differentiation (GO:0042692),0.48783075674512044,1.268985578727431,0.19738988580750408,0.8773727891845495,1.0,5/32,3.64%,WNT5B;RORA;NEBL;DUSP29;SPEG
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.42132668922428657,-1.2689059943294356,0.11471321695760599,0.4896228850097642,1.0,8/35,9.02%,MEF2C;PTPRM;CAV1;THBS1;CAV2;APOE;ATOH8;XDH
prerank,negative regulation of cell communication (GO:0010648),-0.4701678897450816,-1.2688276049112697,0.1832579185520362,0.48883326834343555,1.0,9/21,25.03%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1;OPRM1;ERBB3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.40668271206261286,-1.2680260023747731,0.13064133016627077,0.48982795737017687,1.0,15/39,11.10%,PTPRG;PODXL;EFNA5;TENM3;FUT9;JAG1;MINK1;EPHA7;TGFB1;CEACAM1;PTK2;SMAD7;CD47;CDH1;ZDHHC2
prerank,cellular response to alkaloid (GO:0071312),-0.5008861903869767,-1.267998399757314,0.16880341880341881,0.4889124829489605,1.0,8/17,22.49%,SLC8A1;RYR2;RYR3;HTR1B;CASP6;CASQ2;GSTM2;BLM
prerank,steroid catabolic process (GO:0006706),0.6134716259497989,1.2678636440169049,0.21485943775100402,0.8795193247748423,1.0,1/10,2.01%,SPP1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5066369111326992,-1.2677735571660513,0.18737270875763748,0.4884602116436094,1.0,5/16,10.38%,NRP1;PTPRJ;PDGFC;PDGFA;BCAR1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4509118519767606,-1.2676468406519756,0.13849765258215962,0.4878010771024666,1.0,10/26,8.88%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B;TMEM108;APP;RELN;MTMR2
prerank,phospholipid translocation (GO:0045332),-0.4447371676722092,-1.2670906140916907,0.13784461152882205,0.48811363079364145,1.0,10/28,14.38%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;MFSD2A;TMEM30A;ABCB4;ATP8B2
prerank,chordate embryonic development (GO:0043009),0.43802266290854824,1.2668201568119863,0.14954682779456194,0.8814177220945001,1.0,11/55,7.88%,ALDH1A2;BMP7;FGFR2;ZNF568;FGFR1;TGFBR1;ARNT2;SULF2;FUT8;CHD7;RBP4
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6135965817629374,1.2663319738653547,0.21564885496183206,0.8811697411720183,1.0,2/10,3.77%,UPB1;DPYD
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4705701497241517,1.2662033614744725,0.1607717041800643,0.8796281096356647,1.0,7/40,8.07%,SLC13A3;SLC38A4;SLC38A3;SLC7A11;SLC19A1;SLC27A1;SLC38A1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.532011565224666,-1.266200518705071,0.17970401691331925,0.4892809805291928,1.0,5/13,11.46%,LTBP1;GREM2;FBN2;BMP2;NRROS
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4307009163917261,1.266079498717216,0.1411229135053111,0.8781244542270087,1.0,19/63,16.32%,WWOX;IGF1;CFLAR;FGFR1;PHIP;DEPTOR;TGFBR1;BID;HTT;TCF7L2;RIPK1;SH3RF1;TMC8;ITGAV;PML;AGTR2;LGALS3;BIRC6;SP100
prerank,regulation of phosphatase activity (GO:0010921),0.511096958535181,1.2658819856049157,0.18584070796460178,0.8768571497408206,1.0,4/24,8.57%,SH3RF2;SH2D4A;CDK5RAP3;HTT
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5876736807750242,1.265070789839749,0.2222222222222222,0.8779451579984032,1.0,2/12,0.74%,WNK4;ATP1B3
prerank,clathrin-dependent endocytosis (GO:0072583),0.5073718368865947,1.2646286795259727,0.1903114186851211,0.8775606109590668,1.0,3/26,2.21%,DNAJC6;PICALM;FCHSD2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.44023896321863043,1.264616644270966,0.15912636505460218,0.8756257734229895,1.0,18/52,20.71%,ME2;ADHFE1;GPT2;SLC19A1;MTHFR;GOT2;OGDH;IDH1;ALDH1L1;MTRR;ACOT8;D2HGDH;GOT1;MTHFD1;IDH2;PHYH;FOLR2;ACLY
prerank,catecholamine metabolic process (GO:0006584),0.5874364708747473,1.264568780153519,0.20708955223880596,0.873841799547174,1.0,3/14,8.78%,SNCAIP;PRKN;LRTOMT
prerank,regulation of cholesterol esterification (GO:0010872),-0.5769524737978814,-1.264283161985044,0.21030927835051547,0.49306835378697156,1.0,5/10,19.95%,APOE;ABCG1;AGTR1;STARD4;AGT
prerank,cellular calcium ion homeostasis (GO:0006874),-0.32550771541766776,-1.2641620990247058,0.0411522633744856,0.49237048632346453,1.0,39/133,12.92%,SLC8A1;CAV1;SLC24A2;RYR2;CAMK2D;NPTN;HTR2C;STIM2;TPT1;CXCL12;ATP2C1;ATP1B1;SLC35G1;CAV2;TRPC3;YWHAE;ATP2B2;TRPC4;MICU3;SLC10A7;TRPC1;HTR2A;TRPC6;PSEN1;CALR;ATP2A3;TRPV4;ATP2B4;EDN1;SELENOK;GPER1;SMDT1;PTH1R;HCRTR2;PACS2;ATP2B1;SLC30A1;MCUB;EDN3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5146424874057737,1.2636859795097581,0.21731448763250882,0.8753698160947095,1.0,6/23,8.49%,TULP3;GLI3;SUFU;MGRN1;BTRC;IFT122
prerank,receptor internalization (GO:0031623),-0.40335621781563047,-1.2636048534293391,0.13314447592067988,0.4926838577911797,1.0,14/44,13.17%,DNM3;CALCRL;CAV1;CD9;TFRC;RAB31;RAMP2;ACKR3;ITGB1;DNM1;CEACAM1;AP2M1;RAMP1;SNCA
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5518732704224689,1.2634242897555155,0.19012797074954296,0.8743739096727128,1.0,4/16,9.90%,ACE;KLK2;ADM;SPX
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3367935226987649,1.2632229739472907,0.006128702757916241,0.8732216805672605,1.0,191/1082,13.91%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;BMP7;THRB;SMAD3;TFDP2;GLIS3;AUTS2;WNT4;OSR1;ZIC2;PPARGC1A;PICALM;IGF1;KMT2A;RHOQ;BRD8;PPARA;SSBP2;FGFR2;CREBRF;CXXC1;SPP1;PRKN;IL18;GLI2;ZNF423;FHOD1;HOXB4;CREB5;CSRP3;NPAS3;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;NR2F2;HDAC8;PHIP;PCGF5;BMPR1A;GLI3;MITF;ELOF1;ELF1;TGFBR1;ARNT2;FOXC1;MLLT10;HOXB3;CAND2;NFIB;ZBTB38;VEZF1;ASCL3;CREB3L2;ZNF462;NFYB;TLR3;NHLH2;RGMB;MEIS1;RREB1;NSD1;TET2;ATM;TLR4;TRIM56;DDX3X;FZD5;ARRB1;NCOA3;CAPRIN2;GPS2;MAP2K5;CAMK1;ATRX;ABHD14B;ESRRA;ZNF318;TBL1X;HMGA1;LBH;CREBL2;TP53;BCAS3;CAMTA2;LAGE3;BCLAF3;SMARCD3;SERPINE1;AFAP1L2;MED12;ARHGEF11;RORC;WWTR1;CCNT2;SOX12;PLSCR1;FBXW11;LDB2;LDB1;ATAD2B;ELF2;NR1D2;SMARCA4;MEF2A;ZIC1;HOXC4;BTRC;KAT6B;SSBP3;TBL1XR1;TMF1;CALCOCO1;SMARCC2;GDNF;JMJD6;TCF4;TCF7L2;HDAC1;TFDP1;NIBAN2;MYBL1;NSD3;GLI1;NR2C2;TEAD2;PARP9;HDAC4;SIRT1;RIPK1;WASL;ZFP90;ELL;RIPK2;FOXC2;MED17;GTF2F1;MAVS;THRAP3;ABL1;RBL1;KMT2C;SCAF8;DYRK1A;ZMIZ1;ATF2;TEAD1;PRKDC;RARG;NFATC3;ZBTB48;SNAI1;PHF5A;IRF1;MLLT6;ZMIZ2;MSANTD1;MYBL2;HOXB2;CCDC62;DEAF1;BRD7;FOXA2;KMT2D;MLXIPL;EDRF1;KAT7;ZXDC;MAP2K1;OGT;FOXJ2;WDR43;PTOV1;DHX33;PBX4;NFIA;MAP2K2;PML;MLLT11;DNM2;ATF6B;FLCN
prerank,macroautophagy (GO:0016236),0.3969426207645836,1.2631735601243141,0.11936339522546419,0.8715066435297425,1.0,27/118,17.36%,PRKAG2;PRKAA2;PRKN;MTMR3;PRKAG3;LAMP2;ATG10;UVRAG;ATG5;WIPI1;AMBRA1;LIX1L;ATG7;BECN1;TOMM70;CSNK2A2;CSNK2A1;MFN2;VIPAS39;VPS37A;VPS4A;SNF8;ACBD5;SNX14;ZFYVE1;SQSTM1;CHMP4C
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5518538819586631,-1.2631188109063152,0.20944558521560575,0.4928510441492512,1.0,3/11,14.17%,ANXA1;SMAD7;SOCS5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5323707265545591,-1.2627223264687457,0.19166666666666668,0.49283622851909936,1.0,7/13,27.51%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B3GNT6;B4GAT1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5191928390643047,-1.2625373573041578,0.18818380743982493,0.49228866452525005,1.0,6/15,17.78%,RYR2;SRPRA;SRP14;SPCS1;SRPRB;ZFAND2B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.356885714841678,1.2623050357136225,0.058056872037914695,0.8728013259524695,1.0,72/327,15.82%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;CXXC1;ZNF423;POLR2A;CRABP2;MITF;CTR9;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;BNC2;RREB1;NSD1;IFNK;ASCC2;WWC2;SBNO1;ATRX;ESRRA;HMGA1;CREBL2;TP53;CHD7;WWTR1;SOX12;LDB1;NR1D2;KAT6B;CCAR1;TCF7;MYBL1;NSD3;NR2C2;TEAD2;SOX13;ZNF219;ABL1;AJUBA;ZMIZ1;ZKSCAN5;ATF2;SKOR1;MLLT6;MYBL2;PHF1;HES6;KMT2D;MLXIPL;KAT7;NFIA;PML;DNM2;ACVR2B;ACVR1B;CELSR2;APBB3;WTIP;ATXN1L;TGIF2;MZF1;CREBBP;MED23
prerank,insulin secretion (GO:0030073),-0.47998348863906204,-1.262014071090431,0.17954545454545454,0.4926464293094795,1.0,4/19,12.74%,RIMS2;PTPRN2;ANXA1;RAB11FIP5
prerank,neuron differentiation (GO:0030182),-0.3171643539386148,-1.260663524495877,0.04205607476635514,0.4951014076257439,1.0,32/165,10.02%,TENM2;MEF2C;PTPRD;IL1RAPL1;EPHA5;TENM3;TGFB2;PBX3;TENM4;FUT9;ATP8A2;ACSL3;RUNX1;NTRK2;MYT1L;UGCG;ATP2B2;MYEF2;RORB;FZD4;MET;VSX1;ACSL4;LHX6;SPOCK1;ATOH8;WNT9A;PPT1;DDIT4;ERBB2;PBX1;ID2
prerank,regulation of hydrolase activity (GO:0051336),-0.3587013751428373,-1.2602420580832814,0.1059190031152648,0.49511467703636874,1.0,17/71,8.83%,PRKG1;CHN2;CAV1;FGD5;EPHA5;EFNA5;CHN1;RASIP1;NTRK2;DAB2IP;CRK;RDX;PLXNA4;PLXNC1;RAPGEF6;PTK2;ARHGAP15
prerank,positive regulation of reproductive process (GO:2000243),-0.42483430426913793,-1.2595092278415627,0.14457831325301204,0.4959188791714568,1.0,12/31,23.13%,PDE3A;LHFPL2;GLRA1;PGAM4;VEGFA;CFAP69;CACNA1H;INHBA;SIRT2;PRDM9;TACR3;SYDE1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5574276491917932,1.2592339757721618,0.2222222222222222,0.8825370640136339,1.0,3/16,5.45%,APPL2;PPARA;F2
prerank,negative regulation of hydrolase activity (GO:0051346),0.4546868240399229,1.2592280429763096,0.18125960061443933,0.8806082349472724,1.0,7/49,7.02%,CPEB2;SH3RF2;LRRK2;GMIP;MAP2;BCAS3;SH2D4A
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.44563882481804,-1.2581765715595092,0.15776699029126215,0.4982324080119607,1.0,8/26,10.98%,PDE8A;PTPN12;IQGAP1;DAB2IP;EEF1A1;STAT5B;ERBB2;DUSP3
prerank,regulation of vasoconstriction (GO:0019229),-0.43234443516031956,-1.2569548556233636,0.17006802721088435,0.5002917656754171,1.0,9/27,12.45%,CAV1;BMPR2;CHRM3;ADRA1B;ECE1;KCNMB2;AGTR1;ATP2B1;ACE2
prerank,positive regulation of cell growth (GO:0030307),-0.3377284844089438,-1.2568891645864402,0.07744107744107744,0.4994844357876861,1.0,25/96,15.64%,SYT1;RIMS2;AKAP6;RIMS1;TGFB2;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;LGI1;CXCL16;H3-3A;ERBB2;SLC25A33;EDN1;RPS6KA3;MFSD2A;MAPT;RPS6KA1;TAF9B;SMURF1;BDNF
prerank,integrin-mediated signaling pathway (GO:0007229),-0.35245283545510814,-1.2568633447204336,0.08333333333333333,0.49858410825839483,1.0,22/73,10.46%,NRP1;ITGBL1;FN1;SEMA7A;DST;PTK2B;ITGB4;MYH9;DOCK1;ITGB8;ADAM15;ITGB1;LAMA3;CUL3;CEACAM1;PTK2;CD47;PTN;ERBIN;ITGB3;BCAR1;TEC
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.48664518438056953,1.2568065039457754,0.16610738255033558,0.888137334050267,1.0,5/30,6.83%,ACE;KIT;HOXB4;TP53;FLT1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5934791023924431,1.2566997422606274,0.23976608187134502,0.886556256032375,1.0,3/11,7.47%,TGFBR3;TGFBR1;TGFBR2
prerank,positive regulation of axonogenesis (GO:0050772),-0.39315070513606737,-1.2566428424778038,0.13821138211382114,0.4982148250592144,1.0,14/43,9.79%,SLIT2;ROBO2;SEMA7A;CDKL5;NGF;NTRK2;NTN1;SHTN1;TIAM1;SEMA4D;PLXNA4;PLXNC1;MAP6;SLITRK1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5120115172790659,-1.256346398478702,0.19522776572668113,0.49801450410370496,1.0,7/15,16.08%,STOX2;TGFB2;CELF4;UBR3;SCEL;NR5A2;USP22
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4562700399666139,1.256092233645487,0.18630573248407642,0.8869351499167993,1.0,6/43,3.17%,BMP6;BMP7;WNT4;IGF1;NPNT;BMPR1A
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3910224073818422,1.2558826462129478,0.1221476510067114,0.8857627821675044,1.0,16/129,9.18%,RNF220;LRRK1;LGR4;WLS;PTK7;FGFR2;LRRK2;DDX3X;CAPRIN2;TBL1X;SMURF2;TNKS2;ADGRA2;TBL1XR1;GPRC5B;UBR5
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4375556270059189,1.255621026641555,0.1573208722741433,0.8847872239332543,1.0,6/61,9.81%,PRKAG2;PPARA;NCOR2;SIRT5;SIRT1;AZIN1
prerank,cell junction organization (GO:0034330),0.41708226112129815,1.2554074614822166,0.14136904761904762,0.8836076645738277,1.0,9/71,3.98%,SDK1;SLC6A1;SMAD3;LRP4;SDK2;SLC8A3;PKHD1;NLGN2;PPFIA1
prerank,smooth muscle tissue development (GO:0048745),-0.5512219768885798,-1.2550664719485956,0.20925553319919518,0.5002436755819829,1.0,5/10,10.83%,ENG;PTCH1;STRA6;PROX1;BMP4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3861970950169887,-1.2546591009736383,0.13450292397660818,0.5002866234290169,1.0,15/52,11.09%,SPTBN1;DPP10;PRKCH;PIK3R1;EPB41;EPB41L2;STX3;PLS1;NKD2;GNAI1;ITGB1;EPHB2;EFCAB7;ATP2B4;GPER1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3882293818046057,1.2545061898010146,0.1361760660247593,0.8850668866009378,1.0,17/128,7.47%,TGFBR3;BMP6;BMP7;SMAD3;APPL2;PRKCZ;DDX5;ARHGEF18;BMPR1A;TGFBR1;SMAD6;RGMB;USP9X;COL1A2;SMURF2;TWSG1;TGFBR2
prerank,cellular response to chemical stress (GO:0062197),0.405334030116904,1.2540535152704357,0.125,0.8848080215463496,1.0,17/96,10.49%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;ATM;DDX3X;SOD2;ALDH3B1;NOX1;PIK3CA;ATG7;NOX4;ABL1
prerank,primary miRNA processing (GO:0031053),0.604526609112058,1.2539560099273994,0.23529411764705882,0.8833257342753531,1.0,2/10,7.01%,SMAD3;HNRNPA2B1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5343909159712379,1.2538391807091172,0.2103386809269162,0.8818540772625223,1.0,7/19,15.76%,RENBP;UAP1L1;PGM3;GNPDA1;GMPPB;SLC35D1;GFPT1
prerank,visual system development (GO:0150063),0.47070291269791736,1.2537412296867407,0.17011128775834658,0.8803572448253851,1.0,5/37,7.88%,SMOC1;FOXC1;MEIS1;SH3PXD2B;RBP4
prerank,positive regulation of telomerase activity (GO:0051973),-0.4179803614123675,-1.2537137998700885,0.14320987654320988,0.5015113706045685,1.0,16/33,28.44%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;CCT2;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;DKC1;TNKS;NAF1;MAPK3
prerank,sulfation (GO:0051923),0.5908054339971621,1.2534549571493208,0.23247232472324722,0.8795485954347921,1.0,1/11,0.43%,UST
prerank,negative regulation of proteolysis (GO:0045861),0.47132251467902303,1.2533413858345612,0.20607028753993611,0.8780380415316731,1.0,7/34,6.35%,TIMP3;EPHA4;LRRK2;GAS1;KNG1;F2;TM4SF20
prerank,sensory organ development (GO:0007423),0.4378130009187304,1.253135527304469,0.16792738275340394,0.8769621401879801,1.0,7/51,7.88%,SMOC1;SHROOM2;FOXC1;MEIS1;SH3PXD2B;CHD7;RBP4
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5629768722786723,1.2529334674214636,0.20246478873239437,0.8758554158517331,1.0,5/14,8.10%,ATRX;ACD;TPP1;TNKS2;TERT
prerank,protein localization to cell periphery (GO:1990778),-0.31563596591371623,-1.252478307676537,0.04897959183673469,0.503499452436482,1.0,38/133,12.88%,KCNIP4;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;DPP6;EFR3B;CLASP2;MAP7;LIN7A;ATP1B1;EPB41L3;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;FLNA;NKD2;TSPAN14;PTCH1;EHD2;RDX;RAPGEF6;FGF13;RAP2A;KCNB1;CDH1;ZDHHC2;PACS2;IKBKB;EMP2;RAMP1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.4532390577575979,-1.252419136794602,0.1724137931034483,0.5026726200157847,1.0,11/25,26.53%,HIP1;RTN4;BCAR3;CCDC88A;GPER1;CBL;HIP1R;AGT;HAP1;PLAUR;CNOT9
prerank,regulation of acute inflammatory response (GO:0002673),-0.477175454226403,-1.2520586576875643,0.1934782608695652,0.5026218987084864,1.0,3/18,8.52%,OSMR;IL6ST;PTGES
prerank,neutrophil migration (GO:1990266),-0.37687467128534186,-1.2517756245320395,0.1303030303030303,0.5023824284828625,1.0,11/58,18.29%,PDE4B;PECAM1;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4452339616829915,-1.250753200840324,0.18409090909090908,0.5038332608676119,1.0,8/24,14.59%,CTNNA2;MEF2C;CDH2;CDON;BOC;CTNNB1;MYOCD;MAPK12
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5379492780858246,-1.2506138965545723,0.2135523613963039,0.503208109759596,1.0,7/12,27.51%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B3GNT6;B4GAT1
prerank,fatty acid transport (GO:0015908),0.5473918827697289,1.2505278490847302,0.22324723247232472,0.8828497162094648,1.0,4/17,7.53%,ACSL1;SLC5A8;SLC27A1;GOT2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5631268731864223,1.2504134822932522,0.22140221402214022,0.8813802864748912,1.0,2/14,2.05%,PRKCZ;IL18
prerank,long-term memory (GO:0007616),-0.4834132066865604,-1.2496225326419728,0.1848341232227488,0.5046754068578861,1.0,5/19,13.66%,APOE;LDLR;RASGRF1;CAMK4;SHANK1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4468710354776726,1.2490083823090659,0.19092331768388107,0.884930652242144,1.0,6/47,7.09%,C1QTNF3;ROCK2;WNT4;SIK1;SLC27A1;GCK
prerank,regulation of blood coagulation (GO:0030193),-0.44014745889298534,-1.248731364168578,0.155,0.505826607080983,1.0,11/27,13.15%,CAV1;ST3GAL4;SERPINE2;THBS1;CD34;FAP;APOE;EPHB2;EDN1;ENPP4;DMTN
prerank,negative regulation of secretion by cell (GO:1903531),-0.4112571571942015,-1.2485712999743679,0.1546134663341646,0.5052636243237002,1.0,10/38,14.39%,STXBP6;IL1RAPL1;GRM7;NOTCH1;ANXA1;APOE;TNFRSF1B;SLC30A1;SNCA;HTR1B
prerank,cardiac muscle tissue development (GO:0048738),0.44193778201967987,1.2482327665783473,0.18195956454121306,0.8859551940064819,1.0,11/50,9.88%,NOTCH2;BMP7;GJB6;CSRP3;AKAP13;BMPR1A;ADAMTS9;SIK1;RBP4;NRG1;CBY1
prerank,regulation of vasculogenesis (GO:2001212),-0.5171748602182857,-1.2481315569596312,0.18984547461368653,0.5053410453300393,1.0,9/14,15.09%,CD34;KDR;RAP1A;TMEM100;CEACAM1;HEY2;XDH;EMP2;RRAS
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5844365467541774,1.2480986388252941,0.23166023166023167,0.8845627593917336,1.0,2/11,8.01%,GNAT2;GNAT3
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5489978686638545,-1.2478123629869216,0.20123203285420946,0.5051326463803361,1.0,3/11,9.08%,PTPRC;CEACAM1;SMAD7
prerank,positive regulation of B cell activation (GO:0050871),-0.38204270423087255,-1.2472405671730848,0.12462006079027356,0.5054853268860726,1.0,15/50,20.88%,MEF2C;SH3KBP1;TFRC;CD38;PTPRC;EPHB2;HMCES;TIRAP;NOD2;CD74;SYK;IRS2;BTK;CD320;CD81
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4867807506763726,-1.2461628487765184,0.18439716312056736,0.5070829307038599,1.0,3/17,4.22%,ANK3;AKAP6;KCNAB1
prerank,amino sugar biosynthetic process (GO:0046349),0.5736131163054291,1.246110440557488,0.23495145631067962,0.8902835832103312,1.0,5/12,15.76%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,transition metal ion transport (GO:0000041),-0.40865963408191425,-1.245954198789542,0.18328840970350405,0.5066426012669015,1.0,14/35,15.04%,ATP2C1;FTH1;TFRC;TRPC3;TRPC4;TRPC1;TRPC6;ATOX1;SLC30A1;SLC31A1;TRPC5;MT3;TTYH1;TRPC7
prerank,dopamine metabolic process (GO:0042417),0.5446709808320765,1.2457793366671817,0.2423146473779385,0.8896866572456399,1.0,3/18,2.02%,MOXD1;SNCAIP;PRKN
prerank,regulation of gene expression (GO:0010468),0.3330995516551846,1.2456903341025416,0.021806853582554516,0.8881619724979667,1.0,177/903,15.67%,PRDM6;DENND4A;NOTCH2;FGF1;ROBO1;RORA;BMP6;PPARGC1B;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;WNT4;OSR1;FOXN3;TULP3;PPARGC1A;PICALM;IGF1;NFYC;PRKAA2;SSBP2;AFF3;WNT6;CXXC1;PRKN;ZNF423;POLR2A;SON;FOXD1;TNRC6A;CRABP2;BMPR1A;ZC3H7B;MITF;CTR9;SUFU;TGFBR1;ARNT2;FOXC1;PARP10;SNRNP70;DTNBP1;ZBTB38;PCBP2;PABPN1;MBNL2;ZNF462;NFYB;TLR3;PARP14;SMO;CTSH;EZR;BNC2;RREB1;CUX2;NSD1;ATM;TLR4;IGF2BP1;HNRNPH1;DDX3X;IFNK;ASCC2;WWC2;SBNO1;TIPARP;AFF4;BRAF;ATRX;CLK4;ESRRA;CD28;HMGA1;IL12B;CREBL2;TP53;CHD7;WWTR1;TOB2;APLN;SOX12;PTPN22;PLSCR1;IGF2BP2;TNRC6B;LDB1;NR1D2;TERT;RBL2;C1D;KAT6B;LARP1;HRG;CALCOCO1;GDNF;TLE1;NOVA1;CCAR1;TCF7;HDAC1;MYBL1;NSD3;UBR5;CDH5;NR2C2;TEAD2;PARP9;HDAC4;SIRT1;MOV10;LRP3;SOX13;DHH;PRDM5;ZNF219;ABL1;RBL1;AJUBA;CRKL;SRPK2;ZKSCAN5;PIK3R3;ATF2;C1QTNF1;HMG20B;DICER1;HNRNPL;FLOT2;SKOR1;MLLT6;WWP2;MYBL2;NOCT;ZNF148;ATRAID;PHF1;HES6;GLMN;KMT2D;MLXIPL;TDG;KAT7;SNX12;MAP2K1;NFIA;RBMS3;CIAO3;MAP2K2;PML;DNM2;FLCN;NFKB1;ACVR2B;ACVR1B;CELSR2;ZNF507;APBB3;NWD1;ANXA7;TNRC6C;WTIP;ATXN1L;MAPK9;COQ7;CLK1;ZFP36L1;SETDB2;TGIF2;HNRNPDL;FUBP3;MZF1;SNF8;CREBBP
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4426936280250553,-1.24520418626958,0.18160919540229886,0.5074474462533219,1.0,5/24,1.93%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5190213351714791,-1.244925188781713,0.2149122807017544,0.5072120589872192,1.0,4/13,8.41%,NRP1;NRP2;PLXNA4;PLXNC1
prerank,negative regulation of cell motility (GO:2000146),-0.3331000664092092,-1.2448058873002976,0.10197368421052631,0.506599135959245,1.0,22/108,7.16%,TMEFF2;FRMD5;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;CLDN5;MCTP1;ENG;NAV3;PTPRK;SPOCK3;PTPRT;SRGAP1;ADARB1;ACVRL1;JAG1;CYP1B1;RHOB;ADAM15;CRK
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.49762599303021626,1.2445076227589507,0.19243986254295534,0.8905900670245006,1.0,2/26,3.76%,ATP1A2;ADRA2A
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4290788965521136,-1.244486045814417,0.1642512077294686,0.5064141148895325,1.0,10/31,14.59%,CTNNA2;MEF2C;CDH2;HDAC9;CDON;ID2;BOC;CTNNB1;MYOCD;MAPK12
prerank,anterior/posterior axis specification (GO:0009948),0.5542701973657914,1.2440853918607495,0.23251417769376181,0.8902574324577929,1.0,2/15,5.50%,WLS;FZD5
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4835077069829157,-1.2437572184550976,0.18085106382978725,0.5072000554122678,1.0,8/17,16.52%,SFRP4;TMEM100;ATOH8;BTG1;FGF2;BMP4;AHI1;RFX3
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.47048886787970173,-1.243753391208999,0.20652173913043478,0.5062734331178225,1.0,7/18,8.70%,LTBP1;CD200;FN1;TGFB2;CD34;ITGB8;PTGS2
prerank,regulation of protein transport (GO:0051223),-0.43149912495584225,-1.2436816469953977,0.19471153846153846,0.5055180047869037,1.0,10/27,19.27%,STXBP5L;DNAJC1;HSPA8;DISP1;NDFIP2;GAPVD1;PPM1F;DNAJA1;P3H1;PTPN1
prerank,anterior/posterior pattern specification (GO:0009952),0.4388727249960096,1.2434922739583567,0.18181818181818182,0.8905675918538521,1.0,11/53,8.24%,WLS;HOXB4;HOXB6;HOXC6;TGFBR1;HOXB3;HOXB5;HOXB9;HOXA3;BHLHE41;HOXC4
prerank,positive regulation of protein binding (GO:0032092),-0.380355885409446,-1.2426668177996607,0.13730569948186527,0.5070720853556739,1.0,26/56,23.00%,CAV1;CLDN5;EPB41;B2M;GSK3B;TIAM1;APP;APOE;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;SPPL3;BDNF;HIPK2;MEN1;HIP1R;RAN;RPL11;VTN;TRIB3;FLOT1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4903043711120991,-1.2425827924311021,0.17796610169491525,0.506361653819183,1.0,10/17,35.34%,SNAP25;STX3;SYNGR2;STX1B;SNAP23;STX1A;AP3D1;SYP;SYNGR1;PRRT2
prerank,negative regulation of phagocytosis (GO:0050765),0.5399156412697221,1.242344022892642,0.21153846153846154,0.8930181278140726,1.0,4/17,7.41%,SYT11;CD300A;FER1L5;PLSCR1
prerank,negative regulation of wound healing (GO:0061045),-0.4380074885238318,-1.2417883853710932,0.15130023640661938,0.5073775573465592,1.0,11/28,10.59%,SERPINE2;CLASP2;CASK;CD34;SLC12A2;AJAP1;APOE;CRK;CD109;FGF2;EDN1
prerank,regulation of transport (GO:0051049),-0.40222939464880114,-1.2417694443448382,0.16019417475728157,0.5064874436963914,1.0,14/36,17.07%,NRP1;ICA1;ACTB;EPB41;ACTG1;REEP5;WWC1;MYO6;SNCA;GAPVD1;PINK1;FES;DNAJA1;ICA1L
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4108111526990165,-1.2414455585279867,0.18181818181818182,0.506326100433974,1.0,16/32,28.40%,CAV1;AKAP6;TRPC3;CEMIP;TRPC1;GPER1;SNCA;APLNR;GRIN1;NPSR1;F2R;CXCL10;THY1;PLCG1;CASQ1;P2RX7
prerank,cell-matrix adhesion (GO:0007160),-0.33379555516927945,-1.2414330860400162,0.12363636363636364,0.5054430119379942,1.0,23/95,10.63%,ITGBL1;PPFIA2;THSD1;PTPRK;ACTN1;FN1;PEAK1;VCAM1;CD34;ARHGEF7;ITGB4;SGCE;TIAM1;BCAM;MSLN;ITGB8;ADAM15;ITGB1;ITGA4;CD44;ITGB3;PKD1;ITGA8
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.3989346436867591,-1.2411781074595196,0.1801566579634465,0.5050996539931552,1.0,15/42,15.58%,GCNT2;VIT;NDNF;NOTCH1;MINK1;FZD4;FBLN2;CORO2B;CORO1C;SPOCK1;PTK2;EMP2;DMTN;PPM1F;LIMS1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3459857442240377,1.2411377745907948,0.06451612903225806,0.8958416910141286,1.0,82/366,16.65%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;CXXC1;ZNF423;POLR2A;CCNA2;CRABP2;MITF;CTR9;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;BNC2;RREB1;NSD1;IFNK;ASCC2;WWC2;SBNO1;ATRX;ESRRA;ANKRD17;DSCC1;HMGA1;CREBL2;TP53;CHD7;WWTR1;SOX12;ATXN2;LDB1;NR1D2;KAT6B;CCAR1;TCF7;MYBL1;NSD3;NR2C2;TEAD2;SOX13;ZNF219;ABL1;AJUBA;ZKSCAN5;ATF2;SKOR1;MLLT6;MYBL2;PHF1;HES6;KMT2D;MLXIPL;KAT7;NFIA;PML;ORC3;DNM2;ACVR2B;ACVR1B;CELSR2;TSC1;APBB3;WTIP;ATXN1L;TGIF2;MZF1;CREBBP;EHMT2;MED23;USP37;PHF12;SMC3;GPBP1L1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5279455641960942,1.2404463508833898,0.24054982817869416,0.8965854992376029,1.0,3/20,1.94%,ATP1A2;ATP1B3;LACC1
prerank,regulation of viral genome replication (GO:0045069),0.4385330088736397,1.2403752222092854,0.1664190193164933,0.895006045979385,1.0,15/56,13.94%,PPARA;IFIT1;OAS2;PARP10;DDX3X;CD28;EIF2AK2;PLSCR1;LARP1;ZC3HAV1;RSAD2;MAVS;SRPK2;OAS3;HACD3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3469979074225258,-1.240362429461289,0.09446254071661238,0.5061593915662743,1.0,22/73,15.87%,BMPER;BMPR2;ENG;HTRA3;ACVRL1;VWC2;NOTCH1;VWC2L;SFRP4;SMAD5;SORL1;CCN1;BMP2;SMAD1;PCSK6;SMAD7;BMP4;LEMD3;UBE2D3;BMPR1B;SMURF1;HIPK2
prerank,positive regulation of viral genome replication (GO:0045070),0.48118863437460374,1.2403188507909078,0.20361247947454844,0.893350513030772,1.0,7/29,10.73%,PPARA;TOP2B;IFIT1;DDX3X;CD28;LARP1;SRPK2
prerank,regulation of cell communication (GO:0010646),-0.40543468714038206,-1.2400148144896435,0.1510791366906475,0.5060842149711691,1.0,10/35,7.90%,SLC8A1;RYR2;CAMK2D;MGLL;UGCG;ANXA1;TBX18;SOCS2;CRK;YWHAG
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4525428553824169,-1.239645540895789,0.2,0.506031777947463,1.0,9/24,5.59%,NRP1;ROBO2;SEMA3C;ZFPM2;BMPR2;ENG;NRP2;TGFB2;TBX1
prerank,sulfate transport (GO:0008272),0.540756342180693,1.239450911358557,0.24354243542435425,0.8946720021058037,1.0,1/14,0.16%,SLC13A4
prerank,epithelial cell-cell adhesion (GO:0090136),0.5982302329208935,1.2391151692567794,0.24236641221374045,0.8940635119097592,1.0,2/11,2.68%,KIT;PLEKHA7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4012105618971106,1.2390747657598051,0.157001414427157,0.8923780813958051,1.0,16/87,8.66%,NOTCH2;CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;RAPGEF3;EZR;PDGFRB;BAIAP2;ARHGAP17;RICTOR;LRP1;PIK3CA;HRG
prerank,positive regulation of nervous system process (GO:0031646),-0.4810238921995838,-1.2378766876648222,0.17567567567567569,0.5093867550543747,1.0,5/18,7.26%,RIMS2;RIMS1;TENM4;UNC13B;TNFRSF1B
prerank,regulation of microglial cell activation (GO:1903978),0.5602697506416647,1.2377710324430522,0.23035714285714284,0.8954941359647677,1.0,2/15,2.40%,SYT11;SPHK1
prerank,actin filament bundle assembly (GO:0051017),0.47011826775864346,1.2368627618394064,0.18257956448911222,0.897287051674838,1.0,6/33,6.01%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.4269550151310645,1.2364722778355477,0.17235772357723578,0.8968871824595124,1.0,16/57,14.20%,FOXN3;BABAM2;ATM;TP53;DONSON;CDK5RAP3;BRSK1;EME2;CDC14B;ATF2;PRKDC;FZR1;UIMC1;HUS1;BABAM1;SDE2
prerank,adenine nucleotide transport (GO:0051503),-0.48720562318685584,-1.23635984783327,0.2014218009478673,0.5121121502479877,1.0,3/17,3.14%,ABCC4;LRRC8C;LRRC8D
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.44239540454745285,1.23612519980998,0.16639741518578352,0.8963002438844466,1.0,5/45,3.80%,BMP7;SMAD3;TOM1L2;FOXC1;GAS1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5456198442484035,-1.235921480247685,0.18333333333333332,0.5122074897728358,1.0,9/11,41.66%,STAT3;IL6ST;JAK1;STAT4;JAK2;IL27RA;IL12A;EBI3;STAT1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.464588698345843,-1.2355118490114132,0.1720183486238532,0.5122876162654706,1.0,10/20,29.88%,CAMK2D;PSEN1;SELENOK;PACS2;KCTD17;BCAP31;THADA;ATP2A2;TMCO1;FIS1
prerank,regulation of B cell proliferation (GO:0030888),-0.38843873386705335,-1.235389111151749,0.14985590778097982,0.5116938480289822,1.0,13/44,20.88%,MEF2C;TFRC;LYN;CD38;PTPRC;EPHB2;TNFRSF21;TIRAP;CD74;IRS2;TYROBP;CD320;CD81
prerank,regulation of interleukin-1 production (GO:0032652),-0.4932027286937094,-1.2353398548451158,0.20607375271149675,0.5109151079319928,1.0,4/15,8.76%,GAS6;ANXA1;FOXP1;CEACAM1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5800018334554782,1.2352668467306815,0.24453280318091453,0.897688070544865,1.0,2/12,1.81%,PPARGC1A;PPARA
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5168867116053492,-1.235095448635106,0.21666666666666667,0.5105995568752573,1.0,5/13,26.30%,CAV1;USP13;BCAP31;UBQLN2;TMEM259
prerank,T cell receptor signaling pathway (GO:0050852),-0.3178983797309902,-1.2350484712741692,0.07421875,0.5097996858918059,1.0,34/138,19.55%,PDE4D;PDE4B;PTPRJ;PIK3R1;PAK3;INPP5D;RFTN1;PSMB2;PAK1;PTPRC;PLCG2;MAP3K7;MOG;PSMD14;TNFRSF21;PSMC6;BCAR1;TEC;IKBKB;EIF2B3;RBCK1;SPPL3;BTN3A3;PSMB9;NCK1;SKAP1;PSMA4;NFKBIZ;SKP1;PRKCQ;PSMD11;PSMB10;TXK;PSMD2
prerank,positive regulation of neurogenesis (GO:0050769),-0.3536288558363763,-1.2348707698720462,0.13529411764705881,0.5093361456738803,1.0,20/68,12.06%,SLIT2;PTPRD;ROBO2;IL1RAPL1;SHANK3;NPTN;CDKL5;NGF;NTRK2;TIAM1;DISC1;SERPINF1;MME;PLXNA4;PLXNC1;MAP6;SLITRK1;NAP1L1;GPER1;CTNNB1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.47828239831457514,1.2341477746047826,0.18697829716193656,0.9001563186386743,1.0,9/34,14.01%,LGR4;CD300A;TLR3;TLR4;GPS2;LY96;RAB7B;LRRC14;ACOD1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.4425097544650004,-1.2340054839180052,0.1705607476635514,0.5104762322773065,1.0,5/24,10.83%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1
prerank,neuron remodeling (GO:0016322),-0.548749600382529,-1.2338745682379575,0.21855670103092784,0.5098846147306207,1.0,6/10,23.84%,ADGRB3;APP;SCARF1;C1QA;ANKS1A;RND1
prerank,positive regulation of nuclear division (GO:0051785),0.496118678479307,1.2337162492573381,0.21858864027538727,0.8999157618043874,1.0,4/25,6.28%,IGF1;PHIP;PDGFRB;CD28
prerank,macrophage activation (GO:0042116),-0.40256549252011065,-1.2332285859686531,0.17412935323383086,0.5104735496335492,1.0,13/34,19.03%,CD93;FOXP1;APP;PLCG2;DYSF;MAPT;SNCA;SBNO2;CLU;LBP;SYK;ITGB2;C1QA
prerank,snRNA metabolic process (GO:0016073),0.5328632621308239,1.2328947576423521,0.24603174603174602,0.9011046084691093,1.0,10/17,25.21%,INTS10;INTS2;INTS5;INTS3;INTS1;INTS7;INTS8;INTS4;TUT1;ZCCHC8
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3441319915223648,-1.2321408870651158,0.11326860841423948,0.5120776321495828,1.0,19/76,12.01%,MAML2;NOS3;NOTCH3;TGFB2;STAT3;CCN3;NOTCH1;JAG1;IL6ST;EPN2;BEND6;TSPAN14;PRAG1;SREBF2;JAG2;GATA2;LFNG;MFNG;TM2D3
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.48505381783030216,-1.2314651852007386,0.19665271966527198,0.5127939641388694,1.0,4/17,8.94%,HDAC9;SORT1;PCSK5;PCSK6
prerank,artery development (GO:0060840),-0.43877592411012045,-1.2313611598231533,0.1912442396313364,0.5121677929065275,1.0,10/23,9.32%,NRP1;ROBO2;BMPR2;ENG;ACVRL1;TBX1;HES1;STRA6;SMAD7;PDE2A
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.4304663963531431,-1.231353673356138,0.17321016166281755,0.5112890257691203,1.0,12/27,20.70%,UTRN;FGF12;CAMK2D;FXYD5;NEDD4L;ATP2B4;NOS1;PTPN3;SCN2B;FXYD6;COMMD1;SCN1B
prerank,positive regulation of stress fiber assembly (GO:0051496),0.44270872383340104,1.2309895319005524,0.19718309859154928,0.9064237120649314,1.0,9/44,5.04%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,pore complex assembly (GO:0046931),0.5228521813952802,1.2309856841598101,0.2454212454212454,0.9046119433287569,1.0,4/19,11.14%,AFDN;PLEKHA7;ANO6;NUP98
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.31062932212473987,-1.2309372355497705,0.04669260700389105,0.511412538690902,1.0,41/149,18.11%,PRKCH;RPS6KA5;CAV1;ROR1;IL1RAP;STAT3;MID2;NOD1;TFRC;NFKBIA;ARHGEF2;TNFRSF11A;AR;PPIA;TRAF5;APP;CARD14;RPS3;MAP3K7;RTKN2;DDRGK1;IRAK3;TRIM14;ERC1;TRIM27;IKBKB;AIM2;TIRAP;PRKD1;TRIM37;RBCK1;CARD16;TERF2IP;CLU;UBB;MTDH;DHX9;CX3CR1;NOD2;TRAF1;BTK
prerank,mitochondrion organization (GO:0007005),0.3690946305304243,1.2305928841132634,0.11533420707732635,0.9042351061052091,1.0,51/165,20.03%,TRAK1;PPARGC1A;HK2;PRKN;CHCHD3;GABPB1;IFIT2;PYROXD2;LRRK2;BID;AFG1L;MIGA2;SAMM50;ESRRA;SIRT5;CLUH;OPA1;NIPSNAP2;TIMM44;TERT;MEF2A;TWNK;SIRT3;MTFR2;TMEM11;DNM1L;ADCK1;SSBP1;CXADR;TOMM70;NDUFS1;SIRT4;MFN2;DNM2;ATP5F1D;RAB29;PITRM1;SLC25A36;TIMM10;FMC1;MSTO1;MTX2;MTFP1;TRAK2;MFN1;RHOT1;RAB5IF;AFG3L2;TIMM17B;ATP7A;ATPAF1
prerank,skeletal system development (GO:0001501),0.37325775710598685,1.2302844940505664,0.12550066755674233,0.9035783454556451,1.0,28/148,9.97%,WWOX;BMP6;BMP7;DYM;IGF1;FGFR2;GLI2;SOX5;AKAP13;FGFR1;NPR3;SUFU;TGFBR1;SULF2;CREB3L2;COL9A2;SH3PXD2B;COL13A1;COL1A2;FBN1;CHD7;COMP;RBP4;EXTL1;COL11A2;HYAL1;MMP14;BMP1
prerank,liver development (GO:0001889),0.47634668689095905,1.2299317002636074,0.20261437908496732,0.9031719313425384,1.0,2/32,1.00%,TGFBR3;WNT4
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2866029218983571,-1.229864772163718,0.0,0.5131351894503382,1.0,94/348,14.30%,NRP1;LIMCH1;GHR;RPS6KA5;PTPRJ;TEK;BMP5;ERBB4;NTRK3;CAV1;PECAM1;PDE8A;BMPR2;ENG;RASSF2;VEGFC;NPTN;NIBAN1;EFNA5;IQGAP1;TGFB2;PTK2B;BCAR3;GAS6;NGF;ACVRL1;TFRC;NTRK2;HSP90AB1;KRAS;CEMIP;KDR;ARHGEF2;LYN;TBX1;PDGFC;PPIA;CALM1;RAP1A;PAK1;PTPRC;APP;CARD14;PLCG2;CALM2;LIMK2;CSPG4;TGFB3;SEMA4D;RELN;CCN1;BMP2;RALB;TGFB1;DDRGK1;PTK2;FLT4;FNIP2;FGF2;CAMKK2;ERBB2;CD44;ATP2B4;RAP2A;PDGFA;HSP90AA1;ITGB3;TEC;ENPP2;BMP4;CALM3;FXR1;GPER1;XRCC5;FAS;ILK;NOS1;CDKN1A;PRKD1;MMD;PFN2;LRP8;AXIN1;SNCA;TNKS1BP1;TXN;PINK1;VEGFA;FGF7;FGF9;ACVR1;P2RY1;MT3;TERF2IP
prerank,positive regulation of protein acetylation (GO:1901985),0.579688260879826,1.2298438771847235,0.24399260628465805,0.9017198695408221,1.0,4/12,5.98%,PRKAA2;RAPGEF3;DDX3X;CAMK1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.44979671070408034,-1.2290366165963638,0.19730941704035873,0.5141928484456852,1.0,6/22,10.04%,GHR;ERBB4;NOTCH1;CYP1B1;HES1;MGAT5
prerank,response to steroid hormone (GO:0048545),0.47557691333103397,1.2281320259563668,0.20695652173913043,0.9063737429699296,1.0,4/31,3.46%,ATP1A2;TFPI;PAQR7;CATSPERD
prerank,organic anion transport (GO:0015711),-0.34243342753150197,-1.228020914930898,0.10119047619047619,0.5156715352358362,1.0,10/76,6.82%,SLC4A10;ABCC4;ABCG2;SLC26A7;SLCO1C1;LRRC8C;LRRC8D;SLCO2B1;CA4;CA2
prerank,cellular response to interleukin-4 (GO:0071353),-0.5449307332661548,-1.2276520138168296,0.2329896907216495,0.5157342622934686,1.0,1/10,0.47%,LEF1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4433462725778428,1.2275461935561702,0.20063191153238547,0.9068890202374458,1.0,7/46,7.90%,DUSP29;FBLN1;TIMP3;DLG1;EZR;TLR4;PTEN
prerank,necroptotic process (GO:0070266),0.5403501121669593,1.2273317693872434,0.24080882352941177,0.9058832778005984,1.0,5/16,10.38%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,"phototransduction, visible light (GO:0007603)",0.5483749377738198,1.2272830645032586,0.2407766990291262,0.9042732124268552,1.0,2/14,5.90%,ABCA4;RHO
prerank,regulation of autophagy (GO:0010506),0.35715410750995313,1.2271994483111415,0.10840438489646773,0.902800582085959,1.0,24/216,7.57%,PRKAG2;RNF152;LEPR;ITPR1;PRKAA2;PRKN;SNX6;MTMR3;PRKAG3;NUPR1;GPR137;ATP6V0E1;CASP3;LRRK2;TPCN1;NEDD4;SNX32;ATM;FZD5;NPRL2;WDR41;ATP6V0B;PTPN22;PIP4K2C
prerank,response to muramyl dipeptide (GO:0032495),-0.5253471043542708,-1.2268256803853335,0.21621621621621623,0.5167801167384277,1.0,7/12,17.98%,NOD1;ARHGEF2;ERBIN;VIM;NOD2;TRIM41;IRF5
prerank,cellular response to fluid shear stress (GO:0071498),-0.5309396572159137,-1.226467971320781,0.23129251700680273,0.5167148570525545,1.0,4/12,12.89%,MEF2C;SREBF2;KLF2;MTSS1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.48642401529079704,-1.2263299814208568,0.20137299771167047,0.5161347218582956,1.0,8/16,19.63%,PSEN1;IKBKB;SMG5;PGAM1;SRPX2;BARD1;TIGAR;SIRT2
prerank,calcium ion transmembrane transport (GO:0070588),0.39637755435842137,1.2259699627907723,0.15948275862068967,0.9055116632037813,1.0,12/86,7.35%,TRPM3;CACNA1D;SLC24A3;TRPM6;SLC8A3;MCU;CACNA1C;SLC25A23;CACNB3;MICU1;TRPM5;ANO6
prerank,purine ribonucleotide transport (GO:0015868),-0.4882153399386202,-1.2259477881190033,0.21889400921658986,0.5161926343532688,1.0,3/16,3.14%,ABCC4;LRRC8C;LRRC8D
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5402993126301958,1.2258807079284022,0.24050632911392406,0.9041076701219091,1.0,8/14,26.26%,SEC31B;MIA3;SEC31A;SCAP;SEC24A;SEC24C;SEC24D;SEC13
prerank,positive regulation of bone mineralization (GO:0030501),0.46733776460356147,1.2258219605645497,0.2079207920792079,0.902555928608816,1.0,6/35,3.17%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,response to calcium ion (GO:0051592),-0.3296279088584453,-1.2258172098001523,0.10526315789473684,0.5156136064177761,1.0,20/102,7.99%,NLGN1;MEF2C;SYT1;CAV1;CLIC4;KCNMA1;RYR2;THBS1;CAMK2D;IQGAP1;KCNMB2;RYR3;TRPC3;SLC25A13;CPNE8;CALM1;PLCG2;CALM2;TRPC1;PPP3CA
prerank,regulation of protein secretion (GO:0050708),0.3877661365273861,1.225672910456092,0.16346153846153846,0.9013850726490132,1.0,20/119,9.63%,BMP6;CACNA1D;FRMD4A;ITPR2;IGF1;ITPR1;KCNA5;ADRA2A;MYO18A;CACNA1C;RAPGEF3;DPP4;EZR;IL12B;GCK;EIPR1;DNM1L;GOLPH3L;PICK1;RSAD2
prerank,chondrocyte differentiation (GO:0002062),0.4718487890125755,1.2255863635079371,0.21635434412265758,0.8999516272397551,1.0,6/32,4.52%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5187700740507794,-1.2250093231620514,0.2129817444219067,0.5165703345313599,1.0,9/12,40.37%,GNL3L;CCT2;CCT8;CCT6A;CCT7;DKC1;CCT3;CCT5;GNL3
prerank,mitochondrial membrane organization (GO:0007006),0.46747974362000994,1.2245170910884613,0.21717171717171718,0.9020512989955701,1.0,10/32,18.34%,CHCHD3;SAMM50;OPA1;MICOS10;TMEM11;MFN2;MICOS13;IMMT;MTX2;MFN1
prerank,regulation of cartilage development (GO:0061035),-0.4711263360266467,-1.2244924250415339,0.22174840085287847,0.5169284380223799,1.0,7/18,13.91%,BMPR2;TRPS1;ZBTB16;BMP2;BMP4;PTHLH;BMPR1B
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4380500400497248,1.2242691525519513,0.19155844155844157,0.9012076539632341,1.0,10/43,11.35%,SMAD3;DDX5;PPARA;NFIB;TP53;APLN;SMARCA4;TERT;TEAD1;NFATC3
prerank,regulation of protein localization to cell surface (GO:2000008),0.47520828866122883,1.2241321870943949,0.22240802675585283,0.8999461028197249,1.0,3/33,1.42%,ACTN2;LEPROT;PICALM
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4339488917678643,-1.2237075550056276,0.17966903073286053,0.5178636235511453,1.0,8/27,7.85%,SLC47A1;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5588636280841611,1.2236689366398548,0.22580645161290322,0.899978991390332,1.0,4/13,9.84%,RENBP;UAP1L1;PGM3;GNPDA1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3236325632007372,1.2235997913076646,0.003009027081243731,0.8985130555865248,1.0,316/1646,15.73%,DENND4A;EPAS1;HLF;ZKSCAN2;RORA;MAF;KDM7A;PPARGC1B;BMP7;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;TRAK1;FOXN3;TULP3;KIT;DDX5;MXI1;PPARGC1A;PICALM;IGF1;KMT2A;NFYC;CUX1;PKNOX2;PPARA;SSBP2;CREBRF;FOXP4;ZFHX2;CXXC1;SPP1;IKZF2;GLI2;ZNF423;POLR2A;JARID2;HOXB4;CREB5;ZBTB20;ZNF160;HOXB6;NPAS3;ZHX2;SNX6;FOXD1;HOXC6;HOXA1;SOX5;DKK3;ZNF568;ARID4A;NFAT5;NR2F2;NCOR2;CRABP2;PHIP;PCGF5;GLI3;TSHZ3;MITF;CTR9;SUFU;ELF1;ZNF697;NR6A1;TGFBR1;ARNT2;VGLL3;FOXC1;HOXB3;CAND2;NFIB;ZBTB38;RFX8;MAFG;VEZF1;LOXL3;NACC2;ASCL3;ATOH1;CREB3L2;VGLL4;NFYB;CCNA1;SMAD6;NHLH2;PRKCB;SALL4;FOXP2;RGMB;MEIS1;PIAS1;BNC2;RREB1;CHD4;PPP1R13L;CUX2;NSD1;FBXL19;TEF;SFMBT1;TRIM56;IFNK;ARRB1;TEAD3;ASCC2;WWC2;SBNO1;ARID3A;SOD2;ATRX;ESRRA;LCOR;CBFA2T2;STAT2;HOXB5;ZNF318;TBL1X;HMGA1;HOXB9;BAZ1B;LBH;TSHZ1;HOXA3;CREBL2;TP53;CAMTA2;SMURF2;SMARCD3;CHD7;NIPBL;AFAP1L2;MED12;BHLHE41;ARHGEF11;RORC;MGA;WWTR1;ZSCAN29;CCNT2;SOX12;FBXW11;ZIC5;LDB1;ELF2;NR1D2;BCOR;SMARCA4;SRCAP;KDM2B;ZSCAN25;RBM15;SPEN;MEF2A;ZIC1;HOXC4;BTRC;KDM2A;SLTM;KAT6B;TBL1XR1;NRG1;CALCOCO1;SMARCC2;ZIC4;JMJD6;TCF4;TCF7L2;IRX1;TLE1;NUPR2;CCAR1;NEUROD4;TCF7;HDAC1;TFDP1;KLF3;NIBAN2;MYBL1;NSD3;GLI1;SMARCE1;NR2C2;ZBTB26;TEAD2;PARP9;HDAC4;SPINDOC;SIRT1;SCML4;ZFP90;CBY1;HIVEP2;HBP1;SOX13;CHMP1A;FOXC2;MED17;PRDM5;ZBTB8B;ZNF219;THRAP3;ABL1;SAP18;ZFP28;FOXL1;AJUBA;BAZ1A;DYRK1A;ZMIZ1;ZFP3;ZNF367;ZBTB6;ZKSCAN5;BAHD1;ATF2;RBBP8;ZNF569;TEAD1;ZFX;NFATC3;MNT;NOP2;ZSCAN22;CBX5;ZBTB48;HR;ZNF467;KDM3B;SNAI1;TFAP2D;PHF5A;SKOR1;IRF1;MLLT6;ZMIZ2;ZBTB1;UIMC1;WWP2;MSANTD1;MYBL2;ZNF148;HOXB2;BRWD3;PHF1;PHF2;HES6;ZNF235;DEAF1;BRD7;KMT5A;FOXA2;KMT2D;MLXIPL;EDRF1;KAT7;ZXDC;BRD9;ZNF483;MAP2K1;OGT;FOXJ2;ZKSCAN7;TGFA;PBX4;NFIA;PRKAR1A;PSIP1;BCL7A;NCOR1;MAP2K2;PML;MLLT11;DNM2;ATF6B;NR3C2;SIN3A;ILF2;ZBTB32;PGBD1;TLE2;CRYAB;PER2;NFKB1;ACVR2B;ACVR1B;CELSR2;TAF7;ZKSCAN3;APBB3;CCNL1;HSF2;PURB;E2F4;WTIP;ATXN1L;HOXA7;MPHOSPH8;PEX14;ZFP2;SETDB2;NAA16;TGIF2;FUBP3;STAT6;SATB2;MZF1;SNF8;HOXB8;CREBBP;PIAS3;ARID1B
prerank,eye morphogenesis (GO:0048592),0.5140270533606037,1.2235423384611415,0.21611721611721613,0.8969566032148439,1.0,6/19,11.32%,COL5A1;SHROOM2;FBN1;NIPBL;IFT122;RARG
prerank,regulation of axon guidance (GO:1902667),-0.5528704700047188,-1.2232334277244667,0.23354564755838642,0.5180974989282491,1.0,4/10,15.12%,NRP1;MYCBP2;VEGFA;TUBB2B
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.38316209301758414,1.2231944697328683,0.1440329218106996,0.8964095958440296,1.0,21/112,11.98%,WWOX;TGFBR3;SMAD3;APPL2;WNT4;PRKCZ;ARHGEF18;SOX5;BMPR1A;TGFBR1;SMAD6;USP9X;COL1A2;TWSG1;TGFBR2;CDH5;SIRT1;CRKL;ZMIZ1;ZMIZ2;GDF15
prerank,cellular response to oxygen levels (GO:0071453),0.5899542792609747,1.2226292558422913,0.24606299212598426,0.8968229711393234,1.0,4/10,20.88%,CPEB4;PICK1;ATP6V0D1;CCDC115
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5350659174567483,1.221740856052361,0.25585585585585585,0.8983693352215449,1.0,6/16,14.63%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1
prerank,negative regulation of neuron projection development (GO:0010977),0.4295019595360981,1.2216633116400466,0.21374045801526717,0.8969505382120311,1.0,10/56,8.15%,EFNB2;LRP4;LPAR1;PTPN9;EPHA4;NGEF;RUFY3;CBFA2T2;PTEN;DENND5A
prerank,prostanoid metabolic process (GO:0006692),0.5435257231923004,1.22119883667495,0.26666666666666666,0.8968934592662912,1.0,2/13,9.87%,PTGS1;PTGR2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5291749846654934,1.2210358044405836,0.24431818181818182,0.8957756621443754,1.0,3/18,6.56%,IGF1;IL18;IL12B
prerank,regulation of T cell proliferation (GO:0042129),-0.3609219878774902,-1.2209408310004874,0.15644171779141106,0.5226202793832695,1.0,9/61,9.20%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;TNFRSF1B;TNFRSF21
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.47255407912626496,-1.2209098043933866,0.22657952069716775,0.5218025382012408,1.0,10/16,42.56%,CADM1;PVR;RAET1E;RASGRP1;LAMP1;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,receptor metabolic process (GO:0043112),-0.37208836595676686,-1.2208069570494355,0.16338028169014085,0.521174912854759,1.0,21/53,18.91%,DNM3;CALCRL;CAV1;CD9;TFRC;RAB31;RAMP2;SH3GLB1;ACKR3;ITGB1;DNM1;TGFB1;AP2M1;RAMP1;SNCA;SMURF1;EHD3;SYK;ITGB2;ARRB2;LDLRAP1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.4941833240937718,-1.2205737040586384,0.22008547008547008,0.5208422933220498,1.0,3/14,13.14%,THBS1;IRAK3;CMKLR1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4213561849911299,-1.220447800888916,0.22646310432569974,0.5202712624974544,1.0,7/27,19.07%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;PLA2G4E;PLA2G15
prerank,monocyte differentiation (GO:0030224),-0.5367856171809298,-1.2202638292798262,0.22745901639344263,0.519823489182221,1.0,6/10,15.09%,MYH9;MT1G;BMP4;THOC5;VEGFA;IL31RA
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5094435251630018,-1.2202399364801,0.2092511013215859,0.519006846719184,1.0,7/14,30.72%,THBS1;PTK2;CMKLR1;RARRES2;MDK;MAPK3;CSF1R
prerank,primary alcohol metabolic process (GO:0034308),0.49390876297140407,1.2202087332731675,0.21465076660988075,0.8971112139841758,1.0,5/25,7.88%,IGF1;NAPEPLD;NAAA;DHRS3;RBP4
prerank,cholesterol efflux (GO:0033344),-0.45643256266780446,-1.220118802630115,0.1729490022172949,0.5183979898329685,1.0,5/20,11.20%,SCARB1;APOE;ABCG1;NPC2;STX12
prerank,regulation of myelination (GO:0031641),-0.44020338508657786,-1.2200536508662763,0.20374707259953162,0.5176862157230001,1.0,11/25,24.04%,TENM4;JAM2;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;EIF2AK3;TPPP;SIRT2;LGI4;KIF14
prerank,regulation of fibroblast migration (GO:0010762),-0.45627465070594936,-1.2195144892457783,0.22317596566523606,0.5180317285004515,1.0,10/20,13.15%,PRR5L;THBS1;ARHGEF7;ITGB1;CORO1C;TGFB1;PTK2;GNA12;FGF2;DMTN
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3430120417106646,1.2193756342018074,0.09761634506242906,0.8983692278546512,1.0,40/308,9.97%,EPAS1;DAB2;ACSL1;PPARGC1B;C1QTNF3;SMAD3;APPL2;LEPR;PPARGC1A;NPR1;IL18;FOXD1;SOX5;BMPR1A;TGFBR1;FOXC1;PDPN;ADRA2A;KMT5C;SMO;RREB1;NCOA3;CD28;EIF2AK2;KMT5B;IL12B;SMURF2;SLC27A1;SERPINE1;WWTR1;TGFBR2;TERT;LRP1;CPT2;GDNF;NIBAN2;NR2C2;SIRT1;GRB10;BMP1
prerank,sarcomere organization (GO:0045214),0.475895913305065,1.21913730639654,0.2534965034965035,0.8975683178232363,1.0,3/27,5.04%,ACTN2;CSRP3;TPM1
prerank,regulation of myoblast differentiation (GO:0045661),0.46249367649026457,1.2191307126772088,0.21258503401360543,0.8958989218716826,1.0,1/32,0.01%,RANBP3L
prerank,signal transduction by p53 class mediator (GO:0072331),0.4694498459605116,1.218881741279583,0.1919191919191919,0.8950835763519607,1.0,5/30,6.65%,DDX5;FHIT;SESN2;ATRX;TP53
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5370515505033988,1.2185025072300055,0.26605504587155965,0.894713729428283,1.0,3/16,4.60%,ATP1A2;ANK2;CACNA1C
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5015046085948011,1.2180383851406476,0.23208191126279865,0.8947003797642461,1.0,4/24,5.72%,ROCK2;ERRFI1;FOXC1;NCOA3
prerank,protein localization to vacuole (GO:0072665),-0.5015246938652096,-1.217517361944676,0.24572649572649571,0.5219016076037675,1.0,9/13,35.27%,RTN4;SH3GLB1;SH3BP4;CD81;RNF128;LMBRD1;SZT2;LAMTOR4;MFSD1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.42973974225452277,-1.2174493375989277,0.20634920634920634,0.5212014668447483,1.0,8/24,14.30%,DACH1;BMPR2;ACVRL1;RPS3;XRCC5;ERCC1;CDKN1A;TERF2IP
prerank,epithelial cell migration (GO:0010631),-0.39646653154555245,-1.2173123145137246,0.17696629213483145,0.5206374746038888,1.0,15/37,17.36%,NRP1;CDH13;NOS3;FAP;CYP1B1;ANLN;PLEKHG5;STARD13;LPXN;PKN3;SCG2;FAT2;PTP4A3;PLXND1;KANK1
prerank,negative regulation of cell cycle process (GO:0010948),0.4141281073871767,1.2172727209191905,0.19726858877086495,0.8957926050497151,1.0,14/61,16.03%,BMP7;TFDP2;TOM1L2;PCGF2;MGA;TFDP1;NME6;AURKB;RBBP8;CBX5;WAPL;VPS4A;EHMT2;EHMT1
prerank,atrioventricular valve development (GO:0003171),-0.5047526144633194,-1.2172618277481722,0.23529411764705882,0.5198671833565494,1.0,9/14,20.59%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;ACVR1;APLNR;ZFPM1;SLIT3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5337414459918803,1.2169705107825584,0.2378167641325536,0.895216387777251,1.0,4/15,11.31%,ROCK2;IGF1;MEF2A;PRKCA
prerank,entry into host (GO:0044409),-0.4950779145413158,-1.2166338682903106,0.20841683366733466,0.5205750893041656,1.0,6/13,23.60%,PPIA;MET;CDH1;CTNNB1;CBL;CXCR4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.37989551343232375,1.216314687571345,0.15217391304347827,0.8959723946666617,1.0,10/113,3.48%,NOTCH2;FGF1;BMP6;OSR1;IGF1;STXBP4;FGFR2;LAMC1;PKHD1;TGFBR1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5650753388691214,1.2162524117595757,0.25673249551166966,0.8944959171249109,1.0,6/13,18.75%,ATG10;ATG7;UBA6;DESI1;DESI2;UBA5
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5230768136362757,-1.2159915341692353,0.24086021505376345,0.5211734366693089,1.0,9/13,30.10%,SORL1;TMEM30A;BCAP31;CD81;SAR1B;SEC16B;TMEM30B;EDEM1;SAR1A
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4513112364155409,-1.2159128023413246,0.20642201834862386,0.5205044874969265,1.0,6/21,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4033687691270704,1.215520610205017,0.18898809523809523,0.895529309255453,1.0,13/68,11.91%,WNT5B;WNT4;WNT6;LRRK2;FZD8;FZD5;PTEN;RYK;TCF7L2;CSNK1A1;TCF7;RARG;PORCN
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.48519173593588794,1.2153552158208119,0.24149659863945577,0.8944212115477009,1.0,7/27,12.55%,DDX5;ATM;YJU2;SIRT1;DYRK1A;SNAI1;KMT5A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5236000179858666,-1.2148075765577309,0.21987315010570824,0.5222590537799984,1.0,6/11,26.82%,TERF1;CCT2;CCT8;CCT6A;CCT7;DKC1
prerank,autonomic nervous system development (GO:0048483),-0.4665783516241029,-1.214696379873839,0.23094170403587444,0.5216834287325289,1.0,5/17,18.20%,NRP1;FN1;KIF26A;EDNRB;SOX8
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5475495902564023,1.2143475534479808,0.24906367041198502,0.8965367729613869,1.0,3/14,9.86%,PPARGC1A;SIRT1;SLC45A3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4795354184303444,1.2143183767453334,0.23183391003460208,0.8949705559443676,1.0,8/26,14.58%,ROCK2;PRKN;FHOD1;ASAP3;CDC42;VIL1;ALMS1;TSC1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4424966083634121,-1.2137669676897398,0.19457013574660634,0.5231073287117924,1.0,11/22,34.60%,PSMB2;PSMB9;PSMA4;PSMB10;PSMA2;PSMB3;PSMB5;PSMA5;ENC1;PSME4;PSMA7
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5270567000707244,-1.2136645086159639,0.22453222453222454,0.5224927629597607,1.0,5/12,26.70%,SNAP25;STX3;STX1B;SNAP23;STX1A
prerank,histone H2B ubiquitination (GO:0033523),0.578894569262822,1.2131422413678106,0.2723735408560311,0.8976290109532062,1.0,4/10,18.69%,CTR9;RNF8;UBE2E1;RNF20
prerank,negative regulation of developmental growth (GO:0048640),-0.41345968786396514,-1.2129597927831717,0.19106699751861042,0.5233439705079216,1.0,12/30,14.68%,RTN4;DCC;DIP2B;PTCH1;ULK1;ULK2;WWC1;FGF13;SEMA3G;CDKN1A;MT3;FGFR3
prerank,retrograde axonal transport (GO:0008090),-0.49350842888269264,-1.2128353352425152,0.21951219512195122,0.5227259096283797,1.0,3/16,4.94%,DLG2;DST;TMEM108
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4449931069236634,-1.2127909816904618,0.22687224669603523,0.521966543919946,1.0,6/21,10.62%,PPP1R16B;YWHAE;GSK3B;YWHAB;MFHAS1;FKBP1A
prerank,myelin maintenance (GO:0043217),-0.5430090418461783,-1.2124192638436526,0.25416666666666665,0.5220069371950095,1.0,6/10,23.60%,EPB41L3;ABCD2;PRX;CLU;SOD1;CXCR4
prerank,negative regulation of cellular component movement (GO:0051271),0.5317899327160617,1.2122252608585877,0.24750499001996007,0.8993331912921579,1.0,3/15,2.31%,TGFBR3;FBLN1;PKHD1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5396140193955512,-1.2119226798433624,0.257201646090535,0.5223550391824126,1.0,2/10,5.59%,ACTN4;TBX1
prerank,oxoacid metabolic process (GO:0043436),0.47737021431523097,1.2103624949898306,0.23599320882852293,0.9044304084834729,1.0,4/27,11.81%,DDO;ABHD14B;SULT2B1;TPST1
prerank,potassium ion transport (GO:0006813),0.37756926594691004,1.2103219401155938,0.16120576671035386,0.9029079568898247,1.0,8/120,1.95%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.389760200382826,1.210120762749154,0.187683284457478,0.9020160479646478,1.0,7/86,3.48%,DAB2;BMP6;BMP7;ZNF423;FOXD1;BMPR1A;TGFBR1
prerank,keratinocyte differentiation (GO:0030216),-0.4201221807804708,-1.209613190270132,0.18536585365853658,0.5271694404840535,1.0,9/29,21.04%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;EXPH5;WNT16;ASAH1
prerank,epithelium development (GO:0060429),0.38558968478467603,1.20918298675784,0.1859799713876967,0.9036332744437775,1.0,13/107,8.49%,ALDH1A2;WNT4;OSR1;ERRFI1;FGFR2;KANK2;DAG1;CPT1A;LOXL3;SMO;TPP1;BDH2;IFT122
prerank,cellular response to leucine (GO:0071233),0.568164025358554,1.208707943747199,0.26506024096385544,0.9020709191664127,1.0,6/10,17.57%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,response to leucine (GO:0043201),0.568164025358554,1.208707943747199,0.26506024096385544,0.9020709191664127,1.0,6/10,17.57%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,myelin assembly (GO:0032288),-0.5334812510922001,-1.208350416751702,0.22792607802874743,0.5291862623409224,1.0,3/10,3.69%,CD9;TENM4;EPB41L3
prerank,RNA destabilization (GO:0050779),0.5205158107604024,1.2081244897642291,0.2539964476021314,0.9024455965843224,1.0,3/18,10.02%,ROCK2;ZC3H18;YTHDF3
prerank,regulation of synapse maturation (GO:0090128),-0.5438315244375515,-1.2078718836527684,0.24008350730688935,0.5294583494526546,1.0,4/10,7.72%,NRXN1;DAB2IP;ARHGEF15;RELN
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.532916607524512,-1.2076592846509175,0.24583333333333332,0.5291550480645184,1.0,6/10,16.57%,CORO2B;NDFIP2;MAPT;PPM1F;TERF1;DNAJA1
prerank,male meiosis I (GO:0007141),0.5316500548283821,1.207474375377694,0.2585895117540687,0.9031000407643553,1.0,4/16,13.17%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4611378808695098,-1.207196662087823,0.20297029702970298,0.5294111196865603,1.0,8/20,13.66%,NLGN1;SHANK3;APOE;PSEN1;RELN;LLPH;LRP8;SHANK1
prerank,protein dephosphorylation (GO:0006470),0.37086399443176377,1.2063267807928972,0.16266666666666665,0.9055228673711093,1.0,30/135,12.34%,EYA1;PTPN13;EYA2;DUSP29;PPP2R2B;PTPN14;PTPN9;MTMR3;PPEF2;PPP1CB;EYA4;PPM1E;TNS2;DAPP1;LHPP;PTPN22;PTPRU;FBXW11;PTEN;BTRC;PP2D1;PPP2R1B;PTPN21;CDC14B;PPP2R5E;DUSP10;DUSP2;PTPN4;CTDSP2;PTPN11
prerank,cellular response to fatty acid (GO:0071398),-0.5133932414404424,-1.2062950893992874,0.2570281124497992,0.5306566940551753,1.0,1/12,0.44%,PID1
prerank,positive regulation of macrophage migration (GO:1905523),-0.461270879022479,-1.2059905867703629,0.19474835886214442,0.5304807210103377,1.0,5/19,15.36%,THBS1;PTK2;P2RY12;CMKLR1;RARRES2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3765912942689738,1.2059491431924623,0.17623497997329773,0.9052084298732935,1.0,30/104,17.16%,KSR1;SLC8A3;CCNA2;PPEF2;CCNA1;DDX3X;UVRAG;CAMK1;TRIB2;SLC27A1;CCNT2;CCND3;CDK5RAP3;HTT;CDC25A;SIRT1;CCNB2;GTPBP4;IRGM;ABL1;TRIB1;MAP2K1;MAP2K2;GADD45A;RPTOR;CCNG1;SNF8;TELO2;CCNE1;RB1
prerank,DNA catabolic process (GO:0006308),0.5650981442671703,1.2059164213392584,0.2600806451612903,0.9036616962416271,1.0,4/11,15.69%,DNASE1L1;FBH1;DFFB;DNASE1L2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.47906022881102417,-1.2054674118673843,0.22899159663865545,0.5309130412864512,1.0,3/14,8.70%,OSMR;IL6ST;PTGS2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.36084494308715886,1.2054442297675527,0.159846547314578,0.9035761143636264,1.0,45/182,15.44%,NOTCH2;ROBO1;SLC24A3;ROCK2;WNT4;PICALM;IGF1;PRKAA2;PRKN;TNRC6A;BMPR1A;PARP10;PARP14;SMO;TIPARP;RIN3;CD28;APLN;PTPN22;TNRC6B;ATXN2;TERT;RBL2;HDAC1;PARP9;SIRT1;MOV10;LRP3;RBL1;CRKL;DICER1;FLOT2;WWP2;NOCT;ZNF148;SNX12;MAP2K1;RBMS3;MAP2K2;FLCN;NFKB1;ANXA7;TNRC6C;TET1;SETDB2
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5315531886617708,1.2048879541041375,0.2462962962962963,0.9039510453137037,1.0,3/16,3.66%,HOXB4;SOX5;FOXC1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5266389376743899,1.204271474921951,0.23837209302325582,0.9044619034294105,1.0,1/18,0.08%,ATP1A2
prerank,T cell mediated immunity (GO:0002456),-0.5043929032692649,-1.204140732921487,0.2249488752556237,0.5331960463324581,1.0,4/13,14.95%,CADM1;JAG1;EMP2;BTN3A3
prerank,C4-dicarboxylate transport (GO:0015740),-0.4908333308649173,-1.2039986495962585,0.24835164835164836,0.532636974532084,1.0,4/14,5.22%,LRRC8D;SLC1A2;SLC1A1;SLC25A13
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4774443567373728,1.2035899741257337,0.23809523809523808,0.9053099919427191,1.0,4/28,4.16%,ARHGAP28;FCHSD2;ARHGAP18;NAA80
prerank,neutrophil mediated immunity (GO:0002446),-0.2694302227932794,-1.20300337727797,0.009900990099009901,0.5341430155746313,1.0,103/432,19.55%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;PTPRN2;RAB31;HSP90AB1;PRG2;GPI;PPIA;RAP1B;RAP1A;ACTR2;CD93;PTPRC;STK10;RAB27A;PSAP;CTSD;HSPA8;CTSC;TSPAN14;TIMP2;TNFRSF1B;DYNLL1;PSEN1;PGLYRP1;NPC2;SLC44A2;OSTF1;FTL;MME;EEF1A1;HEXB;CKAP4;STOM;CEACAM1;CTSB;PSMD14;CRACR2A;CD47;RAB18;CD44;DOCK2;HSP90AA1;CYBA;IMPDH1;GOLGA7;XRCC5;ENPP4;CTSS;HRNR;ARPC5;TNFAIP6;SLC2A3;LRG1;TMEM30A;SRP14;PGAM1;FABP5;QPCT;DOK3;SCAMP1;TRPM2;ALDOA;RAB6A;APEH;CAT;PKM;PDXK;CCT2;CCT8;SVIP;GCA;STXBP3;RAB37;C3AR1;ITGB2;CYB5R3;ATP11B;EEF2;QSOX1;SPTAN1;CTSZ;CAND1;PSMD11;TMEM63A;TYROBP;SLC27A2;PSMD2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.48428554482631847,-1.202787191743918,0.248868778280543,0.5338494335298989,1.0,7/15,7.88%,KCNJ3;KCNJ2;KCNN2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,actin nucleation (GO:0045010),-0.439732365869504,-1.2026722573689566,0.24269662921348314,0.533260360910702,1.0,6/21,13.81%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,regulation of neuron projection arborization (GO:0150011),-0.49202999763248395,-1.2026614241253386,0.21691973969631237,0.5324420606382665,1.0,4/15,10.77%,GRIP1;NTNG1;FZD4;MFSD2A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.36676946949542155,1.2022303607929554,0.14873837981407703,0.9086856104309826,1.0,36/148,16.03%,PRKAG2;PRKAA2;PRKAG3;TP53RK;CHD4;PPP1R13L;ATM;TP53;RICTOR;CDK5RAP3;PDPK1;RNF34;HDAC1;AURKB;RBBP8;NOP2;MAPKAP1;CSNK2A2;CSNK2A1;HUS1;TAF11;BRD7;RAD50;KMT5A;TOP3A;USP7;TAF4;TBP;PPP1R13B;PML;TAF7;MTA2;MAP2K6;CCNG1;EHMT2;EHMT1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.36878316963267416,-1.202041198627723,0.1936416184971098,0.5330954970025699,1.0,14/52,11.10%,SPTBN1;DPP10;PRKCH;PIK3R1;ATP2C1;ACSL3;STX3;PLS1;NKD2;ITGB1;EPHB2;ATP2B4;GPER1;ZDHHC2
prerank,protein K48-linked ubiquitination (GO:0070936),0.42189418570853726,1.2018820468560485,0.2078125,0.9082976709951228,1.0,16/54,17.46%,RNF152;UBE2E2;PRKN;IFI27;NHLRC4;TTC3;RNF8;RNF34;UBR5;UBE2H;RNF115;AMFR;RNF146;UBE2E1;SYVN1;CDC34
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.41504431760538263,-1.200950326772146,0.20100502512562815,0.5349119854813724,1.0,9/28,14.65%,MAP3K5;DAB2IP;DNAJC10;ATP2A3;AIFM1;TMEM117;SELENOK;ATF4;BBC3
prerank,hexose biosynthetic process (GO:0019319),0.4355363303622853,1.2007052776235794,0.21553090332805072,0.9108554952296414,1.0,14/42,18.24%,PPARGC1A;SORD;CHST15;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;CRY1;SLC37A4
prerank,negative regulation of protein metabolic process (GO:0051248),-0.37058616063876754,-1.2005181483001295,0.18085106382978725,0.5350977358101007,1.0,15/48,20.08%,FMN2;HSP90AB1;FLNA;APOE;LDLR;IRAK3;ITGB3;EDN1;CD84;ADGRB1;CLU;EDNRB;IAPP;SIRT2;CYP51A1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5293555881598337,-1.2004606697144637,0.2608695652173913,0.5343808447123424,1.0,4/11,8.70%,CD200;THBS1;CD34;PTGS2
prerank,protein sumoylation (GO:0016925),0.42284391476139527,1.1999326194275,0.22560975609756098,0.9120017589799851,1.0,13/49,21.42%,EYA1;PIAS1;NUP42;NUP98;NSMCE2;NUP43;PIAS3;NUP155;NUP188;SUMO1;PIAS4;NUP153;UBE2I
prerank,potassium ion import across plasma membrane (GO:1990573),0.4463782285528479,1.1996393966816994,0.23285486443381181,0.9114933122297847,1.0,3/41,0.90%,ATP1A2;ATP1B3;KCNJ13
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.42248909086756226,-1.1994802653989716,0.19950124688279303,0.5358254057288687,1.0,4/25,1.42%,SLC8A1;TMTC2;CAV1;ANK3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4252799530940689,1.1989363577760404,0.22290076335877862,0.9123249721131214,1.0,6/48,13.57%,PRKAG2;GCK;NUP42;NUP98;OGT;NUP43
prerank,positive regulation of transferase activity (GO:0051347),-0.30701915614507347,-1.198439982712607,0.08823529411764706,0.5374333689703167,1.0,33/142,13.67%,TEK;ERBB4;NTRK3;CD200;EPHB1;ROR1;EPHA5;MERTK;EPHA6;TIE1;PARM1;NTRK2;HSP90AB1;NEK7;KDR;MET;ROR2;SORL1;EPHB2;EPHA7;TGFB1;FLT4;RPS2;ERBB2;HSP90AA1;SERINC1;XRCC5;CTNNB1;AXIN1;SERINC5;ARRDC4;RET;PINK1
prerank,positive regulation of binding (GO:0051099),-0.33418987098773095,-1.197789590817811,0.14613180515759314,0.5381762929064521,1.0,36/84,23.00%,CAV1;CLDN5;EPB41;B2M;NGF;GSK3B;TIAM1;APP;HES1;MET;APOE;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;TXN;SPPL3;STMN1;HIPK2;DHX9;MEN1;HIP1R;KDM4D;RAN;CLN5;HMBOX1;SIRT2;EDF1;RPL11;VTN;TRIB3;FLOT1
prerank,SNARE complex assembly (GO:0035493),-0.5402118987927335,-1.1975998538876786,0.2719665271966527,0.5377775520484493,1.0,2/10,4.54%,STXBP6;VAMP4
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5491258850394383,-1.197400083207832,0.25763358778625955,0.5374292414018926,1.0,4/10,19.50%,BASP1;BMP4;PAX2;PAX8
prerank,negative regulation of leukocyte activation (GO:0002695),-0.46659639590578716,-1.1973326251612826,0.25892857142857145,0.5367203619076444,1.0,6/15,15.09%,CD200;LRFN5;GPER1;HAVCR2;CD84;IL31RA
prerank,metanephros development (GO:0001656),0.4801294986966907,1.1972871576917432,0.25215889464594127,0.9167259123001729,1.0,6/26,8.74%,BMP7;OSR1;FOXD1;CTSH;NIPBL;GDNF
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.4399569388900032,-1.1969114758863801,0.2222222222222222,0.5368192361887457,1.0,4/24,5.31%,SLIT2;CXCL12;CCN3;LYN
prerank,negative regulation of gene expression (GO:0010629),0.3411093205140117,1.1961767285853848,0.11910377358490566,0.9190052554114633,1.0,63/302,15.15%,NOTCH2;ROBO1;LGR4;SLC24A3;ROCK2;WNT4;SYT11;PICALM;IGF1;PRKAA2;PRKN;DNMT3A;JARID2;TNRC6A;NCOR2;BMPR1A;PARP10;PARP14;SMO;SRGN;IGF2BP1;DDX3X;TIPARP;CD28;EIF2AK2;TWSG1;APLN;PTPN22;IGF2BP2;TNRC6B;SAMD4A;TERT;RBL2;LARP1;CNOT10;CPEB3;HDAC1;PARP9;SIRT1;MOV10;LRP3;LSM14A;RBL1;CRKL;DICER1;FLOT2;WWP2;NOCT;ZNF148;DDX6;PHF1;SNX12;MAP2K1;RBMS3;NCOR1;MAP2K2;FLCN;NFKB1;TSC1;KAT2B;ANXA7;TNRC6C;MPHOSPH8
prerank,receptor clustering (GO:0043113),-0.4080465729184809,-1.1961438433480327,0.2109375,0.5378509374359419,1.0,9/27,11.00%,NLGN1;DLG2;NRXN1;LRRC7;FLNA;ITGA4;PTN;AGRN;NRXN2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3377111799000571,-1.1957010574200881,0.16816816816816818,0.5379672753296543,1.0,27/72,20.92%,SLIT2;SHANK3;NAV3;KANK3;CLASP2;KANK4;ARHGEF2;LIMA1;STMN2;APOE;LDLR;HSPA8;FGF13;TUBB4A;SPEF1;PFN2;SNCA;SHANK1;CLU;STMN1;APC;IAPP;KANK1;HIP1R;MYADM;TWF2;SSH2
prerank,magnesium ion transport (GO:0015693),0.5619717978963188,1.195676829718277,0.2796116504854369,0.9192555591777143,1.0,3/12,9.23%,SLC41A1;MRS2;NIPA2
prerank,muscle tissue development (GO:0060537),-0.5010301153559961,-1.1948793399201374,0.2660753880266075,0.539138687374413,1.0,6/13,10.83%,PGM5;ENG;PTCH1;CSRP2;STRA6;BMP4
prerank,nuclear export (GO:0051168),0.3950909660181136,1.1942350243159618,0.191044776119403,0.9227234308584161,1.0,19/80,20.72%,RANBP3L;SRSF5;PHAX;POLDIP3;NUP42;RANBP3;NXF1;SRSF11;DESI1;SARNP;NUP155;NEMF;CCHCR1;SRSF1;NUP188;U2AF1;CDC40;NUP153;SRSF7
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.48543672324645365,1.1940940473788395,0.2609457092819615,0.921591585827343,1.0,7/23,15.69%,CASP3;DNASE1L1;FBH1;DICER1;DFFB;DFFA;DNASE1L2
prerank,presynapse assembly (GO:0099054),-0.48392649693449385,-1.1940284382937598,0.2528473804100228,0.5402885779234198,1.0,5/16,3.60%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,positive regulation of developmental process (GO:0051094),-0.3008209705673565,-1.1940117113218587,0.09787234042553192,0.5394862235017254,1.0,46/164,15.53%,NLGN1;NRXN1;SLC6A6;BMP5;SHANK3;BMPR2;RTN4;CLASP2;DCN;GRIP1;PHLDB1;TFRC;ZBTB16;ARHGEF7;HSP90AB1;KDR;DAB2IP;AR;FZD4;APOE;BASP1;PSEN1;B4GALT5;CORO1C;RELN;SORL1;BMP2;PTN;ENPP2;RPS6KA3;BMP4;HMCES;LLPH;EDN3;VLDLR;LRP8;CFL1;SHANK1;PINK1;RPS6KA1;VEGFA;BMPR1B;ACVR1;COBL;PAX2;PACSIN1
prerank,regulation of cellular component size (GO:0032535),0.46605800127757807,1.1936719034468009,0.24292845257903495,0.9215264626192678,1.0,10/30,15.35%,PICALM;PEX11A;EZR;RIN3;PTEN;PEX11B;RARG;RAB22A;VAV3;RPTOR
prerank,negative regulation of viral genome replication (GO:0045071),0.44714123661529276,1.1936657532556905,0.2484472049689441,0.9199269442292507,1.0,12/40,16.22%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;ZC3HAV1;RSAD2;MAVS;SRPK2;OAS3;MPHOSPH8;ILF3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.40789094314068786,-1.193376804716587,0.19315403422982885,0.5401204959003454,1.0,4/29,7.52%,RPS8;RPS19;RPS21;RPS16
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5525635823771762,1.193187938135597,0.2909090909090909,0.9200945981425918,1.0,2/13,5.24%,DDX5;ATM
prerank,actin filament bundle organization (GO:0061572),0.4506186402293762,1.1926472091056473,0.24373956594323873,0.9204617969925116,1.0,6/33,6.01%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,sterol transport (GO:0015918),-0.4527168445204415,-1.1923623638836804,0.2234513274336283,0.541766113006781,1.0,6/19,21.14%,CAV1;LDLR;NPC2;LDLRAP1;OSBP;STARD3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4188495493914334,1.192337572452892,0.21286370597243492,0.9199602730366913,1.0,9/51,5.04%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5294781198690965,1.1921754615906708,0.25475285171102663,0.9189627749254321,1.0,2/14,0.89%,ACE;CORIN
prerank,regulation of cellular respiration (GO:0043457),-0.4579053557158663,-1.1920723418422754,0.23972602739726026,0.5415477212745526,1.0,4/17,13.83%,PRDM16;PNPT1;CBFA2T3;NOP53
prerank,regulation of angiogenesis (GO:0045765),-0.2917246095731091,-1.1910221437586053,0.09644670050761421,0.5431731339382834,1.0,62/192,17.18%,PTPRM;TEK;BMPER;SEMA6A;RHOJ;CLDN5;PDE3B;NOS3;THBS1;VEGFC;DCN;TGFB2;SEMA5A;TIE1;PPP1R16B;GAB1;CD34;COL4A2;PTGIS;RUNX1;F3;CYP1B1;SEMA3E;KDR;RAMP2;DAB2IP;RHOB;ITGB8;PIK3R6;TSPAN12;SERPINF1;ITGB1;ECM1;STAB1;GATA2;HSPG2;CEACAM1;AMOT;BTG1;FGF2;ERBB2;HIPK1;ATP2B4;CTNNB1;ISM1;TWIST1;EMP2;PRKD1;HIF1A;ECSCR;ADGRB1;VEGFA;SPRED1;MTDH;RRAS;APLNR;HIPK2;HHEX;PLXND1;CHRNA7;PDCL3;HSPB1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4852879825916916,-1.1909782710040824,0.2288888888888889,0.5424352610493083,1.0,9/14,28.03%,THBS1;ITGA4;GPER1;ECSCR;PDCD4;RGCC;PLCG1;CCL2;CD40
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.41732037664064076,-1.1908764856833869,0.22062350119904076,0.5418153114978849,1.0,10/27,12.55%,PDE4D;CACNB2;AHNAK;CAMK2D;YWHAE;CALM1;CALM2;FKBP1A;JPH2;NOS1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.43035484418313347,1.190282909957712,0.23378582202111614,0.9241097579900244,1.0,4/44,0.78%,WNK4;ACTN2;ATP1B3;ANK2
prerank,neurotransmitter transport (GO:0006836),-0.3412644631575952,-1.1898635141580678,0.15963855421686746,0.543357413840296,1.0,15/73,7.06%,NRXN1;SYT1;PPFIA2;SNAP25;RIMS1;LIN7A;CASK;SLC1A2;GABRA2;PTPRN2;UNC13B;SLC1A1;SYN2;HSPA8;GLS
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.45675275457815245,-1.1898142616062308,0.22588235294117648,0.5426306737979902,1.0,5/18,7.72%,NLGN1;NRXN1;SHANK3;PTK2B;RELN
prerank,negative regulation of cell growth (GO:0030308),-0.3063339587296961,-1.189574355412404,0.12030075187969924,0.5424145666278338,1.0,47/121,24.58%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;DCC;TGFB2;CCN3;ACVRL1;SOX17;DIP2B;ADAM15;PPP2R1A;ULK1;SH3BP4;ULK2;ENPP1;RERG;TGFB1;SERTAD2;BTG1;PPT1;FGF13;FRZB;SEMA3G;CDKN1A;JADE1;EI24;MT3;DCBLD2;CCDC85B;NDRG3;SIPA1;CDKN2AIP;DCUN1D3;INHBA;RTN4R;ESR2;SLIT3;WFDC1;DACT3;SMARCA2;SFRP1;HYAL2;ING1;FHL1;NDUFA13
prerank,response to amino acid starvation (GO:1990928),0.4008592477982635,1.1892083111208218,0.22590361445783133,0.9263919090644411,1.0,18/72,15.80%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;EIF2AK2;ATP6V0B;LARP1;ATP6V1D;ATF2;ATP6V1E1;IMPACT;FLCN;KPTN;DEPDC5;RPTOR;WDR24
prerank,protein ubiquitination (GO:0016567),0.32553639655295147,1.1890566577644217,0.10231023102310231,0.9253494194965691,1.0,92/471,17.46%,RNF220;EPAS1;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;SASH1;PRKN;FBXL17;SPSB1;RNF213;TRIM63;CTR9;DTX1;NEDD4;CAND2;RNF151;RNF135;FBXL19;ARRB1;USP9X;KLHL41;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;FBH1;RNF141;TRIP12;RNF217;HUWE1;TNKS2;BTRC;RNF19A;EIPR1;KLHL7;RNF34;UBR5;NPEPPS;HERC6;SIRT1;FBXO22;PEX10;ZSWIM8;FBXL12;SH3RF1;RTF1;FBXW8;RNF41;FBXO4;PRKDC;RNF13;CUL9;CUL4A;WWP2;UBA6;ASB5;FBXO10;USP7;TRIM62;NUB1;DTX3;ASB12;DDB2;FBXO11;SDE2;FBXL20;DZIP3;LONRF1;RMND5A;UBE2H;RNF115;PEX14;AMFR;RNF19B;ANAPC16;RNF31;BIRC6;RNF146;UBE2E1;UBR1;SYVN1;PEX5;RNF7;FBXW10;KCTD13;CDC34
prerank,protein targeting to peroxisome (GO:0006625),0.46241624558801747,1.1887883402790098,0.25597269624573377,0.92469479882619,1.0,11/29,17.40%,ZFAND6;PEX11B;PXMP2;PEX10;PEX14;RAB8B;ACBD5;PEX19;PEX5;SLC25A17;PEX16
prerank,regulation of vacuole organization (GO:0044088),0.5060100261081736,1.1887833804660106,0.27454545454545454,0.9230995644778665,1.0,5/20,10.85%,MTMR3;NPRL3;NPRL2;PIKFYVE;IFT88
prerank,electron transport chain (GO:0022900),0.5338230799191828,1.1882451970557812,0.27289048473967686,0.9233620016473854,1.0,2/15,5.07%,PPARGC1A;POR
prerank,maturation of LSU-rRNA (GO:0000470),0.4688136422237055,1.1875997528942308,0.2645051194539249,0.9241219693113497,1.0,7/26,18.93%,NSA2;DDX18;NOP2;RSL1D1;MRPL1;ZNHIT6;WDR12
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5711675082946627,1.1874865374153727,0.292910447761194,0.9229024490359016,1.0,1/11,0.51%,AFDN
prerank,positive regulation of phosphorylation (GO:0042327),-0.291417585466313,-1.187325379392107,0.06875,0.5469225043776285,1.0,67/240,14.22%,NRP1;LIMCH1;TEK;ERBB4;NTRK3;PECAM1;ITGA6;PDE8A;ENG;EPHB1;ROR1;THBS1;EPHA5;VEGFC;NPTN;MERTK;NIBAN1;EFNA5;EPHA6;TIE1;GAS6;TFRC;NTRK2;KRAS;KDR;LYN;TBX1;AR;PPIA;PAK1;APP;CARD14;MET;LIMK2;SEMA4D;ROR2;PSEN1;CCN1;BTBD10;EPHB2;BMP2;EPHA7;RALB;TGFB1;PTK2;FLT4;FGF2;CAMKK2;ERBB2;RAP2A;HSP90AA1;ITGB3;BMP4;FXR1;GPER1;FAS;ILK;PFKFB1;HIF1A;AXIN1;RET;PINK1;VEGFA;FGF7;FGF9;P2RY1;MT3
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4462693417689115,1.1872140967288687,0.23697478991596638,0.922282862174647,1.0,8/35,10.72%,PPARGC1B;DDX5;PMEPA1;NEDD4;TMF1;CALCOCO1;UBR5;ZMIZ1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3868996058443251,-1.1871449151786393,0.19689119170984457,0.5465570330460278,1.0,13/36,13.85%,ENG;RASSF2;PPP2R5A;PDGFC;CALM1;CALM2;ENPP1;EPHA7;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,presynapse organization (GO:0099172),-0.5280213634564104,-1.186898577867528,0.2725409836065574,0.5462579279444356,1.0,2/10,3.60%,NLGN1;LRRTM3
prerank,cellular response to hormone stimulus (GO:0032870),0.3970589138341864,1.1866932653628408,0.21669106881405564,0.922551599108514,1.0,10/69,7.09%,ATP1A2;THRB;TFPI;SLC5A5;BRD8;ADRA2A;CTSH;NCOA3;BCAS3;GCK
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.464309079814011,-1.1859539255822076,0.24780701754385964,0.5476106604711916,1.0,5/16,8.47%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST6GALNAC5;ST8SIA6
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5196888140706117,1.1859345383725948,0.26857142857142857,0.9237542510738836,1.0,3/16,6.47%,PIGN;PIGW;PIGQ
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.33441968108436393,-1.1858379313646457,0.1414790996784566,0.5470617752029753,1.0,27/84,10.83%,NRP1;TEK;BMPR2;TMSB4X;NOS3;THBS1;NRP2;SEMA5A;PTK2B;SCARB1;AKT3;KDR;GPI;FOXP1;MET;RHOB;GATA2;PROX1;TGFB1;ATOH8;CALR;FLT4;FGF2;ITGB3;BCAR1;EDN1;BMP4
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5251085396193044,-1.1855688013796257,0.25661914460285135,0.5468345534575707,1.0,4/11,10.47%,SEMA5A;STMN2;TRPV4;WDR1
prerank,lipid transport (GO:0006869),-0.3265596687967943,-1.1855344490699409,0.14893617021276595,0.546079736194302,1.0,25/97,11.28%,ABCC4;ATP8A1;ATP8B1;SLCO1C1;CERT1;PITPNC1;PPARD;SCARB1;SLCO2B1;PLTP;UGCG;SPNS2;APOE;LDLR;ABCG1;NPC2;GLTP;CEACAM1;PITPNB;STARD5;TNFAIP8L3;ABCD2;MTTP;MFSD2A;PITPNA
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.528968671577528,1.1854240831247869,0.2756052141527002,0.9238926623773397,1.0,5/15,7.47%,FGFR2;HOXA1;TGFBR1;NIPBL;TGFBR2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.47817205319513095,-1.1851803568098211,0.2608695652173913,0.5461184397252853,1.0,8/15,28.12%,CCT2;CCT8;CCT6A;CCT7;NHP2;RUVBL2;DKC1;NAF1
prerank,negative regulation of biosynthetic process (GO:0009890),0.5169607543251797,1.1849656449686423,0.2851919561243144,0.9239889343285019,1.0,2/16,2.07%,PPARA;SLC30A10
prerank,glycoprotein catabolic process (GO:0006516),0.5272851709544726,1.184951662481132,0.286527514231499,0.9224477326534137,1.0,4/17,8.48%,NGLY1;NEU2;ADAMTS9;MANBA
prerank,positive regulation of cyclase activity (GO:0031281),0.5268539692798252,1.1845372637047247,0.29442508710801396,0.9223866929300931,1.0,3/14,9.92%,CACNA1D;CACNA1C;STIM1
prerank,potassium ion homeostasis (GO:0055075),0.4886948145339868,1.184296255625645,0.2663230240549828,0.921672571345646,1.0,2/23,0.74%,ATP1A2;ATP1B3
prerank,organophosphate biosynthetic process (GO:0090407),0.4480859778505209,1.1837534285649245,0.2401883830455259,0.9221046745530195,1.0,14/37,19.19%,AGPAT4;GPAT2;CPS1;GK5;MOCOS;GK;ITPKB;PPIP5K2;GPAM;NFS1;TPK1;IP6K3;MOCS1;PCYT2
prerank,ESCRT III complex disassembly (GO:1904903),0.5694247061800601,1.1835664344841719,0.30178571428571427,0.919661857315948,1.0,6/10,28.94%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.5694247061800601,1.1835664344841719,0.30178571428571427,0.919661857315948,1.0,6/10,28.94%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,cellular amide metabolic process (GO:0043603),0.37240863163704585,1.183431805264152,0.19467787114845939,0.918637686092049,1.0,31/102,21.94%,AEBP1;ST6GAL1;PCCA;NAPEPLD;PM20D1;NAAA;SLC19A1;MTHFR;ALDH1L1;ACOT11;MCCC1;MLYCD;MTRR;ACOT8;HLCS;THEM4;NSMAF;SMPD3;CERK;SGPL1;MTHFD1;ACOT12;SMPD2;MCCC2;FOLR2;ACSF2;ABCA2;AASDHPPT;PLAAT3;DNPEP;ORMDL3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5461443276683517,1.1833001970348473,0.30492424242424243,0.9175479230490708,1.0,2/13,2.58%,ERRFI1;SNX6
prerank,iron ion transmembrane transport (GO:0034755),-0.5267947341613397,-1.181894999876423,0.2833333333333333,0.5530780308684043,1.0,2/10,5.54%,SCARA5;SLC40A1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.4569157566413725,-1.1818279969184615,0.2361111111111111,0.5524289748964268,1.0,5/20,9.58%,FAR2;ACSL3;ACSL4;PPT1;SCD
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.42243364525416355,1.1817357915666167,0.24798711755233493,0.9215499253661488,1.0,9/48,8.47%,ADCY5;NPR1;ADCY1;AMPD3;NPR2;ADCY9;PANK1;SLC26A1;DCAKD
prerank,positive regulation of T cell activation (GO:0050870),-0.34603241449546923,-1.1812778181684285,0.17313432835820897,0.5529138140048173,1.0,21/62,24.95%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;DOCK8;CD47;RHOH;NCK1;NOD2;PRKCQ;CCL19;CD81;PYCARD;CD86;LGALS9;MDK;THY1;CD276
prerank,regulation of neuron death (GO:1901214),-0.32875297183510266,-1.1808967895536335,0.14685314685314685,0.5529529485603903,1.0,38/82,23.17%,GRID2;MEF2C;MAP3K5;CD200;EPHB1;DCC;GRIN2B;CD34;TRIM2;GSK3B;TNFRSF1B;SORL1;BTBD10;EGR1;DDIT4;NENF;MAPT;SNCA;CLU;UBB;EGLN2;CHRNA7;FAIM2;DHCR24;HTRA2;ITGB2;CTSZ;C1QA;TYROBP;EGLN3;CHMP4B;CHMP4A;AKT1S1;GRM4;SNCG;FYN;CHGA;LANCL1
prerank,"transcription, DNA-templated (GO:0006351)",0.3502274104698222,1.180838177507277,0.17310087173100872,0.9232461128453688,1.0,39/207,15.56%,MAF;THRB;GLIS3;DDX5;POLR2A;SOX5;CTR9;DTX1;ATOH1;RREB1;TTF2;AFF4;CREBL2;TP53;CCNT2;TSC22D1;POLR2D;MEF2A;TWNK;TFDP1;ELL;GTF2A1L;GTF2F1;RTF1;MNT;NELFCD;NOCT;TAF11;HIPK3;DEAF1;POLR3A;TAF4;TBP;PMF1;NFKB1;TAF7;CTDP1;BRF1;FUBP3
prerank,regulation of neurotransmitter transport (GO:0051588),-0.46968070689067387,-1.1807480981541079,0.25571725571725573,0.5525201824096831,1.0,3/16,2.20%,MEF2C;MCTP1;RIMS1
prerank,stabilization of membrane potential (GO:0030322),0.5142489455062849,1.1804289940361976,0.2938053097345133,0.9230717842382034,1.0,1/16,0.26%,KCNK2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5001888967679541,1.1799783142933156,0.2798507462686567,0.9230858422572521,1.0,5/19,10.20%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.49464809685114275,1.1799626155466987,0.25,0.9216015870606425,1.0,4/22,3.63%,ROCK2;PICALM;EPHA4;CASP3
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5416800637370596,-1.1789113145037846,0.2670807453416149,0.5561468262564029,1.0,4/10,27.26%,HSPA5;ATF4;EIF2AK3;CCL2
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.331636689739025,-1.1787569935583149,0.16095890410958905,0.5557011828126689,1.0,19/72,10.29%,NRP1;ARHGEF28;HEG1;RIT2;ARHGEF3;F11R;RASIP1;NET1;ARHGEF2;STARD8;MET;APOE;PRAG1;KCTD10;ARHGDIB;MYOC;CUL3;STARD13;EPS8
prerank,protein heterooligomerization (GO:0051291),-0.46346108128154617,-1.1787246405819762,0.2676991150442478,0.5549416922014566,1.0,5/17,15.74%,KCNC2;GRIN2B;MAT2A;PKD1;GRIN1
prerank,regulation of regulated secretory pathway (GO:1903305),0.4353406086547081,1.1786636097191268,0.2558922558922559,0.9247332751939421,1.0,5/34,3.97%,SYT9;SYT11;SYT12;LRRK2;DTNBP1
prerank,negative regulation of kinase activity (GO:0033673),0.4052344102857999,1.1785100934266743,0.23503649635036497,0.9237078163948376,1.0,8/62,8.69%,PRKAG2;PPM1E;DEPTOR;DTNBP1;NPRL2;TRIB2;WWTR1;PDPK1
prerank,response to estradiol (GO:0032355),-0.39898255634913726,-1.1783762534758155,0.24271844660194175,0.5549852830205214,1.0,8/31,12.06%,ESR1;STAT3;ANXA1;SOCS2;TGFB1;STAT5B;GPER1;CTNNB1
prerank,amino acid import (GO:0043090),0.4856764295452298,1.1782127499356556,0.2785234899328859,0.9232438024811684,1.0,4/21,7.03%,SLC6A13;SLC6A1;SFXN2;SLC1A3
prerank,alpha-amino acid metabolic process (GO:1901605),0.42260122254077953,1.1780167516003526,0.2313915857605178,0.9223942790209448,1.0,13/45,13.09%,ASPA;ASPG;CPS1;KYAT3;GPT2;MTHFR;GOT2;SRR;GLUL;SLC25A12;NOX4;MTRR;FOLH1
prerank,keratan sulfate catabolic process (GO:0042340),0.5507591264737123,1.1779441132213426,0.29118773946360155,0.9210997294672539,1.0,2/11,5.33%,OGN;FMOD
prerank,positive regulation of cellular component organization (GO:0051130),0.3738744063023993,1.1773581719889235,0.1962864721485411,0.9216931284366332,1.0,20/107,9.52%,DAB2;BMP7;LRP4;FNIP1;FRMPD4;TRABD2B;TGFBR1;BID;RAPGEF3;ADGRL1;MPP7;PTPN23;ASAP1;ANAPC2;CAMK1;NOX1;LRP1;NRG1;CDH5;HYAL1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.49946852024149924,-1.1771837036475956,0.28252032520325204,0.5569888652417951,1.0,6/12,10.02%,SERPINE2;NOTCH1;HES1;BMP2;BIN1;ID2
prerank,lytic vacuole organization (GO:0080171),0.4560147487717677,1.1769299780907407,0.26174496644295303,0.9216915570941437,1.0,13/32,21.38%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;TPCN2;LAMTOR1;SNAPIN
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.49585338505324267,1.1769178354557435,0.26857142857142857,0.9202131453737046,1.0,5/21,7.31%,ADCY5;NPR1;ADCY1;NPR2;ADCY9
prerank,limb morphogenesis (GO:0035108),-0.43828467420033207,-1.1767928124067626,0.2651685393258427,0.5571597451608238,1.0,5/20,7.95%,MBNL1;TGFB2;TBX3;PTCH1;PCSK5
prerank,regulation of multicellular organism growth (GO:0040014),-0.47740864446804193,-1.1765382638938802,0.2440087145969499,0.5569221997355355,1.0,6/15,10.77%,GHR;APP;PTCH1;PPIB;STAT5B;MFSD2A
prerank,positive regulation of lyase activity (GO:0051349),0.5381854686438693,1.1762708433972815,0.2765957446808511,0.9209367707146019,1.0,3/14,9.92%,CACNA1D;CACNA1C;STIM1
prerank,cellular response to hypoxia (GO:0071456),0.36576180488315907,1.1760409326000354,0.19972826086956522,0.9201812218724312,1.0,5/126,2.03%,EPAS1;CPEB2;RORA;BMP7;SLC8A3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.46924042730823345,1.1759384514872946,0.2543859649122807,0.9190647708275659,1.0,7/27,3.98%,ARHGAP28;CGNL1;PRKN;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,atrial septum morphogenesis (GO:0060413),0.5575562155249189,1.1759173211317322,0.30326295585412666,0.9176403377479818,1.0,1/10,0.19%,NOTCH2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3879051724739907,1.1754739037476727,0.2227204783258595,0.917613514227521,1.0,18/76,15.84%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;PTEN;RNF217;CDK5RAP3;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;ZYG11B;DNAJB2;RNF19B;HECTD1
prerank,response to exogenous dsRNA (GO:0043330),0.49396737721929973,1.175338547682153,0.2803738317757009,0.9165975464815123,1.0,4/18,5.52%,COLEC12;IFIT1;TLR3;IFNK
prerank,negative regulation of MAPK cascade (GO:0043409),0.38225704777644315,1.1753182376624869,0.20614035087719298,0.9151873080560385,1.0,10/87,5.28%,BMP7;DUSP29;FBLN1;TIMP3;DLG1;CD300A;PPEF2;DAG1;EZR;TLR4
prerank,snRNA processing (GO:0016180),0.5144462933684102,1.1752727657297517,0.26011560693641617,0.9138737613337266,1.0,9/16,22.28%,INTS10;INTS2;INTS5;INTS3;INTS1;INTS7;INTS8;INTS4;TUT1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.39530378513225795,1.1751081125479483,0.25880551301684535,0.9129734704806195,1.0,23/68,20.93%,RHOQ;AMPD3;LRRK2;ABHD14B;OPA1;ACOT11;SULT2B1;AK4;AK3;NT5C2;MLYCD;TPST1;ACOT8;THEM4;AMPD2;ACOT12;MFN1;ADSS1;CROT;ACSF2;GMPR2;ACLY;ENTPD7
prerank,embryonic skeletal system development (GO:0048706),0.4485547065605268,1.1749253070529948,0.2652388797364086,0.9121140899339731,1.0,12/35,13.96%,OSR1;HOXB4;HOXB3;SULF2;HOXB9;HOXA3;RBP4;HOXC4;DYNC2I1;SULF1;DEAF1;PDGFRA
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.44255692823572484,1.1746660872099062,0.253781512605042,0.9114692244490856,1.0,5/33,9.25%,APPL2;STXBP4;PLK5;PTEN;GLI1
prerank,positive regulation of TOR signaling (GO:0032008),0.43956826827039336,1.17412790648384,0.27344992050874406,0.9118060615571,1.0,17/40,26.94%,FNIP1;GPR137;RICTOR;PIK3CA;FLCN;RPTOR;WDR24;TELO2;RRAGD;LAMTOR1;RRAGB;SLC38A9;SIK3;RRAGC;HTR6;SEC13;GPR137B
prerank,regulation of protein phosphorylation (GO:0001932),-0.28418087674031883,-1.1740258290804937,0.06338028169014084,0.5621971752733088,1.0,71/256,14.30%,SLIT2;LIMCH1;PID1;TEK;BMPER;PRR5L;GRM5;ERBB4;NTRK3;PECAM1;PDE8A;ENG;PLCE1;VEGFC;NPTN;NIBAN1;FN1;EFNA5;SH3GL2;GAS6;CCDC88A;TFRC;NTRK2;KRAS;KDR;LYN;PPP2R5A;TBX1;DAB2IP;PPIA;PAK1;APP;OCLN;CARD14;LIMK2;SEMA4D;CORO1C;CCN1;EPHB2;BMP2;EPHA7;RALB;TGFB1;PTK2;DNAJC10;XDH;FLT4;FNIP2;FGF2;CAMKK2;ERBB2;RAP2A;PDGFA;HSP90AA1;ITGB3;BMP4;FXR1;GPER1;ATF4;FAS;ILK;AXIN1;PINK1;NOP53;VEGFA;FGF7;CCDC88C;FGF9;P2RY1;MT3;TERF2IP
prerank,establishment of protein localization to membrane (GO:0090150),0.3965335521895844,1.1739270155863182,0.2222222222222222,0.9110251882262582,1.0,27/66,24.51%,AFDN;SYNE3;BID;RAB3IP;BRAF;PIKFYVE;RAB11B;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;VPS37A;ARL6;GORASP2;RABGEF1;ZDHHC23;NECTIN3;SDCBP;ZDHHC12;GORASP1;RAB10;ICMT;RAB3GAP1;ATG3;ZDHHC19
prerank,mRNA metabolic process (GO:0016071),0.3760317329121675,1.1738375778342147,0.2225237449118046,0.9098364470914077,1.0,25/90,21.77%,DDX5;PPARGC1A;SON;PCBP2;HNRNPR;SRSF5;TP53;HNRNPA2B1;CNOT10;TBRG4;PRPF18;SRSF11;HIPK3;SCAF11;PRPF3;CPSF3;ALKBH5;USP39;SRSF1;PCF11;U2AF1;DXO;SRSF7;SF3B2;U2AF2
prerank,response to ionizing radiation (GO:0010212),0.39364602123410636,1.1737212635294045,0.2314674735249622,0.9087912565900755,1.0,23/70,20.62%,EYA1;BABAM2;ATM;NHEJ1;TP53;RNF8;XRCC4;SIRT1;BRSK1;UIMC1;HUS1;BABAM1;GADD45A;BRAT1;INTS3;CLK2;INTS7;MAPK14;TANK;MTA1;RAD9A;FANCD2;LIG4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4357096114666474,1.1732542322526918,0.2582781456953642,0.9088747641230226,1.0,11/34,16.87%,RORA;SMAD3;GPS2;TRIB2;WWTR1;SIRT1;LRP3;ANKRD26;FLCN;WNT5A;YAP1
prerank,negative regulation of glycolytic process (GO:0045820),0.5630416384171767,1.173240609623291,0.3115079365079365,0.9060023343322483,1.0,4/10,13.70%,PPARA;NUPR1;HDAC4;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5630416384171767,1.173240609623291,0.3115079365079365,0.9060023343322483,1.0,4/10,13.70%,PPARA;NUPR1;HDAC4;NCOR1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4035623270786775,-1.1730178374161115,0.24934383202099739,0.5636430476302942,1.0,7/29,4.22%,KCNIP4;DPP10;FGF12;DPP6;KCNN2;KCNIP1;KCNAB1
prerank,diterpenoid metabolic process (GO:0016101),0.40526031481380337,1.1726046619872763,0.2372093023255814,0.906802729013594,1.0,11/55,8.24%,ABCA4;NAPEPLD;RBP1;ALDH1A1;AKR1B10;APOM;RHO;DHRS3;PNLIP;RBP4;LRP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.43179499711928826,1.1720872710222563,0.256,0.9070228101479179,1.0,10/40,11.66%,DAB2;SMAD3;TGFBR1;FOXC1;PDPN;WWTR1;TGFBR2;TCF7L2;AXIN2;SNAI1
prerank,negative regulation of transposition (GO:0010529),0.5242064218815766,1.1718954209928543,0.3099099099099099,0.9062331254717819,1.0,5/16,16.29%,UBR2;TUT4;MYBL1;MOV10;TUT7
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5632864966718552,1.1716379938313484,0.3194444444444444,0.9056260284251946,1.0,7/11,17.63%,ENPP3;CTPS2;SLC19A2;THTPA;SLC25A19;NT5C3A;TPK1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4368261018060596,1.1711606264922927,0.2627388535031847,0.9058794786787169,1.0,6/37,9.03%,APPL2;PPARA;TLR4;F2;IL17D;IL17RA
prerank,cellular response to peptide (GO:1901653),-0.34794838856466215,-1.170784055913065,0.1875,0.5683689126533255,1.0,15/56,12.24%,GRM5;CAV1;CACNA2D1;VCAM1;NOD1;ARHGEF2;GSK3B;APP;ICAM1;GRIN2A;PSEN1;ITGA4;RPL23;GPER1;VIM
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3212393390328949,-1.1705610486520646,0.14634146341463414,0.5680575576373995,1.0,32/91,21.99%,ABCG2;SCARA5;SLC39A10;FTH1;HMOX2;TFRC;SLC40A1;APP;FBXL5;FTL;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;ATOX1;SLC30A1;SLC31A1;SLC39A12;MT3;SLC22A17;ISCU;SKP1;GLRX3;CAND1;MT2A;IREB2;SOD1;CYBRD1
prerank,neuron projection extension (GO:1990138),-0.4022963992044686,-1.1699161195148127,0.22077922077922077,0.5687786033014386,1.0,14/32,12.39%,NRP1;MAP1B;NRP2;IQGAP1;SEMA5A;SH3GL2;HSP90AB1;TMEM108;ULK1;ULK2;SLC9A6;HSP90AA1;CTNNB1;LLPH
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5076480649650407,1.1692815761111597,0.2987012987012987,0.9109104341842846,1.0,4/16,16.85%,APPL2;SIRT4;NCOR1;ERLIN2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.531211065130899,-1.1689860328541002,0.2885032537960954,0.5702246312671226,1.0,8/10,45.82%,SMAD7;NFKBIZ;MALT1;RC3H2;IL4;ZC3H12A;FOXP3;TBX21
prerank,regulation of monooxygenase activity (GO:0032768),-0.4199695227631538,-1.1687866364860227,0.24170616113744076,0.5698873553272954,1.0,7/23,14.11%,CAV1;NOS3;NOSTRIN;CALM1;HSP90AA1;SNCA;CYGB
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5265932670868196,1.168785659185249,0.2773851590106007,0.9110465471809229,1.0,1/16,0.70%,LEPROT
prerank,glucose import (GO:0046323),-0.4974348185312704,-1.1686967510813084,0.27429805615550756,0.5692797850586614,1.0,3/13,13.09%,SLC2A1;SORT1;SLC2A3
prerank,pyroptosis (GO:0070269),0.5245111016662518,1.1686690154978314,0.3133208255159475,0.9100253717465505,1.0,1/15,1.39%,GSDME
prerank,regulation of steroid metabolic process (GO:0019218),0.4751725375125081,1.168279593434581,0.26032315978456017,0.9099021884405127,1.0,10/23,23.34%,RORA;RORC;ARV1;TTC39B;EPHX2;LAMTOR1;ABCA2;NR5A1;GNB3;STAR
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.37879034810602064,-1.1682649830341132,0.2154255319148936,0.5695004475480121,1.0,9/39,8.93%,MYO1D;ACTN4;PPFIA2;MYO1B;FNBP1L;TANC2;MYO5A;DYNC1I1;MYO6
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4858092204645741,-1.1682284974594555,0.2771855010660981,0.5687424132703298,1.0,3/13,9.00%,TMSB4X;PSEN1;HEY2
prerank,membrane organization (GO:0061024),-0.2759002889133696,-1.1680124226694881,0.06790123456790123,0.5684565995475975,1.0,43/227,11.04%,SGCZ;DNM3;SPTBN1;HIP1;SGIP1;SYT1;ANK3;ACTB;FNBP1;CERT1;SH3KBP1;FNBP1L;REPS2;RIMS1;REEP1;ATP2C1;STON2;ACTG1;SH3GL2;AGFG1;CCDC88A;TFRC;VAMP4;EPN2;FZD4;ACTR2;LDLR;SH3GLB1;HSPA8;AMPH;CORO1C;DNM1;LPCAT2;GLTP;CHRM2;DYSF;BIN1;AP2B1;PPT1;TRIP10;ACTR3;PDCD6IP;AP2M1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.37963117413572167,1.167342600202672,0.21929824561403508,0.9117367622871414,1.0,17/85,13.91%,DENND4A;NOTCH2;IGF1;ARHGEF18;KANK2;AKAP13;ARHGAP17;SYNGAP1;OPHN1;EPS8L2;CRKL;MAPKAP1;EPS8L1;DENND4C;OGT;MFN2;FLCN
prerank,regulation of cellular component movement (GO:0051270),0.41844287540600883,1.1672201822158212,0.2583732057416268,0.9107162598913595,1.0,12/49,11.77%,TGFBR3;ROCK2;PKHD1;ARHGAP18;TGFBR1;PDPN;NRG1;DIAPH1;ZSWIM8;HBEGF;ABL1;ADAM17
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4785489953590602,-1.1671845538153298,0.27450980392156865,0.5695703972047391,1.0,8/15,22.51%,RPL5;RPS7;SMAD7;RPL23;RPL11;BAG5;BAG2;MAD2L1
prerank,barbed-end actin filament capping (GO:0051016),0.5059154971628069,1.1670614045761982,0.2881679389312977,0.9084124802465746,1.0,4/18,7.26%,ADD3;AVIL;CAPZB;TRIOBP
prerank,actin filament capping (GO:0051693),0.5059154971628069,1.1670614045761982,0.2881679389312977,0.9084124802465746,1.0,4/18,7.26%,ADD3;AVIL;CAPZB;TRIOBP
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.32496016041217324,-1.1664242664496551,0.18292682926829268,0.5705363920931251,1.0,32/80,19.11%,MAP3K5;THBS1;NOD1;GAS6;NGF;TNFSF10;YWHAE;CTSD;EPHA7;SIAH2;ARL6IP1;CD44;GRAMD4;RPS6KA3;GPER1;SOX7;DAPK1;SNCA;RPS6KA1;VEGFA;MT3;CARD16;PPM1F;PAX2;GPX1;SYK;DHCR24;HTRA2;SOX2;BCAP31;FOXL2;CYCS
prerank,extracellular structure organization (GO:0043062),0.34408889842213575,1.1662817870098472,0.18414634146341463,0.909603774550359,1.0,30/204,7.58%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;SPP1;COL18A1;NPNT;COL4A3;LOXL1;ADAMTS2;ADAMTS15;TGFBR1;DAG1;ADAMTSL5;ITGA10;ADAMTS9;COL9A2;COL13A1;COL1A2;FBN1;COL27A1;SERPINE1;COMP
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4866480377290936,1.166232387353095,0.2867012089810017,0.9083489251622137,1.0,3/21,4.03%,ROCK2;ERRFI1;MAFG
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5430280183407753,1.1660864652553269,0.3038461538461538,0.90743005326141,1.0,2/12,2.89%,COLEC12;IFIT1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.3666351796281896,-1.1652054736745618,0.21024258760107817,0.5725949509027787,1.0,16/44,17.54%,THBS1;GAS6;NGF;YWHAE;SIAH2;ARL6IP1;CD44;RPS6KA3;SNCA;RPS6KA1;VEGFA;MT3;CARD16;PAX2;GPX1;DHCR24
prerank,lymphocyte chemotaxis (GO:0048247),-0.39004158720229826,-1.1645980396470297,0.2344139650872818,0.5732715396130803,1.0,11/34,27.26%,CYP7B1;SLC12A2;GAS6;CXCL16;CCL13;CH25H;CCL19;HSD3B7;PIK3CD;CXCL10;CCL2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3042991788662473,-1.1644406361185604,0.1276595744680851,0.5728236641772617,1.0,32/114,24.90%,ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;PSMB2;TNFRSF11A;TRAF5;CARD14;TNFRSF1B;PSMD14;PSMC6;IKBKB;ILK;AIM2;LIMS1;PSMB9;PSMA4;EDAR;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;PYCARD;TXNDC17;PSMA2;MAP3K14;RELA;PSMB3;TNFSF8
prerank,positive regulation of cell development (GO:0010720),-0.39406036253768484,-1.1642725972947578,0.25120772946859904,0.5723574284302213,1.0,9/31,19.31%,PDE3A;SERPINF1;MME;NAP1L1;BMP4;GPER1;CX3CR1;RFX3;TYROBP
prerank,regulation of kinase activity (GO:0043549),-0.32158247405550966,-1.163979851724074,0.1821561338289963,0.5722082278607026,1.0,24/89,13.54%,TEK;ERBB4;NTRK3;EPHB1;ROR1;PLCE1;EPHA5;MERTK;EPHA6;TIE1;NTRK2;KDR;MET;ROR2;EPHB2;EEF1A1;EPHA7;FLT4;CAMKK2;ERBB2;NLRC5;EMP2;MAPT;RET
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4283659672076655,-1.1636215383713755,0.25934065934065936,0.572202742961554,1.0,7/21,14.09%,SLC8A1;MEF2C;BMP2;MYH11;MYOCD;VEGFA;ACVR1
prerank,membrane repolarization during action potential (GO:0086011),-0.49149746600675454,-1.1632751835094395,0.31880733944954126,0.572224382893134,1.0,5/13,7.88%,KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,cellular response to dsRNA (GO:0071359),0.5178432425173964,1.1629459648982885,0.2922794117647059,0.9167093951118047,1.0,2/15,2.89%,COLEC12;IFIT1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.45663044454681023,-1.1627905790888537,0.2691511387163561,0.5725106417121278,1.0,10/19,9.99%,CSGALNACT1;HS6ST2;NDST3;HS6ST3;HS3ST5;EXT1;XYLT1;GLCE;NDST4;EXT2
prerank,regulation of actin filament-based process (GO:0032970),0.3883130565991096,1.1626770742189603,0.2429210134128167,0.9162723129773175,1.0,13/70,8.66%,CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;EZR;PDGFRB;BAIAP2;ARHGAP17;RICTOR;LRP1;HRG
prerank,axon extension (GO:0048675),-0.4163617070656006,-1.1625479756355015,0.2511520737327189,0.5722960074088371,1.0,10/23,10.29%,NRP1;SLIT2;MAP1B;NRP2;SEMA5A;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1
prerank,protein localization to organelle (GO:0033365),0.35686863550335535,1.1624451159470053,0.2179144385026738,0.915583412570656,1.0,21/133,13.90%,BMP7;ANK2;TULP3;ZNF423;OBSL1;CSRP3;CEP250;LRRK2;LAMP2;DDX3X;TRAM2;TIA1;UBAC2;GBP2;IFT122;PIKFYVE;ATP6V1D;DCP1A;ROPN1;WDR35;STX5
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3911904903230994,-1.1623902105327824,0.24205378973105135,0.571830071148112,1.0,16/34,21.80%,NRP1;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR;ILK;DMTN;LIMS1;MYADM;CSPG5;S100A10;RAC3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3265066886518815,1.1622444213536853,0.14857142857142858,0.914904223381164,1.0,43/348,9.92%,FGF1;ROBO1;BMP6;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;PPARGC1A;IGF1;WNT6;PRKN;FOXD1;TNRC6A;MITF;MAGI2;TGFBR1;DTNBP1;TLR3;SMO;CTSH;EZR;CUX2;ATM;TLR4;DDX3X;ARRB1;MAP2K5;BRAF;CD28;TP53;PTPN22;PLSCR1;TNRC6B;CALCOCO1;TLE1;UBR5;CDH5;PICK1;MOV10;LRP3
prerank,regulation of amyloid-beta formation (GO:1902003),0.44301045217874646,1.1619155793266223,0.28183361629881154,0.9145928875313942,1.0,5/34,3.63%,ROCK2;PICALM;IGF1;EPHA4;CASP3
prerank,granulocyte differentiation (GO:0030851),-0.4429745845819444,-1.1619051562725502,0.2885032537960954,0.5721501002515669,1.0,4/18,14.01%,LEF1;CBFA2T3;CDKN1A;TAL1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.45505965133149634,-1.1618107332419167,0.26576576576576577,0.5715571260996694,1.0,4/16,11.38%,CAV1;HS3ST5;TRIM14;TRIM27
prerank,negative regulation of cell projection organization (GO:0031345),0.41924799217228714,1.1617073855950253,0.25961538461538464,0.9138796151547484,1.0,7/48,8.15%,EFNB2;LPAR1;PTPN9;EPHA4;CBFA2T2;PTEN;DENND5A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.48600670667647583,-1.1616881963870833,0.30462184873949577,0.5702078076176261,1.0,3/13,10.39%,STAT3;STAT5B;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),-0.48600670667647583,-1.1616881963870833,0.30462184873949577,0.5702078076176261,1.0,3/13,10.39%,STAT3;STAT5B;JAK1
prerank,neutrophil chemotaxis (GO:0030593),-0.35606050923222643,-1.1604664895198584,0.21893491124260356,0.5722642565855928,1.0,11/53,20.34%,PDE4B;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19
prerank,regulation of peptide hormone secretion (GO:0090276),0.39291884943505756,1.1603123148104126,0.2503725782414307,0.9174158256148381,1.0,12/67,9.42%,CACNA1D;ITPR2;ITPR1;KCNA5;ADRA2A;CACNA1C;RAPGEF3;DPP4;CHD7;GCK;EIPR1;PICK1
prerank,positive regulation of phagocytosis (GO:0050766),-0.36079433795067023,-1.1602589490074244,0.20565552699228792,0.5719272446895914,1.0,12/47,10.78%,PTPRJ;MERTK;GAS6;RAB31;PTPRC;RAB27A;GATA2;CALR;CD47;DOCK2;CYBA;C4B
prerank,regulation of cellular response to heat (GO:1900034),-0.33035101353015395,-1.160026241236241,0.19195046439628483,0.5716654225236282,1.0,32/77,29.27%,CAMK2D;CD34;HSP90AB1;YWHAE;GSK3B;HSPA8;HSP90AA1;NUP210;DNAJC2;MAPT;HSPB8;RPA1;FKBP4;CAMK2B;PTGES3;HSPH1;NUP107;AKT1S1;DNAJB1;POM121;BAG5;BAG2;NUP93;NUP50;NUP85;CCAR2;MLST8;NUP54;HSF1;MAPK3;RPA3;CAMK2A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4662300336843416,1.1596344433904024,0.28028933092224234,0.9169334386520268,1.0,1/23,0.24%,DAB2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4662300336843416,1.1596344433904024,0.28028933092224234,0.9169334386520268,1.0,1/23,0.24%,DAB2
prerank,regulation of cell migration (GO:0030334),0.3199126857933419,1.1588689339141838,0.1425339366515837,0.9182725394250189,1.0,73/382,11.94%,DAB2;FGF1;ROBO1;WNT5B;AFDN;SH3RF2;SYNE2;ROCK2;APPL2;ACE;KIT;LAMC2;IGF1;ZMYND8;SASH1;KIF2A;PLXNA2;RHOD;EPHA4;SPHK1;LMO4;SRGAP3;SRGAP2;PHACTR1;MITF;ARID2;MGAT3;MAGI2;TGFBR1;PDPN;ADRA2A;DAG1;RUFY3;SMO;CTSH;TPM1;ATM;SEMA3B;TBCCD1;SOD2;PDGFRB;LDLRAD4;FLT1;CPNE3;SERPINE1;PTPRU;LDB2;LDB1;PTEN;CCAR1;CDH5;AMOTL2;GTPBP4;MMP14;YTHDF3;SLURP1;ARSB;HBEGF;CYRIB;CARMIL2;TRIP6;FER;SULF1;PIK3R3;CASS4;RNF41;MYLK;PRKCA;DUSP10;VIL1;SNAI1;ADAM17;OSGIN1
prerank,positive regulation of MAPK cascade (GO:0043410),0.3344878188491659,1.1587858904819965,0.1807081807081807,0.9171877404689809,1.0,24/245,6.83%,NOTCH2;FGF1;ROBO1;ROCK2;LPAR1;TPD52L1;KSR1;PRKCZ;KIT;GSDME;IGF1;CCN2;FGFR2;SLC30A10;NPNT;FGFR1;LRRK2;ADRA2A;ARRB1;PDGFRB;BRAF;EPHA8;EIF2AK2;FLT1
prerank,glucan catabolic process (GO:0009251),0.5146459492375126,1.1585866345339724,0.28277153558052437,0.9164516395840587,1.0,4/15,9.21%,PYGM;PHKB;MGAM;PHKG1
prerank,neural tube development (GO:0021915),0.5121660032803456,1.1585059578952555,0.30824372759856633,0.9152998140664464,1.0,1/15,0.31%,ALDH1A2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.47948954417162065,-1.1584152764538467,0.2813141683778234,0.5747338605101804,1.0,4/14,10.25%,THBS1;MEOX2;NOTCH1;STARD13
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4146995034642176,-1.1583752494336859,0.24819277108433735,0.5740261743568212,1.0,8/22,11.07%,AKAP6;RYR2;ATP1B1;VMP1;CALM1;CALM2;CALM3;JPH2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4543383579059347,1.158229686462481,0.2926829268292683,0.9148013782614003,1.0,10/26,18.57%,ERRFI1;SNX6;ADRA2A;HBEGF;ADAM17;GPRC5A;TGFA;BTC;SOCS4;ZGPAT
prerank,histone deubiquitination (GO:0016578),0.49850086741523275,1.1579548163834734,0.3157894736842105,0.9143729253010234,1.0,7/18,20.07%,USP3;UIMC1;USP49;USP7;EPOP;USP21;USP16
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3763341571361837,-1.157907660689531,0.21173469387755103,0.5743951541191075,1.0,18/40,20.91%,PTK2B;RPL5;RPS7;XPO1;PTK2;GNA12;RPL23;RAD23B;FOXF2;AXIN1;LAPTM5;SMURF1;CLU;HIPK2;UBE3A;PDCL3;COMMD1;RPL11
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4798319872532288,1.1576959452564342,0.3065953654188948,0.9138046146020472,1.0,9/23,22.49%,NMT2;METAP2;RHO;FNTB;SAG;FNTA;GRK4;PDE6B;CAMKMT
prerank,positive regulation of response to wounding (GO:1903036),-0.41533446590530043,-1.1576664790841324,0.2757009345794392,0.5741298379240103,1.0,8/24,13.15%,ACTG1;ANXA1;OCLN;ITGB1;PTK2;SCARF1;PTN;DMTN
prerank,positive regulation of type I interferon production (GO:0032481),0.38153524174416226,1.157064920568707,0.23391812865497075,0.9145614903836271,1.0,20/73,15.67%,OAS2;TLR3;RNF135;TLR4;TRIM56;DDX3X;PTPN22;RIPK2;MAVS;TOMM70;DHX58;PRKDC;IRF1;PTPN11;POLR3A;DHX33;OAS3;NFKB1;STAT6;CREBBP
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.3431205163643812,-1.1566746004301829,0.19390581717451524,0.5756547202912506,1.0,11/53,15.95%,CALCRL;CHRM3;HTR2C;ANXA1;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.47450213688154363,1.1558518879578334,0.2920353982300885,0.9172730369003622,1.0,8/24,9.50%,ARHGAP28;CGNL1;ARHGEF18;CLASP1;ARHGAP6;PPFIA1;RHPN2;PHLDB2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.44147637213716906,-1.1556617155457953,0.25910064239828695,0.577260654256873,1.0,9/21,9.99%,HS6ST2;NDST3;HS6ST3;HS3ST4;HS3ST5;EXT1;XYLT1;GLCE;EXT2
prerank,DNA methylation or demethylation (GO:0044728),0.49132999088862883,1.1555240801051065,0.29895104895104896,0.9156028152154376,1.0,7/19,17.48%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,DNA alkylation (GO:0006305),0.49132999088862883,1.1555240801051065,0.29895104895104896,0.9156028152154376,1.0,7/19,17.48%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3653366372612846,-1.1554757375114282,0.2159383033419023,0.5768586555379857,1.0,12/39,7.82%,ROBO2;MAML2;NOS3;TGFB2;STAT3;CCN3;NOTCH1;JAG1;IL6ST;EPN2;TSPAN14;JAG2
prerank,cellular response to amino acid starvation (GO:0034198),0.39079340643547283,1.1554181127361578,0.2627627627627628,0.914581263959951,1.0,17/71,15.80%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;EIF2AK2;ATP6V0B;ATP6V1D;ATF2;ATP6V1E1;IMPACT;FLCN;KPTN;DEPDC5;RPTOR;WDR24
prerank,maturation of SSU-rRNA (GO:0030490),-0.38381736106558106,-1.155318351843593,0.23622047244094488,0.5763976141522981,1.0,5/34,8.66%,RPS8;RPS19;RPS28;RPS16;WDR3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3671323007208498,1.1552913346647629,0.22315202231520223,0.9136349546385197,1.0,10/107,3.58%,ATP13A5;SLC41A1;SLC24A3;ANK2;ATP13A3;SLC8A3;SLC30A10;PKHD1;CSRP3;DMPK
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3846336613171577,-1.1552206762638728,0.22,0.5758206179333182,1.0,13/33,13.85%,BMPER;SEMA6A;RHOJ;THBS1;PPP1R16B;EPN2;KLF2;SMAD1;CEACAM1;FGF2;JAK1;CREB3L1;VEGFA
prerank,secretory granule organization (GO:0033363),0.5581080886794916,1.1548204884284703,0.3138401559454191,0.9137647833009421,1.0,5/10,22.82%,DTNBP1;SRGN;BLOC1S2;VPS33B;LYST
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.37556383604502896,1.154449334003452,0.22425952045133993,0.9136152950603003,1.0,18/87,11.98%,TGFBR3;SMAD3;APPL2;PRKCZ;ARHGEF18;BMPR1A;TGFBR1;SMAD6;FMOD;USP9X;COL1A2;TWSG1;TGFBR2;CDH5;SIRT1;ZMIZ1;ZMIZ2;GDF15
prerank,inorganic cation import across plasma membrane (GO:0098659),0.38643052153822166,1.1541056796818099,0.2474074074074074,0.9134721203527042,1.0,5/75,2.03%,ATP1A2;SLC6A1;ATP1B3;KCNJ13;SLC8A3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3201800752241769,-1.1540442881013158,0.17350157728706625,0.5777568323767777,1.0,17/80,10.31%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L;PLCE1;CCDC88A;CDC42EP3;ACTR2;OCLN;TGFB3;ANLN;PLPPR5;AGRN;P2RY12;EPS8;ACTR3
prerank,gland development (GO:0048732),0.3963523644290798,1.1534513391476635,0.25656877897990726,0.9143743956274222,1.0,9/59,8.66%,TGFBR3;WNT4;FGFR2;GLI2;DKK3;TGFBR1;EZR;CDK5RAP3;NRG1
prerank,focal adhesion assembly (GO:0048041),0.48023123255089567,1.1534473842465989,0.2814070351758794,0.9130058453443418,1.0,3/21,2.10%,ACTN2;SORBS1;RHOD
prerank,response to cytokine (GO:0034097),0.34573056258095597,1.1532914619871375,0.23150684931506849,0.9121623416054563,1.0,24/141,12.70%,ALDH1A2;PTPN13;SMAD3;TIMP3;PTPN14;AFF3;PTPN9;SPHK1;NFAT5;CASP3;IKBKE;TRIM56;PTPN23;EIF2AK2;PLSCR1;MAPKAPK3;HDAC4;RIPK1;CD274;PRKCA;PTPN4;PTPN11;FOXA2;NUB1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3991967797909496,1.1530253966673116,0.25688073394495414,0.9117176780624376,1.0,17/59,14.49%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;PRKCA;CSNK2A2;CSNK2A1;HIPK3;MAP2K1;WNK1;CAD;ACVR1B
prerank,regulation of extracellular matrix organization (GO:1903053),0.5133331648413787,1.152387380077398,0.31784386617100374,0.9124193198835094,1.0,1/15,0.11%,AEBP1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4447370719316393,1.1523580014820658,0.3129370629370629,0.9111838840415654,1.0,3/27,1.32%,SYT9;SYT11;SYT12
prerank,regulation of endocytic recycling (GO:2001135),0.5423072312021198,1.152233001301909,0.32342007434944237,0.9102480376991816,1.0,3/11,10.37%,ACTN2;EIPR1;RAB11B
prerank,positive regulation of ossification (GO:0045778),0.42923638244739454,1.1515590381237883,0.2915980230642504,0.9112384074785268,1.0,6/39,3.17%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4758056228854701,1.1513448016428662,0.2949640287769784,0.9106002889990983,1.0,2/22,1.51%,MAN1A2;MAN1C1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.48422469075345,-1.1509154498589376,0.30405405405405406,0.584462547142356,1.0,3/13,10.29%,NLGN1;P2RY12;EPS8
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.35840865771068364,-1.1502273733912942,0.2268041237113402,0.5853011430336117,1.0,14/47,20.89%,GRM5;NFKBIA;APP;APOE;AGTR1;TGFB1;EDN1;EDNRB;EIF4E;PUM3;INHBA;AGT;RBM4B;RBM3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.36092909616868074,-1.1501753756296085,0.2064343163538874,0.5846187034160972,1.0,13/47,8.80%,NRP1;ACTN4;EFNA5;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;CORO1C;MYOC;CALR;PTK2
prerank,programmed necrotic cell death (GO:0097300),0.49688089786493883,1.1501056097647864,0.31970260223048325,0.9133778426688179,1.0,5/18,10.38%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4689423978831005,1.1499342432359265,0.30601092896174864,0.9126274168110791,1.0,6/21,15.25%,IGF1;CTSH;ITGAV;MAP2K1;MAP2K2;ZFP36L1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4933383894356723,1.1497828541809854,0.3102189781021898,0.9118144203102588,1.0,1/17,0.82%,LPGAT1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4939314885477096,1.149251030211555,0.2992831541218638,0.912268974879549,1.0,6/18,17.96%,PPARA;PTPN22;MIA3;WNK1;GPNMB;LAX1
prerank,activation of adenylate cyclase activity (GO:0007190),0.4433302856457176,1.1491698945358975,0.29152542372881357,0.9112249107524595,1.0,3/35,2.01%,ADCY5;LGR4;ADCY1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4986423753572511,1.148620370885853,0.2990990990990991,0.911796536300209,1.0,2/17,0.54%,ROBO1;EFNB2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3668888428059423,-1.1485817797076374,0.23421052631578948,0.587627685916276,1.0,7/38,6.18%,BMP5;NOS3;THBS1;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,response to cholesterol (GO:0070723),0.506520553958196,1.1484542244406948,0.3106060606060606,0.9109881126878427,1.0,4/17,7.47%,GRAMD1B;TGFBR1;SMO;TGFBR2
prerank,defense response to virus (GO:0051607),0.36427070528471356,1.148330103904256,0.23055162659123055,0.910089163662085,1.0,23/100,14.68%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;RNF135;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MOV10;MAVS;ATG7;ZDHHC1;IRF1;AKAP1;OAS3;ACOD1;IFNAR2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.34248631034691174,1.1480788969258529,0.20098643649815043,0.9096381152756599,1.0,25/166,10.02%,SMAD3;LPGAT1;SORBS1;PPARGC1A;IGF1;SMOC2;GLI2;LARP4B;DUOXA1;SLC6A9;TLR4;DDX3X;PDGFRB;CD28;POLDIP3;SLC27A1;GCK;SAMD4A;LDB1;PAOX;CPEB3;GLI1;SIRT1;SLC45A3;YTHDF3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.467051318815062,-1.1480573707998445,0.2807017543859649,0.5880310390167799,1.0,5/13,27.70%,RPS21;ABT1;RRS1;NOL9;KRI1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5109347177596234,1.1477484376571168,0.3138401559454191,0.9093793430440267,1.0,5/14,17.33%,OXSR1;ADAM17;WNK1;WNT5A;CCR2
prerank,Notch signaling involved in heart development (GO:0061314),0.5472512996352004,1.1477304420975378,0.32954545454545453,0.9081295266542793,1.0,1/11,0.19%,NOTCH2
prerank,spliceosomal complex assembly (GO:0000245),0.41575792671187106,1.1473476215510943,0.27899686520376177,0.9080499013224737,1.0,12/46,21.35%,CELF2;SRSF5;KHDC4;LUC7L3;SRPK2;SCAF11;USP39;SRSF1;PRPF6;SRSF10;SF1;SF3B1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.4155393081722808,-1.147145637325077,0.2843601895734597,0.589415838029234,1.0,9/24,14.22%,NOTCH1;KLF2;HSPA5;ATF4;HIF1A;CREB3L1;GCN1;VEGFA;MT3
prerank,aortic valve morphogenesis (GO:0003180),-0.386037320135933,-1.1467204190844644,0.24390243902439024,0.5896952769803329,1.0,12/30,10.83%,SLIT2;ROBO2;ELN;NOS3;TIE1;NOTCH1;JAG1;NFATC1;HEYL;TGFB1;HEY2;BMP4
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.49752896983226386,-1.1465867044670113,0.294,0.5891822535216131,1.0,4/12,4.45%,SYT1;RIMS2;RIMS1;UNC13B
prerank,cellular component assembly (GO:0022607),-0.2714397692285644,-1.1461810598183444,0.11949685534591195,0.589429443293605,1.0,51/253,13.21%,NLGN1;SPTBN1;RHOJ;SLC2A1;GSN;ANK3;ACTB;MYO1B;REPS2;RIMS1;RTN4;PARVB;IL1RAP;LIN7A;PCLO;PTK2B;LRRTM3;ACTG1;GAS6;SKAP2;VMP1;GPM6B;PLS1;OCLN;FLNA;LIMA1;HES1;DCX;CD2AP;LIMS2;PPP2R1A;ELOB;TGFB1;TUBGCP2;RP1;RHOH;ARL6IP1;SHROOM1;ADD2;PDGFA;EPS8;CAPZA2;CLDN14;FAM107A;CALD1;FAS;ILK;SPEF1;LPXN;DMTN;MDN1
prerank,regulation of synapse organization (GO:0050807),-0.40208887799022053,-1.1458036524263038,0.28,0.5894724411773389,1.0,4/26,4.02%,CTNNA2;MEF2C;IL1RAPL1;CDKL5
prerank,bicellular tight junction assembly (GO:0070830),0.41369388933837103,1.1457391557345498,0.2779552715654952,0.9120524190746753,1.0,3/46,1.68%,PARD6G;AFDN;DLG1
prerank,cell-substrate junction assembly (GO:0007044),0.44315183989154844,1.1455476207355442,0.29064039408866993,0.9113226973557255,1.0,5/33,2.10%,ACTN2;SORBS1;LAMC2;LAMC1;RHOD
prerank,hyaluronan catabolic process (GO:0030214),-0.4431036574412148,-1.1454966341620265,0.2857142857142857,0.5893582183232932,1.0,5/18,9.82%,CEMIP;HEXB;TGFB1;FGF2;CD44
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.5063214094461607,-1.1451948010001405,0.30628803245436104,0.5892889302251942,1.0,7/10,39.14%,CCT2;CCT8;CCT6A;CCT7;DKC1;CCT3;CCT5
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.516318682101369,1.1451395101674469,0.3159851301115242,0.911325073694817,1.0,3/14,7.15%,PRKN;LRRK2;OPA1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.48792562964539143,1.145051854512329,0.3225225225225225,0.9102919850318147,1.0,3/20,4.60%,ATP1A2;ANK2;CACNA1C
prerank,protein oxidation (GO:0018158),0.5480547884584723,1.144945882785849,0.3090909090909091,0.9092915130746055,1.0,2/11,4.22%,LOXL1;LOXL3
prerank,positive regulation of signal transduction (GO:0009967),0.3292429635841221,1.1449406854703739,0.2091020910209102,0.9079995516088103,1.0,27/238,5.78%,FGF1;ROBO1;BMP6;RSPO2;WLS;TSPAN5;SORBS1;TPD52L1;PRKCZ;IGF1;SMOC2;SASH1;FGFR2;DCDC2;NLGN2;PHIP;TTC23;TGFBR1;AAK1;LRRK2;SULF2;LOXL3;PRKCB;SMO;CUX2;RAB34;GPS2
prerank,external encapsulating structure organization (GO:0045229),0.3368168503350393,1.1444791036112285,0.211864406779661,0.9082022208224209,1.0,29/205,7.58%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;SPP1;COL18A1;NPNT;COL4A3;LOXL1;ADAMTS2;ADAMTS15;DAG1;ADAMTSL5;ITGA10;ADAMTS9;COL9A2;COL13A1;COL1A2;FBN1;COL27A1;SERPINE1;COMP
prerank,central nervous system neuron development (GO:0021954),-0.4674939883365372,-1.1443657853244578,0.30284552845528456,0.5904056152468302,1.0,6/15,12.71%,NTRK2;HSP90AB1;LHX6;B4GALT5;HSP90AA1;MAPT
prerank,positive regulation of response to external stimulus (GO:0032103),0.3521653541394052,1.143429279834778,0.2297476759628154,0.910432369512315,1.0,24/128,14.01%,BMP6;SASH1;IL18;NAPEPLD;TLR3;TLR4;F2;IFNK;PDGFRB;ANKRD17;IL12B;SERPINE1;PLSCR1;GPRC5B;HRG;IL17RA;DDX60;RIPK1;LY96;DHX58;PRKCA;NMI;IFI35;ACOD1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.49993753920405826,1.143201468767078,0.3112701252236136,0.9098596000267245,1.0,7/16,26.94%,GPR137;FLCN;TELO2;RRAGD;RRAGB;SIK3;GPR137B
prerank,response to peptide (GO:1901652),-0.3775782134137047,-1.1430834544996682,0.2558139534883721,0.5927507248802115,1.0,14/33,26.82%,STAT3;ANXA1;CACNA1B;GNAI1;STAT5B;ERBIN;EIF2B3;CHRNA7;NOD2;IRF5;IRS1;FYN;STAT4;EIF2B2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4204602127911982,-1.1425139052373232,0.3039647577092511,0.593365050182375,1.0,7/21,11.71%,MEF2C;HSP90AB1;CALM1;CALM2;BMP2;CALM3;MTMR9
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.42518625106680835,-1.1424220053180052,0.2938388625592417,0.5927839192563309,1.0,7/21,16.28%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;SPEF1;APC
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4824968501409229,1.142013883590177,0.3181019332161687,0.9124352563739375,1.0,7/19,9.25%,TGFBR3;FGFR2;BMPR1A;TGFBR1;VGLL4;RBP4;GLI1
prerank,intestinal lipid absorption (GO:0098856),-0.5046129505365377,-1.1418833189714592,0.2890792291220557,0.593210686523019,1.0,3/11,6.54%,UGCG;LIMA1;LDLR
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.386853645679223,1.1418129196783053,0.27314814814814814,0.9117815449591626,1.0,7/66,3.96%,ROBO1;TGFBR3;FGFR2;MCC;NUPR1;NR2F2;NFIB
prerank,membrane depolarization during action potential (GO:0086010),0.4609046041848173,1.1418119394475703,0.3063063063063063,0.9104761863648605,1.0,3/26,4.60%,ATP1A2;CACNA1D;CACNA1C
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5042726584059686,-1.1416350452752855,0.30416666666666664,0.5930053532214545,1.0,4/10,15.91%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,regulation of cellular catabolic process (GO:0031329),0.3875850180819688,1.1413752245035473,0.2671532846715328,0.9106163941930625,1.0,23/62,23.01%,ITPR1;PRKN;MTMR3;NUPR1;GPR137;LRRK2;ATM;WDR41;PIP4K2C;ABL1;DEPDC5;RPTOR;WDR24;WDR91;RRAGD;TYSND1;USP33;TPCN2;MTMR4;RMC1;CISD2;BOK;EP300
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5036306554652739,-1.141234214595504,0.3171247357293869,0.5931954415219247,1.0,3/11,12.07%,CAV1;FOXO1;FAS
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5281246883415949,1.1408726251858474,0.3302238805970149,0.9109678488651402,1.0,3/12,3.96%,GLI2;EPHA4;NFIB
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4434395266712958,1.1406275217071196,0.3093645484949833,0.9104367655244409,1.0,2/29,1.42%,NOTCH2;IGF1
prerank,regulation of T cell cytokine production (GO:0002724),-0.4602032387172865,-1.1404758213729658,0.27941176470588236,0.594167949662094,1.0,4/15,9.08%,B2M;MAP3K7;TNFRSF1B;SMAD7
prerank,regulation of developmental growth (GO:0048638),-0.3954930820736444,-1.1396670272729206,0.2683544303797468,0.5952387292955504,1.0,10/29,14.68%,GHR;GSK3B;APP;APOE;NRCAM;SIX1;STAT5B;MFSD2A;SPAAR;FGFR3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.38178345003232755,-1.1387907207954742,0.2769607843137255,0.5965252077068974,1.0,8/35,6.44%,GHR;ERBB4;CAV1;NOTCH1;CYP1B1;NLK;PTPRC;HES1
prerank,negative regulation of signal transduction (GO:0009968),0.32779912270310974,1.1386342110105103,0.20921985815602837,0.9155831746745038,1.0,46/249,11.98%,WWOX;LGR4;LEPROT;RNF43;NXN;TULP3;PRKCZ;KANK2;DKK3;TRABD2B;GLI3;SUFU;APCDD1;LRRK2;CXXC4;NEDD4;SULF2;VGLL4;CYP26B1;PRKCB;TNS2;ARRB1;GPS2;IL12B;MGRN1;APLN;PIP4K2C;PTEN;IGFBP3;LRP1;BTRC;IFT122;HRG;TLE1;NIBAN2;GRB10;CBY1;MMP14;PHACTR4;SULF1;TRIB1;CNMD;CSNK2A2;CSNK2A1;WWP2;GDF15
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4185657792755492,1.1385151683134362,0.2988871224165342,0.9147059580845288,1.0,8/40,9.43%,LPAR1;KIT;LPAR2;FGFR1;ARHGAP6;PDGFRB;FLT1;NMUR1
prerank,regulation of cell projection organization (GO:0031344),-0.46852604858030017,-1.137802476879488,0.31666666666666665,0.5980902986917388,1.0,5/13,20.34%,NTNG1;SEMA4D;MFSD2A;ERMN;CCL19
prerank,protein tetramerization (GO:0051262),0.3911120547400661,1.1375768483174131,0.2723076923076923,0.916503319016897,1.0,9/67,10.04%,ALDH1A2;APPL2;UPB1;KRT1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,lipid homeostasis (GO:0055088),0.3915976663085117,1.1372845401488896,0.2671875,0.9160766103211831,1.0,11/57,13.10%,PRKAA2;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;ADCK1;SIRT1;ACOXL;MLXIPL;ACOX3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.48998734415126627,1.13720392345031,0.3406998158379374,0.9150629890152199,1.0,2/17,1.93%,ANK2;SNTA1
prerank,positive regulation of programmed cell death (GO:0043068),-0.26911825059455036,-1.1370553242254273,0.09550561797752809,0.5990819852742142,1.0,94/272,23.31%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;RASGRF2;ARHGEF3;APAF1;CSRNP3;RPS6;NGF;UNC13B;ARHGEF9;ARHGEF7;TRIO;NET1;CYP1B1;TNFSF10;ARHGEF2;DAB2IP;TIAM1;SFRP4;CTSD;ARHGEF17;RHOB;TGFB3;RYBP;FOXO1;ITGB1;PSEN1;BMP2;BIN1;PLEKHG5;AIFM1;ARHGEF26;RPS6KA2;FRZB;BMP4;GPER1;ATF4;CTNNB1;FAS;DAPK1;SNCA;SUDS3;GADD45G;LAPTM5;KLF11;CLU;UBB;CRADD;PHLDA3;APC;TOP2A;DNAJA1;VAV1;DIABLO;IAPP;RNPS1;SCRIB;SYK;CASP2;BARD1;APH1A;HTRA2;IRF5;STPG1;HIP1R;FOXL2;PHLDA1;RNF122;BCL2L11;PNMA2;DCUN1D3;GADD45B;ECT2;CALHM2;PREX1;DAPK2;TIAM2;MAP3K11;BNIP3;PYCARD;MCF2;SOD1;FGD3;SOS1;UBC;RPS27A;TFAP4;PRR7;SFRP1
prerank,positive regulation of apoptotic process (GO:0043065),-0.26508087732014307,-1.1370337896886396,0.11976047904191617,0.598309323079747,1.0,95/293,21.55%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;RASGRF2;TGFB2;ARHGEF3;APAF1;CSRNP3;FAP;RPS6;PTGIS;NGF;UNC13B;ARHGEF9;ARHGEF7;TRIO;NET1;CYP1B1;TNFSF10;ARHGEF2;DAB2IP;TIAM1;SFRP4;RPS3;CTSD;ARHGEF17;RHOB;TGFB3;RYBP;FOXO1;ITGB1;PSEN1;BMP2;BIN1;EPHA7;BTG1;PLEKHG5;AIFM1;ARHGEF26;RPS6KA2;FRZB;BMP4;GPER1;ATF4;CTNNB1;FAS;DAPK1;SNCA;SUDS3;GADD45G;CDK5R1;KLF11;CLU;UBB;CRADD;PHLDA3;APC;MYBBP1A;TOP2A;DNAJA1;VAV1;DIABLO;IAPP;RNPS1;SCRIB;CASP2;BARD1;APH1A;HTRA2;IRF5;STPG1;HIP1R;FOXL2;PHLDA1;RNF122;BCL2L11;PNMA2;DCUN1D3;GADD45B;ECT2;PTRH2;SIRT2;CALHM2;PREX1;DAPK2;TIAM2;MAP3K11;BNIP3;PYCARD;MCF2;SOD1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4898223535014004,1.136987587345684,0.31970260223048325,0.9145444048013579,1.0,6/19,16.48%,POLD2;AMPD3;TERT;AMPD2;POLL;APRT
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5393533918802662,1.1368655924944948,0.31368821292775667,0.9136308079810203,1.0,3/12,10.43%,FYCO1;UVRAG;IRGM
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3438221142617826,1.1362920206487668,0.22457067371202113,0.9141563752360752,1.0,21/161,9.96%,DAB2;TMEM64;LRP4;BICC1;MCC;PRKN;DKK3;GLI3;LZTS2;APC2;WWTR1;UBAC2;PTPRU;TCF7L2;CSNK1A1;TLE1;HDAC1;TMEM170B;GLI1;INVS;SOX13
prerank,positive regulation of cell death (GO:0010942),0.3968852626535821,1.1360342334298628,0.28093158660844253,0.9137277492950407,1.0,10/59,11.52%,SLC6A13;EFNB2;PICALM;PRODH;LRRK2;LRP1;RIPK1;RIPK2;RARG;AXIN2
prerank,hemopoiesis (GO:0030097),0.36656762429563994,1.1359039760572276,0.2699300699300699,0.9128863345336705,1.0,13/87,7.47%,NOTCH2;TGFBR3;KIT;KMT2A;FGFR2;ZNF160;MEIS1;TET2;PGM3;TP53;FLT1;FUT10;TGFBR2
prerank,lysosome organization (GO:0007040),0.42885417232504425,1.1358302010694976,0.3069139966273187,0.9118980743035313,1.0,13/36,21.38%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;TPCN2;LAMTOR1;SNAPIN
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.43577539985162955,-1.1357753777879687,0.2964509394572025,0.6005532173245589,1.0,8/19,15.95%,PLCE1;PPP3R1;NFATC1;PPP3CA;EDN1;EDN3;PPP3CC;HRH1
prerank,protein K11-linked ubiquitination (GO:0070979),0.4518203535763248,1.1356977145295217,0.2910714285714286,0.9110820978005791,1.0,3/27,5.98%,UBE2E2;PRKN;ANAPC2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.4553409000101492,-1.1352107834858525,0.2832618025751073,0.6010299225685407,1.0,7/15,22.36%,RTN4;REEP1;RAB18;ARL6IP1;ATL2;RTN3;REEP3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4480994964477438,1.1351311299046434,0.2917369308600337,0.9115597762633759,1.0,11/25,24.89%,IGF1;NSD1;NIBAN2;SIN3A;PER2;DOT1L;RB1;POU4F1;MSX2;MAD2L2;H1-0
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4425990003796152,-1.1347526231467129,0.2811158798283262,0.6005423346227553,1.0,6/17,21.82%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),-0.4425990003796152,-1.1347526231467129,0.2811158798283262,0.6005423346227553,1.0,6/17,21.82%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5352445982813377,1.1346909694590481,0.34594594594594597,0.9104719541484173,1.0,6/11,26.22%,TNRC6A;TNRC6C;RBM4;AGO1;AGO2;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5352445982813377,1.1346909694590481,0.34594594594594597,0.9104719541484173,1.0,6/11,26.22%,TNRC6A;TNRC6C;RBM4;AGO1;AGO2;AGO4
prerank,regulation of cholesterol efflux (GO:0010874),-0.3889857969254396,-1.1343471228732065,0.30256410256410254,0.6007137950101372,1.0,7/30,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;SREBF2;EEPD1
prerank,plasma membrane organization (GO:0007009),0.3896539696507646,1.1343208922516015,0.2631578947368421,0.9104550353342031,1.0,12/61,11.42%,COL5A1;ANK2;SYT11;MYOF;FER1L5;ANO6;PLSCR1;TLCD2;PLSCR2;BIN3;A4GALT;ARV1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.30115444943741143,-1.1342165142003244,0.16044776119402984,0.6002438974540648,1.0,25/110,15.14%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;ADCY7;GNG2;RAMP2;ADCY4;S1PR1;LGR5;GPER1;PTH1R;PTHLH;RAMP1;ADGRB1;GPR26;ADGRG1;GNB1;GNAL
prerank,sensory perception of smell (GO:0007608),-0.49070571064423163,-1.133867115777645,0.3458333333333333,0.6002906528213878,1.0,4/11,21.03%,UBR3;ADCY3;SYT10;DRD2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3243770668838208,-1.133576910749001,0.24675324675324675,0.6002435746952665,1.0,20/75,13.71%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;THBS1;DCN;TGFB2;COL4A2;SEMA3E;DAB2IP;SERPINF1;STAB1;HSPG2;AMOT;ATP2B4;CTNNB1;ISM1;ECSCR;ADGRB1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.34349708255192923,-1.1335220669349841,0.24157303370786518,0.5995708828898837,1.0,23/55,36.03%,FBXL7;PSMB2;PSMD14;PSMC6;ATF5;PSMB9;PSMA4;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;FHL1;PSMB3;PSMB5;PSMD7;PSMF1;AURKA;PSMA5;PSME4;PSMA7;PSMD3;PSMD4
prerank,regulation of microtubule-based process (GO:0032886),-0.3698506076016106,-1.1333955120011197,0.2696335078534031,0.5990352990453682,1.0,14/36,17.34%,CLASP2;EFNA5;PHLDB1;GSK3B;MAP6;ERBB2;MARK2;FAM107A;TRIM36;MAPT;BICD2;ATF5;APC;TPPP
prerank,androgen metabolic process (GO:0008209),0.48711948590622145,1.1330301614568627,0.33458646616541354,0.9135114643479743,1.0,3/18,17.43%,SPP1;SRD5A2;MED1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4740862857625701,-1.1329141289073146,0.2943722943722944,0.5993912761506491,1.0,5/13,10.52%,NFKBIA;YWHAB;FLNA;GOPC;PKD1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3149449416278544,-1.1328941059736983,0.22142857142857142,0.5986347855528235,1.0,34/92,15.09%,NRP1;TEK;BMPR2;RTN4;THBS1;CLASP2;NRP2;TGFB2;PTK2B;SCARB1;EPB41L4B;KDR;DOCK1;GPI;IQSEC1;FOXP1;PLCG2;RHOB;PROX1;ATOH8;CALR;FLT4;FGF2;ITGB3;BCAR1;EDN1;ENPP2;BMP4;PRKD1;HIF1A;VEGFA;FGF7;PPM1F;RRAS
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3313124779852775,1.1323566651849402,0.21895006402048656,0.9143592825025424,1.0,31/199,10.04%,ROBO1;LGR4;ROCK2;LRP4;LAMA4;SYT11;MCC;ZNF423;ALDH1A1;NPR3;NFIB;PCTP;SMAD6;APOM;SRGN;TLR4;SFMBT1;IL17D;WWC2;PTPN23;LDLRAD4;TWSG1;PTEN;ADM;SLC6A4;NOVA1;ACOT11;CHSY1;DOCK7;SPX;FOXC2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3751964214823983,-1.1323175327233013,0.2849740932642487,0.5991306628044895,1.0,8/33,10.17%,PDE3B;TGFB2;ACER2;NEXMIF;CYP1B1;LYN;PTK2;P2RY12
prerank,regulation of muscle contraction (GO:0006937),0.4412278589142273,1.132279829887593,0.3003472222222222,0.9133393589384855,1.0,2/26,5.04%,ATP1A2;TPM1
prerank,negative regulation of growth (GO:0045926),-0.29247166701664495,-1.131838362318051,0.1897810218978102,0.5994878616139285,1.0,29/121,10.64%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;TGFB2;CCN3;ACVRL1;NOTCH1;SOX17;ADAM15;PPP2R1A;SH3BP4;ENPP1;RERG;TGFB1;SERTAD2;BTG1;PNPT1;PPT1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;FRZB
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.35966149918516493,1.131825811578099,0.2590975254730713,0.9135889133791695,1.0,14/95,6.97%,HS3ST3A1;UST;HS3ST3B1;OGN;NDST1;CHST15;CHST11;HS2ST1;HS3ST6;ST3GAL3;FMOD;B4GALT1;DSE;PXYLP1
prerank,regulation of establishment of protein localization (GO:0070201),-0.480530661882958,-1.1317222664908777,0.3225806451612903,0.5989947549178795,1.0,5/13,16.57%,CORO2B;CTSD;GAPVD1;PTP4A3;DNAJA1
prerank,long-chain fatty acid import into cell (GO:0044539),0.5419208826520132,1.1306653313341466,0.344106463878327,0.91625550724755,1.0,3/10,9.90%,ACSL1;SLC27A1;SPX
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.34558939649292897,-1.1306532771883773,0.26536312849162014,0.6009078714677284,1.0,11/51,15.36%,THBS1;VEGFC;CXCL12;GAS6;CALR;PTK2;PTN;EDN3;CMKLR1;VEGFA;RARRES2
prerank,cation transport (GO:0006812),0.33716238033105433,1.1305100479771715,0.23918575063613232,0.9154906313159354,1.0,16/167,7.79%,TRPM3;ATP1A2;SLC41A1;KCNJ13;TRPM6;SLC5A5;KCND3;KCNA5;SLC8A3;SLC22A18;SLC6A9;KCNS1;SLC5A8;TRPM5;ANO6;KCNH4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4171913104005731,-1.130041631864312,0.28227571115973743,0.6016067526323294,1.0,10/24,17.27%,PTK2B;APOE;CTSC;PSMD14;PKD1;PINK1;UBB;GPX1;UBE3A;USP14
prerank,response to amyloid-beta (GO:1904645),-0.3525796330831332,-1.1298603382519983,0.25984251968503935,0.6012687419365726,1.0,10/44,7.45%,GRM5;CACNA2D1;VCAM1;GSK3B;APP;ICAM1;CACNA1B;GRIN2A;PSEN1;ITGA4
prerank,serine family amino acid metabolic process (GO:0009069),0.49241686955545705,1.129751190149637,0.3481349911190053,0.9167256315419519,1.0,7/16,25.89%,SRR;CTH;SEPSECS;MTHFD1;THNSL2;CBS;CDO1
prerank,mitochondrion morphogenesis (GO:0070584),-0.5036846018454739,-1.1296178771831686,0.3326488706365503,0.6010487762801935,1.0,3/11,16.03%,PID1;PNPT1;WASF1
prerank,cellular respiration (GO:0045333),0.41208305091262504,1.129355842678934,0.3023255813953488,0.9167715120350319,1.0,14/41,19.38%,PPARGC1A;SIRT3;MTFR2;COQ10A;UQCRC2;NDUFS1;COX10;LYRM7;SDHAF4;ATP5F1D;SDHB;UQCRC1;NDUFS4;ETFDH
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3813266256233777,-1.1284191858015997,0.2584541062801932,0.6031843995383613,1.0,8/30,11.39%,SPTBN1;ANK3;RAB31;VAMP4;PREPL;NSF;GCC2;GOLGA7
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.35758082671073427,1.128379935383525,0.2664756446991404,0.9187048013069042,1.0,36/100,22.58%,DAB2;SH3RF2;FHIT;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;ARAF;TRIB1;GLMN;USP7;NUB1;OGT;DESI1;ZYG11B;DNAJB2;RNF19B;HECTD1;TLK2;ARIH1;HFE;TAF1;SUMO1;ZER1;GSK3A;USP5;ANKIB1;SDCBP;CAMLG;TRIM39;ARIH2;BAG6
prerank,lipid droplet organization (GO:0034389),-0.41519790541584534,-1.128198561161066,0.26744186046511625,0.60291299730381,1.0,8/22,28.25%,PPIA;RAB18;PNPLA3;CDS1;SQLE;AUP1;CDS2;FAF2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.413558815960019,-1.127872558444613,0.2840909090909091,0.6028139065257393,1.0,8/21,10.98%,LIMCH1;EFNA5;PEAK1;ACTG1;GPM6B;CORO1C;PTK2;DUSP3
prerank,synaptic vesicle endocytosis (GO:0048488),0.4325844246402687,1.1277471808536905,0.330550918196995,0.9195361237559689,1.0,6/33,4.52%,DNAJC6;PICALM;NLGN2;STON1;CEL;SYNJ2
prerank,Rap protein signal transduction (GO:0032486),-0.5002253031912844,-1.127040904039624,0.3446969696969697,0.6040435221832411,1.0,4/10,10.17%,RAP1B;PLK2;RAP1A;RAP2A
prerank,regulation of cellular component organization (GO:0051128),-0.2917797854553323,-1.126621935271339,0.19117647058823528,0.6042115540700408,1.0,35/135,16.53%,NRG3;HIP1;CDH13;LTBP4;PLCE1;CAMK2D;RIT2;PAK5;STON2;TFRC;NET1;DAB2IP;RAP1B;RAP1A;APOE;SOCS2;HSPA8;SEMA4D;SPOCK1;AGTR1;CEACAM1;HJURP;IRAK3;HSP90AA1;BCAR1;FAM107A;SNX17;PINK1;ATF5;ERMN;PTCH2;RASGRP2;PACSIN1;EGLN2;MLLT3
prerank,negative regulation of lipid storage (GO:0010888),0.4731285204067177,1.1266207020764742,0.2906574394463668,0.9218391700830201,1.0,2/19,1.81%,OSBPL8;PPARA
prerank,regulation of lamellipodium organization (GO:1902743),0.5143290491283824,1.126501307275444,0.3567251461988304,0.9209499284579257,1.0,6/14,11.48%,CAPZB;PDPN;CARMIL2;FER;CDC42;VIL1
prerank,regulation of ion transport (GO:0043269),0.3766691644270095,1.1263319791093773,0.2797101449275362,0.9202326866732198,1.0,16/76,11.97%,SYT9;KCNJ13;SYT11;SYT12;KCNA5;PRKN;SNX6;NEDD4;DTNBP1;SIK1;GDNF;KCNJ14;HTR1A;RAB11B;SCN10A;WWP2
prerank,cytoskeleton organization (GO:0007010),-0.2962396579919979,-1.126270208644792,0.2014388489208633,0.6042683895106644,1.0,19/114,6.81%,FMNL2;ARHGAP10;RHOBTB1;SEMA6A;MARK1;FGD5;SH3KBP1;PLCE1;MAST4;MICAL2;DST;RND3;PCLO;PAK5;EPB41L3;ARAP3;STRIP2;APOE;RHOB
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3650980136258834,1.125910673201653,0.26483357452966716,0.9202800523358022,1.0,17/85,15.84%,DAB2;SH3RF2;PRKN;NUPR1;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;ZYG11B;DNAJB2;RNF19B;HECTD1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4245478167936721,1.1258641132545792,0.3083197389885807,0.9191476086591505,1.0,8/37,10.39%,GSDME;NUPR1;BID;NACC2;TP53;FBH1;DNM1L;BECN1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4675690556797447,1.1254964491436728,0.3268206039076377,0.9178095243024116,1.0,6/20,13.05%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4675690556797447,1.1254964491436728,0.3268206039076377,0.9178095243024116,1.0,6/20,13.05%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,response to hydroxyurea (GO:0072710),0.5332404738166479,1.1254813944553408,0.34600760456273766,0.91659623130776,1.0,5/11,20.67%,ATRX;KAT7;DDI1;FMR1;RTF2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.30761264704474955,1.1249750908333858,0.19934640522875818,0.9169978166322358,1.0,86/476,13.87%,RORA;BMP7;SMAD3;WNT4;ZIC2;PPARGC1A;PICALM;IGF1;KMT2A;PPARA;CXXC1;SPP1;GLI2;ZNF423;CREB5;NPAS3;NR2F2;PHIP;GLI3;MITF;ELF1;TGFBR1;ARNT2;FOXC1;CAND2;NFIB;CREB3L2;RGMB;RREB1;NSD1;TRIM56;ZNF318;TBL1X;HMGA1;LBH;CREBL2;TP53;SMARCD3;AFAP1L2;MED12;ARHGEF11;RORC;FBXW11;ELF2;NR1D2;SMARCA4;ZIC1;BTRC;KAT6B;TBL1XR1;CALCOCO1;SMARCC2;JMJD6;TCF4;HDAC1;NIBAN2;MYBL1;NSD3;GLI1;TEAD2;PARP9;HDAC4;ZFP90;FOXC2;MED17;THRAP3;DYRK1A;ZMIZ1;TEAD1;ZBTB48;SNAI1;PHF5A;IRF1;MSANTD1;DEAF1;BRD7;FOXA2;MLXIPL;EDRF1;ZXDC;MAP2K1;PBX4;MAP2K2;PML;MLLT11;DNM2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4165030897984992,1.1247154907004782,0.32148626817447495,0.9166035352553613,1.0,7/40,9.00%,IGF1;PRKN;BID;FAM162A;TP53;OPA1;DNM1L
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3590791693380636,-1.1246553476492054,0.25984251968503935,0.6073674981290748,1.0,12/39,17.11%,PTPRJ;SH3KBP1;PTPN12;SH3GL2;ARHGEF7;DAB2IP;ERBB2;DUSP3;PTPN3;SPRY1;ZFYVE28;CBL
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5352512074717605,1.1242492755631721,0.36801541425818884,0.9169393101449711,1.0,7/12,22.56%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;GORASP1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4748148712313138,1.1242194754916803,0.32105263157894737,0.9145578383715919,1.0,4/19,7.88%,POLR2A;ATRX;ACD;POLR2D
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4748148712313138,1.1242194754916803,0.32105263157894737,0.9145578383715919,1.0,4/19,7.88%,POLR2A;ATRX;ACD;POLR2D
prerank,response to ATP (GO:0033198),-0.4407309367954048,-1.1231695799554868,0.3080459770114943,0.6100984432122674,1.0,5/18,14.20%,ABCC9;RYR3;TRPC3;P2RY12;P2RY1
prerank,response to peptide hormone (GO:0043434),0.4076612850030142,1.1227086358253768,0.3190839694656489,0.918105598998918,1.0,10/43,15.59%,TGFBR3;ROCK2;STAT2;SLC27A1;SIRT1;OGT;TSC1;ZFP36L1;EIF2B1;STAT6
prerank,vasculogenesis (GO:0001570),-0.3714406882120986,-1.1224286730567745,0.27722772277227725,0.6110189943555643,1.0,15/32,15.72%,CAV1;ENG;RASIP1;NOTCH1;KDR;RAMP2;SOX17;ITGB8;TGFB1;HEY2;RASA1;SOX18;VEGFA;SPRED1;APLNR
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.32644347313023675,-1.1224147376985125,0.24925816023738873,0.6102450746497968,1.0,13/67,11.08%,ATP8B1;CAV1;MYO10;PODXL;TBC1D1;PPP1R16B;CDKL5;TBC1D5;TBC1D8;RDX;GAP43;TBC1D2B;FXR1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5361526621115259,1.1222756363753421,0.3509090909090909,0.9182772874487592,1.0,1/10,0.40%,BMP6
prerank,glucose transmembrane transport (GO:1904659),-0.4373591547930064,-1.1216561820690605,0.32027649769585254,0.611315168210978,1.0,5/18,18.01%,SLC2A1;PPARD;SORT1;SLC2A3;SLC45A1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4033231043305767,-1.12146843830812,0.3033175355450237,0.6109607234333068,1.0,10/24,25.90%,TPT1;CXCL12;ACKR3;CD44;TAF9B;CLU;CD74;TRIAP1;CCAR2;SNAI2
prerank,positive regulation of gene expression (GO:0010628),0.3103329355404642,1.1213911932165446,0.20309050772626933,0.9199242074135086,1.0,58/442,11.28%,FGF1;ROBO1;BMP6;BMP7;C1QTNF3;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;DDX5;PPARGC1A;IGF1;WNT6;PRKN;POLR2A;FOXD1;TNRC6A;MITF;TGFBR1;LARP4B;TAF1D;ADRA2A;DTNBP1;TLR3;SMO;CTSH;EZR;CUX2;ATM;TLR4;DDX3X;BRAF;CD28;EIF2AK2;BAZ1B;POLDIP3;TP53;PTPN22;PLSCR1;TNRC6B;SAMD4A;CALCOCO1;CPEB3;TLE1;UBR5;CDH5;RIPK1;MOV10;LRP3;YTHDF3;DYRK1A;SRPK2;PIK3R3;ATF2;C1QTNF1;PRKDC
prerank,positive regulation of chromosome organization (GO:2001252),0.4942553463689384,1.121386922957702,0.3150943396226415,0.9186991856318658,1.0,8/15,27.32%,ATRX;RAD50;PML;NBN;FEN1;LIG4;PPP1R10;RTEL1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5254678570145371,1.1210790693387664,0.3474088291746641,0.918472998720594,1.0,1/12,0.47%,BMP7
prerank,positive regulation of cell motility (GO:2000147),0.3252937274540229,1.1209810350249874,0.25156445556946183,0.9175680670359894,1.0,37/205,11.77%,DAB2;FGF1;WNT5B;SH3RF2;SYNE2;ROCK2;KIT;LAMC2;IGF1;RHOD;SPHK1;TGFBR1;PDPN;ADRA2A;RUFY3;SMO;CTSH;ATM;SEMA3B;SOD2;PDGFRB;FLT1;CPNE3;CCAR1;CDH5;MMP14;HBEGF;CARMIL2;TRIP6;FER;PIK3R3;CASS4;MYLK;PRKCA;VIL1;SNAI1;ADAM17
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3370122189816363,1.1201590363722551,0.2609271523178808,0.918959215004957,1.0,11/142,5.45%,ATP1A2;ADCY5;SMAD3;LPAR1;ACKR2;CCR9;LPAR2;CACNA1C;BDKRB2;KNG1;F2
prerank,import into cell (GO:0098657),0.41322979587723935,1.1201503055530209,0.31129032258064515,0.9177537712699312,1.0,8/41,9.78%,ATP1A2;SLC6A13;SLC5A3;SLC19A1;SLC1A3;SLC27A1;SLC38A1;GLUL
prerank,membrane raft organization (GO:0031579),-0.46662268675880747,-1.1198798376088024,0.3088235294117647,0.6139672496287709,1.0,7/15,23.85%,RFTN1;PPT1;EMP2;MYADM;S100A10;FLOT1;NAXE
prerank,heart trabecula morphogenesis (GO:0061384),0.4804013322073531,1.1189675529963372,0.344954128440367,0.920396615471976,1.0,6/18,8.66%,TGFBR3;BMP7;BMPR1A;TGFBR1;RBP4;NRG1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4567304488729491,1.1187990396029877,0.32123411978221417,0.9196992644064692,1.0,7/24,14.09%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,intestinal absorption (GO:0050892),-0.4717059376730607,-1.1187048323228042,0.3051948051948052,0.6159890128814494,1.0,3/13,7.88%,F11R;UGCG;KCNQ1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.49542763923543454,1.1183381783666624,0.33086876155268025,0.9199407386874651,1.0,7/16,22.02%,AMPD3;LHPP;AMPD2;GART;ADSS1;ADSL;GMPS
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4898547103768529,1.1182038922078177,0.330188679245283,0.9191421710969137,1.0,6/17,11.66%,PRKN;YJU2;RNF34;SIRT1;DYRK1A;SNAI1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.37971044866138237,1.1179414948807493,0.30627871362940273,0.9187624871457338,1.0,6/59,7.87%,ALDH1A2;CYP27A1;AMACR;OSBPL9;NDUFAB1;SRR
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5214789731795348,1.1178793439001569,0.3509127789046653,0.9177090920832875,1.0,2/12,7.88%,TLR4;RBP4
prerank,B cell activation (GO:0042113),-0.32755688674384204,-1.1177857298176082,0.2727272727272727,0.6174028230669774,1.0,10/68,8.13%,MEF2C;PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;EPHB2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4721472405627826,1.117762957880285,0.3345724907063197,0.9168585732234223,1.0,7/20,8.24%,ACE;IGF1;BMPR1A;PDGFRB;SERPINE1;IGFBP3;LRP1
prerank,calcium ion homeostasis (GO:0055074),0.35975481395603925,1.1167999064760286,0.26805555555555555,0.9185963266582721,1.0,9/95,3.58%,ATP13A5;SLC24A3;ANK2;ATP13A3;FAM20A;SLC8A3;PKHD1;CSRP3;DMPK
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.45467804855717303,1.1166154721759105,0.33273703041144903,0.9179914972859089,1.0,3/22,9.64%,BMP7;TP53;SIRT1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.48088991826837885,-1.115999465165482,0.3263598326359833,0.6207671512498366,1.0,3/11,19.95%,ABCG1;AGTR1;AGT
prerank,regulation of cell differentiation (GO:0045595),0.3346645422725944,1.115688388991616,0.2801047120418848,0.9197771638890683,1.0,23/148,9.50%,SMOC1;DDX5;CCN2;FGFR2;ZFHX2;FGFR1;TGFBR1;CLASP1;DAG1;PRKCB;PPP1R13L;KLHL41;GPS2;APC2;CAMK1;EIF2AK2;SIK1;RORC;NR1D2;CDK5RAP3;GDNF;NEUROD4;PHLDB2
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2844964072190912,-1.1156338026617334,0.2,0.6208906595985316,1.0,30/150,10.29%,KITLG;HIP1;PTPRJ;TEK;ERBB4;PIK3R1;ESR1;GCNT2;ENG;RTN4;THBS1;SEMA5A;GAB1;GAS6;F3;NRG2;HSP90AB1;MET;ITGB1;MYOC;TGFB1;PTK2;TNFAIP8L3;MFHAS1;FGF2;ERBB2;PIK3AP1;P2RY12;PDGFA;HSP90AA1
prerank,negative regulation of protein modification process (GO:0031400),-0.31384201572829384,-1.1154123618034417,0.2310126582278481,0.6206234840318661,1.0,20/79,10.14%,SLIT2;PID1;PRR5L;NTRK3;NIBAN1;PPP1R16B;SH3GL2;LYN;GSK3B;DAB2IP;PPIA;YWHAB;OCLN;CORO1C;EPHB2;TGFB1;DNAJC10;XDH;MFHAS1;ATP2B4
prerank,cell part morphogenesis (GO:0032990),-0.4774220034381946,-1.1153605532094832,0.3347547974413646,0.6199402539636201,1.0,5/13,24.68%,PID1;PNPT1;WASF1;CSPG5;NUBPL
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5150339722245731,1.1153266880471135,0.365702479338843,0.9197977000489144,1.0,2/10,7.47%,FGFR2;TGFBR2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5132526878114764,1.1146825268412224,0.3404669260700389,0.9206247791803726,1.0,2/11,3.03%,EFNB2;FRS2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.42351336968069564,1.1145224256303043,0.3280757097791798,0.9199244145284962,1.0,6/36,7.39%,SH3RF2;DLG1;PRKN;EZR;GPS2;PTPN22
prerank,positive regulation of intracellular transport (GO:0032388),0.41930651150985093,1.1143626901173307,0.32125984251968503,0.9192105427819025,1.0,6/38,8.54%,ACTN2;STX18;NEDD4;RUFY3;BCAS3;EIPR1
prerank,cytosolic calcium ion transport (GO:0060401),-0.38809614468414594,-1.1142328144739475,0.30952380952380953,0.6220003873718605,1.0,10/28,12.55%,SLC8A1;RYR2;CACNA2D1;SLC35G1;MICU3;ATP2A3;JPH2;SMDT1;ATP2B1;MCUB
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3626093020248763,1.1141089217471427,0.2877094972067039,0.9188421383315801,1.0,19/88,15.63%,BMP7;SMAD3;STX18;FNIP1;TRABD2B;BID;MPP7;NRG1;CDH5;HYAL1;AJUBA;PRKCA;VIL1;SDC4;SMPD3;LGALS3;FAF1;VPS4A;SNF8
prerank,regulation of protein polymerization (GO:0032271),0.42410551631194127,1.1140304687740405,0.3231292517006803,0.9178726042514799,1.0,6/35,10.83%,ARHGAP28;FCHSD2;ARHGAP18;MAP2;ABL1;PRUNE1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3804908639958382,-1.1138530727298948,0.3086734693877551,0.6221618931435543,1.0,6/30,6.18%,BMP5;NOS3;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,carbohydrate catabolic process (GO:0016052),0.4149954935808248,1.1135871214753335,0.33004926108374383,0.9181031268357006,1.0,7/38,9.26%,HK2;NEU2;PGAM2;DERA;GCK;MANBA;NEU3
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3933362843836548,-1.1135805389679734,0.2882205513784461,0.6219734660790259,1.0,7/27,14.21%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1;ABCB4
prerank,blood vessel diameter maintenance (GO:0097746),0.4165276526189896,1.1135708957233859,0.3316831683168317,0.9169577005283439,1.0,6/34,7.48%,ROCK2;ACE;NPR1;CPS1;BDKRB2;SCPEP1
prerank,negative regulation of protein polymerization (GO:0032272),-0.3875532801123586,-1.1134217597453255,0.2873303167420814,0.6215875857891623,1.0,13/27,20.92%,SLIT2;KANK3;KANK4;STMN2;TUBB4A;PFN2;SNCA;STMN1;KANK1;HIP1R;MYADM;TWF2;SSH2
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.29474182509757885,-1.112766872240692,0.23588039867109634,0.6223580792521771,1.0,32/107,23.27%,PIK3R1;MAP3K5;THBS1;NIBAN1;RASGRF2;GSK3B;DAB2IP;RASGRF1;HSPA5;DDRGK1;DNAJC10;ATP2A3;PDIA3;AIFM1;UFM1;TMEM117;SELENOK;ATF4;CREB3L1;BBC3;NCK1;EIF2AK3;RHBDD1;TMX1;BCAP31;BCL2L11;CFTR;RCN3;THBS4;TRIB3;FLOT1;ATP2A2
prerank,organelle fusion (GO:0048284),0.45865270240734657,1.1121425716007485,0.34935304990757854,0.9201595479018913,1.0,8/22,22.46%,CHCHD3;MIGA2;OPA1;MFN2;EEA1;MFN1;AFG3L2;STX4
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4734292463727593,-1.1117810985802166,0.3403805496828753,0.6238736271825891,1.0,4/12,17.04%,APOE;LDLR;CLU;IAPP
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3476653340196262,-1.1117627553211082,0.2887700534759358,0.6231110929437029,1.0,12/48,8.79%,NRP1;PTPRD;IL1RAPL1;CARMIL1;CDKL5;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR
prerank,aminoglycan metabolic process (GO:0006022),-0.4989353657294583,-1.1117519491740204,0.34516765285996054,0.6223398668514496,1.0,6/10,24.92%,XYLT1;B3GAT2;CHST9;B3GALT6;B3GAT3;B3GAT1
prerank,female gonad development (GO:0008585),0.4734415802167627,1.111450603940926,0.3392539964476021,0.9213417239015842,1.0,2/19,2.95%,KIT;NR2F2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.43817195188836794,1.1114083073415202,0.31040564373897706,0.9202814654852839,1.0,5/30,4.60%,CACNA1D;ANK2;KCNA5;SNTA1;CACNA1C
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5159969759893513,1.1111348646375478,0.37250996015936255,0.9200137443807901,1.0,5/12,18.95%,HDAC8;AXIN2;WAPL;RB1;FEN1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4450370122778753,-1.1110947586866255,0.33186813186813185,0.6223189549696165,1.0,7/16,13.15%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4450370122778753,-1.1110947586866255,0.33186813186813185,0.6223189549696165,1.0,7/16,13.15%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,erythrocyte differentiation (GO:0030218),0.4018592437814635,1.1103217752851648,0.2936378466557912,0.9215252075232895,1.0,3/44,3.63%,TGFBR3;KIT;CASP3
prerank,negative regulation by host of viral process (GO:0044793),0.5570867446096088,1.1101993770776166,0.3500931098696462,0.9207061658855928,1.0,1/10,2.02%,PRKN
prerank,ganglioside metabolic process (GO:0001573),-0.4150000544082774,-1.1101264191995834,0.3055555555555556,0.623859349780121,1.0,5/20,8.47%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;ST8SIA6
prerank,glycoprotein biosynthetic process (GO:0009101),-0.31256480509264517,-1.10974510440819,0.24147727272727273,0.6239674497904406,1.0,19/79,15.27%,CSGALNACT1;ST3GAL4;ST8SIA4;BMPR2;GCNT2;FUT9;XYLT1;ST8SIA1;B4GALT5;ST3GAL6;B3GALT1;ST8SIA6;B3GALNT1;DAD1;B3GALT5;BMPR1B;CHST12;NUS1;CHST9
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4241926323039933,-1.1096204882205578,0.30699774266365687,0.6234525625542316,1.0,8/18,26.82%,CORO2B;PTP4A3;CCT2;CCT8;CCT6A;CCT7;CEP135;DKC1
prerank,synaptonemal complex assembly (GO:0007130),0.4821747831175052,1.1095288528822567,0.34363636363636363,0.920425479360254,1.0,7/15,25.76%,TEX12;REC8;STAG3;P3H4;BAG6;SYCE2;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.4821747831175052,1.1095288528822567,0.34363636363636363,0.920425479360254,1.0,7/15,25.76%,TEX12;REC8;STAG3;P3H4;BAG6;SYCE2;TRIP13
prerank,sphingolipid catabolic process (GO:0030149),-0.4477081102578403,-1.1093257150793832,0.3375796178343949,0.6234433867652215,1.0,6/15,11.65%,ACER3;ACER2;PPT1;ENPP2;ASAH2;SMPDL3A
prerank,amino acid transport (GO:0006865),0.3942041294155811,1.1092625649018664,0.3162118780096308,0.9201014568124056,1.0,7/49,4.33%,SLC6A12;SLC38A4;SLC38A3;SLC7A2;SLC7A11;PDPN;SLC25A48
prerank,negative regulation of response to stimulus (GO:0048585),-0.325895980666447,-1.1086593461396328,0.2893258426966292,0.6242663661113377,1.0,16/60,14.73%,SLIT2;KLF7;MCTP1;UBASH3B;CASK;CD34;YBX1;AKT3;LYN;HHIP;AQP11;KIF26A;TWIST1;ACVR1;SOCS5;CLU
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.487696529363306,-1.1085340911343016,0.3436213991769547,0.6237570090051945,1.0,3/11,10.68%,SLIT2;CCN3;DUSP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.42808035828573854,-1.108530753082504,0.331002331002331,0.6229792818820262,1.0,8/17,19.63%,CALM1;CALM2;SMAD7;DDIT4;CALM3;DMTN;SPRED1;SIRT2
prerank,regulation of proteolysis (GO:0030162),-0.3357655837129424,-1.108473754416629,0.26881720430107525,0.6223020524012073,1.0,7/48,7.36%,CAV1;LTBP4;SERPINE2;CST3;DNAJC1;GSAP;PERP
prerank,collagen fibril organization (GO:0030199),0.3597773790616817,1.1083263985069949,0.2939521800281294,0.9218429273402317,1.0,15/88,6.63%,COL5A1;COL22A1;COL26A1;LAMC2;COL4A5;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;LOXL3;COL9A2;COL13A1;COL1A2;COL27A1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.42661092909643317,-1.1082945708529282,0.3056179775280899,0.6219742371013295,1.0,6/17,19.60%,MID1;TGFB2;LYN;SEMA4C;NOD2;KLHDC10
prerank,zinc ion homeostasis (GO:0055069),-0.3862074574055443,-1.1081806601355857,0.29767441860465116,0.6214480623025946,1.0,12/28,14.22%,SLC39A10;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC30A1;SLC39A12;MT3
prerank,negative regulation of anoikis (GO:2000811),-0.4582556165540521,-1.1075685883526054,0.3471933471933472,0.6222162930269763,1.0,4/14,8.80%,CAV1;NOTCH1;ITGB1;PTK2
prerank,cell projection organization (GO:0030030),-0.37448166783873876,-1.1073409304755888,0.3047858942065491,0.6220074651765278,1.0,7/30,10.20%,RHOJ;GSN;PARVB;ITGB1;RHOH;P2RY12;PDGFA
prerank,positive regulation of protein sumoylation (GO:0033235),0.5283936502154123,1.1072167081549498,0.3801980198019802,0.9241267649946231,1.0,4/10,19.70%,PIAS1;HDAC4;PIAS3;PIAS4
prerank,retina homeostasis (GO:0001895),-0.40494346749796417,-1.107205665626622,0.32242990654205606,0.6215693945178318,1.0,4/23,3.93%,ACTB;POTEF;B2M;ACTG1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4193688231142232,-1.1068148195002523,0.32134831460674157,0.621768706424666,1.0,6/19,9.00%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;HEY2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.4076394962828559,-1.1066060539514366,0.30337078651685395,0.6214557442820288,1.0,9/25,12.15%,CSGALNACT1;NDST3;FUT9;EXT1;NDST4;B3GALT1;B3GALNT1;EXT2;B3GALT5
prerank,nitric oxide metabolic process (GO:0046209),-0.44689571036681175,-1.1065891570018391,0.34375,0.620713068438255,1.0,5/14,18.38%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,lipoprotein localization (GO:0044872),0.5141069147276618,1.1065399427061897,0.3463687150837989,0.9249929971908409,1.0,4/11,13.20%,PRKCB;LRP1;MIA3;UNC119B
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4790121423699,1.1065352639989068,0.34296028880866425,0.9238203235835891,1.0,1/17,0.26%,FGF1
prerank,nucleosome organization (GO:0034728),0.3802580869001855,1.1064390475409511,0.3235747303543914,0.9229792595646403,1.0,11/55,9.31%,ARID2;CHAF1B;ATRX;HMGA1;SMARCD3;RNF8;SMARCA4;SRCAP;KAT6B;SMARCC2;SMARCE1
prerank,endomembrane system organization (GO:0010256),0.33324521809707963,1.106323494938436,0.2687116564417178,0.9221765390029115,1.0,53/178,17.98%,FAM174B;DYM;HOOK2;MYOF;OBSL1;ALS2;SEC31B;DMPK;CLASP1;LRRK2;MYO18A;SRGN;ATL1;ARFGEF2;BCAS3;FER1L5;TLCD2;HUWE1;LEMD2;HTT;CSNK1A1;DNM1L;TRAPPC12;GOLPH3L;RAB43;CDC42;FBXW8;A4GALT;RAB22A;MIA3;REEP4;PLEKHF1;TRAPPC11;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS4A;GOLGA8B;GOLGA5;VPS51;HOOK3;PI4K2B;NUP155;RAB30;SEC31A;WASHC5;COG4;GORASP2;OPTN;SQSTM1;PHETA1;NPLOC4
prerank,secondary palate development (GO:0062009),0.48847034643663145,1.105865365836203,0.35009671179883944,0.9224600905268854,1.0,3/14,7.47%,TGFBR3;CHD7;TGFBR2
prerank,apoptotic mitochondrial changes (GO:0008637),0.4165123729930767,1.1052260405979766,0.3481717011128776,0.9232482375205057,1.0,7/32,13.46%,HK2;IFIT2;BID;SOD2;DNM1L;NDUFS1;THEM4
prerank,regulation of cellular protein localization (GO:1903827),-0.34779616889096293,-1.105121404426584,0.2819843342036554,0.6235093437250907,1.0,13/45,16.32%,GPC5;GPC6;HSP90AB1;RALB;HSP90AA1;GPC4;CTNNB1;SETD2;MAPT;RAB11FIP5;PPM1F;BDNF;VCPIP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.44357776955416933,-1.1051126976691183,0.3356009070294785,0.6227452008904671,1.0,1/15,0.39%,HECW2
prerank,heterochromatin assembly (GO:0031507),0.4550971293587968,1.1050007037517544,0.36203866432337434,0.9227739261585696,1.0,9/20,20.40%,HMGA1;HDAC1;SIRT1;BAHD1;BEND3;SMCHD1;CENPV;EZH1;MBD2
prerank,protein homooligomerization (GO:0051260),0.34824789460614985,1.1049333750159833,0.2877094972067039,0.921851417304906,1.0,18/114,10.04%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CLYBL;NACC2;ITLN1;RNF135;P2RX3;ATL1;SOD2;MICU1;SAMHD1;JMJD6;SSBP1;CBY1;CTH
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4602031002480108,1.1048500149542724,0.34022556390977443,0.9209139005335267,1.0,4/20,3.85%,ACTN2;OSR1;ADRA2A;NEDD4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36295959385808196,1.1044063692145902,0.2949852507374631,0.921130386603459,1.0,17/78,15.84%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;FZR1;NUB1;ZYG11B;DNAJB2;RNF19B;HECTD1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4803850331789303,1.103576823709898,0.3376146788990826,0.9225818105270049,1.0,4/16,3.17%,TGFBR3;IGF1;FGFR2;BMPR1A
prerank,negative regulation of GTPase activity (GO:0034260),0.45798568911295523,1.1034509411277325,0.3506944444444444,0.9218285039139897,1.0,4/22,6.66%,CPEB2;LRRK2;GMIP;BCAS3
prerank,regulation of protein localization (GO:0032880),0.3804281669277487,1.103406079900999,0.3216995447647951,0.9208155857823215,1.0,6/58,5.98%,AFDN;PICALM;DLG1;AAK1;MAP2;CAMK1
prerank,cellular macromolecule catabolic process (GO:0044265),0.39423881487808476,1.1029929700611938,0.3246753246753247,0.9209510183291234,1.0,13/49,15.69%,PRKN;NGLY1;NEU2;ADAMTS9;SIDT2;DNASE1L1;EXOSC7;MANBA;SND1;RIPK1;MAGEC2;DFFB;DNASE1L2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4643746454569647,-1.1029615430932773,0.3434959349593496,0.6271270131582154,1.0,5/13,16.98%,KDR;IL33;NAMPT;EDN1;NOD2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4725084979556185,1.1027838696672343,0.35135135135135137,0.920397044820728,1.0,3/18,3.69%,SMAD3;CLASP1;PDPN
prerank,cellular response to oxidative stress (GO:0034599),0.3465888084698618,1.1017806219672466,0.308411214953271,0.9224460877951041,1.0,12/118,6.65%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;TPM1;SOD2;ALDH3B1;TP53
prerank,L-glutamate transmembrane transport (GO:0015813),-0.49689615905337503,-1.1017028234599746,0.3587174348697395,0.6294596779509604,1.0,3/10,5.22%,SLC1A2;SLC1A1;SLC25A13
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4883007087204494,-1.1016855688430918,0.33541666666666664,0.6287142506109666,1.0,4/10,4.77%,HECW2;HECW1;CAMK2D;NEDD4L
prerank,cellular polysaccharide catabolic process (GO:0044247),0.48312626118610524,1.1016375660516957,0.3582089552238806,0.9217161125708361,1.0,4/16,9.21%,PYGM;PHKB;MGAM;PHKG1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5022709480072897,1.101273132980707,0.35587188612099646,0.9217394047273955,1.0,2/14,1.42%,SYT11;IGF1
prerank,response to ketone (GO:1901654),-0.39221562817278266,-1.1004398730056317,0.3488372093023256,0.630975894063925,1.0,7/24,8.59%,SLIT2;ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,protein deacylation (GO:0035601),0.455133348316646,1.1003894147039428,0.3469750889679715,0.9233713418194138,1.0,8/23,14.09%,ABHD17C;SIRT5;LYPLA1;SIRT3;HDAC1;HDAC4;SIRT1;SIN3A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.49640116670217116,-1.1002927937147517,0.3603960396039604,0.6305708104400183,1.0,4/11,18.91%,NOTCH1;FOXO1;ATP2B4;GLRX3
prerank,mitochondrion localization (GO:0051646),0.46948241293624354,1.0999585308233712,0.3481349911190053,0.9235269976023815,1.0,8/19,18.34%,TRAK1;LRRK2;MEF2A;MFN2;BRAT1;MSTO1;TRAK2;MFN1
prerank,chromosome organization (GO:0051276),0.3498622086527844,1.0999041689477989,0.30914368650217705,0.9225343277455162,1.0,31/99,20.62%,TOP2B;HDAC8;SETD7;MTHFR;LDB1;SMARCA4;TCF7L2;HDAC1;SIRT1;ABL1;BAHD1;AXIN2;MSH3;CUL4A;PHF1;HMGN3;CDAN1;DDB2;DOT1L;LRWD1;EHMT1;NUP155;TCF7L1;PADI4;CENPV;CENPT;EZH1;COPS8;XPA;BRWD1;LIG4
prerank,vesicle transport along microtubule (GO:0047496),0.4482105713055114,1.099256421166599,0.3487544483985765,0.9234285469790029,1.0,6/23,13.03%,TRAK1;FYCO1;FBXW11;HTT;KIF1C;KIF5B
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.4451723044614775,1.098872587154233,0.36185383244206776,0.9234532046072831,1.0,3/23,8.74%,WNT5B;SMO;GDNF
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4391991983674244,1.0987277058638756,0.3502626970227671,0.9227295743981688,1.0,3/26,2.22%,ROCK2;PICALM;EPHA4
prerank,cortical cytoskeleton organization (GO:0030865),0.40861431106189056,1.0985882295903915,0.3365231259968102,0.9220356985146725,1.0,7/41,4.89%,ROCK2;RHOQ;DLG1;RHOBTB2;RHOD;FHOD1;EZR
prerank,defense response to bacterium (GO:0042742),0.34934876634550543,1.0985812552487626,0.316,0.9209102999470807,1.0,19/105,14.93%,COLEC12;OAS2;TLR3;TLR4;DEFB1;ANKRD17;GBP7;IL12B;SERPINE1;GBP2;PLA2G6;MAVS;IRGM;ADAM17;ANXA3;CAMP;OAS3;GBP6;CFP
prerank,protein maturation (GO:0051604),0.3551165115360381,1.0982832007470666,0.3237822349570201,0.9207416134076651,1.0,16/95,15.44%,AEBP1;NNAT;TSPAN5;SRGN;METAP2;NDUFAB1;APH1B;MMP14;ADAM17;NFU1;OGT;PCSK7;SDE2;ISCA1;PITRM1;NAA16
prerank,response to unfolded protein (GO:0006986),-0.34347662630906817,-1.097546614124193,0.3041095890410959,0.6365988036587279,1.0,18/48,20.96%,HSP90AB1;DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;HSP90AA1;TM7SF3;HSPB8;SERPINH1;DNAJA1;RHBDD1;HSPB1;PTPN1;HSPE1;HSPH1;HSPA4L;DNAJB1
prerank,potassium ion transmembrane transport (GO:0071805),0.33658401427903256,1.0974636265064113,0.30164765525982257,0.9221458835170089,1.0,8/135,1.95%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,positive regulation of kinase activity (GO:0033674),-0.2932787114596431,-1.0974017821436344,0.2565217391304348,0.6361556109556576,1.0,26/107,9.79%,TEK;ERBB4;NTRK3;EPHB1;ROR1;RASSF2;EPHA5;MERTK;EPHA6;IQGAP1;TIE1;PTK2B;GAS6;NTRK2;KDR;RAP1A;PTPRC;MET;ROR2;RELN;CCN1;EPHB2;EPHA7;PTK2;FLT4;ERBB2
prerank,V(D)J recombination (GO:0033151),0.5234654661941158,1.0965163907595987,0.38076923076923075,0.9238912500659693,1.0,4/11,20.62%,XRCC4;PRKDC;LIG1;LIG4
prerank,lipoprotein transport (GO:0042953),0.5205702493444728,1.0964116256013332,0.3743016759776536,0.9230927635041084,1.0,4/10,13.20%,PRKCB;LRP1;MIA3;UNC119B
prerank,aorta development (GO:0035904),0.4951401591253911,1.0962351611334475,0.36036036036036034,0.9225157614572514,1.0,4/14,8.24%,ROBO1;ADAMTS9;PDGFRB;LRP1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5434596606181633,1.0960593084501846,0.36639676113360325,0.9219173005727128,1.0,1/10,1.22%,KIT
prerank,regulation of adaptive immune response (GO:0002819),-0.42279236396096015,-1.0958958406964128,0.33116883116883117,0.6390956520241372,1.0,6/18,21.37%,ADCY7;IL6ST;TRIM27;SAMSN1;SKAP1;PYCARD
prerank,steroid metabolic process (GO:0008202),0.36531179443259654,1.0958716969216413,0.33084947839046197,0.92130588207802,1.0,12/72,12.83%,CYP27A1;LIPA;CYP21A2;CYP26B1;AMACR;FDXR;DHRS11;CYP2R1;SULT2B1;GC;ARV1;SRD5A2
prerank,apical junction assembly (GO:0043297),0.3864904082254538,1.0958312647534736,0.32866043613707163,0.9203054507046448,1.0,3/53,1.68%,PARD6G;AFDN;DLG1
prerank,cellular response to interleukin-1 (GO:0071347),-0.2880093141331014,-1.0957181485459067,0.2540983606557377,0.6387556716026785,1.0,47/143,29.96%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;PTGIS;NFKBIA;PSMB2;DAB2IP;MAP3K7;EGR1;PSMD14;IRAK3;CD47;PSMC6;IKBKB;HIF1A;UBB;PSMB9;PSMA4;PELI1;NOD2;CCL13;SKP1;PSMD11;PSMB10;PSMD2;CCL19;HAS2;PYCARD;PSMA2;UBC;RPS27A;SFRP1;HYAL2;RELA;PSMB3;TAB1;PSMB5;CCL2;MAP3K8;CD40;MAPK3;TOLLIP;PSMD7;IRAK4;PSMF1
prerank,apical protein localization (GO:0045176),0.5246675508106949,1.095674517253162,0.352165725047081,0.9196375211971191,1.0,3/10,2.25%,CELSR1;SHROOM2;SHROOM3
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3405286163462957,-1.0953389745965338,0.3176178660049628,0.6388662838411834,1.0,10/42,10.19%,ST6GALNAC3;ESYT2;UGCG;ST8SIA1;PSAP;ST6GALNAC5;GLTP;HEXB;B3GALNT1;ESYT3
prerank,peroxisome organization (GO:0007031),0.43234643894159164,1.0946055911294605,0.3546712802768166,0.9219606655295824,1.0,8/25,17.40%,PEX11A;PEX11B;DNM1L;PEX10;ACOT8;PEX14;PEX19;PEX16
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3836787778915177,-1.0942562514793932,0.31353919239904987,0.6408246159699101,1.0,14/27,20.91%,CSGALNACT1;DCN;CHSY3;BGN;XYLT1;CSPG4;VCAN;CHST12;B3GAT2;CHST9;CHST7;CSPG5;B3GAT3;BCAN
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.49960998295274167,1.094202072246576,0.36446886446886445,0.9220776892764558,1.0,2/14,3.77%,UPB1;DPYD
prerank,glycoprotein metabolic process (GO:0009100),0.3814682316802092,1.0938913175095062,0.3263327948303716,0.921895499707827,1.0,14/53,13.06%,MAN1A2;MAN1C1;LARGE1;NGLY1;NEU2;ADAMTS9;FUT8;ST6GALNAC6;MANBA;GAL3ST4;CNMD;MAN2A1;GANC;PRKCSH
prerank,B cell proliferation (GO:0042100),-0.424707343517091,-1.0937417064720338,0.33874709976798145,0.641243013616922,1.0,2/17,6.10%,MEF2C;PTPRC
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2510910945450441,-1.0933963433516192,0.1574074074074074,0.6413208000312774,1.0,75/423,11.11%,MEF2C;PID1;LEF1;KITLG;PRKCH;BMP5;ZFPM2;ERBB4;NTRK3;CDH13;CLDN5;OSMR;GCNT2;THBS1;LIFR;VEGFC;FN1;ACER3;TGFB2;TBX3;ACER2;PTK2B;TOX;GAS6;RPS6;S100A6;NOTCH1;NTRK2;IL6ST;KRAS;RPS15A;KDR;LYN;TBC1D8;TNFRSF11A;TBX1;PDGFC;TIAM1;STX3;AR;PAK1;PTPRC;FOXP1;NAMPT;HES1;TGFB3;AQP11;SSR1;CCN1;MEIS2;BMP2;RTKN2;PROX1;CUL3;TGFB1;DDRGK1;CALR;PTK2;CD47;S100B;FLT4;PTN;FGF2;RPS9;ERBB2;NAP1L1;ID2;PDGFA;RPL23;SLC25A33;EDN1;BMP4;ESM1;GPER1;SHANK2
prerank,plasma membrane tubulation (GO:0097320),-0.45602639142781254,-1.0931403435473868,0.3237885462555066,0.6411880102852607,1.0,5/13,19.84%,FNBP1L;CAVIN2;EHD2;PACSIN1;CHMP4A
prerank,megakaryocyte differentiation (GO:0030219),0.5214367775489768,1.093010899041711,0.360377358490566,0.9235063055127584,1.0,1/11,1.22%,KIT
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.41269865507821524,1.0929704577624986,0.33934426229508197,0.9224914492949723,1.0,8/33,12.42%,DLG1;KANK2;NACC2;PLK5;PTEN;RBL2;RBL1;BRD7
prerank,muscle contraction (GO:0006936),0.3404612163789243,1.0926481652489304,0.3202702702702703,0.9223809010367542,1.0,18/126,9.43%,ROCK2;ACTN2;SORBS1;SNTA1;MYOF;TMOD2;PABPN1;PGAM2;BDKRB2;TLN1;DTNA;TPM1;TMOD3;KLHL41;ARHGEF11;CHRNG;MYL4;NMUR1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.322424086948811,1.0923526893334428,0.2862644415917843,0.9221635360103692,1.0,38/190,14.58%,UACA;RORA;BMP7;C1QTNF3;CGNL1;ITPR1;PRKAA2;PPARA;FNIP1;PKHD1;PPEF2;NPRL3;DEPTOR;MAGI2;DAG1;VGLL4;DDX3X;WWC2;NPRL2;MGRN1;UBR2;PTEN;TLE1;RNF34;SIRT1;RIPK1;CYRIB;AJUBA;ARHGAP12;PHLPP2;NMI;MAPKBP1;IFI35;THEM4;FLCN;DEPDC5;PPM1B;TSC1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3363866683259833,-1.0919909539133759,0.2857142857142857,0.6431784699827441,1.0,21/50,24.43%,THBS1;GAS6;NGF;YWHAE;SIAH2;ARL6IP1;CD44;RPS6KA3;SNCA;RPS6KA1;VEGFA;MT3;CARD16;PAX2;GPX1;DHCR24;RFFL;TRIAP1;HGF;PLAUR;KLF4
prerank,regulation of intracellular pH (GO:0051453),-0.3684604338487818,-1.0917897440428892,0.3047619047619048,0.642916537439997,1.0,10/34,21.95%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1;GPR89B;GPR89A;CFTR;SLC4A2
prerank,T cell activation (GO:0042110),0.37618001609122326,1.091583726257425,0.32116788321167883,0.9233882350855233,1.0,9/69,7.39%,LEPR;KIT;KIF13B;DPP4;IFNK;NHEJ1;CD28;CHD7;PTPN22
prerank,negative regulation of signaling (GO:0023057),-0.3884540348809101,-1.0913364473096636,0.33569739952718675,0.6432624898251826,1.0,9/25,25.03%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1;OPRM1;ERBB3
prerank,negative regulation of cation channel activity (GO:2001258),-0.384052495844152,-1.090935410345479,0.33906633906633904,0.643441380028042,1.0,9/26,21.47%,KCNAB1;CALM1;CALM2;EPHB2;FKBP1A;CALM3;CASQ2;DRD2;GSTM2
prerank,cellular response to amyloid-beta (GO:1904646),-0.3574600545904732,-1.0903773882139571,0.32653061224489793,0.6439531305241315,1.0,9/35,7.45%,GRM5;CACNA2D1;VCAM1;GSK3B;APP;ICAM1;GRIN2A;PSEN1;ITGA4
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3310253172261947,-1.0901995551062629,0.28415300546448086,0.6435814108679145,1.0,11/47,11.39%,STXBP6;SPTBN1;ANK3;EXOC6;RAB31;VAMP4;PREPL;GOPC;NSF;GCC2;GOLGA7
prerank,in utero embryonic development (GO:0001701),0.4429512086549011,1.0898736292748272,0.3645833333333333,0.9276497365501661,1.0,6/25,6.96%,FGFR2;ZNF568;TGFBR1;ARNT2;FUT8;CHD7
prerank,snRNA transcription (GO:0009301),0.36801963887133243,1.089754921453607,0.3288888888888889,0.92691223758106,1.0,22/70,21.89%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;GTF2F1;INTS10;TAF11;INTS2;INTS5;TBP;INTS3;INTS1;TAF13;INTS7;INTS8;INTS4;GTF2A1;POLR2G;SP1;USPL1
prerank,fatty acid oxidation (GO:0019395),0.37715033630734324,1.089658150943202,0.3313343328335832,0.926080623656174,1.0,20/57,22.54%,PPARGC1A;ALOX12;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ECHDC1;DECR1;EHHADH;SLC25A17;ECI2;PHYH;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,cAMP biosynthetic process (GO:0006171),0.526956486786833,1.0895133829176367,0.39553752535496955,0.9254165985028452,1.0,3/10,7.31%,ADCY5;ADCY1;ADCY9
prerank,heart contraction (GO:0060047),0.3974497748400308,1.0894762322946943,0.3486529318541997,0.92440691455693,1.0,8/41,12.06%,ATP1A2;ACE;CSRP3;TPM1;PIK3CA;MYL4;TNNI3;TNNC1
prerank,positive regulation of coagulation (GO:0050820),-0.49728887493316243,-1.0884383646193072,0.391304347826087,0.6463306958279835,1.0,4/10,13.15%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,positive regulation of hemostasis (GO:1900048),-0.49728887493316243,-1.0884383646193072,0.391304347826087,0.6463306958279835,1.0,4/10,13.15%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,autophagy of peroxisome (GO:0030242),0.5014571937660857,1.0882900894181324,0.3937621832358674,0.9269837905548579,1.0,6/12,26.51%,ATM;ACBD5;PEX5;SQSTM1;PIK3C3;TRAPPC8
prerank,response to insulin (GO:0032868),0.35859802928275003,1.0882021832415858,0.3148148148148148,0.9261243022218154,1.0,19/80,16.47%,CPEB2;SORBS1;RHOQ;INSIG2;SLC27A1;GCK;PDPK1;SIRT1;RAB13;FER;PRKDC;PRKCI;DENND4C;OGT;TSC1;KAT2B;ZFP36L1;RAB8B;GOT1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.36036374444260616,-1.0881454973953688,0.3261455525606469,0.6462739891639788,1.0,16/33,25.03%,PIK3R1;NYAP2;PIK3C2B;PLEKHA1;HTR2A;ERBB2;EDN1;MYO16;PIK3C2A;TYRO3;PIK3R5;SIRT2;IRS1;TPTE;PIK3CD;ERBB3
prerank,cell-cell junction organization (GO:0045216),0.36045664577504316,1.0879769140121658,0.3333333333333333,0.9257047019861819,1.0,8/79,2.84%,SDK1;AFDN;SMAD3;PKP4;SDK2;PKHD1;NLGN2;ARVCF
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4165913150412158,1.0877532340787335,0.3570219966159052,0.9253249063139858,1.0,3/29,5.04%,TGFBR3;FGFR2;TPM1
prerank,negative regulation of DNA replication (GO:0008156),0.49936814679170305,1.0876370159261435,0.379182156133829,0.9245468437987774,1.0,4/13,13.64%,PDS5A;GTPBP4;WAPL;CDAN1
prerank,negative regulation of macrophage activation (GO:0043031),-0.42203777893140115,-1.0870639317691206,0.35469107551487417,0.6481244649130575,1.0,4/16,6.54%,CD200;LRFN5;PTPRC;LDLR
prerank,histone ubiquitination (GO:0016574),0.4556414917006556,1.0869302198632842,0.3505535055350554,0.9255753697958891,1.0,4/21,7.97%,CTR9;UBR2;RNF8;HUWE1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4592768098821868,-1.0864403437855408,0.34917355371900827,0.6488017018990391,1.0,6/12,24.55%,ANK3;CNKSR3;NOS1;SCN1B;PKP2;GPD1L
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5133812864128996,1.0861657368858522,0.3735632183908046,0.9257567787211637,1.0,1/12,1.19%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5133812864128996,1.0861657368858522,0.3735632183908046,0.9257567787211637,1.0,1/12,1.19%,FHL2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3033333988370824,1.0858960482779392,0.2947845804988662,0.925507727540935,1.0,69/351,14.60%,ALDH1A2;TGFBR3;APPL2;FBLN1;OGN;GSDME;FGFBP1;PTPN14;MCC;COL18A1;KANK2;CD300A;NUPR1;COL4A3;ARID2;IGFBP7;MAGI2;SPEG;PDPN;IFIT3;PARP10;NACC2;VGLL4;SMAD6;TNS2;CLMN;IFNK;SOD2;EIF2AK2;HMGA1;IL12B;TP53;SSTR3;DLG3;PTPRU;RBP4;PTEN;KDM2B;IGFBP3;HRG;NUPR2;TFDP1;NIBAN2;SULT2B1;GTPBP4;SLURP1;NOX4;RNF41;TRIB1;RARG;DUSP10;MNT;AXIN2;IRF1;ATRAID;GLMN;BRD7;FRK;NMI;MAP2K1;IFI35;PODN;PML;MFN2;FLCN;DNAJB2;PER2;TSC1;KAT2B
prerank,regulation of inclusion body assembly (GO:0090083),0.518245806886004,1.0857263084098256,0.398422090729783,0.9249301713671166,1.0,1/11,1.27%,SNCAIP
prerank,negative regulation of defense response (GO:0031348),0.36023700431082906,1.0857156059461883,0.33380281690140845,0.9238539426156148,1.0,13/77,14.36%,RORA;C1QTNF3;PPARA;PCBP2;METRNL;GPS2;ENPP3;CDH5;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,visual perception (GO:0007601),0.35846743258416874,1.0855144344975385,0.3293768545994065,0.9234078124674613,1.0,11/84,8.02%,ZIC2;COL18A1;EML2;RGS16;CEP250;EYA4;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3665857227494361,1.085206198082044,0.3343195266272189,0.9232209002230028,1.0,21/69,21.53%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;GTF2F1;INTS10;TAF11;INTS2;INTS5;TBP;INTS3;INTS1;TAF13;INTS7;INTS8;INTS4;GTF2A1;POLR2G;SP1
prerank,response to organophosphorus (GO:0046683),-0.4331243890212798,-1.0847152016569246,0.3502202643171806,0.6523296939835479,1.0,2/16,4.86%,ABCC9;TRPC3
prerank,signal transduction in response to DNA damage (GO:0042770),0.38624166555051986,1.0841847741064523,0.3390625,0.9251564190595591,1.0,28/49,29.17%,BID;SESN2;ATM;ATRX;TP53;DONSON;ABL1;HUS1;GADD45A;DOT1L;CEP63;CLSPN;INTS7;NBN;MAPK14;RAD9A;CASP9;CDC5L;MAD2L2;NDRG1;USP28;TIPRL;GRB2;E2F1;E2F7;CHEK1;BATF;ATR
prerank,neuron projection regeneration (GO:0031102),-0.4905254668656467,-1.0840724174354106,0.3659574468085106,0.6531570967485683,1.0,3/10,14.05%,GAP43;PTN;RTN4RL1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.46506142674796974,-1.0840144074401772,0.3452631578947368,0.652493310623087,1.0,4/12,8.37%,CAV1;CTNNA3;RYR2;BIN1
prerank,regulation of bone mineralization (GO:0030500),0.38132767747050983,1.083792804305793,0.35139318885448917,0.9252752879172474,1.0,9/55,7.86%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A;SRGN;ANO6;BCOR
prerank,cartilage development (GO:0051216),0.381273858872105,1.0836769142548348,0.3338533541341654,0.9245387581043332,1.0,6/49,4.52%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3757060421539283,1.0831609988015913,0.3365231259968102,0.9250793415686903,1.0,7/54,7.42%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6;PXYLP1;CLN6
prerank,maintenance of protein location in nucleus (GO:0051457),-0.40480810632027825,-1.0831395693545751,0.31554524361948955,0.6539332638320531,1.0,9/20,30.18%,SYNE1;MORC3;BARD1;BCL3;SKP1;SUN2;RANGAP1;CHCHD10;PARK7
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.33143142290141187,1.0829502895701786,0.3010471204188482,0.924661521796235,1.0,32/140,12.41%,ARHGAP28;ARHGAP29;CGNL1;RHOQ;ARHGEF18;RHOD;ARHGEF16;SRGAP3;SRGAP2;FGD4;ARHGAP18;SYDE2;ARHGAP9;NGEF;AKAP13;ARHGAP6;GMIP;ARHGAP26;ARHGAP17;ARHGEF12;ARHGEF11;ARHGAP23;ARHGEF1;OPHN1;CYRIB;CDC42;ARHGAP12;FGD1;SOS2;OCRL;ITGAV;RALBP1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.35275929431663317,-1.0825114134828904,0.3263707571801567,0.6546469553239905,1.0,13/37,17.34%,CLASP2;EFNA5;PHLDB1;GSK3B;STMN2;MAP6;MARK2;FAM107A;TRIM36;MAPT;BICD2;STMN1;TPPP
prerank,neuromuscular process (GO:0050905),-0.42293714754755996,-1.0822786018248864,0.33488372093023255,0.6544146801741346,1.0,4/16,8.10%,NRXN1;GCH1;STRA6;MYCBP2
prerank,negative regulation of viral transcription (GO:0032897),-0.44983683454905243,-1.0820166786501613,0.3597560975609756,0.6542952385984949,1.0,4/13,11.76%,MID2;TRIM14;TRIM27;IFITM3
prerank,regulation of histone acetylation (GO:0035065),0.41602568973863296,1.081781462903095,0.36348949919224555,0.927150745550473,1.0,5/33,5.98%,PPARGC1A;KMT2A;RAPGEF3;ARRB1;CAMK1
prerank,sensory perception of light stimulus (GO:0050953),0.3555623420667917,1.0816152931366938,0.3541666666666667,0.9265630941313701,1.0,11/87,8.02%,ZIC2;WHRN;COL18A1;EML2;RGS16;EYA4;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5150566524216862,1.0814318484936218,0.3796477495107632,0.9260298181106598,1.0,3/10,12.74%,LPGAT1;SLC45A3;MLXIPL
prerank,acylglycerol biosynthetic process (GO:0046463),0.4476399117278511,1.081336693136072,0.3844797178130511,0.9252021305582234,1.0,4/23,7.09%,LPGAT1;MOGAT3;GPAT2;GK
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.38430174667389194,-1.0811092084095786,0.34513274336283184,0.655696220633979,1.0,12/25,38.46%,HSPA8;HSPA5;HSPE1;PTGES3;DNAJB1;ERO1A;HSPA13;HSPA9;DNAJB4;HSPA1L;ST13;SDF2L1
prerank,defense response to symbiont (GO:0140546),0.34665539496891584,1.0806410223627614,0.3559322033898305,0.9261701695315682,1.0,20/92,14.68%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MOV10;MAVS;ATG7;IRF1;OAS3;ACOD1;IFNAR2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4107500167057033,1.0806129225630339,0.34840871021775544,0.9251583310835014,1.0,8/31,12.06%,TGFBR3;FGFR2;BMPR1A;TGFBR1;TPM1;NRG1;TNNI3;TNNC1
prerank,skeletal muscle contraction (GO:0003009),0.4603245218144669,1.0792576182435063,0.36813186813186816,0.9282667821207711,1.0,4/19,12.06%,RCSD1;CCDC78;TNNI3;TNNC1
prerank,androgen receptor signaling pathway (GO:0030521),0.5136453546254018,1.079194992582149,0.39363817097415504,0.9273670739034174,1.0,4/11,10.72%,DDX5;PMEPA1;TMF1;ZMIZ1
prerank,regulation of DNA replication (GO:0006275),0.3846175234714131,1.0791311291269199,0.350547730829421,0.9264854921837712,1.0,16/49,16.60%,GLI2;CCNA2;ZBTB38;ANKRD17;DSCC1;PDS5A;GLI1;GTPBP4;WAPL;KAT7;CDAN1;ORC3;FAF1;EHMT2;USP37;SMC3
prerank,positive regulation of lipid localization (GO:1905954),0.5143723561188304,1.079003931823213,0.39433962264150946,0.9258093224177195,1.0,3/11,14.40%,IKBKE;LRP1;NFKB1
prerank,positive regulation of immune effector process (GO:0002699),0.42940348781888,1.0786718242632807,0.36258278145695366,0.9257429093928594,1.0,6/27,11.11%,APPL2;MYO18A;ANKRD17;IL12B;DDX60;DHX58
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3414497981140109,1.0785643862217307,0.332421340629275,0.924996252004962,1.0,21/102,15.54%,CPEB2;ADCY5;SORBS1;RHOQ;ADCY1;SLC30A10;INSIG2;GCK;ADCY9;PDPK1;RAB13;FER;PRKDC;PRKCI;DENND4C;PRKAR1A;ADCY6;NFKB1;KAT2B;ZFP36L1;RAB8B
prerank,regulation of osteoclast differentiation (GO:0045670),0.4055751824792831,1.0784814685608832,0.3580858085808581,0.9241784858023239,1.0,5/33,6.62%,GPR137;TLR3;TLR4;IL12B;FBN1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.326855099241581,-1.0783182901994466,0.3109919571045576,0.6619051684957071,1.0,32/50,48.85%,PSMB2;PSMD14;PSMC6;PSMB9;PSMA4;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;OAZ1;PSMB5;OAZ2;ODC1;PSMD7;PSMF1;PSMA5;PSME4;PSMA7;PSMD3;PSMD4;PSMC2;OAZ3;PSMD1;PSMC3;PSMD8;PSMB11;PSMB8;PSMB7;PSMB1;PSMA8;PSMD5
prerank,replicative senescence (GO:0090399),0.5160108702147871,1.0778271150887915,0.38791423001949316,0.9250715945850244,1.0,4/12,8.10%,ATM;TP53;SERPINE1;TERT
prerank,acyl-CoA metabolic process (GO:0006637),0.40820857775904934,1.077756011380644,0.36019736842105265,0.9242034063065655,1.0,8/35,13.46%,SUCLG2;OGDH;HMGCS2;ACOT11;MLYCD;ACOT8;SUCLA2;THEM4
prerank,regulation of protein ubiquitination (GO:0031396),0.341425522725614,1.0777304724076253,0.3203342618384401,0.9232090562673582,1.0,14/108,9.85%,SH3RF2;NXN;SASH1;PRKN;SPHK1;HDAC8;TGFBR1;LRRK2;ARRB1;FANCI;HUWE1;CDK5RAP3;RIPK2;GTPBP4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.37247482866171067,-1.0777302202435892,0.32235294117647056,0.6625888962952949,1.0,14/29,31.15%,RAD23B;UBB;RPA1;CETN2;GTF2H4;GTF2H1;GTF2H5;ERCC2;UBC;RPS27A;ERCC3;DDB1;RPA3;RPA2
prerank,regulation of transmembrane transport (GO:0034762),-0.35942622288513826,-1.0776125269437584,0.3381294964028777,0.6621089013318812,1.0,12/31,15.93%,SLC2A1;ACTB;KCNJ3;KCNJ2;NEDD4L;OCLN;ACE2;SNCA;KCNJ8;KCNJ6;KCNJ12;PIM1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.44863435742374763,1.077522186600874,0.37918871252204583,0.9227756221375468,1.0,4/20,6.95%,SLC8A3;MCU;SLC25A23;MICU1
prerank,cell projection assembly (GO:0030031),-0.39373874038251283,-1.0769728465954747,0.34558823529411764,0.6628775588614131,1.0,5/22,10.20%,RHOJ;GSN;PARVB;RHOH;PDGFA
prerank,embryonic organ development (GO:0048568),0.372225587497135,1.0768556514373846,0.35098335854765506,0.9237409034605307,1.0,15/61,11.18%,KIT;KMT2A;FGFR2;GLI2;BMPR1A;GLI3;TEAD3;COL13A1;TGFBR2;RBP4;IFT122;GDNF;TEAD2;FLT3LG;TEAD1
prerank,glycolipid biosynthetic process (GO:0009247),0.3963100883341055,1.0767734025369997,0.3560732113144759,0.9229178592320413,1.0,6/38,6.47%,LARGE1;GBGT1;PIGN;PIGW;ST3GAL5;PIGQ
prerank,negative regulation of dephosphorylation (GO:0035305),0.4560361222074509,1.0766847634386498,0.3644067796610169,0.922135114735428,1.0,2/18,7.02%,SH3RF2;SH2D4A
prerank,regulation of autophagosome maturation (GO:1901096),0.5002184220158792,1.0766114531014792,0.394392523364486,0.9212887711099683,1.0,4/13,16.43%,FYCO1;UVRAG;IRGM;TBC1D25
prerank,regulation of B cell activation (GO:0050864),-0.3840414011906565,-1.0764968201244263,0.3583959899749373,0.6632430814012673,1.0,13/25,41.77%,SH3KBP1;SAMSN1;LAPTM5;NOD2;AHR;FOXJ1;THEMIS2;TNFAIP3;BANK1;IL4;CD22;IL4I1;IL6
prerank,diol biosynthetic process (GO:0034312),-0.4410517279358176,-1.0762016215797685,0.37250554323725055,0.6631759808697192,1.0,6/15,13.69%,ACER3;ACER2;SPTLC2;GCH1;ASAH2;QDPR
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3853608839787882,-1.0758422435921478,0.34988179669030733,0.6633104497168254,1.0,6/23,22.91%,PLA2G4A;MBOAT1;PLA2G12A;ABHD4;PLA2G4E;PLA2G4F
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4738464820396228,1.0755104489705298,0.37785588752196836,0.9235670650352729,1.0,4/15,13.35%,TLR4;DDX3X;EIF2AK2;DHX33
prerank,regulation of cytoplasmic transport (GO:1903649),0.5175460507135259,1.0754871881085974,0.3684210526315789,0.9225657445433855,1.0,5/11,20.36%,LRRK2;USP7;MAP2K1;MAP2K2;DNAJC13
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4317693368866059,-1.0754806640280736,0.3789237668161435,0.6633656119304938,1.0,4/15,10.46%,PTK2B;KDR;BMX;TEC
prerank,double-strand break repair (GO:0006302),0.3214459668502928,1.0752917259445631,0.33246753246753247,0.9221107069450184,1.0,36/158,19.93%,EYA1;PAXX;POLM;BABAM2;DNTT;ATM;NHEJ1;BAZ1B;RNF8;FBH1;SAMHD1;KDM2A;IFFO1;XRCC4;PARP9;EME2;RBBP8;PRKDC;UIMC1;HUS1;RAD50;NSMCE2;BABAM1;ZFYVE26;TDP2;POLL;XRCC3;NBN;APTX;FEN1;SUMO1;SLX4;RAD51D;PIAS4;MCM9;MTA1
prerank,cardiac muscle cell development (GO:0055013),-0.400439350059211,-1.0751633687450184,0.3686635944700461,0.6633244917805637,1.0,5/20,9.47%,SORBS2;SLC8A1;FHOD3;HEY2;MYH11
prerank,protein trimerization (GO:0070206),-0.43104886390908675,-1.0751164778136595,0.3681917211328976,0.6618565658672484,1.0,6/14,12.76%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,protein homotrimerization (GO:0070207),-0.43104886390908675,-1.0751164778136595,0.3681917211328976,0.6618565658672484,1.0,6/14,12.76%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,negative regulation of defense response to virus (GO:0050687),0.5133725137621753,1.075048710262445,0.4048964218455744,0.9218060260822699,1.0,2/10,14.36%,PCBP2;PPM1B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.504184561232187,1.074841923447572,0.3896353166986564,0.921374217215007,1.0,3/11,11.58%,DONSON;FBH1;MSH3
prerank,negative regulation of autophagy (GO:0010507),0.3770115718005603,1.0746404915354075,0.3474320241691843,0.9208381197348516,1.0,17/54,19.63%,LEPR;NUPR1;LRRK2;SNRNP70;SMG1;PTPN22;PIK3CA;TAB2;ATG7;TSC1;ZKSCAN3;TLK2;MCL1;EIF4G1;TBC1D14;GOLGA2;EIF4G2
prerank,pulmonary valve morphogenesis (GO:0003184),0.46170476078109957,1.0744594888789707,0.3747779751332149,0.9203200357379605,1.0,2/17,0.29%,NOTCH2;ROBO1
prerank,regulation of activated T cell proliferation (GO:0046006),0.4174977519039393,1.0739751121816812,0.36869565217391304,0.9206825776072968,1.0,7/30,18.45%,IGF1;IL18;IL12B;CD274;PRKAR1A;IGFBP2;AGER
prerank,positive regulation of phospholipase activity (GO:0010518),0.4483556917758318,1.0738109698217257,0.3786231884057971,0.9201200971805248,1.0,6/22,8.69%,KIT;FGFR2;FGFR1;PDGFRB;FLT1;PDPK1
prerank,cellular response to lectin (GO:1990858),-0.2879158375898983,-1.0735686856037274,0.31690140845070425,0.6641326789409333,1.0,21/104,19.55%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;PSMB9;RELB;PSMA4;SYK;ICAM2;SKP1;PSMD11;PSMB10;TYROBP;PSMD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2879158375898983,-1.0735686856037274,0.31690140845070425,0.6641326789409333,1.0,21/104,19.55%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;PSMB9;RELB;PSMA4;SYK;ICAM2;SKP1;PSMD11;PSMB10;TYROBP;PSMD2
prerank,receptor-mediated endocytosis (GO:0006898),-0.27655037237088337,-1.0728878450566968,0.25301204819277107,0.6650136553352172,1.0,33/132,13.17%,LRP1B;DNM3;SGIP1;CALCRL;CAV1;CD9;FNBP1L;SCARB1;CAV2;TFRC;RAB31;TMEM108;RAMP2;SNAP91;APOE;LDLR;ACKR3;ITGB1;DNM1;SORL1;STAB1;HSPG2;AP2B1;CALR;SCARF1;CXCL16;PPT1;HSP90AA1;AP2M1;CTSL;RAMP1;VLDLR;SNCA
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3624230393234645,-1.072812672411427,0.33915211970074816,0.6644164127649677,1.0,10/30,22.05%,DACH1;BMPR2;ACVRL1;GNL3L;CDKN1A;STN1;TERF1;MEN1;EXOSC10;DCP2
prerank,regulation of protein acetylation (GO:1901983),0.4925226755779809,1.0725516272754054,0.3643122676579926,0.9228667955380553,1.0,4/12,9.64%,RAPGEF3;DDX3X;CAMK1;SIRT1
prerank,tight junction assembly (GO:0120192),0.3849325976420133,1.0720920149243571,0.3632,0.9231160444815251,1.0,3/49,1.68%,PARD6G;AFDN;DLG1
prerank,histone deacetylation (GO:0016575),0.39100189521326545,1.0719016681185163,0.3546325878594249,0.9226528225545052,1.0,16/43,23.97%,HDAC8;TBL1X;TBL1XR1;HDAC1;HDAC4;SIRT1;PRDM5;SIN3A;PER2;MTA2;MIER3;RCOR1;MTA1;REST;MIDEAS;MSL3
prerank,negative regulation of cell development (GO:0010721),0.41496523350812736,1.071777622099766,0.3701754385964912,0.9219195557264818,1.0,3/25,6.62%,APPL2;IGF1;FBN1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2861320277248064,-1.0714225799441304,0.31010452961672474,0.6671202641006805,1.0,21/105,19.55%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;PSMB9;RELB;PSMA4;SYK;ICAM2;SKP1;PSMD11;PSMB10;TYROBP;PSMD2
prerank,smoothened signaling pathway (GO:0007224),0.4134225711547332,1.0709344328541681,0.37335526315789475,0.9233065862177426,1.0,12/32,19.14%,CC2D2A;GLI2;GLI3;SMO;GLI1;DHH;TMEM231;STK36;EVC2;TCTN3;TMEM17;IHH
prerank,response to glucocorticoid (GO:0051384),-0.3796405913676183,-1.0708649412978466,0.3556085918854415,0.6676856800040714,1.0,5/26,20.59%,SLIT2;ANXA1;FAM107A;BCL2L11;SLIT3
prerank,nucleotide metabolic process (GO:0009117),0.4409149037636555,1.0707123160100105,0.3910806174957118,0.9229311965327935,1.0,7/23,16.60%,FHIT;NMNAT1;ENPP3;AK4;CTPS2;AK8;NMNAT2
prerank,calcium ion import (GO:0070509),-0.3705729216864221,-1.0705062151617115,0.3597122302158273,0.6677301807677366,1.0,10/28,12.55%,SLC8A1;CACNB2;CACNA1E;CACNA1G;TRPC4;MICU3;CACNA1B;TRPV4;SMDT1;MCUB
prerank,negative regulation of transport (GO:0051051),0.3757129471288766,1.0703925150512623,0.38284839203675347,0.922883309665971,1.0,18/51,20.96%,SYT11;PRKN;FER1L5;PLSCR1;PTEN;NRG1;ITGAV;WWP2;SNX12;EPHA3;PIP4P2;CRYAB;LGALS3;NDFIP1;NR1H3;SIRPA;SNX33;RAB7A
prerank,dephosphorylation (GO:0016311),-0.27573846745369535,-1.0702160510862737,0.2663755458515284,0.667635695556698,1.0,29/147,10.98%,PTPRB;PTPRM;PTPRD;PTPRJ;PTPRG;PTPN12;PPM1H;PTPRK;PTPRT;PPM1L;PLPP1;PTPRN2;PLPPR1;PPP1R12A;PPP2R5A;PTPRC;PTPRF;ALPL;PPP2R1A;MTMR6;PPP3CA;PTPRZ1;PTPRE;MTMR2;PLPPR5;PLPPR4;MTMR7;DUSP1;DUSP3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4954579444451526,1.0701309435319137,0.37401574803149606,0.9226696278206697,1.0,4/12,7.81%,CD300A;ELF1;PTPN22;ELF2
prerank,mitochondrial fusion (GO:0008053),0.45676650317027984,1.06999599380046,0.3827392120075047,0.9220443518566782,1.0,6/18,19.58%,CHCHD3;MIGA2;OPA1;MFN2;MFN1;AFG3L2
prerank,positive regulation of cartilage development (GO:0061036),-0.42514326092836546,-1.069904036727318,0.37831858407079644,0.6676095742942832,1.0,7/17,18.13%,BMPR2;ACVRL1;ZBTB16;BMP2;BMP4;BMPR1B;PKDCC
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4712353960456527,1.0697858226884573,0.39926062846580407,0.921662164067209,1.0,2/15,1.53%,FGF1;SMOC2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3916467659259049,1.0692740529258609,0.357487922705314,0.922110849501578,1.0,11/41,13.28%,ACE;EPHA4;ADRA2A;DLG3;GPRC5B;HBEGF;NOX4;CASS4;ADAM17;SRCIN1;TGFA
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.42780730839168146,1.0691882284566145,0.368141592920354,0.9213121642929748,1.0,8/24,15.76%,LEPR;PPARGC1A;COQ10A;NDUFS1;COX10;LYRM7;SDHAF4;GFPT1
prerank,regulation of protein export from nucleus (GO:0046825),0.44231895314179026,1.069078714015717,0.37043478260869567,0.9205988670506765,1.0,6/23,8.90%,PTPN14;IFI27;RAPGEF3;CAMK1;TP53;TCF7L2
prerank,epidermal cell differentiation (GO:0009913),-0.34740851382323623,-1.0684143401964818,0.3333333333333333,0.670536960987576,1.0,11/41,21.04%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;CTNNB1;WNT16;ERCC2;GATA6;ASAH1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.45246888809020935,-1.0683548570620192,0.39835728952772076,0.6698993022590428,1.0,5/13,19.27%,HSPA5;DDRGK1;BFAR;NCK1;PTPN1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2931570804091722,-1.0682745372392743,0.29591836734693877,0.6693067843056161,1.0,11/91,6.10%,NRP1;HIP1;SYT1;RIMS2;CDH13;STXBP5L;RIT2;SCARB1;STON2;RAB3C;PTPRC
prerank,regulation of nervous system development (GO:0051960),-0.34260475632128917,-1.0668731859193903,0.3426395939086294,0.6719555019617016,1.0,13/37,21.68%,TENM4;HES1;TNFRSF1B;HEYL;PTPRZ1;HEY2;PTN;CTNNB1;CX3CR1;SIRT2;YTHDF2;LGI4;GBX1
prerank,muscle cell development (GO:0055001),0.4203484671920764,1.0664273437487592,0.3729641693811075,0.9276065882230979,1.0,4/30,2.11%,NEBL;ANK2;IGF1;MYOF
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.36555057949674186,-1.066259602894341,0.34782608695652173,0.6726685004698265,1.0,7/29,14.84%,BMP5;DAB2IP;IL17RD;SMAD7;ADIPOR1;SPRY1;SPRED1
prerank,macrophage activation involved in immune response (GO:0002281),-0.4345012900964255,-1.0659543415125825,0.34894613583138173,0.6726693346350492,1.0,7/13,19.31%,PLCG2;DYSF;SBNO2;CX3CR1;LBP;SYK;TYROBP
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4749337028973436,1.0658849069262364,0.3694390715667311,0.9281650566220204,1.0,2/15,3.76%,SH3D19;ADRA2A
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4657867811395461,1.0658488527571892,0.38446969696969696,0.9272327200082859,1.0,5/16,19.01%,TOP2B;FANCM;EME2;MSH4;SLX4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3558154787941468,1.06584824723718,0.3637702503681885,0.9261919032306957,1.0,16/74,13.31%,DAB2;SMAD3;TGFBR1;FOXC1;CLASP1;PDPN;DAG1;LDLRAD4;WWTR1;TGFBR2;PTEN;PHLDB2;AXIN2;SNAI1;FOXA2;EPHA3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.32010420824719743,-1.0654827647742986,0.3601108033240997,0.6731070793127557,1.0,22/53,36.03%,PSMB2;PSMD14;PSMC6;PSMB9;PSMA4;PSMD11;PSMB10;PSMD2;BCKDK;PSMA2;PSMB3;OAZ1;PSMB5;OAZ2;ODC1;PSMD7;PSMF1;PSMA5;PSME4;PSMA7;PSMD3;PSMD4
prerank,epidermis development (GO:0008544),0.36807644652574073,1.0652061121357455,0.363914373088685,0.9269709855145463,1.0,8/56,11.54%,LAMC2;CCN2;FGFR2;CRABP2;SVEP1;HDAC1;GLI1;FLOT2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.40611194317583316,-1.0651553454096205,0.3877551020408163,0.6731676797657525,1.0,5/19,6.21%,PRKCH;CLDN5;F11R;RUNX1;OCLN
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.48000449543925305,-1.065041432277236,0.3784313725490196,0.6726344970866058,1.0,3/10,6.13%,KDR;IL33;NAMPT
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4835464516036182,1.0649349874968659,0.4084249084249084,0.9267575387188302,1.0,3/15,8.69%,FGF1;FUT1;PDPK1
prerank,serine family amino acid catabolic process (GO:0009071),0.5096005662467886,1.0647998197039876,0.40789473684210525,0.9261048386051498,1.0,4/10,22.51%,DLD;THNSL2;AMT;CBS
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.34633860297516605,-1.0642158548880378,0.3350125944584383,0.673846535698158,1.0,12/36,15.05%,LEF1;GNG2;NLK;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;CTNNB1;GNAO1;GNB1
prerank,regulation of anoikis (GO:2000209),-0.4104324301461501,-1.0638381315060288,0.34649122807017546,0.6741018926698145,1.0,8/19,19.61%,CAV1;NOTCH1;ITGB1;PTK2;ANKRD13C;MYBBP1A;ITGA5;PTRH2
prerank,zinc ion transport (GO:0006829),0.4436160550441061,1.0636404625910165,0.39152542372881355,0.9284236439177487,1.0,3/21,8.32%,SLC30A10;SLC30A2;SLC39A13
prerank,negative regulation of apoptotic process (GO:0043066),0.2942817640976613,1.0632930660713393,0.3082872928176796,0.9283758603702145,1.0,54/444,9.82%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;PPARGC1A;IGF1;PRKAA2;PRKN;SLC30A10;RETREG1;FNIP1;PKHD1;GRK5;ALOX12;SPHK1;SON;SNX6;CPEB4;RNF213;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;TNFAIP8;BABAM2;BID;ZFAND6;MYO18A;SMAD6;CTSH;DDX3X;CD27;MAP2K5;SOD2;BRAF;AVEN;NUAK2;CD28;TP53;OPA1;COMP;ANXA5;KDM2B;PIK3CA;GDNF;TLE1;HDAC1;NIBAN2;SIRT1;RIPK1;RIPK2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4069334169926979,-1.0632300156885373,0.3995584988962472,0.674791049763452,1.0,6/17,13.53%,CAV1;KLF7;AJAP1;CEACAM1;APOLD1;MAFF
prerank,second-messenger-mediated signaling (GO:0019932),-0.2949790306669979,-1.063144903053317,0.3018867924528302,0.6742440715269611,1.0,28/82,20.73%,MCTP1;PLCE1;NOS3;CHRM3;RYR2;NDNF;GUCY1B1;KSR2;GUCY1A1;APOE;PLCG2;ACKR3;PPP2R1A;AGTR1;CAMKK2;P2RY12;EDN1;NOS1;EDN3;EDNRB;HRH1;CX3CR1;EIF2AK3;BTK;PPP1R9A;MCTP2;AGT;RCAN3
prerank,actin filament organization (GO:0007015),0.3205562354803352,1.062831440527548,0.3416230366492147,0.9286924923081218,1.0,29/151,11.48%,NEBL;CGNL1;DLG1;SHROOM2;RHOBTB2;AVIL;RHOD;FHOD1;SHROOM3;INPPL1;TMOD2;MYO5C;MCU;RUFY3;TPM1;TMOD3;BAIAP2L1;BAIAP2;ARHGAP17;MPRIP;TRIOBP;MYO19;WASL;CARMIL2;CDC42;CASS4;ARHGAP12;BIN3;VIL1
prerank,regulation of signal transduction (GO:0009966),-0.26097962156041987,-1.0622727128852103,0.25892857142857145,0.6756318430417985,1.0,45/190,14.17%,ESR1;RSPO3;PLCE1;RGS3;LIFR;UBASH3B;RGS5;MDFIC;KCTD8;RGS6;SEMA5A;NCK2;RUNX1;MGLL;TMEM108;UGCG;PPIA;IGFBP4;APP;HHIP;SOCS2;PTCH1;PRAG1;TSPAN12;SREBF2;CRK;IGFBP6;PPP2R1A;TMEM204;FRMPD1;YWHAG;TGFB1;LFNG;KIF26A;RGS4;MFNG;GLRX2;HOMER1;ILK;PRKD1;AXIN1;RGS20;RGS12;ACVR1;SOCS5
prerank,UV protection (GO:0009650),-0.46769623010282596,-1.061887110709857,0.3824130879345603,0.675770366375968,1.0,5/10,20.37%,MFAP4;SDF4;CAT;GPX1;ERCC2
prerank,reverse cholesterol transport (GO:0043691),-0.4511854921228633,-1.0618041704525607,0.3859275053304904,0.6751990650675903,1.0,4/13,14.73%,SCARB1;APOE;ABCG1;CLU
prerank,alcohol catabolic process (GO:0046164),0.5150358422149979,1.0617538167989937,0.40329218106995884,0.9308366182381305,1.0,2/10,3.83%,CYP27A1;CEL
prerank,regulation of exosomal secretion (GO:1903541),0.4412402001985123,1.0614222326210583,0.3789279112754159,0.9308101758593352,1.0,8/19,21.92%,PRKN;SDC4;SMPD3;VPS4A;SNF8;CHMP2A;RAB7A;SDCBP
prerank,positive regulation of viral process (GO:0048524),0.36571327872356657,1.0612610436919958,0.3610698365527489,0.9302494515414141,1.0,15/60,15.49%,PPARA;POLR2A;IFIT1;DDX3X;CD28;POLR2D;LARP1;GTF2F1;SRPK2;KPNA6;NELFCD;HACD3;AXL;CTDP1;VPS4A
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.44689382783110815,1.0610601631323475,0.4175824175824176,0.9297798346149901,1.0,2/22,3.42%,ROCK2;PPP4R4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4242224610179123,-1.0609954345983277,0.3619631901840491,0.6764031907798506,1.0,9/15,22.56%,SIX1;BMP4;VEGFA;PAX2;SOX8;SIX4;PAX8;AGT;LHX1
prerank,regulation of cell development (GO:0060284),0.40102555125082195,1.0607527697278827,0.38449111470113084,0.9296605686861709,1.0,8/36,14.38%,NOTCH2;BHLHE41;ADGRA2;DOCK7;FBXO22;PRUNE1;HES6;PER2
prerank,positive regulation of cell cycle process (GO:0090068),0.34284929644906736,1.0604611656350935,0.3627450980392157,0.9294497465207339,1.0,19/91,18.95%,PKP4;IGF1;PHIP;PDGFRB;ATRX;CD28;CDC14A;PLSCR1;AURKB;CDC14B;CDC42;TGFA;DYNC1LI1;CENPV;PKN2;BTC;XRCC3;CEP120;FEN1
prerank,nucleic acid metabolic process (GO:0090304),0.3578839126097858,1.0602794711445196,0.38200589970501475,0.9290020009894044,1.0,20/69,19.51%,POLR2A;PCBP2;DNTT;POLG;HNRNPR;HNRNPH1;HNRNPA2B1;DNASE1L1;ATXN2;POLR2D;GTF2F1;HNRNPL;RAD50;HNRNPC;WTAP;DNASE1L2;HNRNPM;MMS19;FEN1;DXO
prerank,cellular protein modification process (GO:0006464),0.2815117063782086,1.0600486551145893,0.2649746192893401,0.9286651882734936,1.0,174/982,14.49%,PRKAG2;EPAS1;UST;WNK4;PTPN13;ROCK2;APLP2;UBE2E2;DUSP29;ITIH2;OXSR1;MSRA;PRKCZ;ASB2;CP;SERPIND1;FAM20A;PRKAA2;PTPN14;LAMC1;SPP1;PTPN9;MACROD1;OBSL1;GRK5;SPSB1;LARGE1;MTMR3;PRKAG3;PPEF2;PPP1CB;FGFR1;NGLY1;LOXL1;BMPR1A;PPM1E;IGFBP7;TGFBR1;DMPK;AAK1;LRRK2;PARP10;CEL;TP53RK;NAA80;KRT1;FUT1;DCAF11;ST3GAL3;IKBKE;PARP14;PRKCB;DAPP1;ATG10;LHPP;KNG1;FBXL19;ATM;METAP2;ST3GAL5;PRRT1;KLHL41;TIPARP;CAMK1;BRAF;ATG5;NUAK2;SPSB4;TRIB2;EIF2AK2;WIPI1;SIK1;FBN1;CDC42BPG;LGALS1;SIRT5;FUT10;PARP4;TRIOBP;PTPN22;TGFBR2;PTPRU;FBXW11;PTEN;RABGGTA;TNKS2;IGFBP3;COQ8B;BTRC;PP2D1;RYK;SIRT3;MANBA;PPP2R1B;PDPK1;NUCB1;CSNK1A1;PARP9;RCE1;PICK1;PTPN21;ASB15;ZC3HAV1;SIRT1;DCAF10;FBXO22;LRRC41;CTH;MKNK1;BRSK1;FBXL12;ATG7;RAB11B;RAB13;ABL1;FER;ARAF;DYRK1A;SRPK2;AURKB;CDC14B;PARP6;MYLK3;UBE2M;FBXW8;FNTB;FBXO4;TRIB1;PPP2R5E;PRKDC;PRKCA;DUSP10;SOCS3;DUSP2;CUL9;MAPK6;PTPN4;CSNK2A1;CUL4A;PORCN;MAN2A1;WWP2;ASB14;CTDSP2;HIPK3;ASB5;FBXO10;MIA3;FRK;NUB1;HLCS;SIRT4;MBTPS1;MAP3K1;PRKCI;MAPK10;PRKCSH;MAP2K1;WNK1;ART4;ASB12;GRK3;ROS1;DDB2;FBXO11;BMP2K;COQ8A;STK36;FBXL20;PPM1B;SERPINC1;ACVR2B;STK17B;ACVR1B
prerank,cell differentiation in hindbrain (GO:0021533),-0.4581432878673085,-1.060029327709907,0.4100418410041841,0.6780514479747205,1.0,2/11,8.35%,GRID2;PROX1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3375592210169857,-1.0597269595665098,0.353099730458221,0.677996108975075,1.0,12/44,15.91%,GSN;NCK2;EVL;PTK2B;CARMIL1;CDC42EP3;BIN1;PFN2;ARPC4;CDC42EP2;NCK1;ARF6
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.35515601988000534,-1.0596227072797653,0.3569620253164557,0.67748432511506,1.0,9/34,10.98%,PTPRB;PTPRJ;PTPN12;UBASH3B;PTPRT;PTPRF;PTPRZ1;DUSP1;DUSP3
prerank,response to axon injury (GO:0048678),-0.40430251382065774,-1.0594752630905033,0.39732142857142855,0.6770556574768778,1.0,6/18,21.55%,GAP43;APOD;P2RY12;RTN4RL1;TYROBP;SOD1
prerank,neural crest cell differentiation (GO:0014033),-0.40780695323515737,-1.0593704164529538,0.40792540792540793,0.6765508607426586,1.0,2/18,1.17%,MEF2C;CDH2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.46614545896229687,1.0588756631754648,0.39421338155515373,0.9311273650186938,1.0,8/16,25.84%,NAA80;NAA20;KAT2B;NAA16;CREBBP;EP300;NAA50;AANAT
prerank,receptor catabolic process (GO:0032801),0.42525670411744415,1.0581963504052054,0.40176991150442476,0.9320192883992524,1.0,5/24,10.39%,RNF43;NEDD4;UVRAG;CLTC;BECN1
prerank,icosanoid biosynthetic process (GO:0046456),-0.47946789069580664,-1.0581365845621888,0.4011627906976744,0.6788045264387357,1.0,5/10,29.91%,PLA2G4A;LTA4H;FADS1;MGST2;ALOX5AP
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.37123151611009286,1.0579348451574373,0.3673469387755102,0.9317318263061587,1.0,13/50,13.89%,SASH1;SPHK1;NFAT5;TLR3;TLR4;DDX3X;CD27;EIF2AK2;IL12B;TRIP6;NMI;IFI35;NR3C2
prerank,isotype switching (GO:0045190),0.5189802962744949,1.0578529512285604,0.4144486692015209,0.930937421440628,1.0,6/10,31.09%,RNF8;EXOSC3;LIG4;BATF;HSPD1;MSH6
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.44064590911213203,1.0573933021549746,0.4100346020761246,0.9313088702958529,1.0,4/21,6.95%,SLC8A3;MCU;SLC25A23;MICU1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.402669117104029,1.0573008651844733,0.3853989813242784,0.9305530837429313,1.0,8/34,18.32%,IGF1;PHIP;PDGFRB;CD28;NSMCE2;TGFA;RB1;BTC
prerank,muscle tissue morphogenesis (GO:0060415),0.4615955161124308,1.0567474353228516,0.4010889292196007,0.9311337729317669,1.0,1/16,0.33%,TGFBR3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4655883546542522,1.0566345124891394,0.41834862385321103,0.9304503515013257,1.0,2/17,3.17%,NOTCH2;BMPR1A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.49824436902581126,1.0563784015735374,0.4101123595505618,0.9301483582341601,1.0,3/10,9.75%,APPL2;PRKCB;GRB10
prerank,actin filament network formation (GO:0051639),-0.46354865590695327,-1.0563768168385221,0.4321503131524008,0.6823005428221871,1.0,6/11,16.44%,ACTN1;CARMIL1;FHOD3;PLS1;COBL;PLS3
prerank,rRNA transcription (GO:0009303),-0.4089849198499249,-1.0562310937888366,0.3648068669527897,0.6818919911882593,1.0,4/17,12.97%,CAVIN1;SPIN1;GTF3C5;TAF1B
prerank,skin development (GO:0043588),0.3562264431135211,1.0561037462303562,0.36603221083455345,0.9299077912773519,1.0,6/65,6.54%,COL5A1;ERRFI1;ALOX12;CASP3;DACT2;COL1A2
prerank,positive regulation of organelle organization (GO:0010638),0.4101879795730582,1.0559290776897103,0.3983606557377049,0.9293749081098834,1.0,4/32,5.81%,PPARGC1A;STX18;FYCO1;UVRAG
prerank,regulation of postsynapse organization (GO:0099175),-0.3594792291524438,-1.0558815738606429,0.3611111111111111,0.6819685295072772,1.0,10/28,14.04%,IL1RAPL1;PPFIA2;SHANK3;TANC2;CDKL5;ABI3;HOMER1;CFL1;ABHD17B;CDK5R1
prerank,regulation of peptidase activity (GO:0052547),-0.4006584174243389,-1.0558235647567429,0.3842887473460722,0.6813418875533378,1.0,5/19,14.59%,CAV1;CST3;ECM1;PINK1;MAPK12
prerank,postsynaptic membrane organization (GO:0001941),-0.4133171450258587,-1.0554932220589743,0.4178082191780822,0.6813799952912015,1.0,5/17,6.50%,NLGN1;NRXN1;SHANK3;GPHN;APOE
prerank,digestive tract morphogenesis (GO:0048546),0.4688386128832216,1.0550089715203956,0.40535372848948376,0.9310355134027607,1.0,5/14,13.96%,FGFR2;NIPBL;GLI1;RBPMS2;PDGFRA
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.360625511327701,-1.05442457955013,0.3460559796437659,0.683224511355938,1.0,9/30,17.22%,TPT1;CXCL12;RPS3;ACKR3;CD44;TWIST1;THOC5;CLU;CD74
prerank,aminoglycan biosynthetic process (GO:0006023),0.36953138626102033,1.0543690757563546,0.3664,0.9319083257303796,1.0,5/49,4.40%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.34743667457279737,-1.0542375252865976,0.37054631828978624,0.6828959863787186,1.0,7/36,13.03%,NRP1;SHANK3;ITGB1;RELN;EPHB2;EDN1;HIF1A
prerank,serine family amino acid biosynthetic process (GO:0009070),0.47536186812101383,1.0536579873079042,0.3931947069943289,0.9330286630647491,1.0,5/12,22.51%,SRR;CTH;PHGDH;MTHFD1;CBS
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4365301956381718,-1.0536063823684447,0.40492170022371365,0.6836449542917121,1.0,5/13,21.03%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3294400315611808,-1.053540965050227,0.3633720930232558,0.6830094006033292,1.0,18/47,19.95%,PID1;THBS1;RAB27A;PLCG2;AGTR1;TGFB1;XDH;CYBA;ACE2;CDKN1A;MAPT;ADGRB1;GRIN1;SYK;ITGB2;ROMO1;TYROBP;AGT
prerank,plasma membrane repair (GO:0001778),0.4763653739830654,1.0533304376608577,0.4098360655737705,0.9329760521573331,1.0,3/13,6.98%,SYT11;MYOF;FER1L5
prerank,positive regulation of cell adhesion (GO:0045785),-0.29774182414084266,-1.0532281330977453,0.36728395061728397,0.6829997226525993,1.0,19/74,14.41%,FRMD5;ZFHX3;PTPRJ;TGFB2;VIT;CXCL12;NDNF;EPB41L4B;STX3;FBLN2;PPP3CA;SMAD7;CD47;ERBB2;P2RY12;RET;VEGFA;ADGRG1;PPM1F
prerank,negative regulation of phosphorylation (GO:0042326),0.34710567324367997,1.052944202694192,0.35555555555555557,0.9330474691047103,1.0,17/85,11.60%,BMP7;PTPN13;FBLN1;PPARA;PRKN;NUPR1;LRRK2;NPRL2;WWTR1;PTEN;IGFBP3;CDK5RAP3;HDAC4;SIRT1;CRKL;PRKDC;IMPACT
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5152783303132069,1.0526133719788566,0.43151969981238275,0.9329790830671806,1.0,2/10,6.56%,TLR4;IL12B
prerank,negative regulation of cell junction assembly (GO:1901889),0.42454458957247554,1.0521387085018954,0.39078498293515357,0.9333948547445065,1.0,6/25,9.50%,ROCK2;ACE;ARHGAP6;BCAS3;PTEN;PHLDB2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2681514263791879,-1.0517935099297908,0.3333333333333333,0.6857635423041499,1.0,66/145,36.17%,FBXL7;YWHAE;PSMB2;RAD51B;DYNLL1;PPP2R1A;YWHAG;PSMD14;TUBA1A;HAUS2;CDK5RAP2;TUBB4A;PSMC6;KCNH5;HSP90AA1;PRKAR2B;PSMB9;HAUS5;CEP78;PSMA4;CETN2;SKP1;TUBA4A;SSNA1;PSMD11;PSMB10;PSMD2;CEP131;PSMA2;DTL;HMMR;KIF14;FHL1;MECP2;NEDD1;HAUS4;PSMB3;TPX2;NDE1;CCP110;CEP135;ACTR1A;HAUS6;CEP76;PSMB5;CCND1;CENPF;CDC7;PSMD7;CEP43;PSMF1;AURKA;CDK1;CSNK1D;HAUS8;DCTN1;MAPRE1;BRD4;PSMA5;PSME4;PSMA7;DYNC1I2;PSMD3;CCNB1;PSMD4;HAUS1
prerank,ethanol metabolic process (GO:0006067),0.49238888540542414,1.0517581638411064,0.4208566108007449,0.9335563703361205,1.0,2/12,8.09%,ALDH1A1;ALDH2
prerank,glycogen catabolic process (GO:0005980),0.4658421964460089,1.051385365351218,0.40601503759398494,0.9336489935280297,1.0,3/15,9.21%,PYGM;PHKB;PHKG1
prerank,negative regulation of endocytosis (GO:0045806),0.43168130345577627,1.0512865421451978,0.4020979020979021,0.9329503447256491,1.0,3/24,2.80%,SYT11;PICALM;CD300A
prerank,negative regulation of neuron death (GO:1901215),-0.28933739152690174,-1.051188902737457,0.3343949044585987,0.6864311033833551,1.0,34/93,19.84%,MEF2C;CD200;CD34;PTK2B;NDNF;NGF;NTRK2;GSK3B;APOE;TGFB3;TNFRSF1B;SORL1;BTBD10;SIX1;PTPRZ1;FOXQ1;TOX3;PPT1;RASA1;ATF4;UNC5B;NENF;SNCA;PINK1;MT3;BDNF;FBXO7;TYRO3;HTRA2;CRLF1;VSTM2L;SIX4;CHMP4B;CHMP4A
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4913137181553865,1.0511281063975024,0.41505791505791506,0.9324057782374018,1.0,3/12,11.31%,PRKCB;CCNB2;PRKCA
prerank,muscle cell migration (GO:0014812),-0.4712121640396918,-1.0510236838935845,0.3866943866943867,0.6860579885806103,1.0,5/10,23.06%,CCN3;SIX1;ITGB3;THBS4;AAMP
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3187131832942411,1.0509657639818664,0.3656618610747051,0.9318613368362076,1.0,21/150,8.81%,PRKAG2;PTPN13;FBLN1;ERRFI1;PRKCZ;PRKN;PPEF2;PMEPA1;PPM1E;DEPTOR;LRRK2;DTNBP1;SMAD6;LDLRAD4;TRIB2;WWTR1;PTEN;IGFBP3;CDK5RAP3;PDPK1;MVP
prerank,regulation of neuron apoptotic process (GO:0043523),-0.28600809725363097,-1.0506641140389343,0.3400673400673401,0.6862128801372447,1.0,35/96,21.55%,GRID2;MEF2C;TGFB2;TRIM2;PTK2B;NDNF;NGF;NTRK2;APOE;TGFB3;SIX1;PTPRZ1;EPHA7;FOXQ1;TOX3;PPT1;KCNB1;RASA1;ATF4;CTNNB1;UNC5B;PINK1;CDK5R1;MT3;BDNF;EGLN2;FAIM2;TYRO3;CRLF1;VSTM2L;SIX4;EGLN3;AKT1S1;GRM4;SOD1
prerank,histone H3 deacetylation (GO:0070932),0.4678402920100029,1.0501302727756272,0.4088397790055249,0.9333203220730155,1.0,5/15,14.38%,HDAC8;HDAC1;HDAC4;SIRT1;PER2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.37377846111768537,-1.0500984073799384,0.37823834196891193,0.6868567223997737,1.0,8/26,12.55%,NOS3;ACER3;ACER2;CYP1B1;SPTLC2;GCH1;ASAH2;NOS1
prerank,negative regulation of blood coagulation (GO:0030195),0.3918236173636797,1.0499570404735108,0.387459807073955,0.9328075330532068,1.0,11/38,14.78%,TFPI;F11;KRT1;KNG1;F2;SERPINE1;HRG;C1QTNF1;PDGFRA;F8;PLAT
prerank,cellular response to organic substance (GO:0071310),0.32567273353081994,1.0499239514095566,0.36213991769547327,0.9319134417887323,1.0,18/116,7.47%,PTPN13;SMAD3;PTPN14;IL18;PTPN9;SPHK1;NFAT5;BMPR1A;TGFBR1;LRRK2;ADRA2A;NCOA3;PTPN23;MAP2K5;TIPARP;PLK5;CPNE3;TGFBR2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.39926331729667736,1.049379271027724,0.4039408866995074,0.9324739009173374,1.0,7/38,11.87%,LEPROT;PRKN;LRRK2;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.43641403361784836,-1.0493381168260203,0.41098901098901097,0.6879541257279802,1.0,9/14,43.43%,ENTPD1;ENTPD2;ENTPD3;NUDT9;NUDT16;NUDT15;ENTPD5;NUDT1;NUDT18
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4490794046317852,1.049216455424875,0.43956043956043955,0.9319699460569347,1.0,5/18,15.51%,NXF2;PABPN1;POLDIP3;NXF1;SARNP
prerank,negative regulation of cyclase activity (GO:0031280),-0.42572237816195924,-1.049201946458471,0.40898876404494383,0.6875414555130953,1.0,5/14,21.03%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,camera-type eye morphogenesis (GO:0048593),0.4900560737512552,1.0491158493428625,0.4083969465648855,0.9312529878969983,1.0,3/10,8.49%,SHROOM2;KDM2B;IFT122
prerank,embryonic limb morphogenesis (GO:0030326),0.387909175057214,1.048917366386924,0.39152542372881355,0.9308484391917015,1.0,9/34,13.50%,OSR1;AFF3;GLI3;CACNA1C;CYP26B1;NIPBL;HDAC1;RARG;WDPCP
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.38202235857508426,1.0485533951522854,0.39228295819935693,0.9309324500199921,1.0,7/44,10.02%,ROCK2;TNRC6A;TNRC6B;CPEB3;ZC3HAV1;MOV10;YTHDF3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4922618309813167,1.0485348066397466,0.4144981412639405,0.929991971490945,1.0,4/13,13.99%,IL18;IL12B;ZBTB1;AXL
prerank,cell differentiation in spinal cord (GO:0021515),-0.47484557087188767,-1.0484640259305962,0.42829076620825146,0.688579909147989,1.0,1/10,0.34%,MDGA2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.36493927660078207,-1.0484482803760966,0.3829268292682927,0.6878473584101962,1.0,7/29,13.10%,ESR1;RUNX1;PAK1;DDRGK1;CNOT2;UFM1;AXIN1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3565973801653312,-1.048184373010042,0.3791469194312796,0.687700325706741,1.0,8/30,8.46%,CSGALNACT1;DCN;CHSY3;NDNF;BGN;CSPG4;VCAN;HEXB
prerank,positive regulation of protein transport (GO:0051222),0.3575025142814527,1.0477818148943652,0.3845029239766082,0.9312039184410608,1.0,9/67,9.40%,BMP6;FRMD4A;IGF1;MYO18A;RUFY3;EZR;BCAS3;DNM1L;GOLPH3L
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4250798073358483,1.0470020385840078,0.37142857142857144,0.9325587025707303,1.0,3/20,9.11%,IGF1;FOXC1;NIBAN2
prerank,vasodilation (GO:0042311),-0.42601754871300357,-1.0469802286380014,0.4,0.6899386329534195,1.0,5/13,12.55%,NOS3;KCNMA1;KLF2;GPER1;NOS1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.42011286170076284,1.0465704484143192,0.4090909090909091,0.9328615482573541,1.0,10/25,24.24%,FBXL17;NGLY1;ZYG11B;UFD1;CLPP;ZER1;BAG6;DERL1;TOR1A;RNF5
prerank,acylglycerol catabolic process (GO:0046464),-0.3592814980259453,-1.0463038482620832,0.400990099009901,0.6908426479632896,1.0,5/30,13.94%,ABHD2;MGLL;LIPE;PNPLA3;FABP5
prerank,regulation of fibrinolysis (GO:0051917),0.48729098402347515,1.0461871127965707,0.44814814814814813,0.9329865021486219,1.0,4/13,8.66%,F11;F2;SERPINE1;HRG
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.38425076471876823,-1.0453270460380721,0.4134831460674157,0.6923797058948948,1.0,8/23,15.05%,PDE4B;RYR2;GNG2;KCNQ1;ATP2B4;ATF4;SNCA;GNB1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.34985004124286967,-1.0450686100636575,0.37866666666666665,0.692272123204345,1.0,12/34,14.68%,TEK;PIK3R1;PTK2B;DAB2IP;TGFB1;PTK2;TNFAIP8L3;FGF2;P2RY12;PIK3IP1;PRKD1;FGFR3
prerank,peroxisomal membrane transport (GO:0015919),0.4063578772127415,1.0449652364626896,0.40134907251264756,0.935646953470565,1.0,10/27,17.40%,PEX11B;PXMP2;PEX10;PEX14;RAB8B;ACBD5;PEX19;PEX5;SLC25A17;PEX16
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3916243070190716,1.0449376578913614,0.3961352657004831,0.9347446973143918,1.0,5/38,4.60%,CACNA1D;ANK2;KCND3;KCNA5;CACNA1C
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5030390383535837,1.0448081974629733,0.4377358490566038,0.9341253952512907,1.0,2/10,12.39%,TLR4;MIA3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4003857567036179,1.0447554743664564,0.3951473136915078,0.9332906585194866,1.0,9/27,15.07%,DDX5;TP53;TNRC6B;RIPK1;AJUBA;DDX6;MAP2K1;MAP2K2;WTIP
prerank,covalent chromatin modification (GO:0016569),0.4737599753452165,1.0445269814141702,0.4215500945179584,0.9329876451872879,1.0,4/14,12.80%,HDAC1;SIRT1;AURKB;HLCS
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4207284399554262,1.0440291344511943,0.42805100182149364,0.9334288967592271,1.0,3/26,3.76%,ADCY5;STXBP4;ADRA2A
prerank,organophosphate ester transport (GO:0015748),-0.37226174421192915,-1.0439989980968456,0.37735849056603776,0.6940979685237469,1.0,9/24,11.28%,PITPNC1;SCARB1;PLTP;LDLR;NPC2;PITPNB;TNFAIP8L3;MTTP;PITPNA
prerank,cilium organization (GO:0044782),0.3077151637280526,1.0439421978757177,0.3728395061728395,0.9327096892732003,1.0,58/209,19.53%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;CPLANE2;RILPL1;RAB3IP;CYS1;PTPN23;ASAP1;RHO;EXOC2;CCDC28B;CEP162;SSTR3;CDC14A;IFT122;WDR19;CATIP;DYNC2I1;CLUAP1;MKKS;TMEM231;CDC14B;IFT88;ATP6V1D;GALNT11;PDE6D;OCRL;TTC17;ROPN1;UNC119B;WDPCP;WDR35;CFAP410;EXOC4;STK36;PARVA;B9D2;EXOC3;RAB8B;ARL6;RP2;BBS2;RFX2;RILPL2;PIBF1;TMEM237;TRAPPC14;PCM1;PCNT;TCTN3;ATP6V0D1;TMEM17;CEP164;OFD1
prerank,ventricular septum morphogenesis (GO:0060412),0.40919501815522313,1.043800226425893,0.3976510067114094,0.9321132780850375,1.0,4/27,3.48%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,regulation of GTPase activity (GO:0043087),0.31321677305521883,1.0437366815956903,0.39210526315789473,0.9313138137868343,1.0,18/177,4.79%,CPEB2;DOCK11;AFDN;PKP4;PICALM;SIPA1L1;PLXNA2;EPHA4;SRGAP2;FGD4;ALS2;ARHGAP9;RGS16;NGEF;ASAP3;LRRK2;GMIP;RAPGEF3
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2372426834702676,-1.0437158736520782,0.24770642201834864,0.6940128881514591,1.0,79/416,13.28%,PID1;LEF1;LRCH1;GHR;IL1RAPL1;PTPRJ;PIK3R1;IL1R1;GREM2;OSMR;AKAP6;PTPN12;LIFR;IL1RAP;FN1;PTPRT;VCAM1;CXCL12;INPP5D;STAT3;SLC12A2;MAOA;GAS6;PTGIS;F3;IL6ST;ARHGEF2;RO60;GSK3B;ANXA1;DAB2IP;STX3;ICAM1;RPS3;SOCS2;HSPA8;AQP4;CRK;FOXO1;ITGB1;TNFRSF1B;ST3GAL6;MME;PTPRZ1;SYNCRIP;TGFB1;S1PR1;PTGS2;EGR1;TNFRSF21;DOCK8;IRAK3;PNPT1;PDE2A;CD47;STAT5B;IFNGR2;FGF2;GBP4;ERBIN;HSP90AA1;JAK1;MT1X;TEC;DUSP1;IL4R;GPER1;ASAH2;VIM;IKBKB;AIM2;YBX3;CNTFR;DAPK1;CDKN1A;TWIST1;HIF1A;LRP8;SBNO2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2931034604818802,1.043516274847849,0.37542662116040953,0.9309590971708291,1.0,88/336,20.07%,UBE2E2;PAXX;STXBP4;MACROD1;BABAM2;BID;ZBTB38;KMT5C;SUSD6;USP3;IKBKE;ATM;UVRAG;RAD54L;PLK5;KMT5B;BAZ1B;TP53;SETD7;PARP4;NIPBL;RNF8;FBH1;TRIP12;SAMHD1;PDS5A;NUPR2;UBR5;SIRT1;ASH2L;WDR76;BRSK1;ABL1;ATF2;RBBP8;PRKDC;DCUN1D5;CBX5;MSH3;CUL4A;ZBTB1;HUS1;UBA6;IGHMBP2;PHF1;FANCA;RAD50;PNKP;SIRT4;MCM7;POLE2;PML;DDB2;MGMT;GADD45A;VAV3;DOT1L;MAP2K6;BRAT1;INTS3;CEP63;TLK2;YAP1;ZBTB40;MCL1;BCL6;MBD4;PIDD1;CRY1;MMS19;XRCC3;ASF1A;OGG1;TAF1;PDS5B;NBN;APTX;FEN1;SUMO1;SLX4;MAPK14;LIG1;XPA;RAD51D;TANK;MCM9;RAD9A;USP16
prerank,positive regulation of translational initiation (GO:0045948),0.43836879401985873,1.0432549841492176,0.4141791044776119,0.9307065556783991,1.0,7/18,21.65%,DDX3X;POLR2D;LARP1;YTHDF3;BOLL;POLR2G;RPS6KB2
prerank,polyol metabolic process (GO:0019751),0.37352427410173117,1.043078452114139,0.39375,0.9302416673836587,1.0,10/46,11.59%,ISYNA1;NUDT4;INPPL1;SLC5A3;PLCD3;PTEN;PLCD1;ITPKB;PPIP5K2;OCRL
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3808572032811625,-1.0430538010087005,0.4153498871331828,0.6948694616460391,1.0,6/21,17.06%,CAV1;GSK3B;CTNNB1;AXIN1;APC;PPP1CA
prerank,regulation of cytoskeleton organization (GO:0051493),0.3283082057823346,1.0429831186661038,0.39094650205761317,0.9295262511422016,1.0,17/108,9.50%,CELSR1;ROCK2;RHOQ;PRKAA2;RHOBTB2;RHOD;ARHGAP18;CLASP1;EZR;PDGFRB;BAIAP2;ARHGAP17;RICTOR;LRP1;HRG;DIAPH1;PHLDB2
prerank,regulation of transferase activity (GO:0051338),0.4396398191431702,1.0429302908496239,0.4065934065934066,0.9287112272389589,1.0,4/17,7.71%,ATM;PARP4;LDB2;LDB1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4173552607550929,1.0429260814047203,0.41680672268907565,0.9277479377173804,1.0,5/26,9.57%,PPARA;SLC30A10;SLC5A3;TLR4;PIKFYVE
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.35516613652825335,1.0425312928640347,0.37888198757763975,0.9279505517352937,1.0,12/65,9.64%,SMAD3;PPARA;SNX6;PMEPA1;TGFBR1;SMAD6;LDLRAD4;FBN1;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,positive regulation of secretion (GO:0051047),0.493288771535184,1.041764740099973,0.42065009560229444,0.9292064740377767,1.0,1/11,1.94%,NPR1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.39167386297945883,-1.0416157389119731,0.41262135922330095,0.6976210684922703,1.0,7/21,12.15%,ST3GAL4;FUT9;ST6GALNAC5;ST3GAL6;B3GALT1;ST8SIA6;B3GALT5
prerank,protein kinase A signaling (GO:0010737),0.47780982609630923,1.0414583033597005,0.4249084249084249,0.929079655322166,1.0,5/12,17.16%,TCP11X2;EZR;RAB13;TCP11;PRKACB
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2796374254697194,-1.0412603165494696,0.3519736842105263,0.6977491629068429,1.0,44/109,30.36%,PIK3R1;LYN;PSMB2;CALM1;PAK1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;PSMC6;TEC;IKBKB;PSMB9;PSMA4;VAV1;SYK;SKP1;BTK;PRKCQ;PSMD11;PSMB10;PSMD2;SHC1;PSMA2;SOS1;MAP2K7;RELA;PSMB3;TAB1;PLCG1;NR4A3;PSMB5;MAPK8;CARD11;JUN;MAPK3;FOS;LCP2;MALT1;PSMD7;PSMF1;NFATC2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.27691995687226306,-1.041203789100036,0.35797665369649806,0.6971162111435703,1.0,24/121,10.65%,NRP1;GHR;PTPRJ;GRM5;ERBB4;PECAM1;EFNA5;PTK2B;STAT3;GAS6;IL6ST;ARHGEF2;LYN;PTPRC;HES1;PLCG2;CSPG4;SEMA4D;RELN;TGFB1;CD44;ITGB3;TEC;ENPP2
prerank,ion homeostasis (GO:0050801),-0.3529925143328967,-1.0411095443542724,0.3961352657004831,0.6965979557484155,1.0,6/30,7.28%,SLC4A10;CAMK2D;UNC80;NEDD4L;KLHL3;WNK2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.4074085759610852,1.0410902541398763,0.40134907251264756,0.9291664557444926,1.0,3/30,5.61%,ACSL1;HACD4;HACD1
prerank,cellular response to retinoic acid (GO:0071300),0.37572381877809663,1.0407077264013258,0.4073455759599332,0.9293078804909919,1.0,4/42,5.24%,WNT5B;PTK7;WNT6;ATM
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.45150881644326474,1.040442014663877,0.4051094890510949,0.9291032854915952,1.0,1/17,0.82%,LPGAT1
prerank,regulation of interleukin-13 production (GO:0032656),0.4805676488838465,1.040410717604816,0.4301675977653631,0.928229654411591,1.0,2/13,2.05%,PRKCZ;IL18
prerank,regulation of intracellular signal transduction (GO:1902531),0.28954851515589725,1.0401365420722157,0.36574585635359114,0.9280903457584438,1.0,89/420,15.41%,PRKAG2;FGF1;ARHGAP28;PTPN13;ARHGAP29;RHOQ;PRKAA2;DLG1;ARHGEF18;RHOD;PKHD1;ARHGEF16;SRGAP3;SRGAP2;FGD4;ARHGAP18;SYDE2;ARHGAP9;PRKAG3;NGEF;AKAP13;LRRK2;ARHGAP6;AKAP12;ZFAND6;TP53RK;GMIP;ARHGAP26;EZR;CHD4;PPP1R13L;ATM;WWC2;ARHGAP17;LBH;TP53;RICTOR;ARHGEF12;ARHGEF11;PTPN22;PIP4K2C;ARHGAP23;PTEN;ARHGEF1;PDPK1;OPHN1;RNF34;HDAC1;ARAF;AURKB;CDC42;ARHGAP12;RBBP8;RNF41;NOP2;FGD1;SOS2;OCRL;MAPKAP1;CSNK2A2;CSNK2A1;ITGAV;HUS1;TAF11;RALBP1;BRD7;RAD50;KMT5A;TOP3A;USP7;TAF4;TBP;PRKAR1A;PPP1R13B;PML;FLCN;ROS1;ARHGAP21;ULK4;SPHK2;VAV3;TAF7;MTA2;MAP2K6;BIRC3;STK4;MOB3B;AKAP7;CCNG1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3973498522845472,1.0398204503706598,0.3996316758747698,0.9280554283419864,1.0,16/29,23.79%,SMARCA4;TERT;TCF7L2;TLE1;TCF7;HDAC1;ASH2L;AXIN2;KMT2D;TLE2;CREBBP;TCF7L1;PYGO2;RUVBL1;EP300;BCL9
prerank,regulation of interferon-alpha production (GO:0032647),0.4235068607115129,1.0397524559435243,0.3960573476702509,0.9272764714977358,1.0,5/23,10.20%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,positive regulation of hydrolase activity (GO:0051345),-0.26749082010141834,-1.0394435082874125,0.3735408560311284,0.6999254479222314,1.0,29/137,10.88%,DOCK9;DOCK10;ITGA6;RGS7;CD200;RGS6;F11R;BCAR3;CDKL5;CAV2;ARHGEF7;NET1;GSK3B;TBC1D30;CALM1;RAP1A;RPS3;PSAP;CALM2;SEMA4D;ITGB1;BMP2;RAPGEF6;RASGRF1;MTCL1;DOCK8;ERBB2;AGRN;CALM3
prerank,N-glycan processing (GO:0006491),0.4320499521670253,1.0391187443029029,0.42585551330798477,0.9281300409108708,1.0,6/18,13.06%,MAN1A2;MAN1C1;FUT8;MAN2A1;GANC;PRKCSH
prerank,calcium ion transport (GO:0006816),0.32627339246606973,1.0390866833926495,0.3935119887165021,0.927271007264892,1.0,12/113,7.35%,TRPM3;CACNA1D;SLC24A3;ANK2;TRPM6;ITPR1;SLC8A3;CACNA1C;CACNB3;MICU1;TRPM5;ANO6
prerank,organelle fission (GO:0048285),0.42967794320639124,1.038414484903089,0.42047531992687387,0.9282748010653763,1.0,11/24,17.86%,PRKN;PEX11A;OPA1;PEX11B;MTFR2;DNM1L;ACOT8;DNM2;PEX19;WASHC5;MTFP1
prerank,superoxide anion generation (GO:0042554),0.4693860104400024,1.038362950189099,0.4260700389105058,0.9274666611415431,1.0,3/13,10.41%,ALOX12;NOX1;NOX4
prerank,negative regulation of programmed cell death (GO:0043069),0.2929300347011055,1.0379964113150206,0.37813211845102507,0.9275571541300522,1.0,41/355,9.82%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;IGF1;PRKAA2;KANK2;PKHD1;GRK5;SPHK1;SON;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;TNFAIP8;BABAM2;BID;ZFAND6;MYO18A;SMAD6;CTSH;DDX3X;CD27;BRAF;AVEN;NUAK2;CD28;TP53;OPA1;COMP;ANXA5;GDNF;HDAC1;NIBAN2;SIRT1;RIPK1;RIPK2
prerank,cellular response to growth factor stimulus (GO:0071363),0.31438123800462703,1.037956763098967,0.4124668435013263,0.9267353658442998,1.0,18/151,7.47%,WWOX;BMP6;BMP7;SMAD3;APPL2;WNT4;SPHK1;SOX5;BMPR1A;MAGI2;TGFBR1;FOXC1;GAS1;MAP2K5;PLK5;FLT1;CPNE3;TGFBR2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.46993825431774205,1.037953598044514,0.4128787878787879,0.9257899738313681,1.0,3/13,3.17%,TGFBR3;FGFR2;BMPR1A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.38292096194117353,-1.037766274789945,0.42696629213483145,0.7033358410844904,1.0,11/21,20.91%,CSGALNACT1;DCN;CHSY3;BGN;CSPG4;VCAN;CHST12;CHST9;CHST7;CSPG5;BCAN
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4682604634358718,-1.0374825393814069,0.4171779141104294,0.7032892767952923,1.0,3/10,8.30%,DCN;KDR;MYOC
prerank,regulation of microtubule polymerization (GO:0031113),-0.33126212549751083,-1.0365354508575808,0.3672922252010724,0.70486424782767,1.0,14/40,15.11%,NAV3;PAK1;OCLN;STMN2;MET;RPS3;CDK5RAP2;TUBB4A;CLIP1;MAPT;SNCA;CDK5R1;FES;STMN1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3018325753919038,1.0363450682681359,0.39272271016311167,0.9292434104913319,1.0,48/193,18.96%,RNF43;ASB2;ANAPC15;PRKN;SPSB1;RNF213;NEDD4;ARRB1;ANAPC2;UBR4;SPSB4;SMURF2;TTC3;RNF8;TRIP12;RNF217;BTRC;RNF19A;RNF34;FBXO22;AURKB;RNF13;FZR1;UBA6;FBXO10;NUB1;FBXO11;UBE2H;AMFR;RNF19B;ANAPC16;BIRC6;RNF146;WDR91;UBE2E1;SYVN1;UFD1;KCTD21;RNF7;SQSTM1;CDC34;ARIH1;NPLOC4;TAF1;MIB1;NDFIP1;RNF20;USP33
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3873718773565818,1.0362921053474288,0.4153094462540717,0.9284204223122242,1.0,5/33,9.07%,IGF1;PRKN;OPA1;HUWE1;ADCK1
prerank,transition metal ion homeostasis (GO:0055076),0.40576648954426636,1.0362885459507287,0.4214876033057851,0.9274832071330994,1.0,3/28,2.02%,CP;PICALM;PRKN
prerank,actin cytoskeleton reorganization (GO:0031532),0.35026819180929286,1.0358436684862318,0.413312693498452,0.9277498180854398,1.0,11/63,6.72%,AUTS2;KIT;SIPA1L1;PTK7;NPHS2;PHACTR1;MCU;DTNBP1;EZR;CDC42BPG;RICTOR
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4174142770460342,-1.0357318529901711,0.45785876993166286,0.706047642878662,1.0,9/16,19.20%,THBS1;PPP1R16B;GATA2;AGTR1;JCAD;FGF2;VEGFA;APLNR;DLL4
prerank,regulation of gastrulation (GO:0010470),0.4636975303437231,1.0355818969471735,0.42010771992818674,0.9275731099065326,1.0,5/14,12.58%,OSR1;CLASP1;DAG1;PHLDB2;FOXA2
prerank,protein lipidation (GO:0006497),0.3583548484474201,1.03556213050453,0.39939024390243905,0.9266824770811961,1.0,11/59,11.91%,PIGN;ATG10;PIGW;ATG5;PIGQ;WIPI1;GLUL;ATG7;ZDHHC18;ZDHHC1;PORCN
prerank,cardiac muscle contraction (GO:0060048),0.3899918131997432,1.0351578558199106,0.4053156146179402,0.9269480937542209,1.0,7/34,12.06%,ATP1A2;CSRP3;TPM1;PIK3CA;MYL4;TNNI3;TNNC1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.46036296432706963,1.035020129692689,0.44028520499108736,0.9263770622938827,1.0,2/15,2.84%,WNT5B;RNF213
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.429221154084948,1.0347252082574878,0.42704626334519574,0.9262302847830731,1.0,3/21,4.60%,ATP1A2;ANK2;CACNA1C
prerank,MAPK cascade (GO:0000165),-0.2412976360999172,-1.0344550872470228,0.3767123287671233,0.7084461259301623,1.0,66/295,16.12%,DLG2;SPTBN1;MEF2C;KITLG;TEK;ERBB4;PIK3R1;SHANK3;RASAL2;MAP3K5;RASGRP3;LRRC7;GRIN2B;RIT2;RASGRF2;NRG2;NRK;KRAS;YWHAE;KDR;MBP;PSMB2;DAB2IP;YWHAB;CALM1;MINK1;PAK1;MET;IL17RD;MAP3K7;ZDHHC9;RASGRF1;CUL3;TGFB1;PEBP1;RASGEF1A;PTK2;PSMD14;FGF2;FGF13;CAMKK2;ERBB2;PSMC6;PDGFA;JAK1;PRKG2;GOLGA7;RASA1;IKBKB;SPTB;ABHD17B;RET;PTPN3;FGF7;FGF9;MT3;SCG2;MAPK12;FGFR3;UBB;SPRED1;IL31RA;PSMB9;GRIN1;GFRA1;PSMA4
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4264389709861293,1.0339772024597134,0.40827338129496404,0.9273934488392528,1.0,7/21,16.03%,CEL;CYP26B1;LDHD;FAH;ACOT8;ACBD5;NUDT19
prerank,brain morphogenesis (GO:0048854),-0.44811521235768054,-1.0336535058896406,0.45188284518828453,0.7096616338851051,1.0,2/12,1.39%,CTNNA2;SHANK3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.2738005187659043,-1.0334241533346666,0.3893129770992366,0.709457533192633,1.0,37/117,23.56%,CALCRL;ADCY2;ADCY7;GNG2;MYH9;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;CYSLTR1;PTH1R;CYSLTR2;PRKAR2B;PRKAR1B;HTR4;PTHLH;RAMP1;GNB1;VIPR2;IAPP;SYK;PRKAR2A;ADCY3;ADCY8;GPR45;HRH2;CD81;NPSR1;YES1;ADCYAP1R1;FYN;LHCGR;RHBDF2;GPR176
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4337452709480527,-1.0332893803846899,0.4366812227074236,0.7090317637492615,1.0,10/13,32.78%,PDE8A;MET;TXN;HGF;GPR37L1;NR4A3;PYCR1;RACK1;PARK7;GPR37
prerank,glycine metabolic process (GO:0006544),0.4814526028339431,1.0332315307460973,0.43703703703703706,0.9284878373490095,1.0,2/12,9.17%,GCAT;DLD
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4617412465321056,-1.033159039976727,0.41082164328657317,0.7086182419053818,1.0,2/10,7.73%,SACS;SORL1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.32191387071620214,-1.0326920688814565,0.3863013698630137,0.7090095960116273,1.0,4/48,3.05%,PDE4D;PDE4B;IL1R1;SLC7A5
prerank,negative regulation of cytokine production (GO:0001818),0.31188698395562797,1.0322478240392514,0.4139240506329114,0.9302602217366308,1.0,19/163,7.39%,C1QTNF3;LGR4;APPL2;SYT11;PPARA;PCBP2;IKBKE;SSC5D;EZR;SRGN;RNF135;TLR4;F2;ARRB1;MAP2K5;TRIB2;IL12B;TWSG1;PTPN22
prerank,positive regulation of protein maturation (GO:1903319),-0.45807053671746456,-1.0319662550131947,0.43209876543209874,0.7100269934114513,1.0,4/11,21.33%,CCBE1;NKD2;RHBDD1;BAG2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.38162911865103855,-1.0319176705217563,0.4139433551198257,0.7093564827142376,1.0,2/20,2.27%,PDE4D;ADRA1B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.31497024076359914,-1.031832948082899,0.4036458333333333,0.7087911186438204,1.0,17/53,17.27%,HSP90AB1;DAB2IP;APOE;XPO1;DDRGK1;GNA12;PSMD14;PSMC6;PKD1;RAD23B;FOXF2;ECSCR;PINK1;UBB;GPX1;GABARAPL2;USP14
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.42295893136392837,1.0315821207314217,0.43018867924528303,0.9312792443745854,1.0,2/22,1.42%,ROCK2;IGF1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4554401958284613,-1.031531025742662,0.46168958742632615,0.7087696477880109,1.0,2/11,6.54%,CDH13;PLCG2
prerank,vitamin transport (GO:0051180),0.4020822669077279,1.0314491261675032,0.4299363057324841,0.9307448428919356,1.0,8/29,10.66%,PDPN;SLC35F3;SLC19A1;TCN1;SLC27A1;TCN2;SLC19A2;GC
prerank,regulation of apoptotic process (GO:0042981),-0.22151371742591075,-1.0306349147129865,0.3137254901960784,0.7102518792183126,1.0,173/676,19.51%,GRID2;SLIT2;MEF2C;LEF1;HIP1;TEK;ARHGAP10;ACTN4;PIK3R1;ITGA6;MAP3K5;FMN2;RASSF2;KCNMA1;RTN4;THBS1;MCF2L;ACTN1;ABR;RASGRF2;TPT1;TBX3;ACER2;RNF144B;ARHGEF3;TRIM2;PTK2B;APAF1;CSRNP3;GAS6;RPS6;NGF;TFRC;UNC13B;NFKBIA;ARHGEF9;ARHGEF7;TRIO;NET1;IL6ST;CYP1B1;TNFSF10;KDR;ARHGEF2;GSK3B;ANXA1;DAB2IP;TIAM1;CD38;PPIA;SFRP4;PTMA;PHLPP1;PLK2;FLNA;CARD14;RPS3;SOCS2;CTSD;ARHGEF17;RHOB;TGFB3;RYBP;SEMA4D;FOXO1;ITGB1;PSEN1;PERP;BMP2;BIN1;HSPA5;SIAH2;DDRGK1;CALR;PTK2;VDAC1;TMBIM6;CTSB;TOX3;FLT4;PLEKHG5;PPT1;ARL6IP1;CD44;AIFM1;UFM1;ANP32A;ARHGEF26;HSP90AA1;RPS6KA2;BCAR1;FRZB;ERC1;RPS6KA3;BMP4;GPER1;HNRNPK;MAGED1;RASA1;ATF4;CTNNB1;FAS;IKBKB;ANKRD13C;SERPINB9;DAPK1;LCMT1;AHI1;LRP8;SNCA;SUDS3;CFL1;PINK1;GADD45G;NOP53;RPS6KA1;VEGFA;TAF9B;DNAJA3;MT3;ATF5;KLF11;CASP6;CLU;UBB;MTDH;CRADD;IL31RA;PAX2;PHLDA3;BFAR;CAT;PIM1;EGLN2;APC;TOP2A;DNAJA1;RHBDD1;FAIM2;VAV1;ARHGDIA;DIABLO;IAPP;CBL;RNPS1;HSPB1;SCRIB;CD74;PIM2;CASP2;DHCR24;BARD1;APH1A;HTRA2;BCL3;IRF5;TNFRSF25;STPG1;SOX8;HIP1R;FOXL2;PHLDA1;RNF122;BCL2L11;COPS5;PNMA2;DCUN1D3;SIX4;IER3IP1;GADD45B;ECT2;PAX8;EGLN3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4453403667073941,1.0304903870411664,0.43413729128014844,0.9324128076137301,1.0,2/17,4.60%,ATP1A2;CACNA1C
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.45262899114262967,1.0303539550212484,0.43087971274685816,0.931855659712969,1.0,5/16,12.55%,ANK2;LRRK2;UBAC2;MIA3;TAPT1
prerank,cellular response to osmotic stress (GO:0071470),0.43136086091313774,1.0297986267586092,0.42003853564547206,0.9324285915758055,1.0,7/21,15.25%,OXSR1;RCSD1;DDX3X;MYLK;LRRC8E;ZFAND1;ZFP36L1
prerank,negative regulation of phosphatase activity (GO:0010923),0.4197695080756295,1.029652815839353,0.427536231884058,0.931918808410139,1.0,3/25,7.02%,SH3RF2;PPP4R4;SH2D4A
prerank,blood vessel endothelial cell migration (GO:0043534),0.41924554313665285,1.029548729311555,0.4165232358003442,0.9312792983270447,1.0,2/22,0.54%,ROBO1;EFNB2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4308578463296656,-1.0294012924101208,0.42535787321063395,0.7125285434225297,1.0,10/13,42.35%,HSP90AB1;STX3;TYROBP;GPD1L;RANGRF;TMEM35A;MAP1A;ABCA7;TM9SF4;TNF
prerank,protein localization to plasma membrane (GO:0072659),0.3161435197145009,1.029341728095377,0.3984375,0.9309327749469373,1.0,16/129,6.93%,AFDN;ROCK2;ACTN2;ATP1B3;ANK2;TSPAN5;TTC7B;DLG1;FYB1;KCNIP3;EZR;TMEM150A;PIGW;RAB34;FYB2;CACNB3
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3315283117219063,-1.0292238778549518,0.41424802110817943,0.7122124510439484,1.0,17/39,17.70%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;HSPB1;STXBP3
prerank,regulation of macrophage activation (GO:0043030),-0.3448706773747975,-1.0290983540552894,0.4151436031331593,0.7117580354640888,1.0,8/30,17.22%,CD200;LRFN5;THBS1;IL33;MFHAS1;IL31RA;LBP;CD74
prerank,regulation of axonogenesis (GO:0050770),0.36241858278152844,1.0290834978709902,0.4140030441400304,0.9307321606362094,1.0,6/51,2.22%,ROBO1;LRP4;KIF13B;SIPA1L1;PLXNA2;EPHA4
prerank,cellular response to virus (GO:0098586),0.39636321127378793,1.0285544795527655,0.39865996649916247,0.9312533507257652,1.0,4/30,10.66%,GSDME;DDX3X;IRGM;TOMM70
prerank,positive regulation of cellular protein localization (GO:1903829),0.33996822181692904,1.0284818074682331,0.422475106685633,0.930523082565154,1.0,11/69,9.38%,SYT11;PRKAA2;PRKN;CEP250;SLC5A3;SESN2;F2;WWTR1;CDK5RAP3;TRAPPC12;PARP9
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4049958230065067,-1.0283154191448427,0.40969162995594716,0.7128891182785191,1.0,4/16,6.76%,TPT1;CXCL12;RPS3;ACKR3
prerank,regulation of establishment of cell polarity (GO:2000114),0.45376412916391584,1.0280830352682417,0.45539033457249073,0.9307118276256198,1.0,6/16,13.29%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1
prerank,long-term synaptic potentiation (GO:0060291),-0.3814279507872842,-1.0279627422701767,0.41451990632318503,0.712969641525235,1.0,6/21,7.25%,SLC24A2;NPTN;GRIN2B;PTK2B;PLK2;GRIN2A
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3495840579535223,-1.0276926359389384,0.4116279069767442,0.7128902043655159,1.0,10/31,11.20%,DLG2;LRRC7;LIN7A;MTCL1;RAP2A;ERBIN;WDR1;PDCD6IP;MSN;MARK2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4187465150464478,-1.02700647333354,0.4166666666666667,0.713770863891893,1.0,4/14,10.52%,TMSB4X;NFKBIA;G3BP2;PKD1
prerank,regulation of response to external stimulus (GO:0032101),0.31758428183219856,1.0268606424534628,0.40808344198174706,0.9332591815412172,1.0,31/121,17.48%,EFNB2;APPL2;NMT2;LACC1;RNF135;METAP2;F2;RHO;TKFC;PTPN22;NR1D2;SAMHD1;ADGRA2;HRG;CYRIB;NLRP6;DHX58;FNTB;IRF1;FOXA2;PDGFRA;ERAP1;USP18;BIRC3;ZMPSTE24;WNT5A;SAG;FNTA;CCR2;BCL6;ZBP1
prerank,embryonic digestive tract development (GO:0048566),0.4475856168100205,1.0267422352462194,0.44106463878326996,0.9326511277931724,1.0,6/18,13.96%,FGFR2;GLI2;GLI3;NIPBL;RBPMS2;PDGFRA
prerank,potassium ion export across plasma membrane (GO:0097623),0.4721071643680501,1.0265433950796012,0.4490909090909091,0.9322812790373759,1.0,2/13,1.75%,KCND3;KCNA5
prerank,amino acid transmembrane transport (GO:0003333),0.3686613566911826,1.025949514631162,0.4305555555555556,0.9330384345176127,1.0,5/45,4.69%,SLC6A13;SLC38A4;SLC38A3;SLC7A11;SFXN2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4351824668502583,1.0253381060891247,0.4363957597173145,0.9338446874098845,1.0,4/20,9.63%,PRKCZ;IL18;FZD5;RSAD2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4826985854339768,1.0251584500320439,0.44676409185803756,0.9333862726914591,1.0,3/10,18.27%,HK2;GFPT1;PFKM
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.43577802804285276,-1.0244370900959923,0.4389233954451346,0.7195288536111092,1.0,4/13,15.81%,RYR2;NOTCH1;HEY2;CPE
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3439425023706172,1.0227892967369663,0.43759177679882527,0.9390677659352364,1.0,8/78,3.98%,DAB2;SORBS1;PICALM;RHOQ;DLG1;PTPN9;ARHGEF16;PPFIA1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.46517226067020234,1.0227759289675002,0.44204322200392926,0.9381712929851288,1.0,3/13,11.35%,PPARA;NFIB;NFATC3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.333503761105007,1.0227354699535935,0.4248062015503876,0.9373415572903749,1.0,8/75,6.64%,ROCK2;TULP3;NMT2;GRK5;RGS16;METAP2;RHO;MGRN1
prerank,protein acetylation (GO:0006473),0.396128843775568,1.022712795228373,0.41986062717770034,0.9364708605680753,1.0,7/30,15.67%,SPHK1;NAA80;DSCC1;SIRT1;KAT2B;NAA16;CREBBP
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4161072086456047,-1.0223099055044633,0.44967880085653106,0.7240682545726173,1.0,6/14,15.58%,FLNA;LIMS2;EMP2;PRKD1;DMTN;LIMS1
prerank,connective tissue development (GO:0061448),0.38364939991067665,1.0221675241491568,0.424390243902439,0.9370347584744559,1.0,9/35,10.98%,SOX5;SULF2;CREB3L2;SH3PXD2B;RORC;SLC39A13;COL11A2;HYAL1;SULF1
prerank,negative regulation of viral process (GO:0048525),0.3557226351987026,1.022072962043574,0.42857142857142855,0.9363594030285419,1.0,13/57,13.81%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;ZC3HAV1;RSAD2;LARP7;MAVS;SRPK2;TRIM62;OAS3;PML
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2751843343313103,-1.0220383371861144,0.3904109589041096,0.7239928512416104,1.0,27/98,19.95%,PID1;SLCO1C1;THBS1;PPARD;ECE1;NFKBIA;TBC1D5;SFRP4;APOE;AGTR1;TGFB1;XDH;NSF;STARD4;ACE2;CDKN1A;AHI1;SNCA;VEGFA;MT3;SCRIB;ATAD1;ARRB2;ROMO1;INHBA;PAX8;AGT
prerank,ceramide catabolic process (GO:0046514),-0.42203175105326063,-1.0218172523231401,0.42250530785562634,0.7237897961416433,1.0,4/14,11.54%,ACER3;ACER2;HEXB;ASAH2
prerank,regulation of coagulation (GO:0050818),-0.4502608877849527,-1.0215741346802307,0.4140786749482402,0.7235893953810879,1.0,3/11,8.13%,CAV1;HS3ST5;EPHB2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4936391035709715,1.0214923592242797,0.45366795366795365,0.9370700260575592,1.0,3/10,17.19%,EMC2;EMC1;EMC3
prerank,pulmonary valve development (GO:0003177),0.42699584568550736,1.0214617284691319,0.4148936170212766,0.9362329534100327,1.0,2/18,0.29%,NOTCH2;ROBO1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35341665367373765,1.0212272916862821,0.4024390243902439,0.9359468277857891,1.0,14/56,19.04%,UBE2E2;DDX3X;ANKRD17;CCND3;CDC25A;TFDP1;HYAL1;ADAM17;NSMCE2;RPTOR;RB1;KMT2E;EIF4G1;KLHL18
prerank,supramolecular fiber organization (GO:0097435),0.28710824821560793,1.0209339652051976,0.42621015348288077,0.9358682513799309,1.0,37/333,6.63%,COL5A1;TSPAN5;COL22A1;COL26A1;CGNL1;SNCAIP;LAMC2;COL4A5;DLG1;SHROOM2;HOOK2;KIF2A;RHOBTB2;AVIL;PRKN;RHOD;SHROOM3;COL18A1;INPPL1;COL4A3;LOXL1;TMOD2;ADAMTS2;MYO5C;TGFBR1;LOXL3;RUFY3;TPM1;TMOD3;USP9X;KLHL41;COL9A2;COL13A1;ARHGAP17;MPRIP;COL1A2;COL27A1
prerank,negative regulation of binding (GO:0051100),0.3399580462474552,1.0209173606206814,0.4234769687964339,0.9349992625319145,1.0,24/81,19.48%,DAB2;ARHGAP28;IFIT1;IFIT2;LRRK2;SMO;CAMK1;GTPBP4;GTF2F1;AURKB;TMC8;WAPL;STYX;EFHB;DNAJB2;PEX14;PEX19;TFIP11;SP100;KDM1A;ITGB1BP1;USP33;SUMO1;GOLGA2
prerank,ventricular septum development (GO:0003281),0.3744557658750231,1.0207374395408289,0.41412520064205455,0.934579727662107,1.0,4/37,3.48%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.344589040757537,-1.020550324089822,0.43719806763285024,0.7253280341117226,1.0,9/32,10.88%,PPP1R16B;HSP90AB1;PPP2R5A;PPIA;CALM1;CAMTA1;CALM2;TGFB1;CALM3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.33462720510724653,-1.0204072987653634,0.4194373401534527,0.7248926615829592,1.0,7/35,5.11%,NRP1;TEK;NTRK3;ESAM;PTK2B;F11R;SEMA3E
prerank,organelle disassembly (GO:1903008),0.3861837057606853,1.0202327130942075,0.4312080536912752,0.9350364164874593,1.0,11/33,19.48%,RETREG1;PLK5;KLC1;KIF5B;ATG2A;ZFAND1;STX5;TEX264;GFM2;UBA5;GOLGA2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2911330802563711,-1.0200086140107738,0.42483660130718953,0.7251532135618899,1.0,18/76,16.27%,GRM5;ESR1;PLCE1;ADRA1B;HTR2C;ANO1;HTR2A;GRM1;CHRM2;AGTR1;P2RY12;GNA14;PTH1R;HOMER1;CMKLR1;P2RY1;HRH1;CX3CR1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.45057112707308233,-1.019782842647639,0.4376321353065539,0.7250052794198103,1.0,4/11,24.78%,SETD2;DHX9;NCBP2;IWS1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2553543018580526,-1.0190293250683802,0.41304347826086957,0.7260315638589138,1.0,43/159,20.99%,STXBP6;HIP1;SGIP1;RTN4;NCK2;VAMP4;HSP90AB1;RPL38;TIAM1;NSG2;PDE4DIP;IMMP2L;SMAD1;BIN1;ANLN;TGFB1;AIFM1;HSP90AA1;CYBA;FKBP1A;AP2M1;PSMG2;MAPT;AXIN1;SNCA;CLU;NCK1;DHX9;PIK3C2A;DNAAF3;CCT2;CENPE;CASQ2;HIP1R;TBCE;PSMD11;POMP;PTGES3;CHMP4B;CHMP4A;NUP107;DMD;BBS12
prerank,epithelial cell differentiation (GO:0030855),0.3306595873989612,1.0183137008256253,0.41887905604719766,0.9395752807746767,1.0,8/88,9.25%,DAB2;MAF;FGFR2;CPT1A;TPP1;BDH2;HDAC1;GLI1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4370577392975398,1.0174700701339072,0.45750452079566006,0.9409860444418269,1.0,7/18,14.82%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1;LLGL2
prerank,histone H2A monoubiquitination (GO:0035518),0.4326321915721426,1.0172020469308916,0.43413729128014844,0.9407622928089089,1.0,4/17,7.97%,PCGF5;PCGF2;BCOR;KDM2B
prerank,neural tube closure (GO:0001843),0.3895088095467287,1.017132522997021,0.44549763033175355,0.9400370321008277,1.0,7/34,12.40%,CELSR1;LMO4;MTHFR;KDM2B;IFT122;PHACTR4;DEAF1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.47486137466548484,1.0168437233155228,0.4442307692307692,0.939929269476195,1.0,5/15,14.26%,STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,Ras protein signal transduction (GO:0007265),0.31340383766176544,1.016786577193145,0.4295125164690382,0.9391566282012053,1.0,21/137,10.64%,CELSR1;ARHGAP29;ROCK2;KSR1;IGF1;RHOD;CCNA2;PDPN;ARHGAP6;ADRA2A;RAPGEF3;RREB1;COL1A2;TP53;ARHGEF11;ARHGEF1;CTNNAL1;RRAS2;EPS8L2;PHACTR4;CRKL
prerank,cellular component disassembly (GO:0022411),-0.30690423003171874,-1.0166309133158478,0.4233983286908078,0.7313480608815882,1.0,12/53,13.59%,TLL1;BSG;GSN;ADAMTS5;ADAM15;TIMP2;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,regulation of actin filament polymerization (GO:0030833),-0.2965518893565996,-1.016628180273936,0.43037974683544306,0.7305802201279628,1.0,25/69,21.54%,SLIT2;ESAM;KANK3;PAK3;NCK2;EVL;PTK2B;CARMIL1;KANK4;CDC42EP3;BIN1;RASA1;PFN2;CDC42EP2;NCK1;ARF6;KANK1;HIP1R;NCKAP1;MYADM;TWF2;SSH2;PYCARD;GBA2;HCLS1
prerank,ion transport (GO:0006811),0.3193544374155548,1.0164993414203276,0.4263233190271817,0.939024200312406,1.0,13/111,8.79%,TRPM3;WNK4;SLC24A3;SLC5A5;SLC8A3;VDAC2;SLC26A3;SLC5A8;SLC1A3;SLC20A2;ANO6;SLC26A1;CTNS
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.4090137536000257,-1.0161958840287248,0.4258474576271186,0.7309544575025257,1.0,8/15,17.18%,TMSB4X;SEMA5A;KDR;MET;FGF2;PRKD1;VEGFA;HSPB1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2694882763428779,-1.0161048976952665,0.4329501915708812,0.7304283835184553,1.0,36/116,23.56%,CALCRL;ADCY2;ADCY7;GNG2;MYH9;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;CYSLTR1;PTH1R;CYSLTR2;PRKAR2B;PRKAR1B;HTR4;PTHLH;RAMP1;GNB1;VIPR2;IAPP;SYK;PRKAR2A;ADCY3;ADCY8;GPR45;HRH2;NPSR1;YES1;ADCYAP1R1;FYN;LHCGR;RHBDF2;GPR176
prerank,positive regulation of catabolic process (GO:0009896),-0.29992062169082295,-1.0158484011729536,0.4212121212121212,0.7303241451138625,1.0,18/65,17.55%,HECW2;WWP1;HECW1;NEDD4L;GSK3B;DAB2IP;PLK2;FOXO1;VSIR;SORL1;DACT1;NSF;AXIN1;SMURF1;HACE1;EGLN2;APC;BARD1
prerank,regulation of endopeptidase activity (GO:0052548),0.35171173826085755,1.0156373946817339,0.4489795918367347,0.9405005518274889,1.0,9/59,9.69%,TIMP3;SERPIND1;PICALM;KNG1;SERPINE1;SERPINA9;HRG;HDAC1;APH1B
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3173810231915096,-1.0155643338443898,0.44146341463414634,0.7302267108605656,1.0,14/45,20.56%,CAMK2D;MID1;VCAM1;B2M;ICAM1;IFNGR2;CD44;JAK1;IRF5;IRF2;CAMK2B;IRF8;TRIM68;MT2A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3351294688897236,-1.0154379996734268,0.42144638403990026,0.7297425317028697,1.0,14/35,23.00%,HIP1;SGIP1;B2M;SNAP91;PPT1;HNRNPK;CLU;ARF6;CBL;HIP1R;LDLRAP1;CCL19;VTN;FLOT1
prerank,cellular response to unfolded protein (GO:0034620),-0.3608743019772659,-1.015025447719699,0.43457943925233644,0.7299415715623072,1.0,9/26,19.27%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;RHBDD1;PTPN1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4192321424770845,-1.0148204790685011,0.4551569506726457,0.7296468573790336,1.0,3/13,2.15%,PID1;TMSB4X;NOS3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.37547432504251976,-1.0136375901670962,0.43891402714932126,0.7318376059421313,1.0,11/22,28.56%,RAD23B;UBB;CETN2;GTF2H4;GTF2H1;GTF2H5;ERCC2;UBC;RPS27A;ERCC3;DDB1
prerank,dendritic cell differentiation (GO:0097028),-0.36949142187835365,-1.0136005936861183,0.43779904306220097,0.731167110365535,1.0,7/22,21.84%,GAS6;LYN;CAMK4;TRPM2;IRF8;CCL19;LGALS9
prerank,endochondral bone morphogenesis (GO:0060350),-0.4466034092548251,-1.013546127402618,0.44676409185803756,0.730536186816449,1.0,7/11,16.62%,MEF2C;BMPR2;TRPV4;BMP4;BMPR1B;FGFR3;TMEM119
prerank,extracellular matrix disassembly (GO:0022617),-0.306927080387976,-1.01351374013623,0.4293785310734463,0.7298488539724254,1.0,12/53,13.59%,TLL1;BSG;GSN;ADAMTS5;ADAM15;TIMP2;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,regulation of organelle assembly (GO:1902115),0.3428025286405433,1.0132403907103307,0.4831130690161527,0.9462829969001569,1.0,14/72,10.89%,STX18;DCDC2;MTMR3;NPRL3;TBC1D16;EZR;NPRL2;ATG5;RABEP2;ATXN2;TRAPPC12;PIKFYVE;IFT88;SDCCAG8
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4365475241936303,1.0129239291588208,0.4469565217391304,0.9462295417924557,1.0,3/17,9.00%,BID;SOD2;DNM1L
prerank,positive regulation of telomere maintenance (GO:0032206),0.3827141674690032,1.0127664651232036,0.44607843137254904,0.9457365431872733,1.0,10/31,19.01%,ATM;ATRX;HNRNPA2B1;TNKS2;AURKB;RAD50;PNKP;PML;NBN;SLX4
prerank,cellular glucose homeostasis (GO:0001678),0.3769588924164332,1.012688463398645,0.4551386623164764,0.9450310620918552,1.0,4/41,2.18%,PPARGC1A;PRKAA2;HK2;ZBTB20
prerank,respiratory electron transport chain (GO:0022904),0.4567105906531899,1.012678442638115,0.46139705882352944,0.9441430983317073,1.0,4/14,19.38%,PPARGC1A;SLC25A12;SDHB;ETFDH
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4486371409039572,-1.012259541783436,0.44468546637744033,0.7323218372043526,1.0,3/10,14.53%,ESR1;PSMC6;ATF7IP
prerank,actin filament-based transport (GO:0099515),-0.37542395808307005,-1.0115884686175731,0.45670995670995673,0.7332080561318941,1.0,5/21,4.40%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A
prerank,activation of phospholipase C activity (GO:0007202),0.3994766579291444,1.0115129042980384,0.467005076142132,0.9463926378413953,1.0,3/29,3.75%,LPAR1;LPAR2;ARHGAP6
prerank,mitochondrion transport along microtubule (GO:0047497),-0.42398045270301016,-1.0113066281670873,0.43655913978494626,0.7331227427941626,1.0,5/13,18.40%,SYBU;MAPT;HIF1A;UBB;SPAST
prerank,positive regulation of vasculogenesis (GO:2001214),-0.45514667309306,-1.0112897823294114,0.47283702213279677,0.7323921904779163,1.0,5/10,8.76%,CD34;KDR;RAP1A;TMEM100;CEACAM1
prerank,purine-containing compound salvage (GO:0043101),0.47589310661565065,1.0111561020988147,0.4820717131474104,0.9464566240630373,1.0,4/12,20.60%,AMPD3;AMPD2;APRT;GMPR2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.33445463882936005,-1.0109712359360585,0.44191919191919193,0.7324130153461957,1.0,7/33,6.81%,MAP3K5;NET1;CYP1B1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,urogenital system development (GO:0001655),0.47360031140689246,1.0107686073195548,0.46530612244897956,0.946566788773472,1.0,1/11,1.08%,OSR1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.37456943571315565,-1.0107052516094737,0.4104803493449782,0.7323071472854485,1.0,6/21,9.20%,SLIT2;TGFB2;DAB2IP;CD2AP;EPHB2;ARHGAP25
prerank,regulation of leukocyte activation (GO:0002694),-0.40800532864164446,-1.0105995295194743,0.4650112866817156,0.7318446546049019,1.0,4/14,11.09%,CD200;LYN;MFHAS1;GPER1
prerank,amino acid import across plasma membrane (GO:0089718),-0.36796947563992966,-1.0105270680731053,0.4351851851851852,0.7312848230393177,1.0,8/24,7.83%,SLC6A6;SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC1A4
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.43596347001218816,1.0104990440327581,0.45555555555555555,0.9463963607274423,1.0,3/17,7.31%,AKAP13;ADRA2A;ADCY9
prerank,regulation of water loss via skin (GO:0033561),-0.41568626034262296,-1.010222931284373,0.4651685393258427,0.7305330026375063,1.0,5/15,15.11%,UGCG;LSR;MET;HRNR;STMN1
prerank,establishment of skin barrier (GO:0061436),-0.41568626034262296,-1.010222931284373,0.4651685393258427,0.7305330026375063,1.0,5/15,15.11%,UGCG;LSR;MET;HRNR;STMN1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.43620766730435506,1.0100860637669435,0.44919786096256686,0.9466874498449042,1.0,3/18,5.61%,ACSL1;ACSBG2;HACD1
prerank,protein deacetylation (GO:0006476),0.3720026240351216,1.0099635708155146,0.4453507340946166,0.9461196225702825,1.0,12/41,14.80%,TBL1X;SIRT5;SIRT3;TBL1XR1;HDAC1;HDAC4;SIRT1;PRDM5;SIRT4;SIN3A;MTA2;MIER3
prerank,UV-damage excision repair (GO:0070914),-0.4350072281984829,-1.009654048270666,0.45661157024793386,0.7311349785827556,1.0,3/12,12.31%,POLA1;POLD3;ERCC1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3567278853565906,-1.0091074869904275,0.4462616822429907,0.7317195719316685,1.0,12/26,28.56%,RAD23B;ERCC1;UBB;CETN2;GTF2H4;GTF2H1;GTF2H5;ERCC2;UBC;RPS27A;ERCC3;DDB1
prerank,regulation of defense response to virus by host (GO:0050691),0.390418180704976,1.0090449970101563,0.4532871972318339,0.947719762122999,1.0,7/30,14.09%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.454503429612698,-1.0088306769876074,0.4668094218415418,0.7316517250655018,1.0,2/11,1.15%,GHR;PIK3R1
prerank,negative regulation of cell cycle (GO:0045786),0.3353458883269043,1.0087862127217522,0.43815201192250375,0.9475112632018222,1.0,6/73,3.80%,BMP7;SMAD3;NUPR1;NR2F2;FOXC1;GAS1
prerank,regulation of aerobic respiration (GO:1903715),-0.40664341784846103,-1.0087323188058963,0.45739910313901344,0.7311449451561044,1.0,4/15,13.83%,CBFA2T3;SLC25A33;PINK1;NOP53
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.27342978240109195,-1.008694003390333,0.4307116104868914,0.7304965792671144,1.0,30/104,15.87%,BMPER;CAV1;BMPR2;HTRA3;CCN3;VWC2;NOTCH1;VWC2L;PRDM16;ASPN;SMAD5;IL17RD;CD109;SORL1;BMP2;SMAD1;TGFB1;SMAD7;FKBP1A;LEMD3;UBE2D3;SPRY1;BMPR1B;PPM1A;ACVR1;SMURF1;UBB;SPRED1;CILP;HIPK2
prerank,aorta morphogenesis (GO:0035909),-0.3967420332118847,-1.0086240519452268,0.4652777777777778,0.7299138291270516,1.0,6/17,9.00%,ENG;ACVRL1;JAG1;TBX1;PROX1;HEY2
prerank,heart process (GO:0003015),-0.41589385661518596,-1.0084742741239947,0.4376417233560091,0.7295131451055608,1.0,2/14,0.40%,SGCZ;SGCD
prerank,regulation of mRNA processing (GO:0050684),0.39122398151799925,1.00846547672765,0.43140495867768597,0.9474656970094475,1.0,9/32,10.73%,SON;PABPN1;AHCYL1;TIA1;RBM39;SLTM;JMJD6;LARP7;SRPK2
prerank,Golgi organization (GO:0007030),0.32051799382548196,1.008402639380114,0.4450402144772118,0.946736936034476,1.0,31/112,17.07%,FAM174B;DYM;OBSL1;CLASP1;LRRK2;MYO18A;PLK5;BCAS3;HUWE1;HTT;CSNK1A1;TRAPPC12;GOLPH3L;RAB43;CDC42;FBXW8;TRAPPC11;VTI1A;STX5;TANGO2;ARHGAP21;SEC23IP;RAB29;GOLGA8B;GOLGA5;VPS51;PI4K2B;RAB30;COG4;GORASP2;OPTN
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3562505432296573,1.008401119564216,0.4609494640122512,0.9458295464157785,1.0,8/52,9.49%,TFDP2;LEPROT;BID;FZD5;TP53;HUWE1;TFDP1;NPEPPS
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.22392448169048884,-1.0083301370683713,0.42696629213483145,0.7291400133080003,1.0,110/532,18.07%,GHR;RPS6KA5;PTPRJ;ACTN4;ADIPOR2;PIK3R1;IL1R1;GREM2;TMSB4X;OSMR;LIFR;CAMK2D;IL1RAP;MID1;FN1;ST18;VCAM1;B2M;CXCL12;INPP5D;PTK2B;STAT3;NOD1;MAOA;F3;TNFRSF11B;NFKBIA;IL6ST;UGCG;PSMB2;TNFRSF11A;ANXA1;STX3;PPIA;IL33;RAP1B;RPLP0;TRAF5;ICAM1;CARD14;SOCS2;HSPA8;ACKR3;MAP3K7;CRK;FOXO1;ITGB1;TNFRSF1B;PTPRZ1;TGFB1;S1PR1;PTGS2;CEACAM1;EGR1;PSMD14;IRAK3;STAT5B;IFNGR2;FGF2;CD44;PSMC6;HSP90AA1;JAK1;TEC;IL4R;MSN;PITPNA;IFITM3;ADIPOR1;VIM;IKBKB;ILK;AIM2;CNTFR;CDKN1A;TWIST1;HIF1A;LRP8;TALDO1;CFL1;VEGFA;SOCS5;MT3;UBB;JUNB;IL31RA;LIMS1;PSMB9;PIM1;PSMA4;NDN;VAV1;PELI1;NOD2;CCL13;LBP;CBL;AIP;SYK;EDAR;CAPZA1;PDCD4;TRAF1;CRLF1;SKP1;IRF5;TNFRSF25;IRF2;IRS2;SOX2
prerank,negative regulation of blood pressure (GO:0045776),-0.42357202290040863,-1.007741932459101,0.45132743362831856,0.7298698369391332,1.0,2/13,2.15%,BMPR2;NOS3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4280708116983931,1.0074711551032565,0.4519056261343013,0.9475253092972477,1.0,4/19,8.66%,ROBO1;SMOC2;IL12B;HRG
prerank,peptidyl-threonine modification (GO:0018210),0.3397195035481842,1.00714773589564,0.43862275449101795,0.9474686744416906,1.0,18/66,14.49%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;PRKCA;GALNT11;CSNK2A2;CSNK2A1;HIPK3;MAP2K1;WNK1;CAD;ACVR1B
prerank,regulation of protein import into nucleus (GO:0042306),-0.33144089824014933,-1.0071268664920716,0.45083932853717024,0.7306024296213097,1.0,11/36,11.03%,PIK3R1;MDFIC;FLNA;PSEN1;TGFB1;APOD;UFM1;EFCAB7;BMP4;CDH1;CABP1
prerank,cellular response to hydroxyurea (GO:0072711),0.4872008752858882,1.0070136701644934,0.4678030303030303,0.9469259646963697,1.0,4/10,20.67%,ATRX;DDI1;FMR1;RTF2
prerank,peptidyl-methionine modification (GO:0018206),0.46585477857505425,1.0066477286101125,0.44954128440366975,0.9470269377215059,1.0,3/12,15.44%,METAP2;NAA20;NAA16
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2908381200271608,-1.0066400135380114,0.40119760479041916,0.7310425503407525,1.0,25/73,21.84%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;HAVCR2;TIRAP;TWIST1;CLU;DHX9;NOD2;LBP;HSPB1;SYK;TYROBP;CCL19;PYCARD;CD86;LGALS9
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4335137380343046,1.0064134932121689,0.44935543278084716,0.9467469813975604,1.0,2/16,1.42%,ROCK2;IGF1
prerank,regulation of cholesterol storage (GO:0010885),-0.407652151316179,-1.0061125176041998,0.4564755838641189,0.731662773145399,1.0,4/15,7.13%,PPARD;SCARB1;ABCG1;SREBF2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3545819887920327,-1.005866531079264,0.43908045977011495,0.7315180331759419,1.0,13/29,20.92%,SLIT2;SHANK3;KANK3;KANK4;LIMA1;PFN2;SHANK1;KANK1;FKBP4;HIP1R;MYADM;TWF2;SSH2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3758355748490906,1.0058478778389304,0.4440619621342513,0.9474063693212242,1.0,9/33,16.47%,PRODH;CPS1;ALDH4A1;GOT2;GLUL;SIRT4;ART4;CAD;GOT1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27943318402318656,1.0058017018420644,0.4677777777777778,0.9466152526934498,1.0,102/417,18.61%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;DKK3;ZNF568;ARID4A;NR2F2;NCOR2;GLI3;TSHZ3;ZBTB38;LOXL3;NACC2;VGLL4;FOXP2;SFMBT1;CBFA2T2;ZNF318;HMGA1;LBH;TP53;SMURF2;NIPBL;BHLHE41;FBXW11;LDB1;NR1D2;BCOR;SMARCA4;RBM15;SPEN;BTRC;KAT6B;NRG1;SMARCC2;TCF7L2;TLE1;HDAC1;NIBAN2;SMARCE1;HDAC4;SPINDOC;SIRT1;SCML4;CBY1;SOX13;CHMP1A;PRDM5;ZNF219;SAP18;BAHD1;EIF4A2;CBX5;IRF1;UIMC1;WWP2;ZNF148;DEAF1;BRD7;KMT5A;MLXIPL;KAT7;BCL7A;NCOR1;PML;SIN3A;TLE2;CRYAB;PER2;TAF7;ZKSCAN3;HOXA7;MPHOSPH8;PEX14;SETDB2;EHMT1;ILF3;NKX2-1;PHF12;WNT5A;SMAD4;RB1;BCL6;CTBP2;KDM1A;NACC1;CHD8;IKZF4;MBD1;CRY1;HEXIM2;L3MBTL3;RUNX1T1;ZGPAT;RCOR1
prerank,positive regulation of vacuole organization (GO:0044090),-0.44307037377786684,-1.005356572150455,0.45194274028629855,0.7320451219903142,1.0,5/10,20.44%,PIP4K2A;SH3GLB1;RALB;LRSAM1;PIP4K2B
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.36732600066983384,1.0052558094803186,0.45901639344262296,0.9472148843110362,1.0,12/46,13.81%,OGN;IGF1;IL18;PDGFRB;NOX1;IL12B;IGFBP3;TCF7L2;TRIB1;PRKDC;RBPMS2;MFN2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3163861159358,-1.0051734134030381,0.4363143631436314,0.7317378827789327,1.0,13/39,14.41%,PODXL;FXYD5;NEXMIF;NOTCH1;JAG1;MBP;BMP2;RDX;TGFB1;PTK2;CDH1;VEGFA;PPM1F
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3828795340648323,-1.0048924401680903,0.4393939393939394,0.7316847022220454,1.0,1/17,0.38%,CADM1
prerank,regulation of protein processing (GO:0070613),-0.37752261259655556,-1.0048526028647882,0.44772727272727275,0.7310405392957138,1.0,5/21,10.81%,SERPINE2;CCBE1;RUNX1;NKD2;TMEM59
prerank,regulation of autophagosome assembly (GO:2000785),0.382405993130048,1.0048494308319067,0.45737704918032784,0.9474368781815532,1.0,8/33,10.85%,MTMR3;NUPR1;NPRL3;LRRK2;NPRL2;PIP4K2C;PIKFYVE;IFT88
prerank,fatty acid catabolic process (GO:0009062),0.33883099820381385,1.0046681917324902,0.4442815249266862,0.9470510631449649,1.0,23/67,22.54%,PCCA;CEL;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ACOT8;ECHDC1;DECR1;ACBD5;NUDT19;EHHADH;SLC25A17;ECI2;PHYH;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,regulation of actin filament-based movement (GO:1903115),-0.45357181952443604,-1.0045981837415314,0.4824742268041237,0.7309183344062881,1.0,2/10,0.62%,PDE4D;PDE4B
prerank,positive regulation of vasculature development (GO:1904018),0.32259947807585604,1.0041685399194114,0.4491525423728814,0.9475594919671526,1.0,16/94,9.92%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1
prerank,icosanoid metabolic process (GO:0006690),0.36856678498758205,1.0040783768003736,0.4438943894389439,0.9469193825170693,1.0,6/40,8.03%,PTGS1;ALOX12;EPHX1;DAGLA;PON3;ABCC10
prerank,mitotic cytokinesis (GO:0000281),-0.30288417356196273,-1.0037577466200125,0.4154727793696275,0.7321981554041893,1.0,21/47,24.61%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;USP8;APC;NUSAP1;EFHC2;SPAST;ECT2;CHMP4B;CUL7;KIF4A;RHOC;KIF23;CENPA
prerank,actin-myosin filament sliding (GO:0033275),0.37125953283135993,1.0036614718024852,0.4462279293739968,0.9462663940835492,1.0,5/38,12.06%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,muscle filament sliding (GO:0030049),0.37125953283135993,1.0036614718024852,0.4462279293739968,0.9462663940835492,1.0,5/38,12.06%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,regulation of mitochondrion organization (GO:0010821),0.3583019384556115,1.0034625910376012,0.45161290322580644,0.9459140249513632,1.0,10/47,13.91%,PPARGC1A;PRKN;LRRK2;FZD5;STAT2;MYO19;DNM1L;CYRIB;CSNK2A2;FLCN
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.29294728106088386,-1.0030463076545622,0.4152046783625731,0.7331057496209539,1.0,24/69,21.84%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;HAVCR2;TIRAP;TWIST1;CLU;DHX9;NOD2;LBP;HSPB1;SYK;TYROBP;CCL19;PYCARD;LGALS9
prerank,O-glycan processing (GO:0016266),0.35433261678100436,1.002939544370996,0.45535714285714285,0.9464368190812291,1.0,4/54,4.64%,GXYLT2;ST6GAL1;GALNT12;ST3GAL3
prerank,protein import into peroxisome membrane (GO:0045046),0.41594456298574867,1.0028927538787393,0.4591304347826087,0.9456651909320343,1.0,9/22,17.40%,PEX11B;PXMP2;PEX14;RAB8B;ACBD5;PEX19;PEX5;SLC25A17;PEX16
prerank,regulation of cell adhesion (GO:0030155),0.30838290149824094,1.0025681858126847,0.459387483355526,0.9456664769268297,1.0,25/129,12.39%,ROCK2;PKP4;FBLN1;IL18;PLXNA2;RHOD;EPHA4;PKHD1;PPP1CB;C2CD4B;FUT1;DACT2;TPM1;KNG1;ATM;EPHA8;IL12B;TNFRSF18;HRG;HYAL1;ABL1;PRKCA;ITGAV;PTPN11;MIA3
prerank,positive regulation of mitochondrion organization (GO:0010822),0.34811186122094795,1.0024489337568303,0.4505327245053272,0.945131845657109,1.0,9/57,9.07%,PPARGC1A;PRKN;MCU;BID;FAM162A;TP53;HTT;DNM1L;ADCK1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.3951978892369673,1.0019486082899027,0.4826989619377163,0.9455715273978095,1.0,6/28,9.75%,APPL2;PRKCZ;PRKCB;TNS2;PIP4K2C;GRB10
prerank,regulation of mast cell degranulation (GO:0043304),0.45451997336296146,1.0019295343838361,0.46897810218978103,0.944729185662865,1.0,6/14,16.30%,CD300A;STXBP2;GAB2;FER;SPHK2;UNC13D
prerank,phosphatidylserine metabolic process (GO:0006658),0.3896828184795002,1.0014094250225372,0.44711538461538464,0.94524279267536,1.0,11/32,21.43%,OSBPL8;PLA1A;SLC27A1;PLSCR1;ABHD12;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PTDSS1;PLAAT3
prerank,apoptotic process (GO:0006915),-0.2407658796564748,-0.9996652935050518,0.44571428571428573,0.7406759407826876,1.0,39/203,13.00%,HIP1;MAGI3;SEMA6A;RTN4;DCC;EFNA5;MAL;PPARD;PTK2B;PAK5;APAF1;FAP;CIT;SCN2A;ZBTB16;NFKBIA;PLAGL1;TBX1;PPIA;APP;RHOB;MAP3K7;PRUNE2;TNFRSF19;ADAM15;FOXO1;PPP2R1A;VDAC1;TNFRSF21;DDIT4;AIFM1;ELMO1;FXR1;GLRX2;FAS;PAEP;DAPK1;RFK;JADE1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.39511233190825745,-0.9995091299323401,0.4419642857142857,0.7402957317779709,1.0,9/17,23.41%,RTN4;NTRK2;APOE;SORL1;BIN1;CLU;CHRNA7;RTN3;HAP1
prerank,spinal cord development (GO:0021510),0.46434934638394,0.9993169244369855,0.4763705103969754,0.9501614364894637,1.0,3/12,7.36%,GLI2;LOXL3;SOX12
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3894753042186686,-0.9992987545791142,0.45454545454545453,0.7400405310365608,1.0,5/17,14.08%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,positive regulation of blood coagulation (GO:0030194),-0.39278163213574113,-0.9990432218341285,0.47045951859956237,0.7398573691130874,1.0,5/17,13.15%,ST3GAL4;THBS1;F3;ENPP4;DMTN
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.44604524568077486,0.9988636662012629,0.47680890538033394,0.9504737507819395,1.0,5/15,15.42%,TNRC6A;TNRC6B;CPEB3;TNRC6C;TENT4B
prerank,regulation of protein modification process (GO:0031399),-0.30828339752761585,-0.9988351139164418,0.47129909365558914,0.7396041784221244,1.0,19/50,19.29%,GRM5;FN1;PPP1R16B;CCDC88A;LYN;FKTN;CORO1C;PPIB;PTK2;PPP1R16A;FNIP2;NOP53;CCDC88C;MT3;SPRED1;HPF1;HSPB1;KDM4D;PUM3
prerank,AMP metabolic process (GO:0046033),0.4640322869212645,0.9986789298861717,0.4774436090225564,0.9501070042265589,1.0,6/13,19.75%,AMPD3;AK4;AK3;AMPD2;ADSS1;ADSL
prerank,homeostasis of number of cells (GO:0048872),-0.4276608050054528,-0.9985476658417747,0.4591194968553459,0.7395624833938534,1.0,3/12,4.67%,NOS3;CCN3;NOTCH1
prerank,regulation of phospholipase C activity (GO:1900274),0.4447507955609108,0.9983208778419201,0.46972477064220186,0.9501928374282915,1.0,6/15,13.96%,KIT;FGFR1;PDGFRB;FLT1;ABL1;PDGFRA
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.2635653570219873,-0.9978729959255741,0.4132841328413284,0.7404321174394425,1.0,29/112,17.38%,PTPRJ;THBS1;CD34;STAT3;GAS6;ARHGEF2;IL33;PTPRC;FOXP1;APP;PLCG2;PSEN1;VSIR;EPHB2;IRAK3;CD47;CYBA;TRIM27;HAVCR2;TIRAP;TWIST1;CLU;DHX9;CX3CR1;CHRNA7;NOD2;LBP;HSPB1;SYK
prerank,post-translational protein modification (GO:0043687),0.2803594823838218,0.9978666107370746,0.4668192219679634,0.9505152092649621,1.0,50/332,14.44%,EPAS1;APLP2;ITIH2;ASB2;CP;SERPIND1;LAMC1;SPP1;OBSL1;SPSB1;IGFBP7;DCAF11;KNG1;FBXL19;KLHL41;ATG5;SPSB4;DSCC1;FBN1;LGALS1;FBXW11;RABGGTA;IGFBP3;BTRC;NUCB1;ASB15;DCAF10;FBXO22;LRRC41;FBXL12;RAB11B;RAB13;UBE2M;FBXW8;FBXO4;SOCS3;CUL9;CUL4A;ASB14;ASB5;FBXO10;MIA3;NUB1;MBTPS1;PRKCSH;ASB12;DDB2;FBXO11;FBXL20;SERPINC1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3518425512002566,-0.9977315105798991,0.4534005037783375,0.7400073138468835,1.0,8/25,10.88%,CAV1;CTNNA3;RYR2;CAMK2D;CALM1;TBX18;FGF13;CALM3
prerank,gluconeogenesis (GO:0006094),0.36487055278314073,0.9977194807993762,0.4599358974358974,0.950007934486844,1.0,12/39,18.24%,PPARGC1A;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;CRY1;SLC37A4
prerank,leukotriene biosynthetic process (GO:0019370),-0.4167834802026872,-0.9975422694547673,0.4803312629399586,0.739713132006114,1.0,6/14,32.35%,PLA2G4A;GGT7;LTA4H;MGST2;ALOX5AP;GGT1
prerank,lipoprotein biosynthetic process (GO:0042158),0.4720393098864979,0.9972817333939896,0.46880907372400754,0.9503380850306896,1.0,4/11,11.91%,ATG10;WIPI1;ATG7;PORCN
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.415755681536837,0.9965571924717334,0.4685185185185185,0.951424022711343,1.0,4/20,11.39%,ZC3H7B;SNIP1;TERT;DICER1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.2358810514462942,-0.9962854301285614,0.4513888888888889,0.7419986633704153,1.0,56/291,15.18%,SLIT2;MEF2C;PID1;PDE4B;PDE3A;KCNC2;ACTB;ESR1;AKAP6;BRINP3;HCN1;PTPRK;PTK2B;BRINP1;RYR3;GNG2;GUCY1B1;LYN;RORB;TBX1;DAB2IP;RAP1B;FZD4;RAP1A;RPS3;FOXO1;TNFRSF1B;KCNQ1;SH3BP4;WNT9A;GLRA1;EGR1;PDE2A;CAMKK2;BRINP2;ATP2B4;P2RY12;CAPN2;GPER1;VIM;SPAAR;TIRAP;DAPK1;MAPT;PRKD1;GLRA2;DMTN;SBNO2;RET;P2RY1;ABCB4;MT3;CARD16;FES;GNB1;PAX2
prerank,cGMP biosynthetic process (GO:0006182),0.48781468714766835,0.996150565211127,0.48360655737704916,0.9516529886460869,1.0,2/10,5.86%,NPR1;NPR2
prerank,negative regulation of developmental process (GO:0051093),-0.28647141496152295,-0.9959138279656882,0.4521452145214521,0.742150073723502,1.0,17/69,14.68%,KLF7;NOS3;DCC;CST3;GAS6;TFRC;NOTCH1;GRIN3A;TBX1;ARHGEF15;BMP2;TGFB1;HEY2;BMP4;MAPT;PINK1;FGFR3
prerank,positive regulation of transporter activity (GO:0032411),0.4466900592956437,0.9959136380622554,0.4393638170974155,0.9514157968771835,1.0,1/13,1.45%,KMT2A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3247393515392387,0.9958929374751413,0.4576523031203566,0.9505865241011492,1.0,14/77,11.89%,IGF1;PRKN;CFLAR;PHIP;TGFBR1;DDX3X;OPA1;HTT;TCF7L2;RIPK1;SH3RF1;CSNK2A2;CSNK2A1;ITGAV
prerank,icosanoid secretion (GO:0032309),0.4640284008539338,0.9958127387031457,0.4637404580152672,0.9499076992108063,1.0,2/12,4.76%,ACE;BDKRB2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4209973821586479,-0.9955466369421225,0.46680497925311204,0.7422437958369659,1.0,7/13,19.33%,SHANK3;APP;RELN;EPHB2;ZDHHC2;CHRNA7;ADCY8
prerank,regulation of mRNA polyadenylation (GO:1900363),0.42605332000408924,0.9952646608565417,0.46880907372400754,0.950482824195821,1.0,7/17,23.31%,CTR9;CPEB3;VIRMA;RNF20;CPSF7;ZC3H3;NUDT21
prerank,regulation of MAPK cascade (GO:0043408),0.30207381446524983,0.9952224684406371,0.46266666666666667,0.9497219858344151,1.0,13/157,3.86%,TGFBR3;ROCK2;LPAR1;KSR1;KIT;GSDME;IGF1;FGFR2;PKHD1;PPEF2;FGFR1;ADRA2A;DAG1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.30564267111831056,0.995021884049606,0.4613333333333333,0.9493727080759892,1.0,17/132,10.43%,RNF152;IGF1;SH3D19;PRKAA2;PPARA;ZBTB20;LRRK2;TPCN1;ADRA2A;VGLL4;EZR;NPRL2;ZC3H18;ZC3HAV1;MOV10;ZSWIM8;IRGM
prerank,error-prone translesion synthesis (GO:0042276),-0.3710506775627358,-0.9949513284491235,0.47058823529411764,0.742947076993979,1.0,12/21,31.15%,REV3L;PRIMPOL;UBB;RPA1;RFC4;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.41523477029682865,-0.9945314914890093,0.4906832298136646,0.7432543118889152,1.0,6/13,31.76%,ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4339121769403729,0.9941046023330561,0.463898916967509,0.9510222439611157,1.0,6/17,22.58%,EMC2;EMC1;EMC3;CAMLG;GET4;BAG6
prerank,regulation of membrane depolarization (GO:0003254),-0.3842842297857132,-0.9937232506932725,0.4873417721518987,0.7445023271433686,1.0,11/18,32.29%,CAMK2D;NEDD4L;SMAD7;PTPN3;SCN2B;SCN1B;FHL1;GPD1L;RANGRF;GJA5;SCN3B
prerank,membrane lipid catabolic process (GO:0046466),-0.44719967094961355,-0.993707508263795,0.4838709677419355,0.7437890000885662,1.0,4/10,19.97%,CYP1B1;PPT1;ENPP2;SMPDL3B
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3937944499809631,-0.9935394716163406,0.497737556561086,0.743459132902052,1.0,5/17,8.52%,SLC8A1;SLC9A2;SLC12A2;SLC9A6;SLC9A7
prerank,T-helper cell differentiation (GO:0042093),-0.41365844473006275,-0.9934821098758255,0.4765957446808511,0.7428499067168411,1.0,2/14,6.11%,LEF1;FOXP1
prerank,regulation of protein catabolic process (GO:0042176),-0.27058454636413326,-0.9928061408983089,0.46996466431095407,0.7437628424913315,1.0,22/99,16.28%,HECW2;WWP1;HECW1;FMN2;NEDD4L;GSK3B;DAB2IP;PLK2;FLNA;FOXO1;SORL1;DACT1;EEF1A1;IRAK3;NSF;ZDHHC2;AXIN1;ADGRB1;SMURF1;HACE1;EGLN2;APC
prerank,negative regulation of neuron differentiation (GO:0045665),0.406498984705413,0.9927500800616632,0.4543795620437956,0.9537839024525644,1.0,2/22,3.79%,BMP7;DTX1
prerank,positive regulation of DNA binding (GO:0043388),0.3774069977889737,0.9916592466678993,0.4750830564784053,0.9558497356875783,1.0,3/31,3.66%,IGF1;PRKN;FOXC1
prerank,modulation by host of viral genome replication (GO:0044827),0.46471003085422424,0.9910388624738034,0.47201492537313433,0.9566100944280632,1.0,2/13,4.03%,PRKN;IFI27
prerank,skeletal muscle organ development (GO:0060538),0.39097887476741533,0.9909448272549867,0.46935201401050786,0.956001014550025,1.0,4/26,2.92%,IGSF8;CSRP3;LARGE1;CFLAR
prerank,renal absorption (GO:0070293),0.4747781592270395,0.989785351390736,0.484375,0.9581716102122912,1.0,1/10,0.46%,WNK4
prerank,regulation of sodium ion transport (GO:0002028),0.37615416632666804,0.9897664109032346,0.46410684474123537,0.9573373279799529,1.0,6/34,6.57%,WNK4;DLG1;SNTA1;NEDD4;AHCYL1;SIK1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3252432003730948,0.9896061188091028,0.48676470588235293,0.9568892340918551,1.0,26/80,19.92%,SNX6;SNX32;DENND2A;CLTC;VPS54;DENND5A;PIKFYVE;RAB7B;VPS50;RGP1;SNX8;SNX12;VTI1A;STX5;SGSM2;RAB29;VPS51;RAB9A;HEATR5B;VPS35;TMEM87B;PHETA1;TBC1D14;EVI5;STX16;ANKFY1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.23966457330497606,-0.9894929632154966,0.495,0.7513012926300877,1.0,32/198,11.50%,PTPRB;PTPRD;PLCB4;INPP4B;PLA2G4A;PLCE1;PIP4K2A;INPP5D;STAT3;PLPP1;PLPPR1;GPI;CALM1;PAK1;PTPRC;PLCG2;LIMK2;ALPL;PPP3CA;EPHB2;ENPP1;ITPK1;EPHA7;TGFB1;TNFAIP8L3;PLCH1;PLPPR5;PLPPR4;DUSP3;LIMD1;PGM2L1;GFPT2
prerank,cellular response to nutrient levels (GO:0031669),0.3398755564792052,0.9891312327752144,0.46533127889060094,0.9572868724118041,1.0,18/62,19.88%,PRKAA2;PPARA;FNIP1;LRRK2;LAMP2;WIPI1;NUPR2;SIRT1;ATG7;FLCN;TSC1;RPTOR;EHMT2;ZFYVE1;RRAGD;EIF4G1;USP33;RIPOR1
prerank,stress granule assembly (GO:0034063),0.4079382046496919,0.9891299727387792,0.46994535519125685,0.9564063744692407,1.0,8/20,17.29%,DDX3X;ATXN2;YTHDF3;LSM14A;DDX6;UBAP2L;ATXN2L;OGFOD1
prerank,negative regulation of locomotion (GO:0040013),-0.42222034645464357,-0.9889377272786862,0.5,0.7519031066143611,1.0,4/12,10.98%,FRMD5;SPOCK3;CRK;DUSP3
prerank,regulation of interferon-gamma production (GO:0032649),-0.2818435002224474,-0.9886508939868905,0.46932515337423314,0.7518364204405428,1.0,18/71,21.84%,PDE4D;PDE4B;IL1R1;SLC7A5;GAS6;VSIR;CD47;TRIM27;HAVCR2;LAPTM5;SCRIB;ZFPM1;TXK;INHBA;TLR7;PYCARD;NR1H4;LGALS9
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.47439532242870164,0.9882499926074658,0.47339449541284406,0.9579016030106207,1.0,5/11,21.14%,ARRB1;ADM;GRK3;SAG;ARR3
prerank,negative regulation of cell migration (GO:0030336),0.3048192265935348,0.988239744353659,0.4735376044568245,0.9570436492465795,1.0,29/137,11.37%,ROBO1;AFDN;ZMYND8;MCC;EPHA4;SRGAP3;SRGAP2;BMPR1A;MITF;ARID2;MAGI2;CLASP1;DAG1;TPM1;PTPN23;LDLRAD4;SERPINE1;PTPRU;PTEN;IGFBP3;LRP1;PHLDB2;GTPBP4;SLURP1;SULF1;HAS1;RNF41;TRIB1;DUSP10
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.383246507793068,-0.9881517116064845,0.4700854700854701,0.7523095776498646,1.0,3/17,10.77%,PDE3B;SORL1;MFSD2A
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3586277884954919,0.9880786629097177,0.4895330112721417,0.9566211436026653,1.0,10/43,13.15%,SORBS1;PRKCZ;PRKCB;TNS2;GKAP1;PIP4K2C;SIRT1;GRB10;PTPN11;OGT
prerank,inner mitochondrial membrane organization (GO:0007007),0.3538923448241717,0.9877648338604064,0.48242811501597443,0.9565551295590052,1.0,14/47,19.58%,CHCHD3;SAMM50;OPA1;MICOS10;TMEM11;TOMM70;ATP5F1D;MICOS13;IMMT;ATP5F1C;TIMM10;MTX2;DMAC2L;AFG3L2
prerank,GPI anchor metabolic process (GO:0006505),0.3944489339340107,0.987701092600116,0.47442680776014107,0.9558757882705073,1.0,3/26,6.47%,PIGN;PIGW;PIGQ
prerank,piRNA metabolic process (GO:0034587),0.4235799728712726,0.9875575044716426,0.46223021582733814,0.9553529211287913,1.0,3/19,9.13%,GPAT2;MOV10L1;MYBL1
prerank,nuclear membrane disassembly (GO:0051081),0.4521364988509936,0.9873287204178758,0.4952015355086372,0.9551028588915624,1.0,3/14,11.31%,PRKCB;CCNB2;PRKCA
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.47147545436433297,0.9873082755927423,0.49193548387096775,0.9542726566564371,1.0,1/11,0.65%,ACTN2
prerank,proteolysis (GO:0006508),0.28559309200032207,0.9872792325155031,0.5118764845605701,0.9534742210436981,1.0,41/252,15.47%,AEBP1;ACE;CPQ;BACE2;TRABD2B;SUFU;CASP3;CPA4;CTSH;DPP4;DPP8;SRGN;METAP2;ADAMTS9;TPP1;CLPX;TBL1X;OLR1;MMP19;NPEPPS;APH1B;MMP14;BMP1;ADAM17;MBTPS1;ATG4D;FOLH1;OGT;DESI1;DESI2;CAPN15;PCSK7;SDE2;ADAMTS7;ERAP1;ANPEP;PLAT;ATG4C;PITRM1;TMPRSS5;ZMPSTE24
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.27075556709689125,-0.986992283079668,0.4964788732394366,0.7545075700597798,1.0,21/98,11.09%,SPTBN1;DPP10;PRKCH;PIK3R1;ANK3;CEMIP;YWHAE;STX3;YWHAB;PLS1;NKD2;PPP3R1;ITGB1;YWHAG;EPHB2;MTCL1;ERBB2;EFCAB7;ATP2B4;KCNB1;GPER1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3908480022384162,0.9869636280943846,0.4752136752136752,0.9534114426227055,1.0,5/27,9.48%,NAPEPLD;NAAA;ETNK2;SLC27A1;PLA2G6
prerank,regulation of phosphorylation (GO:0042325),0.30984585992132735,0.9868725761843631,0.50480109739369,0.9527919716595591,1.0,22/120,13.91%,PRKAG2;BMP7;FNIP1;PHIP;SESN2;ROPN1L;STAT2;GCK;LDB2;LDB1;CDH5;SIRT1;NUP42;FER;NUP98;GLMN;ROPN1;OGT;MCM7;NUP43;PML;FLCN
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.30967031711975135,0.9861553821791509,0.48322147651006714,0.9538611607153055,1.0,22/119,11.64%,PTPN13;TTC7B;INPPL1;PI4KA;MTMR3;PIGN;SYNJ2;SMG1;TMEM150A;PIGW;PLEKHA2;PIGQ;SLC27A1;PIP4K2C;PTEN;PIK3CA;ITPKB;PIKFYVE;PLEKHA8;PIK3R3;OCRL;SOCS3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.35034557193269733,0.9860673982174845,0.46634615384615385,0.9532184748705295,1.0,8/50,14.38%,SH3RF2;NXN;HDAC8;ARRB1;GTPBP4;ABL1;OGT;PER2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.32366800508828936,-0.9858138591066399,0.4857142857142857,0.7566569197126666,1.0,19/37,29.09%,POLD3;ERCC1;UBB;RPA1;GTF2H4;GTF2H1;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;ERCC3;DDB1;RPA3
prerank,hexose metabolic process (GO:0019318),0.36284718877329303,0.9856350735167702,0.4786184210526316,0.953544947221351,1.0,8/39,15.95%,SORD;CHST15;GALM;GALK2;GALK1;PGM1;BRAT1;FPGT
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4703187242093017,0.985133981078379,0.4753787878787879,0.9540407114898412,1.0,3/10,17.25%,WHRN;IFT88;ADGRV1
prerank,regulation of JUN kinase activity (GO:0043506),-0.33400898434197923,-0.9848223426961876,0.4925,0.758238183219615,1.0,8/33,10.59%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;AIDA;EDN1
prerank,regulation of telomere maintenance (GO:0032204),0.39403747929154864,0.9845329455671691,0.4856175972927242,0.9547945920748577,1.0,10/26,22.29%,HDAC8;SMG1;ATRX;RAD50;USP7;PML;TINF2;NBN;YLPM1;SMG6
prerank,protein O-linked glycosylation (GO:0006493),0.31983867581210706,0.9842549682159618,0.4825662482566248,0.954670072469392,1.0,9/96,5.87%,GXYLT2;TRAK1;ST6GAL1;TMTC4;GALNT12;LARGE1;ST3GAL3;TET2;PGM3
prerank,negative regulation of cell death (GO:0060548),0.3155017584792663,0.9841802479955815,0.48066298342541436,0.9540216248804472,1.0,9/88,6.18%,BMP7;PPARGC1A;CCN2;PRKN;KANK2;SRGAP2;LRRK2;PM20D1;ATG5
prerank,regulation of cellular metabolic process (GO:0031323),0.35483962712910777,0.9840438215294518,0.4813008130081301,0.953514528714746,1.0,21/45,25.69%,PPARA;PRKN;NCOR2;TBC1D16;ANGPTL8;RNF34;RNF41;AGPAT1;COQ7;VPS35;BCO2;MKLN1;LAMTOR1;ABCA2;ACLY;GNB3;PDK2;KIF16B;PM20D2;FOXM1;SSH1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3723201451409838,0.9835458899613632,0.4676145339652449,0.9539587515033334,1.0,11/36,17.48%,PRKN;PARP14;PARP9;RIPK1;MAVS;IRGM;ADAM17;AXL;AGPAT1;WNT5A;ZBP1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.40240464687192246,0.983236913503645,0.4973730297723292,0.9539128797524239,1.0,2/21,3.17%,IGF1;BMPR1A
prerank,response to retinoic acid (GO:0032526),0.34095775217334007,0.9831796930570983,0.45878693623639194,0.9532191018590364,1.0,7/59,7.88%,WNT5B;PTK7;WNT6;CTSH;ATM;OVCA2;RBP4
prerank,activation of protein kinase activity (GO:0032147),0.31253133587027565,0.9831230317963786,0.476056338028169,0.9525046154788742,1.0,13/106,8.69%,FGF1;ADCY5;OSBPL8;IGF1;ADCY1;IL18;ADRA2A;TLR3;RICTOR;ADCY9;TGFBR2;NRG1;PDPK1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.2868620483041286,-0.9830169698015244,0.5015576323987538,0.7619542865108843,1.0,15/67,11.81%,GHR;TEK;ERBB4;PTK2B;KDR;LYN;BMX;RELN;EPHB2;PTK2;ABI1;FLT4;ERBB2;TEC;ABI3
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3749444712421657,-0.982786841598441,0.4892703862660944,0.7617497070258601,1.0,6/19,11.20%,DLG2;CLIC4;LRRC7;MTCL1;ERBIN;MARK2
prerank,actin filament polymerization (GO:0030041),0.3882058880724555,0.9824400231909344,0.47157190635451507,0.9535151018833902,1.0,7/29,11.83%,GAS7;ARHGAP6;DIAPH1;CATIP;WASL;VIL1;TTC17
prerank,cognition (GO:0050890),-0.3079806554601039,-0.9822823052283733,0.4601063829787234,0.7621825779815314,1.0,11/42,11.47%,GRM5;ST3GAL4;SHROOM4;DOP1B;APP;PTCHD1;SLC1A4;STRA6;GPR155;MFSD2A;FAM107A
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3699637486036925,0.982109225826681,0.45107794361525705,0.9535276671529614,1.0,8/36,16.03%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5;EHMT2;EHMT1
prerank,negative regulation of JNK cascade (GO:0046329),0.3801472895353468,0.981932423267856,0.47704918032786886,0.9531503632208248,1.0,7/31,13.70%,SH3RF2;PRKN;GPS2;PTPN22;DUSP10;HIPK3;NCOR1
prerank,organelle organization (GO:0006996),0.27453421864451594,0.9818170768035918,0.5089086859688196,0.9526065609578359,1.0,93/388,17.40%,FAM174B;SYNE3;DYM;PPARGC1A;MICAL3;SH3D19;PRKN;OBSL1;FGD4;GABPB1;CAPZB;PHIP;PYROXD2;SEC31B;CLASP1;LRRK2;PEX11A;AFG1L;MYO18A;TPM1;RAB34;ATL1;ESRRA;BCAS3;SIRT5;CLUH;OPA1;NIPSNAP2;CNTNAP1;HUWE1;TERT;TWNK;PEX11B;SIRT3;MTFR2;HTT;DIAPH1;CSNK1A1;TMEM11;DNM1L;ADCK1;TRAPPC12;GOLPH3L;SSBP1;PIKFYVE;CATIP;WASL;PEX10;CHMP1A;YTHDF3;RAB43;CXADR;AJUBA;ZFYVE16;CDC42;FBXW8;FGD1;TTC17;BRWD3;MIA3;SIRT4;ROPN1;PRKCI;PLEKHF1;TRAPPC11;ZMYM6;WDPCP;CFAP410;TANGO2;ARHGAP21;SEC23IP;RAB29;WTIP;ZMYM4;PEX14;VPS4A;SLC25A36;PEX19;GOLGA8B;GOLGA5;VPS51;PI4K2B;RAB30;MSTO1;SEC31A;MTX2;MICAL1;COG4;GORASP2;OPTN;RANBP9;CHMP4C;PEX16
prerank,embryonic hemopoiesis (GO:0035162),0.4524432214897391,0.9816148078501371,0.4686907020872865,0.9522788593115491,1.0,4/12,10.51%,KIT;KMT2A;TGFBR2;FLT3LG
prerank,regulation of vasculature development (GO:1901342),-0.3466929001917467,-0.9815792457544048,0.5314009661835749,0.7631331581925316,1.0,14/26,31.88%,BMPER;TSPAN12;FGF2;ERBB2;CTNNB1;EMP2;PLXND1;SFRP1;HTATIP2;VASH1;HMOX1;NF1;VASH2;PROK2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.38570182067835307,-0.9812592910104762,0.4880694143167028,0.7631645239920369,1.0,5/18,18.18%,LYN;BCAR1;SH2B2;CMKLR1;C3AR1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3258951144574419,-0.9808182367371683,0.4689119170984456,0.7634771010102349,1.0,8/33,8.14%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,negative regulation of cellular process (GO:0048523),0.2691639536306539,0.9807983666620466,0.5417118093174431,0.9536458512825041,1.0,91/521,14.60%,ALDH1A2;TGFBR3;BMP7;SMAD3;APPL2;FBLN1;SYT11;GSDME;FGFBP1;CCN2;PTPN14;NPR1;PRKN;PLXNA2;COL18A1;KANK2;PKHD1;SRGAP2;NUPR1;COL4A3;ARID2;IGFBP7;MAGI2;SPEG;PDPN;IFIT3;SESN2;NACC2;VGLL4;SMAD6;DACT2;TNS2;KNG1;CLMN;DDX3X;IFNK;CAPRIN2;SOD2;ATG5;EIF2AK2;HMGA1;TP53;UBR2;FER1L5;SSTR3;DLG3;PLSCR1;PTPRU;SMARCA4;PTEN;IGFBP3;OSGIN2;HRG;NUPR2;NIBAN2;MYBL1;SULT2B1;HYAL1;SIRT1;GTPBP4;CHMP1A;SLURP1;BECN1;NOX4;NME6;RNF41;RARG;MNT;AXIN2;IMPACT;IRF1;OSGIN1;GLMN;MIA3;BRD7;FRK;NMI;MAP2K1;IFI35;PODN;PPP1R13B;PIP4P2;PML;FLCN;DNAJB2;CRYAB;SPHK2;ACVR1B;AGTR2;TSC1;KAT2B
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.43434109042795277,0.9805167571049911,0.4823091247672253,0.9535168304005728,1.0,2/15,1.59%,KIT;WHRN
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4438836217451886,0.9804556988266665,0.46983546617915906,0.9528002219268422,1.0,7/15,24.00%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;POP7;POP1;LACTB2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.3712321121295954,-0.9804185881263021,0.4871244635193133,0.7636919918437894,1.0,10/19,32.45%,CYBA;CAT;GPX1;PRDX1;SOD1;GPX3;PRDX2;PARK7;PRDX4;PRDX3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4223243946843858,0.9802497145665784,0.4604051565377532,0.9524839766583529,1.0,1/19,1.42%,IGF1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4760281829494632,0.9800641673042524,0.4914933837429111,0.9520916865619482,1.0,3/10,11.07%,BMP7;PHACTR4;ARHGAP12
prerank,ovarian follicle development (GO:0001541),0.45217885097513166,0.9791533758430904,0.49427480916030536,0.9536858431859819,1.0,1/13,1.22%,KIT
prerank,primary neural tube formation (GO:0014020),0.38433139267719363,0.9790569880167508,0.48946515397082657,0.9530828776799906,1.0,6/30,12.40%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1
prerank,positive regulation of GTPase activity (GO:0043547),0.2895033523397654,0.9787094004835148,0.5090439276485789,0.9531156748502218,1.0,16/188,4.79%,DOCK11;AFDN;ARHGAP29;PKP4;PICALM;SIPA1L1;ARHGEF16;SRGAP2;SYDE2;ALS2;RGS16;NGEF;TBC1D16;ASAP3;GMIP;RAPGEF3
prerank,regulation of cell motility (GO:2000145),0.3023895240455345,0.9786768122100551,0.4786206896551724,0.9523477379050237,1.0,17/121,10.49%,FGF1;ROCK2;FBLN1;KIF2A;PLXNA2;LMO4;ARHGAP18;MGAT3;TBCCD1;LDB2;LDB1;NRG1;DIAPH1;AMOTL2;HBEGF;CYRIB;ABL1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4058659373186603,0.978663569350419,0.48408710217755446,0.9515265666097605,1.0,3/20,5.54%,PPARGC1A;PRKAA2;ARRB1
prerank,postreplication repair (GO:0006301),-0.30382076393337215,-0.97857366084269,0.4583333333333333,0.7675731788396936,1.0,24/45,31.15%,UBE2V2;POLD3;RAD18;FAAP20;PRIMPOL;UBB;UBE2B;RPA1;WDR33;RFC4;NSMCE1;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF;UBE2A;RPA3;BRCA1;RPA2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.34787945001291687,0.9784488856425354,0.4697674418604651,0.9512679774099636,1.0,14/48,15.73%,ELOF1;TAF1D;HMGA1;BAZ1B;ATAD2B;ZMIZ1;ZMIZ2;PHF2;MYO1C;POLR1G;TBP;SPHK2;KAT2B;ARID1B
prerank,epithelial structure maintenance (GO:0010669),0.4573816944543271,0.9778359412005082,0.4798387096774194,0.9519918018661793,1.0,2/11,10.61%,RBP4;CXADR
prerank,response to amino acid (GO:0043200),-0.3295092632005155,-0.9777960625222942,0.49876543209876545,0.7687126655946603,1.0,9/31,15.74%,GLRB;GLRA3;SH3BP4;GLRA1;TMBIM6;CAPN2;SPAAR;GLRA2;GRIN1
prerank,catecholamine biosynthetic process (GO:0042423),0.451037072464828,0.9776918893669776,0.4632768361581921,0.9515387712018627,1.0,1/11,1.03%,MOXD1
prerank,retinal metabolic process (GO:0042574),0.45787348050024995,0.9775625516601287,0.48863636363636365,0.9510424997573317,1.0,1/12,1.10%,ABCA4
prerank,regulation of gene silencing by RNA (GO:0060966),0.34639666134876457,0.9773779206368887,0.4953271028037383,0.9498103462960983,1.0,25/50,29.86%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;FMR1;NUP153;POLR2G;AGO1;POLR2F;AAAS;POLR2K;AGO2;PUM2;NUP88;SEC13;IPO8;RAE1;NUP37;NUP160;RANBP2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.34639666134876457,0.9773779206368887,0.4953271028037383,0.9498103462960983,1.0,25/50,29.86%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;FMR1;NUP153;POLR2G;AGO1;POLR2F;AAAS;POLR2K;AGO2;PUM2;NUP88;SEC13;IPO8;RAE1;NUP37;NUP160;RANBP2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3574755586616594,0.9772490379890566,0.48796147672552165,0.9492953887277683,1.0,4/41,7.52%,BMP7;AFDN;PTPN23;PTPRU
prerank,mitotic recombination (GO:0006312),0.4339867578492288,0.9772194922421752,0.4737827715355805,0.9485300559379255,1.0,7/15,19.57%,TPRKB;TEP1;MSH3;RAD50;NSMCE2;XRCC3;RAD51D
prerank,lymphocyte proliferation (GO:0046651),-0.351893777667472,-0.9768233527266308,0.5122549019607843,0.7704204459217041,1.0,3/22,11.13%,MEF2C;PTPRC;MSN
prerank,sphingosine metabolic process (GO:0006670),-0.3849869933170461,-0.9766919674399581,0.5054945054945055,0.7699885147416318,1.0,4/17,5.48%,ACER3;ACER2;PLPP1;SPTLC2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3759594761830189,0.9765775684300275,0.48299319727891155,0.9493283459955459,1.0,5/30,10.33%,PRKCZ;TLR4;CD28;IL12B;CD274
prerank,glial cell development (GO:0021782),-0.34780129084164535,-0.9760146216863965,0.48693586698337293,0.770933167362861,1.0,16/25,39.94%,APP;NRROS;EIF2B3;MT3;TPPP;CSPG5;SOX10;MDK;EIF2B2;NF1;PRDM8;EIF2B5;TLR2;MYRF;SOX4;HES5
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3522323190820446,-0.9759978175011419,0.4939467312348668,0.7702171520502421,1.0,7/24,12.34%,NAV3;CLASP2;ARHGEF2;LIMA1;STMN2;FGF13;SPEF1
prerank,regulation of interleukin-17 production (GO:0032660),0.3697461597348915,0.9758445416482749,0.4904153354632588,0.9504396387765417,1.0,4/31,6.56%,IL18;SPHK1;TLR4;IL12B
prerank,DNA conformation change (GO:0071103),0.42706469626750054,0.9756793101817215,0.4954296160877514,0.9500297959560018,1.0,3/17,12.56%,TOP2B;ABL1;TOP3A
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.34804703660960945,-0.9755919036254811,0.5,0.7705011181471968,1.0,9/28,11.47%,SHANK3;GSK3B;APP;APOE;RELN;EPHB2;PTN;ZDHHC2;FAM107A
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3214651008522726,0.9752853277416795,0.49266862170087977,0.950181503296296,1.0,6/73,6.04%,ROBO1;SMAD3;CFLAR;COL4A3;BID;FAM162A
prerank,negative regulation of immune system process (GO:0002683),-0.38118816533954003,-0.9751267060997906,0.48148148148148145,0.7709548536030928,1.0,3/16,11.09%,CD200;LYN;GPER1
prerank,motor neuron axon guidance (GO:0008045),-0.398879172252321,-0.9750673458636345,0.5222929936305732,0.7703543490537323,1.0,5/15,9.60%,SLIT2;TMEFF1;CHN1;NTN1;RHOH
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.28429222915003394,0.9748141414915131,0.5049382716049383,0.9505308597842164,1.0,17/214,6.05%,NOTCH2;TGFBR3;DUSP29;FBLN1;TIMP3;PRKCZ;DLG1;CCN2;FGFR2;SLC30A10;PKHD1;NPNT;EZR;TLR4;ARRB1;PDGFRB;BRAF
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.43146126806567553,-0.9746037420241072,0.5072463768115942,0.7707435969013186,1.0,4/11,16.20%,STAT3;LIMD1;FXR1;DHX9
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.24100274082530987,-0.9737219873588593,0.582010582010582,0.7722258502548028,1.0,52/173,25.67%,SPTBN1;ANK3;GRIA1;GAS6;VAMP4;CTSC;DYNC1I1;DYNLL1;LMAN2L;GOPC;CUL3;DYNC1LI2;NSF;KDELR3;COG5;CAPZA2;DCTN4;TMED1;TMED5;PROS1;CNIH1;SPTB;ATL2;TMED4;LMAN2;TMED7;CAPZA1;KLHL12;COPE;ATL3;BCAP31;SPAST;SPTBN2;SPTAN1;CTSZ;IER3IP1;TMED9;TFG;MCFD2;BCAP29;TRAPPC2L;VAPA;TMED10;SAR1B;DCTN6;TMED2;TRAPPC3;ARFGAP2;COG1;RAB1B;COL7A1;ACTR1A
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4262701034826476,0.9736714541679492,0.4802158273381295,0.9527628605031677,1.0,5/15,21.60%,GLI3;IL12B;CCR2;IHH;CD55
prerank,chromatin remodeling (GO:0006338),0.3088495296517876,0.9734083713214668,0.5028248587570622,0.952630380967582,1.0,32/100,21.45%,JARID2;CHD4;ATRX;BAZ1B;SMARCD3;SMARCA4;SRCAP;SMARCC2;HDAC1;SMARCE1;HDAC4;SIRT1;BAZ1A;BAHD1;ZBTB1;HNRNPC;KAT2B;MTA2;SATB2;ARID1B;RB1;KDM6B;PADI4;CHD8;EZH1;MPND;MBD2;SMARCD2;RUVBL1;CECR2;KDM6A;TAF6L
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3816999480311082,0.9732079189071583,0.4828150572831424,0.9522947574426458,1.0,4/26,6.62%,GPR137;TLR3;TLR4;FBN1
prerank,regulation of G0 to G1 transition (GO:0070316),0.36025555773951123,0.9731295978373214,0.4666666666666667,0.951659194281275,1.0,8/38,16.03%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5;EHMT2;EHMT1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4518175492393094,0.9730638612278131,0.501937984496124,0.9510153618826602,1.0,3/13,4.60%,ANK2;KCNA5;CACNA1C
prerank,regulation of ERAD pathway (GO:1904292),-0.4307540694146884,-0.9727447901238834,0.49173553719008267,0.7737991423231066,1.0,2/11,7.92%,AQP11;USP13
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.43113450585161794,0.9723178359554288,0.5,0.952213579198444,1.0,5/16,13.17%,HMGA1;TWNK;SSBP1;MCM7;MCM2
prerank,chemical homeostasis (GO:0048878),0.3255531035474843,0.9721529165714532,0.492603550295858,0.9518411758742344,1.0,12/61,15.42%,WNK4;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;ADCK1;ACOXL;ACOX3;WNK1;SLC66A1;TENT4B
prerank,clathrin coat assembly (GO:0048268),-0.39733458488831425,-0.9720014365700698,0.5042372881355932,0.774820533236799,1.0,3/15,6.77%,HIP1;SGIP1;NSG2
prerank,cellular defense response (GO:0006968),0.36223565758475823,0.9719145300246299,0.4889589905362776,0.951648089248767,1.0,6/40,12.04%,CCR9;DCDC2;VEZF1;LY96;BECN1;ZNF148
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.4585964688653801,0.971647554882784,0.5060483870967742,0.9515411945116369,1.0,3/10,11.48%,ACTN2;CARMIL2;VIL1
prerank,negative regulation of ossification (GO:0030279),0.3930994896815135,0.9716193160074724,0.5088652482269503,0.9507839194757767,1.0,5/23,9.20%,LRP4;SMAD6;SRGN;BCOR;CHSY1
prerank,pharyngeal system development (GO:0060037),0.41861483477631517,0.9713431233782294,0.49245283018867925,0.9506482648227459,1.0,3/15,3.48%,BMP7;BMPR1A;TGFBR1
prerank,embryonic organ morphogenesis (GO:0048562),0.3495098997032608,0.9713077417391196,0.49445324881141045,0.949897326016491,1.0,13/42,13.96%,FGFR2;HOXB4;HOXB3;HOXB9;HOXA3;FBN1;NIPBL;RBP4;HOXC4;DYNC2I1;RARG;RBPMS2;PDGFRA
prerank,regulation of myeloid cell differentiation (GO:0045637),0.32827151417397343,0.9713043059707559,0.4851190476190476,0.9490773861495683,1.0,19/62,15.67%,KMT2A;TNRC6A;CTR9;PRKCB;MEIS1;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;KMT2D;SIN3A;KAT2B;PURB;TNRC6C;LGALS3;HOXB8;CREBBP
prerank,glucose metabolic process (GO:0006006),0.33676187598716617,0.9710441001028018,0.49921507064364207,0.9489588036181554,1.0,15/58,18.24%,PPARGC1A;SORD;PGAM2;GALM;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;BRAT1;SLC25A10;GOT1;CRY1;SLC37A4
prerank,negative regulation of response to wounding (GO:1903035),-0.3678766544247194,-0.9709856600273161,0.5064655172413793,0.7765757316304128,1.0,9/19,23.54%,CASK;AJAP1;CRK;CD109;FGF2;RTN4RL1;RTN4R;GIT1;MDK
prerank,glutathione biosynthetic process (GO:0006750),-0.4204671871151702,-0.9709663804917816,0.4942084942084942,0.7758695556155151,1.0,7/11,32.35%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.37684804347414746,0.9706964546477681,0.5126050420168067,0.9489799535414231,1.0,4/29,6.76%,ACSL1;ACSBG2;HACD1;SCD5
prerank,negative regulation of neurogenesis (GO:0050768),0.3669371984511324,0.9704705570222957,0.5097087378640777,0.9487788631678847,1.0,4/34,7.90%,APPL2;LRP4;RUFY3;PTEN
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2664007195856083,0.9704639463096386,0.556407447973713,0.9479686469253104,1.0,115/497,18.28%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;DKK3;ZNF568;ARID4A;NR2F2;NCOR2;GLI3;TSHZ3;ZBTB38;LOXL3;NACC2;VGLL4;FOXP2;SFMBT1;IGF2BP1;DDX3X;CBFA2T2;EIF2AK2;ZNF318;HMGA1;LBH;TP53;SMURF2;NIPBL;BHLHE41;IGF2BP2;FBXW11;SAMD4A;LDB1;NR1D2;BCOR;SMARCA4;RBM15;SPEN;BTRC;KAT6B;LARP1;CNOT10;NRG1;SMARCC2;CPEB3;PDS5A;TCF7L2;TLE1;HDAC1;NIBAN2;SMARCE1;HDAC4;SPINDOC;SIRT1;SCML4;GTPBP4;CBY1;SOX13;CHMP1A;LSM14A;PRDM5;ZNF219;SAP18;BAHD1;CBX5;IRF1;WAPL;UIMC1;WWP2;ZNF148;DDX6;DEAF1;BRD7;KMT5A;MLXIPL;KAT7;BCL7A;CDAN1;NCOR1;PML;SIN3A;TLE2;CRYAB;PER2;TAF7;TSC1;ZKSCAN3;HOXA7;MPHOSPH8;PEX14;SETDB2;RBM4;EHMT1;ILF3;NKX2-1;PHF12;WNT5A;SMAD4;RB1;BCL6;CTBP2;KDM1A;NACC1;CHD8;IKZF4;MBD1;CRY1;HEXIM2;L3MBTL3;RUNX1T1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34538212122099354,0.9702662893321604,0.5045871559633027,0.9476481728855031,1.0,13/49,14.97%,KMT2A;TNRC6A;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;RAB7B;KMT2D;SIN3A;KAT2B;TNRC6C
prerank,positive regulation of cytokinesis (GO:0032467),0.37325363158586206,0.9701231973048192,0.49421487603305786,0.9471841544678717,1.0,5/32,10.98%,PKP4;CDC14A;AURKB;CDC14B;CDC42
prerank,positive regulation of RNA metabolic process (GO:0051254),0.35462621746989015,0.9700416597110593,0.5078864353312302,0.9465996970331405,1.0,11/45,14.40%,DDX5;POLR2A;TP53;ZC3H18;RIOK2;RIPK1;DYRK1A;MAP2K1;WDR43;MAP2K2;NFKB1
prerank,regulation of endocytosis (GO:0030100),0.3327110463102545,0.9697643191291926,0.49258160237388726,0.9464637839140605,1.0,5/61,3.76%,DAB2;SYT11;PICALM;SPHK1;STON1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.30162974537406684,-0.9695842207365767,0.5378378378378378,0.7785035893282719,1.0,8/46,14.27%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,microtubule bundle formation (GO:0001578),-0.30561285812393735,-0.96953846902888,0.49019607843137253,0.7778592251030289,1.0,20/42,32.14%,NCKAP5;DCX;MTCL1;RP1;CDK5RAP2;SPEF1;CLIP1;TPPP;CAPN6;SPAST;LRGUK;TPPP3;MARK4;KIF20A;CFAP206;RSPH9;FOXJ1;CCDC66;PSRC1;TTLL3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3049574274594671,0.9695006172724062,0.5110803324099723,0.9463339890530075,1.0,8/108,6.04%,UACA;ROBO1;SMAD3;CFLAR;COL4A3;BID;DDX3X;FAM162A
prerank,lipid catabolic process (GO:0016042),0.42157564046955315,0.9694389877897303,0.4904580152671756,0.9456770377677217,1.0,3/18,7.43%,CEL;PLA1A;PNLIP
prerank,myoblast fusion (GO:0007520),-0.415113154899547,-0.9691527142697984,0.528604118993135,0.7780072852403643,1.0,5/12,6.53%,ADGRB3;CD9;ADAMTS5;PTGFRN;JAM2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.33486798954398356,-0.9690291588826377,0.4940047961630695,0.7775692693591905,1.0,15/30,38.87%,HSPA8;HSPA5;CCT2;HSPE1;PTGES3;DNAJB1;ERO1A;HSPA13;HSPA9;DNAJB4;ENTPD5;HSPA1L;ST13;SDF2L1;UGGT1
prerank,regulation of inflammatory response (GO:0050727),0.2860576152959937,0.9689609495686906,0.5110565110565111,0.9461522636298444,1.0,21/190,9.65%,RORA;C1QTNF3;PPARA;LACC1;IL18;NAPEPLD;SPHK1;SNX6;TLR3;METRNL;TLR4;GPS2;IL12B;DAGLA;ENPP3;SERPINE1;NR1D2;GPRC5B;IL17RA;CDH5;RIPK1
prerank,regulation of immunoglobulin production (GO:0002637),-0.35824637043349705,-0.9689566248683317,0.48711943793911006,0.7769938087133058,1.0,3/23,8.13%,GPI;PTPRC;EPHB2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.33127427826471045,-0.9687099201763043,0.5037783375314862,0.77685995524368,1.0,13/31,27.02%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;UBE2W;RHBDD1;PTPN1;ERN1;STUB1;HSF1
prerank,response to lipid (GO:0033993),-0.2586517670029122,-0.968507619468041,0.5163636363636364,0.7766153406569014,1.0,23/105,13.17%,ESR1;NOS3;ACER2;PPARD;STAT3;TNFRSF11A;ANXA1;FOXP1;GCH1;SOCS2;ABCG1;ALPL;FOXO1;TGFB1;IRAK3;STAT5B;SCD;ERBIN;RPS6KA3;CTNNB1;TIRAP;NOS1;SNCA
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.3886766103035155,-0.9683771597869757,0.4894067796610169,0.7762123224987454,1.0,4/15,18.92%,ANXA1;GPER1;FAM107A;BCL2L11
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3668414078954243,-0.9681185839969275,0.5129310344827587,0.7761085546614149,1.0,6/20,13.56%,ENTPD1;HSP90AB1;APP;TXNIP;NT5E;TXN
prerank,tube closure (GO:0060606),0.37839436936131865,0.9680608801226791,0.5088566827697263,0.947758417779159,1.0,10/31,19.62%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2
prerank,Notch signaling pathway (GO:0007219),-0.2910529951943132,-0.9680026176027215,0.5267857142857143,0.7756529427720672,1.0,14/59,9.85%,SORBS2;MAML2;NOTCH3;YBX1;NOTCH1;JAG1;HES1;PSEN1;JAG2;HEYL;BMP2;WWC1;HEY2;PBX1
prerank,positive regulation of protein deacetylation (GO:0090312),0.43100791458189547,0.9676972272702882,0.5133689839572193,0.9478097168585955,1.0,6/14,25.35%,NIPBL;DYRK1A;FNTA;ZBTB7B;AKAP8;ING2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3665711850455776,-0.9674120693754,0.4977973568281938,0.7763529549593048,1.0,9/20,10.83%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;HEYL;BMP2;HEY2;BMP4
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.36598385725254573,-0.9673905621721028,0.5215419501133787,0.7756590908139745,1.0,6/18,11.13%,APOE;CTSC;DACT1;RDX;HSP90AA1;MSN
prerank,regulation of cytokine production (GO:0001817),0.29984357734413936,0.9667091368318774,0.521970705725699,0.9495623238576317,1.0,13/126,7.50%,C1QTNF3;LGR4;SYT11;ADRA2A;SRGN;IGF2BP1;TRIM56;CD28;EIF2AK2;IL12B;TWSG1;AFAP1L2;IGF2BP2
prerank,carbohydrate transport (GO:0008643),-0.41351158945052857,-0.966543914077267,0.4872881355932203,0.7769345247806435,1.0,5/11,29.85%,AQP11;SLC50A1;SLC23A1;SLC23A2;AQP1
prerank,pyruvate metabolic process (GO:0006090),0.33797691535796964,0.9662316846942881,0.5247208931419458,0.9500225447215397,1.0,7/52,9.17%,ME2;HK2;LDHB;PGAM2;GCK;SRR;DLD
prerank,myotube differentiation (GO:0014902),0.413709507415019,0.9657325855423633,0.48056537102473496,0.9504460510417259,1.0,3/17,3.47%,ADAM12;IGF1;ADAMTS15
prerank,positive regulation of angiogenesis (GO:0045766),0.3058773689125617,0.965704051643955,0.5163043478260869,0.9497002003086884,1.0,18/108,10.04%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;FUT1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1;FOXC2
prerank,motile cilium assembly (GO:0044458),0.4531255259821629,0.965599302174675,0.5105162523900574,0.9491549588016768,1.0,7/12,25.85%,E2F4;CCDC39;BBOF1;CCDC40;SPATA6;RSPH6A;BBS5
prerank,oogenesis (GO:0048477),-0.38803878459535124,-0.9654156543789987,0.5206073752711496,0.778903946633638,1.0,6/15,25.75%,FMN2;PTN;METTL3;MEI4;MDK;NANOS3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3472766488336822,-0.965262675747688,0.5234899328859061,0.7785510634404915,1.0,11/25,24.94%,SLIT2;EVL;TBC1D30;LIMK2;ABI3;PFN2;KANK1;ODF2L;ARHGAP44;PLXNB3;CCP110
prerank,inorganic anion transport (GO:0015698),0.33724036363274446,0.9650095243411575,0.5199362041467305,0.9498156125885323,1.0,7/53,9.43%,SLC13A4;SLC5A5;CLCN2;ENPP3;ANO6;SLC26A1;NMUR1
prerank,RNA biosynthetic process (GO:0032774),0.3739128513847578,0.9647995336792472,0.5180327868852459,0.9495043315032642,1.0,10/31,16.76%,POLR2A;TTF2;TERT;TAF4;TBP;POLA2;TAF7;BRF1;TTF1;TAF13
prerank,protein catabolic process (GO:0030163),0.3345674857827012,0.9647688759206471,0.5007751937984496,0.9487659949875744,1.0,13/59,13.36%,PRKN;NGLY1;LAMP2;NEU2;ADAMTS9;TPP1;CLPX;CLN6;MANBA;RIPK1;RNF41;MAGEC2;DDI1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.28118733215940067,-0.9646305793856077,0.5263157894736842,0.7793580106022427,1.0,21/70,27.46%,PLA2G4A;MBOAT1;CEPT1;SLC44A5;SLC44A2;LPCAT2;ENPP2;MFSD2A;PLA2G12A;SLC44A1;LPIN3;ABHD4;PLA2G4E;PLA2G15;PCYT1B;CHAT;PLA2G4F;ABCA3;MBOAT7;DBI;CSNK2B
prerank,meiosis I (GO:0007127),0.39380339505247186,0.9645161277351323,0.5034965034965035,0.9486015969883002,1.0,4/23,13.17%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.23888501080346153,-0.9643534769473376,0.5898617511520737,0.7792827450553612,1.0,46/175,24.38%,PID1;ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;ARHGEF2;PSMB2;TNFRSF11A;DAB2IP;TRAF5;CARD14;RPS3;TNFRSF1B;PSMD14;TNFRSF21;PSMC6;ERBIN;GPER1;IKBKB;ILK;AIM2;YBX3;LIMS1;PSMB9;PSMA4;DHX9;CCL13;EDAR;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;CCL19;HAS2;ASAH1;PYCARD;TXNDC17;PSMA2;MAP3K14;SFRP1;HYAL2;RELA;PSMB3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.29758465772788806,0.9641966419650524,0.5391766268260292,0.9486342992079461,1.0,19/122,10.02%,SORBS1;IGF1;SMOC2;GLI2;LARP4B;SLC6A9;TLR4;DDX3X;PDGFRB;NOX1;CD28;POLDIP3;GCK;SAMD4A;LDB1;CPEB3;GLI1;SIRT1;YTHDF3
prerank,activation of protein kinase A activity (GO:0034199),0.4319007019404545,0.9641300478782531,0.5058139534883721,0.9479931847821851,1.0,5/16,13.78%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.40812398697847946,0.9638862796744118,0.5249110320284698,0.9477892417985018,1.0,7/21,24.27%,MITF;MED12;MED17;MED1;MED13;MED24;BCLAF1
prerank,pre-replicative complex assembly (GO:0036388),-0.2815757651534238,-0.9638049783128908,0.5242424242424243,0.7798766541127714,1.0,29/64,38.90%,PSMB2;PSMD14;PSMC6;UBB;PSMB9;ORC5;PSMA4;ORC2;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;PSMD7;PSMF1;MCM4;MCM8;PSMA5;PSME4;PSMA7;PSMD3;PSMD4;ORC4;PSMC2;UBA52
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3701292562776307,-0.9636520397693037,0.4978448275862069,0.779510345957558,1.0,6/17,10.88%,HSP90AB1;PPP1R12A;CALM1;PTPRC;CALM2;CALM3
prerank,regulation of tissue remodeling (GO:0034103),0.4261153243507552,0.9635365795619083,0.5083179297597042,0.9478374620531315,1.0,4/18,10.80%,LEPR;IL18;IL12B;SUCO
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.41900732598527113,-0.9630661306354249,0.5137420718816068,0.7801789709021586,1.0,2/11,4.22%,FAP;PTGIS
prerank,positive regulation of interleukin-4 production (GO:0032753),0.4121308411748094,0.9627672289077421,0.5,0.9490476041448114,1.0,2/17,6.28%,PRKCZ;CD28
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.31365039637128,0.9627335303137868,0.5181564245810056,0.9483297585619246,1.0,16/84,11.50%,CELF2;DDX5;SON;MBNL2;TIA1;RBM39;RBM15;JMJD6;NOVA1;LARP7;THRAP3;SAP18;SRPK2;SFSWAP;NUP98;HNRNPL
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.38878236145635664,0.9626668390517412,0.5081967213114754,0.9477007124203684,1.0,2/26,1.42%,FHL2;IGF1
prerank,response to alcohol (GO:0097305),0.3787936133332779,0.9625818414168202,0.49829931972789115,0.9471197886936598,1.0,4/27,7.53%,TGFBR3;TGFBR1;TGFBR2;GOT2
prerank,cardiac atrium morphogenesis (GO:0003209),0.41902943806779214,0.9623310733119085,0.5097345132743363,0.9470256759335736,1.0,1/16,0.19%,NOTCH2
prerank,regulation of nervous system process (GO:0031644),0.41264043969243613,0.9621575895466294,0.5245009074410163,0.9466564617640969,1.0,3/18,4.81%,ROCK2;SLC8A3;DLGAP4
prerank,small GTPase mediated signal transduction (GO:0007264),0.30391370015651503,0.9621195686016709,0.518467852257182,0.9459362647844315,1.0,10/103,5.06%,RAPGEF5;KSR1;IGF1;RIN2;ARHGEF18;ARHGAP18;CCNA2;RGL1;ADRA2A;RREB1
prerank,endoplasmic reticulum organization (GO:0007029),-0.26899856565221925,-0.9619799986903796,0.5406360424028268,0.7821213639495653,1.0,23/72,22.36%,RTN4;REEP1;CAV2;DOP1B;SHTN1;APP;REEP5;LMAN2L;RAB18;SEC61B;ATL2;LMAN2;CYB5A;VCPIP1;EIF2AK3;EMD;ATL3;SPTSSB;RTN3;TLE6;TRAM1;VAPA;REEP3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.42259739175539973,-0.9616800085925473,0.5141129032258065,0.7820872148231329,1.0,3/11,10.77%,SCARB1;LDLR;MFSD2A
prerank,positive regulation of cation channel activity (GO:2001259),0.35105589927630476,0.961663491600197,0.5077399380804953,0.946282734716872,1.0,3/40,1.95%,ACTN2;ANK2;LRRC38
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.39232826115908304,0.9615165882072267,0.48586572438162545,0.9458608285099086,1.0,3/20,7.39%,IL18;TLR4;PTPN22
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2846973280886598,0.9612859719556957,0.5317258883248731,0.9456589354202017,1.0,18/170,10.28%,PRDM6;ROCK2;IGF1;AFF3;MTMR3;TBC1D16;PCBP2;ZNF462;IGF2BP1;AFF4;TOB2;IGF2BP2;C1D;HRG;GDNF;NOVA1;DHH;PRDM5
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.43459861830993557,0.9608762845338719,0.5279850746268657,0.945904642309641,1.0,2/16,4.72%,LEPROT;PARP14
prerank,oligodendrocyte development (GO:0014003),-0.38888658396391895,-0.960659762448895,0.5,0.7838064316908308,1.0,9/15,31.95%,PLP1;B4GALT5;EIF2B3;TPPP;SOX10;B4GALT6;EIF2B2;PRDM8;EIF2B5
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24244142100661706,-0.9603732539476607,0.5588235294117647,0.7837569745815252,1.0,34/172,14.35%,DGKH;DGKB;PIP5K1B;PIK3R1;INPP4B;PLA2G4A;PIP4K2A;PIK3C2B;INPP5D;CEPT1;BMX;PLCG2;PLEKHA1;PIK3R6;SLC44A5;MTMR6;SLC44A2;LPCAT2;MTMR2;FGF2;MTMR7;MFSD2A;PLA2G12A;MTMR9;SLC44A1;ETNK1;DGKG;DGKZ;PLEKHA3;PITPNM3;LPIN3;PNPLA3;ABHD4;CDS1
prerank,positive regulation of autophagy (GO:0010508),0.3139361699611838,0.9602558455937681,0.5278969957081545,0.9466993139597977,1.0,12/81,10.43%,RNF152;PRKAA2;PRKN;SESN1;LRRK2;TPCN1;SESN2;NPRL2;LARP1;HTT;SIRT1;IRGM
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3911025828309381,0.9601417370945099,0.49812734082397003,0.9461908149014016,1.0,6/20,14.91%,NUPR1;CFLAR;RIPK1;FLOT2;OGT;BIRC3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2775841723463982,-0.9599353394214921,0.5365853658536586,0.7841264273884523,1.0,29/75,23.81%,SLC8A1;PTPRJ;HEG1;RASIP1;LYN;DAB2IP;APOE;SORL1;IRAK3;DUSP1;UCHL1;BMP4;PRKAR2B;PRKAR1B;MYOCD;SPRY1;HHEX;APC;MEN1;SPRY4;PRKAR2A;PTPN1;AGT;PYCARD;PAQR3;STK38;LRP6;TFAP4;HYAL2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.33123512546730277,-0.9598911391238056,0.5,0.7834854722831311,1.0,12/27,28.44%,MAP3K5;MAP3K7;IKBKB;CCDC88C;UBB;SKP1;UBC;RPS27A;MAP2K7;MAPK8;MAP3K8;MAPK3
prerank,positive regulation of potassium ion transport (GO:0043268),0.3590264807259579,0.9597037314911594,0.5253968253968254,0.9464902999727799,1.0,4/38,3.76%,ACTN2;ANK2;DLG1;ADRA2A
prerank,negative regulation of histone modification (GO:0031057),0.4341067344639056,0.9596770994968205,0.5160075329566854,0.9457562725588511,1.0,4/14,14.54%,JARID2;AASS;SPHK2;TAF7
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.34981726247117,0.959437178712744,0.5267295597484277,0.9455513982791044,1.0,6/43,11.39%,SYT11;IGF1;TLR4;PTPN22;CD274;DICER1
prerank,tRNA 5'-leader removal (GO:0001682),0.4521000616734671,0.9594066059449009,0.5178236397748592,0.9448324545852816,1.0,5/13,20.12%,RPP21;PRORP;RPP25L;POP7;POP1
prerank,amyloid fibril formation (GO:1990000),-0.295354313474823,-0.9593847213468304,0.5555555555555556,0.7840056008798292,1.0,23/51,23.44%,GSN;CST3;B2M;APP;TSPAN14;TGFBI;SORL1;HSPG2;SIAH2;H3-3A;FKBP1A;ITM2B;MAPT;SNCA;MFGE8;UBB;IAPP;APH1A;TSPAN33;TSPAN15;UBC;RPS27A;SERF1A
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.46875058194129987,0.9592954419738732,0.5177865612648221,0.9443227564828576,1.0,1/10,2.02%,PRKN
prerank,positive regulation of secretion by cell (GO:1903532),0.3248774994153212,0.9591827748249623,0.5029850746268657,0.9438245092405289,1.0,7/70,4.89%,BMP6;FRMD4A;IGF1;CLASP1;DTNBP1;MYO18A;EZR
prerank,response to estrogen (GO:0043627),-0.3226796814291354,-0.9590955684258267,0.5144230769230769,0.7839561425056634,1.0,3/31,5.77%,CAV1;ESR1;AR
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.441826277220539,0.9573670975767888,0.49906191369606,0.9477342415740313,1.0,2/12,6.74%,UST;DSE
prerank,intermediate filament organization (GO:0045109),-0.3751750370551443,-0.9572239653525055,0.5131578947368421,0.7877637746115647,1.0,6/17,26.33%,VIM;BFSP2;PKP2;GFAP;NEFL;DES
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4099662575245707,-0.9571322360237553,0.5243362831858407,0.7872245520169697,1.0,3/13,11.65%,ENTPD1;ENPP1;SMPDL3A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3892631376633507,0.9562579455663607,0.5035087719298246,0.9497990662922513,1.0,6/23,13.10%,ERRFI1;SNX6;SH3BP5;MVP;SRCIN1;GPRC5A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3746188815885366,0.9551649323513209,0.5126475548060708,0.9518035227439657,1.0,3/24,6.03%,RORA;SULF2;NOX1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3869163791519973,0.9550138522717575,0.5034602076124568,0.9514103740342109,1.0,2/24,7.06%,LPGAT1;SLC27A1
prerank,inositol phosphate metabolic process (GO:0043647),0.34064853395519884,0.954981331285763,0.511520737327189,0.9506947999333221,1.0,9/46,11.59%,ISYNA1;NUDT4;INPPL1;PLCD3;PTEN;PLCD1;ITPKB;PPIP5K2;OCRL
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.35543829589601567,0.9548388739759468,0.5047619047619047,0.9502797089332645,1.0,9/38,13.91%,PPARA;PKHD1;MAGI2;DAG1;PTEN;SIRT1;PHLPP2;THEM4;FLCN
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.43677823840195407,0.9547955514110964,0.4915254237288136,0.9496035467575269,1.0,3/12,13.05%,DPYD;CTPS2;ALDH6A1
prerank,positive regulation of calcium ion transport (GO:0051928),0.3576064667561334,0.9547624572600478,0.5107794361525705,0.9488839741776794,1.0,4/36,6.00%,CACNA1D;ANK2;P2RX3;PDGFRB
prerank,regulation of oxidative phosphorylation (GO:0002082),0.42122634941806714,0.9547607186587056,0.5210526315789473,0.9481008728828993,1.0,5/16,21.65%,NUPR1;AK4;MLXIPL;ATP7A;PPIF
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.26218847626004854,-0.9545963937100173,0.558282208588957,0.792677001490738,1.0,40/82,32.87%,YWHAE;DYNLL1;PPP2R1A;YWHAG;TUBA1A;HAUS2;CDK5RAP2;TUBB4A;KCNH5;HSP90AA1;PRKAR2B;ATAD5;ATF5;HAUS5;CEP78;CETN2;TUBA4A;SSNA1;CEP131;NPM1;NEK10;HMMR;KIF14;NEDD1;HAUS4;TPX2;NDE1;CCP110;CEP135;ACTR1A;HAUS6;CEP76;CENPF;CEP43;AURKA;CDK1;CSNK1D;HAUS8;DCTN1;MAPRE1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4581525777510968,0.9545883610889762,0.5142857142857142,0.9477345852246253,1.0,4/10,12.32%,EPHA4;CDK5RAP3;ATRAID;RGP1
prerank,B cell differentiation (GO:0030183),-0.3005936350798993,-0.9536995029719091,0.5355191256830601,0.7940855593061122,1.0,8/46,7.45%,PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2766457582275822,-0.953385277763118,0.5394736842105263,0.794132249583469,1.0,13/69,10.59%,PLCB4;PIK3R1;PLCL1;PLCE1;NYAP2;PIK3C2B;NGF;PLEKHA1;PLCL2;HTR2A;PLCH1;ERBB2;EDN1
prerank,positive regulation of JNK cascade (GO:0046330),-0.2752241309126487,-0.9533157600645471,0.5398773006134969,0.7935403343323747,1.0,25/70,21.37%,MAP3K5;RASSF2;SH3RF3;PTK2B;DAB2IP;MINK1;TRAF5;APP;TNFRSF19;ANKRD6;MFHAS1;FLT4;TIRAP;AXIN1;GADD45G;MBIP;HIPK2;NOD2;EDAR;TRAF1;GADD45B;WNT16;CCL19;MAP3K11;PYCARD
prerank,eye photoreceptor cell development (GO:0042462),-0.38054769016020806,-0.9532380822340192,0.5228758169934641,0.7929729027254928,1.0,3/15,13.85%,RORB;RP1;VEGFA
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3671603486912406,0.9532311248958607,0.5206896551724138,0.9503647382702608,1.0,6/32,13.81%,DDX5;FHIT;TP53;SIRT1;PPP1R13B;PML
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4361559086766815,0.9531912923764859,0.5,0.9496711326636849,1.0,4/13,14.97%,TNRC6A;TNRC6B;CPEB3;TNRC6C
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3284470363635638,0.9528946768536747,0.5403348554033486,0.9495850751846304,1.0,10/62,11.81%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2561388075717807,-0.9528801353690334,0.553030303030303,0.7930633161475267,1.0,34/110,18.08%,GSN;TFRC;GSK3B;DAB2IP;APOE;RPS3;SH3GLB1;HSPA8;ULK1;SORL1;HSPA5;RALB;TGFB1;HJURP;AIDA;FNIP2;GNL3L;HSP90AA1;TIRAP;LCMT1;PINK1;NOP53;VEGFA;TAL1;CDC42EP2;ATF7IP;CLU;FBLIM1;NAPB;SVIP;IAPP;TPPP;SYK;STX1B
prerank,axonal transport (GO:0098930),-0.3137642018932192,-0.9525486285801151,0.5314136125654451,0.7930923180646401,1.0,18/36,28.67%,SYBU;DST;TMEM108;AP3S1;MAPT;HIF1A;KIF3A;AP3S2;SPAST;AP3B2;SOD1;KIF4A;HAP1;KIF3B;NEFL;KIF1A;AP3D1;AP3M2
prerank,lung epithelium development (GO:0060428),0.458995532058777,0.9524805201452603,0.5188866799204771,0.9498762342800114,1.0,1/10,1.16%,ERRFI1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.45381531597759217,0.9524481890641859,0.531021897810219,0.9491565771746968,1.0,4/11,9.00%,PCBP2;IGF2BP1;IGF2BP2;NOVA1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.28724390766276076,-0.952117677250821,0.5431034482758621,0.7934437016111032,1.0,8/55,6.52%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;RPS3
prerank,dermatan sulfate metabolic process (GO:0030205),0.43198584067798296,0.9518380679405422,0.48507462686567165,0.9498988675153275,1.0,2/13,6.74%,UST;DSE
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3927408897499981,0.9516532138579294,0.5225694444444444,0.9495838466349139,1.0,4/22,13.33%,BMP7;MAP2K5;FLOT2;WNK1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3908886834492687,0.9516368833311205,0.531951640759931,0.9480590904332326,1.0,4/23,9.08%,TFDP2;BID;TP53;TFDP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3908886834492687,0.9516368833311205,0.531951640759931,0.9480590904332326,1.0,4/23,9.08%,TFDP2;BID;TP53;TFDP1
prerank,regulation of p38MAPK cascade (GO:1900744),0.3603764569516939,0.9514332385557009,0.5057096247960848,0.9477992777866191,1.0,8/35,14.36%,SASH1;DLG1;SPHK1;EZR;PTPN22;DUSP10;GADD45A;ULK4
prerank,peptidyl-amino acid modification (GO:0018193),0.46504717462981604,0.9512009887930442,0.52,0.947620801077609,1.0,4/10,19.71%,METAP2;TTLL4;FKBP10;ATP7A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.38711384511383096,-0.9511622445521798,0.5133333333333333,0.7950819978056662,1.0,9/15,31.37%,TSEN34;FAM98B;RTCB;TSEN54;ERN1;CPSF4;TSEN15;CLP1;CPSF1
prerank,cellular lipid catabolic process (GO:0044242),-0.33334609486754957,-0.9510747682287768,0.5421412300683371,0.7945545498968711,1.0,9/27,19.97%,PPARD;CYP1B1;ENPP2;LPIN3;MT3;AOAH;PLA2G15;SIRT2;SMPDL3B
prerank,filopodium assembly (GO:0046847),-0.3698833905351629,-0.9510321329753346,0.5406593406593406,0.7939205841764791,1.0,3/16,4.18%,DNM3;FGD5;SPATA13
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.40350687877194114,-0.9507934638193287,0.5353319057815846,0.7937696514656758,1.0,5/13,16.60%,ELOVL7;ELOVL5;ELOVL6;TECRL;TECR
prerank,negative regulation of T cell differentiation (GO:0045581),0.4549110281365858,0.9507592490504225,0.5067698259187621,0.9479108595964925,1.0,4/10,21.39%,GLI3;IRF1;IHH;CTLA4
prerank,cellular response to metal ion (GO:0071248),0.2943453638738871,0.9506786986187657,0.5605633802816902,0.9473039155939802,1.0,9/123,3.69%,BMP6;SLC41A1;SYT9;SYT11;SYT12;PRKAA2;ADCY1;PRKN;LRRK2
prerank,embryonic digit morphogenesis (GO:0042733),0.4012113810752367,0.9503522483616765,0.511070110701107,0.9473460373601568,1.0,5/18,15.67%,OSR1;GLI3;HDAC1;WDPCP;CREBBP
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.38762325751057564,-0.9501989028413064,0.5292841648590022,0.7944996405863489,1.0,4/13,11.65%,BMP5;APOE;BMP2;ERLIN1
prerank,cristae formation (GO:0042407),0.3811067816044138,0.9496422009671115,0.5573192239858906,0.9483446250739099,1.0,8/27,19.58%,CHCHD3;SAMM50;ATP5F1D;MICOS13;IMMT;ATP5F1C;DMAC2L;AFG3L2
prerank,cytosolic transport (GO:0016482),0.2980685221931479,0.9495841280914077,0.5464632454923717,0.9477204688682243,1.0,36/108,20.96%,HOOK2;SNX6;SNX32;DENND2A;PTPN23;CLTC;VPS54;DENND5A;PIKFYVE;BECN1;VPS50;RGP1;ANKRD27;VTI1A;STX5;AP2A1;RAB29;SNF8;EEA1;VPS51;HOOK3;VPS13A;RAB9A;WDR91;HEATR5B;CCDC91;VPS35;AP4M1;TMEM87B;PHETA1;MON2;EVI5;STX16;ANKFY1;WDR81;RAB7A
prerank,genitalia development (GO:0048806),-0.40434246404923385,-0.9489893970827991,0.5368852459016393,0.7966402384063718,1.0,4/12,12.02%,TBX3;STRA6;PKD1;FOXF2
prerank,protein phosphorylation (GO:0006468),0.2594654168562783,0.9489752972893262,0.6183206106870229,0.948391882976754,1.0,83/478,14.49%,PRKAG2;TGFBR3;WNK4;ROCK2;OXSR1;PRKCZ;KIT;FAM20A;PRKAA2;FGFR2;EPHA4;GRK5;CCNA2;PRKAG3;FGFR1;STK32B;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;TLR3;IKBKE;SMG1;PRKCB;ATM;TLR4;PRRT1;CAMK1;PDGFRB;BRAF;EPHA8;NUAK2;TRIB2;EIF2AK2;BAZ1B;SIK1;CDC42BPG;RICTOR;FLT1;TGFBR2;IGFBP3;COQ8B;RYK;MAPKAPK3;PDPK1;CSNK1A1;PICK1;RIOK2;RIPK1;MKNK1;BRSK1;ABL1;FER;DYRK1A;SRPK2;AURKB;MYLK3;TRIB1;PRKDC;PRKCA;MAPK6;CSNK2A2;CSNK2A1;HIPK3;FRK;MAP3K1;PRKCI;MAPK10;MAP2K1;EPHA3;WNK1;GRK3;ROS1;PDGFRA;CAD;BMP2K;COQ8A;STK36;ACVR2B;STK17B;ACVR1B
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4082853732863511,-0.9488935260403043,0.5264227642276422,0.796143703633165,1.0,2/11,4.92%,MAP3K5;CYP1B1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.44793008909038307,0.9488731790007081,0.491395793499044,0.947853136840815,1.0,2/12,6.56%,IL18;IL12B
prerank,lymphocyte differentiation (GO:0030098),-0.27384068081426244,-0.9487566205945306,0.6096774193548387,0.7957425605969959,1.0,14/68,10.03%,PTPRJ;TPD52;VCAM1;TOX;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;IKZF1;JAG2;RHOH;PBX1;LFNG
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.38219986695776265,0.9482908849334523,0.5193929173693086,0.9484899195547968,1.0,10/29,17.48%,STAT2;SAMHD1;YTHDF3;MAVS;PTPN11;OAS3;USP18;IFNAR2;WNT5A;ZBP1
prerank,L-amino acid transport (GO:0015807),-0.33507012821253906,-0.9482262105203955,0.5460992907801419,0.7962811753339021,1.0,7/28,7.85%,SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,ncRNA transcription (GO:0098781),-0.39499069288017064,-0.9480534232580523,0.5195876288659794,0.7959441530509933,1.0,2/13,7.65%,CAVIN1;SPIN1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3740434083203241,-0.9480164567291829,0.5384615384615384,0.7953126322398191,1.0,9/18,30.50%,APOE;ABCG1;PSEN1;TMCC2;APH1A;LDLRAP1;BACE1;ADAM19;ACHE
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.39165435799297577,0.9473927055838937,0.5342237061769616,0.9499757109804426,1.0,5/22,14.01%,APPL2;PTPN22;RAB7B;IFI35;ACOD1
prerank,histone mRNA catabolic process (GO:0071044),0.4161825269386158,0.9472832494952514,0.5313653136531366,0.9494616218108125,1.0,7/15,23.18%,ATM;TUT4;TENT2;TENT4B;TUT7;TUT1;XRN1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3241632310386494,0.9472108885411358,0.5537065052950075,0.948882478874477,1.0,10/64,11.81%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,protein glycosylation (GO:0006486),-0.25087375635415465,-0.9466256732308678,0.5914396887159533,0.7978622333623806,1.0,37/125,22.44%,MGAT4C;ST3GAL4;ST8SIA4;EOGT;GCNT2;FUT9;MGAT4A;ST3GAL1;ST8SIA1;GALNT7;FKTN;B4GALT5;AQP11;ST3GAL6;B3GALT1;ST8SIA6;B3GALNT1;MGAT5;DAD1;GFPT2;B3GALT5;GAL3ST1;NUS1;RPN1;GALNT2;GALNT10;MGAT5B;ALG6;TUSC3;DPM3;POFUT1;POGLUT1;ALG8;B3GNT3;B3GNT2;PMM1;PLOD3
prerank,purine nucleotide catabolic process (GO:0006195),-0.4044751332707992,-0.9463629320171819,0.5336225596529284,0.7977290655969602,1.0,6/13,15.98%,XDH;HINT1;NT5E;GDA;NT5C1A;GPX1
prerank,calcium import into the mitochondrion (GO:0036444),0.4580704467341049,0.9460235058329552,0.5531914893617021,0.9510496747907683,1.0,3/10,6.95%,MCU;SLC25A23;MICU1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3564539682329785,0.9459801252385578,0.5317324185248714,0.950382996815923,1.0,4/36,5.73%,AFDN;VAMP5;RILPL1;RAB34
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.25028227725938046,-0.9454326588076174,0.5918367346938775,0.7992114674490115,1.0,32/113,19.36%,ESR1;TFRC;UNC13B;RASIP1;GSK3B;DAB2IP;RAP1B;RPS3;SH3GLB1;PIEZO1;TGFB1;FNIP2;GNL3L;PSMC6;HSP90AA1;ERCC1;TIRAP;SNCA;VEGFA;TAL1;CDC42EP2;TERF1;CLU;USP50;RPA1;SKAP1;TPPP;SYK;BCL2L11;GTF2H4;GTF2H1;GTF2H5
prerank,regulation of cell morphogenesis (GO:0022604),0.3617266668310558,0.9447867907604469,0.5213523131672598,0.952460706757551,1.0,12/30,19.99%,SH3D19;CAPZB;PHIP;PDPN;MOV10;VIL1;ZMYM6;WTIP;ZMYM4;MYO9A;LARP4;CAMSAP1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.39739378578845824,0.9447670370430341,0.5033557046979866,0.9517314527153269,1.0,2/21,5.43%,OSBPL8;PLA1A
prerank,organelle transport along microtubule (GO:0072384),0.35875988728055663,0.9442862929031479,0.5304054054054054,0.9521640722558354,1.0,10/31,20.42%,TRAK1;FBXW11;HTT;CDC42;KIF5B;ARHGAP21;PEX14;TRAK2;RHOT1;MAP1S
prerank,response to hydrogen peroxide (GO:0042542),-0.29380166638038185,-0.9439141749731109,0.5426356589147286,0.8021440672743309,1.0,12/45,15.98%,MAP3K5;NET1;CYP1B1;ANXA1;RPS3;PLEKHA1;RHOB;GLRX2;TRPM2;PAX2;CAT;GPX1
prerank,iron ion homeostasis (GO:0055072),0.33165421864121514,0.9435247770347177,0.5253456221198156,0.9532390642689674,1.0,3/58,1.42%,BMP6;CP;PICALM
prerank,cell proliferation in forebrain (GO:0021846),0.4490548918219409,0.9431221090108326,0.5343811394891945,0.9534645212258485,1.0,7/10,31.09%,DOCK7;HOOK3;PCM1;CEP120;NUMBL;NUMB;AKNA
prerank,phagosome-lysosome fusion (GO:0090385),0.449886238753406,0.9429180872760536,0.5304990757855823,0.9531753557709883,1.0,5/10,20.96%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,protein K48-linked deubiquitination (GO:0071108),-0.34201085228428296,-0.9428616684822357,0.5379310344827586,0.8038330588001256,1.0,8/23,22.59%,OTUD7A;OTUD7B;YOD1;USP50;USP8;VCPIP1;MINDY1;BAP1
prerank,mRNA processing (GO:0006397),0.269520273999565,0.9427726237202163,0.6007109004739336,0.9527266744867792,1.0,77/287,23.36%,SRRM2;DDX5;PPARGC1A;POLR2A;SON;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;POLDIP3;HNRNPA2B1;SNIP1;RPRD2;POLR2D;RBM15;SPEN;NOVA1;CCAR1;GPKOW;TBRG4;GTF2F1;CWC27;PRPF18;HNRNPL;SRSF11;PHF5A;CWC15;IK;USP49;RAMAC;CMTR2;PRCC;HNRNPC;SCAF11;SNRNP40;PRPF3;SARNP;CPSF3;RBM4;HNRNPM;TFIP11;ALKBH5;CWF19L1;USP39;FRG1;CSTF1;SRSF1;ZCRB1;FUS;PRPF6;HNRNPH3;PCF11;U2AF1;EFTUD2;CDC40;SRSF10;PRPF31;SNRPC;SF1;PNN;SRSF7;WBP4;POLR2G;SF3B2;SF3B1;SNRPA1;U2AF2;CPSF7;PPWD1;SF3B5;RNPC3;GCFC2;CDC5L;NUDT21;PQBP1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.39943685949283947,-0.9426360598549963,0.5372233400402414,0.8036403959364313,1.0,8/12,22.56%,SIX1;VEGFA;PAX2;SOX8;SIX4;PAX8;AGT;LHX1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3811589439129316,-0.9424946188494203,0.5324675324675324,0.8032465559069257,1.0,2/15,7.33%,NLGN1;CNTNAP4
prerank,negative regulation of nervous system development (GO:0051961),-0.36050893991638155,-0.9421019127246857,0.5376344086021505,0.8034841969125913,1.0,4/17,7.73%,ROBO2;B2M;NOTCH1;SORL1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3945955729833041,0.9417735104157492,0.5372340425531915,0.9544166770895891,1.0,3/21,7.15%,PRKN;LRRK2;OPA1
prerank,negative regulation of B cell proliferation (GO:0030889),0.4434582528782563,0.9417384474495913,0.5274102079395085,0.9537356044096535,1.0,2/11,5.24%,CD300A;ATM
prerank,positive regulation of dendrite development (GO:1900006),0.4555718624073536,0.9417256866629831,0.5484496124031008,0.9529895921066767,1.0,1/10,0.47%,BMP7
prerank,cellular response to glucagon stimulus (GO:0071377),0.40917511007812013,0.9417172925861145,0.508411214953271,0.9522337862536527,1.0,5/17,13.78%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,central nervous system myelination (GO:0022010),-0.413196800003224,-0.9412507826580356,0.5316973415132924,0.8047405568073079,1.0,6/11,24.11%,PLP1;TENM4;B4GALT5;CLU;SOX10;B4GALT6
prerank,cellular response to leucine starvation (GO:1990253),0.4544634847249511,0.9411965647749427,0.5395256916996047,0.952667570233507,1.0,4/10,17.57%,SESN1;SESN2;IMPACT;RRAGD
prerank,mesenchymal cell development (GO:0014031),-0.36285950526194927,-0.941038410512735,0.5681818181818182,0.8045182410612693,1.0,4/18,9.00%,CDH2;NOTCH1;HEYL;HEY2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3691592586820631,0.9409409044195108,0.5438898450946644,0.9525171442796447,1.0,7/30,13.02%,PRKCZ;CD300A;PARP14;SH3BP5;MVP;SOCS3;SRCIN1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.33001079003224776,-0.940803381721365,0.5636792452830188,0.8043324942802403,1.0,10/26,25.08%,NOD1;ALPK1;MAP3K7;UBB;NOD2;TIFA;AAMP;UBC;RPS27A;TAB1
prerank,antibacterial humoral response (GO:0019731),0.4072256922085335,0.9407688297133611,0.5179856115107914,0.9521545894295761,1.0,4/16,17.08%,DEFB1;PLA2G6;CAMP;DMBT1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3082235676563111,0.9406482477490165,0.5402777777777777,0.9517010037934737,1.0,19/80,15.14%,ROCK2;PICALM;EPHA4;LARP4B;CASP3;DDX3X;CD28;POLDIP3;SAMD4A;SIRT3;CPEB3;PLA2G6;YTHDF3;PRKDC;PLD1;SPHK2;NSMAF;SMPD3;ZCCHC4
prerank,histone monoubiquitination (GO:0010390),0.3780413986879776,0.940639785534221,0.5347593582887701,0.9509578779594182,1.0,7/24,18.69%,CTR9;BCOR;KDM2B;DDB2;UBE2E1;RNF2;RNF20
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3481336112514483,0.9405801569294896,0.5353697749196141,0.95034962839535,1.0,2/38,0.64%,SMAD3;ROCK2
prerank,glial cell differentiation (GO:0010001),-0.32932497204722294,-0.9404845888455066,0.5347721822541966,0.8043847762546873,1.0,9/28,18.20%,CDH2;ADGRG6;STAT3;RELN;PTPRZ1;PAX2;TPPP;SOX2;SOX8
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.43138654745018007,0.9402987237429757,0.540952380952381,0.950257908574641,1.0,1/13,1.42%,IGF1
prerank,negative regulation of hormone secretion (GO:0046888),-0.42019987510589796,-0.9402369032704039,0.5239085239085239,0.8042051903629057,1.0,8/10,49.60%,RAB11FIP1;RAB11FIP5;RAB11FIP3;LIF;FGF23;OSM;GJA1;IL1B
prerank,regulation of lymphocyte migration (GO:2000401),-0.42139651359348895,-0.9400209672123401,0.5625,0.803979430553584,1.0,3/10,11.13%,STK10;JAM2;MSN
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4470924117124443,0.939795442634287,0.5245579567779961,0.9507251846907367,1.0,1/11,2.02%,PRKN
prerank,cell chemotaxis (GO:0060326),0.32339379700758947,0.9397797572622547,0.5531914893617021,0.949996920922321,1.0,10/60,10.44%,LPAR1;KIT;ACKR2;CCR9;ARHGEF16;PDGFRB;HOXB9;HBEGF;CCL25;RAB13
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3646005354788198,-0.9397030389574658,0.5299145299145299,0.8040053432734251,1.0,7/17,31.76%,NUS1;ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,regulation of cell death (GO:0010941),0.30374330520526777,0.9395570056684583,0.5649867374005305,0.949778683552686,1.0,15/94,11.60%,BMP7;CCN2;PRKN;SRGAP2;PRODH;LRRK2;RILPL1;OLFM4;ATG5;LRP1;RRAS2;RIPK2;BECN1;AXIN2;IMPACT
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.36800604454704194,0.9394160146181829,0.5377855887521968,0.9493754785924895,1.0,9/29,20.16%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3629004840099941,-0.938869470798852,0.5391705069124424,0.8052882609046321,1.0,10/19,35.02%,SLCO1C1;APP;KLF2;CHRNA7;PAX8;KLF4;MAPK8;HPN;MTPN;GATA3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3471485272938847,0.9385765951394924,0.535483870967742,0.9506262096324376,1.0,9/46,10.20%,SMAD3;NEDD4;RAPGEF3;CAMK1;TP53;ZIC1;TCF7L2;UBR5;MAVS
prerank,organic substance transport (GO:0071702),0.2941169681237329,0.9383800911035213,0.5720053835800808,0.9503473555207143,1.0,19/121,10.43%,SLC22A6;ABCA4;SLC35F3;PCTP;SLC22A18;ABCA9;SLC22A5;SLC19A1;TCN1;TCN2;TOM1;SLC6A4;SLC48A1;HRG;PICK1;CHMP1A;MFSD2B;PLEKHA8;SLC19A2
prerank,protein N-linked glycosylation (GO:0006487),0.31609873519790266,0.9382678739304791,0.5471976401179941,0.9498530023273231,1.0,7/66,6.42%,MAN1C1;ST6GAL1;MGAT3;ASGR1;PGM3;B4GALT1;FUT8
prerank,regulation of osteoblast proliferation (GO:0033688),0.4092725429080649,0.938226489065492,0.5298507462686567,0.9491987728315158,1.0,3/17,6.39%,FGFR2;NPR3;EIF2AK2
prerank,nitrogen compound transport (GO:0071705),0.28669157275804913,0.9381970685920149,0.5788787483702738,0.9485044823266491,1.0,20/141,10.43%,SLC6A13;SLC6A12;SLC38A4;SLC38A3;SLC7A2;SLC7A11;PDPN;SLC35F3;SLC25A48;SLC22A5;TCN1;TCN2;SLC38A1;TOM1;SLC6A4;SLC48A1;HRG;PICK1;CHMP1A;SLC19A2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.388643990564624,0.938020707501758,0.5277777777777778,0.9481770606891637,1.0,3/25,5.50%,KIT;LACC1;FZD5
prerank,response to glucagon (GO:0033762),0.39340016120045307,0.9373648283675722,0.5235507246376812,0.9489992297862679,1.0,7/19,18.10%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6;PRKACB;CRY1
prerank,cellular response to interleukin-12 (GO:0071349),-0.28685726372388914,-0.9373223497588028,0.5643044619422573,0.8082203550742979,1.0,12/48,17.57%,PPIA;RAP1B;RPLP0;CD47;JAK1;MSN;PITPNA;TALDO1;CFL1;AIP;CAPZA1;PDCD4
prerank,telomere maintenance via recombination (GO:0000722),0.4350865117909423,0.9372943756716948,0.5309568480300187,0.9484096544079074,1.0,6/11,19.57%,TPRKB;TEP1;RAD50;NSMCE2;XRCC3;RAD51D
prerank,regulation of cell population proliferation (GO:0042127),0.2524043070272149,0.9371855159062425,0.6855941114616193,0.9479331115900912,1.0,102/691,12.74%,FGF1;ALDH1A2;BMP6;EFNB2;KSR1;KIT;LAMC2;GSDME;IGF1;FGFBP1;IL13RA1;PTPN14;FGFR2;COL18A1;KANK2;PKHD1;GRK5;NUPR1;COL4A3;FGFR1;PHIP;NPR3;BMPR1A;ARID2;IGFBP7;MAGI2;TGFBR1;SPEG;PDPN;ADRA2A;IFIT3;NACC2;CDCA7L;SMAD6;CTSH;TNFSF13;DPP4;TNS2;MEIS1;PIAS1;CLMN;IFNK;KLHL41;SOD2;PDGFRB;NOX1;STAT2;GAB2;CACUL1;EIF2AK2;HMGA1;TP53;FLT1;SSTR3;DLG3;WWTR1;TGFBR2;PTPRU;PTEN;IGFBP3;NRG1;HRG;GDNF;TCF7L2;NUPR2;CCAR1;HDAC1;NIBAN2;GLI1;SULT2B1;HDAC4;SIRT1;ASH2L;GTPBP4;TBRG4;SLURP1;HTR1A;HBEGF;NOX4;FLT3LG;FER;CRKL;SRPK2;RNF41;PRKDC;RARG;MNT;NOP2;AXIN2;TFAP2D;ADAM17;IRF1;CSNK2A1;ITGAV;OSGIN1;GLMN;BRD7;FRK;VEGFD;KMT2D;NMI;MLXIPL
prerank,striated muscle cell development (GO:0055002),0.4236349783920772,0.9371335729342752,0.51434034416826,0.9473298689273232,1.0,3/14,5.60%,TMOD2;TMOD3;KLHL41
prerank,proteoglycan metabolic process (GO:0006029),0.36669125243358613,0.9371129780219234,0.5460992907801419,0.9466280144328361,1.0,7/26,11.25%,IGF1;CHST11;SULF2;GAL3ST4;FOXL1;SULF1;CNMD
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.3645565037779178,0.9370640905001258,0.5422297297297297,0.9460013110762713,1.0,3/26,6.03%,RORA;SULF2;NOX1
prerank,phospholipid dephosphorylation (GO:0046839),-0.3000905617340889,-0.9370332041866907,0.5523560209424084,0.8081506183765634,1.0,9/37,11.71%,PLPP1;PLPPR1;MTMR6;MTMR2;MTMR11;PLPPR5;PLPPR4;MTMR7;MTMR9
prerank,regulation of cellular component biogenesis (GO:0044087),0.3490797068155814,0.9369696066781166,0.5463414634146342,0.9454696166629204,1.0,8/39,12.34%,ROCK2;SNCAIP;PARP10;EZR;HRG;IRGM;BBS10;PTPN11
prerank,long-chain fatty acid metabolic process (GO:0001676),0.31875434346495063,0.936376632548173,0.5519877675840978,0.9461723318840918,1.0,7/64,8.33%,ACSL1;ALOX12;CPT1A;ACSBG2;EPHX1;DAGLA;CPT2
prerank,regulation of protein kinase activity (GO:0045859),0.29809159133493,0.935382875669976,0.552,0.9477910716024919,1.0,13/106,9.74%,PRKAG2;ALS2;PPM1E;DEPTOR;DTNBP1;UVRAG;TRIB2;CACUL1;WWTR1;PDPK1;TAB2;SIRT1;JTB
prerank,positive regulation of protein modification process (GO:0031401),0.2762710517675913,0.9353094706664182,0.615,0.9472200145525563,1.0,32/203,12.50%,DAB2;FGF1;ROCK2;LEPR;ACE;FAM20A;FNIP1;TRABD2B;LRRK2;ITLN1;RAPGEF3;ATG10;F2;DDX3X;ARRB1;CAMK1;FBH1;CCND3;CDH5;SIRT1;RIPK1;MAVS;ATG7;IRGM;ABL1;CRKL;DYRK1A;PIK3R3;AXIN2;ADAM17;RALBP1;VEGFD
prerank,protein localization to cell junction (GO:1902414),0.3871749791780066,0.9351996796300437,0.5487804878048781,0.9467259101847554,1.0,3/22,2.52%,CGNL1;ARHGEF18;NLGN2
prerank,zymogen activation (GO:0031638),0.3546855441814511,0.9351217332805257,0.5414551607445008,0.9461658049517766,1.0,7/39,15.58%,KLK2;F11;CTSH;RIPK2;MMP14;PLAT;ASPH
prerank,telomere maintenance (GO:0000723),0.3300273372855297,0.9349559209765922,0.5742128935532234,0.9458336096562245,1.0,16/50,19.57%,POLD2;TPRKB;ATM;ACD;TEP1;TERT;PRKDC;ZBTB48;HUS1;RAD50;NSMCE2;SP100;TINF2;XRCC3;NBN;RAD51D
prerank,negative regulation of synaptic transmission (GO:0050805),0.3804942409521027,0.9349203943325525,0.5509868421052632,0.9451723941823359,1.0,5/23,9.42%,SYT11;LRRK2;PRRT1;PTEN;PICK1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3998355995871432,0.9345454340477413,0.5377176015473888,0.9453530421451475,1.0,4/18,12.41%,PRKN;MCU;DNM1L;RALBP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.3787227845101877,0.934237771356547,0.5686619718309859,0.9453160964226838,1.0,2/24,3.69%,COL5A1;PDPN
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.33125811197850863,-0.9342362518174647,0.5408653846153846,0.8140373749003631,1.0,13/23,26.30%,MYO10;CCDC88A;DYNC1I1;KIF5C;MAP6;TUBA1A;CCDC88C;CCDC186;TUBA1B;KIF5A;TUBA1C;F8A1;KIF1A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.32172006539560516,-0.9340475118795855,0.5472154963680388,0.8137633297298213,1.0,10/28,14.73%,DAB2IP;CTSC;DDRGK1;PTK2;PSMC6;AXIN1;ECSCR;LAPTM5;SMURF1;CLU
prerank,cilium assembly (GO:0060271),0.26517536367223354,0.9339325380221537,0.6320645905420992,0.9453510786764829,1.0,72/296,19.72%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TNPO1;CLASP1;CPLANE2;NINL;RILPL1;RAB3IP;KIF3C;CYS1;PTPN23;ASAP1;RHO;EXOC2;CCDC28B;CEP162;SSTR3;CDC14A;IFT122;WDR19;DYNC2I1;CLUAP1;MKKS;TMEM231;CDC14B;IFT88;ATP6V1D;SDCCAG8;BBS10;GALNT11;PDE6D;OCRL;NPHP1;UNC119B;ALMS1;WDPCP;GORAB;WDR35;CFAP410;EXOC4;STK36;PARVA;B9D2;EXOC3;E2F4;CCDC39;RAB8B;CEP63;ARL6;RP2;BBS2;RFX2;BBOF1;RILPL2;PIBF1;TMEM237;TRAPPC14;PCM1;CCDC40;CEP57;AKAP9;PCNT;TCTN3;ATP6V0D1;TMEM17;CEP164;OFD1;DCTN3
prerank,cellular response to inorganic substance (GO:0071241),-0.3500977325034069,-0.9337703305425635,0.5653206650831354,0.8136830950111881,1.0,3/21,7.22%,KCNC2;GUCY1B1;FOXO1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3741201008811606,-0.9334153843348151,0.55119825708061,0.8137820115717289,1.0,6/15,16.27%,TAFA1;DISC1;PTN;CTNNB1;VEGFA;CX3CR1
prerank,polyamine metabolic process (GO:0006595),0.4376362639668815,0.9333870407035795,0.5758683729433273,0.9458986322981066,1.0,3/13,8.35%,SMOX;SAT1;PAOX
prerank,phosphatidic acid metabolic process (GO:0046473),-0.28524741495393546,-0.9327654225983549,0.5918918918918918,0.8145528245530941,1.0,8/48,14.27%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3698274735922251,0.9324706900872133,0.5507745266781411,0.9473728269131382,1.0,5/26,8.94%,LARGE1;GBGT1;GK5;GK;GAL3ST4
prerank,cellular response to chemokine (GO:1990869),-0.2980287526717447,-0.9323057982880989,0.556497175141243,0.8149018699472732,1.0,7/46,10.68%,LRCH1;CXCL12;PTK2B;SLC12A2;ACKR3;DOCK8;DUSP1
prerank,telomere capping (GO:0016233),0.41428857076726766,0.932237328297594,0.5489130434782609,0.9472123699208261,1.0,6/16,18.82%,ACD;PRKDC;RAD50;TFIP11;TINF2;NBN
prerank,myeloid leukocyte differentiation (GO:0002573),-0.27465270829882654,-0.9320253307347517,0.5959595959595959,0.8148293522090733,1.0,14/65,15.09%,LEF1;RUNX1;MYH9;TNFRSF11A;FOXP1;CAMK4;CBFA2T3;MT1G;BMP4;CDKN1A;THOC5;SBNO2;VEGFA;IL31RA
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.33837061013045494,-0.9316915277583724,0.5581395348837209,0.8148987139405438,1.0,7/24,9.68%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,regulation of cell cycle (GO:0051726),0.2634182706348078,0.9316435949628158,0.6146458583433373,0.9478783660827577,1.0,52/271,15.88%,NOTCH2;BMP7;SMAD3;FGFR2;GRK5;SON;FBXL17;NUPR1;MAGI2;TGFBR1;ATM;ANKRD17;IL12B;SIK1;TP53;AFAP1L2;CDC14A;CDK5RAP3;SND1;TCF7L2;NUPR2;CDC25A;LIN52;SIRT1;CCNB2;HBP1;CHMP1A;TBRG4;PHACTR4;FBXL12;ABL1;SRPK2;CDC14B;IRF1;CSNK2A2;CSNK2A1;MYBL2;MLXIPL;MAP2K1;PPP1R13B;PRCC;PML;MFN2;GADD45A;PER2;TSC1;KAT2B;MAP2K6;BIRC3;CCPG1;INHA;MAEA
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.41700125188593196,-0.9314738672467778,0.5642570281124498,0.8146659517430845,1.0,3/10,19.07%,PLA2G4A;ENPP2;PLA2G15
prerank,regulation of programmed cell death (GO:0043067),-0.2403277270014056,-0.9313856843574108,0.6694560669456067,0.8141421903281277,1.0,46/161,22.57%,MECOM;HIP1;ACTN4;RTN4;ACTN1;ACER3;TPT1;ACER2;APAF1;PHLPP1;RPS3;PERP;CALR;CTSB;TOX3;ANP32A;HSP90AA1;BCAR1;MAGED1;FAS;DAPK1;LCMT1;TM7SF3;LRP8;PINK1;NOP53;DNAJA3;CASP6;CLU;CRADD;PAX2;CASP2;BCL3;TNFRSF25;TIGAR;BCL2L11;PAX8;AGT;DAPK2;AKT1S1;ASAH1;BNIP3;CHM;SLK;USP42;TRIAP1
prerank,hyaluronan metabolic process (GO:0030212),-0.3392388918758177,-0.9313773228458833,0.5649202733485194,0.8134330699488789,1.0,5/23,9.82%,CEMIP;HEXB;TGFB1;FGF2;CD44
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3140429857819017,0.931153130515268,0.5575485799701047,0.9483148452635365,1.0,19/70,19.29%,SMAD3;CASP3;BID;IFI27;TLR3;DDX3X;CD27;PDPK1;RIPK1;RNF41;ITGAV;BLOC1S2;MLLT11;ACVR1B;DEDD;MCL1;TNFRSF1A;G0S2;DELE1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3953024101734815,-0.9311418177878794,0.5621181262729125,0.8132340574417021,1.0,5/12,22.57%,RPL26;CD44;TAF9B;CD74;TRIAP1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.43569728474428016,0.9309741387049123,0.5510204081632653,0.948014006502195,1.0,4/12,14.63%,PCGF5;RBM15;LRIF1;SMCHD1
prerank,protein destabilization (GO:0031648),0.35319744060397584,0.930973975877703,0.5440931780366056,0.9472733705596154,1.0,7/32,10.43%,PRKN;CTSH;FBXW11;BTRC;HTT;SIRT1;IRGM
prerank,renal water homeostasis (GO:0003091),0.37605814141461463,0.9306791688318942,0.5541044776119403,0.9472572194910791,1.0,2/23,2.01%,ADCY5;ADCY1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3940019319287219,0.9301804190920236,0.5623869801084991,0.9477307816267199,1.0,6/19,19.54%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3788844866983896,0.930126008955494,0.5348432055749129,0.947129407461866,1.0,6/23,10.97%,EFNB2;IGF1;NRG1;NIBAN2;MMP14;MYLK3
prerank,folic acid metabolic process (GO:0046655),0.3930859332897229,0.9298613431089353,0.5115452930728241,0.9470247174833325,1.0,6/18,19.54%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,histone H4 deacetylation (GO:0070933),0.4435847243484339,0.9294209937961345,0.5495145631067961,0.947344353344896,1.0,3/10,9.46%,HDAC8;HDAC1;HDAC4
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3988940889567928,0.9293385169698003,0.5612431444241316,0.9468022027652202,1.0,5/19,11.87%,PRKN;FZD5;HTT;DNM1L;CSNK2A2
prerank,estrogen metabolic process (GO:0008210),-0.37881895006791777,-0.9293381280589665,0.5676855895196506,0.8167500823537432,1.0,3/15,27.00%,CYP1B1;HSD17B2;HSD17B7
prerank,positive regulation of vascular permeability (GO:0043117),0.4339866221973625,0.9292967033610336,0.5535714285714286,0.9461625813181554,1.0,1/12,0.40%,BMP6
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.35908643876387664,0.9292791835269728,0.5462328767123288,0.9454771015607224,1.0,9/30,20.16%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,RNA processing (GO:0006396),0.27710494649115036,0.9292158897240568,0.6259640102827764,0.9449029275479353,1.0,38/176,18.98%,CELF2;PPARGC1A;SON;RBMS2;PABPN1;HNRNPR;HNRNPH1;SRSF5;YJU2;TSEN2;HNRNPA2B1;TUT4;RBM39;RBMS1;NOVA1;TENT2;LUC7L3;SRPK2;PRPF18;DICER1;HNRNPL;SRSF11;HNRNPC;SCAF11;SNRNP40;PRPF3;TENT4B;RBM4;TFIP11;TUT7;ALKBH5;USP39;SRSF1;ZCRB1;FUS;PRPF6;HNRNPH3;U2AF1
prerank,regulation of telomere capping (GO:1904353),0.37501676773679304,0.9289148127360747,0.5506993006993007,0.9448608102895638,1.0,6/23,12.61%,ATM;TNKS2;AURKB;RAD50;PNKP;USP7
prerank,regulation of Golgi organization (GO:1903358),0.40433142037278896,0.9288657416559782,0.567219152854512,0.9442427683429105,1.0,5/17,13.90%,STX18;ARMH3;MAP2K1;MAP2K2;STX5
prerank,regulation of RNA metabolic process (GO:0051252),0.3179393323021333,0.9280858572182403,0.5599415204678363,0.9454140885472737,1.0,19/59,17.67%,SON;MITF;OAS2;SNRNP70;PCBP2;MBNL2;IGF2BP1;HNRNPH1;CLK4;IGF2BP2;NOVA1;HNRNPL;OAS3;CLK1;GRSF1;CLK2;MED1;FUS;FASTK
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4066240066491665,0.9279159091494523,0.5415094339622641,0.9450818659371124,1.0,3/15,9.86%,PPARA;ADM;SLC45A3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.302381474198486,-0.9277796134979797,0.5957446808510638,0.8197145253388078,1.0,19/39,29.09%,POLD3;ERCC1;UBB;RPA1;GTF2H4;GTF2H1;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;ERCC3;DDB1;RPA3
prerank,negative regulation of protein kinase activity (GO:0006469),0.3003782179328078,0.9274731680180043,0.5558659217877095,0.9453985236083329,1.0,18/88,14.88%,PRKAG2;SLC8A3;PPM1E;DEPTOR;DTNBP1;TRIB2;WWTR1;CDK5RAP3;SH3BP5;PDPK1;MVP;ABL1;TRIB1;DUSP10;SRCIN1;GADD45A;TAF7;CEP85
prerank,negative regulation of cellular senescence (GO:2000773),0.41911659209459073,0.9273299440492248,0.5507518796992481,0.9450051961458197,1.0,5/13,14.72%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,relaxation of muscle (GO:0090075),0.4293701694259552,0.9270609012047906,0.5464895635673624,0.9449091226101726,1.0,1/13,0.08%,ATP1A2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.25992363751045655,-0.9265861181446113,0.6185897435897436,0.8217361491951588,1.0,30/79,24.46%,SH3GL2;CTSD;DYNC1I1;MFSD6;DYNLL1;AP1S2;AP2B1;DYNC1LI2;KIF26A;CAPZA2;AP2M1;DCTN4;CTSL;CTSS;KIF3A;AP1S3;CENPE;KIF15;CD74;CAPZA1;SPTBN2;AP1S1;KIF11;KIF4A;KIF22;KIF5A;SAR1B;KIF3B;DCTN6;KIF23
prerank,regulation of cell division (GO:0051302),0.3069154829689843,0.926560420713832,0.5742424242424242,0.9453730149277132,1.0,8/72,10.74%,FGF1;FGFR2;NCOA3;UVRAG;PLK5;MYO19;BECN1;AURKB
prerank,lipid droplet formation (GO:0140042),-0.42275694133551756,-0.9265014432306833,0.5546038543897216,0.8211976812888131,1.0,4/10,25.54%,CDS1;SQLE;AUP1;CDS2
prerank,endosome organization (GO:0007032),0.34547274046582505,0.9264421182396441,0.5707547169811321,0.9449123800505824,1.0,18/41,23.76%,HOOK2;ALS2;ARFGEF2;RAB22A;PLEKHF1;EEA1;HOOK3;PI4K2B;WASHC5;SQSTM1;PHETA1;LAMTOR1;DNAJC13;SNX33;VPS33B;PI4K2A;RILP;HOOK1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4386967617367177,0.9260904280674744,0.5437262357414449,0.9450368853695157,1.0,4/11,15.73%,ELOF1;ZMIZ1;ZMIZ2;ARID1B
prerank,chromatin assembly (GO:0031497),0.3422004272406894,0.9254415948007007,0.5643086816720257,0.945798337844012,1.0,16/38,27.37%,CHAF1B;ATRX;TP53;KAT6B;SIRT1;BAHD1;CDAN1;PADI4;EZH1;ASF1A;NOC2L;NAP1L2;H1-0;M1AP;RSF1;RBBP4
prerank,organelle assembly (GO:0070925),0.2578065888996158,0.9253816995845231,0.6589147286821705,0.9452322053849,1.0,96/384,19.67%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TMOD2;CPLANE2;RILPL1;RAB3IP;TMOD3;CYS1;DDX3X;KLHL41;PTPN23;ASAP1;RHO;SH3PXD2B;ATG5;EXOC2;CCDC28B;WIPI1;CEP162;SSTR3;AMBRA1;CDC14A;ATXN2;IFT122;WDR19;CHMP1A;YTHDF3;DYNC2I1;LSM14A;ATG7;RAB43;BECN1;IRGM;CLUAP1;MKKS;TMEM231;CDC14B;IFT88;ATP6V1D;HPS1;GALNT11;PDE6D;MAPRE2;OCRL;DDX6;UNC119B;WDPCP;ATG2A;NCOR1;WDR35;CFAP410;EXOC4;STK36;UBAP2L;PARVA;B9D2;EXOC3;E2F4;VPS37A;LMOD3;VPS4A;RAB8B;SNF8;CEP63;GOLGA8B;ARL6;RP2;BBS2;RFX2;GORASP2;CENPC;ATXN2L;RILPL2;PIBF1;ZFYVE1;LMOD1;OGFOD1;TMEM237;CHMP4C;TRAPPC14;CENPT;PCM1;CCDC61;PCNT;TCTN3;ATP6V0D1;TMEM41B;TMEM17;CEP164;GOLGA2;OFD1;TUBGCP4
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32648425592070607,0.9253081969189664,0.5783521809369951,0.9446841360742674,1.0,4/54,5.54%,SH3RF2;NXN;HDAC8;ARRB1
prerank,protein transport (GO:0015031),-0.2157925430381332,-0.9251264838375773,0.8076923076923077,0.823637100292501,1.0,62/332,16.24%,LRP1B;SPTBN1;CALCRL;ANK3;TBC1D4;TBC1D1;ATP6V0A1;RABGAP1L;TFRC;RAB31;VAMP4;SYNDIG1;MYH9;RAMP2;RAB3C;ARHGEF2;VMP1;TBC1D5;TBC1D8;TBC1D30;STX3;APOE;TXNIP;SLC10A7;ABCG1;ATP6V0A4;SGSM1;PREPL;LMAN2L;MYO6;NSF;PPT1;RAB18;MTTP;ARL1;TBC1D2B;ARL5A;STX12;GCC2;GOLGA7;TMED1;TMED5;RAMP1;VLDLR;TVP23B;SNX17;ARL5B;ARRDC4;SCAMP3;KIF3A;LAPTM5;RAB38;SCG2;SCAMP1;CLU;RAB6A;ARF5;TMED4;RAB32;SNX27;ARF6;NAPB
prerank,cellular response to hexose stimulus (GO:0071331),0.37901330545241996,0.9250316075007173,0.5443478260869565,0.9446231857033361,1.0,2/23,2.18%,PRKAA2;ZBTB20
prerank,calcium-mediated signaling (GO:0019722),0.29426859676869327,0.9244253150682885,0.5885714285714285,0.9453497781975372,1.0,11/93,5.56%,ANK2;NUDT4;ACKR2;CCR9;SPHK1;MCU;DMPK;LRRK2;CACNA1C;DEFB1;ADGRL1
prerank,macromolecule catabolic process (GO:0009057),0.36798311337352946,0.924280091078877,0.5745454545454546,0.9449870976373629,1.0,6/26,10.39%,NEDD4;UVRAG;TPP1;CLPX;CLN6;BECN1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2784055307191696,-0.9242327953402498,0.5893854748603352,0.8250013446138706,1.0,20/57,19.11%,MAP3K5;GRIN2B;NOD1;TNFSF10;CTSD;GRIN2A;PERP;GRAMD4;GPER1;SOX7;AIM2;DAPK1;PPM1F;USP50;GRIN1;SYK;HTRA2;BCAP31;FOXL2;CYCS
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2779573161299588,0.9242065025605659,0.6023622047244095,0.9444349325886503,1.0,41/153,19.16%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;IKBKE;SMG1;PRKCB;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;PIKFYVE;RIPK1;MKNK1;BRSK1;DYRK1A;SRPK2;PRKDC;PRKCA;CSNK2A2;CSNK2A1;HIPK3;PRKCI;WNK1;MAP2K2;STK4;MAPK9;TLK2;CLSPN;PKN2;PAK2;TAF1;CAMK1D;SGK3;SGK2;MAPK14
prerank,hexose transmembrane transport (GO:0008645),0.3931524635712762,0.9240878910010398,0.5482695810564663,0.9439990385397226,1.0,3/21,9.86%,SLC2A12;SLC5A3;SLC45A3
prerank,negative regulation of ATP metabolic process (GO:1903579),0.39683355918783175,0.9238101007610354,0.5486238532110091,0.9439291714399232,1.0,6/17,13.91%,PPARA;NUPR1;HDAC4;MLXIPL;NCOR1;FLCN
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.32091948592428626,-0.9235849267329701,0.582392776523702,0.8257942973034023,1.0,7/27,12.80%,DACH1;BMPR2;ACVRL1;FGF2;PDGFA;CDKN1A;SMG5
prerank,embryonic axis specification (GO:0000578),0.40486356256118683,0.9233110303833613,0.5424610051993067,0.9443583307887985,1.0,3/15,5.50%,CXXC4;SMAD6;FZD5
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.37292215281457625,0.922972950836178,0.5497382198952879,0.9443893412184885,1.0,6/25,13.29%,RNF8;LDB1;ELL;LARP7;NELFCD;WDR43
prerank,positive regulation of interleukin-17 production (GO:0032740),0.37133365044866506,0.9225945533574584,0.5501730103806228,0.9445583930052238,1.0,3/22,6.56%,IL18;SPHK1;IL12B
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4196618631573029,0.9224835887309681,0.5380228136882129,0.9440840063359468,1.0,3/12,5.28%,SLC5A3;DUOXA1;TLR4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4286528079323297,0.9218823010670023,0.5662188099808061,0.9447600695843528,1.0,3/12,17.33%,IL12B;ZBTB1;CCR2
prerank,establishment of melanosome localization (GO:0032401),0.39499052658381567,0.9216048715813664,0.5706806282722513,0.9446706836946418,1.0,6/19,16.08%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.40612415072293,0.9215650207765856,0.5580985915492958,0.9440522237217299,1.0,5/16,14.38%,PPARGC1A;PPARA;AK4;FLCN;SPHK2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.33913793946968485,0.921358898919361,0.5843949044585988,0.9438525728341827,1.0,4/41,7.39%,SYT11;IGF1;TLR4;PTPN22
prerank,apoptotic DNA fragmentation (GO:0006309),0.4074156039416047,0.9212806192802275,0.5652173913043478,0.9433265739256121,1.0,6/16,24.89%,CASP3;DICER1;DFFB;DFFA;CECR2;H1-0
prerank,regulation of platelet activation (GO:0010543),-0.35120644646572413,-0.921210788343775,0.5606407322654462,0.8306069506802826,1.0,9/21,19.45%,PLA2G4A;NOS3;LYN;APOE;PDGFA;TEC;SYK;PRKCQ;TXK
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2283344562037394,-0.9211143267716121,0.6774193548387096,0.8300972962030442,1.0,45/158,20.74%,ROR1;ATP2C1;MID2;NOD1;TFRC;TNFSF10;ALPK1;PLK2;TRAF5;FLNA;MAP3K7;TNFRSF19;ECM1;SLC44A2;SHISA5;NDFIP2;S100B;PLEKHG5;TRIM14;FKBP1A;TRIM27;IKBKB;TIRAP;REL;PRKD1;PINK1;PPM1A;RBCK1;CARD16;TERF2IP;MTDH;TMED4;PELI1;NOD2;GPR89A;CD74;PIM2;EDAR;TMEM101;TIFA;TFG;ECT2;TRIM68;CCL19;EEF1D
prerank,camera-type eye development (GO:0043010),-0.3290368803391817,-0.9208977393664126,0.5754716981132075,0.8298731424060694,1.0,9/25,19.83%,LAMA1;TENM3;CYP1B1;FBN2;STRA6;VEGFA;PAX2;FOXL2;ALDH1A3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3883352424407436,0.9205602610030235,0.5466417910447762,0.9442975117316953,1.0,4/18,12.82%,PRKN;ADRA2A;MIDN;SIRT4
prerank,regulation of RNA splicing (GO:0043484),-0.26401490742468614,-0.9205240000005821,0.6448598130841121,0.8300170822617122,1.0,15/69,15.26%,QKI;MBNL1;AHNAK;PIK3R1;KHDRBS2;AHNAK2;HNRNPLL;SRRM4;TMBIM6;PRX;HNRNPK;RBM20;ZNF326;RPS26;AFF2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3019274435665589,-0.9203868532500875,0.6009615384615384,0.829616655939625,1.0,2/33,0.36%,PRKG1;MEF2C
prerank,plasma membrane invagination (GO:0099024),-0.3187378055911541,-0.9201452927355819,0.5943877551020408,0.8294305093770293,1.0,5/29,10.45%,GSN;MYH9;DOCK1;ARHGAP25;ELMO1
prerank,microtubule polymerization (GO:0046785),-0.31289101513482165,-0.9198617857920547,0.593103448275862,0.8293416834778272,1.0,12/28,26.09%,CLASP2;TUBGCP2;TRPV4;FGF13;MAPT;MAP7D3;TPPP;TPX2;NDE1;TUBG2;NDEL1;TPPP3
prerank,positive regulation of peptidase activity (GO:0010952),-0.34839598070742533,-0.9196839553495326,0.5961123110151187,0.8290186009291105,1.0,9/20,26.31%,VSIR;DDRGK1;PINK1;MAPK12;APH1A;RCN3;NDUFA13;PRELID1;GRN
prerank,histone methylation (GO:0016571),0.36695166842951504,0.9195117510868761,0.5631578947368421,0.9459893905082225,1.0,6/26,16.03%,SMYD3;NSD1;NSD3;CREBBP;EHMT2;EHMT1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3907297180241568,-0.9194615465804091,0.5699152542372882,0.8287938314185791,1.0,2/13,4.57%,PLA2G4A;MGLL
prerank,DNA repair (GO:0006281),0.2607502799183967,0.9192288316052046,0.6647264260768335,0.9459127519192614,1.0,69/284,21.00%,EYA1;POLD2;BABAM2;KMT5C;USP3;ATM;ASCC2;UVRAG;RAD54L;KMT5B;BAZ1B;TP53;PARP4;RNF8;FBH1;FANCI;HUWE1;PDS5A;FANCM;XRCC4;PARP9;SIRT1;ABL1;EME2;RBBP8;PRKDC;MSH3;ZBTB1;UIMC1;HUS1;IGHMBP2;FANCA;RAD50;PNKP;TDG;POLE2;BABAM1;DDB2;MGMT;GADD45A;TDP2;DOT1L;INTS3;TEX264;POLL;ALKBH5;MBD4;USP1;MMS19;XRCC3;ASF1A;OGG1;PDS5B;NBN;APTX;FEN1;SUMO1;SLX4;LIG1;XPA;RAD51D;PIAS4;MTA1;RAD9A;FANCD2;MLH1;LIG4;EID3;PARP3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3561934479207024,0.9191273014497364,0.565068493150685,0.9454420455874866,1.0,6/31,12.42%,DLG1;KANK2;PTEN;RBL2;RBL1;BRD7
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.36972639181989575,0.9188985085229194,0.5503472222222222,0.9452591829282762,1.0,3/24,7.15%,PRKN;LRRK2;OPA1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4173328069635744,0.9188632796701284,0.573170731707317,0.9446226832062756,1.0,1/14,1.08%,OSR1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.26523203126424505,-0.9185434582634672,0.6383647798742138,0.830234168388262,1.0,21/68,23.91%,STAT3;MBP;ARHGEF2;IL33;APP;PLCG2;CYBA;TIRAP;TWIST1;DHX9;NOD2;LBP;CD74;SYK;TYROBP;TLR7;PYCARD;LGALS9;IL6R;HYAL2;F2R
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.33544034218828034,0.9183692562325775,0.5691056910569106,0.9450354298380219,1.0,18/42,22.85%,CHD4;RNF8;SMARCA4;SRCAP;SMARCC2;HDAC1;SMARCE1;NASP;HNRNPC;MTA2;ARID1B;ACTR6;CHD8;MBD2;SMARCD2;CECR2;SMARCB1;DMAP1
prerank,positive regulation of T cell differentiation (GO:0045582),0.3427601639689003,0.9182154791214574,0.5927750410509032,0.944674788106328,1.0,7/36,11.91%,GLI2;GLI3;IL12B;SOX12;ZMIZ1;DUSP10;ZBTB1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.41841750722909876,0.9179406487882065,0.5387453874538746,0.9445928815781873,1.0,4/13,15.73%,ELOF1;ZMIZ1;ZMIZ2;ARID1B
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.2991020896699882,-0.9176877706344653,0.5859375,0.831504433914656,1.0,8/37,14.39%,PRKG1;MEF2C;TGFB3;FGF2;GPER1;CDKN1A;FGF9;HTR1B
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.29879954418478843,-0.9173772938099819,0.6243523316062176,0.8315327972862715,1.0,7/39,7.28%,UTRN;FGF12;CHRM3;FXYD5;NEDD4L;YWHAE;TRPC6
prerank,glucose catabolic process to pyruvate (GO:0061718),0.37247554064184785,0.9169291822825638,0.5573770491803278,0.9454840937800646,1.0,3/24,7.09%,HK2;PGAM2;GCK
prerank,canonical glycolysis (GO:0061621),0.37247554064184785,0.9169291822825638,0.5573770491803278,0.9454840937800646,1.0,3/24,7.09%,HK2;PGAM2;GCK
prerank,regulation of protein kinase B signaling (GO:0051896),0.27119613652812896,0.9160436499627768,0.6517967781908303,0.9468371827747961,1.0,36/193,13.99%,FGF1;OSBPL8;KIT;PPARA;FGFR2;KL;IL18;PKHD1;FRS2;FGFR1;MAGI2;TGFBR1;DAG1;PDGFRB;CD28;GAB2;RICTOR;PTEN;PIK3CA;NRG1;PDPK1;TCF7L2;SIRT1;HBEGF;FLT3LG;CASS4;RNF41;KLB;PHLPP2;GDF15;PTPN11;TGFA;THEM4;FLCN;PDGFRA;AXL
prerank,regulation of ion transmembrane transport (GO:0034765),-0.299388082140044,-0.91537504482555,0.5910224438902744,0.8354302254979938,1.0,7/33,7.88%,AKAP6;KCNJ3;CHRM3;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,regulation of viral life cycle (GO:1903900),-0.3379484332066215,-0.9149070492523854,0.5776805251641138,0.8357561746699035,1.0,6/21,20.10%,HS3ST5;PPIA;TRIM14;TRIM27;TYRO3;TRIM68
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3722819884247927,0.9145120597567743,0.5824915824915825,0.9496862445242477,1.0,5/24,10.98%,AUTS2;AVIL;PIK3CA;CARMIL2;CDC42
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3988956890649335,0.9144956501765896,0.5437262357414449,0.9490092940161641,1.0,4/16,16.33%,CPEB3;MOV10;ZFP36L1;PLEKHN1
prerank,establishment of epithelial cell polarity (GO:0090162),0.38864919246973906,0.9139289624164882,0.5551537070524413,0.9496055216754994,1.0,7/19,17.18%,CLASP1;MYO18A;EZR;OPHN1;CDC42;PARD3;MYO9A
prerank,presynaptic endocytosis (GO:0140238),-0.32605804176217257,-0.9136716023940818,0.5882352941176471,0.8378076991755898,1.0,4/24,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3717823251990467,0.913448343313766,0.5719237435008665,0.9499482196471285,1.0,2/25,5.28%,SMAD3;TLR4
prerank,rRNA 3'-end processing (GO:0031125),0.43650882779382005,0.9134366983794362,0.5489833641404805,0.949263110177765,1.0,4/10,17.39%,ERI3;EXOSC7;ERI2;EXOSC3
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.38456916556861065,-0.9133913304564454,0.5983606557377049,0.8377167728548868,1.0,2/13,9.31%,PRR5L;PNPT1
prerank,stem cell development (GO:0048864),-0.3551594642726122,-0.9133761479194097,0.5664488017429193,0.8370052480299891,1.0,4/16,18.20%,CDH2;PTPRC;KLHL12;SOX8
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4102238354025398,-0.913176007481393,0.5838383838383838,0.8367377233019944,1.0,5/10,21.03%,DISC1;CTNNB1;VEGFA;CX3CR1;DRD2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.43505473231504627,0.9126248238386575,0.5465587044534413,0.9504089813494795,1.0,4/10,18.19%,APOM;BMP1;PRKACB;ZDHHC8
prerank,B cell homeostasis (GO:0001782),0.43983901490508553,0.9121810543211547,0.5735849056603773,0.9507422946806842,1.0,1/10,0.43%,DOCK11
prerank,intraciliary retrograde transport (GO:0035721),0.42681330261855477,0.9120505782756545,0.5703125,0.9503529583686285,1.0,4/12,13.74%,IFT122;WDR19;DYNC2I1;WDR35
prerank,negative regulation of hemostasis (GO:1900047),0.4278277832825657,0.9117828628829072,0.5649717514124294,0.9502340808384487,1.0,3/12,7.10%,TFPI;KNG1;SERPINE1
prerank,cellular response to alcohol (GO:0097306),0.33042846910811036,0.911446063367751,0.5830670926517572,0.9503072791704793,1.0,4/42,4.85%,ADCY5;ADCY1;GRAMD1B;SMO
prerank,mRNA 3'-end processing (GO:0031124),0.2993881986293409,0.9113066182021066,0.6090775988286969,0.9499387504616394,1.0,23/78,22.28%,PABPN1;SRSF5;AHCYL1;POLDIP3;RPRD2;POLR2D;TENT2;SCAF8;SRSF11;TENT4B;SARNP;CPSF3;PAPOLG;GRSF1;CSTF1;SRSF1;PCF11;U2AF1;CDC40;SRSF7;U2AF2;CPSF7;TUT1
prerank,myelination in peripheral nervous system (GO:0022011),-0.378022220162269,-0.9111976409337443,0.5883620689655172,0.8405588249200587,1.0,6/13,21.55%,ADGRG6;MYOC;PRX;SIRT2;LGI4;SOD1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3656653512135079,0.9111862795103727,0.5672913117546848,0.9495098038995056,1.0,2/26,5.28%,SMAD3;TLR4
prerank,female gamete generation (GO:0007292),0.3601128394798171,0.9111640580026091,0.5758620689655173,0.948848687317896,1.0,4/29,7.33%,SPO11;DIAPH2;USP9X;TOB2
prerank,apoptotic nuclear changes (GO:0030262),0.3692458838177797,0.9108452293284631,0.5790378006872853,0.9488784911271483,1.0,8/24,21.28%,CASP3;CDK5RAP3;BLCAP;DICER1;DFFB;DFFA;ACIN1;CECR2
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.39158098789869816,-0.910740265537928,0.5817805383022774,0.8400317179179877,1.0,6/11,26.82%,CCT2;CCT8;CCT6A;CCT7;MEPCE;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.39158098789869816,-0.910740265537928,0.5817805383022774,0.8400317179179877,1.0,6/11,26.82%,CCT2;CCT8;CCT6A;CCT7;MEPCE;DKC1
prerank,TOR signaling (GO:0031929),0.3591969909825524,0.9105571444729909,0.5795847750865052,0.9488133825722096,1.0,8/26,15.35%,FNIP1;NPRL3;SMG1;RICTOR;LARP1;MAPKAP1;FLCN;RPTOR
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.32624984877766355,0.9104324558766901,0.5981735159817352,0.9483945084860285,1.0,6/48,10.02%,ROBO1;PARP14;GPS2;STAT2;SAMHD1;YTHDF3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.37623732061702647,0.9103629423711451,0.5699831365935919,0.9478482668140481,1.0,3/23,5.61%,ACSL1;ACSBG2;HACD1
prerank,neuron apoptotic process (GO:0051402),-0.3484887628717678,-0.9101667397057771,0.5854700854700855,0.840611137266601,1.0,7/19,16.96%,CIT;SCN2A;APP;TNFRSF21;FAS;TRPC5;DIABLO
prerank,phosphorylation (GO:0016310),0.2523969370912822,0.9100611649176681,0.696045197740113,0.9478201966171222,1.0,73/384,15.10%,PRKAG2;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;PI4KA;GRK5;SPHK1;PRKAG3;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;IKBKE;PRKCB;GK5;ATM;PRRT1;CAMK1;BRAF;NUAK2;TRIB2;EIF2AK2;SIK1;CDC42BPG;TKFC;GK;TGFBR2;IGFBP3;COQ8B;RYK;PIK3CA;PDPK1;CSNK1A1;PICK1;MKNK1;BRSK1;ABL1;FER;DYRK1A;SRPK2;AURKB;MYLK3;TRIB1;PRKDC;PRKCA;MAPK6;CSNK2A1;HIPK3;FRK;PNKP;MAP3K1;PRKCI;MAPK10;MAP2K1;WNK1;GRK3;ROS1;BMP2K;COQ8A;STK36;SPHK2;ACVR2B;STK17B;ACVR1B;STK4;CERK;MAPK9
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.32699533668641206,-0.9099061059206286,0.5965346534653465,0.8404691308021122,1.0,7/26,9.68%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,hemidesmosome assembly (GO:0031581),0.43675513338910793,0.9099006166232085,0.5697445972495089,0.9474975780339586,1.0,2/11,1.98%,LAMC2;LAMC1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4169669300066112,0.9097989061225672,0.5883534136546185,0.947015264945287,1.0,2/11,7.47%,FGFR2;TGFBR2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3487801732152115,0.908679863579663,0.5924657534246576,0.9489604336253374,1.0,9/31,22.41%,CD300A;ATM;CD274;GLMN;SDC4;GPNMB;DLG5;CTLA4;ARG1
prerank,protein localization to lysosome (GO:0061462),-0.3178680059265465,-0.9086657861813149,0.594059405940594,0.8426286650304943,1.0,12/28,25.59%,RTN4;SORL1;SH3BP4;GCC2;LAPTM5;NCOA4;M6PR;CD81;RNF128;SCARB2;LMBRD1;NAGPA
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2885557111066904,-0.9084165060644901,0.581267217630854,0.8425087802235096,1.0,17/40,33.87%,PID1;SLC25A33;MAPT;PINK1;UBB;RNF122;SOD1;PRELID1;STOML2;PYCR1;PMAIP1;SPART;PARK7;PIP5KL1;SLC4A11;PRDX3;BAD
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3783972028767004,0.9084046468305164,0.5920138888888888,0.9488660640936475,1.0,6/21,16.29%,SAMD4A;TUT4;CNOT10;PAN3;PNLDC1;TUT7
prerank,relaxation of cardiac muscle (GO:0055119),0.42541024048343995,0.9081949610254223,0.6023391812865497,0.9486357734022107,1.0,1/13,0.08%,ATP1A2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3416701118072322,0.9080815409554411,0.5773710482529119,0.9482065587094396,1.0,6/35,9.01%,ALOX12;ACSS3;BDH1;SCD5;BDH2;HMGCS2
prerank,regulation of dephosphorylation (GO:0035303),-0.35611079793132056,-0.9080427436186456,0.5905172413793104,0.8426943174618314,1.0,5/15,12.80%,PPP1R16B;MTMR2;PPP1R16A;MTMR9;SMG5
prerank,protein localization to chromosome (GO:0034502),0.34991823753847706,0.9079103686962086,0.5790349417637272,0.9478937104200649,1.0,12/34,21.00%,ATRX;ACD;TPP1;TNKS2;LEMD2;IFFO1;XRCC4;WAPL;RB1;TINF2;MCM9;PARP3
prerank,smooth muscle contraction (GO:0006939),-0.3645892531438302,-0.9075299867549148,0.583710407239819,0.8430819203041621,1.0,5/14,9.98%,SLC8A1;EDNRA;SMTN;MYH11;ACTA2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36546954816371563,0.9074871832926091,0.5844370860927153,0.9481868544484218,1.0,2/24,2.13%,DNMT3A;JARID2
prerank,lipoxygenase pathway (GO:0019372),0.40251338345600496,0.9074156294724677,0.5722222222222222,0.9476591497366652,1.0,2/14,7.40%,ALOX12;PON3
prerank,actin polymerization or depolymerization (GO:0008154),0.323325874346688,0.9073171076413875,0.6137404580152672,0.9471860162016372,1.0,9/50,11.83%,MICAL3;GAS7;AVIL;ARHGAP6;DIAPH1;CATIP;WASL;VIL1;TTC17
prerank,regulation of JNK cascade (GO:0046328),0.2879116645853793,0.9069133049939723,0.598893499308437,0.9474181127786558,1.0,5/101,2.02%,TGFBR3;SH3RF2;TPD52L1;CCN2;PRKN
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3770130526586242,0.906897151207278,0.6017391304347826,0.9467632244245529,1.0,5/20,6.49%,FUT1;ST3GAL3;B4GALT1;FUT8;ST6GALNAC6
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.39501592042001205,0.9067993019967989,0.5701107011070111,0.9463218512022162,1.0,7/16,20.98%,PRPF39;SFSWAP;CWC15;PSIP1;SRSF1;SNRPC;WBP4
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.26786394327720403,-0.9067901115952063,0.6528662420382165,0.8440374009704352,1.0,22/56,24.61%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;USP8;SEPTIN9;APC;NUSAP1;EFHC2;SPAST;ECT2;CHMP4B;CUL7;KIF4A;RHOC;KIF23;CENPA
prerank,gonad development (GO:0008406),0.33297231172343245,0.9066360030817827,0.5996884735202492,0.9459798155793326,1.0,3/41,2.95%,WNT4;KIT;NR2F2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.33919262982912923,0.9058057690280826,0.5795454545454546,0.9471782723708875,1.0,6/33,11.18%,SMAD3;TP53;APLN;SMARCA4;TERT;TEAD1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.27560853449524986,0.9057429430287631,0.6528704939919893,0.9466297387777222,1.0,15/152,8.13%,ADCY5;CACNA1D;LGR4;LPAR1;ADCY1;GRK5;LPAR2;ADRA2A;AKAP12;GNAT2;ADGRL1;ADCY9;MC2R;GNAT3;ADM
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2897421497819906,-0.9056471780300513,0.6149870801033591,0.8458519104040372,1.0,10/40,13.71%,FMN2;CST3;NELL1;DAB2IP;FLNA;TIMP2;IRAK3;SNCA;PTPN3;ADGRB1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3496170526437683,0.9054061047513381,0.58,0.9466806903397416,1.0,8/34,10.98%,AUTS2;AVIL;CAPZB;PIK3CA;HRG;CARMIL2;FER;CDC42
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4143312041711048,0.9052831286722346,0.566990291262136,0.9462666638465971,1.0,4/12,20.88%,LRRK2;CLN6;ATP6AP2;CCDC115
prerank,sphingosine biosynthetic process (GO:0046512),-0.4016428156727092,-0.9050188292119976,0.5804480651731161,0.8458212248655109,1.0,4/11,11.54%,ACER3;ACER2;SPTLC2;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),-0.4016428156727092,-0.9050188292119976,0.5804480651731161,0.8458212248655109,1.0,4/11,11.54%,ACER3;ACER2;SPTLC2;ASAH2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4131673012251114,0.9048812725106439,0.5738317757009346,0.9464966491315279,1.0,4/14,10.20%,KIT;GPRC5B;SIRT1;MAVS
prerank,cellular response to amino acid stimulus (GO:0071230),0.35255262127232895,0.9040384095677894,0.5975609756097561,0.9476383684028366,1.0,9/33,17.57%,CPEB4;SESN1;SESN2;UBR2;CPEB3;RPTOR;UBR1;NSMF;RRAGD
prerank,inositol phosphate dephosphorylation (GO:0046855),0.43571658462350277,0.9040001104911805,0.5807050092764379,0.9463314386884552,1.0,3/11,11.59%,SYNJ2;PTEN;OCRL
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.43571658462350277,0.9040001104911805,0.5807050092764379,0.9463314386884552,1.0,3/11,11.59%,SYNJ2;PTEN;OCRL
prerank,homologous chromosome segregation (GO:0045143),-0.3383346428668266,-0.9039250047417725,0.6088794926004228,0.847532761119219,1.0,4/20,21.20%,FMN2;ZCWPW1;MEI4;PRDM9
prerank,regulation of primary metabolic process (GO:0080090),0.2831208533746776,0.9037720379580927,0.6283783783783784,0.9461657007390156,1.0,13/126,8.47%,ROCK2;NFYC;CHD9;PPARA;NCOR2;NFYB;GPS2;TBL1X;C1QTNF2;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,regulation of feeding behavior (GO:0060259),0.43280047664155463,0.903569768673933,0.573076923076923,0.9459363116320427,1.0,1/11,0.70%,LEPR
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.33033466012657847,-0.9035589682896221,0.5981735159817352,0.8476216176522603,1.0,8/22,17.55%,MDFIC;APOD;UFM1;CABP1;DMTN;SIAH3;GDI1;BARD1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4220967431274129,0.9034598539201804,0.5736842105263158,0.9454994015230151,1.0,3/11,18.33%,ITPKB;PPIP5K2;IP6K3
prerank,negative regulation of DNA recombination (GO:0045910),0.3286680453600151,0.903255146076877,0.5769230769230769,0.945241058576339,1.0,16/43,26.16%,POLR2A;ATRX;ACD;FBH1;POLR2D;MSH3;SMCHD1;TINF2;PARP3;POLR2G;POLR2F;MAD2L2;H1-0;SHLD2;POLR2K;UBQLN4
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2859374746858059,0.9030758171760335,0.6191117092866757,0.9449618405313618,1.0,18/109,11.59%,PTPN13;LPGAT1;INPPL1;PI4KA;MTMR3;SYNJ2;PIGW;PLEKHA2;PDGFRB;SLC27A1;PIP4K2C;PTEN;PIK3CA;PLCD1;PIKFYVE;PLEKHA8;PIK3R3;OCRL
prerank,regulation of keratinocyte migration (GO:0051547),-0.3845514314697986,-0.9029642036874793,0.5900216919739696,0.8482822274049799,1.0,4/12,15.91%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,regulation of embryonic development (GO:0045995),0.3471282722628818,0.9028788285640864,0.5680672268907563,0.9447594770984152,1.0,10/34,13.50%,CLASP1;DAG1;NIPBL;TRIP12;NIBAN2;NR2C2;PHLDB2;FOXA2;TDG;WDPCP
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3379273131470753,0.9027390051465433,0.595,0.9443918898089178,1.0,8/37,13.74%,TNPO1;KIF3C;IFT122;WDR19;DYNC2I1;CLUAP1;IFT88;WDR35
prerank,cellular response to insulin stimulus (GO:0032869),0.28303234185480614,0.9027134221558515,0.614010989010989,0.9437618963427229,1.0,21/124,12.98%,CPEB2;SORBS1;RHOQ;INSIG2;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;SLC27A1;GCK;PDPK1;GRB10;FOXC2;RAB13;FER;ATP6V1D;PIK3R3;PRKDC;ATP6V1E1;PRKCI;DENND4C
prerank,mammary gland development (GO:0030879),0.3737958126901951,0.9022420832957,0.5697278911564626,0.9441273090574233,1.0,4/21,8.66%,WNT4;GLI2;APLN;NRG1
prerank,protein autophosphorylation (GO:0046777),0.2720484809175962,0.9020849064345443,0.6573248407643312,0.9438082686775592,1.0,25/157,10.74%,OXSR1;KIT;FGFR2;EPHA4;GRK5;FGFR1;AAK1;LRRK2;SMG1;ATM;PDGFRB;EPHA8;EIF2AK2;SIK1;FLT1;MAPKAPK3;PDPK1;PIKFYVE;RIOK2;RIPK1;MKNK1;ABL1;FER;DYRK1A;AURKB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.38429000962184356,0.9020064558029006,0.5787545787545788,0.9432978513682737,1.0,2/19,1.42%,PICALM;IGF1
prerank,striated muscle cell differentiation (GO:0051146),-0.3621559743738022,-0.9017263356502478,0.5920502092050209,0.8503314648930093,1.0,4/16,8.19%,MEF2C;MYEF2;SORT1;BMP2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3787379720588828,0.9015990847570978,0.6059544658493871,0.9435514509280959,1.0,6/22,15.63%,NEDD4;PTPN23;RNF115;VPS37A;VPS4A;SNF8
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2961991011140379,0.9015580339725808,0.6185714285714285,0.9429398388354526,1.0,11/80,9.56%,KIF2A;STX18;KIF3C;UVRAG;ARFGAP3;HTT;KIF1C;GOLPH3L;COPZ2;PICK1;KLC1
prerank,response to chemokine (GO:1990868),-0.38663586493546964,-0.9014880947007975,0.59375,0.8501232020656627,1.0,5/13,10.68%,LRCH1;CXCL12;SLC12A2;DOCK8;DUSP1
prerank,blood circulation (GO:0008015),0.3228780701238007,0.9014107308023119,0.5727699530516432,0.9426007632122172,1.0,8/49,8.59%,ROCK2;ACE;NPR1;MYOF;COL4A3;BDKRB2;SCPEP1;OLR1
prerank,regulation of monocyte differentiation (GO:0045655),-0.37550043460780735,-0.9008393364581189,0.5991091314031181,0.8508456095808855,1.0,4/14,17.22%,FOXP1;CTNNBIP1;FES;CD74
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3655048640715039,0.9008002693820527,0.6126279863481229,0.9432615003146582,1.0,2/22,4.60%,CACNA1D;CACNA1C
prerank,DNA damage checkpoint signaling (GO:0000077),0.35439042947863836,0.9007008860665862,0.5777385159010601,0.9427933769329765,1.0,15/28,29.17%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A;CDC5L;USP28;TIPRL;E2F1;CHEK1;ATR
prerank,kinetochore organization (GO:0051383),-0.372402884541486,-0.9006727839073687,0.5960698689956332,0.8504682614083525,1.0,8/13,30.99%,CENPE;CENPH;NDC80;CENPA;CENPF;DLGAP5;NUF2;POGZ
prerank,carboxylic acid metabolic process (GO:0019752),0.33895554683787776,0.9006125060541942,0.6027633851468048,0.9423217156238574,1.0,2/33,1.66%,DDO;ST6GAL1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.31027435295530603,-0.900517980565447,0.5954773869346733,0.8500816857190981,1.0,10/29,20.38%,HSP90AB1;PPIA;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;PTGES3;NHP2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.304719631060507,0.9000096549603891,0.6053412462908012,0.9430212235057527,1.0,11/66,10.20%,SMAD3;SESN2;F2;WWTR1;TERT;ZIC1;CDK5RAP3;UBR5;PARP9;LARP7;MAVS
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25980051659020453,0.8999401681748888,0.6963855421686747,0.9425122114389386,1.0,81/241,26.88%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;HNRNPA2B1;SNIP1;POLR2D;RBM15;SPEN;NOVA1;CCAR1;GPKOW;GTF2F1;CWC27;HNRNPL;SRSF11;PHF5A;CWC15;IK;USP49;PRCC;HNRNPC;SNRNP40;PRPF3;CPSF3;RBM4;HNRNPM;TFIP11;CWF19L1;USP39;FRG1;CSTF1;SRSF1;ZCRB1;FUS;PRPF6;HNRNPH3;PCF11;U2AF1;EFTUD2;CDC40;SRSF10;PRPF31;SNRPC;SF1;PNN;SRSF7;WBP4;POLR2G;SF3B2;SF3B1;SNRPA1;U2AF2;CPSF7;PPWD1;SF3B5;RNPC3;GCFC2;CDC5L;NUDT21;PQBP1;POLR2F;DDX41;GEMIN5;WBP11;LSM6;ZCCHC8;DHX8;SRSF4;DDX46;POLR2K;LSM3;SF3B3;RBM6;CTNNBL1;UBL5
prerank,positive regulation of chemokine production (GO:0032722),0.3253753031499437,0.8995305462069161,0.5959752321981424,0.9427445950699321,1.0,9/44,13.58%,IL18;TLR3;TLR4;DDX3X;EIF2AK2;IL17RA;MAVS;ADAM17;OAS3
prerank,response to growth factor (GO:0070848),0.33077078061179654,0.8993798880826486,0.60828025477707,0.9424052668323313,1.0,7/41,7.47%,SPHK1;BMPR1A;TGFBR1;MAP2K5;PLK5;CPNE3;TGFBR2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3628781889891253,0.8990878688895487,0.602112676056338,0.9423659041366593,1.0,7/23,17.36%,PLK5;CDK5RAP3;AURKB;PRCC;INTS3;VPS4A;CHMP4C
prerank,T cell differentiation in thymus (GO:0033077),0.40300549883177106,0.8990035694599272,0.5789473684210527,0.941874208175932,1.0,4/14,20.62%,GLI3;ADAM17;ZFP36L1;LIG4
prerank,tRNA 5'-end processing (GO:0099116),0.4090208233458825,0.8989309221577011,0.5748175182481752,0.9413664491392206,1.0,5/15,20.12%,RPP21;PRORP;RPP25L;POP7;POP1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.24489210762588923,0.8981881179095998,0.7251082251082251,0.9423172775177304,1.0,63/509,10.51%,FGF1;ROCK2;OSBPL8;WLS;LPAR1;KSR1;KIT;GSDME;IGF1;SASH1;FGFR2;KL;PRKN;IL18;FNIP1;SPHK1;NFAT5;NUPR1;CFLAR;AKAP13;FRS2;FGFR1;TGFBR1;CXXC5;ADRA2A;NEDD4;BID;TLR3;IKBKE;PRKCB;TLR4;DDX3X;P2RX3;CD27;PDGFRB;EPHA8;CD28;ANKRD17;GAB2;EIF2AK2;IL12B;TP53;RICTOR;LGALS1;FLT1;CDK5RAP3;RYK;PIK3CA;GPRC5B;NRG1;PDPK1;TCF7L2;DNM1L;TAB2;SIRT1;DDX60;RIPK1;RIPK2;MAVS;HBEGF;BECN1;TRIP6;FLT3LG
prerank,positive regulation of macrophage activation (GO:0043032),-0.3470451497221409,-0.8981683197529475,0.6334106728538283,0.8546314137838957,1.0,2/17,5.87%,THBS1;IL33
prerank,intracellular sterol transport (GO:0032366),-0.38856305459267204,-0.8981177193171387,0.5901639344262295,0.8539863781393052,1.0,5/13,20.05%,ABCG1;NPC2;STARD4;RELCH;OSBP
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.39238888946621997,0.8978604436868403,0.5596491228070175,0.9424064689979097,1.0,7/16,23.30%,ATM;HNRNPA2B1;TNKS2;TINF2;SLX4;SMG6;PINX1
prerank,melanosome localization (GO:0032400),0.37777453186323684,0.8977818995335156,0.5912280701754385,0.9419015114822471,1.0,6/21,16.08%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,skeletal muscle tissue development (GO:0007519),0.3362496979900557,0.8975466271382998,0.5664335664335665,0.9417372708379498,1.0,5/32,8.25%,IGSF8;CSRP3;CFLAR;KLHL41;LEMD2
prerank,negative regulation of DNA binding (GO:0043392),-0.30184494265858464,-0.8970907684804938,0.638676844783715,0.8555793699997047,1.0,3/28,9.00%,LEF1;NFKBIA;HEY2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.32607663487217287,0.89662373286959,0.606418918918919,0.9431153715530416,1.0,5/41,7.47%,TGFBR3;FGFR2;BMPR1A;TPM1;TGFBR2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.39657831484247075,-0.8960949744238472,0.5983086680761099,0.8570532586468994,1.0,2/11,4.43%,PID1;TFRC
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.334178596267596,-0.89608513505336,0.5990783410138248,0.8563362601817369,1.0,9/22,13.85%,RASSF2;PDGFC;CALM1;CALM2;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,positive regulation of rRNA processing (GO:2000234),0.43527724626278086,0.8960472059910438,0.5816135084427767,0.9437456979028508,1.0,3/10,18.04%,RIOK2;WDR43;BUD23
prerank,negative regulation of cell aging (GO:0090344),0.3922263972959322,0.8957503672907046,0.5780669144981413,0.9437459533288773,1.0,5/16,14.72%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,establishment of spindle orientation (GO:0051294),0.34394798562477846,0.8955332956969583,0.5858585858585859,0.943570444294324,1.0,6/28,14.82%,PKHD1;CLASP1;FBXW11;HTT;MISP;LLGL2
prerank,mRNA modification (GO:0016556),-0.33247656704606204,-0.8955323082981368,0.6165919282511211,0.8568339088861563,1.0,13/22,39.87%,TRMT61B;METTL3;TRMT6;PUS1;TRUB1;PUS7;DKC1;CBLL1;ZC3H13;TRMT10C;RPUSD2;TRMT61A;TRUB2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3567269986616038,0.8955075971704382,0.6006546644844517,0.9429543532455794,1.0,7/26,14.36%,PCBP2;DHX58;TRIB1;NMI;MAPKBP1;ACOD1;PPM1B
prerank,cellular response to calcium ion (GO:0071277),0.2963659519834745,0.8954889012677499,0.6330827067669172,0.9423308156919981,1.0,9/67,9.53%,SYT9;SYT11;SYT12;PRKAA2;ADCY1;BRAF;CPNE3;MEF2A;ITPKB
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2986465496054664,0.8950127132289313,0.6330935251798561,0.9427639637348966,1.0,15/73,15.15%,DNMT3A;JARID2;TAF1D;BAZ1B;HDAC4;PHF1;PHF2;GLMN;MYO1C;TDG;POLR1G;TBP;SPHK2;KAT2B;MPHOSPH8
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.231943986074836,-0.8946223844801326,0.7396694214876033,0.8581127626205952,1.0,27/136,14.08%,ESR1;TMSB4X;CD200;GAS6;ID1;PTGIS;NFKBIA;CYP1B1;DAB2IP;SFRP4;FLNA;HES1;PTCH1;CTNNBIP1;HEYL;PROX1;SMAD7;IRAK3;ID2;ERBIN;PKD1;HAVCR2;NLRC5;AIM2;CMKLR1;TRIM37;RBCK1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3634505115458615,-0.8944626390222826,0.5964523281596452,0.8577347676735962,1.0,3/16,10.77%,SCARB1;LDLR;MFSD2A
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3492848524823394,0.8943511960524132,0.5767195767195767,0.9435255475980308,1.0,6/29,14.52%,WWOX;BID;PPP2R1B;RIPK1;PML;AGTR2
prerank,transferrin transport (GO:0033572),0.34255829950764816,0.894287034672601,0.598705501618123,0.9429998491265619,1.0,11/33,19.04%,ATP6V0E1;ATP6V0B;CLTC;RAB11B;ATP6V1D;ATP6V1E1;DNM2;STEAP3;HFE;ARHGAP1;ATP6V0D1
prerank,proteasome assembly (GO:0043248),-0.3859280651220339,-0.8936892922690154,0.6092436974789915,0.8586612925416747,1.0,5/11,36.03%,PSMG2;PSMD11;POMP;ADRM1;PSMD4
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3761764976462966,-0.893419692036976,0.6303901437371663,0.8585399300492128,1.0,7/12,28.49%,MAOA;DDC;SMS;AMD1;SLC22A3;OAZ2;ODC1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2897354457007088,-0.8932409161344089,0.6212121212121212,0.858263076948586,1.0,20/40,39.71%,BACH2;XPO1;ANP32A;RBM15B;SNRPF;NXT1;SNRPD3;NPM1;NCBP2;SNRPB;HTATIP2;MALT1;RITA1;SNRPG;NUP205;LSG1;GEMIN2;NCBP1;GEMIN6;HNRNPA1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.30750556494254816,-0.893240425930355,0.6555819477434679,0.8575288912540191,1.0,5/25,10.52%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,inner ear morphogenesis (GO:0042472),0.36921367784929837,0.8932304750453403,0.5910714285714286,0.944651166034037,1.0,4/22,8.20%,FGFR2;HOXA1;CHD7;ZIC1
prerank,intracellular protein transport (GO:0006886),0.25055593310984475,0.893037198272534,0.7276887871853547,0.9444323369011332,1.0,63/304,20.11%,RANBP3L;APPL2;WLS;TRAK1;KIF13B;SNX6;TBC1D16;SEC31B;TNPO1;LAMP2;STXBP2;ACD;CLTC;ARFGAP3;FUT10;VPS26C;IPO13;COPZ2;PICK1;ARL4A;GRTP1;NUP42;RAB43;RANBP3;RAB22A;VPS45;MYO1C;SNX8;DESI1;STX5;SGSM2;SNX15;VIPAS39;RAB21;SEC23IP;AP2A1;RAB29;SCFD1;ARFIP2;SNF8;ARL6;NUP155;CLIP3;TBC1D25;SEC31A;CCHCR1;SGSM3;FAM91A1;VPS35;AP4M1;C2CD5;TBC1D14;TRAK2;NUP188;KATNB1;EVI5;KIF13A;TBC1D22B;TSC2;EVI5L;STX16;LTBP2;RTN2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.39106990923970836,0.8928699821615043,0.5638686131386861,0.9441205637220624,1.0,4/17,9.70%,IGF1;DOCK5;PDGFRB;DOCK7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3798930612844781,-0.8924323810964508,0.6271551724137931,0.8586247322515146,1.0,5/13,17.55%,MDFIC;APOD;UFM1;CABP1;BARD1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.25656233860988276,0.8924295328558096,0.6793611793611793,0.9444084004716706,1.0,28/234,11.05%,PPARGC1B;SMAD3;ZIC2;PRKCZ;KIT;PPARGC1A;ADCY1;IL18;SPHK1;CFLAR;EDA;IKBKE;NHLH2;PRKCB;SMO;TLR4;EIF2AK2;SMARCA4;PTEN;TFDP1;TAB2;HDAC4;RIPK1;RIPK2;MAVS;FER;RAB7B;ATF2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.36282485302512035,0.892252909364079,0.6134020618556701,0.9441281270014772,1.0,1/25,0.70%,LEPROT
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3642586071636211,0.8918752282150884,0.5876288659793815,0.9443121545502545,1.0,6/21,7.81%,CD300A;ELF1;PRKCB;GPS2;PTPN22;ELF2
prerank,cellular response to heat (GO:0034605),0.337027828345617,0.891843404410368,0.5996649916247906,0.9437127335183929,1.0,3/35,8.04%,FGF1;POLR2D;HSBP1L1
prerank,vesicle organization (GO:0016050),-0.2729058470911383,-0.8917508596557283,0.6563380281690141,0.8593424330289033,1.0,8/46,8.05%,CAV1;FNBP1L;CD34;CAV2;LAPTM4B;SORT1;DNM1;ALS2CL
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3134223341237256,0.8916921793833531,0.6424050632911392,0.9433881167181105,1.0,7/49,10.39%,GSDME;NUPR1;BID;DDX3X;TP53;DNM1L;BECN1
prerank,heterochromatin organization (GO:0070828),-0.3749873700003932,-0.891474113749586,0.5905172413793104,0.8592068204170386,1.0,2/14,5.51%,MECOM;PRDM16
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3630892107869138,-0.8913028527474746,0.6200873362445415,0.8588712227300869,1.0,6/15,15.64%,NGF;NTRK2;SORT1;DDIT4;BCAR1;BDNF
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.30814946949082295,0.8912561218691094,0.6112804878048781,0.9436988407777372,1.0,7/57,8.01%,ADCY5;LPAR1;ADCY1;ADRA2A;AKAP12;ADCY9;GNAT3
prerank,peptidyl-lysine methylation (GO:0018022),0.3536238680576175,0.8906634819475604,0.6006944444444444,0.9443857994758278,1.0,8/26,23.70%,SMYD3;SETD7;KMT5A;EHMT2;EHMT1;SETD3;N6AMT1;EEF1AKMT1
prerank,response to tumor necrosis factor (GO:0034612),0.2827871318270013,0.8906598285429668,0.6528803545051699,0.9437268866505227,1.0,12/91,10.32%,GSDME;AFF3;NPNT;SPHK1;CASP3;ZFAND6;GBP3;GBP2;HYAL1;SIRT1;RIPK1;CCL25
prerank,positive regulation of neuron death (GO:1901216),0.31886421080218186,0.8905630962818322,0.620845921450151,0.9432775660288151,1.0,4/46,5.28%,EFNB2;PICALM;NUPR1;TLR4
prerank,methylguanosine-cap decapping (GO:0110156),-0.40308479271346154,-0.8900251978230862,0.6155378486055777,0.8609801185920894,1.0,4/10,22.05%,DCP1B;PNRC2;LSM1;DCP2
prerank,respiratory chain complex IV assembly (GO:0008535),0.3681917180423794,0.8899223162380732,0.5956284153005464,0.9440463640397003,1.0,12/21,30.47%,COX16;COX10;SMIM20;COX19;FASTKD3;COX15;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,ruffle organization (GO:0031529),-0.34716346571986306,-0.8897996297425497,0.6077235772357723,0.8607125665266568,1.0,3/16,6.58%,CARMIL1;LIMA1;PLEKHA1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.23182091003401445,-0.8897329510924626,0.7773584905660378,0.8601308890692345,1.0,28/124,16.12%,LEF1;PRICKLE2;DAAM1;GNG2;PSMB2;NLK;TIAM1;CALM1;SFRP4;FZD4;MAP3K7;PPP3R1;ROR2;NFATC1;PPP3CA;AP2B1;PSMD14;PSMC6;VANGL2;FRZB;AP2M1;CTNNB1;CCDC88C;GNAO1;SMURF1;GNB1;PSMB9;PSMA4
prerank,establishment of protein localization to organelle (GO:0072594),0.29287213433414955,0.8891324432745853,0.6198224852071006,0.9450642590698198,1.0,4/72,3.92%,APPL2;HK2;TNPO1;LAMP2
prerank,regulation of interleukin-4 production (GO:0032673),-0.3287959961414848,-0.8890850201738919,0.6138392857142857,0.8608109841847407,1.0,8/21,21.84%,LEF1;SLC7A5;HAVCR2;SYK;ZFPM1;PRKCQ;CD86;LGALS9
prerank,placenta development (GO:0001890),-0.390710880468317,-0.8888210944759257,0.614190687361419,0.8606686405833194,1.0,7/12,35.37%,PTK2;CUL7;SOD1;PLAC1;ADAM19;E2F8;PPARG
prerank,snRNA 3'-end processing (GO:0034472),0.3838235264061466,0.8886509376220387,0.5996376811594203,0.9454889316976319,1.0,7/19,17.39%,EXOSC7;INTS2;INTS5;INTS1;INTS7;INTS8;EXOSC3
prerank,regulation of phagocytosis (GO:0050764),-0.26936925865025413,-0.888618237280351,0.6701570680628273,0.8603652414483307,1.0,11/53,10.54%,MERTK;SCARB1;GAS6;PTPRC;RAB27A;GATA2;DYSF;CALR;CD47;DOCK2;CYBA
prerank,regulation of transposition (GO:0010528),0.4113093281922247,0.8879149672149695,0.5908256880733945,0.9463763865730195,1.0,2/13,9.13%,UBR2;MYBL1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.2766116128545635,-0.8879068202231126,0.6354430379746835,0.8611728655441288,1.0,18/44,22.11%,PTPRJ;LYN;DAB2IP;APOE;SORL1;AIDA;IRAK3;DUSP1;UCHL1;BMP4;SPRY1;DNAJA1;PDCD4;SPRY4;PTPN1;AGT;PAQR3;STK38
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3208104901781872,-0.8878541296721183,0.6382022471910113,0.8605457457480579,1.0,13/21,40.52%,RAD51B;ATAD5;NPM1;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A;CDC25B
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2556968104426703,0.8877362233621937,0.7260920897284534,0.9461449721759896,1.0,54/259,16.08%,CFAP44;ACTN2;KIT;AVIL;CC2D2A;RHOD;PKHD1;DCDC2;SRGAP2;FGD4;CEP250;CPLANE2;RILPL1;EZR;RAB3IP;CYS1;PTPN23;ASAP1;RHO;EXOC2;CCDC28B;CEP162;SSTR3;CDC14A;ANO6;IFT122;OPHN1;WDR19;DYNC2I1;CLUAP1;MKKS;TMEM231;CDC14B;IFT88;ATP6V1D;MYLK;GALNT11;PDE6D;FGD1;OCRL;UNC119B;WDPCP;WDR35;CFAP410;EXOC4;STK36;PARVA;B9D2;EXOC3;RAB8B;ARFIP2;ARL6;RP2;BBS2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.422630333664767,0.8875384676966744,0.5863970588235294,0.945911148803772,1.0,2/10,9.52%,ATRX;SSBP1
prerank,cardiocyte differentiation (GO:0035051),0.42724056013465694,0.8874690399809496,0.5774378585086042,0.945383272327906,1.0,4/10,9.88%,AKAP13;SIK1;NRG1;CBY1
prerank,mammary gland epithelium development (GO:0061180),0.4019643224382185,0.8873182987247548,0.5877862595419847,0.9450376919124335,1.0,1/14,1.00%,WNT4
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4259919649346874,0.8871461686262876,0.5900383141762452,0.9447505711058478,1.0,4/10,17.18%,EZR;OPHN1;CDC42;MYO9A
prerank,endodermal cell fate commitment (GO:0001711),0.4275712071588669,0.887103850741271,0.5956607495069034,0.9441809949491318,1.0,2/10,10.76%,CTR9;RTF1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3801457583039646,0.8864286338983077,0.5905797101449275,0.9449969071485853,1.0,1/19,1.81%,PPARA
prerank,zinc ion transmembrane transport (GO:0071577),0.36697779955571025,0.8863577565800775,0.6030927835051546,0.9444735576175658,1.0,3/22,8.32%,SLC30A10;SLC30A2;SLC39A13
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.38426651173973897,-0.8861319876905391,0.6381709741550696,0.8628795356849694,1.0,5/12,16.76%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.38426651173973897,-0.8861319876905391,0.6381709741550696,0.8628795356849694,1.0,5/12,16.76%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.356051436798773,0.8859932570628994,0.5989304812834224,0.9445923260666571,1.0,6/25,13.29%,CCNT2;LDB1;ELL;SCAF8;KAT7;WDR43
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3443210434685061,0.8858087122133089,0.616260162601626,0.9443445808901939,1.0,7/31,7.90%,SIPA1L1;EPHA4;NGEF;LRRK2;CUX2;CAPRIN2;PTEN
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3802708871226881,-0.8848758090250605,0.615071283095723,0.8648276830545893,1.0,3/12,20.02%,ANO1;ADCY8;CFTR
prerank,negative regulation of type I interferon production (GO:0032480),0.32698703966754633,0.8845381470071867,0.620253164556962,0.9464608187713677,1.0,12/40,21.63%,PCBP2;IKBKE;RNF135;MAVS;DHX58;ACOD1;PPM1B;UFD1;NPLOC4;TAX1BP1;SIRPA;YY1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4168903967276349,0.8845293223833726,0.5849056603773585,0.9458198087626207,1.0,3/12,13.33%,PPARA;MIA3;WNK1
prerank,regulation of cell killing (GO:0031341),-0.3547649195373149,-0.8840148436448617,0.6509240246406571,0.865939447932903,1.0,3/16,10.54%,TGFB2;ICAM1;CYBA
prerank,positive regulation of lipid transport (GO:0032370),0.4107578505128049,0.8836892931687415,0.6066536203522505,0.9470700013407076,1.0,2/12,8.24%,SPP1;LRP1
prerank,tRNA aminoacylation (GO:0043039),-0.2902760666405989,-0.883629312085689,0.638676844783715,0.8660364483165942,1.0,4/37,11.74%,LARS2;WARS2;GARS1;DARS2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.37337002818860304,0.8834069108135397,0.5933682373472949,0.9470448906252334,1.0,6/19,13.99%,CD27;MMP14;ZMIZ1;PRKDC;ZBTB1;AXL
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3117405868969303,0.883216875934026,0.6246056782334385,0.946795623429952,1.0,12/49,17.03%,PRKCZ;PMEPA1;SMAD6;DDX3X;LDLRAD4;CDC42;TMC8;IMPACT;ANKRD27;CRYAB;TFIP11;PEX5
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3971605195627147,-0.883084111982228,0.6202783300198808,0.866497478278234,1.0,2/10,5.26%,CSGALNACT1;XYLT1
prerank,fatty acid elongation (GO:0030497),-0.3725558890040226,-0.8829908140207438,0.6361746361746362,0.8659745388821644,1.0,4/13,16.60%,ELOVL7;ELOVL5;ELOVL6;TECR
prerank,negative regulation of lyase activity (GO:0051350),-0.3446554419121735,-0.8826055199234761,0.6327944572748267,0.8660467932499163,1.0,5/16,21.03%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4062304599743494,0.8821462465688822,0.5858778625954199,0.9484296842698952,1.0,1/12,0.59%,CELSR1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2719982795670992,-0.8818485757628088,0.6898395721925134,0.8669328016389444,1.0,11/46,17.57%,PPIA;RAP1B;RPLP0;JAK1;MSN;PITPNA;TALDO1;CFL1;AIP;CAPZA1;PDCD4
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3931613255240397,0.8815960566239397,0.6090909090909091,0.9482263113042516,1.0,4/15,15.25%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3931613255240397,0.8815960566239397,0.6090909090909091,0.9482263113042516,1.0,4/15,15.25%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4284941364597858,0.8810684779567725,0.6254545454545455,0.9487185442097339,1.0,1/11,1.95%,LRRC38
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3583669633138557,0.8810459254731848,0.6159292035398231,0.9481179978552544,1.0,10/25,22.02%,AMPD3;PRPSAP1;AMPD2;PRPSAP2;APRT;MTHFD1;GART;ADSL;GMPR2;GMPS
prerank,histone H2A acetylation (GO:0043968),0.39065447417794646,0.8805795132400182,0.6138433515482696,0.9484356027894209,1.0,1/16,1.52%,BRD8
prerank,establishment of spindle localization (GO:0051293),-0.35752263997723915,-0.8796638983588659,0.6353711790393013,0.870914781377161,1.0,6/14,25.20%,CLASP2;MAP4;CFL1;NUSAP1;TLE6;KPNB1
prerank,hippo signaling (GO:0035329),0.34937698450686067,0.8793147161698659,0.6020408163265306,0.9504573950310478,1.0,9/26,16.87%,CASP3;TEAD3;WWTR1;TEAD2;AMOTL2;TEAD1;SAV1;STK4;YAP1
prerank,N-terminal protein amino acid modification (GO:0031365),0.3982323236615822,0.879119376949343,0.5959780621572212,0.9502226382769833,1.0,8/14,33.15%,METAP2;NAA16;NAA50;AANAT;NAA15;NAA40;NAA60;METAP1D
prerank,positive regulation of inflammatory response (GO:0050729),0.28617755085785496,0.8788277925910051,0.6601123595505618,0.9501948478712278,1.0,11/86,9.65%,IL18;NAPEPLD;NUPR1;C2CD4B;TLR3;TLR4;IL12B;SERPINE1;GPRC5B;IL17RA;RIPK1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3571087353276015,0.8788112124019632,0.6115107913669064,0.9495704689255906,1.0,5/25,11.89%,PICALM;RIN3;ATXN2;NEU3;ITGAV
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.41667542918809747,0.87871081206013,0.6407766990291263,0.9491069288755561,1.0,1/11,0.70%,LEPROT
prerank,protein polymerization (GO:0051258),0.30509598518456343,0.878659250846867,0.6646433990895296,0.9485667824128857,1.0,9/55,11.83%,GAS7;PRKN;ARHGAP6;RNF135;DIAPH1;CATIP;WASL;VIL1;TTC17
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.24734899877298827,-0.8786159136232036,0.7060702875399361,0.8717369195903569,1.0,29/78,24.46%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;AP2B1;DYNC1LI2;KIF26A;CAPZA2;AP2M1;DCTN4;CTSL;CTSS;KIF3A;AP1S3;CENPE;KIF15;CD74;CAPZA1;SPTBN2;AP1S1;KIF11;KIF4A;KIF22;KIF5A;SAR1B;KIF3B;DCTN6;KIF23
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.24734899877298827,-0.8786159136232036,0.7060702875399361,0.8717369195903569,1.0,29/78,24.46%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;AP2B1;DYNC1LI2;KIF26A;CAPZA2;AP2M1;DCTN4;CTSL;CTSS;KIF3A;AP1S3;CENPE;KIF15;CD74;CAPZA1;SPTBN2;AP1S1;KIF11;KIF4A;KIF22;KIF5A;SAR1B;KIF3B;DCTN6;KIF23
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.31846134238528945,0.8782747074323162,0.6449044585987261,0.9487174187946655,1.0,7/49,9.38%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,establishment of apical/basal cell polarity (GO:0035089),0.39256866434528637,0.8781007985801745,0.5861423220973783,0.948415741553444,1.0,5/14,17.18%,EZR;OPHN1;CDC42;PATJ;MYO9A
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.370529549898662,-0.8779939888914186,0.6486486486486487,0.8723140594973411,1.0,6/13,11.09%,ABHD2;ESR1;PLPP1;AR;BMP4;GPER1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.41898153029787655,0.8775127818801208,0.6022514071294559,0.9490623101104422,1.0,2/11,5.87%,STX18;ATL1
prerank,positive regulation of cellular process (GO:0048522),0.23860356577021247,0.8771430862031325,0.8058568329718004,0.9492076054368883,1.0,74/565,11.89%,FGF1;BMP6;COLEC12;EFNB2;LAMC2;IGF1;PRKAA2;CCN2;IL13RA1;FGFR2;RHOD;ECHDC3;EPHA4;PKHD1;GRK5;SPHK1;NUPR1;FGFR1;PHIP;PRODH;TGFBR1;PDPN;ADRA2A;CDCA7L;SLC30A2;CTSH;TNFSF13;DPP4;MEIS1;TPM1;PPP1R13L;ATM;TLR4;DDX3X;P2RX3;PDGFRB;NOX1;ANKRD17;GAB2;CACUL1;IL12B;FLT1;WWTR1;TGFBR2;PTEN;TNFRSF18;LRP1;NRG1;GDNF;CCAR1;NEUROD4;HDAC1;GLI1;HDAC4;HYAL1;SIRT1;ASH2L;RIPK2;MMP14;TBRG4;HTR1A;HBEGF;FLT3LG;FER;CRKL;SRPK2;CDC42;PRKCA;DICER1;NOP2;AXIN2;ADAM17;CSNK2A1;ITGAV
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.42038576452603443,0.8767631511718922,0.5985267034990792,0.9493553784929135,1.0,4/10,17.21%,PRKAA2;SIRT1;FLCN;KLF15
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.41561587978558956,0.8766558874886109,0.6296296296296297,0.9489484002039594,1.0,1/11,0.54%,EFNB2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3459868592323184,0.8765049811449861,0.6208112874779541,0.9486402470553056,1.0,4/25,8.57%,ITPR1;LRRK2;P2RX3;HTT
prerank,sulfur compound biosynthetic process (GO:0044272),0.2738918208568926,0.8763707465002574,0.6942028985507246,0.9482757353652973,1.0,13/104,10.40%,UST;OGN;CHST15;CHST11;GSTT1;ST3GAL3;FMOD;B4GALT1;DSE;SLC26A1;CHSY1;CTH;GSTA3
prerank,miRNA metabolic process (GO:0010586),0.36247543752204836,0.8762508872839387,0.6463195691202872,0.9478710025361237,1.0,8/20,26.53%,TUT4;SND1;DICER1;TENT4B;TUT7;XPO5;AGO2;KHSRP
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3252289433770661,-0.8759340843266066,0.6644295302013423,0.8760129783326768,1.0,10/23,28.56%,RAD23B;UBB;COPS4;CETN2;COPS5;COPS6;UBC;RPS27A;COPS2;DDB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2256802603814243,-0.8754166028639637,0.7984496124031008,0.8762945043491689,1.0,56/125,32.87%,CLASP2;PLK2;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;SETD2;BUB3;CLIP1;MAP4;STMN1;NUSAP1;CENPE;EFHC2;EML1;TBCE;RAN;KIF11;NUP107;PPP1CC;CENPH;SUN2;BCCIP;NDC80;MAD2L1;NSL1;KIF4A;KIF3B;DCTN6;KNTC1;NUP85;MECP2;NEK6;CENPA;NDE1;CDCA8;TUBG2;KPNB1;NDEL1;RANGAP1;NUDC;TNKS;CENPF;STIL;PTPA;DLGAP5;NUF2;AURKA;CENPI;SPC24;CDC20;BUB1;ZWILCH;MAPRE1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3299023199113821,0.8743790632651108,0.6503164556962026,0.9512032649185322,1.0,14/39,18.87%,TTC7B;PI4KA;SMG1;TMEM150A;PIP4K2C;PIK3CA;ITPKB;PIK3R3;SOCS3;PI4K2B;IP6K3;SOCS4;SOCS7;PI4KB
prerank,cellular response to interferon-gamma (GO:0071346),-0.24086176331492953,-0.874055392139617,0.7627627627627628,0.8785341067466094,1.0,22/88,20.56%,CAMK2D;MID1;VCAM1;B2M;ICAM1;AQP4;SYNCRIP;CD47;IFNGR2;GBP4;CD44;JAK1;DAPK1;CCL13;RPL13A;IRF5;IRF2;CAMK2B;IRF8;TRIM68;CCL19;MT2A
prerank,proteoglycan biosynthetic process (GO:0030166),0.3338887845164773,0.8739886100457728,0.6129032258064516,0.9513983955616907,1.0,6/31,10.62%,HS3ST3B1;IGF1;CHST11;PXYLP1;GAL3ST4;FOXL1
prerank,membrane fusion (GO:0061025),-0.29024946062596596,-0.8737605559765732,0.6813725490196079,0.8783966940837195,1.0,5/33,9.32%,DNM3;RIMS1;DNM1;DYSF;NSF
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.29397018107684136,-0.8734143239464245,0.6825,0.8783964495550974,1.0,11/32,17.36%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TUBB4A;SPEF1;SNCA;STMN1;APC;FKBP4
prerank,DNA metabolic process (GO:0006259),0.24899701357974569,0.873163087897759,0.7532163742690059,0.9525165972637256,1.0,70/270,21.68%,TOP2B;POLD2;KMT5C;USP3;DNTT;POLG;ATM;UVRAG;RAD54L;ACD;KMT5B;PARP4;DNASE1L1;TERT;SAMHD1;PDS5A;TCF7L2;SRPK2;RBBP8;PRKDC;AXIN2;MSH3;ZBTB1;HUS1;IGHMBP2;FANCA;RAD50;PNKP;TOP3A;USP7;TDG;MCM7;MCM2;POLE2;ORC3;DDB2;POLA2;DFFB;MGMT;GADD45A;DOT1L;INTS3;LRWD1;DNASE1L2;POLL;SP100;MBD4;CDC34;TINF2;MMS19;XRCC3;ASF1A;OGG1;PDS5B;NBN;FEN1;SUMO1;SLX4;RFC1;LIG1;XPA;RAD51D;ZNF445;RAD9A;LIG4;EID3;PARP3;TOP1MT;ORC6;MCM5
prerank,regulation of protein binding (GO:0043393),-0.23612775027968574,-0.8731212378928553,0.7796610169491526,0.8783156693138094,1.0,34/114,18.91%,CAV1;ACTB;CLDN5;EPB41;B2M;GSK3B;TIAM1;APP;DISC1;CRK;CTNNBIP1;PSEN1;SORL1;DACT1;BMP2;RALB;TMBIM6;GNL3L;ADD2;PKD1;FKBP1A;BMP4;MARK2;CDKN1A;CARD16;SPPL3;HIPK2;PPP1CA;ZFPM1;MEN1;HIP1R;RAN;CTSZ;LDLRAP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.36395444355490203,-0.8729445659768569,0.631236442516269,0.8779235304483689,1.0,8/14,31.37%,TSEN34;FAM98B;RTCB;TSEN54;CPSF4;TSEN15;CLP1;CPSF1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.2958906883017782,-0.8716613791370175,0.6626506024096386,0.8799285458608161,1.0,12/25,25.56%,CACNB2;AKAP6;CEMIP;TRPC1;GPER1;SNCA;APLNR;NPSR1;F2R;CXCL10;THY1;PLCG1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3707134095608041,-0.8716587709783594,0.6321353065539113,0.879202283606957,1.0,3/12,5.43%,PROM1;STAT3;RORB
prerank,protein complex oligomerization (GO:0051259),0.28534629306584003,0.8716474959525851,0.6978102189781021,0.9551005458944299,1.0,12/85,9.00%,UPB1;ALS2;RNF213;MCU;NACC2;RNF135;ATL1;MICU1;OPA1;TWNK;JMJD6;DNM1L
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.3327070928576123,-0.871284211842286,0.6529680365296804,0.8792462523439861,1.0,8/18,21.37%,PLCG2;DYSF;DOCK2;SBNO2;LBP;SYK;TYROBP;PYCARD
prerank,pinocytosis (GO:0006907),-0.38798892775225857,-0.8710770701460901,0.6369047619047619,0.8789460558863208,1.0,3/10,9.92%,CARMIL1;PPT1;DOCK2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.35163694301253934,0.8707864649141521,0.6166365280289331,0.9562639190395922,1.0,3/25,7.09%,HK2;PGAM2;GCK
prerank,histone H3 acetylation (GO:0043966),-0.27500758074359966,-0.8706470936738334,0.6971279373368147,0.879097011424833,1.0,9/40,19.51%,LEF1;MAP3K7;YEATS2;JADE3;JADE1;MBIP;BRPF3;MEAF6;TAF5
prerank,male gonad development (GO:0008584),0.33520417451754225,0.8705094353136059,0.6606260296540363,0.9561858060798545,1.0,2/34,1.22%,WNT4;KIT
prerank,Fc receptor signaling pathway (GO:0038093),-0.23350699782872594,-0.8704794972485579,0.77,0.878719949860964,1.0,43/110,30.36%,PIK3R1;LYN;PSMB2;CALM1;PAK1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;PSMC6;TEC;IKBKB;PSMB9;PSMA4;VAV1;SYK;SKP1;BTK;PRKCQ;PSMD11;PSMB10;PSMD2;SHC1;PSMA2;SOS1;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;MAPK8;CARD11;JUN;MAPK3;FOS;LCP2;MALT1;PSMD7;PSMF1;NFATC2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.41945932440564504,0.8695639083532141,0.6106719367588933,0.9575707429728868,1.0,4/10,18.13%,SETD7;KMT5A;EHMT1;SETD3
prerank,myotube cell development (GO:0014904),0.40652041849762727,0.8691663062689186,0.6274509803921569,0.9577175769477931,1.0,1/10,1.42%,IGF1
prerank,response to organonitrogen compound (GO:0010243),-0.2856684648879221,-0.8690967031731315,0.6816976127320955,0.8808580081852295,1.0,11/38,21.63%,GLRB;GLRA3;GLRA1;IRAK3;GLRA2;TRPM2;RHBDD1;IRF5;RCN3;DRD2;NR1H4
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3555408741765195,0.8689174905634518,0.6092943201376936,0.9575908633818315,1.0,2/22,2.40%,SASH1;SPHK1
prerank,heterocycle biosynthetic process (GO:0018130),-0.3587155857223078,-0.868682395264269,0.6286919831223629,0.8809898170456536,1.0,2/14,6.37%,GPHN;GCH1
prerank,embryonic eye morphogenesis (GO:0048048),-0.3713340463194098,-0.8683559441829989,0.6242038216560509,0.8809573728606588,1.0,6/11,24.24%,MFAP5;FBN2;ALDH1A3;LRP6;TBX2;MFAP2
prerank,regulation of calcium ion transport (GO:0051924),0.3012370788102988,0.8682239302428155,0.6719242902208202,0.958380605739559,1.0,3/54,3.76%,CACNA1D;ANK2;ADRA2A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24293193153530526,0.8681584728981209,0.7753456221198156,0.957853426393951,1.0,73/341,18.96%,RNF43;ASB2;ANAPC15;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;USP9X;PTPN23;ANAPC2;UBR4;SPSB4;TBL1X;SMURF2;TTC3;RNF8;FBXW11;TRIP12;RNF217;HUWE1;BTRC;TBL1XR1;RNF19A;RNF34;SIRT1;FBXO22;ZSWIM8;AURKB;RNF13;FZR1;CUL4A;WWP2;UBA6;FBXO10;NUB1;PML;FBXO11;RMND5A;UBE2H;RNF115;VPS37A;FAF1;AMFR;VPS4A;RNF19B;ANAPC16;BIRC6;MAEA;RNF146;WDR91;UBE2E1;SYVN1;UFD1;KCTD21;RNF7;SQSTM1;KCTD13;CDC34;ARIH1;NPLOC4;TAF1;MIB1;NDFIP1;RNF20;NHLRC3;FBXL22;USP33
prerank,positive regulation of exosomal secretion (GO:1903543),0.3819395416598234,0.868156776539556,0.62109375,0.9572051359758779,1.0,7/15,21.92%,SDC4;SMPD3;VPS4A;SNF8;CHMP2A;RAB7A;SDCBP
prerank,regulation of interleukin-10 production (GO:0032653),0.31263876359768294,0.8681255928742565,0.6505636070853462,0.9566344795858204,1.0,5/44,6.56%,PRKCZ;TLR4;CD28;TRIB2;IL12B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.33153498144121335,0.8680678809499404,0.647887323943662,0.956121462676874,1.0,13/31,26.46%,TIMM44;PEX10;TOMM70;PEX14;PEX5;PEX16;TIMM17B;TIMM17A;TIMM21;PEX26;CHCHD4;DNAJC15;GRPEL2
prerank,coenzyme A metabolic process (GO:0015936),0.3952845360174789,0.8679128620278089,0.6179159049360147,0.9557829227237264,1.0,7/14,27.17%,PANK1;DCAKD;CROT;ACLY;SLC25A16;ACAT1;ACOT7
prerank,response to organic cyclic compound (GO:0014070),0.3072962246776232,0.8677907572879349,0.6556603773584906,0.9553880551426893,1.0,6/52,5.93%,SPP1;IL18;PAQR7;LRRK2;TLR3;TIPARP
prerank,protein localization to cell-cell junction (GO:0150105),0.39628007467172205,0.8674266721742147,0.6398537477148081,0.9555110579274531,1.0,4/15,9.32%,CGNL1;ARHGEF18;MPP7;CDH5
prerank,negative regulation of peptidase activity (GO:0010466),0.30987946788619053,0.8674229672265151,0.6592356687898089,0.9548749028341488,1.0,7/47,8.66%,TIMP3;SERPIND1;KNG1;SERPINE1;LRP1;SERPINA9;HRG
prerank,JNK cascade (GO:0007254),-0.2758644761745708,-0.8674160625888538,0.6926952141057935,0.8821718215290159,1.0,14/40,25.08%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;UBB;NOD2;MAP3K11;SH2D3C;UBC;RPS27A;MAP2K7;TAB1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3164478607740015,-0.8672903250291176,0.6572769953051644,0.8817191842291128,1.0,8/24,17.34%,NCKAP5;STMN2;TRPV4;FGF13;MAPT;STMN1;MAP7D3;TPPP
prerank,positive regulation of wound healing (GO:0090303),0.3256610855326604,0.8672621728821118,0.6411960132890365,0.9545717312901315,1.0,8/36,11.21%,SMOC2;ADRA2A;RREB1;F2;SERPINE1;FOXC2;HBEGF;MYLK
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.30290536688779235,0.8670313165001156,0.649624060150376,0.9543888218391946,1.0,10/54,15.01%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PML;GADD45A;E2F4
prerank,positive regulation of growth (GO:0045927),-0.2523622683474386,-0.8667094252868637,0.7438271604938271,0.8821788208508534,1.0,13/64,14.41%,AKAP6;TGFB2;RFTN1;LGI1;CXCL16;H3-3A;ERBB2;SLC25A33;RPS6KA3;MFSD2A;RPS6KA1;TAF9B;PPM1F
prerank,regulation of protein metabolic process (GO:0051246),0.3130638197772994,0.8666804096939711,0.6368,0.9544897928063414,1.0,4/44,7.56%,ROCK2;ACE;MAP2K5;ANGPTL8
prerank,positive regulation of innate immune response (GO:0045089),0.33415198673258767,0.8656221282331329,0.6173469387755102,0.956138046559714,1.0,9/30,17.48%,IFNK;PLSCR1;MAVS;NMI;TRIM62;IFI35;PLA2G5;WNT5A;ZBP1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.31261458796008224,0.8655899588963349,0.624,0.9555719638720985,1.0,5/43,6.03%,IGF1;IL18;BMPR1A;PDGFRB;NOX1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.25513388589081043,-0.8655582965405699,0.7225433526011561,0.8838891623041412,1.0,8/59,6.81%,MAP3K5;PTPRK;NET1;CYP1B1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3945062475891562,-0.8651297313656311,0.6369294605809128,0.8840366418304927,1.0,4/10,18.13%,ACVRL1;ZBTB16;BMPR1B;PKDCC
prerank,negative regulation of macroautophagy (GO:0016242),0.3501440679279666,0.8645963414015184,0.6322241681260946,0.9569545633577978,1.0,6/26,15.42%,NUPR1;LRRK2;SMG1;PIK3CA;TSC1;SCFD1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3149062174638488,0.8645156531857815,0.66875,0.9564864831658038,1.0,6/51,3.97%,BMP7;GAS7;SRGAP2;ALS2;LRRK2;DTNBP1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.29067412851948216,-0.8641038137620586,0.665,0.885469175107639,1.0,5/32,10.02%,CDK14;CDK17;POLA1;BACH1;ID2
prerank,protein polyubiquitination (GO:0000209),0.24507873643838726,0.8640083704847904,0.7908101571946796,0.9569405229088701,1.0,51/297,16.01%,RNF152;UBE2E2;SASH1;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;NHLRC4;RNF135;FBXL19;TRIM56;ANAPC2;UBR2;SMURF2;TTC3;RNF8;FBXW11;TRIP12;RNF217;HUWE1;TNKS2;BTRC;RNF19A;RNF34;UBR5;NPEPPS;HERC6;FBXO22;FBXL12;FBXW8;RNF41;FBXO4;FZR1;WWP2;FBXO10;TRIM62;DDB2;FBXO11;FBXL20;DZIP3;LONRF1;RMND5A;UBE2H;RNF115;AMFR;RNF19B;HECTD1;RNF31;RNF146
prerank,histone H2A ubiquitination (GO:0033522),0.37177799480712986,0.8635744122756454,0.6056603773584905,0.9572137099718396,1.0,6/17,18.40%,UBR2;RNF8;BCOR;KDM2B;DDB2;RNF2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3406538601883166,0.8630463339935509,0.6252129471890971,0.9576804038490775,1.0,2/24,5.25%,ACE;TAPBPL
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.38557544241625263,0.8630393598509812,0.6094890510948905,0.9570514230491802,1.0,4/13,18.34%,NFU1;CISD3;ISCA1;MMS19
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3345518556310064,0.8623459448704481,0.6527545909849749,0.9578989396267793,1.0,5/30,11.87%,LEPROT;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,nuclear pore organization (GO:0006999),-0.35372722436165827,-0.8622613520666325,0.6607929515418502,0.8885029466608574,1.0,7/14,35.67%,RTN4;NUP107;NUP93;NUP54;TMEM170A;AHCTF1;NUP205
prerank,purine nucleotide metabolic process (GO:0006163),0.34998486137264606,0.8612972046160681,0.6615384615384615,0.9594303553619866,1.0,9/24,19.75%,FHIT;NT5C1B;NT5C2;PRPSAP1;PRPSAP2;MTHFD1;GART;NT5C;ADSL
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.40032358211737473,0.8611952935650299,0.6341463414634146,0.9590039656521091,1.0,4/12,14.20%,PLK5;TP53;PRKDC;SDE2
prerank,negative regulation of response to external stimulus (GO:0032102),0.27444943630637375,0.8611629152217738,0.7114093959731543,0.9584358407737437,1.0,17/105,14.36%,RORA;C1QTNF3;PPARA;EPHA4;PCBP2;METRNL;GPS2;ENPP3;SERPINE1;PTEN;CDH5;DHX58;TRIB1;NMI;MAPKBP1;ACOD1;PPM1B
prerank,regulation of hemopoiesis (GO:1903706),0.4141482143099245,0.8609929266132295,0.6235294117647059,0.9581548579785708,1.0,5/10,15.67%,PRKCB;IL17D;PURB;LGALS3;CREBBP
prerank,protein localization to cell surface (GO:0034394),0.34139066398174517,0.8607226426152034,0.6316666666666667,0.9581115470029284,1.0,3/26,7.52%,ANK2;PRRT1;PTPRU
prerank,negative regulation of cellular component organization (GO:0051129),0.2854823902321398,0.8601162522296096,0.6907216494845361,0.9587073901386046,1.0,18/74,17.03%,BMP6;PRKCZ;SYT11;RAPGEF3;APOM;DDX3X;WASL;CARMIL2;CDC42;TMC8;IMPACT;EPHA3;DNM2;DNAJB2;CRYAB;LGALS3;TFIP11;PEX5
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3257110272019073,-0.8598545028172626,0.671201814058957,0.8927756760898201,1.0,6/18,11.13%,NELL1;DAB2IP;DACT1;RDX;HSP90AA1;MSN
prerank,regulation of lipase activity (GO:0060191),-0.3635190536463592,-0.8597733476261865,0.6857749469214437,0.8922470356688947,1.0,3/13,13.17%,PCSK5;PCSK6;SNCA
prerank,insulin receptor signaling pathway (GO:0008286),0.28728868441533423,0.859338986091768,0.6933333333333334,0.9597295173313808,1.0,13/69,11.43%,SORBS1;RHOQ;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;PIK3CA;GRB10;FOXC2;FER;ATP6V1D;PIK3R3;ATP6V1E1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.38896025881346563,0.8593367149137854,0.62,0.9590938423340254,1.0,1/14,0.46%,WNK4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.38890061307347856,0.8592735889889552,0.6038461538461538,0.9585760469463885,1.0,5/15,10.47%,CLASP1;PDPN;DPP4;LRP1;CARMIL2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3054367585112875,-0.8591034392255789,0.6855791962174941,0.8929330532127479,1.0,11/27,21.82%,PID1;GRB14;PIP4K2A;ENPP1;PTPRE;NCK1;KANK1;PRKCQ;PTPN1;PIP4K2B;IRS1
prerank,cAMP metabolic process (GO:0046058),0.3894607223095625,0.8589512889961676,0.6189516129032258,0.9585839283958256,1.0,3/13,7.31%,ADCY5;ADCY1;ADCY9
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3008347422931167,-0.8587762188758706,0.6619718309859155,0.8928792045965015,1.0,10/24,21.63%,EPN2;DAB2IP;TMEM204;ITGB3;HIF1A;MT3;HHEX;ITGA5;PTPN1;VTN
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3370628461323381,0.8583697228091,0.6235294117647059,0.9591430559728411,1.0,7/28,16.18%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;TFIP11
prerank,protein palmitoylation (GO:0018345),-0.29497328443603926,-0.8581593506806405,0.7,0.8934079607939601,1.0,6/30,12.19%,ZDHHC9;HHAT;SELENOK;ZDHHC2;GOLGA7;ZDHHC14
prerank,positive regulation of isotype switching (GO:0045830),0.3877937693133676,0.8576222152630681,0.6355311355311355,0.9600154902762906,1.0,3/15,6.40%,KMT5C;TNFSF13;KMT5B
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2882681954841273,-0.8575886024995084,0.6820388349514563,0.8938789228072085,1.0,6/33,17.22%,LEF1;RUNX1;CTNNBIP1;ID2;FES;CD74
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.2899578888610682,-0.8575490082422377,0.7007299270072993,0.8932369255479281,1.0,5/31,11.27%,TFRC;GPI;PTPRC;EPHB2;HMCES
prerank,axoneme assembly (GO:0035082),-0.28826170151163955,-0.8574720807242672,0.681592039800995,0.8926587511454851,1.0,20/30,46.81%,DCX;RP1;SPEF1;DNAAF3;LRGUK;CCDC65;SPAG1;CFAP206;RSPH9;FOXJ1;TTLL3;DNAAF2;RSPH1;DNAAF1;RSPH4A;CFAP74;TTC12;DRC1;SPAG16;SPAG17
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3777755509724469,0.8573737146461824,0.6446124763705104,0.9598849285617559,1.0,1/16,1.30%,DDX5
prerank,protein-containing complex subunit organization (GO:0043933),-0.22391542323301747,-0.8573158924682464,0.8033898305084746,0.8922510428912833,1.0,26/109,17.68%,SLC2A1;REPS2;RIMS1;IL1RAP;LIN7A;PTK2B;SKAP2;OCLN;HES1;CD2AP;PPP2R1A;ELOB;TUBGCP2;ADD2;CAPZA2;CLDN14;FAS;LPXN;DMTN;MDN1;SHANK1;WASF1;APC;CD74;CAPZA1;TRAF1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2596988466732365,-0.8561341989876043,0.7277777777777777,0.8939519930275056,1.0,22/54,22.58%,RPL3;RPL26;RPL7;RPLP0;RPL35A;RPL5;RPL14;RPL7A;RPL23A;RPL10A;RPL6;MALSU1;MDN1;NOP53;BRIX1;MRPL20;RPL24;NHP2;RPL11;RSL24D1;NPM1;RRP15
prerank,mitotic spindle assembly (GO:0090307),0.3148586899116635,0.8558870407523191,0.6892109500805152,0.9623271175220992,1.0,14/42,19.80%,KIF2A;CLASP1;LSM14A;KIFC1;AURKB;MISP;STAG2;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.34460018390638636,-0.8558525096132696,0.6775599128540305,0.8937749176339942,1.0,8/14,35.96%,ELAVL4;YBX3;TIRAP;HNRNPA0;ELAVL1;MYD88;DAZL;ANGEL2
prerank,integrated stress response signaling (GO:0140467),-0.3598525625050677,-0.8557574451237429,0.6428571428571429,0.8932303179946288,1.0,3/14,16.50%,HSPA5;ATF4;EIF2AK3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2753643789920167,0.8556676899486287,0.7275362318840579,0.9621362623817102,1.0,9/88,7.85%,DNAJC6;EXOC6B;SH3D19;DTNBP1;ARRB1;ARFGEF2;EXOC2;CLTC;AP1G2
prerank,nuclear pore complex assembly (GO:0051292),-0.3818728381572263,-0.8553831470737402,0.65439672801636,0.8932357617969945,1.0,6/10,35.67%,RTN4;NUP107;NUP93;TMEM170A;AHCTF1;NUP205
prerank,inner dynein arm assembly (GO:0036159),0.4134908972383638,0.8546938432716324,0.6084452975047985,0.963550574512746,1.0,5/10,27.54%,CCDC39;CCDC40;DNAAF5;CFAP73;DNAH1
prerank,cGMP metabolic process (GO:0046068),0.40408954740217645,0.8546461794269683,0.6205450733752621,0.9630151090035537,1.0,2/12,5.86%,NPR1;NPR2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.39501853228728584,0.8545799787876673,0.6553030303030303,0.9625184853074896,1.0,5/13,17.66%,YJU2;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.365578236917523,0.8545405497426319,0.6234234234234234,0.9619598728376753,1.0,3/16,8.11%,IGF1;PHIP;IGFBP3
prerank,axonal transport of mitochondrion (GO:0019896),0.40930976686430615,0.8544502457133304,0.6387832699619772,0.9615123690743632,1.0,2/11,7.15%,TRAK1;OPA1
prerank,protein neddylation (GO:0045116),0.3934072647641852,0.8541092114895613,0.6178107606679035,0.9615440471285321,1.0,3/13,17.09%,UBE2M;DCUN1D5;RNF7
prerank,regulation of myotube differentiation (GO:0010830),0.34561459541747913,0.8539333760079145,0.656896551724138,0.9612604879557212,1.0,7/24,9.89%,DMPK;SIK1;BHLHE41;HDAC1;HDAC4;FBXO22;MMP14
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3571095854412428,0.8537763777396896,0.6300884955752213,0.9609244842590128,1.0,3/18,6.65%,CD300A;PARP10;TP53
prerank,inositol phosphate catabolic process (GO:0071545),0.40105960184130124,0.8537753464924211,0.6507352941176471,0.9602902396296948,1.0,3/12,11.59%,SYNJ2;PTEN;OCRL
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.41589982721384017,0.8535665393165003,0.6150793650793651,0.9600871964357003,1.0,2/10,7.44%,UBAC2;ERLEC1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3954714913545605,0.8535197422763201,0.650853889943074,0.9595347011939284,1.0,2/13,7.47%,GLI3;TGFBR2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3011195642863759,0.8534012963926343,0.6595092024539877,0.9591544678148749,1.0,12/50,17.97%,CCNA2;CCNA1;CCNT2;CCND3;CDK5RAP3;CDC25A;CCNB2;GTPBP4;GADD45A;CCNG1;CCNE1;CNPPD1
prerank,P-body assembly (GO:0033962),0.3874345844070729,0.8531327071096498,0.6224489795918368,0.9590617190163272,1.0,3/12,12.15%,ATXN2;LSM14A;DDX6
prerank,vasculature development (GO:0001944),0.3825194229614696,0.8527805664813535,0.6496350364963503,0.9591173013608125,1.0,6/16,14.47%,ERRFI1;PDGFRB;PIK3CA;CDH5;PDGFRA;ACVR2B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.36987699052721423,-0.8526312148015318,0.6790606653620352,0.8979356373041817,1.0,3/12,8.59%,ESR1;STAT3;TGFB1
prerank,protein acylation (GO:0043543),0.32070731778826134,0.8524456247866116,0.6548821548821548,0.9591631928619722,1.0,10/38,18.38%,SPHK1;NAA80;GLUL;ZDHHC18;ZDHHC1;PORCN;KAT2B;CREBBP;ZDHHC8;ZDHHC23
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.38687537111120834,-0.8518029411155,0.6761710794297352,0.8989089498167524,1.0,2/10,13.69%,ASRGL1;QDPR
prerank,glutathione derivative metabolic process (GO:1901685),0.3464029093130434,0.8513181244798632,0.6498194945848376,0.960260753934606,1.0,2/20,10.40%,GSTT1;GSTA3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3464029093130434,0.8513181244798632,0.6498194945848376,0.960260753934606,1.0,2/20,10.40%,GSTT1;GSTA3
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.28772877373898476,0.8508022373069551,0.6914893617021277,0.9606833497542727,1.0,9/69,8.74%,PPARGC1A;PRKN;SLC30A10;RETREG1;SNX6;CPEB4;SOD2;KDM2B;GDNF
prerank,mitochondrion disassembly (GO:0061726),0.3191637259067495,0.8505791440672109,0.6733001658374793,0.9605451978317306,1.0,7/34,13.56%,PRKN;ATG5;WIPI1;AMBRA1;ATG7;BECN1;ATG2A
prerank,membrane protein proteolysis (GO:0033619),0.31519934343801964,0.8502982171758611,0.6855241264559068,0.9604851937702602,1.0,11/37,19.58%,BACE2;DAG1;CTSH;APH1B;ADAM17;MBTPS1;ERAP1;NFKB1;CLPP;NCSTN;AFG3L2
prerank,cellular senescence (GO:0090398),-0.28931769330620444,-0.8500127003937638,0.6867469879518072,0.9017508627773763,1.0,6/27,12.63%,TBX3;SMC5;CALR;ECRG4;ID2;CDKN1A
prerank,myeloid cell differentiation (GO:0030099),-0.2638644970394328,-0.8496686746540191,0.7519181585677749,0.9016752775801268,1.0,11/47,17.53%,SNRK;RUNX1;ZBTB16;LYN;RPS19;IKZF1;MFHAS1;TIRAP;TAL1;HIPK2;ZFPM1
prerank,response to interleukin-1 (GO:0070555),-0.24224146341473407,-0.8495368852440334,0.797752808988764,0.9012220091934257,1.0,19/73,24.27%,IL1R1;PTGIS;TNFRSF11A;ANXA1;DAB2IP;APP;IRAK3;CD47;HIF1A;SNCA;CCL13;YTHDC2;CCL19;HAS2;PYCARD;LGALS9;SFRP1;HYAL2;RELA
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3106818418858209,0.8492742427943382,0.6639209225700164,0.9619874059775854,1.0,6/38,14.36%,RORA;TLE1;SIRT1;RIPK1;MAPKBP1;PPM1B
prerank,synaptic vesicle recycling (GO:0036465),-0.2902327185845079,-0.8491608456366244,0.6921119592875318,0.901234412913188,1.0,4/31,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,protein localization to kinetochore (GO:0034501),0.3881653798486222,0.8486555702622544,0.6307692307692307,0.9626592241556824,1.0,6/14,25.13%,AURKB;IK;CHAMP1;CENPT;MIS12;SPDL1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.34289831908505114,-0.8484770068232915,0.6961206896551724,0.9019028970283957,1.0,1/15,0.47%,LEF1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.25726269605167473,0.8483807475349993,0.7681159420289855,0.9626011417833907,1.0,11/140,6.93%,ADCY5;LPAR1;ACKR2;CCR9;JPH1;LPAR2;CACNA1C;BDKRB2;KNG1;P2RX3;CACNB3
prerank,regulation of chemotaxis (GO:0050920),0.3331389858799447,0.8479285250554726,0.6688851913477537,0.9628688443969616,1.0,8/30,16.95%,EFNB2;PDGFRB;ADGRA2;ZSWIM8;CYRIB;PDGFRA;ZSWIM5;ZSWIM6
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3871970513425253,-0.8478978959778046,0.683083511777302,0.9023302331377773,1.0,5/10,35.14%,NHP2;DKC1;NAF1;RPUSD3;RPUSD2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.30005345578033954,0.8478601276761912,0.6749611197511665,0.9623711860511407,1.0,13/52,17.39%,SAMD4A;TUT4;POLR2D;EXOSC7;CNOT10;PAN3;PNLDC1;DDX6;DCP1A;DIS3;TUT7;NT5C3B;EXOSC3
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3517913006304918,-0.8477161761903809,0.680672268907563,0.9019743524255142,1.0,2/13,14.06%,MID2;TRIM28
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.3889839082517873,0.847706608352989,0.6294896030245747,0.9620562352221064,1.0,4/13,11.77%,FGFR1;APLN;PDPK1;ADAM17
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39350330033357866,0.847415382851985,0.6346516007532956,0.9620495904365118,1.0,1/13,1.49%,ANAPC15
prerank,tryptophan catabolic process (GO:0006569),0.3950160065281527,0.8472509551249657,0.6358490566037736,0.9617619617476574,1.0,11/11,60.53%,AFMID;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.33341920864482266,-0.8467411761025659,0.652267818574514,0.9031719430167523,1.0,5/16,14.52%,SCARB1;GCH1;APOE;HIF1A;NUS1
prerank,regulation of telomerase activity (GO:0051972),-0.2630975540395284,-0.8460737360127389,0.7406417112299465,0.9037496247596697,1.0,18/45,28.44%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;TERF1;CCT2;MEN1;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;DKC1;TNKS;NAF1;MAPK3
prerank,retinol metabolic process (GO:0042572),-0.3506974508562991,-0.8441711034508518,0.6673640167364017,0.9067276921900137,1.0,3/14,11.12%,CYP1B1;RDH10;ADH1A
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3005423472560411,-0.8441316241671465,0.7125603864734299,0.9060768111182608,1.0,7/25,13.91%,BMPR2;ENG;ACVRL1;NOTCH1;CCN1;BMP4;BMPR1B
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.36105012616790855,-0.8438501637943422,0.7026476578411406,0.9051487833659794,1.0,6/12,18.58%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.36105012616790855,-0.8438501637943422,0.7026476578411406,0.9051487833659794,1.0,6/12,18.58%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,development of primary male sexual characteristics (GO:0046546),0.322474987102634,0.8434452069782428,0.7004830917874396,0.9689803183075114,1.0,2/34,1.22%,WNT4;KIT
prerank,glycogen biosynthetic process (GO:0005978),0.38787143826870535,0.8434180797479169,0.623352165725047,0.9677785254084363,1.0,3/12,14.38%,GYS1;PGM1;PER2
prerank,glucan biosynthetic process (GO:0009250),0.38787143826870535,0.8434180797479169,0.623352165725047,0.9677785254084363,1.0,3/12,14.38%,GYS1;PGM1;PER2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.41361075310937695,0.8432832231908728,0.6358381502890174,0.9673997778603031,1.0,3/10,17.20%,PARP14;SOCS3;PIBF1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3505820178341488,0.8432292665132227,0.6660808435852372,0.966878949884373,1.0,3/21,7.09%,HK2;DERA;GCK
prerank,alanine transport (GO:0032328),-0.374307074144005,-0.8431954709766744,0.6540755467196819,0.9056917020658649,1.0,2/10,7.83%,SLC6A6;SLC1A4
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3379039203660913,-0.8430217165288758,0.6805251641137856,0.9053245753969773,1.0,5/14,25.05%,GAS6;CCDC3;CARD16;RFFL;NLRP2B
prerank,regulation of response to oxidative stress (GO:1902882),0.39316065745078094,0.8429708344318758,0.6408163265306123,0.9667837091192867,1.0,1/11,2.02%,PRKN
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3773335463667851,0.8428109436624789,0.6586270871985158,0.9664727949959194,1.0,1/14,1.13%,PPP2R2B
prerank,exit from mitosis (GO:0010458),-0.3542482461916076,-0.8422314515624304,0.6780383795309168,0.9062220344923383,1.0,5/12,19.83%,CLASP2;EPS8;PPP2R2D;SPAST;CHMP4B
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3579938217813177,0.8412288418552735,0.6768402154398564,0.9690524680315277,1.0,6/18,17.98%,ANKRD17;DDX60;DHX58;BIRC3;UFD1;NPLOC4
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3675807657270404,0.8409079391147625,0.6524163568773235,0.9690786122424261,1.0,6/18,11.77%,COL4A3;FGFR1;FLT1;APLN;PDPK1;ADAM17
prerank,nucleotide catabolic process (GO:0009166),0.37001529908314806,0.8403563697836948,0.6617647058823529,0.9695910579022919,1.0,4/16,10.31%,NT5C1B;DERA;SAMHD1;NT5C2
prerank,tryptophan metabolic process (GO:0006568),0.3950160065281529,0.839819828182801,0.6421845574387948,0.9700536057179209,1.0,11/11,60.53%,ATP7A;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,negative regulation of endopeptidase activity (GO:0010951),0.2980798487061534,0.8392586421374741,0.7071651090342679,0.9704877994183815,1.0,6/47,8.66%,TIMP3;SERPIND1;KNG1;SERPINE1;SERPINA9;HRG
prerank,protein localization to Golgi apparatus (GO:0034067),-0.2945961825914881,-0.839131436505875,0.7002457002457002,0.9116266981051555,1.0,11/27,26.06%,SORL1;ARL1;ARL5A;GCC2;ARL5B;BICD2;RAB6A;PAQR3;TMED10;VPS13C;IFT20
prerank,RNA 3'-end processing (GO:0031123),0.2814691604674241,0.8390482886001029,0.7318518518518519,0.9702633169162692,1.0,21/69,23.31%,PABPN1;SRSF5;POLDIP3;RPRD2;TUT4;TENT2;SRSF11;TENT4B;SARNP;CPSF3;TUT7;CSTF1;SRSF1;PCF11;U2AF1;CDC40;SRSF7;U2AF2;CPSF7;TUT1;NUDT21
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.28888316838344424,0.8389820378817602,0.718562874251497,0.9697921770923489,1.0,12/63,15.01%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PRKDC;PML;SDE2;GADD45A;E2F4
prerank,NAD biosynthetic process (GO:0009435),0.35542614624384977,0.8388072732347666,0.6541737649063032,0.9694960353504699,1.0,7/20,19.86%,PARP10;NMNAT1;SLC5A8;PARP9;QPRT;NMNAT2;PARP16
prerank,positive regulation of bone resorption (GO:0045780),0.40047249022811154,0.8387355565702989,0.6583493282149712,0.96901907990612,1.0,2/11,11.31%,SPP1;PRKCA
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3826071448098364,-0.8384588755925626,0.6847599164926931,0.9121868060106869,1.0,2/10,5.81%,DLGAP1;DLGAP2
prerank,GPI anchor biosynthetic process (GO:0006506),0.32673871991559317,0.8382686240080324,0.6916524701873935,0.9693261610625785,1.0,3/30,6.47%,PIGN;PIGW;PIGQ
prerank,chromatin organization (GO:0006325),0.25737247432593113,0.8365720206047899,0.7661822985468957,0.9721945976619109,1.0,35/132,21.45%,JARID2;HDAC8;ATRX;BAZ1B;SETD7;SMARCD3;SMARCA4;SMARCC2;HDAC1;SMARCE1;HDAC4;SIRT1;BAZ1A;SNAI1;ZBTB1;PHF1;HMGN3;CDAN1;KAT2B;MTA2;LRWD1;SETDB2;SATB2;EHMT1;RB1;KDM6B;TCF7L1;PADI4;EZH1;MPND;BRWD1;SMARCD2;RUVBL1;KDM6A;TAF6L
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3419038366142979,-0.836432418273983,0.6826722338204593,0.9154365782017907,1.0,4/13,11.62%,TOX;CAMK4;BMP4;CLPTM1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.37838537072199246,0.8362421383372374,0.6583011583011583,0.9722430355634591,1.0,4/14,14.21%,TGFBR1;PTPN11;RFLNA;ADAMTS7
prerank,nerve growth factor signaling pathway (GO:0038180),-0.37714558558308564,-0.8362251459942938,0.6850715746421268,0.9151436454661648,1.0,3/10,15.64%,NGF;RAP1A;BDNF
prerank,cellular response to gamma radiation (GO:0071480),0.3649216426781241,0.8355602905529725,0.6695652173913044,0.9729622428735838,1.0,6/17,17.66%,ATM;TP53;CRYAB;TLK2;YAP1;KDM1A
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3527843607969999,0.835550346955013,0.6620450606585788,0.9723566565575699,1.0,4/20,10.24%,FKBP5;NKTR;PPIC;CWC27
prerank,chemokine-mediated signaling pathway (GO:0070098),0.30929579391345025,0.8355347907456951,0.6904376012965965,0.9717693984056645,1.0,7/42,17.33%,OXSR1;FOXC1;RBM15;CCL25;WNK1;CCL15;CCR2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3017084258594128,-0.8354761103943443,0.7116704805491991,0.9158538646386041,1.0,13/24,31.15%,POLD3;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,histone H4-K16 acetylation (GO:0043984),0.3597905072703913,0.8354191339700514,0.6841216216216216,0.9713851976413367,1.0,7/19,23.97%,KMT2A;KAT7;OGT;KANSL1;KANSL3;PHF20;MSL3
prerank,myeloid cell development (GO:0061515),0.3482721620013027,0.834868830598563,0.6587155963302752,0.9717957808661362,1.0,1/18,1.22%,KIT
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3079749206336516,0.8347799914928172,0.6807817589576547,0.9713588881468069,1.0,6/40,9.71%,DAB2;MAGI2;ARRB1;SERPINE1;PICK1;WASL
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.2656561835393126,-0.8346926743723305,0.7532467532467533,0.9166168158565456,1.0,17/42,25.91%,POLA1;POLD3;WRNIP1;FAAP20;PRIMPOL;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF
prerank,positive regulation of macroautophagy (GO:0016239),0.300244461929266,0.8346325705148135,0.7083969465648855,0.9710250753075982,1.0,10/48,10.43%,PRKAA2;SESN1;SESN2;FYCO1;UVRAG;PIP4K2C;LARP1;HTT;SIRT1;IRGM
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3849263089652093,0.8344494570783298,0.6528301886792452,0.9707810248970904,1.0,2/13,3.69%,NUPR1;LRRK2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2868828725655528,-0.8331366381682889,0.7469287469287469,0.9188474737427347,1.0,4/29,8.79%,CXCL12;GAS6;JAM2;CALR
prerank,phospholipid metabolic process (GO:0006644),-0.23710357234041166,-0.8329610714100267,0.8170731707317073,0.9184410633875767,1.0,9/71,10.65%,PLA2G4A;PIP4K2A;PLPP1;MBOAT1;PLPPR1;TNFAIP8L3;PLPPR5;PLPPR4;ENPP2
prerank,cell-cell junction maintenance (GO:0045217),0.40064786819806214,0.8328266882615859,0.6611418047882136,0.9734134928302351,1.0,1/11,2.52%,NLGN2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.384677574195756,0.8325804872941938,0.6435452793834296,0.9732979979167021,1.0,5/12,22.02%,LHPP;GART;ADSS1;ADSL;GMPS
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.27859100437991735,0.8321353291438608,0.7464183381088825,0.9736004040759285,1.0,9/72,9.08%,TFDP2;SESN2;ATM;ARID3A;ATRX;TP53;RBL2;CNOT10;TFDP1
prerank,vitamin D metabolic process (GO:0042359),0.3780085221078605,0.831931431597119,0.6729323308270677,0.9733590685739135,1.0,4/13,22.83%,CYP2R1;GC;PIAS4;CUBN
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.30644331549699083,-0.8318524851483895,0.7074235807860262,0.9197532051550786,1.0,11/18,40.52%,RAD51B;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A;CDC25B
prerank,protein stabilization (GO:0050821),0.2499276072414049,0.831800605956693,0.8018134715025906,0.9729835356055513,1.0,12/168,6.64%,ATP1B3;ANK2;PPARGC1A;IGF1;STXBP4;PRKN;EPHA4;AAK1;LAMP2;USP9X;TBL1X;CREBL2
prerank,copper ion homeostasis (GO:0055070),-0.32804526046664784,-0.8316564893163363,0.7289293849658315,0.9193863715288899,1.0,6/17,24.38%,APP;ATOX1;SLC31A1;COMMD1;MT2A;CUTC
prerank,regulation of sensory perception of pain (GO:0051930),-0.35398103383119295,-0.831650980290207,0.6894409937888198,0.9186701520023856,1.0,3/11,7.11%,CCN3;MGLL;TMEM100
prerank,sterol homeostasis (GO:0055092),0.28206983815519904,0.8314440313069945,0.7480559875583204,0.9730577950756052,1.0,4/65,5.12%,RORA;IL18;GRAMD1B;APOM
prerank,negative regulation of interleukin-8 production (GO:0032717),0.36068396869034547,0.8313683874225485,0.6884955752212389,0.9725840494959664,1.0,4/17,7.39%,SSC5D;ARRB1;MAP2K5;PTPN22
prerank,negative regulation of axonogenesis (GO:0050771),-0.2881891379936734,-0.8309793587399058,0.7481108312342569,0.919180636916887,1.0,11/27,17.28%,RTN4;DCC;DIP2B;ULK1;ULK2;FGF13;LINGO1;SEMA3G;MT3;ARHGDIA;GDI1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3729080719796575,0.8308630674342944,0.6737967914438503,0.9729462335907347,1.0,4/15,8.90%,RAPGEF3;CAMK1;TP53;TCF7L2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3307897627081309,0.8307639685037487,0.6565656565656566,0.9725272017050498,1.0,2/23,4.39%,ALOX12;ACSBG2
prerank,synaptic vesicle transport (GO:0048489),-0.3700571566294547,-0.8304394954679465,0.7041666666666667,0.9194867622923176,1.0,5/11,24.96%,RAB27A;KIF5C;TMEM230;KIF5A;SYNJ1
prerank,regulation of interleukin-6 production (GO:0032675),0.2693406094605497,0.8300366226265576,0.7599451303155007,0.973340850469167,1.0,12/96,12.34%,C1QTNF3;SYT11;TLR3;TLR4;ARRB1;IL17D;AFAP1L2;PTPN22;IL17RA;MAVS;RAB7B;PTPN11
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.23907655382605889,0.829958170385757,0.8562874251497006,0.9728718542465181,1.0,84/264,26.88%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;HNRNPA2B1;SNIP1;POLR2D;RBM15;SPEN;NOVA1;CCAR1;GPKOW;GTF2F1;CWC27;SRPK2;HNRNPL;SRSF11;PHF5A;CWC15;IK;USP49;PRCC;HNRNPC;SCAF11;SNRNP40;PRPF3;CPSF3;RBM4;HNRNPM;TFIP11;CWF19L1;USP39;FRG1;CSTF1;SRSF1;ZCRB1;FUS;PRPF6;HNRNPH3;PCF11;U2AF1;EFTUD2;CDC40;SRSF10;PRPF31;SNRPC;SF1;PNN;SRSF7;WBP4;POLR2G;SF3B2;SF3B1;SNRPA1;U2AF2;CPSF7;PPWD1;SF3B5;RNPC3;GCFC2;CDC5L;NUDT21;PQBP1;POLR2F;DDX41;GEMIN5;WBP11;LSM6;SNUPN;ZCCHC8;DHX8;SRSF4;DDX46;POLR2K;LSM3;SF3B3;RBM6;CTNNBL1;UBL5
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.35513629292776616,-0.8297734460914762,0.717391304347826,0.9200213176251761,1.0,3/13,10.39%,STAT3;IL6ST;JAK1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3597336221283003,0.82920706701344,0.6746166950596252,0.9736966457477285,1.0,3/18,9.64%,PRKN;SOD2;SIRT1
prerank,protein monoubiquitination (GO:0006513),0.31525933207941836,0.8291916638373282,0.6883333333333334,0.9731084482778891,1.0,4/36,7.97%,PRKN;CTR9;MGRN1;HUWE1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3127268374744212,0.8289736188149638,0.7090301003344481,0.9729222077594835,1.0,10/35,19.30%,POLD2;POLG;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;LIG1
prerank,response to molecule of bacterial origin (GO:0002237),0.278942989338015,0.8287188915428565,0.7438136826783115,0.9727745668772414,1.0,14/69,12.02%,CPS1;SMAD6;TLR4;FZD5;PTPN22;SRR;MAPKAPK3;TAB2;CYRIB;LY96;FER;TRIB1;ADAM17;NOCT
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.26805958860154006,0.82852870550311,0.7496423462088698,0.9725287939782788,1.0,7/93,6.39%,SH3RF2;TPD52L1;SASH1;CCN2;SPHK1;CD27;EIF2AK2
prerank,cholesterol homeostasis (GO:0042632),0.28226824219266833,0.828297844293282,0.7515625,0.9723920958488975,1.0,4/64,5.12%,RORA;IL18;GRAMD1B;APOM
prerank,regulation of pH (GO:0006885),0.39224580381240404,0.8280074323217482,0.664804469273743,0.9723864976546063,1.0,1/11,1.94%,LACC1
prerank,positive regulation of protein kinase activity (GO:0045860),0.25291880725922855,0.8279501350520176,0.7847938144329897,0.9718778999477408,1.0,18/148,11.05%,PRKAG2;ACE;EPHA4;ALS2;ADRA2A;DDX3X;CAMK1;CACUL1;IL12B;SLC27A1;DLG3;TGFBR2;GPRC5B;TAB2;JTB;NOX4;IRGM;CASS4
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3105987362289006,0.827918666361148,0.7124802527646129,0.9713273880027306,1.0,9/38,13.02%,ACE;EPHA4;DLG3;SH3BP5;GPRC5B;MVP;NOX4;CASS4;SRCIN1
prerank,thymus development (GO:0048538),-0.3450396520898782,-0.8275553903952337,0.6989898989898989,0.9234676805792135,1.0,3/13,8.15%,TBX1;HES1;SIX1
prerank,negative regulation of immune effector process (GO:0002698),0.38419087517492834,0.827478675529896,0.6742857142857143,0.9715671872381118,1.0,4/13,15.32%,CD300A;ENPP3;FER;LGALS3
prerank,positive regulation of cell cycle (GO:0045787),0.28080536588489585,0.8273740754479199,0.7488921713441654,0.971172188350247,1.0,9/62,11.77%,SMOC2;FGFR2;SPHK1;NUPR1;ANKRD17;CCND3;SRPK2;PRKCA;ADAM17
prerank,positive regulation of defense response (GO:0031349),0.2688593540574036,0.8273461385033787,0.7422535211267606,0.9706176267696548,1.0,18/89,17.70%,IL18;NAPEPLD;TLR3;TLR4;IFNK;IL12B;SERPINE1;PLSCR1;GPRC5B;IL17RA;RIPK1;NMI;IFI35;WNT5A;OPTN;CCR2;ZBP1;TNFRSF1A
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3046219254283941,-0.8272371348398965,0.7094430992736077,0.9233125819563544,1.0,6/24,13.91%,TRPS1;ACVRL1;ZBTB16;WNT9A;PTHLH;BMPR1B
prerank,negative regulation of telomere maintenance (GO:0032205),0.35926434336207114,0.827224865707338,0.6735459662288931,0.9702304950652683,1.0,7/15,23.30%,ATM;TNKS2;RAD50;NBN;SLX4;SMG6;PINX1
prerank,non-motile cilium assembly (GO:1905515),0.32130522659030925,0.8270021840897889,0.6932707355242567,0.9700498261251167,1.0,9/30,21.31%,CEP250;IFT122;IFT88;BBS10;GORAB;PIBF1;PCM1;TMEM17;FUZ
prerank,regulation of neurotransmitter secretion (GO:0046928),0.32031865889750144,0.826956955195571,0.6746575342465754,0.969523445130809,1.0,4/32,3.97%,SNCAIP;SYT11;LRRK2;DTNBP1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3080033076685044,-0.8269430899298852,0.6979405034324943,0.9231462277894796,1.0,5/20,18.24%,HSP90AB1;PROX1;PKD1;CCNY;RGCC
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.2775399207713042,-0.8268194865569025,0.7627551020408163,0.9226518028567726,1.0,5/29,10.52%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3675163909509103,-0.8267742784361237,0.7195652173913043,0.9220121652700087,1.0,4/12,16.62%,CCN3;NOTCH1;BDNF;TMEM119
prerank,regulation of intracellular transport (GO:0032386),0.30983520882548604,0.8263915719051319,0.7068403908794788,0.9700084890294169,1.0,8/38,15.96%,LRRK2;GAS1;MAP2;RAB11B;GRIPAP1;CRYAB;SCFD1;RBM4
prerank,cellular iron ion homeostasis (GO:0006879),0.2911872482367255,0.8261089577618974,0.7299382716049383,0.9699412196151614,1.0,2/55,1.24%,BMP6;CP
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.34329841607372413,0.8260961495166641,0.6889692585895117,0.9693551857004559,1.0,8/22,21.39%,SOX12;TNFRSF18;DUSP10;IRF1;FANCA;BCL6;CD46;CTLA4
prerank,indolalkylamine catabolic process (GO:0046218),0.3949912126537784,0.8260742296499053,0.6628352490421456,0.9687809222582973,1.0,10/10,60.53%,KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,negative regulation of interleukin-10 production (GO:0032693),0.3595383615755994,0.8247768279554131,0.6716697936210131,0.9707034213494793,1.0,3/16,10.33%,TRIB2;IL12B;CD274
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3490097757869652,-0.8247658791783866,0.6932773109243697,0.9250737562025383,1.0,4/12,14.75%,TASOR;TRIM28;ATF7IP;APOBEC1
prerank,protein deneddylation (GO:0000338),-0.37461299769950485,-0.824719817496228,0.6997971602434077,0.9244315803733303,1.0,4/10,27.68%,COPS4;COPS5;COPS6;COPS2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.34631059580473145,0.8243890525349921,0.6869409660107334,0.970856866588815,1.0,3/20,7.06%,WNT4;SIK1;SLC27A1
prerank,mitochondrial fission (GO:0000266),0.3632603957128028,0.8241593206960692,0.6774193548387096,0.9706993473454036,1.0,5/16,13.87%,PRKN;OPA1;MTFR2;DNM1L;DNM2
prerank,DNA-dependent DNA replication (GO:0006261),-0.21359570888884175,-0.8239495882976318,0.9069767441860465,0.9251454355558314,1.0,58/128,36.79%,POLA1;REV3L;PSMB2;PRIM2;POLD3;PSMD14;PSMC6;WRNIP1;PRIMPOL;UBB;TEFM;PSMB9;RPA1;ORC5;PSMA4;ORC2;CDC45;DNA2;PSMD11;PSMB10;RFC4;PSMD2;POLD4;POLD1;RFC2;PSMA2;BLM;UBC;RPS27A;RECQL5;PSMB3;RECQL;MCM6;RFC5;PRIM1;TOPBP1;PSMB5;MGME1;HELB;CDC7;RPA3;CDK2AP1;PSMD7;RAD51;PSMF1;RPA2;MCM4;MCM8;PSMA5;DDX23;PSME4;MCM10;PSMA7;GINS4;PSMD3;PSMD4;GINS1;ORC4
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3699333803788576,0.8230488097998776,0.662431941923775,0.9721811111923525,1.0,5/14,16.60%,NMNAT1;AK4;AK3;AK8;NMNAT2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2885072586762843,0.8227829392609818,0.7190332326283988,0.9721207163509069,1.0,8/52,11.50%,CELF2;DDX5;MBNL2;RBM15;NOVA1;THRAP3;SAP18;HNRNPL
prerank,protein-containing complex assembly (GO:0065003),0.2367436555484092,0.8225878072043887,0.8571428571428571,0.9718998085029423,1.0,62/259,19.91%,AFDN;PPARGC1A;PICALM;KMT2A;LAMC1;PLEKHA7;MCU;MITF;LRRK2;CAND2;SAMM50;SH3PXD2B;TP53;TRAPPC9;OPA1;ANO6;SMARCA4;TERT;TCF7L2;CSNK1A1;TLE1;DNM1L;TCF7;HDAC1;WDR19;TEAD2;RIPK1;WASL;ASH2L;TEAD1;VIL1;AXIN2;FANCA;KMT2D;TGFA;PML;STX5;PARD3;TLE2;F8;SEC23IP;PEX14;SCFD1;DNAJB14;CREBBP;SEC31A;YAP1;TRAPPC5;PPP6R3;RANBP9;TCF7L1;TNFRSF1A;ZNHIT6;ITGB1BP1;HFE;GOLGA2;FOLR1;AFG3L2;BET1;TUBGCP4;PYGO2;DBNL
prerank,negative regulation of bone mineralization (GO:0030502),-0.34563212215553374,-0.8223127311249044,0.7089397089397089,0.9274353271672456,1.0,4/13,15.42%,PTK2B;ECM1;ENPP1;RFLNB
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2918795324121755,0.8220788868559384,0.744945567651633,0.9723022132133894,1.0,7/57,9.38%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2346175284134568,-0.8217238755997135,0.8430769230769231,0.9277952217745642,1.0,29/72,36.03%,PSMB2;CARD14;MAP3K7;PSMD14;PSMC6;TIRAP;REL;PSMB9;RELB;PSMA4;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;MAP3K14;RELA;PSMB3;PSMB5;MALT1;PSMD7;PSMF1;CARD10;TNFSF15;PSMA5;PSME4;PSMA7;PSMD3;PSMD4
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3183505452964261,0.8211485410014718,0.7121212121212122,0.97349751364303,1.0,7/32,11.48%,AUTS2;AVIL;RREB1;PIK3CA;CARMIL2;CDC42;VIL1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3600230291261409,0.821050558589498,0.6836158192090396,0.9730762568598331,1.0,3/16,10.80%,WNT4;F2;SUCO
prerank,regulation of sequestering of calcium ion (GO:0051282),0.37934680207700194,0.8209371256199098,0.7048872180451128,0.9726689269637468,1.0,1/12,0.78%,ANK2
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3024354242639275,-0.820932255178209,0.7321428571428571,0.9285055686843205,1.0,6/21,13.79%,PDE4D;XDH;PDE2A;HINT1;NT5E;NT5C1A
prerank,negative regulation of potassium ion transport (GO:0043267),0.38715065739565024,0.8191085642440608,0.6872509960159362,0.9755441868196837,1.0,1/13,0.65%,ACTN2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3232811870592955,0.8190707747709668,0.7161172161172161,0.9750044278104275,1.0,4/26,6.09%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.30563144375669576,-0.8188728129124576,0.7171492204899778,0.930815388275583,1.0,10/21,31.15%,ERCC1;RPA1;GTF2H4;GTF2H1;GTF2H5;ERCC2;ERCC3;DDB1;RPA3;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.30563144375669576,-0.8188728129124576,0.7171492204899778,0.930815388275583,1.0,10/21,31.15%,ERCC1;RPA1;GTF2H4;GTF2H1;GTF2H5;ERCC2;ERCC3;DDB1;RPA3;RPA2
prerank,cellular protein catabolic process (GO:0044257),-0.24561975698590188,-0.8187760124640042,0.8273809523809523,0.9302943958009481,1.0,19/59,21.08%,FAP;DAB2IP;CTSC;UBE2G1;SIAH2;AP2B1;CTSB;CAPN2;AP2M1;CTSL;CTSS;VLDLR;CTSO;RSPRY1;HTRA2;CHEK2;CTSZ;UBE2G2;BNIP3
prerank,regulation of interleukin-12 production (GO:0032655),-0.253961371032886,-0.818543003774839,0.806970509383378,0.9299857977496254,1.0,13/47,23.54%,THBS1;FOXP1;PLCG2;IRAK3;CD47;TIRAP;CMKLR1;LAPTM5;SYK;IRF5;CCL19;LGALS9;MDK
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.35725488480735285,0.8184588057569814,0.6758747697974218,0.9755809020043829,1.0,3/15,9.03%,TLR4;IL17D;IL17RA
prerank,lipoprotein catabolic process (GO:0042159),-0.35546391498999685,-0.8183319913826173,0.7008032128514057,0.929670364498303,1.0,4/11,13.39%,APOE;CTSD;PPT1;ABHD17B
prerank,regulation of centrosome duplication (GO:0010824),0.32545348938006474,0.8172181722054029,0.7114754098360656,0.9773851317752716,1.0,9/29,20.84%,PKHD1;SIRT1;CHMP1A;ALMS1;CHMP4C;XRCC3;CEP120;CEP295;CHMP2A
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.23751439373966712,-0.8170840576047285,0.8222222222222222,0.9312038410872309,1.0,15/62,17.83%,TPT1;CXCL12;ARHGEF2;PPIA;ACKR3;RTKN2;TMBIM6;YBX3;CREB3L1;ARMC10;PINK1;CLU;DNAJA1;HSPB1;HTRA2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2791857290539265,-0.8169729372655975,0.7272727272727273,0.9306606294098545,1.0,8/28,22.15%,NOTCH3;BEND6;GATA2;LFNG;METTL3;DLL4;YTHDF2;TSPAN15
prerank,phagolysosome assembly (GO:0001845),0.3799917508046992,0.8168529813702652,0.678030303030303,0.9774876261874492,1.0,5/12,20.96%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,peptidyl-asparagine modification (GO:0018196),0.3190935759931372,0.8168177176606249,0.7142857142857143,0.9769419336202227,1.0,8/31,20.10%,ST6GAL1;ASGR1;FUT8;MAGT1;ASGR2;HIF1AN;DDOST;STT3A
prerank,ncRNA catabolic process (GO:0034661),0.324821189999087,0.8165816223861234,0.7064846416382252,0.9767971575303995,1.0,10/28,25.21%,TUT4;EXOSC7;SND1;DIS3;TENT4B;EXOSC3;DIS3L;POP1;XRN1;ZCCHC8
prerank,superoxide metabolic process (GO:0006801),0.3187866546570831,0.8155319293846689,0.7137745974955277,0.978177361704133,1.0,5/29,6.03%,ALOX12;SOD3;SH3PXD2B;SOD2;NOX1
prerank,morphogenesis of an epithelium (GO:0002009),-0.29371191384064,-0.8154955982158089,0.7292682926829268,0.9326736160300104,1.0,10/25,22.94%,ACTB;ACTG1;TBX18;LAMA3;AHI1;SOX8;VCL;LHX1;LRP6;SOX10
prerank,positive regulation of cellular respiration (GO:1901857),0.384688574541016,0.8154326444340069,0.6697936210131332,0.9777455178515898,1.0,1/11,2.86%,NUPR1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3629071691452751,-0.8152314706433336,0.7015209125475285,0.9324332658010953,1.0,5/10,27.83%,PTH1R;SNCA;IRS2;IRS1;PMAIP1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.32541819346374234,0.8145564957674098,0.719327731092437,0.9788292458324104,1.0,6/29,7.27%,KIT;F2;PDGFRB;EPHA8;FLT1;AMBRA1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.35518106498382856,0.8144667456647189,0.6933085501858736,0.9783975336166458,1.0,4/18,9.46%,FRS2;BHLHE41;HDAC1;HDAC4
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.291987508475398,-0.814176860289954,0.723404255319149,0.9337038613744489,1.0,7/26,17.81%,HECW2;CUL3;CDK5RAP2;DUSP1;LCMT1;CENPE;CDC23
prerank,sphingoid metabolic process (GO:0046519),0.37481332268277995,0.8136334836867362,0.6889312977099237,0.9793815756006308,1.0,2/12,5.26%,SPHK1;NAAA
prerank,positive regulation of transport (GO:0051050),-0.22557879525242872,-0.8135595933628665,0.8635014836795252,0.934044179868122,1.0,18/85,15.52%,ACTB;MERTK;GAS6;ACSL3;NEDD4L;GSK3B;ANXA1;RAB27A;APOE;GATA2;CALR;CD47;DOCK2;CYBA;CAPN10;SNCA;CD151;LMAN2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.35132858050850385,0.8132944587987045,0.6933797909407665,0.9794200932637405,1.0,4/19,5.73%,CUX1;OBSL1;CUX2;CAPRIN2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3675239156062425,0.8126669286655889,0.7003891050583657,0.9799898944542302,1.0,1/14,1.81%,PPARA
prerank,cellular response to mechanical stimulus (GO:0071260),-0.25294571587984954,-0.8123510571178731,0.8075949367088607,0.935543640292459,1.0,21/46,34.22%,PIEZO2;F11R;PIEZO1;PDE2A;FAS;CRADD;TMEM150C;CASP2;TLR7;BNIP3;MAP3K14;MAPK8;CD40;MAPK3;AQP1;BCL10;MAP2K4;TLR8;PTGER4;BAD;MYD88
prerank,positive regulation of histone acetylation (GO:0035066),0.32991918117653657,0.8122417172588747,0.7008403361344537,0.9802102174243086,1.0,6/23,17.01%,PPARGC1A;ARRB1;BRD7;KAT7;SPHK2;SMAD4
prerank,lymphocyte migration (GO:0072676),-0.27570623432946584,-0.8120018656554886,0.7475961538461539,0.9354448339853663,1.0,19/32,45.82%,S1PR1;MSN;RET;CCL13;CCL19;CCL2;MYO1G;CCL4;GATA3;CRTAM;CCL8;CCL14;CKLF;ADAM8;CCR6;CCL1;CCL3;CCL11;TBX21
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.33093912225396327,0.8117085781631044,0.7077464788732394,0.9806009269640518,1.0,2/21,3.86%,BACE2;DAG1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.31573983722792276,0.8116177458346797,0.7166666666666667,0.9801413964083454,1.0,4/31,9.08%,TFDP2;BID;TP53;TFDP1
prerank,outer dynein arm assembly (GO:0036158),0.3546144674795437,0.811423076507615,0.6878402903811253,0.9799107028932081,1.0,1/14,2.94%,ODAD1
prerank,positive regulation of protein metabolic process (GO:0051247),0.2569319758796885,0.811323098080674,0.8050139275766016,0.979484069251876,1.0,19/110,12.24%,ROCK2;PRKN;IL18;NEDD4;SLC6A9;IL17D;MAP2K5;TIPARP;APC2;IL12B;SMURF2;LDB1;HUWE1;ATG7;RNF41;FZR1;CSNK2A1;WWP2;ASB5
prerank,positive regulation of myelination (GO:0031643),-0.34936776055800106,-0.8112422292574256,0.7239263803680982,0.9360454245761127,1.0,2/11,7.26%,TENM4;TNFRSF1B
prerank,protein import (GO:0017038),0.2686067436012183,0.8111596966182703,0.7912408759124088,0.9791656398074978,1.0,26/84,24.92%,APPL2;TNPO1;LAMP2;SAMM50;PEX11B;IPO13;PXMP2;HSPA4;PEX14;RAB8B;ACBD5;PEX19;NUP155;PEX5;SLC25A17;PEX16;NUP188;TSC2;NUP153;SNX33;TNPO2;HEATR3;PRICKLE1;PEX26;PPP1R10;HIKESHI
prerank,negative regulation of immune response (GO:0050777),-0.20609565574149386,-0.8106133439419285,0.9539170506912442,0.9364619359159065,1.0,42/154,23.56%,CALCRL;ADCY2;ADCY7;GNG2;MYH9;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;IRAK3;HTR7;CYSLTR1;PTH1R;TRIM27;CYSLTR2;PRKAR2B;HAVCR2;PRKAR1B;HTR4;PTHLH;SAMSN1;RAMP1;GNB1;VIPR2;IAPP;TYRO3;SYK;PRKAR2A;ADCY3;ADCY8;GPR45;SIRT2;HRH2;NPSR1;YES1;ADCYAP1R1;FYN;LHCGR;RHBDF2;GPR176
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.34767810550514616,0.8103727154698717,0.6964618249534451,0.9800541620036655,1.0,3/17,6.56%,IL18;TLR4;IL12B
prerank,actin crosslink formation (GO:0051764),-0.3410981234590541,-0.8102835721978051,0.7313432835820896,0.9363287872829961,1.0,4/12,14.31%,FLNA;GAS2;EPS8;GAS2L3
prerank,defense response to protozoan (GO:0042832),0.37613051982532253,0.809904332942106,0.6666666666666666,0.9802993278585386,1.0,3/12,14.10%,GBP7;GBP2;GBP6
prerank,negative regulation of microtubule polymerization (GO:0031115),0.37550772860575315,0.8098765342171879,0.6912621359223301,0.9797504184150557,1.0,4/12,10.71%,EML2;MAP2;CDH5;DYRK1A
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3449467583673186,-0.8085777255855173,0.7109704641350211,0.9385698380430137,1.0,5/13,34.22%,PIK3AP1;TLR7;IRAK4;PIK3R4;MYD88
prerank,protein K63-linked deubiquitination (GO:0070536),-0.27118440858876736,-0.8081622770755632,0.7822784810126582,0.9386163741023534,1.0,8/31,18.81%,OTUD7A;OTUD7B;USP13;PSMD14;YOD1;USP50;USP8;SPATA2
prerank,positive regulation of receptor internalization (GO:0002092),0.33236455354977223,0.8073194663595546,0.6994818652849741,0.9839264826712565,1.0,4/22,9.42%,MAGI2;ARRB1;APLN;PICK1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.24870183380964817,-0.8072379900352326,0.7955801104972375,0.9395186299141969,1.0,9/47,12.07%,EPHB1;MID1;TGFB2;DAB2IP;PPIA;PHLPP1;FOXO1;RAP2A;FAS
prerank,positive regulation of protein catabolic process (GO:0045732),0.26568103862637216,0.806802310602056,0.7928057553956834,0.9842671591667191,1.0,21/84,15.63%,SH3D19;PRKN;ADRA2A;NEDD4;VGLL4;EZR;TIPARP;APC2;SMURF2;HUWE1;ATG7;RNF41;FZR1;CSNK2A1;WWP2;ASB5;STX5;NKD1;NRDC;FAF1;SNF8
prerank,tRNA modification (GO:0006400),0.2772944299685276,0.806714720732208,0.7589424572317263,0.9838414798888795,1.0,12/62,20.49%,TRMT9B;TPRKB;TRMT44;TYW1;METTL6;PUS10;LCMT2;PUSL1;WDR4;DTWD2;DUS2;ADAT2
prerank,neurotrophin signaling pathway (GO:0038179),0.3364763344040068,0.8065696340256145,0.6911764705882353,0.9834780169200746,1.0,3/21,3.63%,FRS2;MAGI2;CASP3
prerank,autophagy of nucleus (GO:0044804),0.3537689046134387,0.8064782256076222,0.7096188747731398,0.983041374821507,1.0,4/16,13.56%,ATG5;WIPI1;ATG7;ATG2A
prerank,cholesterol biosynthetic process (GO:0006695),-0.2734172748632787,-0.8057333042525617,0.7541371158392435,0.9414168738061185,1.0,15/31,27.00%,HMGCS1;IDI1;SC5D;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;FDPS;HMGCR;HSD17B7
prerank,positive regulation of endocytosis (GO:0045807),0.29245519647927976,0.8055626545733053,0.7477064220183486,0.984162433608662,1.0,2/45,0.66%,DAB2;APPL2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3886124006761178,0.8055564982992026,0.690566037735849,0.9823707966008268,1.0,2/11,8.47%,PANK1;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3886124006761178,0.8055564982992026,0.690566037735849,0.9823707966008268,1.0,2/11,8.47%,PANK1;DCAKD
prerank,coenzyme A biosynthetic process (GO:0015937),0.3886124006761178,0.8055564982992026,0.690566037735849,0.9823707966008268,1.0,2/11,8.47%,PANK1;DCAKD
prerank,response to reactive oxygen species (GO:0000302),-0.24365957318252462,-0.8055011756014924,0.8333333333333334,0.9411037345560841,1.0,24/54,32.93%,PTPRK;APOE;RPS3;APOD;CAMKK2;GLRX2;MAPT;HIF1A;CAT;GPX1;ROMO1;SOD1;FYN;PLK3;HYAL2;MAPK8;HMOX1;JUN;MAPK3;FOS;NCF1;COA8;PRDX3;STK25
prerank,positive regulation of T cell migration (GO:2000406),0.33991190921510067,0.8053596082405051,0.7129277566539924,0.98214264809466,1.0,5/20,17.33%,OXSR1;ADAM17;WNK1;WNT5A;CCR2
prerank,Golgi to lysosome transport (GO:0090160),-0.3505446533951918,-0.804376595849272,0.708502024291498,0.9423197505741124,1.0,3/11,16.20%,SORT1;LAPTM5;EHD3
prerank,spermatid development (GO:0007286),0.3101738585616803,0.8040758112219012,0.7235772357723578,0.983850052574037,1.0,9/32,25.35%,RNF8;TOPAZ1;MKKS;ACRBP;RFX2;CEP57;NECTIN2;TTC21A;ING2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.35275786906884177,0.8035526578106887,0.730909090909091,0.9842107424514096,1.0,1/17,0.64%,ROCK2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.298288463932102,0.803482440676859,0.7418856259659969,0.9837531547722885,1.0,3/36,3.48%,TPD52L1;DEPTOR;TGFBR1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3762479356595222,0.8032331090797226,0.695906432748538,0.983625918582913,1.0,3/12,11.81%,RNF8;LARP7;NELFCD
prerank,DNA dealkylation (GO:0035510),0.39035984479315855,0.8030790880522006,0.677734375,0.9826952979606837,1.0,3/10,16.53%,ASCC2;MGMT;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.39035984479315855,0.8030790880522006,0.677734375,0.9826952979606837,1.0,3/10,16.53%,ASCC2;MGMT;ALKBH5
prerank,histone H4 acetylation (GO:0043967),0.2868510307763572,0.8029038507232967,0.7366818873668188,0.9824168249946679,1.0,8/47,16.00%,KMT2A;BRD8;ZZZ3;ATF2;KAT7;OGT;BEND3;KANSL1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3546041958211662,0.8025176205162785,0.6946107784431138,0.982575757450734,1.0,5/15,20.18%,EME2;ATF2;HUS1;RAD9A;FANCD2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.22201335175023082,-0.8020160050519478,0.8566666666666667,0.945641909339643,1.0,17/83,20.12%,CDK14;CDK17;USP29;POLA1;PLK2;BACH1;CUL3;CDKN1A;E2F3;ACVR1;KLF11;EIF4E;PIM2;CDC45;NPAT;INHBA;PHF8
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.27986482981922933,0.8020020698996976,0.7611710323574731,0.9829083848629712,1.0,12/54,20.12%,PRKN;SPHK1;CFLAR;GPS2;RIPK1;ADAM17;BIRC3;RNF31;CLIP3;TNFRSF1A;TAX1BP1;PYDC1
prerank,negative regulation of reproductive process (GO:2000242),0.3429772459083038,0.8018933465042778,0.7134935304990758,0.9825033644416364,1.0,1/17,1.42%,IGF1
prerank,cellular response to cAMP (GO:0071320),0.31539096366951325,0.8017006789077705,0.7304347826086957,0.9822416911036634,1.0,4/30,5.70%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,activation of GTPase activity (GO:0090630),0.261913416150823,0.8003231682838925,0.7945007235890015,0.9842580889411323,1.0,13/89,10.92%,ARHGAP29;SIPA1L1;ARHGEF16;SYDE2;NGEF;TBC1D16;GMIP;APC2;BCAS3;DOCK7;GRTP1;RALGAPB;MTSS2
prerank,regulation of rRNA processing (GO:2000232),0.3583998665236362,0.8002668810523774,0.697841726618705,0.9837718780898341,1.0,4/16,18.04%,RIOK2;WDR43;KAT2B;BUD23
prerank,7-methylguanosine mRNA capping (GO:0006370),0.30549598407364265,0.8001201529937828,0.7269681742043551,0.9828396641143653,1.0,5/31,13.66%,POLR2A;POLR2D;GTF2F1;RAMAC;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.30549598407364265,0.8001201529937828,0.7269681742043551,0.9828396641143653,1.0,5/31,13.66%,POLR2A;POLR2D;GTF2F1;RAMAC;CMTR2
prerank,peptidyl-serine modification (GO:0018209),0.23737398322794812,0.79999052855013,0.8523748395378691,0.9824775277299752,1.0,27/166,13.33%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;IKBKE;SMG1;PRKCB;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;MKNK1;BRSK1;DYRK1A;SRPK2;PRKDC;PRKCA;CSNK2A2;CSNK2A1;HIPK3;PRKCI;WNK1
prerank,aerobic respiration (GO:0009060),0.32950147970864796,0.7987311023813504,0.7112299465240641,0.984235480218053,1.0,6/20,17.95%,SIRT3;MTFR2;UQCRC2;ATP5F1D;SDHB;UQCRC1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.33724635898213895,0.7982876903552422,0.7040441176470589,0.984487374287842,1.0,3/19,10.80%,WNT4;F2;SUCO
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.35204650615645205,0.7981416535892385,0.6970802919708029,0.9841679589771769,1.0,2/15,6.74%,UST;DSE
prerank,regulation of calcium ion import (GO:0090279),-0.2989665279774095,-0.7978724568702197,0.7664399092970522,0.951985935218451,1.0,6/21,22.31%,CXCL12;TRIM27;CTNNB1;SLC30A1;PLN;FYN
prerank,protein mannosylation (GO:0035268),0.3256363684031243,0.7976023668167851,0.7153024911032029,0.9845634323990158,1.0,5/22,12.64%,TMTC4;LARGE1;DPY19L3;TMTC1;LARGE2
prerank,regulation of centrosome cycle (GO:0046605),0.33158368663807836,0.7975327700898408,0.7305699481865285,0.9840793912470834,1.0,6/21,20.84%,PKHD1;SIRT1;CHMP1A;CHMP4C;XRCC3;CHMP2A
prerank,negative regulation of innate immune response (GO:0045824),0.30870745292031515,0.797478240789658,0.747457627118644,0.9836006462241447,1.0,9/34,14.26%,STAT2;SAMHD1;FAM3A;YTHDF3;DHX58;NMI;OAS3;ACOD1;USP18
prerank,regulation of DNA binding (GO:0051101),0.2906525382500299,0.7966468211053367,0.7631578947368421,0.9844806311583739,1.0,4/44,4.85%,IGF1;PRKN;FOXC1;SMO
prerank,nucleus organization (GO:0006997),-0.2436932423592827,-0.7964637249790978,0.8342541436464088,0.9536294844101122,1.0,6/47,12.05%,SYNE1;RPS19;BIN1;PITPNB;PDCD6IP;LEMD3
prerank,regulation of neurogenesis (GO:0050767),-0.2407056674580112,-0.7964163334713282,0.8305084745762712,0.9529753566888337,1.0,11/55,12.06%,B2M;NOTCH1;HES1;SERPINF1;SORL1;MME;HEYL;HEY2;NAP1L1;GPER1;CTNNB1
prerank,regulation of organelle organization (GO:0033043),0.2643796872664925,0.7962866114967965,0.7913669064748201,0.9845515058691657,1.0,17/80,18.83%,SYT11;STX18;PRKN;CPLANE2;EZR;ARMH3;DIAPH1;DNM1L;MAVS;STX5;TBC1D25;SQSTM1;VPS35;CENPV;PAK2;AKAP9;RHOT1
prerank,actin filament depolymerization (GO:0030042),-0.34710195500173224,-0.7959164765608597,0.7236580516898609,0.9530256773604573,1.0,4/11,13.30%,GSN;MICAL2;WDR1;CFL1
prerank,peptidyl-tyrosine modification (GO:0018212),0.2798607412090796,0.7958850665452715,0.8021472392638037,0.9847022280269737,1.0,12/56,13.96%,KIT;FGFR2;EPHA4;FGFR1;PDGFRB;FLT1;ABL1;FER;DYRK1A;TPST1;EPHA3;PDGFRA
prerank,L-serine metabolic process (GO:0006563),0.38612836496095065,0.7956022218597113,0.7017208413001912,0.9846295607200086,1.0,2/10,12.72%,SRR;PHGDH
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.33006306204294983,0.7952597816036929,0.7191201353637902,0.9846309473531167,1.0,4/20,10.98%,SMOC2;SULF2;APLN;SULF1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.27531915807471075,-0.7952332320402793,0.7818181818181819,0.953401811300714,1.0,1/29,0.38%,CADM1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3134538709500397,0.7951148873021188,0.7372742200328407,0.9843067248325134,1.0,3/30,6.42%,ST6GAL1;ASGR1;FUT8
prerank,response to X-ray (GO:0010165),0.35917951112554136,0.7950984044555839,0.7037037037037037,0.9837419126570326,1.0,3/14,9.33%,ATM;NIPBL;XRCC4
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.32686263602862314,0.7948966096424603,0.7084745762711865,0.9835035819622606,1.0,3/22,8.27%,DDX5;ATM;CDK5RAP3
prerank,microtubule anchoring (GO:0034453),0.3674143260370168,0.7948655975415793,0.6847014925373134,0.9829645287919324,1.0,5/12,18.35%,CLASP1;DAG1;PEX14;PCM1;SAXO2
prerank,response to lipopolysaccharide (GO:0032496),-0.20612507140572867,-0.794842286391047,0.9391304347826087,0.9533280157385567,1.0,25/138,17.57%,MEF2C;PDE4B;NOS3;SCARB1;TNFRSF11A;DAB2IP;FOXP1;GCH1;TNFRSF1B;IRAK3;ERBIN;RPS6KA3;VIM;TIRAP;NOS1;SNCA;SBNO2;CARD16;CX3CR1;PELI1;NOD2;LBP;CD180;TRIM41;PDCD4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.27192270015324216,-0.7947283469664045,0.7918660287081339,0.952782995867889,1.0,9/29,32.68%,PLA2G4A;LPCAT2;PLA2G12A;PLA2G4E;PLA2G4F;MBOAT7;DBI;PLBD1;PLB1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.22707279614102927,-0.7945787299827145,0.9126506024096386,0.9522953928052076,1.0,16/73,20.64%,KITLG;LMO2;RUNX1;PSMB2;GATA2;PSMD14;PSMC6;TCF12;TAL1;METTL3;PSMB9;PSMA4;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,protein heterotetramerization (GO:0051290),-0.3302642855327912,-0.7939129109933202,0.7718550106609808,0.9526653593267528,1.0,3/13,15.74%,GRIN2B;PKD1;GRIN1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.33386777823786096,-0.7936068795649274,0.737417943107221,0.9524395805266487,1.0,6/14,23.94%,TFAM;PNPT1;SLC25A33;TEFM;TFB1M;FASTKD5
prerank,protein insertion into membrane (GO:0051205),-0.2698941572912811,-0.7934685505114724,0.794044665012407,0.9519382528162094,1.0,9/32,27.30%,REEP1;APP;SEC61B;CYB5A;EMD;TRAM1;VAPA;STX1A;HMOX1
prerank,regulation of centriole replication (GO:0046599),-0.3130524547287925,-0.7933048338998206,0.7557077625570776,0.95148853818152,1.0,7/17,30.61%,PLK2;CDK5RAP2;TRIM37;NPM1;CEP76;STIL;BRCA1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.31707247044504916,-0.7931581018253409,0.7465437788018433,0.9509950539422217,1.0,3/15,10.83%,PRKCH;SFRP4;BMP4
prerank,inositol lipid-mediated signaling (GO:0048017),0.286220604135227,0.7931558104455843,0.7476635514018691,0.9854566468506238,1.0,12/50,13.96%,IGF1;PI4KA;FGFR1;EZR;PDGFRB;PLCD3;GAB2;PIK3CA;PLCD1;PITPNM2;OGT;PDGFRA
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2922723109852222,0.7930201862889648,0.7512437810945274,0.9850872787943307,1.0,6/40,11.58%,ATRX;DONSON;FBH1;FANCM;EME2;MSH3
prerank,DNA packaging (GO:0006323),0.34964904128998464,0.7927555056984138,0.7110266159695817,0.9849551036473823,1.0,7/16,27.37%,CHAF1B;TP53;CDAN1;NOC2L;H1-0;M1AP;RBBP4
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.237034350392882,-0.7926059687666502,0.8434065934065934,0.9512043616895891,1.0,18/51,29.45%,STAT3;APP;EGR1;AIM2;USP50;NOD2;HSPB1;PANX1;TYROBP;CCL19;PYCARD;LGALS9;TMED10;TRIM16;JAK2;P2RX7;MALT1;CD36
prerank,translational termination (GO:0006415),0.2526134153863924,0.792464658123649,0.810966810966811,0.9849002035679688,1.0,30/95,26.70%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;ETF1;MRPS26;GSPT2;MRPL48;MTRF1L;MRPL1;GFM2;MRPL45;MRPS17;MTRF1;CHCHD1;N6AMT1;MRPL32;MRPL14;MRPL23;GSPT1;MRPS34;PTCD3;MRPL50;MRPS25;MRPL19;MRPL33;MRPS18B;MRRF
prerank,negative regulation of coagulation (GO:0050819),0.3615997248698022,0.7919354592826529,0.7113207547169811,0.9852564100664376,1.0,3/14,7.10%,TFPI;KNG1;SERPINE1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3395061663699498,-0.7918955894384474,0.7104722792607803,0.9516265753559707,1.0,3/12,15.47%,ABCC9;KCNJ8;CACNA1H
prerank,negative regulation of inflammatory response (GO:0050728),0.23425819932024985,0.791823433292233,0.8641509433962264,0.9848553710128738,1.0,12/182,8.13%,RORA;C1QTNF3;ADCY5;IGF1;PPARA;ADCY1;METRNL;GPS2;ENPP3;ADCY9;MC2R;ADM
prerank,bone morphogenesis (GO:0060349),0.35697400648499467,0.7917774289389183,0.7140186915887851,0.9843521754954482,1.0,2/14,4.73%,FGFR2;CYP26B1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.29119620222178294,0.7914805727853703,0.7642276422764228,0.9842931054217516,1.0,9/42,17.08%,TLR4;DEFB1;F2;IL12B;SERPINE1;IRGM;CAMP;OPTN;DMBT1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3636673207420411,0.7914119543748674,0.7346534653465346,0.983828709012866,1.0,2/12,6.42%,GMDS;FUT8
prerank,selective autophagy (GO:0061912),0.27636985714780393,0.7913471391186453,0.7940717628705148,0.9833590469156819,1.0,17/56,20.96%,PRKN;RETREG1;ATM;ATG5;AMBRA1;BECN1;IFT88;ATG2A;ACBD5;TEX264;PEX5;SQSTM1;DYNC1LI1;PCNT;UBA5;WDR81;RAB7A
prerank,pre-miRNA processing (GO:0031054),0.356242828239529,0.7908565619355913,0.7225325884543762,0.9836561382789242,1.0,6/14,26.22%,TUT4;DICER1;TUT7;AGO1;AGO2;AGO4
prerank,protein depolymerization (GO:0051261),0.3090699789771763,0.7905786026142143,0.7443478260869565,0.9835639026020758,1.0,2/27,1.77%,MICAL3;KIF2A
prerank,negative regulation of cilium assembly (GO:1902018),-0.34231433358852575,-0.7901794861702742,0.7703549060542797,0.9536457197004881,1.0,5/12,24.94%,TBC1D30;LIMK2;MAP4;ODF2L;CCP110
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3265919211597164,0.790124546254352,0.7413793103448276,0.9837669636851831,1.0,3/22,7.97%,APPL2;LRRK2;KDM2B
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.35352985271615,-0.7896882983152224,0.7278761061946902,0.9522334813813037,1.0,4/10,22.49%,ERCC1;TERF1;DNA2;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.35352985271615,-0.7896882983152224,0.7278761061946902,0.9522334813813037,1.0,4/10,22.49%,ERCC1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),-0.35352985271615,-0.7896882983152224,0.7278761061946902,0.9522334813813037,1.0,4/10,22.49%,ERCC1;TERF1;DNA2;BLM
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2817859957196609,-0.7895819485870111,0.804147465437788,0.9516773049196727,1.0,7/23,21.84%,GAS6;VSIR;HAVCR2;LAPTM5;INHBA;NR1H4;LGALS9
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.26531333329580353,0.7895142627925511,0.7851851851851852,0.984249693991386,1.0,1/74,0.14%,EPAS1
prerank,regulation of intracellular protein transport (GO:0033157),0.3021594626331173,0.7893705779965243,0.7600644122383253,0.9839175711794449,1.0,4/32,6.66%,PTPN14;IFI27;RUFY3;BCAS3
prerank,cell junction maintenance (GO:0034331),0.3573255803020516,0.78923712502844,0.7171171171171171,0.9835707632567329,1.0,1/14,2.52%,NLGN2
prerank,reticulophagy (GO:0061709),-0.34177812742578734,-0.7889853474550628,0.7484407484407485,0.9519268016642001,1.0,4/12,9.94%,ULK1;ULK2;DDRGK1;UFM1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3211825233454573,0.788937495004602,0.7451669595782073,0.9835049392295836,1.0,4/22,11.91%,FZD5;IL12B;CYRIB;ZBTB1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.36112544239246724,-0.7888874425885943,0.7703549060542797,0.9513701249606504,1.0,3/10,15.96%,PODXL;PIEZO1;SKAP1
prerank,negative regulation of cartilage development (GO:0061037),0.3630312811857113,0.7887722950674562,0.7170923379174853,0.9832161451056572,1.0,3/13,14.21%,TGFBR1;PTPN11;ADAMTS7
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24425046411910253,0.7884312146891264,0.8590078328981723,0.9832241436047414,1.0,17/144,10.20%,SMAD3;TFDP2;LEPROT;BID;RAPGEF3;RUFY3;FZD5;CAMK1;TP53;BCAS3;HUWE1;ZIC1;TCF7L2;TFDP1;UBR5;NPEPPS;MAVS
prerank,regulation of translation (GO:0006417),-0.1964989203942468,-0.7883923336619796,0.9754098360655737,0.9514493004205805,1.0,42/173,21.72%,GRM5;PRR16;THBS1;NIBAN1;YBX1;RPL26;APP;RPS3;RPL5;SYNCRIP;CALR;ERBB2;RPS6KA3;FXR1;EIF4ENIF1;RPS4X;VIM;DAPK1;EIF3B;MALSU1;SHFL;RPS6KA1;MTG2;GLE1;EIF1;METTL3;DHX9;EIF2AK3;EIF4E;HSPB1;RPL13A;BCL3;EEF2;RPS27L;BTG2;PUM3;EIF4A3;EIF3D;RBM4B;RBM3;CNOT7;NPM1
prerank,negative regulation of complement activation (GO:0045916),-0.3580114809245609,-0.7883888175420452,0.7379032258064516,0.9507300800047236,1.0,4/10,36.31%,SUSD4;A2M;CR1L;SERPING1
prerank,regulation of chromosome organization (GO:0033044),0.324041210710861,0.7881616958607716,0.7316636851520573,0.9831401260080583,1.0,8/22,22.29%,HDAC8;SMG1;WAPL;RB1;CENPV;LIG4;YLPM1;SMG6
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37304960950838506,0.7877920484495528,0.7098039215686275,0.9831886421468754,1.0,4/10,17.98%,TKFC;DHX58;UFD1;NPLOC4
prerank,autophagy of mitochondrion (GO:0000422),0.29355432970449985,0.7877650250344281,0.7629032258064516,0.9826464147882974,1.0,7/38,13.56%,PRKN;ATG5;WIPI1;AMBRA1;ATG7;BECN1;ATG2A
prerank,microtubule anchoring at centrosome (GO:0034454),0.3785803385702769,0.7877491128595229,0.7120622568093385,0.9820834588049129,1.0,3/10,18.05%,NINL;HOOK3;PCM1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.29707487873453503,0.7869516365587206,0.7392,0.9828523896343082,1.0,7/35,12.56%,ATM;ACD;HNRNPA2B1;TNKS2;AURKB;FBXO4;PNKP
prerank,regulation of fibroblast proliferation (GO:0048145),0.2816502715168273,0.7868177607695213,0.792,0.9825069094223956,1.0,5/45,6.65%,IGF1;SPHK1;CD300A;PARP10;TP53
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.2676325564428172,-0.7864335109556169,0.7888631090487239,0.9531546487946817,1.0,9/29,24.34%,SMAD7;RPS2;AXIN1;ARRDC4;PINK1;DCUN1D3;BAG5;TRIB3;ARRDC3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2589279322382141,0.7847849766447996,0.814388489208633,0.9854888258978053,1.0,16/78,18.23%,CCNA2;NR2F2;CCNA1;CCNT2;PTEN;CCND3;CDK5RAP3;CDC25A;CCNB2;GTPBP4;ADAM17;GADD45A;CCNG1;CCNE1;CNPPD1;HEXIM2
prerank,purine-containing compound catabolic process (GO:0072523),0.3658712077860976,0.784763537715654,0.7210626185958254,0.9849491468888442,1.0,3/13,10.31%,DPYD;NT5C1B;NT5C2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.20402306204746912,-0.7845842471152003,0.9547325102880658,0.9554112623136711,1.0,33/132,21.33%,CELF4;HSP90AB1;RPL3;RPL38;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;HSP90AA1;RPS27;XRCC5;SART1;RPS5;RPL6;CLNS1A;MDN1;NOP53;DHX9;SNRPF;RPSA;BRIX1;MRPL20;CDC73;COIL;RPS27L;PTGES3;RPL24;SNRPD3;RPL11;LSM4;RSL24D1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2622546030082057,-0.7845542537977795,0.7911547911547911,0.9547307370318534,1.0,3/33,4.34%,HIP1;BCAR3;CCDC88A
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.27353686378635234,0.7843219539065284,0.812111801242236,0.9851052402544004,1.0,7/59,10.38%,ROCK2;TLR3;TLR4;TAB2;RIPK1;RIPK2;LY96
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.37301464182177485,0.7838677889731303,0.6948818897637795,0.9852974104161025,1.0,3/10,11.60%,ERRFI1;MVP;IMPACT
prerank,copper ion transport (GO:0006825),-0.3454589501436654,-0.7837147719156924,0.7638603696098563,0.9552897739673241,1.0,6/11,31.39%,ATOX1;SLC31A1;COX17;CUTC;STEAP4;ATP7B
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24102593957289595,-0.7835081058338942,0.8461538461538461,0.9549146696121863,1.0,31/45,45.16%,STAT3;APP;EGR1;AIM2;USP50;NOD2;HSPB1;PANX1;TYROBP;CCL19;PYCARD;LGALS9;TRIM16;JAK2;P2RX7;MALT1;CD36;TLR8;MYD88;GBP5;ISL1;TMEM106A;CASP8;INAVA;NLRP12;IL6;TNF;GSDMD;LILRA5;F2RL1;CCL3
prerank,positive regulation of viral life cycle (GO:1903902),0.3205686504337795,0.7829302356733526,0.743801652892562,0.9863119434868202,1.0,6/22,20.84%,LGALS1;KPNA6;AXL;VPS4A;FMR1;CHMP2A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.31533774239456647,0.7828030037382931,0.735494880546075,0.9859639195184535,1.0,5/23,11.64%,PARP14;PIAS1;PARP9;IRGM;SOCS3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.30224517505749415,-0.7824585315332175,0.7543859649122807,0.9557485842668731,1.0,4/18,10.39%,ST18;STAT3;IL6ST;JAK1
prerank,dendritic cell migration (GO:0036336),-0.30973982745679457,-0.7823882960522667,0.7757437070938215,0.9551512986660065,1.0,8/16,42.98%,EPS8;TRPM2;CCL19;CXCR4;PIK3CG;CCR1;CCR6;CXCR2
prerank,response to cAMP (GO:0051591),0.2910312778375105,0.7823637357364387,0.7714285714285715,0.9861362820250174,1.0,4/37,5.70%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2860903933963421,-0.7821328532151987,0.7654028436018957,0.9548334868123632,1.0,13/23,31.56%,SLIT2;MPP1;TIRAP;CD74;CCL19;DAPK2;THBS4;MDK;BST1;JAM3;C5AR2;MOSPD2;RAC2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2754594007222637,-0.7816435774745193,0.8028846153846154,0.954868018607192,1.0,5/26,12.49%,CAV1;RTN4;MFHAS1;CYBA;TIRAP
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.19343698475561036,-0.7809975466665438,0.9753694581280788,0.9551759657757448,1.0,68/184,30.25%,HECW2;YWHAE;PSMB2;DYNLL1;PPP2R1A;YWHAG;ANLN;CUL3;PSMD14;TUBA1A;HAUS2;CDK5RAP2;ID2;TUBB4A;PSMC6;KCNH5;HSP90AA1;PKD1;PRKAR2B;BUB3;UBB;PSMB9;HAUS5;CEP78;PSMA4;CENPE;CETN2;CDC23;SKP1;RGCC;TUBA4A;SSNA1;PSMD11;PSMB10;PSMD2;SIRT2;ERCC2;CEP131;PSMA2;MAD2L1;UBC;RPS27A;TFAP4;HMMR;KNTC1;KIF14;NEDD1;NEK6;HAUS4;PSMB3;TPX2;NDE1;CCP110;CEP135;ACTR1A;HAUS6;CEP76;UBE2D1;PSMB5;CENPF;APPL1;ERCC3;DDB1;PSMD7;CEP43;PSMF1;AURKA;CDK1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.341013962291021,-0.7803355000085253,0.7631578947368421,0.9554850117100018,1.0,2/11,7.67%,RUNX1;VSIR
prerank,positive regulation of proteolysis (GO:0045862),0.27019351802396324,0.780005049105018,0.7916666666666666,0.9895895324314667,1.0,7/55,8.27%,SH3D19;ADRA2A;CTSH;CLN6;FBXW11;ANGPTL8;BTRC
prerank,protein localization to condensed chromosome (GO:1903083),0.37009155829411167,0.7798210870096108,0.7455621301775148,0.9893251259354024,1.0,3/12,12.48%,AURKB;IK;CHAMP1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.22826732601261107,0.7793458841964288,0.8919597989949749,0.9895502631815846,1.0,20/208,10.20%,RORA;WLS;LPAR1;PRKN;CFLAR;AKAP13;CXXC5;ZFAND6;IKBKE;PRKCB;ANKRD17;LGALS1;GPRC5B;PDPK1;TLE1;TAB2;SIRT1;RIPK1;RIPK2;MAVS
prerank,nuclear membrane organization (GO:0071763),-0.29439791736521786,-0.7793385409942198,0.8014354066985646,0.956339706990668,1.0,6/19,25.67%,GPER1;TMEM43;EMD;SPAST;CHMP4B;UBXN2B
prerank,DNA biosynthetic process (GO:0071897),-0.31510182302332546,-0.7792784335269308,0.8,0.9557134833261055,1.0,4/16,11.86%,POLA1;PPIA;POLD3;WRNIP1
prerank,RNA transport (GO:0050658),0.26107779834625044,0.779217807863413,0.8355957767722474,0.9891990640605006,1.0,20/71,20.72%,NXF2;SRSF5;SIDT2;POLDIP3;HNRNPA2B1;TGFBR2;SIDT1;ATXN2;NXF1;SRSF11;ZFP36L1;SARNP;NUP155;SRSF1;NUP188;U2AF1;CDC40;FMR1;NUP153;SRSF7
prerank,mitotic DNA replication (GO:1902969),-0.3470405376523469,-0.7789968691296965,0.7298387096774194,0.9554247232065485,1.0,1/10,2.36%,POLA1
prerank,keratan sulfate metabolic process (GO:0042339),0.29474731230486506,0.7789436867479337,0.759581881533101,0.9890785712072755,1.0,4/31,6.09%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3466863046985987,-0.7787847595551253,0.759656652360515,0.9550352025427432,1.0,1/10,2.35%,THBS1
prerank,endocytic recycling (GO:0032456),0.27575020932963823,0.7786730680737074,0.7841614906832298,0.9889622278259701,1.0,15/50,18.90%,PTPN23;EIPR1;VPS26C;RAB11B;RAB13;VPS50;ANKRD27;SNX12;MICALL1;SNF8;VPS51;VPS35;CCDC93;VPS35L;CCDC22
prerank,glycolytic process (GO:0006096),0.3054245634013532,0.7781553394676586,0.7542955326460481,0.989271161542948,1.0,3/28,7.09%,HK2;PGAM2;GCK
prerank,protein targeting (GO:0006605),0.24252055522744684,0.7775215672588482,0.8519021739130435,0.9897615830887927,1.0,29/118,19.89%,TRAK1;KIF13B;LAMP2;ZFAND6;RAB3IP;FUT10;TIMM44;PIKFYVE;TOMM70;ZDHHC18;ZDHHC1;MYO1C;PRKCI;MFN2;PARD3;PITRM1;MICALL1;VPS37A;PEX19;ARL6;TIMM10;RABGEF1;PEX16;AP4M1;TRAK2;ZDHHC23;KATNB1;TIMM17B;LTBP2
prerank,positive regulation of ATPase activity (GO:0032781),0.2827857552754167,0.7772938580608015,0.7587939698492462,0.9895747463588851,1.0,6/41,11.58%,ATP1B3;TPM1;PLSCR1;MYL4;SSBP1;MSH3
prerank,amide biosynthetic process (GO:0043604),-0.24165103230117443,-0.7771672724980065,0.8542274052478134,0.9568809595404887,1.0,8/47,11.54%,SGMS1;SGMS2;SPTLC2;DEGS2;PCSK5;PAM;CERS4;ASAH2
prerank,regulation of lipid kinase activity (GO:0043550),0.37151279337434157,0.7769738844920504,0.7094972067039106,0.9895263561347655,1.0,7/11,20.44%,F2;RBL2;RBL1;PIK3R3;WDR91;RB1;WDR81
prerank,response to interferon-beta (GO:0035456),0.3180600130096175,0.7764645837225762,0.7417677642980935,0.9898079750294674,1.0,7/22,17.46%,IKBKE;PLSCR1;IRGM;IRF1;ACOD1;IFNAR2;CDC34
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3633992738846945,0.7764250971966044,0.703921568627451,0.9892939627782044,1.0,1/11,2.02%,PRKN
prerank,lysosome localization (GO:0032418),0.2843629281596422,0.7762277846782312,0.7761194029850746,0.9890622231648795,1.0,5/37,13.91%,KIT;RAB34;BLOC1S2;KIF5B;FLCN
prerank,cellular response to estrogen stimulus (GO:0071391),-0.31609715993642873,-0.7761711499533754,0.781038374717833,0.9576529127310665,1.0,5/14,23.31%,AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,cellular copper ion homeostasis (GO:0006878),-0.3212749512833215,-0.7753607289197256,0.7726269315673289,0.958221779524035,1.0,4/14,20.56%,APP;ATOX1;SLC31A1;MT2A
prerank,negative regulation of protein binding (GO:0032091),0.2611824219732064,0.7750133456551263,0.8242245199409158,0.9905613868083694,1.0,19/71,19.48%,DAB2;IFIT1;IFIT2;LRRK2;MAP2;CAMK1;GTF2F1;AURKB;TMC8;STYX;EFHB;DNAJB2;PEX14;TFIP11;KDM1A;ITGB1BP1;HFE;USP33;GOLGA2
prerank,negative regulation of secretion (GO:0051048),0.37674916454994756,0.7747007351296621,0.7425149700598802,0.9904960448827151,1.0,4/10,22.74%,NRG1;SPX;NR1H3;VAMP8
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3717277647625994,0.7746715948072624,0.7190569744597249,0.9899668955045067,1.0,3/11,14.91%,NUPR1;RIPK1;BIRC3
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2900855588164147,0.7746390432442444,0.768976897689769,0.9894542924529989,1.0,13/37,22.30%,PRKN;RIN3;SIRT5;ATXN2;ITGAV;NCOR1;NFKB1;OPTN;PTX3;ABCA2;SDCBP;ANKRD13B;ANKRD13D
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2652948809409159,0.7745516899244147,0.8101851851851852,0.9890287029328162,1.0,15/63,19.63%,LEPR;TIMP3;NUPR1;PTPN22;CDK5RAP3;TAB2;ATRAID;RGP1;ZKSCAN3;TLK2;MCL1;EIF4G1;TBC1D14;GOLGA2;EIF4G2
prerank,nuclear transport (GO:0051169),-0.30628269844021316,-0.7744201561012403,0.7713097713097713,0.958933372066953,1.0,6/16,21.72%,XPO1;ANP32A;RBM15B;BANF1;NXT1;NPM1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.24942846578363134,0.7742042026288959,0.8343023255813954,0.9890075904475243,1.0,14/94,13.86%,DDX5;ITPR1;FHIT;PRODH;IKBKE;ATM;DDX3X;TP53;ABL1;PRKDC;CUL4A;PPP1R13B;PML;MLLT11
prerank,regulation of type I interferon production (GO:0032479),0.251901131173528,0.7739088411001132,0.8212765957446808,0.9889382349773551,1.0,27/84,24.50%,PCBP2;IKBKE;RNF135;TRIM56;PTPN22;MAVS;DHX58;PRKDC;IRF1;POLR3A;DHX33;ACOD1;NFKB1;STAT6;CREBBP;UFD1;ZBP1;NPLOC4;CD14;TAX1BP1;TRAF3;EP300;PQBP1;POLR2F;POLR3H;POLR3G;DDX41
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.23548953092436087,-0.7734677995208664,0.8950437317784257,0.9596516575743196,1.0,17/56,23.08%,NOD1;ALPK1;PLCG2;SFTPA2;SFTPA1;MAP3K7;CTSB;RPS6KA3;CTSL;CTSS;UBB;NOD2;LBP;TIFA;TLR7;UBC;RPS27A
prerank,somite development (GO:0061053),0.36282841088791995,0.773373971313371,0.7270955165692008,0.9892781446478977,1.0,2/11,4.85%,LOXL3;SMO
prerank,positive regulation of immune system process (GO:0002684),-0.3047174453671776,-0.7732118027098335,0.7857142857142857,0.9593188471047478,1.0,5/16,24.16%,TGFB2;ANXA1;VEGFA;LGALS9;PIK3CD
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3538133899635153,0.7730993347847718,0.7279549718574109,0.9891763823723192,1.0,3/13,11.81%,RNF8;LARP7;NELFCD
prerank,response to UV-B (GO:0010224),-0.3379842596417791,-0.7721237922566003,0.7635270541082164,0.9602355568267777,1.0,6/12,24.27%,MME;MFAP4;CRIP1;CDKN1A;HYAL2;RELA
prerank,telomere organization (GO:0032200),0.27826451209952996,0.771677967561431,0.8009188361408882,0.9908903981984323,1.0,13/43,21.00%,POLD2;ATM;ACD;TERT;PRKDC;HUS1;RAD50;DOT1L;SP100;TINF2;NBN;RAD51D;PARP3
prerank,ether lipid metabolic process (GO:0046485),-0.3182980422147246,-0.7716589314062975,0.7526427061310782,0.9601921979210198,1.0,5/14,25.60%,AGPS;NCEH1;LIPE;GNPAT;DHRS7B
prerank,cell cycle G2/M phase transition (GO:0044839),0.23689386418160605,0.771036124990191,0.8751660026560425,0.9914025034067597,1.0,28/129,19.72%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;ALMS1;DNM2;CEP63;OPTN;PCM1;CEP57;AKAP9;PCNT;FBXL22;CEP164;TAF2;OFD1;DCTN3
prerank,regulation of cytokinesis (GO:0032465),0.2506584995183688,0.770755347742413,0.8636363636363636,0.9913098745637836,1.0,18/78,19.15%,PKP4;UVRAG;PLK5;CDC14A;MYO19;BECN1;AURKB;CDC14B;CDC42;ZFYVE26;FLCN;VPS4A;BIRC6;CHMP4C;CENPV;MAP9;PKN2;KIF13A
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2985562288199445,0.7705547690105619,0.7783595113438045,0.9910679628331603,1.0,8/31,20.26%,CYP21A2;FDXR;DHRS11;MOCOS;SRD5A2;NFS1;MOCS1;LIAS
prerank,positive regulation of double-strand break repair (GO:2000781),0.2853159756546893,0.7702637954285264,0.7725806451612903,0.9910135275153058,1.0,10/39,18.34%,ARID2;KMT5C;KMT5B;PARP9;PRKDC;PNKP;MGMT;SMCHD1;FUS;MMS19
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.22449557738688372,-0.7702200042463826,0.8698412698412699,0.9616110176246568,1.0,30/72,31.15%,POLD3;AQR;ERCC1;ERCC6;POLR2J;UBB;COPS4;RPA1;COPS5;GTF2H4;GTF2H1;COPS6;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLK;POLR2L;UBC;RPS27A;RFC5;COPS2;ERCC3;DDB1;RPA3;XAB2;RPA2
prerank,negative regulation of catabolic process (GO:0009895),-0.23594803460908215,-0.7697489468015071,0.870026525198939,0.9615759720021331,1.0,14/47,23.42%,PDE3B;FMN2;CST3;FLNA;IRAK3;CBFA2T3;PFKFB1;ADGRB1;TIGAR;SIRT2;CYP51A1;GIT1;MAD2L1;PRKAA1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3120126089574603,0.7693313711458045,0.7538994800693241,0.991965240328037,1.0,4/28,10.20%,SMAD3;ZIC1;UBR5;MAVS
prerank,positive regulation of response to stimulus (GO:0048584),-0.24549024317008028,-0.7687480197475342,0.8427835051546392,0.9623323269959212,1.0,11/40,20.48%,TGFB2;B2M;FXR1;ABI3;HOMER1;ILK;SELENON;DHX9;CDKN2AIP;NSMCE1;NSMCE4A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.350137280010714,0.7683774112555938,0.7358490566037735,0.9929135888720004,1.0,2/13,10.34%,IL12B;CYRIB
prerank,tricarboxylic acid metabolic process (GO:0072350),0.36157522162183575,0.7683528097150988,0.7388888888888889,0.9923850760006623,1.0,5/12,20.71%,IDH1;ACO2;SIRT4;IDH2;ACLY
prerank,fluid transport (GO:0042044),-0.32491237989937544,-0.7682842705147046,0.7578947368421053,0.9622690248441211,1.0,2/12,7.46%,AQP4;AQP11
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.280994919071136,-0.7680744569825251,0.8032036613272311,0.9611281769209136,1.0,4/22,12.19%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.280994919071136,-0.7680744569825251,0.8032036613272311,0.9611281769209136,1.0,4/22,12.19%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.32246079466150024,0.7680678341681824,0.7698961937716263,0.9922933282041757,1.0,4/22,7.39%,CD300A;EZR;GPS2;PTPN22
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.34318168711260155,-0.7679455965011072,0.7637969094922737,0.960610979355348,1.0,1/10,0.63%,PRKCH
prerank,protein processing (GO:0016485),0.24600617293458407,0.7678952655086749,0.8531157270029673,0.9920122141857033,1.0,14/102,15.47%,AEBP1;KLK2;CTSH;SRGN;METAP2;RCE1;APH1B;MMP14;ADAM17;OGT;PCSK7;SDE2;PITRM1;ZMPSTE24
prerank,telomere maintenance via telomerase (GO:0007004),-0.2674456870816868,-0.7677568597627517,0.8329177057356608,0.960180696725783,1.0,9/28,20.38%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;PTGES3;NHP2
prerank,regulation of protein localization to centrosome (GO:1904779),0.3643038482456333,0.7677005100511588,0.7225433526011561,0.9917534053324212,1.0,1/10,2.95%,CEP250
prerank,transport along microtubule (GO:0010970),-0.3245036647207588,-0.7674780188839543,0.7773019271948608,0.9598924768937646,1.0,2/13,6.92%,APP;DYNC1I1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3088700040671276,0.7674225072517343,0.775,0.9916266973883906,1.0,5/27,7.27%,KIT;PDGFRB;EPHA8;FLT1;AMBRA1
prerank,response to interferon-alpha (GO:0035455),-0.3031214282655761,-0.7673277957615253,0.8175675675675675,0.959409597638621,1.0,3/16,11.76%,GAS6;RO60;IFITM3
prerank,bile acid biosynthetic process (GO:0006699),0.3117879657438354,0.7668164115813603,0.7689530685920578,0.9920377321712245,1.0,3/24,6.15%,CYP27A1;AMACR;OSBPL9
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.327970878977013,0.7663706691205063,0.75,0.9921714913278775,1.0,10/18,30.47%,COX16;SMIM20;COX19;FASTKD3;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3077694073825014,-0.7663542734224494,0.7902097902097902,0.9600748228863039,1.0,5/15,27.99%,ENTPD1;CMPK1;ENTPD2;CMPK2;ENTPD3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3021257141275334,0.7654869899707241,0.7653239929947461,0.9930169392633608,1.0,4/23,12.31%,PKHD1;FBXW11;HTT;MISP
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.24523486849089926,0.7654415502421489,0.8608695652173913,0.9925217152965672,1.0,24/87,22.94%,NDUFAF4;SAMM50;NDUFAB1;UQCC1;NDUFS1;COX16;NDUFV2;FOXRED1;SMIM20;LYRM7;SDHAF4;NDUFAF5;COX19;TIMMDC1;DMAC2;NDUFS4;NDUFA2;TMEM126B;FASTKD3;NDUFAF7;NDUFS5;NDUFB2;NDUFA9;TIMM21
prerank,regulation of defense response to virus (GO:0050688),0.34904075183141237,0.7654060188373845,0.7385496183206107,0.9920040360793154,1.0,4/14,20.16%,PCBP2;PPM1B;ZMPSTE24;TRAF3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.2905339134918189,0.7642251512093908,0.7860780984719864,0.9933869703943428,1.0,2/33,1.78%,DDX5;KLK2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.3674691042469701,0.7639999293931674,0.7063339731285988,0.9931728800433526,1.0,2/10,19.71%,CTNS;ATP7A
prerank,regulation of interleukin-8 production (GO:0032677),0.25748670447059546,0.7639250429960606,0.8516949152542372,0.9927229993034861,1.0,11/69,10.20%,TLR3;SSC5D;TLR4;ARRB1;IL17D;MAP2K5;SERPINE1;AFAP1L2;PTPN22;RIPK1;MAVS
prerank,amino sugar metabolic process (GO:0006040),-0.3452844981208329,-0.7626661904841204,0.7647058823529411,0.9647063401463879,1.0,3/10,11.50%,CSGALNACT1;ST3GAL1;GFPT2
prerank,regulation of mRNA catabolic process (GO:0061013),-0.1987515025071407,-0.7626311626532928,0.9660377358490566,0.9640500822654672,1.0,40/121,29.99%,PRR5L;PSMB2;YWHAB;HSPA8;XPO1;PSMD14;PNPT1;ANP32A;PSMC6;FXR1;VIM;UBB;PSMB9;PSMA4;HSPB1;ZC3H14;PABPC1;PSMD11;PSMB10;PSMD2;YTHDF2;CNOT7;DCP2;PSMA2;UBC;RPS27A;PSMB3;EXOSC4;EXOSC1;SET;RBM24;ELAVL1;PSMB5;YTHDF1;YWHAZ;HNRNPD;PSMD7;APEX1;PSMF1;RC3H2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.33874619470190315,-0.7623071359289287,0.7394957983193278,0.9638113808479769,1.0,4/10,26.97%,CALM1;CALM3;DRD2;CRHR1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.36040664889334,0.762218850386451,0.7422680412371134,0.9948943246223322,1.0,1/11,1.00%,WNT4
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2794732418144604,-0.762157594904119,0.8236658932714617,0.9633159153307944,1.0,6/22,18.11%,SLC7A5;TNFRSF1B;LAPTM5;TRIL;NOD2;BTK
prerank,protein prenylation (GO:0018342),0.368178885950468,0.7621154463497223,0.71939736346516,0.9944932522398,1.0,4/10,17.11%,RABGGTA;RCE1;FNTB;FNTA
prerank,positive regulation of cytokine production (GO:0001819),0.21639813615967457,0.7611123478942626,0.9489559164733179,0.9955433597742432,1.0,34/292,12.38%,RORA;C1QTNF3;ROCK2;PRKCZ;LACC1;IL18;SPHK1;ADRA2A;SULF2;TLR3;TLR4;FZD5;IL17D;NOX1;CD28;EIF2AK2;IL12B;SERPINE1;AFAP1L2;PTPN22;IL17RA;RIPK1;RIPK2;MAVS;CD274;CYRIB;SULF1;RAB7B;DHX58;PRKDC;ADAM17;IRF1;PTPN11;GLMN
prerank,polarized epithelial cell differentiation (GO:0030859),0.344266513899818,0.760626176697415,0.7411545623836127,0.9957375441884305,1.0,4/13,17.18%,EZR;OPHN1;CDC42;MYO9A
prerank,regulation of mast cell activation (GO:0033003),0.3678875455698679,0.7606221455799514,0.7445109780439122,0.9951728775523365,1.0,2/10,7.41%,HAVCR1;PLSCR1
prerank,regulation of immune response (GO:0050776),0.23232690021766958,0.7603427823623975,0.900523560209424,0.9950362853380142,1.0,13/135,11.82%,COLEC12;APPL2;CD300A;RNF135;COL1A2;TKFC;PTPN22;PLSCR1;SAMHD1;RSAD2;CXADR;DHX58;IRF1
prerank,peptidyl-arginine modification (GO:0018195),0.33790326990322883,0.760246356965298,0.7619926199261993,0.9946139457762423,1.0,4/15,17.68%,ART5;ART4;NDUFAF5;PADI4
prerank,gastrulation (GO:0007369),-0.306145736681723,-0.7602126188616124,0.7978494623655914,0.9654745563368795,1.0,5/15,26.65%,TASOR;LHX1;LMBRD1;UGDH;NR4A3
prerank,cellular protein localization (GO:0034613),0.2166644667446798,0.7598474712506001,0.9528301886792453,0.9946815321625728,1.0,55/285,17.57%,CELSR1;ANK2;WLS;CSRP3;SNX6;CEP250;TBC1D16;SEC31B;LRRK2;CPLANE2;DUOXA1;STXBP2;PRRT1;SH3PXD2B;ACD;WIPI1;CLTC;ARFGAP3;NIPBL;PTPRU;CNTNAP1;VPS26C;COPZ2;PICK1;ARL4A;GRTP1;RAB43;RAB22A;AXIN2;NPHP1;VPS45;SNX8;MFN2;STX5;SGSM2;SNX15;VIPAS39;RAB21;SEC23IP;AP2A1;RAB29;SCFD1;ARFIP2;ARL6;BBS2;TBC1D25;SEC31A;MYO7A;SGSM3;WNT5A;FAM91A1;VPS35;AP4M1;CORO1B;RRAGD
prerank,body fluid secretion (GO:0007589),0.3396728518043212,0.7597288758829759,0.7719298245614035,0.9942983658360471,1.0,2/15,7.33%,NPR1;APLN
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3496768450279649,-0.7590270553334956,0.7940552016985138,0.9664380271637484,1.0,1/10,4.23%,RUNX1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.32715613371944186,-0.7589810802016622,0.8042553191489362,0.9657874890894811,1.0,3/11,14.53%,TASOR;TRIM28;ATF7IP
prerank,positive regulation of cilium assembly (GO:0045724),-0.29248511482035877,-0.7586027289752498,0.7699530516431925,0.9655949299779304,1.0,7/18,28.15%,CCDC88A;KCTD17;SEPTIN9;HAP1;CCP110;CEP135;MARK4
prerank,DNA replication (GO:0006260),0.23978193968516284,0.7583485248281949,0.8743243243243243,0.995940843166901,1.0,29/105,21.68%,POLD2;POLG;ATM;REV1;DONSON;RBMS1;BAZ1A;RBBP8;HUS1;IGHMBP2;RAD50;PNKP;TOP3A;KAT7;MCM7;MCM2;POLE2;ORC3;POLA2;POLL;CLSPN;NBN;FEN1;RFC1;MCM9;RAD9A;TOP1MT;ORC6;MCM5
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3374013187619277,-0.7583398804770394,0.7710084033613446,0.9645409846837761,1.0,3/10,16.28%,CDC42EP3;CDC42EP2;APC
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3374013187619277,-0.7583398804770394,0.7710084033613446,0.9645409846837761,1.0,3/10,16.28%,CDC42EP3;CDC42EP2;APC
prerank,positive regulation of protein import (GO:1904591),0.3022368644982022,0.7582803193635393,0.7614991482112436,0.9954727112205259,1.0,4/30,10.20%,SMAD3;ZIC1;UBR5;MAVS
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3289297053579911,0.7581591524525723,0.7737642585551331,0.9950919771190476,1.0,3/17,10.80%,WNT4;F2;SUCO
prerank,positive regulation of translation (GO:0045727),-0.20601563194949296,-0.7580410496044143,0.9539007092198581,0.9642705866742711,1.0,25/94,21.72%,PRR16;THBS1;NIBAN1;RPL26;RPL5;UHMK1;RPS9;ERBB2;FXR1;RPS4X;EIF5A2;VIM;YBX3;METTL3;RCC1L;PKM;DHX9;BCL3;EEF2;RPS27L;EIF4A3;EIF3D;YTHDF2;RBM3;NPM1
prerank,nuclear envelope organization (GO:0006998),0.319880135096655,0.7575793254878272,0.7781569965870307,0.9954200911474884,1.0,6/20,18.13%,DMPK;LEMD2;REEP4;VPS4A;NUP155;TOR1AIP1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2987218817548857,0.75756018552734,0.7808219178082192,0.994884093860863,1.0,2/26,2.40%,SMOC2;SPHK1
prerank,positive regulation of DNA replication (GO:0045740),0.3286143078309939,0.7575448014485687,0.7714285714285715,0.9943453736618337,1.0,4/16,15.34%,GLI2;GLI1;KAT7;FAF1
prerank,cellular response to pH (GO:0071467),0.32038996317063795,0.7575099107128709,0.7581227436823105,0.993825601190232,1.0,3/17,11.60%,HYAL1;RAB11B;IMPACT
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3651307280822643,0.7574942231365895,0.7442748091603053,0.9932869889936777,1.0,5/11,24.24%,UFD1;BAG6;DERL1;TOR1A;RNF5
prerank,mitochondrial genome maintenance (GO:0000002),0.3605098202484317,0.7573668044447355,0.7391304347826086,0.9929132426605904,1.0,4/11,15.74%,OPA1;MEF2A;TOP3A;SLC25A36
prerank,iron ion transport (GO:0006826),0.27137807093235333,0.7563815967939824,0.8292682926829268,0.9938847987369145,1.0,12/47,19.04%,CP;ATP6V0E1;ATP6V0B;CLTC;RAB11B;ATP6V1D;ATP6V1E1;DNM2;STEAP3;HFE;ARHGAP1;ATP6V0D1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.23295352950151735,0.7553183934580916,0.8935309973045822,0.9949866108203131,1.0,28/128,19.72%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;ALMS1;DNM2;CEP63;OPTN;PCM1;CEP57;AKAP9;PCNT;FBXL22;CEP164;TAF2;OFD1;DCTN3
prerank,phagosome maturation (GO:0090382),0.28894472118670445,0.7551906076686508,0.8112903225806452,0.9946108734286468,1.0,7/35,11.43%,ATP6V0E1;RAB34;ATP6V0B;PIKFYVE;RAB43;ATP6V1D;ATP6V1E1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.31269152347821944,0.755083901921651,0.774822695035461,0.9942112032558148,1.0,1/23,1.42%,IGF1
prerank,protein O-linked mannosylation (GO:0035269),0.3261740350812112,0.754969899667731,0.7811320754716982,0.9938125408389299,1.0,4/18,12.64%,TMTC4;LARGE1;TMTC1;LARGE2
prerank,mitotic spindle organization (GO:0007052),-0.19044920421169884,-0.7548411322454678,0.9728506787330317,0.967986880976781,1.0,65/153,32.87%,CLASP2;PLK2;FLNA;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;BUB3;CLIP1;MAP4;MZT1;STMN1;CENPE;EFHC2;EML1;CHEK2;SPAST;TBCE;RAN;KIF11;STAG1;NUP107;PPP1CC;CENPH;SUN2;BCCIP;NDC80;MAD2L1;NSL1;KIF4A;KIF3B;DCTN6;KNTC1;NUP85;MECP2;NEK6;PRC1;KIF23;TPX2;CENPA;NDE1;CDCA8;TUBG2;KPNB1;NDEL1;RANGAP1;NUDC;TNKS;CENPF;STIL;PTPA;DLGAP5;NUF2;AURKA;TOGARAM2;RHOA;CENPI;SPC24;CDC20;BUB1;ABRAXAS1;ZWILCH;MAPRE1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3274258250078502,0.7547067352499096,0.7686567164179104,0.9936847546615136,1.0,2/15,9.64%,PRKN;SIRT1
prerank,neurogenesis (GO:0022008),0.27392774511799717,0.7544789210453379,0.8249594813614263,0.9934957640603646,1.0,4/43,8.34%,LPAR1;TRAK1;DAGLA;RYK
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3308257454710004,0.7536627338256755,0.7391304347826086,0.9936627687206825,1.0,3/15,12.22%,DTNBP1;BLOC1S6;BLOC1S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3308257454710004,0.7536627338256755,0.7391304347826086,0.9936627687206825,1.0,3/15,12.22%,DTNBP1;BLOC1S6;BLOC1S2
prerank,acute inflammatory response (GO:0002526),0.3107522613568286,0.7534374613435438,0.7465277777777778,0.993461973304175,1.0,4/23,10.97%,C2CD4B;ANO6;PLSCR1;MYLK3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2608146545147025,0.7531696088766234,0.8353658536585366,0.9933259246115048,1.0,16/59,19.49%,TNRC6A;MITF;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;NFKB1;TNRC6C;MED23;MED26;MED1;MED8;MED13
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3710216218996724,0.7529570058329019,0.7515923566878981,0.9931035019811413,1.0,3/10,20.79%,RHO;SAG;PDE6B
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2508589345983917,-0.7528594502494901,0.8592592592592593,0.9699964394305499,1.0,10/33,20.38%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;STN1;TERF1;RPA1;ANKRD28;PTGES3;NHP2
prerank,regulation of leukocyte migration (GO:0002685),-0.2972172008547059,-0.752830480172277,0.7958236658932715,0.9693291574323976,1.0,8/16,31.56%,ANXA1;RHOH;VEGFA;CD81;RHOG;HMOX1;BST1;RAC2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.255897814948535,0.7526499142827124,0.8433908045977011,0.9930052660386404,1.0,19/68,20.45%,PCCA;SLC19A1;TCN1;MTHFR;TCN2;ALDH1L1;MCCC1;FLAD1;SLC19A2;MTRR;HLCS;THTPA;SLC25A19;MTHFD1;TPK1;MMACHC;MCCC2;FOLR2;AASDHPPT
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3441740832229458,0.7524808603162744,0.780114722753346,0.9927062049312925,1.0,8/13,30.13%,TDG;MBD4;OGG1;NT5C;UPP2;SMUG1;NEIL1;NT5M
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3165584190519544,0.7523085890887132,0.7681159420289855,0.9924058313395574,1.0,4/19,10.20%,ELF1;MAP2K5;PARP9;MAVS
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.34338876838510146,0.7517916199095771,0.7633587786259542,0.9926655834851431,1.0,2/14,6.40%,KMT5C;KMT5B
prerank,response to nutrient levels (GO:0031667),0.32655993681191753,0.7513617164507118,0.7592267135325131,0.9927612680930945,1.0,1/17,1.67%,PRKAA2
prerank,positive regulation of exocytosis (GO:0045921),-0.2502204359369487,-0.7510414138030729,0.8536585365853658,0.9710751954347068,1.0,6/35,13.17%,CADPS;CLASP2;RAB27A;PDCD6IP;RAB27B;SNCA
prerank,positive regulation of organelle assembly (GO:1902117),-0.2358936661118277,-0.7507525300356611,0.8900804289544236,0.9707752250193454,1.0,7/44,11.01%,PIP4K2A;CCDC88A;G3BP2;SH3GLB1;RALB;CNOT2;PDCD6IP
prerank,negative regulation of protein processing (GO:0010955),0.3567821028671977,0.7504862411848187,0.7611111111111111,0.9935181630162854,1.0,4/12,13.00%,LRRK2;GAS1;SERPINE1;SNX12
prerank,regulation of chemokine production (GO:0032642),0.2815085831248147,0.7487061520802939,0.8124006359300477,0.9957196103015666,1.0,4/36,6.39%,IL18;TLR3;TLR4;EIF2AK2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2442543221861916,0.7486002731762201,0.8780841799709724,0.9953152387492408,1.0,21/88,16.22%,KNG1;IGF2BP1;F2;DDX3X;TM4SF20;EIF2AK2;IGF2BP2;SAMD4A;CDK5RAP3;LARP1;CNOT10;CPEB3;LSM14A;DDX6;ATRAID;RGP1;NFKB1;TSC1;PLAT;RBM4;ILF3
prerank,negative regulation of organelle assembly (GO:1902116),-0.2506274641314268,-0.7483652843630896,0.8982188295165394,0.9732134768728854,1.0,11/35,19.84%,TBC1D30;LIMK2;FEZ1;CDK5RAP2;TMEM39A;PINK1;TRIM37;FEZ2;ODF2L;CHMP4B;CHMP4A
prerank,mRNA export from nucleus (GO:0006406),0.23721787779434758,0.7482203967935417,0.8876560332871013,0.9953280607409892,1.0,26/102,22.29%,NXF2;PABPN1;SMG1;SRSF5;POLDIP3;HNRNPA2B1;POLR2D;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;NUP188;U2AF1;CDC40;UPF2;NUP153;SRSF7;U2AF2;FYTTD1;SMG6
prerank,establishment of mitotic spindle localization (GO:0040001),0.28961098218229187,0.7474620896347618,0.8159722222222222,0.9959157524045932,1.0,5/28,12.31%,PKHD1;CLASP1;FBXW11;HTT;MISP
prerank,organic cation transport (GO:0015695),-0.2835662434467968,-0.7472830993721485,0.8142857142857143,0.9739000566255072,1.0,4/20,11.79%,SLC47A1;SLC44A2;SEC14L1;SLC44A1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3408773391763198,0.7471906615058437,0.7509433962264151,0.9957562372548995,1.0,4/14,13.69%,ENPP3;AK4;AK3;AK8
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2575763422870573,-0.7470776781601336,0.8353221957040573,0.9734647190894208,1.0,9/29,27.20%,NSF;COG5;RAB6A;GABARAPL2;COPE;TRAPPC3;COG1;NAPG;COPG2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2965509392982936,0.7467417948235908,0.7832764505119454,0.9958602077452554,1.0,10/27,24.00%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;CPSF3;POP7;PCF11;POP1;XRN1;LACTB2
prerank,lymphocyte mediated immunity (GO:0002449),-0.31823284582327377,-0.7467336081885869,0.8077709611451943,0.9731782528204611,1.0,2/12,14.95%,JAG1;BTN3A3
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2427859642660296,-0.7458808192088862,0.8787878787878788,0.9736502347002037,1.0,9/35,21.67%,STAT3;LYN;STAT5B;HIF1A;TAL1;ZFPM1;FAM210B;INHBA;MAFB
prerank,heme biosynthetic process (GO:0006783),-0.28013354111157884,-0.7455313818285931,0.8367816091954023,0.9733950137964036,1.0,1/22,0.75%,ABCG2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.25985107633160154,-0.7455301653362507,0.8305489260143198,0.9726881183615479,1.0,6/25,19.48%,STAT3;STAT5B;HIF1A;TAL1;FAM210B;INHBA
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.24730751777950244,-0.7453375536954019,0.8618925831202046,0.9722288457564341,1.0,6/32,13.75%,CEPT1;SLC44A5;SLC44A2;MFSD2A;SLC44A1;LPIN3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.31496518154138303,-0.7450763565732638,0.7948164146868251,0.9718727250341982,1.0,2/12,8.80%,LYN;PTK2
prerank,I-kappaB phosphorylation (GO:0007252),0.35642364894379375,0.7449883518771423,0.7377690802348337,0.9979681122564714,1.0,2/10,5.28%,TLR3;TLR4
prerank,negative regulation of histone acetylation (GO:0035067),0.3567221554382477,0.744869278173872,0.7423664122137404,0.9975714957381193,1.0,4/11,20.27%,SIRT1;SIN3A;TAF7;NOC2L
prerank,extracellular transport (GO:0006858),0.3445407915406708,0.7445580088915764,0.7461240310077519,0.9974573145109134,1.0,3/12,18.20%,ROPN1L;WWP2;CCDC40
prerank,regulation of mitotic cell cycle (GO:0007346),0.2232050310371725,0.744165521515258,0.9344473007712082,0.9974787154099971,1.0,16/171,11.76%,SMAD3;ANAPC15;SMOC2;OBSL1;SPHK1;FOXC1;GAS1;ANAPC2;SIK1;AFAP1L2;BTRC;CDK5RAP3;SIRT1;PRKCA;CUL9;FZR1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3047627980583535,-0.7439218412006413,0.8140043763676149,0.9726812984733684,1.0,5/15,14.09%,DACT1;SMAD7;FKBP1A;LEMD3;ACVR1
prerank,mitochondrial translational termination (GO:0070126),0.24101844567406583,0.7436520089399282,0.8945022288261516,0.9977157145325778,1.0,26/88,26.70%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;MTRF1L;MRPL1;GFM2;MRPL45;MRPS17;MTRF1;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPL50;MRPS25;MRPL19;MRPL33;MRPS18B;MRRF
prerank,innate immune response in mucosa (GO:0002227),0.35865589595950553,0.7434611347831274,0.7536496350364964,0.9974368814054653,1.0,2/10,12.49%,DEFB1;CAMP
prerank,acute-phase response (GO:0006953),-0.31240756704610995,-0.7434280217837923,0.7892561983471075,0.9726000212960568,1.0,4/12,21.90%,SIGIRR;LBP;IL22;IL6R
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2994868344501384,-0.7432461331906598,0.7965367965367965,0.972132366565621,1.0,3/15,10.77%,SCARB1;LDLR;MFSD2A
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.24492129825930986,0.7428520256921883,0.8726483357452967,0.9977914161844402,1.0,19/76,21.16%,BMP7;PKHD1;PARP10;ARRB1;MAP2K5;CDK5RAP3;SIRT1;USP7;LRRC14;ACOD1;NWD1;FAF1;CCDC22;TAX1BP1;PYDC1;TRAF3;NFKBIB;IRAK2;ANXA4
prerank,sulfur compound catabolic process (GO:0044273),0.27114957773155934,0.7425814788115497,0.7983870967741935,0.9976376492422415,1.0,6/38,10.51%,OGN;FMOD;HYAL1;CTH;ARSB;MLYCD
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.26157092156236617,0.7425132681013477,0.8493150684931506,0.9971828589793229,1.0,12/52,19.86%,CXXC1;TLN1;TPP1;WIPI1;EXTL1;CTDSP2;GFPT1;SEC31A;SYVN1;ATP6V0D1;FKBP14;PARP16
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2577768794156564,-0.7424480702386862,0.8337028824833703,0.972481400315444,1.0,12/27,27.26%,CD47;CD44;SKAP1;ITGB2;PRKCQ;HAS2;PYCARD;MDK;RELA;THY1;NR4A3;CCL2
prerank,negative regulation of hippo signaling (GO:0035331),0.34004241540715363,0.7416802316318661,0.7731568998109641,0.9978755282601465,1.0,6/12,20.87%,VGLL4;WWC2;AJUBA;WTIP;MAPK14;DLG5
prerank,RNA polyadenylation (GO:0043631),0.29262287101727336,0.740905556509564,0.8108581436077058,0.9979203902091202,1.0,8/26,18.86%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11
prerank,mRNA polyadenylation (GO:0006378),0.29262287101727336,0.740905556509564,0.8108581436077058,0.9979203902091202,1.0,8/26,18.86%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.357409101625079,0.7407298603143069,0.7485380116959064,0.997616990887169,1.0,4/10,20.27%,SIRT1;TAF7;KLF15;NOC2L
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2985087663118687,-0.7406823492399692,0.8201284796573876,0.974029036375076,1.0,3/14,12.49%,CARD14;MAP3K7;TIRAP
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2414585347148039,0.7399741679103395,0.8855869242199108,0.9981547070005566,1.0,11/84,10.21%,IGF1;SPHK1;IGF2BP1;DDX3X;EIF2AK2;IGF2BP2;SAMD4A;LARP1;CNOT10;CPEB3;LSM14A
prerank,protein localization to nucleus (GO:0034504),0.23588863240727245,0.7397706794581569,0.8919667590027701,0.9978889710054644,1.0,3/102,3.50%,BMP7;APPL2;TNPO1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3086186992844337,0.7393574360563383,0.7979094076655052,0.9979376572743068,1.0,4/22,12.90%,CCNT2;ELL;SCAF8;KAT7
prerank,innate immune response (GO:0045087),0.2135565665876129,0.7386539263515784,0.95593635250918,0.9984184463913973,1.0,27/217,13.04%,COLEC12;IFIT1;IFI27;KRT1;TLR3;RNF135;TLR4;DEFB1;TRIM56;DDX3X;ANKRD17;COLEC11;TKFC;RIPK2;MAVS;IRGM;FER;SRPK2;DHX58;ANKHD1;ZDHHC1;FRK;CAMP;TRIM62;NUB1;AKAP1;POLR3A
prerank,negative regulation of catalytic activity (GO:0043086),0.3001585149243436,0.7385923473332958,0.81195079086116,0.9979709196801881,1.0,4/24,9.64%,IFIT1;TP53;PARP9;SIRT1
prerank,negative regulation of insulin secretion (GO:0046676),0.31519986791667665,0.7385752742869856,0.7542857142857143,0.9974366892253003,1.0,4/17,12.82%,PRKN;ADRA2A;MIDN;SIRT4
prerank,positive regulation of actin nucleation (GO:0051127),-0.32101388995634783,-0.7378389765120367,0.8076923076923077,0.9769362455065487,1.0,4/11,18.64%,GSN;WASF1;WASF2;NCKAP1
prerank,protein alkylation (GO:0008213),-0.2731429209502397,-0.7371441866446654,0.8697788697788698,0.977092116725453,1.0,11/22,36.66%,LCMT1;FAM98B;METTL22;SNRPD3;SNRPB;PRMT8;PRMT1;PRMT3;EEF1AKMT2;FAM98A;ETFBKMT
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.296469604299738,0.7371122731822333,0.7975986277873071,0.9989768691276819,1.0,1/27,0.97%,LPAR1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3181049146322396,-0.7367574913354388,0.8111753371868978,0.9768619120604677,1.0,4/11,10.65%,ARHGEF7;CORO1C;CD44;ENPP2
prerank,ureteric bud morphogenesis (GO:0060675),-0.2971184925366574,-0.7366074657215643,0.821501014198783,0.976335559567263,1.0,6/16,19.50%,SIX1;BMP2;FGF2;BMP4;PAX2;PAX8
prerank,regulation of cell aging (GO:0090342),-0.32371863054055683,-0.7364190048012949,0.7654320987654321,0.9758743055758798,1.0,4/11,26.38%,PNPT1;NUAK1;NEK6;VASH1
prerank,regulation of defense response (GO:0031347),0.2458599447211815,0.7361337318476369,0.8814055636896047,0.9998433848291153,1.0,18/76,17.48%,APPL2;LACC1;RNF135;TKFC;PTPN22;NR1D2;SAMHD1;NLRP6;DHX58;IRF1;ERAP1;USP18;BIRC3;ZMPSTE24;WNT5A;CCR2;BCL6;ZBP1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24661527111573475,0.7360360983513824,0.8960468521229868,0.9994182306542307,1.0,12/68,18.86%,POLR2A;TAF1D;PABPN1;TTF2;SCAF8;POLR1G;MTERF2;TBP;CPSF3;TTF1;CSTF1;PCF11
prerank,base-excision repair (GO:0006284),0.26143024227772843,0.7357392249246285,0.8510971786833855,0.9992691644941449,1.0,12/48,19.45%,POLD2;POLG;HUWE1;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;LIG1;XPA
prerank,"base-excision repair, AP site formation (GO:0006285)",0.32398950551156647,0.7355285218597496,0.7863720073664825,0.9990327637886327,1.0,5/17,18.52%,ACD;TDG;MBD4;TINF2;OGG1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.26942728961640416,-0.7343504366222706,0.8337028824833703,0.977838957069222,1.0,6/22,20.12%,ERBB2;ATF4;EIF2AK3;NOL11;UTP15;PHF8
prerank,bile acid metabolic process (GO:0008206),0.29078692737158457,0.7342123840519265,0.8053571428571429,1.0,1.0,3/27,6.15%,CYP27A1;AMACR;OSBPL9
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2839829874902483,-0.7340634629160604,0.8524229074889867,0.9775080228950941,1.0,1/17,0.33%,CTNNA2
prerank,membrane lipid metabolic process (GO:0006643),-0.2671543805248326,-0.732480432774192,0.8294392523364486,0.978711692186263,1.0,7/22,19.97%,CYP1B1;ST3GAL6;SERINC1;GAL3ST1;B4GALT4;TECR;SMPDL3B
prerank,RNA stabilization (GO:0043489),0.2815950457790728,0.7321524637364457,0.8272425249169435,1.0,1.0,7/33,12.02%,PHAX;LARP1;GDNF;TENT2;THRAP3;AXIN2;NOCT
prerank,regulation of cilium assembly (GO:1902017),0.24847631335981027,0.7320322660586395,0.881578947368421,1.0,1.0,23/62,24.07%,DCDC2;TBC1D16;ATG5;RABEP2;HTT;IFT88;SDCCAG8;TAPT1;TCHP;SGSM3;YAP1;TBC1D7;TBC1D14;EVI5;CEP120;TBC1D22B;EVI5L;TBC1D24;FUZ;USP6NL;CDK10;ATG3;RABGAP1
prerank,peptidyl-proline modification (GO:0018208),0.29684139440022805,0.7317560595559959,0.8070469798657718,1.0,1.0,4/25,10.24%,FKBP5;NKTR;PPIC;CWC27
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.25099257354294285,-0.731718340597772,0.8693586698337292,0.9789259314526247,1.0,14/30,27.00%,HMGCS1;IDI1;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;FDPS;HMGCR;HSD17B7
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.2888206698747954,0.7316415668172205,0.8027923211169284,1.0,1.0,2/27,2.40%,IGF1;SPHK1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.25328804987389963,0.7315038553931962,0.8810975609756098,1.0,1.0,13/55,15.19%,PRKN;F2;PDGFRB;TP53;SIRT5;TGFBR2;PIKFYVE;RIPK1;RNF41;ACOD1;GADD45A;SPHK2;COQ7
prerank,cellular response to light stimulus (GO:0071482),0.2443482813295245,0.7307910743372772,0.8890510948905109,1.0,1.0,20/66,23.01%,NEDD4;RHO;TP53;CDC25A;AURKB;ZBTB1;SDE2;CREBBP;SAG;KDM1A;TAF1;NOC2L;FMR1;PDE6B;YY1;OPN1SW;CASP9;OPN1MW;OPN1MW3;EP300
prerank,DNA strand elongation (GO:0022616),0.3219735275007045,0.7306877159702644,0.7946902654867256,1.0,1.0,4/18,13.16%,POLD2;TERT;RAD50;MCM7
prerank,regulation of actin nucleation (GO:0051125),0.33657770334493786,0.7300124538877989,0.7777777777777778,1.0,1.0,5/12,17.44%,PICK1;VIL1;ARFIP2;WASHC5;CORO1B
prerank,ATP transport (GO:0015867),0.3532107728477248,0.7297127814913361,0.7599243856332704,1.0,1.0,3/10,17.12%,ABCC6;SLC25A42;SLC25A17
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2675718445446182,0.729439147922723,0.8573692551505546,1.0,1.0,12/43,18.57%,ERRFI1;SNX6;EPS15L1;MVP;HBEGF;CDC42;GPRC5A;TGFA;RNF115;BTC;SOCS4;ZGPAT
prerank,regulation of secretion (GO:0051046),-0.3023321495026124,-0.7293815683904118,0.8176100628930818,0.9809573027039434,1.0,3/13,8.93%,ACSL3;KCNQ1;MYO6
prerank,leukotriene metabolic process (GO:0006691),0.30524998863023134,0.7291646254499018,0.7867383512544803,1.0,1.0,2/19,8.03%,ALOX12;ABCC10
prerank,cellular response to glucose stimulus (GO:0071333),0.2827495708425728,0.7285589594086821,0.8607809847198642,1.0,1.0,2/30,2.18%,PRKAA2;ZBTB20
prerank,protein import into mitochondrial matrix (GO:0030150),0.3132729162593587,0.7282082279982351,0.7886029411764706,1.0,1.0,7/18,26.46%,TIMM44;TOMM70;TIMM17B;TIMM17A;TIMM21;DNAJC15;GRPEL2
prerank,response to interferon-gamma (GO:0034341),-0.21089949726874213,-0.7280983080792436,0.9545454545454546,0.9818557045307439,1.0,21/67,28.03%,GCH1;AQP4;SYNCRIP;CXCL16;CD47;GBP4;IFITM3;DAPK1;SNCA;SHFL;CCL13;CD74;RPL13A;IRF8;CCL19;LGALS9;IFITM1;IFITM2;GAPDH;CCL2;CD40
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3323938406654551,-0.7275142485624164,0.7786407766990291,0.981141089539877,1.0,4/10,14.88%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),-0.3323938406654551,-0.7275142485624164,0.7786407766990291,0.981141089539877,1.0,4/10,14.88%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3371181014373141,0.7267426675338249,0.7946902654867256,1.0,1.0,3/13,9.38%,PARP10;SLC5A8;PARP9
prerank,pentose-phosphate shunt (GO:0006098),-0.3151697819100345,-0.7256040834060216,0.8246753246753247,0.9826707494082817,1.0,4/11,21.46%,TKT;TALDO1;RPE;RPIA
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3547975255753561,0.7255739474894445,0.767175572519084,1.0,1.0,3/10,12.12%,PTPN22;DUSP10;HIPK3
prerank,nucleoside salvage (GO:0043174),-0.3196549840904156,-0.7242806082041829,0.8152866242038217,0.9835928413341116,1.0,4/10,31.16%,HPRT1;UCK2;UPP1;TK2
prerank,regulation of multicellular organismal development (GO:2000026),0.2878297190107673,0.724101166540843,0.8089700996677741,1.0,1.0,5/25,16.03%,OAS2;NIPBL;TRIP12;TDG;EHMT1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.33101424143527325,0.7240744106017893,0.7813688212927756,1.0,1.0,2/12,12.55%,INSIG2;TAPT1
prerank,cholesterol metabolic process (GO:0008203),-0.20773211699128497,-0.7239575050404164,0.9579579579579579,0.9832606669450172,1.0,26/68,27.00%,PPARD;APOE;ABCG1;SCARF1;HMGCS1;IDI1;SNX17;PMVK;MT3;LSS;SQLE;DHCR7;DHCR24;LDLRAP1;CH25H;CYP51A1;MSMO1;STARD3;GBA2;ACAT2;CLN8;EBP;ABCA5;FDPS;HMGCR;HSD17B7
prerank,positive regulation of catalytic activity (GO:0043085),0.2693797138121035,0.7234988029652191,0.8510301109350238,1.0,1.0,8/37,11.58%,SLC5A3;NHEJ1;BCAS3;XRCC4;SSBP1;PHACTR4;ABL1;MSH3
prerank,protein-containing complex disassembly (GO:0032984),-0.21592622793989513,-0.723215518754755,0.9444444444444444,0.9834170307349283,1.0,10/54,17.06%,CAV1;GSK3B;HSPA8;RPL23;CTNNB1;AXIN1;MAP1LC3A;APC;GABARAPL2;PPP1CA
prerank,DNA modification (GO:0006304),0.30399242300472445,0.7227843825818425,0.8153310104529616,1.0,1.0,7/22,21.00%,ACD;TDG;EXOSC3;MBD4;TINF2;OGG1;PARP3
prerank,B cell activation involved in immune response (GO:0002312),0.33910781239043475,0.7227768926707245,0.8029197080291971,1.0,1.0,3/13,20.62%,RNF8;EXOSC3;LIG4
prerank,regulation of protein localization to nucleus (GO:1900180),0.25631652485287665,0.7223238324969291,0.8902627511591963,1.0,1.0,9/43,14.09%,SESN2;F2;WWTR1;CDK5RAP3;PARP9;GLUL;KAT7;FLCN;SIN3A
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3051192812775868,-0.7222451689430048,0.8004484304932735,0.9838222178648087,1.0,3/11,19.31%,CAMK4;ITGB2;TYROBP
prerank,chromosome condensation (GO:0030261),-0.230726452718705,-0.7201961506977606,0.9027431421446384,0.9855237602011742,1.0,14/36,27.46%,AIFM1;GPER1;SMC4;NCAPG2;TOP2A;NUSAP1;BANF1;PHF8;MCPH1;NCAPH;NCAPH2;TTN;SET;CSNK2B
prerank,mitotic metaphase plate congression (GO:0007080),0.2510337298005191,0.7201738472533019,0.879746835443038,1.0,1.0,13/51,23.30%,EML4;CHMP1A;BECN1;KIFC1;CHAMP1;VPS4A;CENPC;PIBF1;CHMP4C;CHMP2A;EML3;MIS12;PINX1
prerank,adipose tissue development (GO:0060612),-0.31714040124939585,-0.7196565494561027,0.8404907975460123,0.9854368878960738,1.0,5/11,24.82%,SPTLC2;NAMPT;SOX8;PGRMC2;DGAT2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.28946993015203004,-0.7193092682822878,0.8171806167400881,0.9851334285813043,1.0,2/15,8.40%,PRKCH;AGTR1
prerank,positive regulation of viral transcription (GO:0050434),0.28713216171526884,0.7191427777350179,0.8364565587734242,1.0,1.0,5/25,14.85%,POLR2A;POLR2D;GTF2F1;NELFCD;CTDP1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.23577846094574106,0.7191307062476221,0.8956521739130435,1.0,1.0,1/86,0.14%,EPAS1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2934205371811211,0.7184550963777986,0.8319039451114922,1.0,1.0,5/23,13.69%,MTMR3;SYNJ2;PTEN;OCRL;PIP4P2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23302659167128864,-0.7182350493471577,0.9238845144356955,0.9856227170026237,1.0,18/38,41.51%,SART1;CLNS1A;SNRPF;COIL;SNRPD3;SRSF12;LSM4;SNRPB;WDR77;SNRPG;LSM2;PRMT5;USP4;GEMIN2;PRPF8;GEMIN6;STRAP;GEMIN8
prerank,dorsal/ventral pattern formation (GO:0009953),0.2994193774795898,0.7170896419564418,0.8348294434470377,1.0,1.0,3/20,9.47%,GLI2;BMPR1A;NBL1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23277071938965832,-0.7170659048036725,0.8992443324937027,0.9862649336244076,1.0,7/33,19.48%,STAT3;STAT5B;HIF1A;TAL1;FES;FAM210B;INHBA
prerank,mitochondrial transport (GO:0006839),-0.21493052173874,-0.7169801743517717,0.9439775910364145,0.9856463850264223,1.0,20/53,33.87%,SLC25A13;HSP90AA1;TOMM7;FBXO7;AIP;GDAP1;BCAP31;TIMM8B;TOMM22;TOMM20;BNIP3;STARD3;TIMM13;TOMM5;SPG7;PMAIP1;FIS1;DNAJC19;TIMM10B;BAD
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.32575261027600755,-0.7166631815267626,0.8347107438016529,0.9853458510965803,1.0,3/10,16.30%,PTPRC;IRAK3;SIGIRR
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32191652916582925,0.7166060566447389,0.8058608058608059,1.0,1.0,3/13,11.25%,NEDD4;NIBAN2;CNMD
prerank,water transport (GO:0006833),-0.30651326012785984,-0.7159523025176551,0.837782340862423,0.9854334075990564,1.0,2/12,7.46%,AQP4;AQP11
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.2833038165520403,0.715791636095364,0.8361486486486487,1.0,1.0,2/27,2.05%,PPARA;IL18
prerank,regulation of response to stress (GO:0080134),-0.32625955596088607,-0.7154683622450149,0.8427184466019417,0.9852564430488394,1.0,6/10,41.59%,CORO2B;ADCY8;OPRM1;CRHBP;MLC1;SLC38A2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3315701134879505,0.7151068427299194,0.7863720073664825,1.0,1.0,2/12,12.85%,CLCN2;MBTPS1
prerank,regulation of humoral immune response (GO:0002920),-0.22245756798533511,-0.7150147719985233,0.9264305177111717,0.9850466109494648,1.0,13/44,24.19%,SUSD4;C1QB;C4B;C1QC;PROS1;CLU;C3AR1;C1QA;CD81;GATA6;VTN;C7;CFH
prerank,ncRNA export from nucleus (GO:0097064),0.26764969133128347,0.7148205707612004,0.8603174603174604,1.0,1.0,18/36,30.66%,PHAX;NUP42;NUP98;NUP43;TSC1;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;RAE1;NUP37;NUP160;NOL6;RANBP2;SSB
prerank,cellular response to ATP (GO:0071318),-0.29754160725922185,-0.7138022695969307,0.8257080610021786,0.9856938626482262,1.0,3/14,14.20%,RYR3;P2RY12;P2RY1
prerank,mRNA catabolic process (GO:0006402),0.26387067985509643,0.7137367548460225,0.8734177215189873,1.0,1.0,4/44,10.36%,DDX5;TUT4;CNOT10;THRAP3
prerank,anterograde axonal transport (GO:0008089),0.2664546430217303,0.7136014708751898,0.8515497553017944,1.0,1.0,8/37,14.57%,TRAK1;DTNBP1;KIF1B;KIF1C;BLOC1S6;BLOC1S2;KIF5B;RAB21
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.28784577946164275,0.7133861311219305,0.8359240069084629,1.0,1.0,4/25,9.00%,BID;FAM162A;TP53;DNM1L
prerank,regulation of lymphocyte differentiation (GO:0045619),0.306561350704493,0.7127521118411058,0.8280961182994455,1.0,1.0,5/18,20.83%,ABL1;PRKDC;ZFP36L1;CCR2;IKZF3
prerank,response to laminar fluid shear stress (GO:0034616),0.3436959755669773,0.7120927821592397,0.8269230769230769,1.0,1.0,2/10,5.80%,SMAD6;MAP2K5
prerank,protein-DNA complex assembly (GO:0065004),-0.18815517009748822,-0.712056114182081,0.988929889298893,0.9869332786486641,1.0,38/116,32.13%,PSMB2;PSMD14;H3-3A;NAP1L1;PSMC6;RAD23B;UBB;SMARCA5;PSMB9;RPA1;ORC5;PSMA4;ORC2;CETN2;GTF2H4;NAP1L4;GTF2H1;PSMD11;PSMB10;GTF2H5;PSMD2;ERCC2;NPM1;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;ERCC3;DDB1;RPA3;PSMD7;RAD51;PSMF1;RPA2;MCM4;MCM8
prerank,mRNA stabilization (GO:0048255),-0.22633305985296598,-0.7118887220455501,0.9300518134715026,0.9864003048593797,1.0,10/40,17.46%,ELAVL4;YBX1;SYNCRIP;TAF15;EIF4ENIF1;YBX3;TIRAP;TENT5A;DHX9;PABPC1
prerank,replication fork processing (GO:0031297),0.2694273472307156,0.7115303552275359,0.8623548922056384,1.0,1.0,5/38,10.68%,ATRX;FBH1;SAMHD1;FANCM;EME2
prerank,regulation of hippo signaling (GO:0035330),0.30477763024820254,0.7115067784269029,0.8043478260869565,1.0,1.0,7/17,20.87%,VGLL4;WWC2;AJUBA;WTIP;MOB3B;MAPK14;DLG5
prerank,positive regulation of histone modification (GO:0031058),0.27207995174736266,0.7114395960462964,0.8557993730407524,1.0,1.0,3/33,7.12%,PPARGC1A;ARRB1;NIPBL
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2968507994341954,0.7113999725088839,0.8426573426573427,1.0,1.0,6/22,18.47%,PPM1E;DUSP10;DUSP2;PPM1B;DUSP18;DUSP4
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3072777818568329,-0.711182260863791,0.8234086242299795,0.9864434466996279,1.0,8/11,37.84%,TIMM29;TIMM8B;ROMO1;TIMM13;NDUFA13;TIMM10B;AGK;TIMM9
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3265350557035005,0.7109803497649968,0.8200757575757576,1.0,1.0,6/14,25.54%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2378123905849967,0.7108854668213613,0.9148311306901615,1.0,1.0,6/71,6.30%,PRKN;FBXL17;NGLY1;CTSH;USP9X;CLPX
prerank,regulation of cellular senescence (GO:2000772),0.28339386197788924,0.7103230611099903,0.8263772954924875,1.0,1.0,7/28,14.72%,SLC30A10;HMGA1;TERT;SIRT1;RBL1;RSL1D1;ZKSCAN3
prerank,regulation of mRNA stability (GO:0043488),0.21937611010987337,0.7102193656822557,0.955026455026455,1.0,1.0,17/145,12.20%,ROCK2;TNPO1;TNFSF13;IGF2BP1;IGF2BP2;SAMD4A;EXOSC7;LARP1;GDNF;CSDC2;YTHDF3;TBRG4;THRAP3;PRKCA;AXIN2;NOCT;DCP1A
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24789091215801434,0.7089470855812846,0.9007633587786259,1.0,1.0,9/60,12.56%,SMOC2;ATM;PDGFRB;ACD;DSCC1;TNKS2;AURKB;FBXO4;PNKP
prerank,regulation of lipid catabolic process (GO:0050994),-0.2715956361670102,-0.7089238431403201,0.8767123287671232,0.9881849969668555,1.0,1/19,2.04%,PDE3B
prerank,microtubule depolymerization (GO:0007019),0.3003088422000168,0.7088176367217893,0.8092691622103387,1.0,1.0,1/17,1.77%,KIF2A
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.26403393664128416,0.7083144777614909,0.850328947368421,1.0,1.0,5/35,8.57%,CD300A;PPP4R4;MAGI2;PDGFRB;HTT
prerank,negative regulation of translational initiation (GO:0045947),0.32336384362265835,0.7082946362652056,0.8142076502732241,1.0,1.0,5/13,26.97%,LARP1;RBM4;FMR1;AGO2;EIF4EBP1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.30047538388111406,-0.7081460546949451,0.8231441048034934,0.9882920426614688,1.0,2/13,7.36%,GRIN2A;PERP
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.2858413396005698,-0.7079514688326295,0.834070796460177,0.9877976948551783,1.0,6/14,24.84%,ATP2B4;PRKAR2B;PRKAR1B;PRKAR2A;PKIG;ADRB2
prerank,positive regulation of RNA splicing (GO:0033120),-0.24684508345144246,-0.7079141555004888,0.8734177215189873,0.9871445078821762,1.0,3/29,4.97%,PIK3R1;CELF4;HNRNPLL
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2081558995606156,-0.7069604287979928,0.9670658682634731,0.9874685242822296,1.0,23/65,36.03%,FBXL7;PSMB2;PSMD14;PSMC6;PSMB9;PSMA4;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;FHL1;PSMB3;PSMB5;ZFYVE19;PSMD7;PSMF1;AURKA;PSMA5;PSME4;PSMA7;PSMD3;PSMD4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.24526513457160687,0.7069035365754339,0.8975155279503105,1.0,1.0,16/56,22.94%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;NDUFA2;TMEM126B;NDUFAF7;NDUFS5;NDUFB2;NDUFA9;TIMM21
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.24526513457160687,0.7069035365754339,0.8975155279503105,1.0,1.0,16/56,22.94%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;NDUFA2;TMEM126B;NDUFAF7;NDUFS5;NDUFB2;NDUFA9;TIMM21
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.22571407810370753,-0.705897282818869,0.9306666666666666,0.9878395859640023,1.0,4/42,11.74%,LARS2;WARS2;GARS1;DARS2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.34050311443317827,0.7058772147556641,0.8091286307053942,1.0,1.0,2/11,14.54%,SIRT1;TAF7
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.2883455231509968,-0.7054727534488276,0.8623024830699775,0.9875908562509307,1.0,5/14,18.58%,THBS1;FGF2;CREB3L1;SPRY1;SPRY4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.31365218534928363,-0.7045213632763635,0.8445378151260504,0.9879065790027985,1.0,7/10,40.92%,APC;ECT2;SIRT2;SPAG5;KNSTRN;CCNB1;NEK2
prerank,regulation of translational initiation (GO:0006446),0.2399655202172792,0.7043306303093209,0.9055472263868066,1.0,1.0,16/63,21.65%,CTIF;MIF4GD;DDX3X;POLR2D;LARP1;YTHDF3;EIF4A2;IMPACT;RBM4;EIF5;EIF4G1;BOLL;EIF4G2;FMR1;POLR2G;RPS6KB2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.28788729534531465,0.7039629711376624,0.839572192513369,1.0,1.0,4/26,8.74%,NPR3;POR;TERT;GDNF
prerank,regulation of receptor internalization (GO:0002090),0.2638075848305395,0.7037670305410879,0.8459016393442623,1.0,1.0,5/35,9.42%,MAGI2;ARRB1;RIN3;ATXN2;PICK1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3077395778519427,-0.7035859291711414,0.8490945674044266,0.9881985227586428,1.0,3/11,13.17%,HSPA5;ATF4;CREB3L1
prerank,positive regulation of chromatin organization (GO:1905269),0.3299483050203442,0.7033683853722217,0.7849264705882353,1.0,1.0,4/12,18.14%,ATRX;ACD;SIN3A;TINF2
prerank,regulation of exit from mitosis (GO:0007096),0.26402205926717104,0.7033286199006304,0.8715447154471545,1.0,1.0,6/38,16.40%,ANAPC15;ANAPC2;CDC14A;CDC14B;ANAPC16;UBE2E1
prerank,regulation of cell cycle process (GO:0010564),-0.1914455198675438,-0.7031418960420062,0.982078853046595,0.9879486071415424,1.0,48/104,34.83%,CAV2;CALM1;PLK2;CALM2;SH3GLB1;CALM3;GPER1;PRPF40A;CTNNB1;SETD2;TXLNG;ATF5;TIPIN;E4F1;APC;CETN2;DCUN1D3;KIF11;ECT2;RAB11FIP4;BORA;YTHDF2;CUL7;GIT1;CCDC8;TTL;PLK3;SPAG5;SFRP1;PRC1;CCP110;CDKN2B;RPRD1B;HMGA2;KLHL13;MARK4;NUDT16;AURKA;RAB11FIP3;KIF20A;KNSTRN;PRMT5;BUB1;PIK3R4;AHCTF1;IHO1;PKMYT1;RMI2
prerank,response to UV (GO:0009411),-0.1901370581327357,-0.7029543234736445,0.986159169550173,0.9874441633678841,1.0,35/95,29.85%,PTPRK;RPL26;MAP4K3;MFAP4;ATF4;ERCC6;SDF4;PRIMPOL;METTL3;UBE2B;CAT;GPX1;RHBDD1;BCL3;MEN1;DCUN1D3;ERCC2;POLD1;NPM1;N4BP1;POLK;TRIAP1;DTL;MAP2K7;RUVBL2;RELA;CCAR2;PCLAF;UBE2A;MAPK8;CCND1;ERCC3;CIRBP;BMF;AQP1
prerank,protein kinase B signaling (GO:0043491),0.2899601524464357,0.7029514232414119,0.8482142857142857,1.0,1.0,5/23,15.25%,IGF1;PTEN;PIK3R3;THEM4;ZFP36L1
prerank,protein targeting to mitochondrion (GO:0006626),-0.21611864646809437,-0.7026152988748285,0.9411764705882353,0.9871114389132384,1.0,14/52,20.19%,IMMP2L;AIFM1;HSP90AA1;TOMM7;FBXO7;AIP;GDAP1;TIMM29;BCAP31;TIMM8B;ROMO1;TOMM22;DNLZ;TOMM20
prerank,regulation of neutrophil migration (GO:1902622),-0.31727039431627163,-0.7022470223173137,0.8428874734607219,0.986795905844903,1.0,6/10,31.56%,MPP1;RHOH;RHOG;BST1;JAM3;RAC2
prerank,histone mRNA metabolic process (GO:0008334),0.2774557198461453,0.7019399629603174,0.8700854700854701,1.0,1.0,6/27,16.29%,ATM;TUT4;TENT2;TENT4B;CPSF3;TUT7
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2754137807469367,0.7019213971800704,0.869639794168096,1.0,1.0,11/29,27.17%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;CROT;ACSF2;ACLY;GPAT4;ACAT1;ACOT7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2754137807469367,0.7019213971800704,0.869639794168096,1.0,1.0,11/29,27.17%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;CROT;ACSF2;ACLY;GPAT4;ACAT1;ACOT7
prerank,protein targeting to lysosome (GO:0006622),-0.26142286286496264,-0.7018057805805394,0.8822222222222222,0.9865636574626035,1.0,7/20,15.66%,HSPA8;SORL1;GCC2;LAPTM5;CLU;NCOA4;M6PR
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.2940041513820253,-0.7016979906749022,0.8449781659388647,0.9859933298348377,1.0,3/14,12.73%,ACTR2;WDR48;ERCC6
prerank,maintenance of protein localization in organelle (GO:0072595),0.29990665426554186,0.7011149394930091,0.8411867364746946,1.0,1.0,8/19,26.05%,HK2;TAPT1;PML;TAF3;TAF8;HK1;SUPT7L;ARL2
prerank,regulation of isotype switching (GO:0045191),0.3211147404978386,0.7004193440226616,0.7957371225577264,1.0,1.0,2/14,6.40%,KMT5C;KMT5B
prerank,positive regulation of interleukin-12 production (GO:0032735),0.27587180686312324,0.7003639495675241,0.8614864864864865,1.0,1.0,4/31,9.82%,TLR3;TLR4;IL12B;RIPK2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2568077150885766,-0.6987753992779738,0.9025522041763341,0.988227105947998,1.0,1/24,0.75%,ABCG2
prerank,regulation of B cell apoptotic process (GO:0002902),0.3192597222434712,0.6986465266035808,0.8159392789373814,1.0,1.0,5/12,21.94%,FNIP1;AURKB;BCL6;NOC2L;ORMDL3
prerank,steroid hormone biosynthetic process (GO:0120178),0.27362811039715385,0.6986099338556498,0.875886524822695,1.0,1.0,4/29,12.83%,CYP21A2;FDXR;TSPOAP1;SRD5A2
prerank,regulation of mRNA metabolic process (GO:1903311),0.32286032692494593,0.6985064959814637,0.7955390334572491,1.0,1.0,2/11,10.73%,SLTM;SRPK2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.32368864110704276,0.6984126807712135,0.8111753371868978,1.0,1.0,1/12,1.81%,PPARA
prerank,regulation of trophoblast cell migration (GO:1901163),0.3057984087033133,0.6979888383466047,0.8255395683453237,1.0,1.0,4/14,16.41%,SMURF2;YTHDF3;ACVR1B;NODAL
prerank,mitotic cytokinetic process (GO:1902410),0.29164120890886114,0.6978847377552314,0.8395061728395061,1.0,1.0,6/20,22.02%,KLHDC8B;CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.25001937873136487,-0.6978516467812712,0.8834498834498834,0.9884729605221129,1.0,2/24,2.05%,AGBL4;TTLL7
prerank,protein import into peroxisome matrix (GO:0016558),-0.2930880368648168,-0.6977534699025868,0.859504132231405,0.9878742324939151,1.0,1/12,2.19%,PEX5L
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.23026933500950464,0.6975686020395399,0.9239940387481371,1.0,1.0,7/85,8.34%,CELSR1;MAGI2;VANGL1;FZD5;SMURF2;CLTC;RYK
prerank,sensory perception (GO:0007600),-0.21880262705556475,-0.6970775641770696,0.9315789473684211,0.9879049135266584,1.0,17/45,28.84%,GNAS;PCDH15;MME;PTGES;SCN9A;GNAL;TMEM150C;CHRNA7;TRPA1;TTC8;PENK;OPRM1;PNOC;OPRL1;CCL2;P2RX7;CDH23
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2382673953108005,0.6966199035941243,0.9121212121212121,1.0,1.0,22/62,26.26%,POLR2A;TNRC6A;POLR2D;NUP42;AJUBA;NUP98;NUP43;WTIP;NUP155;EIF4G1;NUP188;FMR1;NUP153;POLR2G;AGO1;POLR2F;AAAS;POLR2K;AGO2;PUM2;NUP88;SEC13
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2815976817233381,-0.6964000082561349,0.869757174392936,0.9878675277891603,1.0,6/15,32.46%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.256882447920258,-0.6959497933765706,0.9036402569593148,0.9876139703215381,1.0,10/20,32.35%,GATM;GCLM;GAMT;CHAC2;OPLAH;FPGS;GGCT;MGST2;GCLC;GGT1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2953152746040798,0.6953726625524197,0.8469565217391304,1.0,1.0,4/18,10.49%,POR;SIRT3;GDNF;ABL1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3036039090119327,-0.6948461829163799,0.8523908523908524,0.9880154895852284,1.0,3/11,21.72%,CDK5RAP2;TRIM37;NPM1
prerank,T cell homeostasis (GO:0043029),-0.31241964801918,-0.6945352968191119,0.8545081967213115,0.9876293058605636,1.0,8/10,55.71%,FAS;PMAIP1;FOXP3;RIPK3;NCKAP1L;AKT1;PPP2R3C;JAK3
prerank,regulation of cell size (GO:0008361),0.2792884843904835,0.6940343637892996,0.8456260720411664,1.0,1.0,6/23,15.35%,DEPTOR;EZR;PTEN;RARG;VAV3;RPTOR
prerank,purine nucleotide biosynthetic process (GO:0006164),0.32402680702683384,0.6938783019596629,0.822429906542056,1.0,1.0,6/12,19.75%,PRPSAP1;AMPD2;PRPSAP2;MTHFD1;GART;ADSL
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2472533862852657,-0.6938241554459887,0.8995327102803738,0.9876261329082161,1.0,5/24,14.04%,TGFB2;EPHA7;ATF4;CTNNB1;CDK5R1
prerank,intracellular pH reduction (GO:0051452),-0.2296836929467062,-0.6937073614923617,0.9352331606217616,0.9870619104184174,1.0,9/33,21.52%,ATP6V0A1;ATP6V0A4;RAB38;CLCN3;RAB39A;GPR89B;GPR89A;ATP6V1B2;ATP6V1F
prerank,positive regulation of mRNA processing (GO:0050685),-0.259974857347001,-0.6933750923137039,0.8767772511848341,0.9866908837461034,1.0,12/21,40.83%,CELF4;CDC73;TRA2A;RBM3;NCBP2;RBMXL1;CIRBP;SF3B4;CELF3;NCBP1;RBMX;NCL
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.26156001629225,-0.6932081034496637,0.8643326039387309,0.9861648190228475,1.0,7/19,21.37%,DDIT4;HIPK1;PHLDA3;HIPK2;BCL3;RPS27L;PYCARD
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2740170026367323,-0.6924569979793975,0.8881720430107527,0.9861734638092932,1.0,1/16,1.40%,ST3GAL4
prerank,cellular response to ionizing radiation (GO:0071479),0.2477346137417249,0.6924287684707511,0.9030303030303031,1.0,1.0,18/47,24.34%,ATM;TP53;NIPBL;SIRT1;HUS1;GADD45A;CRYAB;TLK2;YAP1;INTS7;KDM1A;MAPK14;TANK;RAD9A;LIG4;FIGNL1;NUCKS1;TSPYL5
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2880755571277246,-0.6922870201687592,0.8471074380165289,0.9856448895155597,1.0,6/12,37.67%,PLK2;WEE1;BUB1;ZWILCH;WEE2;ZW10
prerank,transcription by RNA polymerase III (GO:0006383),-0.24327572674391185,-0.6916761370611377,0.9170616113744076,0.9855424903182619,1.0,3/27,10.85%,IVNS1ABP;RO60;GTF3C5
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24655063638414243,0.6915444109619847,0.9151515151515152,1.0,1.0,7/49,10.20%,TLR3;TLR4;IL17D;SERPINE1;AFAP1L2;RIPK1;MAVS
prerank,protein polyglutamylation (GO:0018095),0.32743375239262185,0.6915230552523013,0.825147347740668,1.0,1.0,2/11,7.28%,TTLL6;TTLL9
prerank,response to UV-A (GO:0070141),-0.2849600627330635,-0.691423492274404,0.8584070796460177,0.9851149067298435,1.0,10/14,53.39%,MME;MMP1;CCND1;MMP3;PPID;OPN5;MMP9;MMP2;AKT1;OPN3
prerank,vacuolar acidification (GO:0007035),-0.24929903162171035,-0.6913687811361476,0.9146919431279621,0.9844876858033085,1.0,3/21,9.57%,ATP6V0A1;ATP6V0A4;PPT1
prerank,negative regulation of bone remodeling (GO:0046851),-0.2980028675446131,-0.6908373862283892,0.855072463768116,0.9843188834875172,1.0,6/11,28.40%,UBASH3B;TMEM119;SFRP1;CALCA;CARTPT;P2RX7
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2564858053544573,-0.6904967947699746,0.8816425120772947,0.9839460622182045,1.0,7/19,21.84%,PIK3AP1;TIRAP;TRIL;LBP;ITGB2;NR1H4;LGALS9
prerank,regulation of actin filament depolymerization (GO:0030834),0.3183505837543581,0.6898510087348951,0.8333333333333334,1.0,1.0,3/12,11.48%,PLEKHH2;PIK3CA;VIL1
prerank,regulation of B cell differentiation (GO:0045577),0.2998815771562194,0.6898209179506049,0.829981718464351,1.0,1.0,5/17,20.83%,CD27;MMP14;ZFP36L1;INHA;IKZF3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.28798565702965273,0.6897428263815615,0.859402460456942,1.0,1.0,5/20,15.66%,CTR9;MEIS1;LDB1;ZFP36L1;HOXB8
prerank,response to gamma radiation (GO:0010332),0.28147533907748484,0.6890491639697566,0.8583333333333333,1.0,1.0,8/24,20.62%,ATM;TP53;CRYAB;TLK2;YAP1;KDM1A;FANCD2;LIG4
prerank,pseudouridine synthesis (GO:0001522),-0.2953146762107114,-0.6887642561346307,0.8526970954356846,0.9848643094082138,1.0,8/13,39.99%,NHP2;PUS1;TRUB1;PUS7;DKC1;RPUSD2;TRUB2;PUS7L
prerank,modulation by host of symbiont process (GO:0051851),0.25768733866707594,0.6884687209207729,0.8885191347753744,1.0,1.0,10/31,23.38%,NAPEPLD;SMARCA4;HDAC1;TAF11;CTDP1;REST;SP1;SMARCB1;EP300;NUCKS1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2902150218678332,0.6881657565234889,0.8482632541133455,1.0,1.0,2/20,7.90%,NR2F2;PTEN
prerank,cytoplasmic microtubule organization (GO:0031122),0.2415151995602577,0.6880629808523663,0.9012539184952978,1.0,1.0,4/54,4.89%,DLG1;HOOK2;CLASP1;EZR
prerank,positive regulation of lipid storage (GO:0010884),0.28818726235918274,0.6875849277000382,0.8436944937833037,1.0,1.0,4/21,14.40%,IKBKE;OSBPL11;PLIN3;NFKB1
prerank,histone exchange (GO:0043486),0.2573323116733309,0.6873156255356792,0.8775834658187599,1.0,1.0,17/37,28.25%,RNF8;SRCAP;NASP;CENPO;CENPC;ACTR6;CENPK;CENPT;ITGB3BP;RUVBL1;DMAP1;RSF1;CENPN;RBBP4;CENPQ;RBBP7;CENPS
prerank,regulation of histone deacetylation (GO:0031063),-0.274629179637651,-0.6872545805684978,0.8465011286681715,0.9855723115487529,1.0,1/13,2.43%,CAMK2D
prerank,regulation of establishment of planar polarity (GO:0090175),0.22575985246456132,0.6868303967008993,0.9417758369723436,1.0,1.0,6/88,6.77%,CELSR1;PKHD1;VANGL1;FZD5;SMURF2;CLTC
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.30724759720619366,-0.6863148204518027,0.8553719008264463,0.9857372226922112,1.0,5/10,21.63%,ITGB3;HIF1A;MT3;ITGA5;VTN
prerank,triglyceride catabolic process (GO:0019433),0.2926330852309844,0.6860901757335404,0.8434163701067615,1.0,1.0,1/19,4.45%,CPS1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.221419758842807,-0.6853383305868078,0.9416445623342176,0.9859326391552945,1.0,10/40,19.43%,PGLYRP1;RPL39;GBP4;DROSHA;TIRAP;MPEG1;RARRES2;LBP;ROMO1;PPP1R11
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.28698419261735847,-0.6850065836507626,0.8583509513742071,0.9855642752091068,1.0,6/14,31.37%,NCBP2;ERN1;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,mitotic sister chromatid segregation (GO:0000070),0.21723643912051355,0.6846484955310675,0.957325746799431,1.0,1.0,19/98,18.58%,EML4;NIPBL;PDS5A;CHMP1A;BECN1;KIFC1;CSNK2A2;CSNK2A1;KMT5A;DSN1;REC8;VPS4A;NCAPD3;RB1;PIBF1;CHMP4C;CENPK;NCAPD2;PDS5B
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.22992655889385627,-0.6845586186641393,0.9251336898395722,0.9852827773295403,1.0,6/33,14.08%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3046681579670055,-0.6845056444027043,0.8622129436325678,0.9839889554369895,1.0,3/10,12.99%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3046681579670055,-0.6845056444027043,0.8622129436325678,0.9839889554369895,1.0,3/10,12.99%,AP2B1;AP2M1;VLDLR
prerank,regulation of stem cell differentiation (GO:2000736),-0.18997768261886763,-0.6838316212332118,0.9906542056074766,0.9839277774799944,1.0,20/89,20.64%,LMO2;RUNX1;NOTCH1;JAG1;PSMB2;HES1;GATA2;PSMD14;PTN;PSMC6;TCF12;TAL1;NELFB;METTL3;PSMB9;PSMA4;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,monocyte chemotaxis (GO:0002548),-0.23076780033704342,-0.6836349932125497,0.9214285714285714,0.983412577763273,1.0,3/32,5.70%,TNFRSF11A;ANXA1;RPS19
prerank,phasic smooth muscle contraction (GO:0014821),-0.31266496903571595,-0.6824351895895856,0.8532494758909853,0.9838262998441273,1.0,4/10,21.03%,EDN1;EDN3;EDNRB;DRD2
prerank,negative regulation of protein transport (GO:0051224),-0.24275077391544045,-0.6823892046069757,0.8928571428571429,0.9831889075646406,1.0,8/25,23.13%,APOE;NDFIP2;PPM1F;ERP29;PKDCC;CYP51A1;DRD2;RHBDF2
prerank,regulation of axon regeneration (GO:0048679),0.3193498078112636,0.6821496778485264,0.8351851851851851,1.0,1.0,1/12,2.22%,EPHA4
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.3162516326545023,0.6821135077478587,0.844106463878327,1.0,1.0,2/12,7.18%,CYP26B1;DHRS3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2643977725173022,0.6820697843722809,0.8835274542429284,1.0,1.0,6/32,12.56%,ATM;ACD;TNKS2;AURKB;FBXO4;PNKP
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3184561629108082,0.6819610335296612,0.8254901960784313,1.0,1.0,2/13,7.44%,UBAC2;ERLEC1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.29736530310843134,-0.6816979322503589,0.8588709677419355,0.983121340682323,1.0,4/11,22.57%,CD44;TAF9B;CD74;TRIAP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.31030678376057513,0.6810262571664096,0.8431734317343174,1.0,1.0,1/13,2.85%,NFAT5
prerank,microtubule-based transport (GO:0099111),0.31362007391600766,0.6805997464436156,0.8330134357005758,1.0,1.0,2/12,8.57%,ROPN1L;HTT
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3131126177257555,0.6805643425432931,0.8292682926829268,1.0,1.0,3/13,18.83%,VDAC2;BLOC1S2;RHOT1
prerank,regulation of cellular response to stress (GO:0080135),0.2104402832570286,0.6804634647471515,0.9710344827586207,1.0,1.0,20/115,18.30%,ROCK2;PRKN;NUPR1;SMG1;ATM;SIRT1;NUP42;ABL1;AJUBA;NUP98;NUP43;RSL1D1;CRYAB;RPTOR;AMFR;CREBBP;NUP155;MCL1;EIF4G1;NUP188
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2334449958755395,-0.6803949244350203,0.9030732860520094,0.9835791325328184,1.0,6/28,17.36%,MAP1B;CLASP2;STMN2;MAPT;STMN1;FKBP4
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.21786827439237802,0.6797962057880073,0.9661971830985916,1.0,1.0,24/96,22.29%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;NUP188;U2AF1;CDC40;UPF2;NUP153;SRSF7;U2AF2;FYTTD1;SMG6
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18947434189851267,-0.6797935746326451,0.9900662251655629,0.9834440047037776,1.0,35/84,36.03%,PSMB2;CUL3;PSMD14;ECRG4;PSMC6;BUB3;UBB;PSMB9;FBXO31;PSMA4;CDC23;PSMD11;PSMB10;PSMD2;PSMA2;MAD2L1;UBC;RPS27A;PSMB3;UBE2D1;PSMB5;PSMD7;PSMF1;AURKA;CDK1;CDC20;UBE2C;PSMA5;PSME4;ANAPC10;PSMA7;ANAPC1;PSMD3;CCNB1;PSMD4
prerank,mRNA transport (GO:0051028),0.21677213609363763,0.6796150453752144,0.958217270194986,1.0,1.0,26/101,22.29%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;ZFP36L1;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;NUP188;U2AF1;CDC40;UPF2;FMR1;NUP153;SRSF7;U2AF2;FYTTD1;SMG6
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3075844175936266,0.6795566323122705,0.8200371057513914,1.0,1.0,3/13,11.81%,ABHD14B;SULT2B1;TPST1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.18211575273176314,-0.6795109336668611,0.9929824561403509,0.9830007109857304,1.0,17/101,18.55%,MEF2C;PDE4B;LYN;DAB2IP;TNFRSF1B;TGFB1;VIM;SBNO2;CARD16;MTDH;CX3CR1;NOD2;LBP;CD180;TRIM41;PDCD4;CDC73
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2755615427612995,0.6794659866227305,0.8724489795918368,1.0,1.0,4/26,9.64%,PRKN;LRRK2;SOD2;SIRT1
prerank,stress-activated MAPK cascade (GO:0051403),-0.19950669512820726,-0.6793517165442587,0.9717514124293786,0.9824737258387926,1.0,20/61,28.44%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;IKBKB;UBB;NOD2;SKP1;MAP3K11;SH2D3C;LGALS9;UBC;RPS27A;MAP2K7;TAB1;MAPK8;MAP3K8;MAPK3
prerank,proteasomal protein catabolic process (GO:0010498),0.1987024016203826,0.6788885238179065,0.991389913899139,1.0,1.0,23/201,11.97%,PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;SPSB4;TBL1X;SMURF2;ERLEC1;FBXW11;HUWE1;BTRC;TBL1XR1;RNF34;SIRT1;ZSWIM8;RNF41;CUL4A;WWP2
prerank,nucleotide-excision repair (GO:0006289),-0.18765149149919155,-0.6787443655947659,0.9848484848484849,0.9823127275137593,1.0,29/101,23.08%,POLA1;POLD3;AQR;RAD23B;ERCC1;ERCC6;POLR2J;UBB;COPS4;RPA1;BRIP1;CETN2;FANCC;COPS5;GTF2H4;GTF2H1;COPS6;GTF2H5;RFC4;COMMD1;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLK;POLR2L;UBC;RPS27A
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.19522998652757775,-0.6784753890028283,0.9700598802395209,0.9818859646663607,1.0,23/66,29.45%,STAT3;FOXP1;APP;EGR1;AIM2;CARD16;USP50;CX3CR1;NOD2;HSPB1;PANX1;TYROBP;CCL19;PYCARD;GIT1;LGALS9;F2R;NLRP2B;TRIM16;JAK2;P2RX7;MALT1;CD36
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2575635716414594,0.6783223610969794,0.8896551724137931,1.0,1.0,15/36,29.17%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A;CDC5L;USP28;TIPRL;E2F1;CHEK1;ATR
prerank,regulation of lymphocyte activation (GO:0051249),0.31814187068424366,0.6779854600174869,0.8238636363636364,1.0,1.0,12/12,68.21%,LAT;IKZF3;DCAF15;PAG1;SIT1;CCL5;KAT2A;CD4;CD19;LCK;CRTAM;THEMIS2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3077241877042721,0.6772879202724933,0.8294573643410853,1.0,1.0,5/14,22.02%,LHPP;GART;ADSS1;ADSL;GMPS
prerank,histone acetylation (GO:0016573),0.22802714820523948,0.677093546701907,0.937592867756315,1.0,1.0,22/69,25.35%,BRD8;CPA4;ZZZ3;KAT6B;ATF2;BRD1;KAT14;KAT7;BEND3;KAT2B;CREBBP;SGF29;RUVBL1;TAF6L;DMAP1;EP300;PHF20;MSL3;SUPT7L;TAF12;NAA50;ING3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3295739577992328,0.67667245391369,0.8468992248062015,1.0,1.0,6/10,33.56%,ATP5F1D;ATP5F1C;ATP5MC3;VPS9D1;ATP5MG;ATP5MC2
prerank,cellular response to UV-A (GO:0071492),-0.29740292389956,-0.676568844321525,0.8648648648648649,0.9828071763054114,1.0,6/11,45.51%,MME;MMP1;MMP3;PPID;OPN5;MMP9
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19532283419390153,-0.6759997291353549,0.9941002949852508,0.9826356830166377,1.0,16/70,20.64%,LMO2;RUNX1;PSMB2;GATA2;PSMD14;N4BP2L2;PSMC6;TCF12;TAL1;METTL3;PSMB9;PSMA4;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,endoderm development (GO:0007492),0.3133323969890107,0.6759287543550974,0.8604206500956023,1.0,1.0,1/13,1.98%,LAMC1
prerank,toll-like receptor signaling pathway (GO:0002224),0.22106941944047437,0.6750949757485967,0.9478260869565217,1.0,1.0,12/84,14.91%,COLEC12;TLR3;TLR4;MAPKAPK3;TAB2;RIPK1;RIPK2;LY96;NMI;MAP3K1;TLR5;BIRC3
prerank,determination of bilateral symmetry (GO:0009855),-0.24399051310634773,-0.6743744550408963,0.9031531531531531,0.983367347855609,1.0,2/24,5.59%,NOTCH1;TBX1
prerank,response to glucose (GO:0009749),0.24393920046121884,0.6740856592640343,0.9230769230769231,1.0,1.0,4/46,8.90%,PRKAA2;ZBTB20;GCK;TCF7L2
prerank,fatty acid biosynthetic process (GO:0006633),0.22843118208225738,0.6739138281995745,0.9360119047619048,1.0,1.0,6/63,7.55%,ALOX12;ACSBG2;HACD4;HACD1;SCD5;NDUFAB1
prerank,mismatch repair (GO:0006298),0.26163542058871286,0.6725301533716771,0.8675496688741722,1.0,1.0,8/27,20.51%,POLD2;ABL1;MSH3;TDG;MSH4;LIG1;MCM9;MLH1
prerank,melanosome transport (GO:0032402),-0.25845768882529735,-0.6723937768257089,0.8860465116279069,0.9837095630694282,1.0,4/18,16.45%,MYO5A;RAB27A;RAB27B;MREG
prerank,pigment granule transport (GO:0051904),-0.25845768882529735,-0.6723937768257089,0.8860465116279069,0.9837095630694282,1.0,4/18,16.45%,MYO5A;RAB27A;RAB27B;MREG
prerank,B cell mediated immunity (GO:0019724),0.3253923233556963,0.671158599060033,0.8346153846153846,1.0,1.0,1/10,5.77%,CD27
prerank,cellular response to acid chemical (GO:0071229),0.2713438364643743,0.6710845916111046,0.8694885361552028,1.0,1.0,10/27,25.37%,CPEB4;SESN2;CPEB3;RPTOR;NSMF;RRAGD;LAMTOR1;RRAGB;SLC38A9;RRAGC
prerank,regulation of acrosome reaction (GO:0060046),-0.29673949509095426,-0.6707534678818211,0.8537074148296593,0.9844192849962496,1.0,2/10,15.47%,GLRA1;CACNA1H
prerank,cellular response to interferon-beta (GO:0035458),-0.27624960581977165,-0.6701159585162056,0.8867521367521367,0.9842606573557839,1.0,6/14,24.58%,PNPT1;AIM2;HTRA2;UBE2G2;IFITM2;NDUFA13
prerank,regulation of protein kinase C signaling (GO:0090036),-0.27874583543432546,-0.6691785047469575,0.8804123711340206,0.984349901832727,1.0,6/14,28.03%,FLT4;DGKG;VEGFA;MYADM;GPD1L;CD40
prerank,regulation of hormone secretion (GO:0046883),0.2987473580354345,0.668731306731701,0.8709055876685935,1.0,1.0,1/15,2.58%,SNX6
prerank,recombinational repair (GO:0000725),-0.18718335386144308,-0.6685744864842464,0.9821958456973294,0.9842055977060218,1.0,28/77,33.64%,REV3L;SMC5;RAD51B;PSMD14;RPA1;RFWD3;KDM4D;EXD2;NSMCE1;MMS22L;POLQ;BLM;AP5S1;RAD54B;RECQL5;RECQL;PALB2;HUS1B;MEIOB;RPA3;SWI5;RAD51;BRCA1;RPA2;SFR1;MCM8;BRCA2;SMC6
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.18495610884870065,-0.6683456753596673,0.9967320261437909,0.9837228256275324,1.0,30/87,30.32%,FBXL7;PSMB2;DACT1;PSMD14;PSMC6;FAM107A;CDKN1A;JADE1;MYO16;PSMB9;PSMA4;APC;SKP1;RGCC;CDC73;DCUN1D3;PSMD11;PSMB10;PSMD2;PSMA2;FHL1;PSMB3;KLF4;CDKN2B;PSMB5;CCL2;PSMD7;PSMF1;AURKA;WEE1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.2988434407292032,0.6676921880949807,0.8446069469835467,1.0,1.0,1/13,2.86%,NUPR1
prerank,RNA modification (GO:0009451),0.23143514091804857,0.6671521933767607,0.934984520123839,1.0,1.0,8/54,18.41%,TRMT9B;RBM15;JMJD6;NOP2;LCMT2;WDR4;NSUN4;DTWD2
prerank,regulation of complement activation (GO:0030449),-0.21585381800068287,-0.6666632461998612,0.9652406417112299,0.9843318404756718,1.0,12/40,24.19%,SUSD4;C1QB;C4B;C1QC;PROS1;CLU;C3AR1;C1QA;CD81;VTN;C7;CFH
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.21703837567163933,-0.6665955468018356,0.9325,0.9837170191639888,1.0,14/37,25.51%,HSP90AB1;RYBP;RPL5;RPS7;DDRGK1;RPL23;NOP53;HIPK2;PDCL3;RPL11;BAG5;N4BP1;CCAR2;WAC
prerank,immunoglobulin mediated immune response (GO:0016064),0.3228444838490364,0.666509525229122,0.8492063492063492,1.0,1.0,1/10,5.77%,CD27
prerank,cytoplasmic translational initiation (GO:0002183),-0.26184118086514796,-0.6663007434348135,0.8852813852813853,0.9832867415012487,1.0,4/17,20.40%,EIF3M;EIF2B3;EIF4A1;EIF3D
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.1989198927711391,-0.6656206834498252,0.9738372093023255,0.9831800785206589,1.0,19/51,28.44%,NEK7;GNL3L;XRCC5;CTNNB1;SMG5;STN1;TERF1;CCT2;CCT8;PRKCQ;HMBOX1;CCT6A;CCT7;EXOSC10;DCP2;MAP2K7;TNKS;NAF1;MAPK3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.25845806179286335,0.6654369575432955,0.8979933110367893,1.0,1.0,4/28,10.43%,LACC1;TAB2;RIPK2;IRGM
prerank,negative regulation of T cell proliferation (GO:0042130),0.25686220854339664,0.6641428152927407,0.8950086058519794,1.0,1.0,7/28,22.41%,CD274;GLMN;PRKAR1A;SDC4;GPNMB;DLG5;ARG1
prerank,regulation of microtubule nucleation (GO:0010968),0.3167041944622837,0.6640380119955867,0.837890625,1.0,1.0,1/10,2.56%,EML2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.205260146189705,-0.6639955055972383,0.9651474530831099,0.9838109259074029,1.0,13/48,18.92%,TNFRSF1B;FNIP2;DDIT4;HIPK1;CRIP1;PHLDA3;HIPK2;CASP2;HTRA2;BCL3;CHEK2;RPS27L;BCL2L11
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.26544047284261046,-0.6639663803456891,0.9009009009009009,0.9831694204167856,1.0,10/16,42.35%,APOE;MYOCD;CLU;CYP51A1;HMGCR;IFNGR1;IL4;ABCA7;LRPAP1;TNF
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2577749513997152,0.6635678491508119,0.9001692047377327,1.0,1.0,6/31,11.76%,PTEN;BTRC;CDC14B;DCUN1D5;MAGEC2;FZR1
prerank,cellular response to superoxide (GO:0071451),0.3203526970857621,0.6630095273056019,0.8484251968503937,1.0,1.0,2/10,5.96%,SOD3;SOD2
prerank,nucleosome assembly (GO:0006334),0.2536356660211898,0.6618129477736404,0.9038461538461539,1.0,1.0,6/31,18.48%,CHAF1B;ATRX;KAT6B;NASP;PADI4;ASF1A
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.21021080549506424,-0.6616902189568048,0.947103274559194,0.9842448868564906,1.0,18/45,34.97%,GRM5;GCNT2;APP;MATR3;EIF4E;PUM3;RBM4B;RBM3;MEX3D;NANOS3;RPL10;DDX25;ATG14;PER1;YTHDC1;MTPN;TCOF1;TRIM71
prerank,positive regulation of calcium ion import (GO:0090280),0.31035797509202095,0.6615396518113142,0.8402255639097744,1.0,1.0,3/12,15.32%,PDGFRB;SPHK2;LGALS3
prerank,establishment of vesicle localization (GO:0051650),0.2815820383510091,0.6614933965421643,0.8814814814814815,1.0,1.0,1/18,1.31%,SYT11
prerank,protein localization to chromatin (GO:0071168),0.2806987746761525,0.6613951026351012,0.8838028169014085,1.0,1.0,6/18,19.85%,NIPBL;LEMD2;WAPL;LRWD1;SGF29;MCM9
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18002820333916356,-0.6611953507780856,0.9933333333333333,0.9839407934431931,1.0,19/95,21.73%,MEF2C;PDE4B;DAB2IP;TNFRSF1B;VIM;TIRAP;SBNO2;CARD16;CX3CR1;NOD2;LBP;CD180;TRIM41;PDCD4;CDC73;SIRT2;PYCARD;CD86;GIT1
prerank,regulation of protein kinase A signaling (GO:0010738),0.27705783419258123,0.6610354134106377,0.8561643835616438,1.0,1.0,5/20,17.25%,LRRK2;AKAP12;PRKAR1A;AKAP7;ADGRV1
prerank,pancreas development (GO:0031016),-0.2741280051653967,-0.6608408837890639,0.9002169197396963,0.9835288612841959,1.0,2/12,8.35%,MET;PROX1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.2972182467278339,0.6607594989876481,0.8481481481481481,1.0,1.0,3/13,9.78%,PRODH;ALDH4A1;GLUL
prerank,regulation of protein sumoylation (GO:0033233),0.28194403865806256,0.6606683696238405,0.8716981132075472,1.0,1.0,5/17,19.70%,PIAS1;HDAC4;ZMIZ1;PIAS3;PIAS4
prerank,ncRNA metabolic process (GO:0034660),0.24491033271579002,0.6606384282565134,0.92776886035313,1.0,1.0,11/37,26.53%,MOV10L1;TUT4;DICER1;TENT4B;TUT7;EXD1;ASZ1;XPO5;ZCCHC8;AGO2;KHSRP
prerank,negative regulation of B cell activation (GO:0050869),-0.24702900249307538,-0.6604451267490304,0.9101382488479263,0.9831656376481687,1.0,7/21,19.48%,LYN;TNFRSF21;ID2;SAMSN1;LAPTM5;TYROBP;INHBA
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.25181160741402975,-0.6603321638896016,0.9166666666666666,0.9825866972110788,1.0,2/18,8.39%,POLA1;POLD3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.32360296734048016,0.6602839158354229,0.8587155963302753,1.0,1.0,2/10,16.18%,ACD;TFIP11
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2555889104651671,-0.6594356070301256,0.9029345372460497,0.9826232570340117,1.0,5/17,21.55%,PPIA;HSPB1;HTRA2;BAG5;SOD1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2962251092491414,0.6581694461572736,0.8597122302158273,1.0,1.0,2/15,5.98%,RAPGEF3;CAMK1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2891696784647623,0.6581569413809867,0.8752327746741154,1.0,1.0,6/17,25.13%,AURKB;IK;CHAMP1;RB1;MIS12;SPDL1
prerank,regulation of lipid storage (GO:0010883),0.2677117649677401,0.6578168506730444,0.8932874354561101,1.0,1.0,4/22,14.40%,IKBKE;SIRT1;ITGAV;NFKB1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3081289658055817,0.6575789020713119,0.8519230769230769,1.0,1.0,3/11,18.48%,ATRX;NASP;ASF1A
prerank,mitotic cell cycle phase transition (GO:0044772),0.1925472295731916,0.6572398085583236,0.9938423645320197,1.0,1.0,44/203,20.97%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;CCNA1;CACUL1;FBXW11;CCND3;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;CUL4A;NASP;ALMS1;DNM2;ACVR1B;CTDP1;CCNG1;CEP63;USP37;CCNE1;OPTN;RB1;CDC34;PCM1;CEP57;AKAP9;PCNT;FBXL22;CEP164;TAF2;OFD1;DCTN3;UBE2S;CUL5;CHMP2A;CCNG2
prerank,regulation of immune effector process (GO:0002697),-0.20962415883563915,-0.656876832481746,0.9608355091383812,0.9838236168232561,1.0,12/41,24.19%,SUSD4;C1QB;C4B;C1QC;PROS1;CLU;C3AR1;C1QA;CD81;VTN;C7;CFH
prerank,sister chromatid segregation (GO:0000819),0.2525649979441681,0.6568734645695257,0.9068100358422939,1.0,1.0,6/31,17.91%,TOP2B;KIFC1;CHAMP1;DSN1;RB1;CENPK
prerank,cardiolipin metabolic process (GO:0032048),0.2933654873909556,0.6564290769997366,0.8587570621468926,1.0,1.0,5/13,21.75%,SLC27A1;PLA2G6;PLA2G5;HADHA;TAMM41
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2982619872518719,-0.6563810393571629,0.8707070707070707,0.9835516530571652,1.0,1/10,7.13%,SREBF2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28929684179820014,0.6561410844270906,0.8590225563909775,1.0,1.0,2/15,9.25%,STXBP4;GLI1
prerank,protein modification by small protein removal (GO:0070646),0.18772816083749805,0.6558596176721772,0.9976275207591934,1.0,1.0,49/252,20.51%,SMAD3;PRKN;SENP3;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;USP11;TP53;SMURF2;PTEN;CDC25A;RCE1;RIPK1;BECN1;INO80D;USP34;UIMC1;USP49;USP12;USP7;OGT;DESI1;DESI2;BABAM1;DDB2;MBD6;USP18;KAT2B;BIRC3;USP37;ASXL2;CLSPN;UFD1;SMAD4;USP1;RHOT1;USP48;USP33;COPS8;USP35;USP21;USP16;TRAF3;INO80E;OTUD3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2668436333114628,0.6549916195399154,0.8879159369527145,1.0,1.0,5/22,18.93%,ERI3;EXOSC7;ERI2;EXOSC3;WDR12
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.24578362781773042,-0.6548504684220472,0.9272727272727272,0.9840326558796221,1.0,4/20,17.42%,DCC;GSK3B;FAS;CASP2
prerank,positive regulation of DNA recombination (GO:0045911),0.2592947544528803,0.6544808289485268,0.8886986301369864,1.0,1.0,3/27,6.40%,ARID2;KMT5C;KMT5B
prerank,cellular response to radiation (GO:0071478),0.2406123915739532,0.6538633584725552,0.922077922077922,1.0,1.0,14/40,23.00%,RHO;TP53;SIRT1;HUS1;GADD45A;INTS7;MAPK14;TANK;RAD9A;LIG4;OPN1SW;FIGNL1;OPN1MW;OPN1MW3
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3159612996676319,0.65333298181959,0.8576923076923076,1.0,1.0,2/10,16.90%,MTHFR;MTHFD1
prerank,mitotic nuclear division (GO:0140014),0.2159986365553263,0.652919166821524,0.9426470588235294,1.0,1.0,19/71,20.84%,KIF2A;CLASP1;KLHDC8B;LSM14A;KIFC1;MISP;DSN1;STAG2;CTDP1;SMC3;PIBF1;CENPK;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;UBE2S;CHMP2A
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2253316690914295,-0.6528975184034517,0.9513888888888888,0.98485848033383,1.0,8/28,27.26%,SH3KBP1;CD47;NOD2;PRKCQ;TYROBP;PYCARD;THY1;CCL2
prerank,sensory perception of taste (GO:0050909),0.3138556304333098,0.651675062312965,0.8543307086614174,1.0,1.0,1/10,8.01%,GNAT3
prerank,secondary alcohol metabolic process (GO:1902652),0.23761542804446273,0.6495055574079958,0.9323671497584541,1.0,1.0,4/42,9.40%,CYP27A1;CLN6;IDH1;SULT2B1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.2462363072301933,-0.6486614617770254,0.9260042283298098,0.9871940344643747,1.0,3/18,9.00%,ESR1;TGFB1;TMBIM6
prerank,neutrophil activation (GO:0042119),-0.27354000968699915,-0.6483944862380611,0.8932461873638344,0.9866997991890057,1.0,3/12,20.07%,SYK;TYROBP;PREX1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.22451976016806544,0.6481290342912683,0.9565868263473054,1.0,1.0,15/60,19.49%,TNRC6A;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;NFKB1;TNRC6C;MED23;MED26;MED1;MED8;MED13
prerank,protein hydroxylation (GO:0018126),0.28974080599259666,0.6479171502397827,0.8775137111517367,1.0,1.0,6/15,22.81%,VIPAS39;ASPH;HIF1AN;OGFOD1;P3H4;VPS33B
prerank,regulation of response to interferon-gamma (GO:0060330),0.2894548558958825,0.6478618788693642,0.8766603415559773,1.0,1.0,3/14,11.64%,PIAS1;PARP9;SOCS3
prerank,axonemal dynein complex assembly (GO:0070286),0.25609536559519,0.6474478400768184,0.8987783595113438,1.0,1.0,7/27,22.16%,ODAD1;CCDC39;CCDC40;DNAI4;DNAAF5;CFAP73;DNAL1
prerank,RNA export from nucleus (GO:0006405),0.20493760985099402,0.6469024902854432,0.9806896551724138,1.0,1.0,25/100,23.01%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;NUP188;U2AF1;CDC40;UPF2;NUP153;SRSF7;U2AF2;FYTTD1;SMG6;XPO5
prerank,protein localization to centrosome (GO:0071539),-0.2511040093845929,-0.64654783862757,0.9263392857142857,0.9872953465502986,1.0,6/17,32.46%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,regulation of chromatin binding (GO:0035561),0.30970262574053126,0.6462330917192959,0.8482490272373541,1.0,1.0,2/10,11.89%,PARP9;WAPL
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.24677404807120493,-0.6455583355135778,0.9111617312072893,0.9873251038337745,1.0,8/19,27.47%,SLC26A2;ENPP1;TPST2;BPNT1;SULT4A1;SLC35B3;PAPSS1;BPNT2
prerank,cobalamin metabolic process (GO:0009235),0.284359786758859,0.6451959776454278,0.8792517006802721,1.0,1.0,3/17,12.23%,TCN1;TCN2;MTRR
prerank,phosphate ion transmembrane transport (GO:0035435),0.3001528646628109,0.6447135228922695,0.8648648648648649,1.0,1.0,5/12,22.80%,SLC20A2;SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.24905608989002914,-0.6447124824815175,0.9061135371179039,0.9872571389208711,1.0,3/18,18.92%,ANXA1;FAM107A;BCL2L11
prerank,mitochondrial translational elongation (GO:0070125),0.20863210677165303,0.644539637038845,0.9674074074074074,1.0,1.0,24/88,27.00%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPL50;MRPS25;MRPL19;MRPL33;MRPS18B;TSFM
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2987761364985315,0.6443734568017908,0.8773584905660378,1.0,1.0,4/13,20.17%,PRPF3;PRPF6;SRSF10;PRPF31
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.30169555459015585,0.6442483017289665,0.8587786259541985,1.0,1.0,3/12,18.05%,NINL;HOOK3;PCM1
prerank,determination of left/right symmetry (GO:0007368),0.24180088356938617,0.6440519559825817,0.939443535188216,1.0,1.0,10/36,21.53%,SMO;MKKS;GALNT11;CCDC39;ARL6;ENKUR;CCDC40;OFD1;CITED2;DAND5
prerank,erythrocyte development (GO:0048821),-0.29062450289086394,-0.6436272863520087,0.8948412698412699,0.9872896512983118,1.0,7/10,46.86%,DMTN;LYAR;ALAS1;SH2B3;ABCB10;GATA1;NCKAP1L
prerank,negative regulation of receptor internalization (GO:0002091),0.30140289941598614,0.6431811378545681,0.8728323699421965,1.0,1.0,5/12,22.30%,RIN3;ATXN2;SDCBP;ANKRD13B;ANKRD13D
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.20382676787576326,0.6431503603712616,0.986468200270636,1.0,1.0,20/101,15.58%,LARP4B;VGLL4;EZR;ATG10;DDX3X;CD28;POLDIP3;CLN6;FBXW11;SAMD4A;BTRC;CPEB3;YTHDF3;ATG7;PRKDC;PLD1;OGT;ZCCHC4;FAF1;ASPH
prerank,protein targeting to membrane (GO:0006612),0.20963744178224689,0.6427589679432859,0.9698275862068966,1.0,1.0,21/83,18.38%,RAB3IP;PEX11B;PIKFYVE;PXMP2;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;PEX14;VPS37A;RAB8B;ACBD5;PEX19;ARL6;PEX5;SLC25A17;RABGEF1;PEX16;ZDHHC23
prerank,mucosal immune response (GO:0002385),-0.2557689201857276,-0.6420904235692041,0.9187935034802784,0.9877483069740056,1.0,2/15,7.93%,OTUD7B;RPL39
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2106947502546978,0.6417585953607569,0.9602941176470589,1.0,1.0,23/76,24.34%,SPHK1;LRRK2;PIAS1;FANCI;HUWE1;CDK5RAP3;HDAC4;RIPK2;FBXO4;DCUN1D5;BIRC3;PIAS3;TBC1D7;CRY1;NDFIP1;PIAS4;TANK;GSK3A;DERL1;PRICKLE1;PHF23;PSMD10;TSPYL5
prerank,positive regulation of cellular senescence (GO:2000774),-0.28522088372097887,-0.6415498898160009,0.8909465020576132,0.9874022529341774,1.0,2/10,11.81%,B2M;ABI3
prerank,regulation of myoblast fusion (GO:1901739),0.30299269977863746,0.641478984793627,0.8359683794466403,1.0,1.0,1/11,2.92%,CFLAR
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2985252327997052,0.6408391287495452,0.871031746031746,1.0,1.0,3/12,13.70%,NCOR2;TERT;NCOR1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2138907444345209,0.640272588796502,0.9684684684684685,1.0,1.0,18/72,19.73%,SPHK1;CFLAR;ELF1;PIAS1;RIPK1;SOCS3;PTPN11;AXL;USP18;AGPAT1;IFNAR2;BIRC3;RNF31;CLIP3;ZBP1;TNFRSF1A;SUMO1;TAX1BP1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.23119210362835066,-0.6395999557302348,0.9365079365079365,0.9880419413943573,1.0,15/23,37.84%,HSP90AA1;TIMM29;TIMM8B;BCL2L11;ROMO1;TOMM22;TIMM13;NDUFA13;PMAIP1;BMF;TIMM10B;BAD;MAIP1;AGK;TIMM9
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.22721238276809524,-0.6390626855738821,0.9314420803782506,0.9877258428566426,1.0,8/24,25.08%,NOD1;MAP3K7;UBB;NOD2;AAMP;UBC;RPS27A;TAB1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21149374506912455,0.6386581901294571,0.9691176470588235,1.0,1.0,15/72,19.51%,SPO11;POLD2;DNASE1L1;FBH1;DICER1;CUL4A;DCP1A;RAD50;DDB2;DNASE1L2;OGG1;FEN1;RFC1;XPA;DXO
prerank,regulation of phospholipid metabolic process (GO:1903725),0.30748778402314,0.6376774244188829,0.8563106796116505,1.0,1.0,1/10,2.72%,MTMR3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.271011747094725,-0.6365786153995249,0.906183368869936,0.9886397864000164,1.0,4/12,21.14%,AKR1B1;STARD3NL;CACNA1H;STARD3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.24146922338933746,-0.6357924484181032,0.9284116331096197,0.988469898618735,1.0,4/20,15.11%,YWHAB;MET;SNCA;STMN1
prerank,regulation of nuclear division (GO:0051783),0.26938988681892573,0.6350498342087868,0.9197860962566845,1.0,1.0,1/20,2.35%,OBSL1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2599930498460375,0.634985836505984,0.9025270758122743,1.0,1.0,2/22,7.90%,NR2F2;PTEN
prerank,toxin transport (GO:1901998),0.30385755081526755,0.6344149499286661,0.8464646464646465,1.0,1.0,2/10,14.94%,ANTXR2;RAB29
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.23970513344688263,-0.6343327200798564,0.9175946547884187,0.9887398874294144,1.0,5/18,23.08%,MAN1B1;UBB;RNF103;UBC;RPS27A
prerank,mitochondrial protein processing (GO:0034982),-0.27700776708576447,-0.6343228599534907,0.9047619047619048,0.9880887907872928,1.0,3/11,27.36%,IMMP2L;STOML2;SPG7
prerank,centromere complex assembly (GO:0034508),-0.20212016645462272,-0.6333942793697611,0.9652406417112299,0.9880125118699122,1.0,14/36,30.99%,HJURP;SMARCA5;CENPE;CENPH;NPM1;CENPA;MIS18BP1;CENPF;MIS18A;CENPX;OIP5;DLGAP5;CENPI;POGZ
prerank,rRNA methylation (GO:0031167),0.2574994625977366,0.6324919968818136,0.9222222222222223,1.0,1.0,10/22,28.38%,NOP2;ZCCHC4;BUD23;NSUN4;FDXACB1;MTERF4;METTL5;MRM1;FBLL1;MRM2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2670897032940481,0.6315365483586987,0.9086115992970123,1.0,1.0,4/20,13.34%,PTGES3L;MKKS;BBS10;HSPA4
prerank,regulation of T cell mediated immunity (GO:0002709),0.30129580812808426,0.6314505043422108,0.89453125,1.0,1.0,3/10,18.45%,ZBTB1;CCR2;AGER
prerank,tetrapyrrole metabolic process (GO:0033013),0.27641438034161625,0.6303532898398923,0.9027303754266212,1.0,1.0,3/18,12.23%,TCN1;TCN2;MTRR
prerank,positive regulation of cell aging (GO:0090343),-0.27405261714734097,-0.6296914107725202,0.9213250517598344,0.989628863042224,1.0,2/11,11.81%,B2M;ABI3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.23967126523236984,0.6296249692675522,0.9324324324324325,1.0,1.0,5/32,12.49%,DEFB1;F2;HRG;FAM3A;CAMP
prerank,positive regulation of leukocyte activation (GO:0002696),0.2689225727830846,0.6294965420104384,0.9128113879003559,1.0,1.0,2/18,5.28%,HAVCR1;TLR4
prerank,COPII vesicle coating (GO:0048208),-0.18543141161242171,-0.6292914613044982,0.9819819819819819,0.9879150035171004,1.0,17/61,25.48%,GRIA1;CTSC;CUL3;NSF;CNIH1;ANKRD28;KLHL12;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;SAR1B;TMED2;TRAPPC3;RAB1B;COL7A1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.18543141161242171,-0.6292914613044982,0.9819819819819819,0.9879150035171004,1.0,17/61,25.48%,GRIA1;CTSC;CUL3;NSF;CNIH1;ANKRD28;KLHL12;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;SAR1B;TMED2;TRAPPC3;RAB1B;COL7A1
prerank,vesicle coating (GO:0006901),-0.18543141161242171,-0.6292914613044982,0.9819819819819819,0.9879150035171004,1.0,17/61,25.48%,GRIA1;CTSC;CUL3;NSF;CNIH1;ANKRD28;KLHL12;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;SAR1B;TMED2;TRAPPC3;RAB1B;COL7A1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.27429786131934386,-0.6274170433687328,0.8936170212765957,0.9884077225364906,1.0,6/10,32.03%,HOMER1;SARAF;CD84;HOMER3;CASQ1;HOMER2
prerank,eosinophil migration (GO:0072677),-0.25743380236828534,-0.6267828253744118,0.9085239085239085,0.9874621947142473,1.0,8/14,45.18%,SCG2;CCL13;CCL2;CCL4;CCL8;CCL1;CCL3;CCL11
prerank,eosinophil chemotaxis (GO:0048245),-0.25743380236828534,-0.6267828253744118,0.9085239085239085,0.9874621947142473,1.0,8/14,45.18%,SCG2;CCL13;CCL2;CCL4;CCL8;CCL1;CCL3;CCL11
prerank,positive regulation of histone deacetylation (GO:0031065),-0.26425715490413537,-0.6265962653211752,0.9160997732426304,0.9869308076160013,1.0,3/12,15.72%,PRKD1;VEGFA;APLNR
prerank,DNA replication initiation (GO:0006270),-0.20633741369211797,-0.6265792320421059,0.9627659574468085,0.986291345356985,1.0,14/37,32.13%,POLA1;PRIM2;RPA1;ORC5;ORC2;CDC45;MCM6;PRIM1;TOPBP1;CDC7;RPA3;RPA2;MCM4;MCM8
prerank,phospholipid biosynthetic process (GO:0008654),0.2336370980387616,0.626354849572292,0.9284552845528455,1.0,1.0,4/36,8.43%,AGPAT4;GPAT2;CPNE3;SAMD8
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20604134975913585,0.6263251493132728,0.9825072886297376,1.0,1.0,11/80,11.74%,SPHK1;LRRK2;SPSB4;FANCI;HUWE1;CDK5RAP3;FANCM;RIPK2;FBXO4;DCUN1D5;MAGEC2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2468592604804299,0.6251679829757211,0.923217550274223,1.0,1.0,7/25,18.55%,EPHA4;OPHN1;CSNK2A2;CSNK2A1;PML;HFE;TAF1
prerank,DNA double-strand break processing (GO:0000729),0.264194458606616,0.6246547584084219,0.9029982363315696,1.0,1.0,5/18,19.01%,ATM;RBBP8;RAD50;NBN;SLX4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.26435935938074717,-0.6245092920524425,0.908,0.9868532459481003,1.0,7/12,32.35%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.25279866609511326,-0.6240658758856698,0.922920892494929,0.9864558517522417,1.0,8/14,39.38%,RPL7;RPL35;NOL9;RPL7L1;RPF2;NIFK;PES1;URB1
prerank,dendritic cell chemotaxis (GO:0002407),-0.2520331850618037,-0.623766233371444,0.9130434782608695,0.9859763646019046,1.0,10/14,53.03%,TRPM2;CCL19;CXCR4;PIK3CG;CCR1;CCR6;CXCR2;HMGB1;CCR7;GPR183
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.21372793573042428,-0.6229391007733692,0.948051948051948,0.985824339142972,1.0,8/30,23.03%,CAVIN1;TAF1B;GTF2H4;GTF2H1;GTF2H5;POLR1F;ERCC2;POLR2L
prerank,cochlea morphogenesis (GO:0090103),0.3021324209982578,0.6222508551064079,0.8900414937759336,1.0,1.0,1/10,2.69%,HOXA1
prerank,inflammatory response (GO:0006954),0.1828979186569951,0.6221805473483925,0.9987277353689568,1.0,1.0,23/195,14.52%,KIT;ADCY1;IL18;LOXL3;BDKRB2;TLR4;IL17D;NOX1;PARP4;AFAP1L2;ADM;OLR1;HDAC4;HYAL1;RIPK2;CCL25;NOX4;NFATC3;TPST1;LAT;TLR5;NFKB1;AGTR2
prerank,glycerophospholipid metabolic process (GO:0006650),0.20857872821893778,0.6221734419542871,0.9716840536512668,1.0,1.0,9/75,10.56%,PIGN;PIGW;PLA1A;PDGFRB;PIGQ;CPNE3;PLCD1;PLA2G6;ABHD12
prerank,defense response to tumor cell (GO:0002357),0.3000396056365919,0.6213724039094437,0.8835341365461847,1.0,1.0,3/10,14.33%,PLK5;RBMS3;DLEC1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.30062119351969424,0.6206916897821027,0.8739837398373984,1.0,1.0,3/10,13.76%,RNF13;MAP2K1;MAP2K2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.23686458226374457,0.6206301610782315,0.9435897435897436,1.0,1.0,3/32,8.43%,PICALM;ATXN2;SAMD8
prerank,glutamate metabolic process (GO:0006536),0.25741908108145756,0.6204731324316407,0.916058394160584,1.0,1.0,3/19,9.78%,PRODH;GOT2;GLUL
prerank,positive regulation of stem cell proliferation (GO:2000648),0.267868946306225,0.6195642558527201,0.8978494623655914,1.0,1.0,5/17,19.90%,TERT;KAT7;CCNE1;KDM1A;LTBP3
prerank,production of siRNA involved in RNA interference (GO:0030422),0.293742403955739,0.6192999419051091,0.8762088974854932,1.0,1.0,2/10,11.39%,TERT;DICER1
prerank,protein secretion (GO:0009306),0.2158021153110627,0.6191585956374576,0.964451313755796,1.0,1.0,9/56,16.12%,WLS;ARFGAP3;RAB13;PORCN;MIA3;MON1A;TANGO2;RAB8B;STEAP3
prerank,protein import into nucleus (GO:0006606),0.20791144325780525,0.6179008314916988,0.9644444444444444,1.0,1.0,2/66,3.50%,APPL2;TNPO1
prerank,receptor recycling (GO:0001881),0.2963954567024999,0.6176901269519647,0.8696498054474708,1.0,1.0,3/10,17.84%,ARFGEF2;RAB11B;PHETA1
prerank,oligodendrocyte differentiation (GO:0048709),0.2664994436199172,0.6174583733684446,0.9157509157509157,1.0,1.0,3/19,15.50%,SLC8A3;SOX13;EIF2B1
prerank,regulation of macrophage differentiation (GO:0045649),0.2749844422176768,0.6174288317221406,0.9097888675623801,1.0,1.0,4/15,15.91%,RIPK1;PRKCA;INHA;IL34
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.24020133106129937,-0.6164436839725398,0.9337748344370861,0.9887791304450242,1.0,4/17,18.24%,PROX1;PKD1;CCNY;RGCC
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2654709956158983,0.6162664156974651,0.9012345679012346,1.0,1.0,3/16,15.32%,IL12B;PTPN22;LGALS3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.17468508322279114,0.6157300853092081,1.0,1.0,1.0,54/314,18.89%,ANAPC15;PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;ANAPC2;SPSB4;TBL1X;UBR2;SMURF2;FBXW11;HUWE1;BTRC;TBL1XR1;FBXO48;RNF34;SIRT1;ZSWIM8;ECPAS;FBXL12;AURKB;FBXO4;FZR1;CUL4A;WWP2;PML;DNAJB2;FBXL20;RMND5A;FAF1;AMFR;DNAJB14;ANAPC16;MAEA;NEMF;UBE2E1;UBR1;SYVN1;ERLIN2;UFD1;RB1;KCTD13;CDC34;DMAC2;NPLOC4;DNAJC18;TAF1;NHLRC3;FBXL22
prerank,natural killer cell activation (GO:0030101),-0.22218134793913166,-0.6147826711044696,0.9569377990430622,0.9890016140327443,1.0,6/23,18.50%,TOX;PTPRC;PBX1;SNX27;PRDX1;NFIL3
prerank,tRNA export from nucleus (GO:0006409),0.23723486202184077,0.61469425981464,0.9523809523809523,1.0,1.0,16/32,30.66%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;RAE1;NUP37;NUP160;NOL6;RANBP2;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.23723486202184077,0.61469425981464,0.9523809523809523,1.0,1.0,16/32,30.66%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;RAE1;NUP37;NUP160;NOL6;RANBP2;SSB
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23406252221700816,0.614496738371087,0.9581881533101045,1.0,1.0,8/33,23.31%,PABPN1;TTF2;SCAF8;CPSF3;CSTF1;PCF11;CPSF7;NUDT21
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.2818858201772036,-0.6142394951928042,0.9344608879492601,0.9886374821005717,1.0,1/10,1.56%,PDE8A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.23603973715207535,0.6141483514043663,0.9356435643564357,1.0,1.0,3/34,7.88%,LACC1;PTPN22;RBP4
prerank,negative regulation of T cell activation (GO:0050868),0.23256796089208243,0.6136768271511917,0.9704347826086956,1.0,1.0,10/35,23.05%,PTPN22;CD274;GLMN;SDC4;LGALS3;GPNMB;LAX1;DLG5;ARG1;RIPOR2
prerank,spindle assembly (GO:0051225),0.20930385973784432,0.6135081130354381,0.9729323308270676,1.0,1.0,18/67,19.80%,KIF2A;CLASP1;LSM14A;KIFC1;MAPRE2;MISP;STAG2;NCOR1;CEP63;GOLGA8B;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;TUBGCP4;ARHGEF10
prerank,protein deubiquitination (GO:0016579),0.17659150862628709,0.6127349954190559,1.0,1.0,1.0,46/242,20.51%,SMAD3;PRKN;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;USP11;TP53;SMURF2;PTEN;CDC25A;RCE1;RIPK1;BECN1;INO80D;USP34;UIMC1;USP49;USP12;USP7;OGT;DESI2;BABAM1;DDB2;MBD6;USP18;KAT2B;BIRC3;USP37;ASXL2;CLSPN;UFD1;SMAD4;USP1;RHOT1;USP48;USP33;USP35;USP21;USP16;TRAF3;INO80E;OTUD3
prerank,negative regulation of protein secretion (GO:0050709),0.2293562382531978,0.6124774185368166,0.9504132231404959,1.0,1.0,5/38,9.63%,PRKN;ADRA2A;IL12B;MIDN;RSAD2
prerank,aggrephagy (GO:0035973),0.2413623760305172,0.6123529871136607,0.9446308724832215,1.0,1.0,8/27,20.44%,PRKN;ATG5;IFT88;ACBD5;SQSTM1;DYNC1LI1;PCNT;WDR81
prerank,sulfur amino acid catabolic process (GO:0000098),0.2939877712072174,0.6122958535137988,0.8909774436090225,1.0,1.0,2/10,12.23%,CTH;MTRR
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.28133959054233587,0.6117155697036687,0.8901515151515151,1.0,1.0,3/12,13.58%,TLR4;MAP2K5;OAS3
prerank,regulation of mitochondrial translation (GO:0070129),-0.22149265848421762,-0.6113953956290769,0.9583333333333334,0.9895110382939503,1.0,11/21,36.88%,MALSU1;MTG2;RCC1L;FASTKD2;NSUN3;COA3;RPUSD3;NGRN;TRMT10C;C1QBP;MTG1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.2603555707393911,-0.6100768205631696,0.9213483146067416,0.9895149776428522,1.0,5/12,31.16%,DHODH;UCK2;UMPS;UPP1;TK2
prerank,osteoclast differentiation (GO:0030316),0.2539513387948278,0.6091360170990755,0.918918918918919,1.0,1.0,2/22,6.32%,OSTM1;GAB2
prerank,gas transport (GO:0015669),-0.276735742158116,-0.6090282599025043,0.9301848049281314,0.9893802644537456,1.0,2/10,14.11%,CA2;CYGB
prerank,DNA duplex unwinding (GO:0032508),-0.1887287541155609,-0.6088475916810183,0.9920844327176781,0.9888198690649366,1.0,21/50,31.86%,ANXA1;RAD23B;UBB;RPA1;DHX9;CETN2;GTF2H4;GTF2H1;GTF2H5;ERCC2;BLM;UBC;RPS27A;RECQL5;RECQL;MCM6;ERCC3;DDB1;RAD51;PIF1;MCM4
prerank,phagosome acidification (GO:0090383),0.2494712941192334,0.6084784053734344,0.9454855195911414,1.0,1.0,4/26,11.43%,ATP6V0E1;ATP6V0B;ATP6V1D;ATP6V1E1
prerank,macrophage differentiation (GO:0030225),-0.25280474399802444,-0.607785034493848,0.9282608695652174,0.9887278687635682,1.0,3/13,15.09%,BMP4;VEGFA;IL31RA
prerank,protein methylation (GO:0006479),0.22163368291821176,0.6066644311320719,0.9686028257456829,1.0,1.0,12/40,23.70%,NSD1;NSD3;ETF1;EHMT2;EHMT1;SETD3;N6AMT1;GSPT1;CAMKMT;PCMT1;ICMT;EEF1AKMT1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.23444059032256337,0.6065516816558725,0.9422066549912435,1.0,1.0,9/29,27.33%,TEX12;REC8;STAG3;FANCD2;P3H4;BAG6;SYCE2;TRIP13;TERB1
prerank,Golgi inheritance (GO:0048313),0.2859433943371962,0.606032878070745,0.8950381679389313,1.0,1.0,3/11,19.48%,PLK5;STX5;GOLGA2
prerank,rRNA catabolic process (GO:0016075),0.2696569776084181,0.60473747356476,0.9095840867992767,1.0,1.0,4/16,17.78%,EXOSC7;DIS3;EXOSC3;DIS3L
prerank,tRNA transport (GO:0051031),-0.1981865687800375,-0.6036690158692583,0.9820051413881749,0.9901866124262807,1.0,10/35,26.55%,YBX1;NUP210;RAN;NUP107;TOMM20;POM121;NUP93;NUP50;NUP85;NUP54
prerank,protein modification process (GO:0036211),0.1988070811341626,0.6036317339329286,0.9850299401197605,1.0,1.0,18/76,20.21%,MSRA;PARP4;RABGGTA;MANBA;FBXO22;ABL1;ARAF;UBE2M;PRKDC;WWP2;FBXO11;PLAT;PPP4R2;CDC34;PADI4;UBE2S;NTAQ1;GNMT
prerank,myeloid dendritic cell activation (GO:0001773),-0.25907023562615417,-0.6029371001569558,0.9342105263157895,0.9898755662458842,1.0,2/12,9.92%,CAMK4;DOCK2
prerank,Golgi ribbon formation (GO:0090161),0.2817432063754348,0.6029000733869659,0.8943396226415095,1.0,1.0,5/13,19.78%,MYO18A;VTI1A;OPTN;GOLGA2;STX16
prerank,nucleotide biosynthetic process (GO:0009165),0.25729056444808907,0.6018495658316212,0.9327433628318584,1.0,1.0,7/18,19.75%,NMNAT1;PRPSAP1;PRPSAP2;NMNAT2;MTHFD1;GART;ADSL
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.29138078265266176,0.6014715719931761,0.883495145631068,1.0,1.0,2/10,13.33%,MAP2K5;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.29138078265266176,0.6014715719931761,0.883495145631068,1.0,1.0,2/10,13.33%,MAP2K5;WNK1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2590857182582646,0.600665102614896,0.9227941176470589,1.0,1.0,2/17,9.00%,MCU;DNM1L
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19126248869118415,0.6001709537389559,0.9942279942279942,1.0,1.0,22/95,21.68%,RAD54L;NIPBL;FBH1;SAMHD1;FANCM;RBBP8;HUS1;RAD50;NSMCE2;MCM7;MCM2;REC8;ZFYVE26;POLL;XRCC3;NBN;FEN1;SLX4;RAD51D;MCM9;YY1;MCM5
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20300099527512236,-0.6000889311667744,0.9741602067183462,0.9905770041951703,1.0,10/32,28.55%,CAVIN1;TAF1B;GTF2H4;GTF2H1;GTF2H5;POLR1F;ERCC2;POLR2L;MAPK3;ERCC3
prerank,cilium movement (GO:0003341),0.21415375911671947,0.5999561266586849,0.9656301145662848,1.0,1.0,10/47,22.53%,ODAD1;ROPN1L;CFAP251;CCDC39;CCDC40;DNAI4;DNAAF5;GAS8;CFAP73;RSPH6A
prerank,renal filtration (GO:0097205),-0.2681733391938484,-0.5997848537334025,0.9156118143459916,0.9900691056101393,1.0,2/10,8.45%,CD34;MCAM
prerank,translesion synthesis (GO:0019985),0.2196699372440216,0.5979215634403566,0.9689034369885434,1.0,1.0,9/42,19.18%,POLD2;PARP10;REV1;POLDIP2;ZBTB1;POLE2;UFD1;NPLOC4;RFC1
prerank,autophagosome maturation (GO:0097352),0.22731802196219636,0.5978441366017995,0.9741100323624595,1.0,1.0,5/32,16.22%,LAMP2;UVRAG;LIX1L;VIPAS39;SNX14
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.228689688728901,0.5974972280977512,0.9581881533101045,1.0,1.0,10/30,22.58%,FHIT;STYX;USP7;OGT;TLK2;HFE;SDCBP;CAMLG;TRIM39;BAG6
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.23885822333993104,0.5973258481914819,0.9357021996615905,1.0,1.0,8/24,23.30%,ACD;TNKS2;HNRNPC;TENT4B;TINF2;SLX4;XRN1;PINX1
prerank,regulation of double-strand break repair (GO:2000779),-0.18934627522780903,-0.5968032215581154,0.9830508474576272,0.9908371588974503,1.0,5/39,14.30%,FMN2;ACTR2;SETD2;TWIST1;TERF2IP
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.24785640702658202,0.5964944985628402,0.9420783645655877,1.0,1.0,7/22,23.98%,TP53;MED12;MED17;MED1;MED13;MED24;PSMC4
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.28391525481121416,0.5964848666316843,0.9092702169625246,1.0,1.0,2/10,13.61%,CD274;PRKAR1A
prerank,negative regulation of mRNA processing (GO:0050686),0.27031242774445724,0.5962717923390296,0.9459962756052142,1.0,1.0,6/15,25.54%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,autophagosome assembly (GO:0000045),0.20975143285462797,0.5958279600010549,0.973724884080371,1.0,1.0,9/52,13.81%,ATG5;WIPI1;AMBRA1;ATG7;RAB43;BECN1;IRGM;ATG2A;MFN2
prerank,autophagosome organization (GO:1905037),0.21000516171625985,0.5945932349843203,0.9646153846153847,1.0,1.0,16/50,24.31%,ATG5;WIPI1;AMBRA1;ATG7;RAB43;BECN1;IRGM;ATG2A;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG3;ATG2B;ULK3
prerank,regulation of viral transcription (GO:0046782),0.21794522187206702,0.5938326528452288,0.956738768718802,1.0,1.0,7/39,14.85%,POLR2A;POLR2D;LARP7;GTF2F1;NELFCD;TRIM62;CTDP1
prerank,phosphate ion transport (GO:0006817),0.26008265169313627,0.5927395959403218,0.939622641509434,1.0,1.0,5/16,22.80%,SLC20A2;SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.2673716405422915,0.5926210694536785,0.9237918215613383,1.0,1.0,2/13,12.31%,KPNA6;RGPD1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.23725624725176458,-0.5915626358130591,0.9422222222222222,0.9926143159297173,1.0,10/16,40.83%,CELF4;TRA2A;RBM3;RBMXL1;CIRBP;SF3B4;CELF3;NCBP1;RBMX;NCL
prerank,positive regulation of neutrophil migration (GO:1902624),0.2511695320498677,0.5908584639929013,0.9367088607594937,1.0,1.0,2/18,9.00%,MCU;DNM1L
prerank,early endosome to Golgi transport (GO:0034498),-0.2587069812491684,-0.5906390365191453,0.9482758620689655,0.9923554044928089,1.0,3/11,19.38%,RAB6A;EHD3;TMED9
prerank,regulation of cholesterol transport (GO:0032374),0.24729777242746515,0.5901463170550565,0.9363957597173145,1.0,1.0,7/20,20.33%,LRP1;ARV1;TTC39B;NFKB1;NR1H3;LAMTOR1;ABCA2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.247431791825167,-0.5886469702726299,0.9398797595190381,0.9925958229442711,1.0,4/12,26.48%,WRNIP1;TIPIN;BLM;WDR18
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.24867667138149965,0.5877424115514153,0.9363957597173145,1.0,1.0,2/19,9.00%,MCU;DNM1L
prerank,mitotic chromosome condensation (GO:0007076),0.23468431159061473,0.5872008890749815,0.9525483304042179,1.0,1.0,7/26,18.03%,CHMP1A;CSNK2A2;CSNK2A1;KMT5A;NCAPD3;RB1;NCAPD2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.23512408070692603,0.5868581496139532,0.9498269896193772,1.0,1.0,4/27,13.69%,NUDT13;AK4;CTPS2;AK8
prerank,tRNA processing (GO:0008033),0.20186246517503362,0.586635625748454,0.9848942598187311,1.0,1.0,9/61,20.49%,TRMT9B;TSEN2;RPP21;LCMT2;WDR4;POP7;DTWD2;POP1;ADAT2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.18599349872104656,0.5857502665527013,0.9957507082152974,1.0,1.0,19/94,19.72%,CC2D2A;CEP250;CLASP1;NINL;RAB3IP;CEP162;SDCCAG8;NPHP1;ALMS1;B9D2;CEP63;PCM1;CEP57;AKAP9;PCNT;TCTN3;CEP164;OFD1;DCTN3
prerank,DNA recombination (GO:0006310),0.21775561025311524,0.5856696744733343,0.9577464788732394,1.0,1.0,8/37,20.62%,RAD54L;FBH1;MSH3;IGHMBP2;RAD50;XRCC3;RAD51D;LIG4
prerank,histone H4-K5 acetylation (GO:0043981),-0.23464037828280548,-0.5847716411719602,0.9509345794392523,0.9929064615197283,1.0,4/15,19.92%,JADE3;JADE1;MEAF6;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),-0.23464037828280548,-0.5847716411719602,0.9509345794392523,0.9929064615197283,1.0,4/15,19.92%,JADE3;JADE1;MEAF6;MCRS1
prerank,regulation of T cell differentiation (GO:0045580),0.22180313358293685,0.5836171998637354,0.966832504145937,1.0,1.0,6/33,12.36%,TNFRSF18;TCF7;ABL1;ZMIZ1;ZBTB1;FANCA
prerank,import into nucleus (GO:0051170),0.1938627292165367,0.5834743203495701,0.9894736842105263,1.0,1.0,2/73,3.50%,APPL2;TNPO1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.285200787391519,0.5829897371105153,0.9130434782608695,1.0,1.0,3/10,20.09%,PTPN22;IFI35;NR1H3
prerank,positive regulation of leukocyte migration (GO:0002687),-0.20142684030475866,-0.5826596557475784,0.9747706422018348,0.9931352722381837,1.0,7/27,24.77%,ICAM1;PTN;EDN3;VEGFA;IL6R;MDK;THY1
prerank,RNA splicing (GO:0008380),0.18706451012117517,0.5820836391440206,0.9943502824858758,1.0,1.0,32/95,26.53%,PPARGC1A;YJU2;NOVA1;LUC7L3;SRPK2;PRPF18;SRSF11;HNRNPC;SCAF11;SNRNP40;PRPF3;USP39;ZCRB1;FUS;PRPF6;HNRNPH3;U2AF1;SRSF10;SRSF7;WBP4;SF3B2;SF3B1;SNRPA1;RNPC3;NRDE2;LSM6;RP9;DHX8;RRAGC;SRSF4;SF3B3;KHSRP
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.1966113878861287,-0.5819367698638489,0.9852941176470589,0.9927866161811114,1.0,18/36,34.14%,HSP90AB1;RYBP;AQP11;DDRGK1;NOP53;GABARAPL2;RPL11;BAG5;N4BP1;PSME3IP1;CCAR2;WAC;F8A1;PSMF1;PARK7;UBXN1;ALAD;UCHL5
prerank,cellular component maintenance (GO:0043954),0.27550746889910865,0.5816415006635629,0.9192100538599641,1.0,1.0,6/12,30.40%,PICK1;ITGA3;CLDN1;PRNP;IGF1R;INSR
prerank,regulation of stem cell population maintenance (GO:2000036),0.24961740093570267,0.5812519670534237,0.9306049822064056,1.0,1.0,5/18,21.45%,NCOA3;WDR43;NODAL;REST;TAF6L
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.26090948335613257,0.5808353430759404,0.9146567717996289,1.0,1.0,1/14,6.56%,IL12B
prerank,regulation of necroptotic process (GO:0060544),0.23694970278801727,0.5807430619376573,0.947565543071161,1.0,1.0,6/23,17.48%,CFLAR;RIPK1;FLOT2;OGT;BIRC3;ZBP1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.238461018330563,-0.5807316888133248,0.9441964285714286,0.9925938842879889,1.0,7/14,35.70%,RPS3;CD81;RELA;CARD11;BCL10;TRAT1;LCK
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.214532085233566,0.58037065435407,0.9715719063545151,1.0,1.0,15/40,27.30%,SMG1;WDR76;ABL1;KMT5A;MCL1;CRY1;USP1;FMR1;CASP9;FBXO5;BCLAF1;PRKCD;ING2;UBE2V1;FXR2
prerank,mitochondrial transcription (GO:0006390),-0.2665411542973789,-0.5790764104033005,0.945031712473573,0.9926509385858486,1.0,4/10,21.93%,TFAM;SLC25A33;TEFM;TFB1M
prerank,regulation of glycogen metabolic process (GO:0070873),0.26735548138885334,0.579065409356224,0.9378531073446328,1.0,1.0,1/12,5.85%,PPP1R3B
prerank,transcription preinitiation complex assembly (GO:0070897),0.2744892686090362,0.5776018016476282,0.943289224952741,1.0,1.0,6/12,25.15%,TAF11;TBP;TAF7;TAF1;TAF12;BDP1
prerank,error-free translesion synthesis (GO:0070987),-0.2120565547296794,-0.5771612280813793,0.967816091954023,0.9927509379930644,1.0,10/22,31.15%,UBB;RPA1;RFC4;POLD1;RFC2;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,response to light stimulus (GO:0009416),-0.17391688133228775,-0.5770979014292766,1.0,0.9921374243817418,1.0,21/55,31.16%,MAP4K3;ERCC6;PRIMPOL;UBE2B;CRY2;MEN1;ERCC2;DRD2;POLD1;DTL;MAP2K7;CCAR2;PCLAF;GPR52;UBE2A;TYR;MAPK8;ERCC3;CIRBP;TRIM32;GPR88
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.23452810203518715,-0.5767954312383989,0.9662162162162162,0.9916287552585653,1.0,2/16,8.76%,PTPRC;CEACAM1
prerank,protein localization to phagophore assembly site (GO:0034497),0.2769794104981027,0.5763038172108608,0.9275929549902152,1.0,1.0,2/11,13.81%,WIPI1;MFN2
prerank,ncRNA 3'-end processing (GO:0043628),0.2599806596190575,0.5755497399956145,0.9322033898305084,1.0,1.0,4/14,17.22%,INTS2;INTS5;INTS7;INTS8
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.26889186884662275,0.5746175082706266,0.9121495327102803,1.0,1.0,5/11,27.65%,TP53;SP100;MAD2L2;FOXM1;MUC1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.27174374151965913,0.5719668567746244,0.8953271028037383,1.0,1.0,3/11,17.39%,LARP7;TENT4B;EXOSC3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.2556254316015647,0.5714071665555054,0.9217221135029354,1.0,1.0,2/14,7.06%,ETNK2;SLC27A1
prerank,mRNA methylation (GO:0080009),-0.23373586429656037,-0.5704409458095346,0.9623430962343096,0.9933876085237462,1.0,7/15,38.13%,TRMT61B;METTL3;TRMT6;CBLL1;ZC3H13;TRMT10C;TRMT61A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.24734827773514542,-0.5695548591117406,0.9453441295546559,0.9930745564789923,1.0,6/11,34.04%,UQCRB;UQCR11;CYCS;UQCC3;UQCR10;CYC1
prerank,tyrosine metabolic process (GO:0006570),0.2681564245810057,0.569469235225955,0.9213483146067416,1.0,1.0,11/11,73.20%,FAH;DCT;GSTZ1;TAT;PAH;TH;HGD;IYD;IL4I1;THAP4;TYR
prerank,tRNA methylation (GO:0030488),-0.1902890793769872,-0.5686770706802294,0.978891820580475,0.9927652581304427,1.0,16/34,41.48%,METTL1;TRMT61B;MTO1;THADA;THUMPD2;METTL2A;METTL2B;TRDMT1;TRMT10C;TRMT5;GTPBP3;TRMT10A;TRMT61A;NSUN6;TRMT13;ALKBH8
prerank,negative regulation of interferon-beta production (GO:0032688),-0.25313823301888716,-0.568333111392689,0.9480249480249481,0.9922287038820872,1.0,3/10,21.37%,REL;RELB;PYCARD
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.22441272985899988,0.5674817298550573,0.9746621621621622,1.0,1.0,6/28,19.29%,BID;DDX3X;BLOC1S2;DEDD;TNFRSF1A;DELE1
prerank,cellular response to UV (GO:0034644),0.18777463584065132,0.5673777627342841,0.9926793557833089,1.0,1.0,19/76,22.00%,NEDD4;TP53;CDC25A;HYAL1;SIRT1;AURKB;IMPACT;ZBTB1;DDB2;SDE2;CREBBP;KDM1A;TAF1;XPA;NOC2L;FMR1;YY1;OPN1SW;CASP9
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.19945549628409967,0.5668989538737422,0.9819819819819819,1.0,1.0,14/51,21.42%,LEMD2;CCNB2;NUP98;REEP4;NUP43;LBR;VPS4A;NUP155;CHMP4C;NUP188;SUMO1;CHMP2A;CC2D1B;UBE2I
prerank,mitotic nuclear membrane organization (GO:0101024),0.19945549628409967,0.5668989538737422,0.9819819819819819,1.0,1.0,14/51,21.42%,LEMD2;CCNB2;NUP98;REEP4;NUP43;LBR;VPS4A;NUP155;CHMP4C;NUP188;SUMO1;CHMP2A;CC2D1B;UBE2I
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.27701620566706997,0.5666619063197347,0.9212598425196851,1.0,1.0,3/10,22.31%,TGFBR2;CD55;ZBTB7B
prerank,positive regulation of immune response (GO:0050778),0.1939220610814526,0.5666492683274313,0.9881305637982196,1.0,1.0,9/64,14.38%,IFNK;IL12B;PLSCR1;HRG;RSAD2;SIRT1;NMI;IFI35;SPHK2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.26736358608178307,0.5654857681700658,0.9275092936802974,1.0,1.0,1/11,6.56%,IL12B
prerank,regulation of cell cycle phase transition (GO:1901987),-0.154653787529069,-0.5641868497815143,1.0,0.992951494568867,1.0,37/91,36.03%,PSMB2;PSMD14;PSMC6;ATP2B4;BUB3;CDKN1A;PSMB9;PSMA4;CDC23;SKP1;PSMD11;PSMB10;PSMD2;ERCC2;PSMA2;MAD2L1;NEK10;TFAP4;PSMB3;UBE2D1;PSMB5;ERCC3;DDB1;PSMD7;PSMF1;CDK1;TCIM;CDC20;UBE2C;PSMA5;PSME4;ANAPC10;PSMA7;ANAPC1;PSMD3;CCNB1;PSMD4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.23717503597474215,0.563925569588484,0.9595782073813708,1.0,1.0,9/21,24.32%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;FBXO5;GORASP1;MAD2L2
prerank,response to hexose (GO:0009746),-0.195600532634633,-0.5618110692055951,0.9830097087378641,0.9930882335452347,1.0,15/25,49.44%,THBS1;EIF2B3;IRS2;EIF2B2;KHK;EIF2B5;ZBED3;SLC2A5;NEUROD1;SELENOT;HNF4A;LPL;MAFA;PFKL;GYS2
prerank,mitochondrial translation (GO:0032543),0.17611701951713218,0.5612788104888073,1.0,1.0,1.0,27/104,27.00%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;MTRF1L;MRPL1;GFM2;MRPL45;MRPS17;MTRF1;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPL50;MRPS25;MRPL19;MRPL33;MRPS18B;MRRF;TSFM
prerank,negative regulation of RNA splicing (GO:0033119),-0.2167941749100815,-0.560108824402279,0.9816091954022989,0.9929708501673026,1.0,7/19,27.22%,TMBIM6;RPS26;RNPS1;RPS13;SRSF12;SRSF6;PTBP2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.26729572612162594,0.5600793742345317,0.94106463878327,1.0,1.0,2/10,16.29%,TUT4;TUT7
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.24023908137885874,0.5592963356853591,0.9630996309963099,1.0,1.0,2/17,7.35%,SERPINE1;ANO6
prerank,regulation of chromosome segregation (GO:0051983),0.24479645153639126,0.5588504392986294,0.943289224952741,1.0,1.0,3/16,11.87%,AURKB;CSNK2A2;CSNK2A1
prerank,regulation of biosynthetic process (GO:0009889),-0.24390582376863568,-0.5587017274533161,0.9605263157894737,0.9928148823250799,1.0,2/11,13.17%,SLC25A33;SNCA
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.22519172276796515,-0.558384481089756,0.9719222462203023,0.9922860260399546,1.0,4/16,21.08%,IRAK3;SHFL;GLE1;BNIP3
prerank,positive regulation of telomere capping (GO:1904355),0.23919269319763126,0.5571648006381239,0.9369202226345084,1.0,1.0,3/17,12.56%,TNKS2;AURKB;PNKP
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.18928797580353723,-0.555697703166872,0.9928909952606635,0.9925095502277689,1.0,11/29,28.66%,YBX1;TAF15;EIF4ENIF1;TENT5A;NBAS;PABPC1;DHX34;RBM24;ELAVL1;PAIP1;CIRBP
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.19990088421469707,0.5534107516023504,0.9818481848184818,1.0,1.0,12/46,24.76%,HK2;TIMM44;TOMM70;MFN2;PITRM1;TIMM10;TIMM17B;TIMM17A;TIMM21;HK1;CHCHD4;DNAJC15
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.2462193316224618,0.5528751127778934,0.960377358490566,1.0,1.0,6/15,27.31%,SYVN1;UFD1;NPLOC4;SELENOS;DERL1;OS9
prerank,glycine transport (GO:0015816),0.26806464928636076,0.5515947475586239,0.9365671641791045,1.0,1.0,4/10,24.91%,SLC6A9;SLC25A38;SLC36A2;SLC7A8
prerank,regulation of receptor recycling (GO:0001919),-0.22376270125858538,-0.5513928159118267,0.9835680751173709,0.9931833859967486,1.0,4/16,17.19%,ECE1;NSF;SNCA;SCRIB
prerank,chromatin remodeling at centromere (GO:0031055),0.21289796026863114,0.5510232534900513,0.971107544141252,1.0,1.0,14/31,28.25%,NASP;CENPO;CENPC;CENPV;CENPK;CENPT;ITGB3BP;RUVBL1;RSF1;CENPN;RBBP4;CENPQ;RBBP7;CENPS
prerank,negative regulation of cell division (GO:0051782),0.2579276131079004,0.5506419357703402,0.9534450651769087,1.0,1.0,4/11,21.58%,AURKB;VPS4A;CHMP4C;ORC6
prerank,C-terminal protein amino acid modification (GO:0018410),0.26009704906310843,0.550139076219894,0.9344894026974951,1.0,1.0,7/11,26.52%,ATG5;ATG7;FOLH1;ICMT;AGTPBP1;ATG12;GPLD1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.2460938766740944,-0.5496981442031734,0.9568788501026694,0.9930569919162604,1.0,5/10,31.24%,THOC5;RFWD3;CCAR2;RPA2;ETAA1
prerank,protein autoprocessing (GO:0016540),-0.21259008307757257,-0.5495813333882114,0.9698275862068966,0.99245743885671,1.0,10/17,48.93%,CTSL;HTRA2;CASP4;FAM111A;MYRF;TMPRSS2;HJV;PCSK9;SPRTN;OMA1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.21994550401823385,0.5493611366048912,0.972027972027972,1.0,1.0,9/25,26.53%,SCAF11;SNRNP40;PRPF3;PRPF6;SRSF10;SF3B1;SRSF4;SF3B3;KHSRP
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.2576047480352449,0.5491466862335619,0.940754039497307,1.0,1.0,2/13,14.38%,GAB2;SPHK2
prerank,negative regulation of double-strand break repair (GO:2000780),0.2144009461103928,0.5481228194086258,0.9747474747474747,1.0,1.0,10/30,26.16%,FBH1;TRIP12;UBR5;SMCHD1;TFIP11;OGG1;OTUB2;MAD2L2;SHLD2;UBQLN4
prerank,regulation of microtubule-based movement (GO:0060632),0.26206444054225986,0.5476913804713125,0.9471624266144814,1.0,1.0,1/11,5.39%,MAP2
prerank,intracellular protein transmembrane transport (GO:0065002),0.20111382491715327,0.5475136009032345,0.9883527454242929,1.0,1.0,14/42,24.76%,TIMM44;PEX10;TOMM70;PEX14;PEX5;PEX16;C2CD5;TIMM17B;RTN2;TIMM17A;TIMM21;PEX26;CHCHD4;DNAJC15
prerank,sensory perception of pain (GO:0019233),0.2298466261386966,0.5461248941775724,0.9679144385026738,1.0,1.0,1/21,2.16%,RETREG1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.23496982658675106,-0.5450550476003697,0.9708333333333333,0.993116042816103,1.0,5/12,30.61%,CEACAM1;ERLIN1;TRIB3;ACADVL;BRCA1
prerank,neuron fate commitment (GO:0048663),0.24494330044805768,0.5448063633904209,0.9410681399631676,1.0,1.0,1/14,3.48%,TGFBR1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.26387784146513027,0.5441811123391747,0.9476635514018692,1.0,1.0,3/11,22.14%,AHCYL1;ZFP36L1;ZC3H3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.24897119818448255,0.54289837837486,0.9433962264150944,1.0,1.0,4/13,16.72%,MAVS;AXL;AGPAT1;WNT5A
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.21379323387574636,-0.5428563343731279,0.9875,0.9930796904828674,1.0,8/16,38.11%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B;ATP5ME
prerank,nuclear membrane reassembly (GO:0031468),0.19001800726454704,0.5426059003179033,0.986322188449848,1.0,1.0,16/54,23.68%,LEMD2;CCNB2;NUP98;REEP4;NUP43;LBR;VPS4A;NUP155;CHMP4C;NUP188;SUMO1;CHMP2A;CC2D1B;UBE2I;UBXN2A;IST1
prerank,Golgi to endosome transport (GO:0006895),0.2379385116874782,0.5414603406858316,0.9529837251356239,1.0,1.0,7/16,24.73%,WIPI1;AP2A1;VPS13A;AP4M1;MON2;KLHL20;KIF16B
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.23347071339932002,0.539998193492135,0.9681050656660413,1.0,1.0,2/19,7.77%,CHRNA5;RAPSN
prerank,tRNA metabolic process (GO:0006399),0.23056022831288844,0.5381172965022691,0.9535315985130112,1.0,1.0,9/17,33.34%,RPP21;POP7;POP1;KARS1;THG1L;SSB;DTD2;DTD1;AARS1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.24207420428149917,0.5354949944756524,0.9506903353057199,1.0,1.0,13/13,75.81%,CPSF7;TUT1;NUDT21;CSTF2;CPSF2;CPSF6;FIP1L1;NCBP1;CPSF1;CSTF2T;CPSF4L;CPSF4;NCBP2
prerank,response to acidic pH (GO:0010447),0.24532744298709075,0.5347707320033689,0.9615384615384616,1.0,1.0,2/13,11.60%,RAB11B;IMPACT
prerank,positive regulation of macrophage differentiation (GO:0045651),0.24820409625710066,0.5342300007382885,0.9566074950690335,1.0,1.0,3/11,15.91%,RIPK1;PRKCA;IL34
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.254581786558044,0.5341256310262854,0.9426386233269598,1.0,1.0,5/10,30.23%,ZNHIT6;RUVBL1;PIH1D2;PIH1D1;NUFIP1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.20217908296053377,-0.5333738906916333,0.9795454545454545,0.9948958283547927,1.0,7/20,28.01%,APOE;SREBF2;RAN;LDLRAP1;NR1H4;KPNB1;ACADVL
prerank,microtubule nucleation (GO:0007020),0.22406102895690072,0.5324605959275517,0.9611111111111111,1.0,1.0,6/19,19.67%,CLASP1;SLAIN2;RANBP9;AKAP9;GOLGA2;TUBGCP4
prerank,metallo-sulfur cluster assembly (GO:0031163),0.21704662493406646,0.530560950922592,0.9734982332155477,1.0,1.0,7/22,24.74%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,T cell activation involved in immune response (GO:0002286),0.2537208540425009,0.5284690947968028,0.9566929133858267,1.0,1.0,1/12,5.52%,IFNK
prerank,regulation of cilium movement (GO:0003352),0.25841074566909367,0.5273913998259467,0.9547169811320755,1.0,1.0,10/10,74.18%,CCDC39;CCDC40;DNAH11;ODAD2;DRC1;DNAAF1;CFAP298;CFAP206;CCDC65;CFAP43
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.19470293051189397,-0.5258916176756154,0.986046511627907,0.9960569233942723,1.0,7/19,34.02%,AR;MAF1;POLR3F;POLR3C;NAB2;TENM1;CEBPA
prerank,acetyl-CoA metabolic process (GO:0006084),-0.21239569385552137,-0.5248292028054036,0.9747706422018348,0.9956809974482477,1.0,3/15,13.29%,HMGCS1;DIP2A;PMVK
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.15305878518670896,-0.5247438342019487,1.0,0.9950641601307003,1.0,15/69,25.26%,HSPA5;DNAJC10;PSMC6;SEC61B;ERLIN1;SGTB;YOD1;MAN1B1;RNF103;UBE2G2;RNF121;UBQLN2;FAM8A1;AUP1;STUB1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.22209824777405762,0.5237071632297629,0.9732142857142857,1.0,1.0,2/20,11.01%,FDXR;TSPOAP1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.24559892612039602,0.5234152479772451,0.9515503875968992,1.0,1.0,4/11,23.93%,P4HA1;OGFOD1;EGLN1;CRTAP
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.14581713750107064,-0.5233303521201246,1.0,0.9947788166723601,1.0,17/88,24.38%,FBXL7;PSMB2;FBXL5;FBXL2;PSMD14;PSMC6;PSMB9;FBXO31;PSMA4;SKP1;PSMD11;PSMB10;PSMD2;AMN1;PSMA2;KIF14;PSMB3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.23150129379091056,0.5230111821931963,0.9586466165413534,1.0,1.0,3/16,13.59%,SCD5;MLYCD;GCDH
prerank,cellular response to estradiol stimulus (GO:0071392),0.21969447579578544,0.5208778629185457,0.96875,1.0,1.0,3/18,12.18%,NCOA3;LCOR;CCDC62
prerank,establishment of protein localization to extracellular region (GO:0035592),0.1936953201288457,0.5175761502268361,0.9948979591836735,1.0,1.0,11/39,23.21%,ARFGAP3;RAB13;MIA3;MON1A;TANGO2;RAB8B;STEAP3;LTBP2;MIA2;AFM;RAB10
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2305465157843412,0.5168930183694417,0.9679245283018868,1.0,1.0,3/14,11.77%,APH1B;DYRK1A;ADAM17
prerank,RNA interference (GO:0016246),-0.19672362654332087,-0.5161786567188847,0.9847826086956522,0.9956893195531459,1.0,3/17,16.20%,TSNAX;DROSHA;DHX9
prerank,midbody abscission (GO:0061952),0.21955514936902396,0.515763612189211,0.968141592920354,1.0,1.0,5/17,22.02%,CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,regulation of oxidoreductase activity (GO:0051341),0.2395100679630847,0.5154804643997977,0.9571428571428572,1.0,1.0,3/13,19.71%,ABL1;SIRT4;ATP7A
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.1985410270671032,-0.5153524784660815,0.9897330595482546,0.9952338342865944,1.0,8/17,38.11%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B;ATP5ME
prerank,natural killer cell mediated immunity (GO:0002228),0.23452149544087136,0.5135252881571912,0.9686346863468634,1.0,1.0,4/15,22.82%,KIF5B;ULBP1;CEBPG;LYST
prerank,transcription by RNA polymerase I (GO:0006360),-0.171789999318465,-0.5131206624543593,0.9973614775725593,0.9950474873541475,1.0,10/34,28.55%,CAVIN1;TAF1B;GTF2H4;GTF2H1;GTF2H5;POLR1F;ERCC2;POLR2L;MAPK3;ERCC3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.19107130235319106,0.5128460881435285,0.993431855500821,1.0,1.0,6/37,15.69%,SIDT2;DNASE1L1;EXOSC7;SND1;DFFB;DNASE1L2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.24638483170586806,0.5110947252853906,0.9596153846153846,1.0,1.0,2/10,16.32%,TP53;SP100
prerank,negative regulation by host of viral transcription (GO:0043922),0.2318895166352793,0.5108957919508635,0.9734345351043643,1.0,1.0,12/12,76.83%,HDAC1;REST;TARDBP;POU2F3;CCL5;CCL3;PSMC3;CCL4;INPP5K;JUN;HMGA2;TFAP4
prerank,negative regulation of lymphocyte activation (GO:0051250),0.21287523393143232,0.5077566114724353,0.9693140794223827,1.0,1.0,5/21,17.96%,PTPN22;LGALS3;PIBF1;GPNMB;LAX1
prerank,defense response to fungus (GO:0050832),0.21836986162908384,0.5076648270182282,0.9711191335740073,1.0,1.0,2/17,9.16%,HRG;FAM3A
prerank,nuclear body organization (GO:0030575),0.23807855512895498,0.507362515807692,0.9751908396946565,1.0,1.0,5/12,24.95%,SRPK2;PML;USPL1;DYRK3;ZPR1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.19500400259922798,-0.5073410389389875,0.9932432432432432,0.9954933444330187,1.0,7/19,30.08%,CTNNB1;VEGFA;MANF;LRP6;LMX1A;LMX1B;WNT2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.2389018342011791,0.5064120400701259,0.9653846153846154,1.0,1.0,2/10,16.72%,RYK;WNT5A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.1953357718187699,0.5063085974605807,0.9916107382550335,1.0,1.0,8/31,21.17%,EXOSC7;DDX6;DCP1A;DIS3;NT5C3B;EXOSC3;EDC4;POLR2G
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.21972306933930008,-0.5032914013371723,0.9820717131474104,0.9955904810213552,1.0,4/12,28.02%,STK33;CHEK2;TOPBP1;HUS1B
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.21874292687424732,0.5032791836061684,0.9663120567375887,1.0,1.0,3/17,15.27%,AFG1L;COX10;COX8A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2238477960567625,0.5028671184308444,0.9712230215827338,1.0,1.0,16/16,77.64%,FBH1;SMCHD1;MAD2L2;SHLD2;UBQLN4;KLHL15;FANCB;SHLD1;RADX;RMI2;PARPBP;RIF1;HELB;SHLD3;CGAS;POLQ
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.19949637758600403,0.50058351065642,0.982078853046595,1.0,1.0,5/27,14.25%,TLR4;TAB2;LY96;MAP3K1;TLR5
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.18589451294214523,0.49908539297372195,0.9902912621359223,1.0,1.0,16/38,28.60%,ATRX;NASP;CENPO;CENPC;CENPK;CENPT;ASF1A;ITGB3BP;RUVBL1;RSF1;CENPN;RBBP4;CENPQ;RBBP7;CENPS;IPO4
prerank,COPII-coated vesicle budding (GO:0090114),0.17024802646452042,0.4977387590516688,1.0,1.0,1.0,20/68,23.46%,SEC31B;TRAPPC9;MIA3;TGFA;STX5;F8;SEC23IP;SCFD1;SEC31A;TRAPPC5;PPP6R3;SCAP;GOLGA2;FOLR1;BET1;SEC24A;SEC24C;SEC16A;GORASP1;F5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.21828541500254633,0.4963543123198074,0.9655172413793104,1.0,1.0,2/16,11.31%,F2;PRKCA
prerank,negative regulation of transferase activity (GO:0051348),0.19103689285198944,0.4934515007318722,0.9879518072289156,1.0,1.0,4/28,11.34%,NPRL2;TP53;ABL1;EIF4A2
prerank,regulation of histone modification (GO:0031056),0.22512623107593838,0.49194273205330097,0.9661016949152542,1.0,1.0,2/13,13.91%,MTHFR;FLCN
prerank,multivesicular body assembly (GO:0036258),0.1927115205801763,0.49178982225815054,0.9935379644588045,1.0,1.0,10/30,26.14%,CHMP1A;VPS37A;VPS4A;SNF8;CHMP4C;CHMP2A;IST1;MVB12A;VTA1;STAM2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.21093946244662137,0.49013609948667797,0.979890310786106,1.0,1.0,18/18,78.93%,THEM4;PPIF;SLC25A4;BCL2;SLC25A31;MUL1;BCL2L1;SLC25A5;HEBP2;NAIF1;BAK1;TMEM102;ALKBH7;BAD;CAMK2A;PMAIP1;SPG7;BNIP3
prerank,glutathione metabolic process (GO:0006749),0.1802762704220022,0.48936632268864666,0.9967948717948718,1.0,1.0,7/38,19.36%,GSTT1;CTNS;GSTA3;MMACHC;GSTT2;ETHE1;CNDP2
prerank,protein insertion into ER membrane (GO:0045048),0.18522857643217208,0.489063779044958,0.996742671009772,1.0,1.0,9/37,22.58%,TRAM2;EMC2;EMC1;STX5;EMC3;UBE2J2;CAMLG;GET4;BAG6
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.1902927648980249,0.48846327916985527,0.9871589085072231,1.0,1.0,13/29,28.25%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RSF1;CENPN;RBBP4;CENPQ;RBBP7;CENPS
prerank,CENP-A containing chromatin organization (GO:0061641),0.1902927648980249,0.48846327916985527,0.9871589085072231,1.0,1.0,13/29,28.25%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RSF1;CENPN;RBBP4;CENPQ;RBBP7;CENPS
prerank,positive regulation of cell killing (GO:0031343),0.2235509102158047,0.4875012128151164,0.9728155339805825,1.0,1.0,2/13,16.72%,NOX1;WNT5A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.20761887521322253,0.4873120872380178,0.9876106194690265,1.0,1.0,9/19,32.13%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;PLK1;HSPA1A;CEP97
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.16036669988306715,-0.4861982537356776,0.9973958333333334,0.9977552822597571,1.0,12/38,28.94%,NDUFB11;NDUFB7;NDUFS6;NDUFB5;NDUFA11;NDUFS7;NDUFA6;NDUFB8;NDUFA13;NDUFA7;NDUFA8;NDUFB10
prerank,mitochondrial gene expression (GO:0140053),0.1754811270216504,0.4830213654587537,0.9983388704318937,1.0,1.0,11/42,23.25%,MRPS6;MRPL2;TWNK;MRPS7;FOXO3;GFM2;MRPS17;MRPL23;MRPS34;POLRMT;PTCD3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.20642957377597276,0.482175290660669,0.9876977152899824,1.0,1.0,1/18,3.95%,BID
prerank,regulation of mitotic spindle organization (GO:0060236),0.1812429596675656,0.47953483775919,0.9935379644588045,1.0,1.0,15/35,32.13%,CLTC;CHMP1A;CHMP4C;MAP9;CHMP2A;PARP3;EML3;FSD1;DRG1;RAE1;CHMP1B;NUMA1;PLK1;HSPA1A;CEP97
prerank,aerobic electron transport chain (GO:0019646),0.16000995880718127,0.479522355872828,0.9970588235294118,1.0,1.0,16/68,23.40%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;UQCRC1;NDUFS4;NDUFA2;COX15;NDUFS5;NDUFB2;NDUFA9;SDHD;UQCRH
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.19820248987248842,0.4790450145419794,0.9907407407407407,1.0,1.0,7/20,23.67%,APH1B;ADAM17;MBTPS1;NFKB1;NCSTN;ADAM9;PSEN2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.19095704139663267,-0.47774362850467883,0.9888143176733781,0.9983556018536092,1.0,5/16,28.02%,TIPIN;CDC45;DNA2;TOPBP1;HUS1B
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.22220812637284984,0.47617162688080356,0.9694072657743786,1.0,1.0,1/11,7.87%,SMARCA4
prerank,RNA catabolic process (GO:0006401),0.17129022922659037,0.4746948864299539,1.0,1.0,1.0,4/46,8.64%,SIDT2;EXOSC7;SND1;CNOT10
prerank,regulation of DNA metabolic process (GO:0051052),0.17430580749015107,0.47465287425366054,0.9949832775919732,1.0,1.0,10/44,23.38%,HDAC8;SMG1;WDR70;KAT7;MPHOSPH8;USP1;NBN;YLPM1;SMG6;NUCKS1
prerank,regulation of viral release from host cell (GO:1902186),0.19779284651503865,0.4739986952053458,0.9785714285714285,1.0,1.0,7/21,25.48%,TRIM62;PML;VPS4A;CHMP2A;TRIM5;TRIM8;TRIM13
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.15738480726571527,0.47243024788835547,0.9985250737463127,1.0,1.0,16/69,23.40%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;UQCRC1;NDUFS4;NDUFA2;COX15;NDUFS5;NDUFB2;NDUFA9;SDHD;UQCRH
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.18422186365968088,0.469917291578444,0.9948542024013722,1.0,1.0,6/29,17.39%,EXOSC7;DDX6;DCP1A;DIS3;NT5C3B;EXOSC3
prerank,ERAD pathway (GO:0036503),0.1543399140237085,0.4692316019080493,0.9985207100591716,1.0,1.0,26/83,27.31%,PRKN;ERLEC1;ECPAS;DNAJB2;AMFR;DNAJB14;SYVN1;ERLIN2;UFD1;NPLOC4;DNAJC18;UBE4B;UBE2J2;GET4;SELENOS;BAG6;DERL1;TOR1A;RNF5;FBXO17;USP19;UBXN4;TRIM13;TMEM67;ANKZF1;OS9
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.20694728958903358,0.46789664408583914,0.9855855855855856,1.0,1.0,4/16,22.82%,KIF5B;ULBP1;CEBPG;LYST
prerank,positive regulation of mitochondrial translation (GO:0070131),0.20733053221577555,0.4640396235230706,0.987012987012987,1.0,1.0,3/14,20.61%,MPV17L2;RPUSD4;FASTKD3
prerank,phospholipid homeostasis (GO:0055091),-0.1999861889947391,-0.45955087089561836,0.9915074309978769,0.9998875165387104,1.0,1/11,6.71%,ABCG1
prerank,regulation of T cell activation (GO:0050863),0.16817159548147032,0.4592358969170745,1.0,1.0,1.0,8/42,17.96%,PTPN22;CYRIB;ABL1;LAT;LGALS3;CCR2;GPNMB;LAX1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.22517638176545288,0.4588579627557589,0.9830827067669173,1.0,1.0,1/10,8.71%,CPEB3
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.192996523959439,0.45756342766938957,0.9843205574912892,1.0,1.0,6/19,23.30%,ACD;HNRNPC;TENT4B;TINF2;XRN1;PINX1
prerank,DNA geometric change (GO:0032392),-0.164881236693119,-0.45634872186310044,1.0,0.9995816332186841,1.0,6/24,24.89%,ANXA1;DHX9;DNA2;BLM;RECQL5;RECQL
prerank,cellular response to misfolded protein (GO:0071218),0.19075414233789548,0.4547148204337433,0.9946902654867257,1.0,1.0,7/20,24.24%,DNAJB14;UFD1;DNAJC18;BAG6;DERL1;TOR1A;RNF5
prerank,double-strand break repair via break-induced replication (GO:0000727),0.21078763120608057,0.45384475238417404,0.9791271347248577,1.0,1.0,3/12,21.68%,MCM7;MCM2;MCM5
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.21589429175742164,0.45373015231288416,0.9721189591078067,1.0,1.0,3/10,20.53%,IMPACT;HIF1AN;CITED2
prerank,cell cycle G1/S phase transition (GO:0044843),0.1563345864178199,0.4528685398443867,1.0,1.0,1.0,16/61,24.49%,CCNA2;CACUL1;CDC25A;CUL4A;NASP;ACVR1B;USP37;CCNE1;RB1;CDC34;CUL5;GSPT1;CDK6;CUL2;LATS1;DBF4
prerank,translational elongation (GO:0006414),0.14559051384151883,0.4524111651705317,1.0,1.0,1.0,25/101,26.29%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;NEMF;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPL50;LTN1;MRPS25;MRPL19;MRPL33;MRPS18B
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.18638718911676425,0.45135402757935505,0.9877622377622378,1.0,1.0,2/20,12.03%,ATM;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.18638718911676425,0.45135402757935505,0.9877622377622378,1.0,1.0,2/20,12.03%,ATM;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.18638718911676425,0.45135402757935505,0.9877622377622378,1.0,1.0,2/20,12.03%,ATM;IK
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18840400302874855,0.45108696629201356,0.9928571428571429,1.0,1.0,8/23,27.31%,SYVN1;UFD1;NPLOC4;SEC16A;SELENOS;DERL1;SEC13;OS9
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.19221972140135368,-0.44834595612302225,0.9958762886597938,0.9997107738265018,1.0,6/11,36.97%,CTNNB1;LRP6;LMX1A;WNT2;NR4A2;FZD1
prerank,macrophage migration (GO:1905517),0.20141529610851844,0.4465527950634613,0.9791271347248577,1.0,1.0,4/13,21.90%,LGALS3;CCR2;CXCL17;P2RX4
prerank,rRNA modification (GO:0000154),0.18202374222724688,0.4404525144158931,0.9907749077490775,1.0,1.0,21/21,81.82%,ZCCHC4;BUD23;NSUN4;MTERF4;METTL5;FBLL1;MRM2;TSR3;THUMPD1;NOP10;GAR1;TRMT112;FTSJ3;DIMT1;TFB2M;NAT10;NSUN3;DKC1;TFB1M;NHP2;FBL
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.16017569419305905,0.43806882747852244,1.0,1.0,1.0,15/42,28.69%,ARID2;FBH1;SMCHD1;PPP4R2;FUS;KDM1A;MMS19;FIGNL1;MAD2L2;SHLD2;UBQLN4;RTEL1;RAD51AP1;CHEK1;WRAP53
prerank,iron-sulfur cluster assembly (GO:0016226),0.17178126390053514,0.4305654255367894,0.9948364888123924,1.0,1.0,7/24,24.74%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,interstrand cross-link repair (GO:0036297),0.14779236150906083,0.43012753191835507,1.0,1.0,1.0,10/53,20.18%,RNF8;FANCI;FANCM;FANCA;USP1;XRCC3;SLX4;XPA;MCM9;FANCD2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.18455769976879824,0.4273175024238779,0.9925512104283054,1.0,1.0,6/17,27.31%,SYVN1;UFD1;NPLOC4;SELENOS;DERL1;OS9
prerank,aromatic amino acid family catabolic process (GO:0009074),0.18745955877173665,0.42587096036661226,0.9982332155477032,0.9999788412439623,1.0,14/15,60.53%,FAH;KMO;HAAO;KYAT1;GSTZ1;TAT;KYNU;HGD;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.172847412152355,0.42387612866241714,0.9965217391304347,0.9996869814700912,1.0,2/21,12.03%,ATM;IK
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.18518334516641016,-0.4214499466332274,1.0,0.9997547672816569,1.0,2/12,17.81%,CUL3;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.18518334516641016,-0.4214499466332274,1.0,0.9997547672816569,1.0,2/12,17.81%,CUL3;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.18518334516641016,-0.4214499466332274,1.0,0.9997547672816569,1.0,2/12,17.81%,CUL3;CDC23
prerank,RNA methylation (GO:0001510),0.14306291584049172,0.41595832272819044,1.0,0.9998766595568256,1.0,10/60,18.31%,TRMT44;RBM15;NOP2;METTL6;WTAP;ZCCHC4;VIRMA;LCMT2;BUD23;NSUN4
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1770144408654313,0.4153105230698762,0.9908424908424909,0.9994690008831952,1.0,4/18,19.53%,ROPN1L;CCDC39;CCDC40;OFD1
prerank,regulation of chromatin organization (GO:1902275),-0.16285786037167255,-0.3976239759379065,0.9978165938864629,1.0,1.0,14/14,83.73%,HPF1;MLLT3;SETD5;SSRP1;HNRNPU;IGF2;PARG;ALKBH4;MKI67;TLK1;CDK9;METTL4;SETD1A;TLK2
prerank,cranial nerve development (GO:0021545),0.18561581772905345,0.3972744484536004,1.0,1.0,1.0,1/11,6.96%,CHD7
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.18202289394906013,0.39267401083166487,0.994328922495274,0.9999783749494184,1.0,3/12,22.86%,CHAMP1;CENPC;MIS12
prerank,regulation of spindle organization (GO:0090224),-0.15277879846491005,-0.3871857690466517,1.0,0.9998551200846669,1.0,6/18,32.78%,GNAI1;BORA;TPX2;SENP6;PSRC1;DCTN1
prerank,multivesicular body organization (GO:0036257),0.14736633699751392,0.3770556233275396,1.0,1.0,1.0,10/31,26.14%,CHMP1A;VPS37A;VPS4A;SNF8;CHMP4C;CHMP2A;IST1;MVB12A;VTA1;STAM2
prerank,regulation of DNA recombination (GO:0000018),0.13166083207533652,0.3488161930704064,1.0,1.0,1.0,11/32,28.46%,MSH3;RAD50;PPP4R2;KDM1A;FIGNL1;H1-0;SHLD2;RTEL1;RAD51AP1;CHEK1;KPNA1
prerank,macrophage chemotaxis (GO:0048246),-0.15321365804669848,-0.3487080962916464,1.0,0.9998399249484184,1.0,10/10,84.69%,EDNRB;CCL2;CKLF;CCL3;CCL5;EDN2;SAA1;TAFA4;CXCL17;LGALS3
prerank,organophosphate catabolic process (GO:0046434),0.16291063006729345,0.34771472128540687,0.997946611909651,1.0,1.0,2/11,20.76%,ABHD12;PLBD2
prerank,regulation of spindle assembly (GO:0090169),0.12259230461624687,0.30638102565036274,1.0,0.9999548444929283,1.0,10/25,32.13%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;NUMA1;PLK1;HSPA1A;CEP97
